0001558370-22-008163.txt : 20220510 0001558370-22-008163.hdr.sgml : 20220510 20220510170629 ACCESSION NUMBER: 0001558370-22-008163 CONFORMED SUBMISSION TYPE: 10-Q PUBLIC DOCUMENT COUNT: 83 CONFORMED PERIOD OF REPORT: 20220331 FILED AS OF DATE: 20220510 DATE AS OF CHANGE: 20220510 FILER: COMPANY DATA: COMPANY CONFORMED NAME: InnovAge Holding Corp. CENTRAL INDEX KEY: 0001834376 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-HEALTH SERVICES [8000] IRS NUMBER: 810710819 STATE OF INCORPORATION: DE FISCAL YEAR END: 0630 FILING VALUES: FORM TYPE: 10-Q SEC ACT: 1934 Act SEC FILE NUMBER: 001-40159 FILM NUMBER: 22910895 BUSINESS ADDRESS: STREET 1: 8950 E. LOWRY BOULEVARD CITY: DENVER STATE: CO ZIP: 80230 BUSINESS PHONE: (303) 869-4664 MAIL ADDRESS: STREET 1: 8950 E. LOWRY BOULEVARD CITY: DENVER STATE: CO ZIP: 80230 FORMER COMPANY: FORMER CONFORMED NAME: TCO GROUP HOLDINGS, INC. DATE OF NAME CHANGE: 20201201 10-Q 1 tmb-20220331x10q.htm 10-Q
0001834376--06-302022Q3false1355165131355250061700000016900000P1Y450000000.3333000001834376innv:AdventistHealthSystemWestJointVentureMember2021-02-090001834376innv:Sh1Member2021-07-012022-03-310001834376innv:PwdMember2022-03-310001834376us-gaap:TreasuryStockMember2021-01-012021-03-310001834376us-gaap:TreasuryStockMember2020-07-012021-03-310001834376innv:EquityIncentivePlan2016Member2020-07-270001834376innv:ThirdAmendedAndRestatedCreditAgreementMember2020-07-272020-07-270001834376innv:TwoThousandSixteenIncentivePlanMemberinnv:OptionCancelationAgreementMember2020-07-272020-07-270001834376us-gaap:AdditionalPaidInCapitalMember2022-01-012022-03-310001834376us-gaap:AdditionalPaidInCapitalMember2021-07-012022-03-310001834376us-gaap:CommonStockMember2022-01-012022-03-310001834376us-gaap:CommonStockMember2021-07-012022-03-310001834376us-gaap:CommonStockMember2021-01-012021-03-310001834376us-gaap:CommonStockMember2020-07-012021-03-310001834376us-gaap:RetainedEarningsMember2022-03-310001834376us-gaap:NoncontrollingInterestMember2022-03-310001834376us-gaap:AdditionalPaidInCapitalMember2022-03-310001834376us-gaap:RetainedEarningsMember2021-12-310001834376us-gaap:NoncontrollingInterestMember2021-12-310001834376us-gaap:AdditionalPaidInCapitalMember2021-12-310001834376srt:ScenarioPreviouslyReportedMemberus-gaap:RetainedEarningsMember2021-06-300001834376srt:ScenarioPreviouslyReportedMemberus-gaap:NoncontrollingInterestMember2021-06-300001834376srt:RestatementAdjustmentMemberus-gaap:RetainedEarningsMember2021-06-300001834376srt:RestatementAdjustmentMemberus-gaap:NoncontrollingInterestMember2021-06-300001834376us-gaap:RetainedEarningsMember2021-06-300001834376us-gaap:NoncontrollingInterestMember2021-06-300001834376us-gaap:AdditionalPaidInCapitalMember2021-06-300001834376srt:ScenarioPreviouslyReportedMemberus-gaap:RetainedEarningsMember2021-03-310001834376srt:ScenarioPreviouslyReportedMemberus-gaap:NoncontrollingInterestMember2021-03-310001834376srt:RestatementAdjustmentMemberus-gaap:RetainedEarningsMember2021-03-310001834376srt:RestatementAdjustmentMemberus-gaap:NoncontrollingInterestMember2021-03-310001834376us-gaap:RetainedEarningsMember2021-03-310001834376us-gaap:NoncontrollingInterestMember2021-03-310001834376us-gaap:AdditionalPaidInCapitalMember2021-03-310001834376srt:ScenarioPreviouslyReportedMember2021-03-310001834376us-gaap:RetainedEarningsMember2020-12-310001834376us-gaap:NoncontrollingInterestMember2020-12-310001834376us-gaap:AdditionalPaidInCapitalMember2020-12-3100018343762020-12-310001834376us-gaap:RetainedEarningsMember2020-06-300001834376us-gaap:NoncontrollingInterestMember2020-06-300001834376us-gaap:AdditionalPaidInCapitalMember2020-06-300001834376us-gaap:CommonStockMember2022-03-310001834376us-gaap:CommonStockMember2021-12-310001834376us-gaap:CommonStockMember2021-06-300001834376us-gaap:CommonStockMember2021-03-310001834376us-gaap:TreasuryStockMember2020-12-310001834376us-gaap:CommonStockMember2020-12-310001834376us-gaap:TreasuryStockMember2020-06-300001834376us-gaap:CommonStockMember2020-06-300001834376innv:EquityIncentivePlan2016Member2021-07-012022-03-310001834376innv:EquityIncentivePlan2016Member2020-07-272020-07-270001834376innv:OmnibusIncentivePlan2021Member2022-03-310001834376innv:EquityIncentivePlan2020Member2022-03-310001834376innv:EquityIncentivePlan2016Member2022-03-310001834376srt:MinimumMemberinnv:TimeVestingAwardsMember2021-07-012022-03-310001834376innv:PerformanceBasedRestrictedStockUnitsMemberinnv:OmnibusIncentivePlan2021Member2022-03-310001834376innv:TimeBasedRestrictedStockUnitsMemberinnv:OmnibusIncentivePlan2021Member2021-06-300001834376innv:TimeVestingUnitsProfitInterestsMember2021-06-300001834376innv:PerformanceVestingUnitsProfitInterestsMember2021-06-300001834376innv:PerformanceBasedRestrictedStockUnitsMemberinnv:OmnibusIncentivePlan2021Member2021-07-012022-03-310001834376innv:EquityIncentivePlan2020Member2021-07-012022-03-310001834376innv:PerformanceVestingUnitsProfitInterestsMember2021-07-012022-03-310001834376innv:OmnibusIncentivePlan2021Member2021-07-012022-03-310001834376innv:OptionCancelationAgreementMember2020-07-272020-07-270001834376innv:TimeBasedOptionAwardMember2021-07-012022-03-310001834376us-gaap:OperatingSegmentsMemberinnv:OtherServiceRevenueMemberus-gaap:AllOtherSegmentsMember2022-01-012022-03-310001834376us-gaap:OperatingSegmentsMemberinnv:OtherServiceRevenueMemberinnv:ProgramOfAllInclusiveCareForElderlyOperatingSegmentsMember2022-01-012022-03-310001834376us-gaap:OperatingSegmentsMemberinnv:CapitationRevenueMemberinnv:ProgramOfAllInclusiveCareForElderlyOperatingSegmentsMember2022-01-012022-03-310001834376us-gaap:OperatingSegmentsMemberinnv:OtherServiceRevenueMember2022-01-012022-03-310001834376us-gaap:OperatingSegmentsMemberinnv:CapitationRevenueMember2022-01-012022-03-310001834376innv:OtherServiceRevenueMember2022-01-012022-03-310001834376innv:CapitationRevenueMember2022-01-012022-03-310001834376us-gaap:OperatingSegmentsMemberinnv:OtherServiceRevenueMemberus-gaap:AllOtherSegmentsMember2021-07-012022-03-310001834376us-gaap:OperatingSegmentsMemberinnv:OtherServiceRevenueMemberinnv:ProgramOfAllInclusiveCareForElderlyOperatingSegmentsMember2021-07-012022-03-310001834376us-gaap:OperatingSegmentsMemberinnv:CapitationRevenueMemberinnv:ProgramOfAllInclusiveCareForElderlyOperatingSegmentsMember2021-07-012022-03-310001834376us-gaap:OperatingSegmentsMemberinnv:OtherServiceRevenueMember2021-07-012022-03-310001834376us-gaap:OperatingSegmentsMemberinnv:CapitationRevenueMember2021-07-012022-03-310001834376innv:OtherServiceRevenueMember2021-07-012022-03-310001834376innv:CapitationRevenueMember2021-07-012022-03-310001834376us-gaap:OperatingSegmentsMemberinnv:OtherServiceRevenueMemberus-gaap:AllOtherSegmentsMember2021-01-012021-03-310001834376us-gaap:OperatingSegmentsMemberinnv:OtherServiceRevenueMemberinnv:ProgramOfAllInclusiveCareForElderlyOperatingSegmentsMember2021-01-012021-03-310001834376us-gaap:OperatingSegmentsMemberinnv:CapitationRevenueMemberinnv:ProgramOfAllInclusiveCareForElderlyOperatingSegmentsMember2021-01-012021-03-310001834376us-gaap:OperatingSegmentsMemberinnv:OtherServiceRevenueMember2021-01-012021-03-310001834376us-gaap:OperatingSegmentsMemberinnv:CapitationRevenueMember2021-01-012021-03-310001834376innv:OtherServiceRevenueMember2021-01-012021-03-310001834376innv:CapitationRevenueMember2021-01-012021-03-310001834376us-gaap:OperatingSegmentsMemberinnv:OtherServiceRevenueMemberus-gaap:AllOtherSegmentsMember2020-07-012021-03-310001834376us-gaap:OperatingSegmentsMemberinnv:OtherServiceRevenueMemberinnv:ProgramOfAllInclusiveCareForElderlyOperatingSegmentsMember2020-07-012021-03-310001834376us-gaap:OperatingSegmentsMemberinnv:CapitationRevenueMemberinnv:ProgramOfAllInclusiveCareForElderlyOperatingSegmentsMember2020-07-012021-03-310001834376us-gaap:OperatingSegmentsMemberinnv:OtherServiceRevenueMember2020-07-012021-03-310001834376us-gaap:OperatingSegmentsMemberinnv:CapitationRevenueMember2020-07-012021-03-310001834376innv:OtherServiceRevenueMember2020-07-012021-03-310001834376innv:CapitationRevenueMember2020-07-012021-03-3100018343762021-12-310001834376srt:RestatementAdjustmentMember2021-03-310001834376srt:MinimumMemberus-gaap:SoftwareAndSoftwareDevelopmentCostsMember2021-07-012022-03-310001834376srt:MinimumMemberinnv:EquipmentAndVehiclesMember2021-07-012022-03-310001834376srt:MinimumMemberinnv:BuildingAndLeaseholdImprovementsMember2021-07-012022-03-310001834376srt:MaximumMemberus-gaap:SoftwareAndSoftwareDevelopmentCostsMember2021-07-012022-03-310001834376srt:MaximumMemberinnv:EquipmentAndVehiclesMember2021-07-012022-03-310001834376srt:MaximumMemberinnv:BuildingAndLeaseholdImprovementsMember2021-07-012022-03-310001834376us-gaap:SoftwareAndSoftwareDevelopmentCostsMember2022-03-310001834376us-gaap:LandMember2022-03-310001834376us-gaap:ConstructionInProgressMember2022-03-310001834376innv:EquipmentAndVehiclesMember2022-03-310001834376innv:BuildingAndLeaseholdImprovementsMember2022-03-310001834376us-gaap:SoftwareAndSoftwareDevelopmentCostsMember2021-06-300001834376us-gaap:LandMember2021-06-300001834376us-gaap:ConstructionInProgressMember2021-06-300001834376innv:EquipmentAndVehiclesMember2021-06-300001834376innv:BuildingAndLeaseholdImprovementsMember2021-06-300001834376us-gaap:VariableInterestEntityNotPrimaryBeneficiaryMember2021-01-012021-03-310001834376us-gaap:VariableInterestEntityNotPrimaryBeneficiaryMemberinnv:EskatonMember2019-03-182019-03-180001834376us-gaap:VariableInterestEntityNotPrimaryBeneficiaryMemberinnv:AdventistHealthSystemWestJointVentureMember2019-03-182019-03-180001834376innv:JetdocInc.Member2021-08-012021-08-310001834376us-gaap:GeneralAndAdministrativeExpenseMember2020-07-012021-03-310001834376us-gaap:NoncontrollingInterestMember2022-01-012022-03-310001834376us-gaap:NoncontrollingInterestMember2021-07-012022-03-310001834376srt:ScenarioPreviouslyReportedMemberus-gaap:RetainedEarningsMember2021-01-012021-03-310001834376us-gaap:NoncontrollingInterestMember2021-01-012021-03-310001834376srt:ScenarioPreviouslyReportedMemberus-gaap:RetainedEarningsMember2020-07-012021-03-310001834376us-gaap:NoncontrollingInterestMember2020-07-012021-03-310001834376innv:InnovageSacramentoMember2020-07-012020-12-310001834376srt:ScenarioPreviouslyReportedMember2021-06-300001834376srt:RestatementAdjustmentMember2021-06-300001834376us-gaap:ServiceOtherMember2022-03-310001834376us-gaap:ServiceOtherMember2021-06-300001834376us-gaap:RevolvingCreditFacilityMemberinnv:CreditAgreement2021CreditFacilityMember2021-03-082021-03-080001834376us-gaap:VariableInterestEntityNotPrimaryBeneficiaryMemberinnv:InnovageSacramentoMemberinnv:EskatonMember2019-03-182019-03-180001834376us-gaap:VariableInterestEntityNotPrimaryBeneficiaryMemberinnv:InnovageSacramentoMemberinnv:AdventistHealthSystemWestJointVentureMember2019-03-182019-03-180001834376innv:InnovageSacramentoMember2019-03-182019-03-180001834376innv:InnovageSacramentoMember2022-01-012022-03-3100018343762021-02-092021-02-090001834376us-gaap:PerformanceSharesMember2022-03-310001834376innv:TimeVestingAwardsMember2022-03-310001834376innv:TimeBasedRestrictedStockUnitsMemberinnv:OmnibusIncentivePlan2021Member2022-03-310001834376innv:TimeVestingUnitsProfitInterestsMember2022-03-310001834376innv:ProfitsInterestsUnitsMember2022-03-310001834376innv:PerformanceVestingUnitsProfitInterestsMember2022-03-310001834376innv:PerformanceBasedRestrictedStockUnitsMember2022-03-310001834376us-gaap:PerformanceSharesMember2021-07-012022-03-310001834376innv:TimeVestingUnitsProfitInterestsMember2021-07-012022-03-310001834376us-gaap:ConvertibleDebtMember2015-09-012015-09-010001834376innv:CreditAgreement2021CreditFacilityMemberus-gaap:SeniorLoansMember2022-03-310001834376us-gaap:RevolvingCreditFacilityMemberinnv:CreditAgreement2021CreditFacilityMember2021-03-080001834376innv:CreditAgreement2021CreditFacilityMemberus-gaap:SeniorLoansMember2021-03-080001834376us-gaap:RevolvingCreditFacilityMemberinnv:CreditAgreement2016CreditFacilityMember2020-07-270001834376innv:CreditAgreement2016CreditFacilityMemberus-gaap:SeniorLoansMember2020-07-270001834376us-gaap:RevolvingCreditFacilityMemberinnv:CreditAgreement2016CreditFacilityMember2019-05-020001834376innv:CreditAgreement2016CreditFacilityMemberus-gaap:SeniorLoansMember2019-05-020001834376innv:CreditAgreement2016CreditFacilityMemberinnv:DelayedDrawTermLoanFacilityMember2019-05-020001834376us-gaap:RevolvingCreditFacilityMemberinnv:CreditAgreement2016CreditFacilityMember2016-05-130001834376innv:CreditAgreement2016CreditFacilityMemberus-gaap:SeniorLoansMember2016-05-130001834376us-gaap:RevolvingCreditFacilityMemberinnv:CreditAgreement2021CreditFacilityMember2022-03-310001834376us-gaap:SeniorLoansMember2022-03-310001834376us-gaap:ConvertibleDebtMember2022-03-310001834376us-gaap:SeniorLoansMember2021-06-300001834376us-gaap:ConvertibleDebtMember2021-06-300001834376us-gaap:OperatingSegmentsMemberus-gaap:AllOtherSegmentsMember2022-01-012022-03-310001834376us-gaap:OperatingSegmentsMemberus-gaap:AllOtherSegmentsMember2021-07-012022-03-310001834376us-gaap:OperatingSegmentsMemberus-gaap:AllOtherSegmentsMember2021-01-012021-03-310001834376us-gaap:OperatingSegmentsMemberus-gaap:AllOtherSegmentsMember2020-07-012021-03-310001834376innv:SeniorHousingMemberinnv:OtherServiceRevenueMemberus-gaap:CustomerConcentrationRiskMember2022-01-012022-03-310001834376innv:SeniorHousingMemberinnv:OtherServiceRevenueMemberus-gaap:CustomerConcentrationRiskMember2021-07-012022-03-310001834376innv:PrivatePayAndOtherCustomerMemberus-gaap:RevenueFromContractWithCustomerMemberus-gaap:CustomerConcentrationRiskMember2021-07-012022-03-310001834376innv:PrivatePayAndOtherCustomerMemberus-gaap:AccountsReceivableMemberus-gaap:CustomerConcentrationRiskMember2021-07-012022-03-310001834376innv:MedicarePartDMemberus-gaap:RevenueFromContractWithCustomerMemberus-gaap:CustomerConcentrationRiskMember2021-07-012022-03-310001834376innv:MedicarePartDMemberus-gaap:CostOfGoodsProductLineMemberus-gaap:CustomerConcentrationRiskMember2021-07-012022-03-310001834376innv:MedicareCustomerMemberus-gaap:RevenueFromContractWithCustomerMemberus-gaap:CustomerConcentrationRiskMember2021-07-012022-03-310001834376innv:MedicareCustomerMemberus-gaap:AccountsReceivableMemberus-gaap:CustomerConcentrationRiskMember2021-07-012022-03-310001834376innv:MedicaidCustomerMemberus-gaap:RevenueFromContractWithCustomerMemberus-gaap:CustomerConcentrationRiskMember2021-07-012022-03-310001834376innv:MedicaidCustomerMemberus-gaap:AccountsReceivableMemberus-gaap:CustomerConcentrationRiskMember2021-07-012022-03-310001834376us-gaap:RevenueFromContractWithCustomerMemberus-gaap:CustomerConcentrationRiskMember2021-07-012022-03-310001834376us-gaap:AccountsReceivableMemberus-gaap:CustomerConcentrationRiskMember2021-07-012022-03-310001834376innv:SeniorHousingMemberinnv:OtherServiceRevenueMemberus-gaap:CustomerConcentrationRiskMember2021-01-012021-03-310001834376innv:PrivatePayAndOtherCustomerMemberus-gaap:AccountsReceivableMemberus-gaap:CustomerConcentrationRiskMember2020-07-012021-06-300001834376innv:MedicareCustomerMemberus-gaap:AccountsReceivableMemberus-gaap:CustomerConcentrationRiskMember2020-07-012021-06-300001834376innv:MedicaidCustomerMemberus-gaap:AccountsReceivableMemberus-gaap:CustomerConcentrationRiskMember2020-07-012021-06-300001834376us-gaap:AccountsReceivableMemberus-gaap:CustomerConcentrationRiskMember2020-07-012021-06-300001834376innv:SeniorHousingMemberinnv:OtherServiceRevenueMemberus-gaap:CustomerConcentrationRiskMember2020-07-012021-03-310001834376innv:PrivatePayAndOtherCustomerMemberus-gaap:RevenueFromContractWithCustomerMemberus-gaap:CustomerConcentrationRiskMember2020-07-012021-03-310001834376innv:MedicarePartDMemberus-gaap:RevenueFromContractWithCustomerMemberus-gaap:CustomerConcentrationRiskMember2020-07-012021-03-310001834376innv:MedicarePartDMemberus-gaap:CostOfGoodsProductLineMemberus-gaap:CustomerConcentrationRiskMember2020-07-012021-03-310001834376innv:MedicareCustomerMemberus-gaap:RevenueFromContractWithCustomerMemberus-gaap:CustomerConcentrationRiskMember2020-07-012021-03-310001834376innv:MedicaidCustomerMemberus-gaap:RevenueFromContractWithCustomerMemberus-gaap:CustomerConcentrationRiskMember2020-07-012021-03-310001834376us-gaap:RevenueFromContractWithCustomerMemberus-gaap:CustomerConcentrationRiskMember2020-07-012021-03-310001834376innv:AdventistHealthSystemWestJointVentureMember2019-03-1800018343762021-03-3100018343762020-06-3000018343762019-03-180001834376srt:MaximumMemberinnv:NewcourtlandLifeProgramMember2018-08-0700018343762018-08-070001834376innv:NewcourtlandLifeProgramMember2018-08-072018-08-070001834376innv:InnovageSacramentoMember2021-03-310001834376innv:InnovageSacramentoMember2021-02-090001834376us-gaap:RevolvingCreditFacilityMemberinnv:CreditAgreement2021CreditFacilityMember2021-07-012022-03-310001834376innv:CreditAgreement2016CreditFacilityMember2020-07-012021-03-310001834376us-gaap:RestrictedStockUnitsRSUMember2021-07-012022-03-310001834376us-gaap:EmployeeStockOptionMember2021-07-012022-03-310001834376innv:ProfitsInterestsUnitsMember2021-07-012022-03-310001834376us-gaap:EmployeeStockOptionMember2020-07-012021-03-310001834376innv:ProfitsInterestsUnitsMember2020-07-012021-03-310001834376innv:OptionCancelationAgreementMember2020-07-270001834376innv:EquipmentUnderCapitalLeaseMember2022-03-310001834376innv:EquipmentUnderCapitalLeaseMember2021-06-300001834376innv:TimeVestingAwardsMember2021-07-012022-03-310001834376innv:PerformanceBasedRestrictedStockUnitsMember2021-07-012022-03-310001834376innv:TimeBasedRestrictedStockUnitsMemberinnv:OmnibusIncentivePlan2021Member2021-07-012022-03-3100018343762020-07-012021-06-3000018343762019-07-012020-06-300001834376innv:AdventistHealthSystemWestJointVentureMember2019-03-182019-03-180001834376innv:ProgramOfAllInclusiveCareForElderlyOperatingSegmentsMember2021-07-012022-03-310001834376us-gaap:RevolvingCreditFacilityMember2022-03-310001834376us-gaap:OperatingSegmentsMemberinnv:ProgramOfAllInclusiveCareForElderlyOperatingSegmentsMember2022-01-012022-03-310001834376us-gaap:OperatingSegmentsMember2022-01-012022-03-310001834376us-gaap:OperatingSegmentsMemberinnv:ProgramOfAllInclusiveCareForElderlyOperatingSegmentsMember2021-07-012022-03-310001834376us-gaap:OperatingSegmentsMember2021-07-012022-03-310001834376us-gaap:OperatingSegmentsMemberinnv:ProgramOfAllInclusiveCareForElderlyOperatingSegmentsMember2021-01-012021-03-310001834376us-gaap:OperatingSegmentsMember2021-01-012021-03-310001834376us-gaap:OperatingSegmentsMemberinnv:ProgramOfAllInclusiveCareForElderlyOperatingSegmentsMember2020-07-012021-03-310001834376us-gaap:OperatingSegmentsMember2020-07-012021-03-310001834376innv:CreditAgreement2021CreditFacilityMemberus-gaap:SeniorLoansMember2021-03-082021-03-080001834376innv:CreditAgreement2016CreditFacilityMember2022-03-310001834376innv:CreditAgreement2016CreditFacilityMemberinnv:DelayedDrawTermLoanFacilityMember2020-07-272020-07-270001834376innv:JetdocInc.Member2021-08-3100018343762021-06-300001834376innv:DispatchhealthHoldingsIncMember2019-12-310001834376srt:ScenarioPreviouslyReportedMemberus-gaap:NoncontrollingInterestMember2021-01-012021-03-310001834376srt:RestatementAdjustmentMemberus-gaap:NoncontrollingInterestMember2021-01-012021-03-310001834376srt:ScenarioPreviouslyReportedMember2021-01-012021-03-310001834376srt:ScenarioPreviouslyReportedMemberus-gaap:NoncontrollingInterestMember2020-07-012021-03-310001834376srt:RestatementAdjustmentMemberus-gaap:NoncontrollingInterestMember2020-07-012021-03-310001834376srt:ScenarioPreviouslyReportedMember2020-07-012021-03-310001834376innv:AdventistHealthSystemWestJointVentureMember2021-02-092021-02-0900018343762022-03-3100018343762021-03-082021-03-080001834376us-gaap:RetainedEarningsMember2022-01-012022-03-3100018343762022-01-012022-03-310001834376us-gaap:RetainedEarningsMember2021-07-012022-03-310001834376srt:RestatementAdjustmentMemberus-gaap:RetainedEarningsMember2021-01-012021-03-310001834376us-gaap:RetainedEarningsMember2021-01-012021-03-310001834376srt:RestatementAdjustmentMember2021-01-012021-03-310001834376srt:RestatementAdjustmentMemberus-gaap:RetainedEarningsMember2020-07-012021-03-310001834376us-gaap:RetainedEarningsMember2020-07-012021-03-310001834376srt:RestatementAdjustmentMember2020-07-012021-03-310001834376us-gaap:AdditionalPaidInCapitalMember2021-01-012021-03-3100018343762021-01-012021-03-310001834376us-gaap:AdditionalPaidInCapitalMember2020-07-012021-03-3100018343762020-07-012021-03-3100018343762022-05-0900018343762021-07-012022-03-31xbrli:sharesiso4217:USDxbrli:pureinnv:Centerinnv:divisioninnv:itemiso4217:USDxbrli:sharesinnv:segment

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 10-Q

(Mark One)

QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES

EXCHANGE ACT OF 1934

For the quarterly period ended March 31, 2022

or

TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES

EXCHANGE ACT OF 1934

For the transition period from to  

Commission File Number: 001-40159

Graphic

InnovAge Holding Corp.

(Exact name of registrant as specified in its charter)

Delaware

81-0710819

(State or Other Jurisdiction of

Incorporation or Organization)

(I.R.S. Employer

Identification Number)

8950 E. Lowry Boulevard

Denver, CO

(Address of Principal Executive Offices)

80230

(Zip Code)

(844) 803-8745

(Registrant’s telephone number, including area code)

Securities registered pursuant to Section 12(b) of the Securities Act:

Title of each class

Trading Symbol(s)

Name of each exchange on which registered

Common Stock, $0.001 par value

INNV

The Nasdaq Stock Market LLC (Nasdaq Global Select Market)

Indicate by check mark whether the registrant: (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.  Yes  No

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).  Yes  No  

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.

Large accelerated filer

Accelerated filer

Non-accelerated filer

Smaller reporting company

Emerging growth company

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).  Yes  No

As of May 9, 2022, there were 135,525,006 of the registrant’s common stock outstanding.

TABLE OF CONTENTS

Page

Part I

Financial Information

Item 1.

Financial Statements (Unaudited)

5

Condensed Consolidated Balance Sheets as of March 31, 2022 (Unaudited) and June 30, 2021

5

Condensed Consolidated Statements of Operations for the three and nine months ended March 31, 2022 and 2021 (Unaudited)

6

Condensed Consolidated Statements of Stockholders’ Equity for the three and nine months ended March 31, 2022 and 2021 (Unaudited)

7

Condensed Consolidated Statements of Cash Flows for the nine months ended March 31, 2022 and 2021 (Unaudited)

9

Notes to Condensed Consolidated Financial Statements as of March 31, 2022 (Unaudited)

10

Item 2.

Management’s Discussion and Analysis of Financial Condition and Results of Operations

32

Item 3.

Quantitative and Qualitative Disclosures About Market Risk

46

Item 4.

Controls and Procedures

46

Part II

Other Information

47

Item 1.

Legal Proceedings

47

Item 1A.

Risk Factors

47

Item 2.

Unregistered Sales of Equity Securities and Use of Proceeds

51

Item 3.

Defaults Upon Senior Securities

51

Item 4.

Mine Safety Disclosures

51

Item 5.

Other Information

51

Item 6.

Exhibits

51

Exhibit Index

52

Signatures

53

2

InnovAge Holding Corp. and Subsidiaries

Quarterly Report on Form 10-Q

For the quarterly period ended March 31, 2022

Cautionary Note on Forward-Looking Statements

Throughout this Quarterly Report on Form 10-Q, we make “forward-looking statements” within the meaning of the U.S. Private Securities Litigation Reform Act of 1995. Forward-looking statements describe future expectations, plans, results or strategies and can often be identified by the use of terminology such as “may,” “will,” “estimate,” “intend,” “plan,” “continue,” “believe,” “expect,” “anticipate,” “target,” “should,” “could,” “potential,” “opportunity,” “goal” or similar terminology. Forward-looking statements may be identified by the fact that they do not relate strictly to historical or current facts and may include statements about our expectations with respect to current audits and legal proceedings and actions, relationships and discussions with regulatory agencies, our expectations with respect to correcting deficiencies raised in audits and other processes, and our expectations to increase the number of participants we serve, to grow enrollment and capacity within existing centers, to build de novo centers, and other similar statements. The forward-looking statements contained in this Quarterly Report on Form 10-Q are generally located in the material set forth under the heading “Management’s Discussion and Analysis of Financial Condition and Results of Operations,” included in Part I, Item 2, and “Risk Factors,” included in Part II, Item 1A, but may be found in other locations as well. These statements are based upon management’s current expectations, assumptions and estimates and are not guarantees of timing, future results or performance. Therefore, you should not rely on any of these forward-looking statements as predictions of future events. Actual results may differ materially from those contemplated in these statements due to a variety of risks and uncertainties and other factors, including, among other things:

the results of periodic inspections, reviews and audits under the federal and state government programs, including the ongoing audits of our Albuquerque, New Mexico center and San Bernadino, California center, the sanctions currently in place on our centers in Colorado and in our Sacramento center in California and our ability to sufficiently cure any deficiencies identified by the respective federal and state government programs;
the results of regulatory processes and voluntary actions relating to planned de novo centers;
the impact on our business of security breaches, loss of data or other disruptions causing the compromise of sensitive information or preventing us from accessing critical information;
our ability to develop and maintain proper and effective internal control over financial reporting;
the impact on our business of disruptions in our disaster recovery systems or management continuity planning;
the impact of any restrictions on our use of or ability to license data or our failure to license data and integrate third-party technologies;
our ability to attract and retain highly qualified personnel;
our management team’s limited experience managing a public company and recent Chief Executive Officer succession;
the impact on our business of the termination of our leases, increases in rent or inability to renew or extend leases;
the impact of failures by our suppliers, material price increases on supplies, lack of reimbursement for drugs we purchase or limitations on our ability to access new technology or products;
our ability to maintain our corporate culture;
the impact of competition for physicians and nurses, shortages of qualified personnel and related increases in our labor costs;
our ability to attract and retain the services of key primary care physicians;
the risk that our submissions to health plans may contain inaccurate or unsupportable information regarding risk adjustment scores of members;
our ability to accurately estimate incurred but not reported medical expense;
the impact of negative publicity regarding the managed healthcare industry;
the impact of state and federal efforts to reduce Medicaid spending;
the impact on our centers of adverse weather conditions and other factors beyond our control;

3

general macro-economic and geopolitical events, including the heightened inflation, increase in interest rates and the war in Ukraine; and
other factors disclosed in the section entitled “Risk Factors” in our Annual Report for the year ended June 30, 2021 filed with the Securities and Exchange Commission (the “SEC”) on September 22, 2021 as well as in this Quarterly Report on Form 10-Q.

We derive many of our forward-looking statements from our operating budgets and forecasts, which are based on many detailed assumptions. While we believe that our assumptions are reasonable, we caution that it is very difficult to predict the impact of known factors, and it is impossible for us to anticipate all factors that could affect our actual results. All written and oral forward-looking statements attributable to us, or persons acting on our behalf, are expressly qualified in their entirety by these cautionary statements as well as other cautionary statements that are made from time to time in our other public communications and filings with the SEC. You should evaluate all forward-looking statements made in this Quarterly Report on Form 10-Q in the context of these risks and uncertainties.

We caution you that the important factors referenced above may not contain all of the factors that are important to you. In addition, we cannot assure you that we will realize the results or developments we expect or anticipate or, even if substantially realized, that they will result in the consequences or affect us or our operations in the way we expect. The forward-looking statements included in this Quarterly Report on Form 10-Q are made only as of the date hereof. We undertake no obligation to update or revise any forward-looking statement as a result of new information, future events or otherwise, except as otherwise required by law. Unless otherwise specified or unless the context requires otherwise, all references in this Quarterly Report on Form 10-Q to “InnovAge,” “the Company,” “we,” “us,” and “our,” or similar references, refer to InnovAge Holding Corp. and our consolidated subsidiaries.

4

PART I —FINANCIAL INFORMATION

Item 1. Financial Statements

INNOVAGE HOLDING CORP. AND SUBSIDIARIES

Condensed Consolidated Balance Sheets

(In thousands, except per share data)

(Unaudited)

    

March 31, 

    

June 30, 

2022

2021

Assets

Current Assets

 

  

 

  

Cash and cash equivalents

$

199,493

$

201,466

Restricted cash

 

18

 

2,234

Accounts receivable, net of allowance ($3,921 – March 31, 2022 and $4,350 – June 30, 2021)

 

31,905

 

32,582

Prepaid expenses and other

 

13,572

 

9,249

Income tax receivable

 

5,461

 

5,401

Total current assets

 

250,449

 

250,932

Noncurrent Assets

 

  

 

  

Property and equipment, net

 

163,882

 

142,715

Investments

 

5,493

 

3,493

Deposits and other

 

5,378

 

3,877

Goodwill

 

124,217

 

124,217

Intangible assets, net

 

8,772

 

6,518

Total noncurrent assets

 

307,742

 

280,820

Total assets

$

558,191

$

531,752

Liabilities and Stockholders' Equity

 

  

 

  

Current Liabilities

 

  

 

  

Accounts payable and accrued expenses

$

41,834

$

32,361

Reported and estimated claims

 

36,012

 

33,234

Due to Medicaid and Medicare

9,530

7,101

Current portion of long-term debt

 

3,793

 

3,790

Current portion of capital lease obligations

 

3,216

 

2,079

Total current liabilities

 

94,385

 

78,565

Noncurrent Liabilities

 

  

 

  

Deferred tax liability, net

 

15,781

 

15,700

Capital lease obligations

 

10,282

 

5,190

Other noncurrent liabilities

 

2,570

 

2,758

Long-term debt, net of debt issuance costs

 

69,051

 

71,574

Total liabilities

 

192,069

 

173,787

Commitments and Contingencies (See Note 9)

 

  

 

  

Redeemable Noncontrolling Interests (See Note 4)

15,996

16,986

Stockholders’ Equity

 

  

 

  

Common stock, $0.001 par value; 500,000,000 authorized as of March 31, 2022 and June 30, 2021; 135,525,006 and 135,516,513 shares issued and outstanding as of March 31, 2022 and June 30, 2021, respectively

 

136

 

136

Additional paid-in capital

 

326,346

 

323,760

Retained earnings

 

17,437

 

10,663

Total InnovAge Holding Corp.

 

343,919

 

334,559

Noncontrolling interests

 

6,207

 

6,420

Total stockholders’ equity

 

350,126

 

340,979

Total liabilities and stockholders’ equity

$

558,191

$

531,752

The accompanying notes are an integral part of these condensed consolidated financial statements.

5

INNOVAGE HOLDING CORP. AND SUBSIDIARIES

Condensed Consolidated Statements of Operations

(In thousands, except number of shares and per share data)

(Unaudited)

Three Months Ended March 31, 

Nine Months Ended March 31, 

2022

    

2021

2022

    

2021

Revenues

  

 

  

  

 

  

 

Capitation revenue

$

176,988

$

155,835

$

524,507

$

464,294

Other service revenue

 

371

 

473

 

1,273

 

1,890

Total revenues

 

177,359

 

156,308

 

525,780

 

466,184

Expenses

 

  

 

  

 

  

 

  

External provider costs

 

103,254

 

75,389

 

284,299

 

224,215

Cost of care, excluding depreciation and amortization

 

46,102

 

39,565

 

129,740

 

115,922

Sales and marketing

 

6,144

 

5,592

 

19,117

 

14,335

Corporate, general and administrative

 

24,682

 

18,595

 

74,248

 

105,901

Depreciation and amortization

 

3,850

 

3,311

 

10,435

 

9,262

Equity loss

 

 

 

 

1,343

Other operating income

 

 

19,222

 

 

18,211

Total expenses

 

184,032

 

161,674

 

517,839

 

489,189

Operating Income (Loss)

 

(6,673)

 

(5,366)

 

7,941

 

(23,005)

Other Income (Expense)

 

  

 

  

 

  

 

  

Interest expense, net

 

(709)

 

(4,876)

 

(1,930)

 

(17,061)

Loss on extinguishment of debt

 

(13,488)

 

(14,479)

Gain on equity method investment

10,871

10,871

Other income (expense)

 

108

 

(2,267)

 

(358)

 

(2,222)

Total other expense

 

(601)

 

(9,760)

 

(2,288)

 

(22,891)

Income (Loss) Before Income Taxes

 

(7,274)

 

(15,126)

 

5,653

 

(45,896)

Provision (Benefit) for Income Taxes

 

(4,116)

 

(4,264)

 

81

 

5,159

Net Income (Loss)

 

(3,158)

 

(10,862)

 

5,572

 

(51,055)

Less: net loss attributable to noncontrolling interests

 

(337)

 

(352)

 

(616)

 

(595)

Net Income (Loss) Attributable to InnovAge Holding Corp.

$

(2,821)

$

(10,510)

$

6,188

$

(50,460)

Weighted-average number of common shares outstanding - basic

 

135,516,608

 

121,324,980

 

135,516,544

 

119,619,806

Weighted-average number of common shares outstanding - diluted

 

135,516,608

 

121,324,980

 

135,530,793

 

119,619,806

Net income (loss) per share - basic

$

(0.02)

$

(0.09)

$

0.05

$

(0.42)

Net income (loss) per share - diluted

$

(0.02)

$

(0.09)

$

0.05

$

(0.42)

The accompanying notes are an integral part of these condensed consolidated financial statements.

6

INNOVAGE HOLDING CORP. AND SUBSIDIARIES

Condensed Consolidated Statements of Stockholders’ Equity

(In thousands, except per share data)

(Unaudited)

For the Three Months Ended March 31, 2022

    

    

    

    

    

    

    

    

Total

    

Redeemable

    

Additional

Retained

Permanent

Noncontrolling

Capital Stock

Paid-in

Earnings

Treasury Stock

Noncontrolling

Stockholders'

Interests

Shares

Amount

Capital

(Deficit)

Shares

Amount

Interests

Equity

(Temporary Equity)

Net Income (Loss)

Balances, December 31, 2021

 

135,516,513

 

136

 

325,501

 

17,695

 

-

 

-

 

6,254

 

349,586

 

18,850

 

Stock-based compensation

8,493

-

845

-

-

-

-

845

-

Net income (loss)

-

-

-

(2,821)

-

-

(47)

(2,868)

(290)

(3,158)

Adjustment to redemption value

 

-

 

-

 

-

 

2,563

 

-

 

-

 

-

 

2,563

 

(2,563)

Balances, March 31, 2022

 

135,525,006

$

136

$

326,346

$

17,437

 

-

$

-

$

6,207

$

350,126

$

15,996

For the Nine Months Ended March 31, 2022

Total

    

Redeemable

Additional

Retained

Permanent

Noncontrolling

Capital Stock

Paid-in

Earnings

Treasury Stock

Noncontrolling

Stockholders'

Interests

Shares

Amount

Capital

(Deficit)

Shares

Amount

Interests

Equity

(Temporary Equity)

Net Income (Loss)

Balances, June 30, 2021

 

135,516,513

 

136

 

323,760

 

10,663

 

-

 

-

 

6,420

 

340,979

 

16,986

 

Stock-based compensation

8,493

-

2,586

-

-

-

-

2,586

-

Net income (loss)

-

-

-

6,188

(213)

5,975

(403)

$

5,572

Adjustment to redemption value

 

-

 

-

 

-

 

586

 

-

 

-

 

-

 

586

 

(586)

Balances, March 31, 2022

 

135,525,006

$

136

$

326,346

$

17,437

 

-

$

-

$

6,207

$

350,126

$

15,996

7

    

For the Three Months Ended March 31, 2021

  

  

  

  

  

  

Total

 

Redeemable

Additional

Permanent

Noncontrolling

Capital Stock

Paid-in

Retained

Treasury Stock

Noncontrolling

Stockholders'

 

Interests

Net Income

    

Shares

    

Amount

    

Capital

    

Earnings

    

Shares

    

Amount

    

Interests

    

Equity

 

(Temporary Equity)

(Loss)

Balances, December 31, 2020

 

132,718,461

$

133

$

24,552

$

15,330

 

16,197,849

$

(77,796)

$

6,492

$

(31,289)

$

-

$

Treasury stock retirement

 

(16,197,849)

 

(16)

 

(77,780)

 

 

(16,197,849)

 

77,796

 

 

-

Stock-based compensation

 

 

 

530

 

 

 

 

 

530

-

Reclassification of warrant liability

2,264

2,264

-

Initial public offering of common stock, net of offering costs of $25,334

18,995,901

19

373,561

373,580

-

Consolidation of equity method investment

 

 

 

 

 

 

 

 

16,838

Adjustment to redemption value

(344)

(344)

 

344

Net income (loss)

 

 

 

 

(10,510)

 

 

 

(89)

 

(10,599)

(263)

$

(10,862)

Balances, March 31, 2021

 

135,516,513

$

136

$

323,127

$

4,476

 

$

$

6,403

$

334,142

$

16,919

    

For the Nine Months Ended March 31, 2021

  

  

  

  

  

  

Total

 

Redeemable

Additional

Permanent

Noncontrolling

Capital Stock

Paid-in

Retained

Treasury Stock

Noncontrolling

Stockholders'

 

Interests

Net Income

    

Shares

    

Amount

    

Capital

    

Earnings

    

Shares

    

Amount

    

Interests

    

Equity

 

(Temporary Equity)

(Loss)

Balances, June 30, 2020

 

132,718,461

$

133

$

36,338

$

64,737

 

102,030

$

(193)

$

6,735

$

107,750

$

-

$

Treasury stock transaction

 

 

 

 

 

16,095,819

 

(77,603)

 

 

(77,603)

-

Treasury stock retirement

(16,197,849)

(16)

(77,780)

(16,197,849)

77,796

-

Stock option cancellation

 

 

 

 

(9,457)

 

 

 

 

(9,457)

-

Time based awards- option cancelation

 

 

 

(32,358)

 

 

 

 

 

(32,358)

-

Stock-based compensation

 

 

 

1,102

 

 

 

 

 

1,102

-

Reclassification of warrant liability

2,264

2,264

-

Capital contribution

20,000

20,000

-

Initial public offering of common stock, net of offering costs of $25,334

18,995,901

19

373,561

373,580

-

Consolidation of equity method investment

 

 

 

 

 

 

 

 

16,838

Adjustment to redemption value

(344)

(344)

 

344

Net income (loss)

 

 

 

 

(50,460)

 

 

 

(332)

 

(50,792)

(263)

$

(51,055)

Balances, March 31, 2021

 

135,516,513

$

136

$

323,127

$

4,476

 

$

$

6,403

$

334,142

$

16,919

The accompanying notes are an integral part of these condensed consolidated financial statements.

8

INNOVAGE HOLDING CORP. AND SUBSIDIARIES

Condensed Consolidated Statements of Cash Flows

(In thousands)

(Unaudited)

For the Nine Months Ended March 31, 

2022

2021

Operating Activities

Net income (loss)

$

5,572

$

(51,055)

Adjustments to reconcile net income (loss) to net cash provided by (used in) operating activities

 

 

  

Loss on disposal of assets

 

358

 

2

Provision for uncollectible accounts

 

4,834

 

4,144

Depreciation and amortization

 

10,435

 

9,262

Gain on equity method investment

(10,871)

Loss on extinguishment of long-term debt

 

 

8,494

Amortization of deferred financing costs

 

322

 

948

Stock-based compensation

 

2,586

 

1,102

Deferred income taxes

 

81

 

(3,464)

Change in fair value of warrants

 

 

2,264

Change in fair value of contingent consideration

1,343

Changes in operating assets and liabilities, net of acquisitions

 

  

 

Accounts receivable, net

 

(4,157)

 

(1,402)

Prepaid expenses and other

 

(4,323)

 

635

Income tax receivable

 

(60)

 

1,613

Deposits and other

 

(1,501)

 

(606)

Accounts payable and accrued expenses

 

4,705

 

7,717

Reported and estimated claims

 

2,778

 

114

Due to Medicaid and Medicare

 

2,429

 

12,732

Net cash provided by (used in) operating activities

 

24,059

 

(17,028)

Investing Activities

 

  

 

  

Purchases of property and equipment

 

(20,141)

 

(14,083)

Purchase of intangible assets

 

(1,437)

 

(2,000)

Purchase of cost method investment

 

(2,000)

 

Net cash used in investing activities

$

(23,578)

$

(16,083)

Financing Activities

 

Distributions to owners

$

$

(9,458)

Owner contributions

 

 

20,000

Payments on capital lease obligations

 

(1,829)

 

(1,685)

Proceeds from long-term debt

375,000

Principal payments on long-term debt

 

(2,841)

 

(512,649)

Payment of financing costs and debt premiums

 

 

(8,896)

Proceeds from initial public offering of common stock

 

 

373,580

Treasury stock purchases

 

 

(77,603)

Payments under acquisition agreements

 

 

(3,622)

Payments related to option cancellation

(32,358)

Net cash provided by (used in) financing activities

 

(4,670)

 

122,309

INCREASE (DECREASE) IN CASH, CASH EQUIVALENTS & RESTRICTED CASH

 

(4,189)

 

89,198

CASH, CASH EQUIVALENTS & RESTRICTED CASH, BEGINNING OF PERIOD

 

203,700

 

114,565

CASH, CASH EQUIVALENTS & RESTRICTED CASH, END OF PERIOD

$

199,511

$

203,763

Supplemental Cash Flows Information

 

  

 

  

Interest paid

$

1,452

$

16,251

Income taxes paid

$

84

$

7,047

Prepayment penalty on extinguishment of debt

$

$

6,000

Intangibles and property and equipment included in accounts payable

$

4,577

$

224

Property and equipment purchased under capital leases

$

8,057

$

3,517

The accompanying notes are an integral part of these condensed consolidated financial statements.

9

INNOVAGE HOLDING CORP. AND SUBSIDIARIES

Notes to Condensed Consolidated Financial Statements

(Unaudited)

Note 1:Business

InnovAge Holding Corp. (formerly, TCO Group Holdings, Inc.) was formed May 13, 2016, to acquire the business of Total Community Options, Inc. d/b/a InnovAge, which was formed in May 2007. In connection with the Company’s initial public offering (“IPO”), which occurred in March 2021, we changed the name of our Company from TCO Group Holdings, Inc. to InnovAge Holding Corp.

InnovAge Holding Corp. and its subsidiaries, are headquartered in Denver, Colorado. The Company manages, and in many cases directly provides, a broad range of medical and ancillary services for seniors in need of care and support to safely live independently in their homes and communities, including in-home care services (skilled, unskilled and personal care); in-center services such as primary care, physical therapy, occupational therapy, speech therapy, dental services, mental health and psychiatric services, meals, and activities; transportation to the Program of All-Inclusive Care for the Elderly (“PACE”) center and third-party medical appointments; and care management. The Company manages its business as one reportable segment, PACE.

As of March 31, 2022, the Company served approximately 6,800 PACE participants, making it the largest PACE provider in the United States of America (the “U.S.”) based upon participants served, and operates 18 PACE centers across Colorado, California, New Mexico, Pennsylvania and Virginia.

PACE is a fully-capitated managed care program, which serves the frail elderly, and predominantly dual-eligible, population in a community-based service model. InnovAge is obligated to provide and participants receive all needed healthcare services through an all-inclusive, coordinated model of care, and the Company is at risk for 100% of healthcare costs incurred with respect to the care of its participants. PACE programs receive capitation payments directly from Medicare Parts C and D, Medicaid, Veterans Administration (“VA”), and private pay sources. Additionally, under the Medicare Prescription Drug Plan, the Centers for Medicare and Medicaid Services (“CMS”) share part of the risk for providing prescription medication to the Company’s participants.

On March 8, 2021, we completed our IPO. The Company’s common stock began trading on the Nasdaq Stock Market LLC (“NASDAQ”) under the ticker symbol “INNV”.

Note 2:Summary of Significant Accounting Policies

The Company described its significant accounting policies in Note 2, “Summary of Significant Accounting Policies” of the Notes to Consolidated Financial Statements in its Annual Report on Form 10-K for the year ended June 30, 2021 (“2021 10-K”). During the nine months ended March 31, 2022, there were no significant changes to those accounting policies.

Basis of Preparation and Principles of Consolidation

The unaudited interim condensed consolidated financial statements and accompanying notes have been prepared in accordance with accounting principles generally accepted in the U.S. (“U.S. GAAP”) for interim financial information and with the instructions to Form 10-Q and Article 10 of Regulation S-X. Accordingly, certain information and footnote disclosures normally included in financial statements prepared in accordance with U.S. GAAP have been omitted pursuant to such regulations. These financial statements have been prepared on a basis consistent with the accounting principles applied for the fiscal year ended June 30, 2021. In the opinion of management, all adjustments (consisting of all normal and recurring adjustments) considered necessary for a fair presentation have been included. The condensed consolidated financial statements include the accounts of InnovAge, its wholly owned subsidiaries, variable interest entities (“VIEs”)

10

for which it is the primary beneficiary and entities for which it has a controlling interest. All intercompany accounts and transactions have been eliminated in consolidation.

The Company does not have any components of comprehensive income and comprehensive income is equal to net income reported in the statements of operations for all periods presented.

Restatement of Prior Period Financial Statements

Subsequent to the issuance of the Company’s consolidated financial statements as of and for the year ended June 30, 2021, we identified an error in our consolidated balance sheet and statement of stockholders’ equity as of June 30, 2021 related to the presentation of redeemable noncontrolling interests. Additionally, the error also impacted our condensed consolidated statements of shareholders’ equity for the three months and nine-months ended March 31, 2021. The Company incorrectly recorded redeemable noncontrolling interests of $17.0 million and $16.9 million as permanent equity rather than temporary equity as of June 30, 2021 and March 31, 2021, respectively.  As a result, the Company restated the June 30, 2021 and March 31, 2021 condensed consolidated financial statements to reflect this reclassification from permanent to temporary equity and to record the related adjustments to redemption value as of June 30, 2021 and March 31, 2021. Management has evaluated the materiality of this misstatement and concluded that it is not material to the prior period.

The effect of the restatement on the consolidated balance sheet as of June 30, 2021 is as follows (in thousands):

As Previously

    

Reported

    

Adjustments

    

As Restated

Redeemable Noncontrolling Interests (See Note 4)

 

 

16,986

 

16,986

Retained earnings

 

11,250

 

(587)

 

10,663

Total InnovAge Holding Corp.

 

335,146

 

(587)

 

334,559

Noncontrolling interests

 

22,819

 

(16,399)

 

6,420

Total stockholders’ equity

 

357,965

 

(16,986)

 

340,979

The effect of the restatement on the balances as of June 30, 2021 included in the consolidated statement of stockholders’ equity as of March 31, 2022 is as follows (in thousands):

Redeemable

Total Permanent

Noncontrolling

Retained

Noncontrolling

Stockholders’

Interests

    

Earnings

    

Interests

    

Equity

    

(Temporary Equity)

As Previously Reported

 

  

 

  

 

  

 

  

Balances, June 30, 2021

 

11,250

 

22,819

 

357,965

 

Adjustments

 

  

 

  

 

  

 

  

Balances, June 30, 2021

 

(587)

 

(16,399)

 

(16,986)

 

16,986

As Restated

 

  

 

  

 

  

 

  

Balances, June 30, 2021

 

10,663

 

6,420

 

340,979

 

16,986

11

The effect of the restatement on the consolidated statement of stockholders’ equity for the three months ended March 31, 2021 is as follows (in thousands):

Redeemable

Total Permanent

Noncontrolling

Retained

Noncontrolling

Stockholders’

Interests

Retained

    

Earnings

    

Interests

    

Equity

    

(Temporary Equity)

Earnings

As Previously Reported

 

  

 

  

 

  

 

  

Consolidation of equity method investment

16,838

16,838

Net income (loss)

(10,510)

(352)

(10,862)

Adjustment to redemption value

Balances, March 31, 2021

 

4,820

 

22,978

 

351,061

 

Adjustments

 

  

 

  

 

  

 

  

Consolidation of equity method investment

(16,838)

(16,838)

16,838

Net income (loss)

263

263

(263)

(10,862)

Adjustment to redemption value

(344)

(344)

344

Balances, March 31, 2021

 

(344)

 

(16,575)

 

(16,919)

 

16,919

As Restated

 

  

 

  

 

  

 

  

Consolidation of equity method investment

16,838

Net income (loss)

(10,510)

(89)

(10,599)

(263)

(10,862)

Adjustment to redemption value

 

(344)

 

 

(344)

 

344

Balances, March 31, 2021

4,476

6,403

334,142

16,919

The effect of the restatement on the consolidated statement of stockholders’ equity for the nine months ended March 31, 2021 is as follows (in thousands):

Redeemable

Total Permanent

Noncontrolling

Retained

Noncontrolling

Stockholders’

Interests

Retained

    

Earnings

    

Interests

    

Equity

    

(Temporary Equity)

Earnings

As Previously Reported

 

  

 

  

 

  

 

  

Consolidation of equity method investment

16,838

16,838

Net income (loss)

(50,460)

(595)

(51,055)

Adjustment to redemption value

Balances, March 31, 2021

 

4,820

 

22,978

 

351,061

 

Adjustments

 

  

 

  

 

  

 

  

Consolidation of equity method investment

(16,838)

(16,838)

16,838

Net income (loss)

263

263

(263)

(51,055)

Adjustment to redemption value

(344)

(344)

344

Balances, March 31, 2021

 

(344)

 

(16,575)

 

(16,919)

 

16,919

As Restated

 

  

 

  

 

  

 

  

Consolidation of equity method investment

16,838

Net income (loss)

(50,460)

(332)

(50,792)

(263)

(51,055)

Adjustment to redemption value

 

(344)

 

 

(344)

 

344

Balances, March 31, 2021

4,476

6,403

334,142

16,919

12

Property and Equipment

Property and equipment were comprised of the following as of March 31, 2022 and June 30, 2021:

    

Estimated

    

    

dollars in thousands

Useful Lives

March 31, 2022

June 30, 2021

Land

 

N/A

$

11,980

$

11,980

Buildings and leasehold improvements

 

10 - 40 years

 

121,661

 

104,724

Software

 

3 - 5 years

 

15,107

 

13,316

Equipment and vehicles

 

3 - 7 years

 

46,655

 

35,341

Construction in progress

 

N/A

 

22,336

 

22,130

 

 

217,739

187,491

Less accumulated depreciation and amortization

 

 

(53,857)

 

(44,776)

Total property and equipment, net

$

163,882

$

142,715

Depreciation of $3.8 million and $3.2 million was recorded during the three months ended March 31, 2022 and 2021, respectively. Depreciation of $9.9 million and $8.8 million was recorded during the nine months ended March 31, 2022 and 2021, respectively.

Coronavirus Pandemic (“COVID-19”)

As a PACE organization, we have been and will continue to be impacted by the effects of COVID-19. We closed all our centers in March 2020 and transitioned to a 100% in-home and virtual care model. We believe that the general lack of in-person interaction and the reduction in healthcare personnel, and specifically, trained personnel, impacted our ability to adhere to the complex government laws and regulations that apply to our business. We remain committed to carrying out our mission of caring for our participants. We continue to closely monitor the impact of COVID-19 on all aspects of our business, including the impacts to our employees, participants and suppliers. Due to the numerous evolving factors, we are unable to reliably estimate the ultimate impact the pandemic will have on our consolidated financial condition, results of operations or cash flows.

On March 27, 2020, the Coronavirus Aid, Relief, and Economic Security Act (“CARES Act”) was signed into legislation. Under the CARES Act, the state of Pennsylvania signed into law the Act 24 of 2020. We received $1.0 million in funding under the Act 24 of 2020, which was allocated to InnovAge centers in Pennsylvania. Of the $1.0 million, $0.7 million was recognized prior June 30, 2020 and the remaining balance of $0.3 million was recognized during the year ended June 30, 2021. The CARES Act also provides for the temporary suspension of the automatic 2% reduction of Medicare claim reimbursements (sequestration) for the period of May 1, 2020 through December 31, 2020. The Consolidated Appropriations Act, 2021, enacted December 27, 2020, extended this suspension for three more months, through March 31, 2021.  H.R. 1868, enacted on April 14, 2021 further extends the suspension through December 31, 2021. On December 10, 2021 the “Protecting Medicare and American Farmers from Sequester Cuts Act” extends the 2% Medicare sequester moratorium through March 31, 2022, and adjusts the sequester to 1% between April 1, 2022 and June 30, 2022.

Recently Adopted Accounting Pronouncements

Income Taxes

In December 2019, the Financial Accounting Standards Board (“FASB”) issued ASU 2019-12, Income Taxes Topic 740-Simplifying the Accounting for Income Taxes (“ASU 2019-12”), which intended to simplify various aspects related to accounting for income taxes. ASU 2019-12 removes certain exceptions to the general principles in Topic 740 and also clarifies and amends existing guidance to improve consistent application of Topic 740. This guidance is effective for companies with fiscal years beginning after December 15, 2020, including interim periods therein, and early adoption is permitted. The Company adopted ASU 2019-12 during the quarter ended September 30, 2021 and it did not have a material effect on the Company’s condensed consolidated financial statements.

13

Recent Accounting Pronouncements Not Yet Adopted

Leases

In February 2016, the FASB issued ASU 2016-02 Leases (“ASU 2016-02”), which was intended to increase transparency and comparability among organizations by recognizing lease assets and liabilities on the balance sheet and disclosing key information about leasing arrangements. Under the new guidance, lessees will be required to recognize a right-of-use asset and a lease liability, measured on a discounted basis, at the commencement date for all leases with terms greater than 12 months. Additionally, this guidance will require disclosures to help investors and other financial statement users to better understand the amount, timing, and uncertainty of cash flows arising from leases, including qualitative and quantitative requirements. The guidance should be applied under a modified retrospective transition approach for leases existing at the beginning of the earliest comparative period presented in the adoption-period financial statements. Any leases that expire before the initial application date will not require any accounting adjustment. In June 2020, FASB issued ASU 2020-05 Revenue from contracts with customers (Topic 606) and leases (Topic 842)—Effective dates for certain entities which deferred the new lease standard effective date for the Company to December 15, 2022, with early adoption permitted. The Company will adopt this ASU in the fiscal year beginning July 1, 2022 and has not yet determined the effect of the standard on its ongoing financial reporting.

Financial Instruments

In April 2019, the FASB issued ASU 2019-04, Codification Improvements to Topic 326, Financial Instruments—Credit Losses, Topic 815, Derivatives and Hedging, and Topic 825, Financial Instruments (“ASU 2019-04”), which requires entities to use a current expected credit loss (“CECL”) model to measure impairment for most financial assets that are not recorded at fair value through net income. Under the CECL model, an entity will estimate lifetime expected credit losses considering available relevant information about historical events, current conditions and supportable forecasts. The CECL model does not apply to available-for-sale debt securities. This guidance also expands the required credit loss disclosures and will be applied using a modified retrospective approach by recording a cumulative effect adjustment to retained earnings as of the beginning of the fiscal year of adoption. ASU 2019-04 is effective for the Company for fiscal years beginning after December 15, 2022, including interim periods within those fiscal years. The Company will adopt this guidance for the annual and interim reporting periods beginning July 1, 2023. The Company has not determined the effect of the standard on its condensed consolidated financial statements.

We do not expect that any other recently issued accounting guidance will have a significant effect on our condensed consolidated financial statements.

Note 3:Revenue Recognition

Under ASC 606, revenue is recognized when a customer obtains control of promised goods or services, in an amount that reflects the consideration which the entity expects to receive in exchange for those goods or services. To determine revenue recognition for arrangements that an entity determines are within the scope of ASC 606, the Company performed the following five steps: (i) Identify the contract(s) with a customer; (ii) Identify the performance obligations in the contract; (iii) Determine the transaction price; (iv) Allocate the transaction price to the performance obligations in the contract; and (v) Recognize revenue as the entity satisfies a performance obligation.

Capitation Revenue and Accounts Receivable

Our capitation revenue relates to contracts with participants in which our performance obligation is to provide healthcare services to the participants. Revenues are recorded during the period our obligations to provide healthcare services are satisfied as noted below within each service type. The Company contracts directly with Medicare and Medicaid on a per member, per month (“PMPM”) basis. We receive 100% of the pooled capitated payment to directly provide or manage the healthcare needs of our participants.

14

Fees are recorded gross in revenues because the Company is acting as a principal in providing for or overseeing comprehensive care provided to the participants. Neither the Company nor any of its affiliates is a registered insurance company because state law in the states in which it operates does not require such registration for risk-bearing providers.

In general, a participant enrolls in the PACE program and is considered a customer of InnovAge. The Company considers all contracts with participants as a single performance obligation to provide comprehensive medical, health, and social services that integrate acute and long-term care. The Company identified that contracts with customers in the PACE program have similar performance obligations and therefore groups them into one portfolio. This performance obligation is satisfied as the Company provides comprehensive care to its participants.

Our revenues are based on the estimated PMPM  amounts we expect to be entitled to receive from the capitated fees per participant that are paid monthly by Medicaid, Medicare, the VA, and private pay sources. Medicaid and Medicare capitation revenues are based on PMPM capitation rates under the PACE program.  VA is included in “Private Pay and other” and is also capitated.  Private pay includes direct payments from participants who do not qualify for the full capitated rate and have to pay all or a portion of the capitated rate.

The Company disaggregates capitation revenue from the following sources for the nine months ended:

    

March 31, 

    

    

2022

    

2021

    

Medicaid

 

53

%

53

%

Medicare

 

46

%

46

%

Private pay and other

 

1

%

1

%

Total

 

100

%

100

%

The Company determined the transaction price for these contracts is the amount we expect to be entitled to, which is the most likely amount. For certain capitation payments, the Company is subject to retroactive premium risk adjustments based on various factors. The Company estimates the amount of the adjustment and records it monthly on a straight-line basis. These adjustments are not expected to be material.

The capitation revenues are recognized based on the estimated PMPM transaction price to transfer the service for a distinct increment of the series (i.e. month). We recognize revenue in the month in which participants are entitled to receive comprehensive care benefits during the contract term. As the period between the time of service and time of payment is typically one year or less, the Company elected the practical expedient under ASC 606-10-32-18 and did not adjust for the effects of a significant financing component.

The Company also provides prescription drug benefits in accordance with Medicare Part D. Monthly payments received from CMS and the participants represent the bid amount for providing prescription drug coverage. The portion received from CMS is subject to risk sharing through Medicare Part D risk-sharing corridor provisions. These risk-sharing corridor provisions compare costs targeted in the Company’s bid to actual prescription drug costs. The Company estimates and records a monthly adjustment to Medicare Part D revenues associated with these risk-sharing corridor provisions. Medicare Part D comprised (i) 12% of capitation revenues for both the nine months ended March 31, 2022 and 2021 and (ii) 23% and 25% of external provider costs for the nine months ended March 31, 2022 and 2021, respectively.

Our accounts receivable as of March 31, 2022 and June 30, 2021 is primarily from capitation revenue arrangements. The concentration of net receivables from participants and third-party payers was as follows:

    

March 31, 

June 30, 

2022

    

2021

Medicaid

 

50

%

60

%

Medicare

 

37

%

20

%

Private pay and other

 

13

%

20

%

Total

 

100

%

100

%

15

The Company records accounts receivable at net realizable value, which includes an allowance for estimated uncollectible accounts. The allowance for uncollectible accounts reflects the Company’s best estimate of probable losses considering eligibility, historical experience, and existing economic conditions. The balance of the allowance for uncollectible accounts was $3.9 million as of March 31, 2022, compared to $4.4 million as of June 30, 2021. Accounts are written off as bad debts when they are deemed uncollectible based upon individual credit evaluations and specific circumstances underlying the accounts.

Other Service Revenue and Accounts Receivable

Other service revenue is comprised of rents earned related to Senior Housing and other fee for service revenue. Other service revenue was 0.2% and 0.4% of total revenue for the nine months ended March 31, 2022 and 2021, respectively, and 0.2% and 0.3% for the three months ended March 31, 2022 and 2021, respectively. Accounts receivable related to other service revenue were not significant as of both March 31, 2022 and June 30, 2021.

Laws and regulations governing the Medicare and Medicaid programs are complex and subject to change, as well as government review. Failure to comply with these laws can expose the entity to significant regulatory action, including fines, penalties, and exclusion from the Medicare and Medicaid programs. See Note 9, “Commitments and Contingencies”.

Note 4:Investments

The Company holds equity method and cost method investments as of:

March 31, 

June 30, 

in thousands

2022

    

2021

Cost method investments

$

4,645

$

2,645

Equity method investments

 

848

 

848

Total investments

$

5,493

$

3,493

Nonconsolidated Entities

Cost Method Investments

The Company maintains two investments that are accounted for using the cost method. The investments do not have a readily determinable fair value and the Company has elected to record the investments at cost, less impairment, if any, plus or minus any changes resulting from observable price changes in orderly transactions for the identical or similar investment of the same issuer. During the nine months ended March 31, 2022 and 2021, there were no observable price changes or impairments recorded.

Jetdoc

In August 2021, the Company acquired a minority interest equal to 806,481 shares of the outstanding common

stock of Jetdoc, Inc. (“Jetdoc”), a telehealth and virtual urgent care app dedicated to effectively connecting users with medical professionals, for cash consideration of $2.0 million. The balance of the Company’s investment in Jetdoc is $2.0 million which represents the maximum exposure to loss.

Dispatch Health

Since 2019, the Company has maintained an investment of $2.6 million in DispatchHealth Holdings, Inc. (“Dispatch Health”). Dispatch Health offers  complete in-home on-demand healthcare. The balance of the Company’s investment is $2.6 million which represents the maximum exposure to loss.

16

Equity Method Investments

Pinewood Lodge

The Company’s operations include a Senior Housing unit that primarily includes the accounts of Continental Community Housing (“CCH”), the general partner of Pinewood Lodge, LLP (“ PWD”) which was organized to develop, construct, own, maintain, and operate certain apartment complexes intended for rental to low-income elderly individuals aged 62 or older.

PWD is a VIE, but the Company is not the primary beneficiary. The Company does not have the power to direct the activities that most significantly impact the economic performance of PWD. Accordingly, the Company does not consolidate PWD. PWD is accounted for using the equity method of accounting. The equity earnings of PWD are insignificant. As of March 31, 2022, the balance of the Company’s investment in PWD is $0.8 million which represents the maximum exposure to loss.

Noncontrolling Interest

Senior Housing

The Company’s operations include a 0.01% partnership interest in InnovAge Senior Housing Thornton, LLC (“SH1”), which was organized to develop, construct, own, maintain, and operate certain apartment complexes intended for rental to low-income elderly individuals aged 62 or older.

SH1 is a  VIE. The Company is the primary beneficiary of SH1 and consolidates SH1. The Company is the primary beneficiary of SH1 as it has the power to direct the activities that are most significant to SH1 and has an obligation to absorb losses or the right to receive benefits from SH1. The most significant activity of SH1 is the operation of the senior housing facility. The Company has provided a subordinated loan to SH1 and has provided a guarantee for a convertible term loan held by SH1.

Redeemable Noncontrolling Interest

InnovAge Sacramento

On March 18, 2019, in connection with the formation of InnovAge Sacramento, the joint venture with Adventist Health System/West (“Adventist”) and Eskaton Properties, Incorporated (“Eskaton”), the Company contributed $9.0 million in cash and land valued at $4.2 million for a 59.9% membership interest in the joint venture, InnovAge Sacramento. Further, Adventist contributed $5.8 million in cash and Eskaton contributed $3.0 million in cash for membership interests of 26.4% and 13.7%, respectively.

Prior to January 1, 2021, the Company did not consolidate InnovAge Sacramento. In the third quarter of fiscal year 2021, the Company made an additional contribution of $52,000 to obtain an additional 0.1% membership interest in the joint venture. With the acquisition of the additional 0.1% membership interest, the Company obtained control of InnovAge Sacramento effective January 1, 2021. Accordingly, beginning January 1, 2021, the results of InnovAge Sacramento are included in our consolidated results of operations.

Before consolidation on January 1, 2021, the Company recorded its proportionate share of net loss, which was a loss of $1.3 million for the six months ended December 31, 2020, as equity loss in the statement of operations.

When the joint venture was formed, the Company issued warrants to Adventist (the “Sacramento Warrants”) to purchase 5% of its issued and outstanding common stock par value $0.001 per share, at an exercise price equal to the fair market value per share at the time of exercise of the warrant. Pursuant to the original warrants, the Sacramento Warrants were to fully vest on the date on which Adventist would have made aggregate capital contributions in an amount greater than $25.0 million to one or more joint venture entities in which Adventist and the Company held equity (the “Investment Threshold”).

17

On February 9, 2021, we entered into an amendment agreement with Adventist to amend the Sacramento Warrants. The amendment removes the Investment Threshold requirement and grants Adventist the right to purchase up to $15.0 million of our common stock at an exercise price equal to the initial public offering price. The warrant was exercisable for one year beginning March 8, 2021, the date of the consummation of our IPO. The Sacramento Warrants expired in March 2022, without being exercised.

At inception, the Sacramento Warrants were initially determined to be equity-based payments to nonemployees and as such the measurement date for these warrants was considered to be the date when the Investment Threshold is reached. At the time of the amendment, due to the removal of the Investment Threshold, the Sacramento Warrants were evaluated under ASC 815-40, “Contracts in an Entity’s Own Equity,” which resulted in a liability classification from the date of the amendment through completion of our IPO, due to the variable amount of shares which could be issued. Upon completion of the IPO, the number of shares to be issued were no longer variable, which resulted in the warrants being recorded in equity. A charge of $2.3 million, representing the fair value of the Sacramento Warrants from inception through the date of completion of the IPO, was recorded in other income (expense) in the condensed consolidated statement of operations.

As described above, we obtained control of InnovAge Sacramento through acquisition of an additional 0.1% membership interest, which we consider to be a step acquisition, whereby the Company remeasured the previously held equity method investment to fair value. The amount by which the purchase price exceeds the fair value of the net assets acquired is recorded as goodwill. The fair value of the previously held equity investments was determined using a discounted cash flow model.  This resulted in recording a gain on consolidation of $10.9 million during the third quarter of fiscal year 2021.

The InnovAge California PACE-Sacramento LLC Limited Liability Company Agreement (the “JV Agreement”) includes numerous provisions whereby, if certain conditions are met, the Joint Venture may be required to purchase, at fair market value, certain members’ interests or certain members may be required to purchase, at fair market value, the interests of certain other members. As of March 31, 2022, none of the conditions specified in the JV Agreement had been met.  At the time the Company became a publicly traded company these put rights held by the noncontrolling interests of the Joint Venture were required to be presented as temporary equity. The redeemable noncontrolling interest of $15.9 million was recorded at carrying value as of March 31, 2022.

Note 5:Fair Value Measurements

Fair value is defined as the price that would be received from selling an asset or paid to transfer a liability (an exit price) in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants, at the measurement date. A fair value hierarchy was established that requires an entity to maximize the use of observable inputs and minimize the use of unobservable inputs when measuring fair value. Observable inputs are inputs that reflect the assumptions market participants would use in pricing the asset or liability developed based on market data obtained from sources outside the reporting entity. Unobservable inputs are inputs that reflect the Company’s own assumptions based on market data and assumptions that market participants would use in pricing the asset or liability developed based on the best information available in the circumstances. The sensitivity to changes in inputs and their impact on fair value measurements can be significant.

The three levels of inputs that may be used to measure fair value are:

Level 1

Unadjusted quoted prices in active markets for identical assets or liabilities that the entity has the ability to access at the measurement date

Level 2

Quoted prices in markets that are not active or inputs that are observable, either directly or indirectly, for substantially the full term of the assets or liabilities

Level 3

Unobservable inputs to the valuation techniques that are significant to the fair value measurements of the assets or liabilities

18

Recurring Measurements

The Company’s investment in InnovAge Sacramento includes a put right for the noncontrolling interest holders to require the Company to repurchase the interest of the noncontrolling interest holders at fair value, after the initial term of the management services agreement in 2028. As a result, at each fiscal period end the Company reports this put right at the greater of i) carrying value of the redeemable noncontrolling interest or (ii) fair value of the redeemable noncontrolling interest. Because this asset does not have observable inputs, level 3 inputs are used to measure fair value. For the three months ended March 31, 2022, the Company recorded an adjustment to redemption value of the redeemable noncontrolling interest of $2.6 million, which was a reduction to carrying value. This adjustment represents the excess amount of fair value over the carrying value as of March 31, 2022.  The fair value of the redeemable noncontrolling interest is determined utilizing a discounted cash flow model.

Effective August 7, 2018, the Company finalized the acquisition of NewCourtland LIFE Program (“NewCourtland”) in Pennsylvania. The Company paid a base purchase price of $30.0 million, subject to certain net working capital and closing adjustments plus contingent consideration of up to $20.0 million. On March 8, 2021, we completed our IPO, which satisfied the condition that the Company sell equity securities pursuant to an effective registration statement. Accordingly, $20.0 million of contingent consideration was paid under the terms of the acquisition agreement. Since all of the contingent consideration of $20.0 million was paid, the lease payments in certain real estate leases between the Company and NewCourtland were reduced from their current amounts and allow the Company to exercise its option to purchase the leased buildings at fair market value, after the initial term of the lease.

As of  June 30, 2021 and March 31, 2022, there are no amounts of contingent consideration outstanding.  

There were no transfers in and out of Level 3 during the nine months ended March 31, 2022 or 2021.

Note 6:Goodwill and Intangible Assets

Goodwill, which represents the excess of consideration paid over the fair value of net assets acquired through business acquisitions. Goodwill amounted to $124.2 million at each of March 31, 2022 and June 30, 2021. Goodwill is not amortized.

Pursuant to ASC 350, “Intangibles – Goodwill and Other,” we review the recoverability of goodwill annually as of April 1 or whenever significant events or changes occur which might impair the recovery of recorded amounts. For purposes of the annual goodwill impairment assessment, the Company has identified three reporting units. There were no indicators of impairment identified and no goodwill impairments recorded during the nine months ended March 31, 2022 and 2021.

Intangibles assets consisted of the following as of:

    

March 31, 

June 30, 

in thousands

2022

    

2021

Definite-lived intangible assets

$

9,350

$

6,600

Indefinite-lived intangible assets

2,000

2,000

Total intangible assets

11,350

8,600

Accumulated amortization

(2,578)

(2,082)

Balance as of end of period

$

8,772

$

6,518

Intangible assets consist primarily of customer relationships acquired through business acquisitions and technology-based assets. The Company recorded amortization expense of $0.5 million and $0.2 million for the nine months ended March 31, 2022 and 2021, respectively.

19

We review the recoverability of other intangible assets in conjunction with long-lived assets whenever events or changes in circumstances indicate the carrying amount of such assets may not be recoverable. There were no intangible asset impairments recorded during the nine months ended March 31, 2022 and 2021.

During the nine months ended March 31, 2022, the market value of our common stock declined below the carrying value of equity. As a result, we were required to qualitatively assess whether a triggering event had occurred and whether it was more likely than not that our goodwill was impaired as of March 31, 2022. We believe the impact of the regulatory actions described below to our planned opening of new centers and expansion into new service areas met the criteria of a triggering event, which required us to perform quantitative procedures as part of a Step 1 goodwill impairment analysis to asses whether it was more-likely-than-not that the fair value of the Company was greater than the net book value.

In September 2021, we were notified that CMS and the State of California had determined to suspend new enrollments at our Sacramento center based on deficiencies detected in an audit related to participant provision of services.  In December 2021, we were notified that CMS and Colorado Department of Health Care Policy and Financing (“HCPF”) had determined to suspend new enrollments at our Colorado centers based on deficiencies detected in an audit related to participant provision of services. In each case, the suspensions will remain in effect until CMS and the respective States determine that we have remediated the deficiencies to their satisfaction. During the third quarter ended March 31, 2022, we were notified by the State of Kentucky that they no longer intend to enter into an agreement with us relating to PACE services, and during the same period, CMS denied our initial application to develop a PACE center in the State of Indiana.

As a result of the above assessment, we concluded that there was no goodwill impairment based on a review of macroeconomic and industry considerations, the Company's financial results in each of our reporting units for the nine months ended March 31, 2022 and financial projections, inclusive of a sustained impact of the enrollment suspension and inability to open new centers. If assumptions or estimates in the fair value calculations change or if future cash flows vary from what was expected, including those assumptions relating to the duration and severity of the financial impact of the enrollment suspension at Sacramento and Colorado or new regulatory sanctions or other actions are imposed on the Company, this may impact the impairment analysis and could reduce the underlying cash flows used to estimate fair values and result in a decline in fair value that may trigger future impairment charges.

Note 7:Leases

Property and equipment includes property under various capital leases. These leases have expiration dates ranging from August 2022 to July 2032, varying interest rates, and generally include an option to purchase the equipment at the end of the underlying lease period. The Company’s capital leases included the following at March 31, 2022 and June 30, 2021:

    

March 31, 2022

June 30, 2021

in thousands

Equipment

$

18,885

$

13,302

Less accumulated depreciation

 

(7,150)

 

(7,081)

Total capital leases

$

11,735

$

6,221

Certain of the Company’s property and equipment is leased under operating leases. Such leases generally have lease terms ranging from years 2022 through 2032 with renewal options. Total rental expense under operating leases was $1.3 million and $3.5 million for the three and nine months ended March 31, 2022, respectively, and $1.4 million and $3.5 million for the three and nine months ended March 31, 2021 respectively.

20

Future minimum lease payments for fiscal years beginning with remainder of fiscal year 2022 for capital leases having initial terms of more than one year and noncancelable operating leases were as follows:

    

    

Operating Leases

Capital Leases

Minimum Lease

in thousands

Obligations

Payments

Amount remaining in 2022

$

958

$

1,203

2023

 

4,405

 

4,872

2024

 

3,909

 

4,582

2025

 

3,126

 

4,122

2026

 

2,092

 

4,061

Thereafter

 

1,927

 

14,029

Total

 

16,417

$

32,869

Less amount representing interest

 

(2,912)

 

  

Total minimum lease payments

 

13,498

 

  

Less current maturities

 

(3,216)

 

  

Noncurrent maturities

$

10,282

 

  

Note 8. Long Term Debt

Long-term debt consisted of the following at March 31, 2022 and June 30, 2021:

Interest rate

Maturity date

March 31, 2022

June 30, 2021

in thousands

Senior secured borrowings:

Term Loan Facility

(a)

March 8, 2026

$

72,188

$

75,000

Revolving Credit Facility (b)

(a)

March 8, 2026

Convertible term loan

6.68%

August 20, 2030

 

2,338

 

2,367

Total debt

 

74,526

 

77,367

Less unamortized debt issuance costs

 

1,681

 

2,003

Less current maturities

 

3,793

 

3,790

Noncurrent maturities

$

69,051

$

71,574

(a)The interest rates on the Term Loan Facility and Revolving Credit Facility are described below.
(b)The remaining capacity under the Revolving Credit Facility as of March 31, 2022 was $100.0 million, subject to (i) any issued amounts under our letters of credit, which as of March 31, 2022 was $2.6 million, and (ii) applicable covenant compliance restrictions and any other conditions precedent to borrowing.

2016 Credit Agreement

The Company originally entered into a senior secured borrowing agreement (the “2016 Credit Agreement”) on May 13, 2016, that consisted of a senior secured term loan for $75.0 million and a revolving credit facility for $20.0 million. The 2016 Credit Agreement was subsequently amended (i) on May 2, 2019 to increase the senior secured term loan to $190.0 million and a revolving credit facility for $30.0 million and a delayed draw term loan facility (“DDTL”) for $45.0 million and (ii) on July 27, 2020, to increase the senior secured term loan to $300.0 million, the revolving credit facility to $40.0 million and to terminate the DDTL.  The structure of the July 27, 2020 amendment to the 2016 Credit Agreement led to an extinguishment of debt for certain lenders and a modification of debt for other lenders. The total debt structure extinguishment for certain lenders was $57.1 million, and the write off of $1.0 million in debt issuance costs was recorded in loss on extinguishment of debt for the nine months ended March 31, 2021. The total debt structure that was modified was $250.0 million, while the new debt issued was $50.0 million, which resulted in $9.1 million of  capitalized debt issuance costs. Total amortization of deferred financing costs was $0.9 million for the nine months ended March 31, 2021.

21

Concurrent with the Company’s entry into the 2021 Credit Agreement (as defined below), the Company terminated and repaid in full all outstanding indebtedness under the 2016 Credit Agreement.

2021 Credit Agreement

On March 8, 2021, concurrently with the closing of the IPO, the Company entered into a new credit agreement (the “2021 Credit Agreement”) that replaced the 2016 Credit Agreement. The 2021 Credit Agreement consists of a senior secured term loan (the “Term Loan Facility”) of $75.0 million principal amount and a revolving credit facility (the “Revolving Credit Facility”) of $100.0 million maximum borrowing capacity. Loans under the 2021 Credit Agreement are secured by substantially all of the Company’s assets. Principal on the Term Loan Facility is paid each calendar quarter beginning September 2021 in an amount equal to 1.25% of the initial term loan on closing date. Proceeds of the Term Loan Facility, together with proceeds from the IPO, were used to repay amounts outstanding under the 2016 Credit Agreement.

Outstanding principal amounts under the 2021 Credit Agreement accrue interest at a variable interest rate. As of March 31, 2022, the interest rate on the Term Loan Facility was 2.21%. Under the terms of the 2021 Credit Agreement, the Revolving Credit Facility fee accrues at 0.25% of the average daily unused amount and is paid quarterly. As of March 31, 2022, we had no borrowings outstanding under the Revolving Credit Facility.

The 2021 Credit Agreement requires the Company to meet certain operational and reporting requirements, including, but not limited to, a secured net leverage ratio. Additionally, annual capital expenditures and permitted investments, including acquisitions, are limited to amounts specified in the 2021 Credit Agreement. The 2021 Credit Agreement also provides certain restrictions on dividend payments and other equity transactions and requires the Company to make prepayments under specified circumstances. As of March 31, 2022, the Company was in compliance with the covenants of the 2021 Credit Agreement.

The deferred financing costs of $2.0 million are amortized over the term of the underlying debt and unamortized amounts have been offset against long-term debt in the consolidated balance sheets. Total amortization of deferred financing costs was $0.3 million for the nine months ended March 31, 2022.

Convertible Term Loan

On June 29, 2015, SH1 entered into a convertible term loan. Monthly principal and interest payments of $0.02 million commenced on September 1, 2015. The loan is secured by a deed of trust to Public Trustee, assignment of leases and rents, security agreements, and SH1’s fixture filing.

Note 9: Commitments and Contingencies

Professional Liability

The Company pays fixed premiums for annual professional liability insurance coverage under a claims-made policy. Under such policy, only claims made and reported to the insurer are covered during the policy term, regardless of when the incident giving rise to the claim occurred. The Company records claim liabilities and expected recoveries, if any, at gross amounts. The Company is not currently aware of any unasserted claims or unreported incidents that are expected to exceed medical malpractice insurance coverage limits.

Litigation

From time to time, in the normal course of business, the Company is involved in or subject to legal proceedings related to its business, including those described below. The Company regularly evaluates the status of claims and legal proceedings in which it is involved in order to assess whether a loss is probable or there is a reasonable possibility that a loss may have been incurred, and to determine if accruals are appropriate. The Company expenses legal costs as such costs are incurred.

22

On October 14, 2021, the Company was named as a defendant in a putative class action complaint filed in the District Court for the District of Colorado on behalf of individuals who purchased or acquired shares of the Company’s common stock during a specified period. Through the complaint, plaintiffs are asserting claims against the Company, certain of the Company’s officers and the underwriters in the Company’s IPO, alleging violations of Sections 11 and 15 of the Securities Act of 1933 for making allegedly inaccurate and misleading statements and omissions in connection with the Company’s IPO and seeking compensatory damages, among other things. The plaintiffs have indicated that they intend to file an amended complaint on or before June 14, 2022. We are currently unable to predict the outcome of this matter.

In July 2021, the Company received a civil investigative demand from the Attorney General for the State of Colorado under the Colorado Medicaid False Claims Act. The demand requests information and documents regarding Medicaid billing, patient services and referrals in connection with the Company’s PACE program in Colorado. We continue to fully cooperate with the Attorney General and produce the requested information and documentation. We are currently unable to predict the outcome of this investigation.

 

In February 2022, the Company received a civil investigative demand from the Department of Justice (“DOJ”) under the Federal False Claims Act on similar subject matter.  The demand requests information and documents regarding audits, billing, orders tracking, and quality and timeliness of patient services in connection with the Company’s PACE programs in the states where the Company operates (California, Colorado, New Mexico, Pennsylvania, and Virginia).  The Company is fully cooperating with the DOJ to produce the requested information and documentation.  We are currently unable to predict the outcome of this investigation.

On April 20, 2022, the Board of Directors of the Company received a books and records demand pursuant to Section 220 of the Delaware General Corporation Law, from a purported stockholder of the Company, in connection with the stockholder’s investigation of, among other matters, potential breaches of fiduciary duty, mismanagement, self-dealing, corporate waste or other violations of law by the Company’s Board with respect to these matters. We are currently unable to predict the outcome of this matter.

Although the results of legal proceedings and claims are inherently unpredictable and uncertain, we do not believe that the outcomes of the legal proceedings with which we are currently involved, based on the currently available information, either individually or in the aggregate, will have a material adverse effect on our business, financial condition, or cash flows, though the outcomes could be material to the Company’s operating results for any particular period; depending in part, upon the operating results of such period. Regardless of the outcome, litigation has the potential to have an adverse impact on us due to any related defense and settlement costs, diversion of management resources, and other factors. 

Note 10: Equity

Equity Owner Transaction

On July 27, 2020, InnovAge Holding Corp. (formerly TCO Group Holdings, Inc.), Ignite Aggregator LP (“Purchaser”), and the former equity holders of InnovAge Holding Corp. (“Sellers”) entered into a Securities Purchase Agreement (the “Agreement”), effective July 27, 2020. Under the terms of the Agreement, the Sellers sold a portion of their equity interest to the Purchaser. The Purchaser and the Sellers then contributed their equity interests in the Company to a newly formed limited partnership, TCO Group Holdings, L.P. (the “LP”) resulting in the Company being wholly owned by the LP.

Concurrently with the entry into the Agreement, the Company amended and restated its 2016 Credit Agreement, see Note 8, “Long Term Debt” for further discussion. A portion of the proceeds from the 2016 Credit Agreement were used by the Company to repurchase 16,095,819 shares of its common stock for $77.6 million from certain members of management, including certain members of the Board of Directors, and certain members of our equity partner. The common stock was then recognized as Treasury stock. The Treasury stock was retired in March 2021.

23

Additionally, as part of the Agreement, the Company executed an Option Cancellation Agreement (the “Cancellation Agreement”), which canceled the Company’s common stock option awards of 16,994,975 granted under the 2016 Equity Incentive Plan for $74.6 million. Such cancellation resulted in a settlement of the awards. Vesting of the contingent performance-based awards was not deemed probable at the time of the settlement resulting in the settlement of the contingent performance-based awards being recorded as Corporate, general and administrative. Vesting of the time vesting awards was deemed probable at the time of the settlement resulting in a portion of the settlement of the time vesting awards being recorded as Corporate, general and administrative expense and the remainder being recorded as a reduction to Additional paid-in capital. Of the total settlement, $45.4 million was recorded as Corporate, general and administrative expense and $32.4 million was recorded as a reduction to Additional paid-in capital. The Cancellation Agreement resulted in the option holders receiving the same amount of cash that they would have received had they exercised their options, participated in the repurchase described above and sold their remaining shares.

As part of the transaction, for the nine months ended March 31, 2021, the Company incurred $22.6 million in transaction costs, of which $13.1 million was recognized as Corporate, general and administrative expense and $9.5 million was recognized as a distribution to owners as the costs were paid on behalf of the owners. These costs were recorded during the nine months ended March 31, 2021.

Note 11: Stock-based Compensation

A summary of our aggregate stock-based compensation expense is set forth below. Stock-based compensation expense is included in corporate, general and administrative expenses on our consolidated statements of operations.

Nine Months Ended

March 31, 

in thousands

2022

    

2021

Stock options (a)

$

359

$

45,387

Profits interests units

 

1,095

 

1,102

Restricted stock units

1,132

Total stock-based compensation expense

$

2,586

$

46,489

(a)The amount for 2021 relates to stock-based compensation expense recognized as a result of the Cancellation Agreement.

2016 Equity Incentive Plan

The Company maintained the 2016 Equity Incentive Plan pursuant to which various stock-based awards were granted to employees, directors, consultants, and advisers. The total number of shares of the Company’s common stock that was authorized under the 2016 Equity Incentive Plan was 17,836,636, of which a total of 16,994,976 awards were granted. On July 27, 2020, the Company, Ignite Aggregator LP, and the equity holders of the Company entered into a Securities Purchase Agreement, and in conjunction therewith, the Company amended and restated the 2016 Credit Agreement. A portion of the proceeds from the 2016 Credit Agreement were used by the Company to repurchase 16,095,819 shares of its common stock from the certain members of management, the Board of Directors, and members of our equity partner. Additionally, as part of the 2016 Credit Agreement, the Company executed the Cancellation Agreement with each of the 2016 Equity Incentive Plan option holders, pursuant to which the Company’s 16,994,976 common stock options which were granted under the 2016 Equity Incentive Plan, were cancelled. The Cancellation Agreement resulted in the option holders receiving the same amount of cash that they would have received had they exercised their options,

24

participated in the repurchase described above and sold their remaining shares. The 2016 Equity Incentive Plan was cancelled and replaced with the 2020 Equity Incentive Plan, as described below.

2020 Equity Incentive Plan

Profits Interests

The LP maintains the 2020 Equity Incentive Plan pursuant to which interests in the LP in the form of Class B Units (profits interests) may be granted to employees, directors, consultants, and advisers. A maximum number of 16,162,177 Class B Units are authorized for grant under the 2020 Equity Incentive Plan. As of March 31, 2022, a total of 13,009,137 profits interests units have been granted under the 2020 Equity Incentive Plan.

The Company used the Monte Carlo option model to determine the fair value of the profits interests units at the time of the grant. There were no grants during the nine months ended March 31, 2022.

A summary of profits interests activity for the nine months ended March 31, 2022 was as follows:

    

    

  

Number of

Weighted average

Time-based unit awards

units

grant date fair value

Outstanding balance, June 30, 2021

 

6,587,261

$

1.28

Forfeited

 

(2,409,972)

$

1.28

Outstanding balance, March 31, 2022

 

4,177,289

$

1.28

Number of

Weighted average

Performance-based unit awards

units

grant date fair value

Outstanding balance, June 30, 2021

 

6,223,262

$

0.57

Forfeited

 

(3,210,939)

$

0.57

Outstanding balance, March 31, 2022

 

3,012,323

$

0.57

The total unrecognized compensation cost related to profits interests units outstanding as of March 31, 2022 was $6.4 million, comprised (i) $4.3 million related to time-based unit awards expected to be recognized over a weighted-average period of 0.9 years and (ii) $2.1 million related to performance-based unit awards, which will be recorded when it is probable that the performance-based criteria will be met.

2021 Omnibus Incentive Plan

In March 2021, the compensation committee of our Board of Directors approved the InnovAge Holding Corp. 2021 Omnibus Incentive Plan (the “2021 Omnibus Incentive Plan”), pursuant to which various stock-based awards may be granted to employees, directors, consultants, and advisers. The total number of shares of the Company’s common stock authorized under the 2021 Omnibus Incentive Plan is 14,700,000. The Company has issued time-based restricted stock units under this plan to its employees which generally vest (i) on March 4, 2023, the second anniversary of the grant date, or (ii) over a three-year period with one-third vesting on each anniversary of the date of grant. Certain other vesting periods have also been used. The grant date fair value of restricted stock units with time based vesting is based on the closing market price of our common stock on the date of grant. Certain awards under this plan vest upon achieving specific share price performance critiera and are determined to have performance-based vesting conditions.

25

Restricted Stock Units

A summary of time-based vesting restricted stock units activity for the nine months ended March 31, 2022 was as follows:

Weighted

    

average

Number of

grant-date fair

Restricted stock units - time based

awards

value per share

Outstanding balance, June 30, 2021

 

48,470

$

22.87

Granted

 

315,177

$

8.99

Forfeited

(9,670)

$

23.35

Exercised

(8,493)

$

17.66

Outstanding balance, March 31, 2022

 

345,484

$

10.50

The total unrecognized compensation cost related to time based restricted stock units outstanding as of March 31, 2022 was $4.0 million and is expected to be recognized over a weighted-average period of 2.0 years.

A summary of performance based vesting restricted stock units activity for the nine months ended March 31, 2022 was as follows:

Weighted

    

average

Number of

grant-date fair

Restricted stock units - performance based

awards

value per share

Outstanding balance, June 30, 2021

 

$

Granted

 

258,767

$

5.18

Forfeited

$

Outstanding balance, March 31, 2022

 

258,767

$

5.18

The fair value of the performance based restricted stock units and performance based stock options granted during the nine months ended March 31, 2022, was based upon a Monte Carlo option pricing model using the assumptions in the following table:

2022

Expected volatility

34.5

%

Expected term (in years)

5.0

Interest rate

 

1.56

%

Dividend yield

 

0

%

Weighted-average fair values

$

5.18

Fair value of underlying stock

 

$

7.89

The total unrecognized compensation cost related to performance based vesting restricted stock units outstanding as of March 31, 2022 was $1.2 million and is expected to be recognized over a weighted-average period of 3.6 years.

26

Nonqualified Stock Options

A summary of time-based vesting stock option activity for the nine months ended March 31, 2022 was as follows:

Weighted

    

average

Number of

grant-date fair

Stock options - time based

awards

value per share

Outstanding balance, June 30, 2021

 

$

Granted

 

554,499

$

1.61

Forfeited

$

Outstanding balance, March 31, 2022

 

554,499

$

1.61

The total unrecognized compensation cost related to time-based vesting stock options outstanding as of March 31, 2022 was $0.7 million and is expected to be recognized over a weighted-average period of 2.5 years.

The fair value of the time-based stock options granted during the nine months ended March 31, 2022, was based upon the Black-Scholes option pricing model using the assumptions in the following table:

2022

Expected volatility

34.5

%

Weighted-average expected life (years) - time vesting units

2.9

Interest rate

 

0.83

%

Dividend yield

 

0

%

Weighted-average fair values

$

1.61

Fair value of underlying stock

 

$

7.89

A summary of performance-based vesting stock option activity for the nine months ended March 31, 2022 was as follows:

Weighted

    

average

Number of

grant-date fair

Stock options - performance based

awards

value per share

Outstanding balance, June 30, 2021

 

$

Granted

 

776,299

$

3.08

Forfeited

$

Outstanding balance, March 31, 2022

 

776,299

$

3.08

The fair value of the performance-based stock options granted during the nine months ended March 31, 2022, was based upon a Monte Carlo option pricing model using the assumptions in the table above under the ‘Restricted Stock Units’ heading.

The total unrecognized compensation cost related to performance-based vesting stock options outstanding as of March 31, 2022 was $2.2 million and is expected to be recognized over a weighted-average period of 3.6 years.

27

Note 12: Income Taxes

The Company recorded an income tax benefit of $4.1 million and $4.3 million for the three months ended March 31, 2022 and 2021, respectively. The Company recorded a tax provision of $0.1 million and $5.2 million for the nine months ended March 31, 2022 and 2021, respectively. This represents an effective tax rate of 56.6% and 28.2% for the three months ended March 31, 2022 and 2021, respectively. This represents an effective tax rate of 1.4% and (11.2)% for the nine months ended March 31, 2022 and 2021, respectively.

The effective rate for the nine months ended March 31, 2022 was different from the federal statutory rate primarily due to the Company’s book loss offset partially by disallowed officers’ compensation under Internal Revenue Code (“IRC”) Section 162(m) and lobbying expenses which occurred during the nine month period.

The Company assesses the valuation allowance recorded against deferred tax assets at each reporting date. The determination of whether a valuation allowance for deferred tax assets is appropriate requires the evaluation of positive and negative evidence that can be objectively verified. Consideration must be given to all sources of taxable income available to realize deferred tax assets, including, as applicable, the future reversal of existing temporary differences, future taxable income forecasts exclusive of the reversal of temporary differences and carryforwards, taxable income in carryback years and tax planning strategies. In estimating income taxes, the Company assesses the relative merits and risks of the appropriate income tax treatment of transactions taking into account statutory, judicial, and regulatory guidance. As of the nine-month period ended March 31, 2022, the Company has determined that it is not “more likely than not” that the deferred tax assets associated with certain state net operating losses will be realized and as such continues to maintain a valuation allowance against these state deferred tax assets.

The CARES Act, among other things, includes provisions relating to refundable payroll tax credits, deferment of the employer portion of social security payments, net operating loss carryback periods, alternative minimum tax credit refunds, modifications to the net interest deduction limitation and technical corrections to tax depreciation methods for qualified improvement property. The Company continues to examine the impacts that the CARES Act may have on its business. While several of these provisions may impact the Company, there have not been any significant impacts noted through March 31, 2022.

Note 13: Earnings per Share

Basic earnings (loss) per share is computed using the weighted-average number of common shares outstanding during the period. Diluted earnings per share is computed using the weighted-average number of common shares outstanding during the period, plus the dilutive effect of outstanding options, using the treasury stock method and the average market price of the Company’s common stock during the applicable period. When a loss from continuing operations exists, all dilutive securities and potentially dilutive securities are anti-dilutive and are therefore excluded from the computation of diluted earnings per share. When net income from continuing operations exists, performance-based units, are omitted from the calculation of diluted EPS until it is determined that the performance criteria has been met at the end of the reporting period.

28

The following table sets forth the computation of basic and diluted net loss per common share:

Three months ended March 31, 

Nine months ended March 31, 

in thousands, except share values

    

2022

    

2021

    

2022

    

2021

Net income (loss) attributable to InnovAge Holding Corp.

$

(2,821)

$

(10,510)

$

6,188

$

(50,460)

Weighted average common shares outstanding (basic)

 

135,516,608

 

121,324,980

 

135,516,544

 

119,619,806

Earnings (loss) per share - basic

$

(0.02)

$

(0.09)

$

0.05

$

(0.42)

Dilutive shares

 

 

 

14,249

 

Weighted average common shares outstanding (diluted)

 

135,516,608

 

121,324,980

 

135,530,793

 

119,619,806

Earnings (loss) per share -diluted

$

(0.02)

$

(0.09)

$

0.05

$

(0.42)

Note 14: Segment Reporting

The Company applies ASC Topic 280, "Segment Reporting," which establishes requirements to report selected segment information quarterly and to report annually entity-wide disclosures about operations, major customers and the geographies in which the entity holds material assets and reports revenue. An operating segment is defined as a component that engages in business activities whose operating results are reviewed by the Company’s chief executive officer, who is the chief operating decision maker (“CODM”), and for which discrete financial information is available. The Company has determined that it has five operating segments, three of which are related to the Company’s PACE offering. The PACE-related operating segments are based on three geographic divisions, which are West, Central, and East. Due to the similar economic characteristics, nature of services, and customers, we have aggregated our West, Central, and East operating segments into one reportable segment for PACE. The Company’s remaining two operating segments relate to Homecare and Senior Housing, which are immaterial operating segments, and are shown below as "Other" along with certain corporate unallocated expenses.

As of March 31, 2022, the Company served approximately 6,800 PACE participants, making it the largest PACE provider in the U.S. based upon participants served, and operates 18 PACE centers across Colorado, California, New Mexico, Pennsylvania and Virginia. PACE, an alternative to nursing homes, is a managed care, capitated program, which serves the frail elderly in a community-based service model. Participants receive all medical services through a comprehensive, consolidated model of care. Capitation payments are received from Medicare parts C and D; Medicaid; the VA, and private pay sources. The Company is at risk for all health and allied care costs incurred with respect to the care of its participants, although it does negotiate discounted rates with its provider network consisting of hospitals, nursing homes, assisted living facilities, and medical specialists. Additionally, under the Medicare Prescription Drug Plan, CMS shares part of the risk for providing prescription medication to the Company’s participants.

The Company evaluates performance and allocates capital resources to each segment based on an operating model that is designed to maximize the provision of services provided and profitability. The Company does not review assets by segment and therefore assets by segment are not disclosed below. For the periods presented, all of the Company’s long-lived assets were located in the U.S. and all revenue was earned in the U.S.

The Company’s management uses Center-level Contribution Margin as the measure for assessing performance of its segments. Center-level Contribution Margin is defined as total revenues less external provider costs and cost of care (excluding depreciation and amortization), which includes all medical and pharmacy costs. The Company allocates corporate level expenses to its segments with a majority of the allocation going to the PACE segment.

29

The following table summarizes the operating results regularly provided to the CODM by reportable segment for the three months ended March 31, 2022 and 2021:

March 31, 2022

March 31, 2021

in thousands

    

PACE

    

All other(1)

    

Totals

    

PACE

    

All other(1)

    

Totals

Capitation revenue

$

176,988

$

$

176,988

$

155,835

$

$

155,835

Other service revenue

 

166

 

205

 

371

 

(47)

 

520

 

473

Total revenues

 

177,154

 

205

 

177,359

 

155,788

 

520

 

156,308

External provider costs

 

103,254

 

 

103,254

 

75,389

 

 

75,389

Cost of care, excluding depreciation and amortization

 

45,995

 

107

 

46,102

 

38,867

 

698

 

39,565

Center-level Contribution Margin

 

27,905

 

98

 

28,003

 

41,532

 

(178)

 

41,354

Overhead costs(2)

 

30,911

 

(85)

 

30,826

 

24,217

 

(30)

 

24,187

Depreciation and amortization

 

3,760

 

90

 

3,850

 

3,181

 

130

 

3,311

Equity loss

 

 

 

 

 

 

Other operating income

 

 

 

 

19,222

 

 

19,222

Interest expense, net

 

(663)

 

(46)

 

(709)

 

(4,824)

 

(52)

 

(4,876)

Loss on extinguishment of debt

 

 

 

 

(13,488)

 

 

(13,488)

Gain on equity method investment

 

 

 

 

10,871

 

 

10,871

Other expense (income)

 

108

 

 

108

 

(2,267)

 

 

(2,267)

Income (Loss) Before Income Taxes

$

(7,321)

$

47

$

(7,274)

$

(14,796)

$

(330)

$

(15,126)

The following table summarizes the operating results regularly provided to the CODM by reportable segment for the nine months ended March 31, 2022 and 2021:

March 31, 2022

March 31, 2021

in thousands

    

PACE

    

All other(1)

    

Totals

    

PACE

    

All other(1)

    

Totals

Capitation revenue

$

524,507

$

$

524,507

$

464,294

$

$

464,294

Other service revenue

 

234

 

1,039

 

1,273

 

213

 

1,677

 

1,890

Total revenues

 

524,741

 

1,039

 

525,780

 

464,507

 

1,677

 

466,184

External provider costs

 

284,299

 

 

284,299

 

224,215

 

 

224,215

Cost of care, excluding depreciation and amortization

 

128,573

 

1,167

 

129,740

 

113,611

 

2,311

 

115,922

Center-Level Contribution Margin

 

111,869

 

(128)

 

111,741

 

126,681

 

(634)

 

126,047

Overhead costs(2)

 

93,463

 

(98)

 

93,365

 

120,249

 

(13)

 

120,236

Depreciation and amortization

 

10,130

 

305

 

10,435

 

8,901

 

361

 

9,262

Equity loss

 

 

 

 

1,343

 

 

1,343

Other operating (income) expense

 

 

 

 

18,211

 

 

18,211

Interest expense, net

 

(1,783)

 

(147)

 

(1,930)

 

(16,919)

 

(142)

 

(17,061)

Loss on extinguishment of debt

 

 

 

 

(14,479)

 

 

(14,479)

Gain on equity method investment

 

 

 

 

10,871

 

 

10,871

Other income

 

(357)

 

(1)

 

(358)

 

(2,222)

 

 

(2,222)

Income (Loss) Before Income Taxes

$

6,136

$

(483)

$

5,653

$

(44,772)

$

(1,124)

$

(45,896)

(1)Center-level Contribution Margin from segments below the quantitative thresholds are attributable to two operating segments of the Company. Those segments consist of Homecare and Senior Housing. Neither of those segments has ever met any of the quantitative thresholds for determining reportable segments.

30

(2)Overhead consists of the Sales and marketing and Corporate, general and administrative financial statement line items.

Note 15: Related-party

Pursuant to the PWD Amended and Restated Agreement of Limited Partnership, the general partner, who is a subsidiary of the Company (the “General Partner”), helped fund operating deficits and shortfalls of PWD in the form of a loan. At each of March 31, 2022 and June 30, 2021, $0.7 million was recorded in Deposits and other. Additionally, the General Partner is paid an administration fee of $35,000 per year.

Note 16: Subsequent Events

The Company has evaluated subsequent events through May 10, 2022, the date on which the condensed consolidated financial statements were issued.

31

Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations

The following discussion of our financial condition and results of operations should be read in conjunction with our condensed consolidated financial statements and the related notes included elsewhere in this Quarterly Report on Form 10-Q. The discussion contains forward-looking statements that are based on the beliefs of management, as well as assumptions made by, and information currently available to, our management. Readers are cautioned not to place undue reliance on any forward-looking statements, as forward-looking statements are not guarantees of future performance and the Company’s actual results may differ significantly due to numerous known and unknown risks and uncertainties, including those discussed below and in the section entitled “Cautionary Note on Forward-Looking Statements.” Those known risks and uncertainties include, but are not limited to, the risk factors identified in the section titled “Risk Factors” in this Quarterly Report on Form 10-Q and in our Annual Report on Form 10-K for the fiscal year ended June 30, 2021 (“2021 10-K”).

Overview

InnovAge Holding Corp. (“InnovAge”), formerly TCO Group Holdings, Inc., became a public company in March 2021. As of March 31, 2022, the Company served approximately 6,800 PACE participants, and operated 18 PACE centers across Colorado, California, New Mexico, Pennsylvania, and Virginia.  

Impact of COVID-19

The COVID-19 virus has and continues to disproportionately impact older adults, especially those with chronic illnesses, which describes our participants.

Despite the challenges brought on by COVID-19, as of March 31, 2022, we continue care delivery through telehealth and predominantly at our centers, all of which remain fully opened during the period. As economies around the world reopened in 2021, sharp increases in demand are creating significant disruptions to the global supply chain. Global logistics network challenges have resulted in higher prices for the medical supplies we require. Uncertainties related to the magnitude and duration of global supply chain disruptions have adversely affected, and may continue to adversely affect, our business and outlook.

For additional information on the various risks posed by the COVID-19 pandemic, please see the section entitled “Risk Factors” included in Part I, Item 1A of our 2021 10-K.

Key Factors Affecting Our Performance

Our historical financial performance has been, and we expect our financial performance in the future to be, driven by the following factors:

Our participants. We focus on providing all-inclusive care to frail, high-cost, dual-eligible seniors. We directly contract with government payors, such as Medicare and Medicaid, through PACE and receive a capitated risk-adjusted payment to manage the totality of a participant’s medical care across all settings. InnovAge manages participants that are, on average, more complex and medically fragile than other Medicare-eligible patients, including those in Medicare Advantage (“MA”) programs. As a result, we receive larger payments for our participants compared to MA participants. This is driven by two factors: (i) we manage a higher acuity population, with an average risk adjustment factor (“RAF”) score of 2.41 based on InnovAge data as of March 31, 2022; and (ii) we manage Medicaid spend in addition to Medicare. Our participants are managed on a capitated, or at-risk basis, where InnovAge is financially responsible for all of participant medical costs. Our comprehensive care model and globally capitated payments are designed to cover participants from enrollment until the end of life, including coverage for participants requiring hospice and palliative care. For dual-eligible participants, we receive per member, per month (“PMPM”) payments directly from Medicare and Medicaid, which provides recurring revenue streams and significant visibility into our revenue. The Medicare portion of our capitated payment is risk-based on the underlying medical conditions and frailty of each participant.

32

Our ability to grow enrollment and capacity within existing centers. We believe all seniors should have access to the type of all-inclusive care offered by the PACE model. Several factors can affect our ability to grow enrollment and capacity within existing centers, including sanctions issued by regulators. Currently, the Centers for Medicare and Medicaid Services (“CMS”) and state agencies have suspended new enrollments at our Sacramento, California center and at our centers in the State of Colorado. See “Risk Factors” in Part II, Item 1A.
Our ability to maintain high participant satisfaction and retention. We achieved an 81% participant satisfaction rating as of December 2021 and average participant tenure was 3.0 years as of March 31, 2022, measured as tenure from enrollment to disenrollment, among our centers that have been operated by us for at least five years. Furthermore, we experience low levels of voluntary disenrollment, averaging 5% annually over the last three fiscal years. Approximately 75% of our historical disenrollments have been involuntary, due primarily to participant death or otherwise due to participants moving out of our service areas.
Effectively managing the cost of care for our participants. We receive capitated payments to manage the totality of a participant’s medical care across all settings. Because our participants are among the most frail and medically complex individuals in the U.S. healthcare system, our external provider costs and cost of care, excluding depreciation and amortization, represented approximately 79% of our revenue in the nine months ended March 31, 2022. While we are liable for potentially large medical claims, our care model focuses on delivering high-quality medical care in cost efficient, community-based settings as a means of avoiding costly inpatient and outpatient services. However, our participants retain the freedom to seek care at sites of their choice, including hospitals and emergency rooms; we do not restrict participant access to care.
Center-level Contribution Margin. As we serve more participants in existing centers, we leverage our fixed cost base at those centers and the value of a center to our business increases over time. The enrollment sanctions in place in Sacramento, California and Colorado limit our ability to grow our participant census and impact Center-level Contribution Margin. See “Risk Factors” in Part II, Item 1A.
Our ability to expand via acquisition or de novo centers within existing and new markets. Several factors can affect our ability to open de novo centers, including sanctions issued by regulators. On January 7, 2022, the Department of Health Care Services (“DHCS”) of the State of California notified us that it was suspending the State’s previously provided assurances that it would enter into a PACE program agreement with the Company (State Attestations) with respect to de novo centers in the State of California until such time as the corrective action plans (“CAPs”) and the remediation and validation processes for our Sacramento center have been successfully completed and the enrollment sanctions are lifted. In addition, on February 9, 2022, we received notice from the Cabinet for Health and Family Services of the State of Kentucky informing us that they no longer intend to enter into an agreement with us to be a PACE provider in the State of Kentucky. On February 14, 2022, CMS denied our application to develop the previously announced PACE center in Terre Haute, Indiana, which was projected to open in fiscal year 2024 based on deficiencies detected during CMS’ 2021 audits of our Sacramento and Colorado PACE programs. In addition, we have committed to CMS and the Agency for Healthcare Administration in the State of Florida, that we will proactively pause remaining steps with respect to de novo centers to focus on remediating deficiencies raised in the audit processes. See “Risk Factors” in Part II, Item 1A.
Execute tuck-in acquisitions. Over the past three fiscal years, we have acquired and integrated three PACE organizations, expanding our InnovAge Platform to one new state and four new markets through those acquisitions. We are disciplined in our approach to acquisitions and have executed multiple types of transactions, including turnarounds and non-profit conversions. When integrating acquired programs, we work closely with key constituencies, including local governments, health systems and senior housing providers, to enable continuity of high-quality care for participants.
Contracting with government payors. Our economic model relies on our capitated arrangements with government payors, namely Medicare and Medicaid. We view the government not only as a payor but also

33

as a key partner in our efforts to expand into new geographies and access more participants in our existing markets. Maintaining, supporting and growing these relationships in existing markets as well as new geographies, is critical to our long-term success.
Investing to support growth. We intend to continue investing in our centers, value-based care model, and sales and marketing organization to support long-term growth. We expect our expenses to increase in absolute dollars for the foreseeable future to support our growth and due to additional costs we are incurring and expect to incur as a public company, including expenses related to compliance with the rules and regulations of the SEC and the listing standards of Nasdaq, additional corporate and director and officer insurance, investor relations and increased legal, audit, reporting and consulting fees. We also expect to incur additional expenses for the foreseeable future in connection with current and future audits to our centers, remediation plans and current and potential legal and regulatory proceedings. We plan to invest in future growth judiciously and maintain focus on managing our results of operations. Accordingly, in the short term we expect the activities noted above to increase our expenses as a percentage of revenue, but in the longer term, we anticipate that these investments will positively impact our business and results of operations.
Seasonality of our business. Our operational and financial results, including medical costs and per-participant revenue true-ups, will experience some variability depending upon the time of year in which they are measured. Medical costs vary most significantly as a result of (i) the weather, with certain illnesses, such as the influenza virus, being more prevalent during colder months of the year, which generally increases per-participant costs and (ii) the number of business days in a period, with shorter periods generally having lower medical costs all else equal. Per-participant revenue true-ups represent the difference between our estimate of per-participant capitation revenue to be received and actual revenue received by CMS, which is based on CMS’s determination of a participant’s RAF score as measured twice per year and is based on the evolving acuity of a participant. Based on the difference between our estimate and the final determination from CMS, we may receive incremental true up revenue or be required to repay certain amounts. Historically, these true-up payments typically occur between May and August, but the timing of these payments is determined by CMS, and we have neither visibility nor control over the timing of such payments.

Components of Results of Operations

Revenue

Capitation Revenue.   In order to provide comprehensive services to manage the totality of a participant’s medical care across all settings, we receive fixed or capitated fees per participant that are paid monthly by Medicare, Medicaid, Veterans Affairs (“VA”) and private pay sources.

Medicaid and Medicare capitation revenues are based on PMPM capitation rates under the PACE program. The PACE state contracts between us and the respective state Medicaid administering agency are amended annually each June 30 in all states other than California and Pennsylvania, which contract on a calendar-year basis. New agreements have been executed for the periods (i) January 1, 2021 through December 31, 2022 for California and (ii) July 1, 2021 through June 30, 2022 for all other states, except Pennsylvania, for which we are currently operating in good standing under the 2020 amended agreement while the agency finalizes its 2021 amendment. For a discussion of our revenue recognition policies, please see Critical Accounting Policies and Estimates below and Note 2 “Summary of Significant Accounting Policies” to our consolidated financial statements included in our 2021 10-K.

Other Service Revenue. Other service revenue primarily consists of revenues derived from fee-for-service arrangements, state food grants, rent revenues and management fees. We generate fee-for-service revenue from providing home-care services to non-PACE patients in their homes, for which we bill the patient or their insurance plan on a fee-for-service basis. For a discussion of our revenue recognition policies, please see Critical Accounting Policies and Estimates below and Note 2, “Summary of Significant Accounting Policies” to our consolidated financial statements included in our 2021 10-K.

34

Operating Expenses

External Provider Costs.   External provider costs consist primarily of the costs for medical care provided by non-InnovAge providers. We separate external provider costs into four categories: inpatient (e.g., hospital and skilled nursing facility), housing (e.g., assisted living), outpatient and pharmacy. In aggregate, external provider costs represent the largest portion of our expenses.

Cost of Care, Excluding Depreciation and Amortization.   Cost of care, excluding depreciation and amortization, includes the costs we incur to operate our care delivery model. This includes costs related to IDTs, salaries, wages and benefits for center-level staff, participant transportation, medical supplies, occupancy, insurance and other operating costs. IDT employees include medical doctors, registered nurses, social workers, physical, occupational, and speech therapists, nursing assistants, and transportation workers. Center-level employees include clinic managers, dieticians, activity assistants and certified nursing assistants. Cost of care excludes any expenses associated with sales and marketing activities incurred at a local level as well as any allocation of our corporate, general and administrative expenses. A portion of our cost of care is fixed relative to the number of participants we serve, such as occupancy and insurance expenses. The remainder of our cost of care, including our employee-related costs, is directly related to the number of participants cared for in a center. As a result, as revenue increases due to census growth, cost of care, excluding depreciation and amortization, typically decreases as a percentage of revenue. As we open new centers, we expect cost of care, excluding depreciation and amortization, to increase in absolute dollars due to higher census and facility related costs.

Sales and Marketing.   Sales and marketing expenses consist of employee-related expenses, including salaries, commissions, and employee benefits costs, for all employees engaged in marketing, sales, community outreach and sales support. These employee-related expenses capture all costs for both our field-based and corporate sales and marketing teams. Sales and marketing expenses also include local and centralized advertising costs, as well as the infrastructure required to support our marketing efforts. We expect these costs to increase in absolute dollars over time as we continue to grow our participant census. We evaluate our sales and marketing expenses relative to our participant growth and will invest more heavily in sales and marketing from time-to-time to the extent we believe such investment can accelerate our growth without negatively affecting profitability.

Corporate, General and Administrative.   Corporate, general and administrative expenses include employee-related expenses, including salaries and related costs. In addition, general and administrative expenses include all corporate technology and occupancy costs associated with our regional corporate offices. We expect our general and administrative expenses to increase in absolute dollars due to the additional legal, accounting, insurance, investor relations and other costs that we incur as a public company, as well as other costs associated with continuing to grow our business. However, we anticipate general and administrative expenses to decrease as a percentage of revenue over the long term, although such expenses may fluctuate as a percentage of revenue from period to period due to the timing and amount of these expenses.

Depreciation and Amortization. Depreciation and amortization expenses are primarily attributable to our buildings and leasehold improvements and our equipment and vehicles. Depreciation and amortization are recorded using the straight-line method over the shorter of estimated useful life or lease terms, to the extent the assets are being leased.

Equity Loss. Equity loss relates to our equity method investment in InnovAge Sacramento, which began operations in July 2020 and subsequently became a consolidated entity effective January 1, 2021.

Other Operating Income. Other operating income consists of the re-measurement of contingent consideration to fair value relating to our acquisition of NewCourtland.

For more information relating to the components of our results of operations, see Results of Operations below and Note 2 “Summary of Significant Accounting Policies” to our consolidated financial statements included in our 2021 10-K.

35

Results of Operations

The results of our operations for the three and nine months ended March 31, 2022 include those of InnovAge Sacramento, which during the same period of the prior year was not a consolidated entity. The following table sets forth our consolidated results of operations for the periods presented:

    

Three Months Ended

Nine Months Ended

March 31, 

March 31, 

in thousands

    

2022

    

2021

2022

    

2021

Revenues

  

 

  

  

 

  

Capitation revenue

$

176,988

$

155,835

$

524,507

$

464,294

Other service revenue

 

371

 

473

 

1,273

 

1,890

Total revenues

 

177,359

 

156,308

 

525,780

 

466,184

Expenses

 

  

 

  

 

  

 

  

External provider costs

 

103,254

 

75,389

 

284,299

 

224,215

Cost of care, excluding depreciation and amortization

 

46,102

 

39,565

 

129,740

 

115,922

Sales and marketing

 

6,144

 

5,592

 

19,117

 

14,335

Corporate, general and administrative

 

24,682

 

18,595

 

74,248

 

105,901

Depreciation and amortization

 

3,850

 

3,311

 

10,435

 

9,262

Equity loss

 

 

 

 

1,343

Other operating income

 

 

19,222

 

 

18,211

Total expenses

 

184,032

 

161,674

 

517,839

 

489,189

Operating Income (Loss)

$

(6,673)

$

(5,366)

$

7,941

$

(23,005)

Other Income (Expense)

 

  

 

  

 

  

 

  

Interest expense, net

 

(709)

 

(4,876)

 

(1,930)

 

(17,061)

Loss on extinguishment of debt

 

 

(13,488)

 

 

(14,479)

Gain on equity method investment

10,871

10,871

Other income (expense)

 

108

 

(2,267)

 

(358)

 

(2,222)

Total other expense

 

(601)

 

(9,760)

 

(2,288)

 

(22,891)

Income (Loss) Before Income Taxes

 

(7,274)

 

(15,126)

 

5,653

 

(45,896)

Provision (Benefit) for Income Taxes

 

(4,116)

 

(4,264)

 

81

 

5,159

Net Income (Loss)

$

(3,158)

$

(10,862)

$

5,572

$

(51,055)

Less: net loss attributable to noncontrolling interests

 

(337)

 

(352)

 

(616)

 

(595)

Net Income (Loss) Attributable to InnovAge Holding Corp.

$

(2,821)

$

(10,510)

$

6,188

$

(50,460)

Revenues

Three Months Ended

    

    

    

    

    

 

Nine Months Ended

    

    

    

    

    

 

March 31, 

Change

March 31, 

Change

    

2022

    

2021

    

$

    

%

2022

    

2021

    

$

%

in thousands

 

  

 

  

 

  

 

  

  

 

  

 

  

 

  

Capitation revenue

$

176,988

$

155,835

$

21,153

 

13.6

%

$

524,507

$

464,294

$

60,213

 

13.0

%

Other service revenue

 

371

 

473

 

(102)

 

(21.6)

%

 

1,273

 

1,890

 

(617)

 

(32.6)

%

Total revenues

$

177,359

$

156,308

$

21,051

 

13.5

%

$

525,780

$

466,184

$

59,596

 

12.8

%

Capitation revenue. Capitation revenue was $177.0 million for the three months ended March 31, 2022, an increase of $21.2 million, or 13.6%, compared to $155.8 million for the three months ended March 31, 2021. This increase was driven by (i) a 9.9% increase in capitation rates and (ii) a 3.4% increase in member months (as defined below). The increase in capitation rates was primarily driven by an annual increase in both Medicaid and Medicare capitation rates as a result of increased risk score and county rates.

Capitation revenue was $524.5 million for the nine months ended March 31, 2022, a decrease of $60.2 million, or 13.0% compared to $464.3 million for the nine months ended March 31, 2021. This increase was driven by (i) a 6.3% increase in capitation rates and (ii) an 6.2% increase in member months (as defined below). The increase in capitation rates

36

was primarily driven by an annual increase in both Medicaid and Medicare capitation rates as a result of increased risk score and county rates.

Other service revenue. Other service revenue was $0.4 million for the three months ended March 31, 2022, a decrease of $0.1 million, or 21.6%, from $0.5 million for the three months ended March 31, 2021. Other service revenue was $1.3 million for the nine months ended March 31, 2022, a decrease of $0.6 million, or 32.6%, from $1.9 million for the nine months ended March 31, 2021.

Operating Expenses

Three Months Ended

    

    

    

    

 

Nine Months Ended

    

    

    

    

 

March 31, 

Change

March 31, 

Change

2022

    

2021

    

$

    

%

2022

    

2021

    

$

    

%

in thousands

 

  

 

 

  

 

 

  

 

  

 

  

 

 

  

 

 

  

 

  

External provider costs

$

103,254

$

75,389

$

27,865

 

37.0

%

$

284,299

$

224,215

$

60,084

 

26.8

%

Cost of care (excluding depreciation and amortization)

46,102

39,565

6,537

 

16.5

%

129,740

115,922

13,818

 

11.9

%

Sales and marketing

6,144

5,592

552

 

9.9

%

19,117

14,335

4,782

 

33.4

%

Corporate, general, and administrative

24,682

18,595

6,087

 

32.7

%

74,248

105,901

(31,653)

 

(29.9)

%

Depreciation and amortization

3,850

3,311

539

 

16.3

%

10,435

9,262

1,173

 

12.7

%

Equity loss

 

 

 

*

 

1,343

 

(1,343)

 

(100.0)

%

Other operating income

 

 

19,222

 

(19,222)

 

(100.0)

%

 

 

18,211

 

(18,211)

 

(100.0)

%

Total operating expenses

$

184,032

 

$

161,674

 

$

22,358

 

$

517,839

 

$

489,189

 

$

28,650

 

___________________

*not meaningful

External provider costs. External provider costs were $103.3 million for the three months ended March 31, 2022, an increase of $27.9 million, or 37.0%, compared to $75.4 million for the three months ended March 31, 2021. The increase is primarily driven by (i) an increase of 32.5% in cost per participant and (ii) an increase of 3.4% in member months. The increase in cost per participant is primarily driven by the net effect of (i) an increase in outpatient and specialist care expenses, in part as a result of our participants seeking healthcare services that were delayed during the COVID-19 pandemic, (ii) an increase in inpatient and medical respite utilization and cost as a result of the Omicron surge, (iii) increased housing utilization, and (iv) increased housing rates as mandated by certain states.

External provider costs were $284.3 million for the nine months ended March 31, 2022, an increase of $60.1 million, or 26.8%, compared to $224.2 million for the nine months ended March 31, 2021. The increase is primarily driven by (i) an increase of 19.4% in cost per participant and (ii) an increase of 6.2% in member months. The increase in cost per participant is primarily driven by the net effect of an increase in housing, outpatient, inpatient and specialist care expenses.

Cost of care (excluding depreciation and amortization). Cost of care (excluding depreciation and amortization) expense was $46.1 million for the three months ended March 31, 2022, an increase of $6.5 million, or 16.5%, compared to $39.6 million for the three months ended March 31, 2021, primarily due to the net effect of (i) an increase of 3.4% in member months and (ii) an increase of 12.7% in cost per participant. The increase in cost per participant was driven by an increase in operational costs of reopening our centers following shutdowns as a result of COVID-19, pre-opening losses associated with de novo locations, and an increase wage rates.

Cost of care (excluding depreciation and amortization) expense was $129.7 million for the nine months ended March 31, 2022, an increase of $13.8 million, or 11.9%, compared to $115.9 million for the nine months ended March 31, 2021, primarily due to the net effect of (i) an increase of 6.2% in member months and (ii) an increase of 5.4% in cost per participant. The increase in cost per participant was driven by an increase in operational costs of reopening our centers following shutdowns as a result of COVID-19, pre-opening losses associated with de novo locations, and an increase in wage rates.

Sales and marketing. Sales and marketing expenses were $6.1 million for the three months ended March 31, 2022, an increase of $0.6 million, or 9.9%, compared to $5.6 million for the three months ended March 31, 2021, primarily due to

37

an increase in employee compensation and benefits due to an increase in full time employees coupled with costs associated with organizational realignment partially offset by a reduction in marketing spend associated with the ongoing sanctions.

Sales and marketing expenses were $19.1 million for the nine months ended March 31, 2022, an increase of $4.8 million, or 33.4%, compared to $14.3 million for the nine months ended March 31, 2021, primarily due to an increase in (i) employee compensation and benefits due to an increase in FTEs and (ii) costs associated with organizational realignment, and (iii) costs associated with certain new advertising campaigns to raise PACE awareness.

Corporate, general and administrative. Corporate, general and administrative expenses were $24.7 million for the three months ended March 31, 2022, an increase of $6.1 million, or 32.7%, compared to $18.6 million for the three months ended March 31, 2021. The increase is related to (i) employee compensation and benefits as the result of an increase in FTEs, (ii) compliance-related expense, (iii) costs associated with organizational realignment, and (iv) increased costs associated with being a publicly traded company.

Corporate, general and administrative expenses were $74.2 million for the nine months ended March 31, 2022, a decrease of $31.7 million, or 29.9%, compared to $105.9 million for the nine months ended March 31, 2021. The decrease was primarily due to the fees incurred during fiscal year 2021 as a result of the Apax Transaction (as defined below). In connection with the Apax Transaction, $45.4 million was recorded related to the cancellation of 16,994,975 common stock options outstanding under the Company’s 2016 Equity Incentive Plan and $13.1 million of transaction related costs were recorded as corporate, general and administrative expenses. Offsetting the decrease of $58.5 million related to the Apax Transaction were expenses related to (i) employee compensation and benefits as the result of an increase in FTEs, (ii) compliance-related expense, (iii) costs associated with organizational realignment, (iv) increased legal costs, (v) costs associated with executive severance and recruiting and (vi) increased costs associated with being a publicly traded company.

Depreciation and amortization. Depreciation and amortization expense was $3.9 million for the three months ended March 31, 2022, an increase of $0.5 million, or 16.3%, compared to $3.3 million for the three months ended March 31, 2021. Depreciation and amortization expense was $10.4 million for the nine months ended March 31, 2022, an increase of $1.2 million, or 12.7%, compared to $9.3 million for the nine months ended March 31, 2021. This increase in both periods is due to an increase in depreciation expense as a result of capital additions in the normal course of business.

Equity loss. Equity loss of $- million for the three months ended March 31, 2021 and $1.3 million for the nine months ended March 31, 2021 related to our equity method investment in InnovAge Sacramento. InnovAge Sacramento began operations in July 2020 and was subsequently consolidated into operations effective January 1, 2021, therefore there are no equity earnings for the three and nine months ended March 31, 2022.

Other operating income. Other operating income was $19.2 million for the three months ended March 31, 2021 and $18.2 million for the nine months ended March 31, 2021 due to the change in fair value of contingent consideration. The contingent consideration was paid in March 2021 and there were no amounts outstanding as of March 31, 2022.

Other Income (Expense)

Three Months Ended

    

    

    

    

    

 

Nine Months Ended

    

    

    

    

    

 

March 31, 

Change

March 31, 

Change

    

2022

    

2021

    

$

    

%

2022

    

2021

    

$

    

%

in thousands

 

 

  

 

 

  

 

 

  

 

  

 

  

 

 

  

 

 

  

 

  

Interest expense, net

 

$

(709)

 

$

(4,876)

 

$

4,167

 

85.5

%

$

(1,930)

 

$

(17,061)

 

$

15,131

 

88.7

%

Loss on extinguishment of debt

(13,488)

13,488

*

(14,479)

14,479

*

Gain on equity method investment

10,871

(10,871)

*

10,871

(10,871)

*

Other expense

 

108

 

(2,267)

 

2,375

 

104.8

%

 

(358)

 

(2,222)

 

1,864

 

83.9

%

Total other expense

 

$

(601)

 

$

(9,760)

 

$

9,159

 

$

(2,288)

 

$

(22,891)

 

$

20,603

 

___________________

*not meaningful

38

Interest expense, net. Interest expense, net, consists primarily of interest payments on our outstanding borrowings, net of interest income earned on our cash and cash equivalents and restricted cash. Interest expense, net was $0.7 million for the three months ended March 31, 2022, a decrease of $4.2 million, or 85.5%, compared to $4.9 million for the three months ended March 31, 2021. Interest expense, net was $1.9 million for the nine months ended March 31, 2022, a decrease of $15.1 million, or 88.7%, compared to $17.1 million for the nine months ended March 31, 2021. The decrease was primarily due to (i) a lower outstanding debt balance and (ii) to a lesser extent, a lower average interest rate. For additional information regarding our outstanding indebtedness, see Note 8, “Long-Term Debt” to our condensed consolidated financial statements.

Loss on extinguishment of debt. We recognized a loss on extinguishment of debt of $13.5 million and $14.5 million for the three and nine months ended March 31, 2021, respectively, and no loss on extinguishment of debt for the three and nine months ended March 31, 2022.

Gain on equity method investment. We recognized a gain on equity method investment of $10.9 million for the three and nine months ended March 31, 2021, related to the consolidation of InnovAge Sacramento beginning January 1, 2021, and no gain on equity method investment for the three and nine months ended March 31, 2022.

Provision for Income Taxes   

The Company and its subsidiaries calculate federal and state income taxes currently payable and for deferred income taxes arising from temporary differences between the financial statement carrying amounts of existing assets and liabilities and their respective tax bases. Deferred tax assets and liabilities are measured pursuant to enacted tax laws and rates applicable to periods in which those temporary differences are expected to be recovered or settled. The impact on deferred tax assets and liabilities of a change in tax rates is recognized in income in the period that includes the date of enactment. The members of SH1 and Sacramento have elected to be taxed as partnerships, and no provision for income taxes for SH1 or Sacramento is included in these condensed consolidated financial statements.

A valuation allowance is provided to the extent that it is more likely than not that deferred tax assets will not be realized. Tax benefits from uncertain tax positions are recognized when it is more likely than not that the position will be sustained upon examination based on the technical merits of the position. The amount recognized is measured as the largest amount of benefit that has a greater than 50% likelihood of being realized upon settlement. The Company recognizes interest and penalty expense associated with uncertain tax positions as a component of provision for income taxes.

During the nine months ended March 31, 2022 and 2021, we reported provision for income taxes of $0.1 million and $5.2 million, respectively. The decrease of $5.1 million is primarily due to certain permanent differences between the financial and tax accounting treatment of (a) the Section 162(m) limitation on compensation of five highest paid officers and (b) transaction costs associated with the Apax Transaction in 2020. These differences resulted in our pretax book loss generating taxable net income for the nine months ended March 31, 2021. The taxable net income for the nine months ended March 31, 2022 was lower than the taxable net income for the nine months ended March 31, 2021.

Net Loss Attributable to Noncontrolling Interests.   

InnovAge Senior Housing Thornton, LLC (“SH1”) is a Variable Interest Entity (“VIE”). The Company is the primary beneficiary of SH1 and consolidates SH1. The Company is the primary beneficiary of SH1 because it has the power to direct the activities that are most significant to SH1 and has an obligation to absorb losses or the right to receive benefits from SH1. The most significant activity of SH1 is the operation of the housing facility. The Company has provided a subordinated loan to SH1 and has provided a guarantee for the convertible term loan held by SH1. The SH1 interest is reflected within equity as noncontrolling interests. Our share of earnings are recorded in the consolidated statements of operations and the share of the other noncontrolling interest holders’ earnings are recorded as net loss attributable to noncontrolling interests.

The Company has a controlling interest in InnovAge Sacramento. As of January 1, 2021, our share of earnings are recorded in the consolidated statements of operations and the share of the other noncontrolling interest holders’ earnings are recorded as net loss attributable to noncontrolling interests.

39

Net Income (Loss)

During the three months ended March 31, 2022 and 2021, we reported net loss of $3.2 million and $10.9 million, respectively, consisting of (i) loss from operations of $6.7 million and $5.4 million, respectively, (ii) other expense of $0.6 million and $9.8 million, respectively, and (iii) provision for income taxes of $4.1 million and $4.3 million, respectively, each as described above.   

During the nine months ended March 31, 2022 and 2021, we reported net income of $5.6 million and a net loss of $51.1 million, respectively, consisting of (i) income from operations of $7.9 million and $23.0 million, respectively, (ii) other expense of $2.3 million and $22.9 million, respectively, and (iii) provision for income taxes of $0.1 million and $5.2 million, respectively, each as described above.   

Key Business Metrics and Non-GAAP Measures

In addition to our GAAP financial information, we review a number of operating and financial metrics, including the following key metrics and non-GAAP measures, to evaluate our business, measure our performance, identify trends affecting our business, formulate business plans and make strategic decisions. We believe these metrics provide additional perspective and insights when analyzing our core operating performance from period to period and evaluating trends in historical operating results. These key business metrics and non-GAAP measures should not be considered superior to, or a substitute for, and should be read in conjunction with, the GAAP financial information presented herein. These measures may not be comparable to similarly-titled performance indicators used by other companies.

Nine Months Ended March 31, 

    

2022

2021

dollars in thousands

Key Business Metrics:

 

  

 

 

  

Centers(a)

 

18

 

 

18

Census(a)(b)

 

6,800

 

 

6,655

Total Member Months(a)

 

62,726

 

 

59,050

Center-level Contribution Margin

$

111,741

$

126,047

Center-level Contribution Margin as a % of revenue

 

21.3

%  

 

27.0

%

 

 

 

Non-GAAP Measures:

Adjusted EBITDA(c)

 

$

34,895

 

$

65,985

Adjusted EBITDA Margin(c)

 

6.6%

 

14.2%

(a)Amount for 2021 includes InnovAge Sacramento, which the Company owns and controls through a joint venture and is consolidated in our financial statements as of January 1, 2021.
(b)Participant numbers are approximate.
(c)Adjusted EBITDA and Adjusted EBITDA margin are non-GAAP measures. For a definition and reconciliation of these non-GAAP measures to the most closely comparable GAAP measures for the period indicated, see below under “Adjusted EBITDA.”

Centers

We define our centers as those centers open for business and attending to participants at the end of a particular period.

Census

Our census is comprised of our capitated participants for whom we are financially responsible for their total healthcare costs.

40

Total Member Months

We define Total Member Months as the total number of participants multiplied by the number of months within a year in which each participant was enrolled in our program. We believe this is a useful metric as it more precisely tracks the number of participants we serve throughout the year.

Center-level Contribution Margin

We define Center-level Contribution Margin as total revenues less external provider costs and cost of care, excluding depreciation and amortization, which includes all medical and pharmacy costs. For purposes of evaluating Center-level Contribution Margin on a center-by-center basis, we do not allocate our sales and marketing expense or corporate, general and administrative expenses across our centers. Center-level Contribution Margin was $111.7 million and $126.0 million for the nine months ended March 31, 2022 and 2021, respectively.

Adjusted EBITDA

We define Adjusted EBITDA as net income adjusted for interest expense, depreciation and amortization, and provision for income tax as well as addbacks for non-recurring expenses or exceptional items, including charges relating to management equity compensation, rate determination, executive severance and recruitment, class action litigation, M&A diligence, transaction and integration, business optimization, electronic medical record (“EMR”) implementation, financing-related fees and contingent consideration. For the nine months ended March 31, 2022 and 2021, net income was $5.6 million and net loss was $51.1 million, respectively, and our net income (loss) margin was 1.1% and (11%), respectively. Adjusted EBITDA was $34.9 million and $66.0 million, for the nine months ended March 31, 2022 and 2021, respectively, representing a year-over-year decrease of 47.1%. The decrease in Adjusted EBITDA and Adjusted EBITDA margin is primarily from (i) the impact of normalization of center-level contribution margin as a result of (a) our participants seeking healthcare services that were delayed during the onset of the COVID-19 pandemic coupled with the Omicron surge and state-mandated increases in housing cost, and (b) costs associated with the re-opening of our centers and higher wage rates, (ii) an increase in sales and marketing expense as a result of growth and our investment in digital and other sales initiatives and (iii) higher corporate, general and administrative expenses, primarily attributable to growth and costs associated with being a publicly traded company.

41

A reconciliation of Adjusted EBITDA to net income, the most directly comparable GAAP measure, for each of the periods is as follows:

Three Months Ended

Nine Months Ended

March 31, 

March 31, 

in thousands

    

2022

    

2021

2022

    

2021

Net income (loss)

    

$

(3,158)

    

$

(10,862)

$

5,572

    

$

(51,055)

Interest expense, net

 

709

 

4,876

 

1,930

 

17,061

Depreciation and amortization

 

3,850

 

3,311

 

10,435

 

9,262

Provision for income tax

 

(4,116)

 

(4,264)

 

81

 

5,159

Stock-based compensation

 

845

 

530

 

2,586

 

1,102

Rate determination(a)

 

 

 

 

(2,158)

Executive severance and recruitment(b)

4,123

Class action litigation (c)

246

292

M&A diligence, transaction and integration(d)

 

693

 

4,548

 

1,533

 

63,333

Business optimization(e)

 

2,460

 

268

 

7,248

 

1,127

EMR implementation(f)

 

402

 

66

 

1,095

 

335

Gain on consolidation of equity investee(g)

 

 

(10,871)

 

 

(10,871)

Financing-related fees(h)

 

 

13,488

 

 

14,479

Contingent consideration(i)

 

 

19,222

 

 

18,211

Adjusted EBITDA

$

1,931

$

20,312

$

34,895

$

65,985

(a)Reflects the CMS settlement payment of approximately $2.2 million related to end-stage renal disease beneficiaries for calendar years 2010 through 2020.
(b)Reflects charges related to executive severance and recruiting.
(c)Reflects charges related to litigation by shareholders.
(d)For the nine months ended March 31, 2021, this primarily represents (i) $45.4 million related to the cancellation of options and the redemption of shares and (ii) $13.1 million of transaction fees and expenses recognized in connection with the July 27, 2020 transaction between us, an affiliate of Apax Partners and our then existing equity holders entering into a Securities Purchase Agreement (the “Apax Transaction”).
(e)Reflects charges related to business optimization initiatives. Such charges relate to one-time investments in projects designed to enhance our technology and compliance systems, and improve and support the efficiency and effectiveness of our operations.
(f)Reflects non-recurring expenses relating to the implementation of a new electronic medical record vendor.
(g)Reflects non-recurring gain on consolidation of InnovAge Sacramento during the three and nine months ended March 31, 2021.
(h)Reflects fees and expenses incurred in connection with amendments to our credit agreements. See Note 8, “Long Term Debt” to the condensed consolidated financial statements.
(i)Reflects the contingent consideration fair value adjustment made during the reporting period associated with our acquisition of NewCourtland.

Net income (loss) margin and Adjusted EBITDA margin

Net loss margin is net loss expressed as a percentage of our total revenue. Adjusted EBITDA margin is Adjusted EBITDA expressed as a percentage of our total revenue less any exceptional, one time revenue items. For the nine months ended March 31, 2022, net income margin was 1.1%, as compared to net loss margin of 11.0% for the nine months ended March 31, 2021. For the nine months ended March 31, 2022, our Adjusted EBITDA margin was 6.6%, as compared to our Adjusted EBITDA margin for the nine months ended March 31, 2021 of 14.2%.

Adjusted EBITDA and Adjusted EBITDA margin are supplemental measures of operating performance monitored by management that are not defined under GAAP and that do not represent, and should not be considered as, an alternative to net income (loss) and net income (loss) margin, respectively, as determined by GAAP. We believe that Adjusted EBITDA and Adjusted EBITDA margin are appropriate measures of operating performance because the metrics eliminate the impact of revenue and expenses that do not relate to our ongoing business performance, allowing us to more effectively evaluate our core operating performance and trends from period to period. We believe that Adjusted EBITDA and Adjusted EBITDA margin help investors and analysts in comparing our results across reporting periods on a consistent basis by excluding items that we do not believe are indicative of our core operating performance. These non-GAAP financial

42

measures have limitations as analytical tools and should not be considered in isolation from, or as a substitute for, the analysis of other GAAP financial measures, including net income (loss) and net income (loss) margin. In evaluating Adjusted EBITDA, you should be aware that in the future we may incur expenses that are the same as or similar to some of the adjustments in this presentation. Our presentation of Adjusted EBITDA should not be construed to imply that our future results will be unaffected by the types of items excluded from the calculation of Adjusted EBITDA. The use of the term Adjusted EBITDA varies from others in our industry.

Liquidity and Capital Resources

General

To date, we have financed our operations principally through cash flows from operations and through borrowings under our credit facilities, and from the sale of common stock in our IPO that occurred in March 2021. As of March 31, 2022, we had cash and cash equivalents of $199.5 million. Our cash and cash equivalents primarily consist of highly liquid investments in demand deposit accounts and cash.

Our capital resources are generally used to fund (i) debt service requirements, the majority of which relate to the quarterly principal payments of the Term Loan Facility (as defined in Note 8, “Long Term Debt” to the condensed consolidated financial statements) due 2026, (ii) capital and operating lease obligations, which are generally paid on a monthly basis and include maturities through 2025 and 2032, respectively, (iii) the operations of our business, including special projects such as our transition to a new electronic medical record vendor, with respect to which we expect to incur non-recurring implementation costs over the next 18 months, and ongoing costs through 2026, and (iv) income tax payments, which are generally due on a quarterly and annual basis. We also expect to use capital resources for capital additions, which we expect to primarily relate to the development of de novo centers to the extent and as they are opened. Collectively, these obligations are expected to represent a significant liquidity requirement of our Company on both a short-term and long-term basis. For additional information regarding our lease obligations, debt and commitments, see Note 7, “Leases”, Note 8, “Long Term Debt” and Note 9, “Commitments and Contingencies” to our condensed consolidated financial statements.

We believe that our cash and cash equivalents and our cash flows from operations will be sufficient to fund our operating and capital needs for at least the next 12 months. We have based this estimate on assumptions that may prove to be wrong, and we could use our available capital resources sooner than we currently expect. Our actual results could vary because of, and our future capital requirements will depend on, many factors, including our growth rate, the timing and extent of spending to open new centers and the expansion of sales and marketing activities. We may in the future enter into arrangements to acquire or invest in complementary businesses, services and technologies. We may be required to seek additional equity or debt financing. In the event that additional financing is required from outside sources, we may not be able to raise it on terms acceptable to us or at all. If we are unable to raise additional capital when desired, or if we cannot expand our operations or otherwise capitalize on our business opportunities because we lack sufficient capital, our business, results of operations, and financial condition would be adversely affected.

On March 8, 2021, concurrently with the closing of the IPO, the Company entered into a new credit agreement, (“the 2021 Credit Agreement”), that replaced the 2016 Credit Agreement, as further discussed in Note 8, “Long Term Debt” to our condensed consolidated financial statements. The 2021 Credit Agreement consists of a senior secured term loan, Term Loan Facility, of $75.0 million principal amount and a revolving credit facility, Revolving Credit Facility, of $100.0 million maximum borrowing capacity, each as defined and described in Note 8, “Long Term debt” to the condensed consolidated financial statements. Principal on the Term Loan Facility is paid each calendar quarter beginning September 2021 in an amount equal to 1.25% of the initial term loan on closing date. Proceeds of the Term Loan Facility, together with proceeds from the IPO, were used to repay amounts outstanding under the 2016 Credit Agreement.

Any outstanding principal amounts under the 2021 Credit Agreement accrue interest at a variable interest rate. As of March 31, 2022, the interest rate on the Term Loan Facility was 2.21%. Under the terms of the 2021 Credit Agreement, the Revolving Credit Facility fee accrues at 0.25% of the average daily unused amount and is paid quarterly. As of March 31, 2022, we had no borrowings outstanding under the Revolving Credit Facility and, therefore, had full capacity thereunder, subject to applicable covenant compliance restrictions and any other conditions precedent to borrowing. As of

43

March 31, 2022, we also had $2.4 million principal amount outstanding under our convertible term loan. Monthly principal and interest payments are approximately $0.02 million, and the loan bears interest at an annual rate of 6.68%. The remaining principal balance is due upon maturity, which is August 20, 2030.

For more information about our debt, see Note 8 “Long Term Debt” to our condensed consolidated financial statements.

We currently intend to retain all available funds and any future earnings to fund the development and growth of our business.

Condensed Consolidated Statements of Cash Flows

Our consolidated statements of cash flows for the nine months ended March 31, 2022 and 2021 are summarized as follows:

    

Nine Months Ended

March 31, 

2022

    

2021

$ Change

in thousands

 

  

Net cash provided by (used in) operating activities

$

24,059

$

(17,028)

$

41,087

Net cash used in investing activities

 

(23,578)

 

(16,083)

(7,495)

Net cash provided by (used in) financing activities

 

(4,670)

 

122,309

(126,979)

Net change in cash

(4,189)

89,198

(93,387)

Cash at beginning of period

203,700

114,565

89,135

Cash at end of period

$

199,511

$

203,763

$

(4,252)

Operating Activities. The change in net cash provided by (used in) operating activities was primarily due to the net effect of (i) net income of $5.6 million in the current year period compared to a net loss of $51.1 million in the prior year period, as described further above, (ii) a net increase in working capital primarily as a result of the impact of the completion of the Colorado Department of Health Care Policy & Financing’s (“HCPF”) reconciliation, as described below, and the timing of accrued expenses.

In fiscal year 2021, the Company and the HCPF completed the reconciliation for fiscal years 2018 and 2019. The reconciliation resulted in a net adjustment of reduction of accounts receivable of $3.4 million, which was recorded in fiscal year 2021. The Company does not expect adjustments related to the reconciliation to be significant in future periods.

Investing Activities. Investing activities were made up of approximately $22.7 million in purchases of property and equipment.

Financing activities. The decrease in net cash used in financing activities was primarily due to the net effect of the Apax Transaction in fiscal year 2021, which included net proceeds on long-term debt of $79.1 million, $77.6 million related to treasury stock purchases and $32.4 million related to stock option cancellation payments, those payments of which did not recur in fiscal year 2022.

Contractual Obligations and Commitments

Our principal commitments consist of repayments of long-term debt and obligations under operating and capital leases. As of March 31, 2022, we had $74.5 million of long-term debt outstanding. See Note 8, “Long Term Debt” in our condensed consolidated financial statements for more information. As of March 31, 2022, we had future minimum operating lease payments under non-cancellable leases through the year 2032 of $33.8 million. We also had non-cancellable capital lease agreements with third parties through the year 2027 with future minimum payments of $14.6 million. See Note 7, “Leases” in our condensed consolidated financial statements for more information.

44

Off Balance Sheet Arrangements

We did not have any off balance sheet arrangements as of March 31, 2022.

JOBS Act

We qualify as an “emerging growth company” pursuant to the provisions of the Jumpstart Our Business Startups (“JOBS”) Act. For as long as we are an “emerging growth company,” we may take advantage of certain exemptions from various reporting requirements that are applicable to other public companies that are not “emerging growth companies,” including, but not limited to, not being required to comply with the auditor attestation requirements of Section 404(b) of the Sarbanes-Oxley Act, only being required to present two years of audited financial statements, plus unaudited condensed consolidated financial statements for applicable interim periods and the related discussion in the section titled “Management’s Discussion and Analysis of Financial Condition and Results of Operations,” reduced disclosure obligations regarding executive compensation in our periodic reports, proxy statements and registration statements, exemptions from the requirements of holding non-binding advisory “say-on-pay” votes on executive compensation and stockholder advisory votes on golden parachute compensation.

In addition, under the JOBS Act, emerging growth companies can delay adopting new or revised accounting standards until such time as those standards apply to private companies. We take advantage of the longer phase-in periods for the adoption of new or revised financial accounting standards under the JOBS Act until we are no longer an emerging growth company. Our election to use the phase-in periods permitted by this election may make it difficult to compare our financial statements to those of non-emerging growth companies and other emerging growth companies that have opted out of the longer phase-in periods permitted under the JOBS Act and who will comply with new or revised financial accounting standards. If we were to subsequently elect instead to comply with public company effective dates, such election would be irrevocable pursuant to the JOBS Act.

Critical Accounting Policies and Estimates

The discussion and analysis of our financial condition and results of operations are based upon our condensed consolidated financial statements, which have been prepared in accordance with GAAP. The preparation of these financial statements requires management to make estimates and judgments that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the condensed consolidated financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results may differ from these estimates under different assumptions or conditions, impacting our reported results of operations and financial condition.

Certain accounting policies involve significant judgments and assumptions by management, which have a material impact on the carrying value of assets and liabilities and the recognition of income and expenses. We consider these accounting policies to be critical accounting policies. The estimates and assumptions used by management are based on historical experience and other factors, which are believed to be reasonable under the circumstances.

For a description of our policies regarding our critical accounting policies, see “Critical Accounting Policies and Estimates” in the 2021 Annual 10-K. There have been no significant changes in our critical accounting policies, estimates, or methodologies to our condensed consolidated financial statements.

45

Item 3. Quantitative and Qualitative Disclosures About Market Risk

Market risk represents the risk of loss that may impact our financial position due to adverse changes in financial market prices and rates. Our market risk exposure is primarily a result of exposure due to potential changes in inflation or interest rates. We do not hold financial instruments for trading purposes.

Interest rate risk

As of March 31, 2022, we had total outstanding debt of $72.1 million in principal amount under the Term Loan Facility, $2.3 million under the convertible term loan, and no outstanding debt under the Revolving Credit Facility (each as defined in Note 8, “Long Term Debt” to our condensed consolidated financial statements). As of June 30, 2021, we had total outstanding debt of $75.0 million in principal amount under the Term Loan Facility and $2.4 million under the Convertible Term Loan.  As of March 31, 2022, the interest rate on the Term Loan Facility was 2.21%

We had cash and cash equivalents of $199.5 million and $201.5 million as of March 31, 2022 and June 30, 2021, respectively, which are deposited with high credit quality financial institutions and are primarily in demand deposit accounts.

Our cash and cash equivalents and interest payments in respect of our debt are subject to market risk due to changes in interest rates. We do not believe that an increase or decrease in interest rates of 100 basis points would have a material effect on our business, financial condition or results of operations.

Inflation risk

Based on our analysis of the periods presented, we believe that inflation has not had a material effect on our operating results. There can be no assurance that future inflation, including as a result of COVID-19, will not have an adverse impact on our operating results and financial condition.

Item 4. Controls and Procedures

Evaluation of Disclosure Controls and Procedures

Under the supervision and with the participation of our management, including the Chief Executive Officer and Chief Financial Officer, we have evaluated the effectiveness of our disclosure controls and procedures (as defined in Rules 13a-15(e) and 15d-15(e) under the Securities Exchange Act of 1934, as amended) as of the end of the period covered by this Report. Based on that evaluation, the Chief Executive Officer and Chief Financial Officer have concluded that these disclosure controls and procedures were effective as of March 31, 2022.

Changes to our Internal Controls over Financial Reporting

There have been no changes in internal control over financial reporting during the quarter ended March 31, 2022 that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.

46

PART II — OTHER INFORMATION

Item 1. Legal Proceedings

For information regarding our material pending legal proceedings, refer to Note 9 to our Condensed Consolidated Financial Statements located in Item 1 of Part I of this Quarterly Report on Form 10-Q.

Item 1.A Risk Factors

Other than the updates to the risk factors set forth below, there have been no material changes to the risk factors disclosed in the “Risk factors” section of our 2021 10-K.

Risks Related to our Business

We may be subject to legal proceedings, enforcement actions and litigation, malpractice and privacy disputes, which are costly to defend and could materially harm our business and results of operations.

We may be party to lawsuits and legal proceedings in the normal course of business. These matters are often expensive and disruptive to normal business operations. We may face allegations, lawsuits and regulatory inquiries, requests for information, audits and investigations regarding care and services provided to participants, the False Claims Act (“FCA”), data privacy, security, labor and employment, consumer protection or intellectual property. We may also face allegations or litigation related to our acquisitions, securities issuances or business practices, including public disclosures about our business. On October 14, 2021, the Company was named as a defendant in a putative class action complaint filed in the District Court for the District of Colorado on behalf of individuals who purchased or acquired shares of the Company’s common stock during a specified period. We are currently unable to predict the outcome of this proceeding. In addition, on April 20, 2022, the Board of Directors of the Company received a books and records demand pursuant to Section 220 of the Delaware General Corporation Law, from a purported stockholder of the Company, in connection with the stockholder’s investigation of, among other matters, potential breaches of fiduciary duty, mismanagement, self-dealing, corporate waste or other violations of law by the Company’s Board with respect to these matters. We are currently unable to predict the outcome of this matter.

Litigation and regulatory proceedings may be protracted and expensive, and the results are difficult to predict. Certain of these matters include claims for substantial or indeterminate amounts of damages and may include claims for injunctive relief. Additionally, our litigation costs could be significant. Adverse outcomes with respect to litigation or any of these legal proceedings may result in significant settlement costs or judgments, penalties, fines and sanctions. In the event of compliance issues, sanctions could include civil monetary penalties, corrective action plans, monitoring, contract termination, and/or CMS and/or Medicaid agencies suspending or restricting enrollment with us (as is the case currently with respect to our Sacramento, California center, and our centers in the State of Colorado), which could negatively impact our geographical expansion and revenue growth. We are also subject to periodic audits, which have and may continue to increase our regulatory compliance costs and may require us to change our business practices, which could negatively impact our revenue growth. Managing legal proceedings, regulatory inquiries, litigation and audits, even if we achieve favorable outcomes, is costly, time-consuming and diverts management’s attention from our business.

The results of regulatory proceedings, investigations, inquiries, litigation, claims, and audits cannot be predicted with certainty, and determining reserves for pending litigation and other legal, regulatory and audit matters requires significant judgment and assumptions. There can be no assurance that our expectations will prove correct, and even if these matters are resolved in our favor or without significant cash settlements, these matters, and the time and resources necessary to litigate or resolve them, cause harm to our reputation, business, financial condition, results of operations and the market price of our common stock.

We are also subject to lawsuits under the FCA and comparable state laws for submitting allegedly fraudulent, inadequately supported or otherwise inappropriate bills for services to the Medicare and Medicaid programs. These

47

lawsuits, which may be initiated by government authorities as well as private party relators, can involve significant monetary damages, fines, attorney fees and the award of bounties to private plaintiffs who successfully bring these suits, as well as to the government programs. In recent years, government oversight and law enforcement have become increasingly active and aggressive in investigating and taking legal action against potential fraud and abuse.

In July 2021, the Company received a civil investigative demand from the Attorney General for the State of Colorado under the Colorado Medicaid False Claims Act. The demand requests information and documents regarding Medicaid billing, patient services and referrals in connection with the Company’s PACE program in Colorado. We continue to fully cooperate with the Attorney General and produce the requested information and documentation. We are currently unable to predict the outcome of this investigation.

In February 2022, the Company received a civil investigative demand from the Department of Justice (“DOJ”) under the Federal False Claims Act on similar subject matter.  The demand requests information and documents regarding audits, billing, orders tracking, and quality and timeliness of patient services in connection with the Company’s PACE programs in the states where the Company operates (California, Colorado, New Mexico, Pennsylvania, and Virginia).  The Company is fully cooperating with the DOJ to produce the requested information and documentation.  We are currently unable to predict the outcome of this investigation.

Furthermore, our business exposes us to potential medical malpractice, professional negligence or other related actions or claims that are inherent in the provision of healthcare services. While the industry has not seen an increase in the number of claims of this nature due to the impact of the COVID-19 pandemic, this remains a possibility due to the relatively lengthy claim development inherent in professional liability claims. These claims, whether or not they have merit, could cause us to incur substantial costs, and could place a significant strain on our financial resources, divert the attention of management from our core business, harm our reputation and adversely affect our ability to attract and retain participants, any of which could have a material adverse effect on our business, financial condition and results of operations.

Although we maintain third-party professional liability insurance coverage, it is possible that claims against us may exceed the coverage limits of our insurance policies. Even if any professional liability loss is covered by an insurance policy, these policies typically have substantial deductibles for which we are responsible. Professional liability claims in excess of applicable insurance coverage could have a material adverse effect on our business, financial condition and results of operations. In addition, any professional liability claim brought against us, whether or not they have merit, could result in an increase of our professional liability insurance premiums. Insurance coverage varies in cost and can be difficult to obtain, and we cannot guarantee that we will be able to obtain insurance coverage in the future on terms acceptable to us or at all. If our costs of insurance and claims increase, then our earnings could decline.

We depend on our senior management team and other key employees, and the loss of one or more of these employees or an inability to attract and retain other highly skilled employees could harm our business.

Our success depends largely upon the services of our senior management team and other key employees. We rely on our leadership team in the areas of operations, provision of medical services, information technology and security, marketing, and general and administrative functions. Since we became a public company, there have been changes in our executive management team resulting from the hiring or departure of executives. Effective January 1, 2022, our Board of Directors elevated Patrick Blair, then President of the Company, to the position of President and Chief Executive Officer to replace Maureen Hewitt, our former Chief Executive Officer, who resigned effective on that same date. Even though Mr. Blair has had a long and successful career in healthcare, joining the Company from BAYADA Home Health Care, where he was the Group President responsible for overall quality and financial performance of the Home Health, Hospice and Personal Care businesses, failure to execute a smooth transition could affect the execution of our business strategy and relationships with regulators and other stakeholders. In addition, our employment agreements with our executive officers and other key personnel do not require them to continue to work for us for any specified period and, therefore, they could terminate their employment with us at any time. The loss, whether as a result of voluntary termination or illness, of one or more of the members of our senior management

48

team, or other key employees, could harm our business. Changes in our executive management team may also cause disruptions in, and harm to, our business.

Risks Related to Regulation

We face inspections, reviews, audits and investigations under federal and state government programs and contracts. These audits require corrective actions and have resulted in adverse findings that have negatively affected and may continue to affect our business, including our results of operations, liquidity, financial condition and reputation.

As a result of our PACE contracts with CMS and state government agencies, state licenses, and participation in Medicaid, we are routinely subject to, and will continue to be subject to, various governmental inspections, reviews, audits, requests for information and investigations to verify our compliance with requirements of these programs and applicable laws and regulations, assess the quality of the services we are providing to our participants, and evaluate the accuracy of the risk adjustment data we have submitted to the government.

Colorado. On May 26, 2021, the Colorado Department of Health Care Policy & Financing (“HCPF”) and the Colorado Department of Public Health and Environment (“CDPHE”) initiated a joint audit of our Colorado PACE centers, and on June 21, 2021, CMS also initiated a separate focused desk audit of our Colorado PACE program. We received preliminary findings from CMS and HCPF/CDPHE in July 2021, followed by validation results in October 2021. In conjunction with providing validation results, the agencies referred our case to the Compliance and Enforcement Division of CMS for review and possible further action. Effective December 23, 2021, CMS suspended new enrollments at the Company’s Colorado centers, based on deficiencies detected in the joint audit related to participant provision of services, which can be categorized as care delivery and management, care coordination and documentation of care. The suspension will remain in effect until CMS determines that we have remediated the deficiencies to their satisfaction. Effective on the same date, HCPF also determined to impose sanctions and suspended new enrollments at the Company’s Colorado centers identifying certain deficiencies specific to Medicaid. In addition, as a result of their specific findings, CDPHE mandated that we retain a consultant for a period of 12 months to oversee our remediation efforts, and issued a $10,000 penalty, which we have paid. On January 17, 2022 and February 5, 2022, we submitted a CAP to each of CDPHE and CMS, respectively. A separate CAP for HCPF was submitted on February 22, 2022. CDPHE and CMS have accepted the CAPs, and as a result, we are currently monitoring the implementation of these CAPs. We cannot guarantee that HCPF will accept the CAP we submitted, that we will be able to implement the CAPs, or that we will be able to remedy the deficiencies specified by each of the agencies. In addition, although these agencies coordinate many of the actions taken with respect to these audits, they each have separate mandates and are not obligated to act together or reach the same decisions. Therefore, we cannot guarantee that the agencies will not separately request further actions or impose additional separate sanctions.

California. On May 10, 2021, CMS began a routine, scheduled audit of our Sacramento, California center. On September 17, 2021, we were notified that CMS had determined to suspend new enrollments at our Sacramento center based on deficiencies detected in the audit related to participant provision of services, which can be categorized as care delivery and management, care coordination and documentation of care, and on September 30, 2021, we were further notified that the Department of Health Care Services (“DHCS”) of the State of California had reached the same determination. The suspension will remain in effect until CMS and DHCS determine that we have remediated the deficiencies to their satisfaction. We submitted a CAP on October 15, 2021, which has been accepted by both CMS and DHCS. As a result, both agencies are currently monitoring the implementation of the CAP. On January 7, 2022, DHCS notified us that it was suspending the State’s previously provided assurances that it would enter into a PACE program agreement with the Company (State Attestations) with respect to de novo centers in the State of California until such time as the CAPs and the remediation and validation processes for our Sacramento center have been successfully completed and the enrollment sanctions are lifted. As a result of the suspension, we will be unable to open one of the de novo centers we had identified in California within our planned timeline. In March 2022, CMS and DHCS began separate audits of our San Bernadino, California center. Both agencies have finalized their field work and recently issued preliminary results identifying certain deficiencies related to participant provision of services, which can be categorized as care delivery and management, care coordination and

49

documentation of care. We are currently in the audit validation process, which entails provision of various participant records. Following such process, we expect to receive results from the audit. At this time, we cannot guarantee the outcome of this audit, including whether or not sanctions will be imposed.

New Mexico. As previously disclosed, in November 2021, CMS began an audit of our Albuquerque, New Mexico center. On November 23, 2021, we received preliminary results identifying certain deficiencies related to participant provision of services, which can be categorized as care delivery and management, care coordination and documentation of care. Validation results were received in March 2022 and in conjunction with providing validation results, the agency referred our case to the Compliance and Enforcement Division of CMS for review and possible further action. At this time, we cannot guarantee the final outcome of this audit. If CMS were to suspend enrollments at, or otherwise curtail, our center or impose other sanctions, such actions could have a material adverse effect on our business operations, financial results and reputation.

Kentucky. On February 9, 2022, we received notice from the Cabinet for Health and Family Services of the State of Kentucky informing us that they no longer intend to enter into an agreement with us to be a PACE provider in the State of Kentucky.

Indiana. On February 14, 2022, CMS denied our initial application to develop the previously announced PACE center in Terre Haute, Indiana, based on deficiencies detected during CMS’ 2021 audits of our Sacramento and Colorado PACE programs.

Florida. We have committed to CMS and the Agency for Healthcare Administration in the State of Florida, that we will proactively pause remaining steps with respect to planned de novo centers in the State of Florida, to focus on remediating deficiencies raised in the audit processes.

At this time, we cannot guarantee the final outcome of any of the audits and processes described above. If we are unable to effectively remediate the deficiencies raised by the audits, implement the CAPs we have submitted, will submit or may be required to submit, or otherwise satisfy the agencies’ concerns, we could be subject to additional sanctions and our business plan, including our growth strategy (including with respect to enrollment growth and de novo openings), would continue to be adversely impacted. Our management has been working collaboratively with the various agencies, including CMS.  

In general, inspections, reviews, audits, requests for information or investigations with adverse findings, and in particular the audits described above, have resulted in and may further result in:

temporary or permanent enrollment sanctions in the affected center(s), as is the case with our Sacramento, California center and our centers in the State of Colorado;
refunding amounts we have been paid by the government;
state or federal agencies imposing CAPs, fines, penalties, training, policies and procedures, and other requirements or sanctions on us;
temporary suspension of payments;
debarment or exclusion from participation in federal health care programs;
self-disclosure of violations to applicable regulatory authorities;
damage to our reputation;
the revocation of a facility’s license; and
loss of certain rights under, or termination of, our contracts with government payors.

We may be required to refund amounts we have been paid and/or pay fines and penalties as a result of these inspections, reviews, audits, requests for information and investigations. Any of the results noted above could have further material adverse effects on our business and operating results. Furthermore, the legal, document production and other costs associated with complying with these inspections, reviews, audits, requests for information or investigations is significant.

50

Item 2. Unregistered Sales of Equity Securities and Use of Proceeds

Unregistered Sales of Equity Securities

There were no unregistered sales of equity securities during the nine months ended March 31, 2022.

Use of Proceeds

On March 8, 2021, we completed the IPO of our common stock pursuant to a Registration Statement on Form S-1 (File No. 333-252853), which was declared effective on March 3, 2021. There have been no material changes in the planned use of proceeds from the IPO from those that were described in the final prospectus filed pursuant to Rule 424(b) with the Securities and Exchange Commission on March 5, 2021.

Item 3. Defaults Upon Senior Securities

None.

Item 4. Mine Safety Disclosures

Not applicable.

Item 5. Other Information

None.

51

Item 6. Exhibits

The following is a list of all exhibits filed or furnished as part of this report:

EXHIBIT INDEX

Exhibit

No.

    

Description

3.1

Second Amended and Restated Certificate of Incorporation of InnovAge Holding Corp., filed March 3, 2021 (incorporated by reference to Exhibit 3.1 to the Company’s Current Report on Form 8-K filed with the SEC on March 8, 2021).

3.2

Amended and Restated Bylaws of InnovAge Holding Corp., effective March 3, 2021 (incorporated by reference to Exhibit 3.2 to the Company’s Current Report on Form 8-K filed with the SEC on March 8, 2021).

10.1

Separation Letter, dated as of January 1, 2022, by and between InnovAge Holding Corp. and Maureen Hewitt (incorporated by reference to Exhibit 10.1 to the Company’s Current Report on Form 8-K filed with the SEC on January 3, 2022).

31.1

Certification of Chief Executive Officer Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002

31.2

Certification of Chief Financial Officer Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002

32.1†

Certification of Chief Executive Officer Pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002

32.2†

Certification of Chief Financial Officer Pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002

101.INS

Inline XBRL Instance Document (the instance document does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document)

101.SCH

Inline XBRL Taxonomy Extension Schema Document

101.CAL

Inline XBRL Taxonomy Extension Calculation Linkbase Document

101.DEF

Inline XBRL Taxonomy Extension Definition Linkbase Document

101.LAB

Inline XBRL Taxonomy Extension Label Linkbase Document

104

Cover Page Interactive Data File (formatted in Inline XBRL and contained in Exhibit 101)

The certifications furnished in Exhibit 32.1 and Exhibit 32.2 hereto are deemed “furnished” with this Quarterly Report on Form 10-Q and will not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, except to the extent that the registrant specifically incorporates it by reference.

52

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned, duly authorized.

Date: May 10, 2022

INNOVAGE HOLDING CORP.

By:

/s/ Barbara Gutierrez

Name:

Barbara Gutierrez

Title:

Chief Financial Officer

53

EX-31.1 2 tmb-20220331xex31d1.htm EX-31.1

Exhibit 31.1

Certification Pursuant to Section 302 of Sarbanes-Oxley Act of 2002

I, Patrick Blair, certify that:

1.

I have reviewed this quarterly report on Form 10-Q of InnovAge Holding Corp.;

2.

Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3.

Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4.

The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

(a)

Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

(c)

Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

(d)

Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

5.

The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

(a)

All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

(b)

Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

Date: May 10, 2022

By:

/s/ Patrick Blair

Name:

Patrick Blair

Title:

Chief Executive Officer


EX-31.2 3 tmb-20220331xex31d2.htm EX-31.2

Exhibit 31.2

Certification Pursuant to Section 302 of Sarbanes-Oxley Act of 2002

I, Barbara Gutierrez, certify that:

1.I have reviewed this quarterly report on Form 10-Q of InnovAge Holding, Corp.;
2.Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;
3.Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;
4.The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:
(a)Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;
(b)Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and
(c)Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and
5.The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):
(a)All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and
(b)Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

Date: May 10, 2022

J.

By:

/s/ Barbara Gutierrez

Name:

Barbara Gutierrez

Title:

Chief Financial Officer


EX-32.1 4 tmb-20220331xex32d1.htm EX-32.1

 

Exhibit 32.1

Certification of Chief Executive Officer

Pursuant to Rule 18 U.S.C. Section 1350

In connection with the Quarterly Report on Form 10-Q of InnovAge Holding Corp. (the “Company”) for the fiscal quarter ended March 31, 2022 as filed with the U.S. Securities and Exchange Commission (the “Report”), I, Patrick Blair, Chief Executive Officer of the Company, hereby certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that, to my knowledge:

(1)

The Report fully complies with the requirements of Section 13(a) or Section 15(d) of the Securities Exchange Act of 1934, as amended; and

(2)

The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

Date: May 10, 2022

By:

/s/ Patrick Blair

Name:

Patrick Blair

Title:

Chief Executive Officer


EX-32.2 5 tmb-20220331xex32d2.htm EX-32.2

 

Exhibit 32.2

Certification of Chief Financial Officer

Pursuant to Rule 18 U.S.C. Section 1350

In connection with the Quarterly Report on Form 10-Q of InnovAge Holding Corp. (the “Company”) for the fiscal quarter ended March 31, 2022 as filed with the U.S. Securities and Exchange Commission (the “Report”), I, Barbara Gutierrez, Chief Financial Officer of the Company, hereby certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that, to my knowledge:

(1)The Report fully complies with the requirements of Section 13(a) or Section 15(d) of the Securities Exchange Act of 1934, as amended; and
(2)The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

Date: May 10, 2022

J.

By:

/s/ Barbara Gutierrez

Name:

Barbara Gutierrez

Title:

Chief Financial Officer


GRAPHIC 6 tmb-20220331x10q004.jpg GRAPHIC begin 644 tmb-20220331x10q004.jpg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end EX-101.SCH 7 tmb-20220331.xsd EX-101.SCH 00100 - Statement - Condensed Consolidated Balance Sheets link:presentationLink link:calculationLink link:definitionLink 00200 - Statement - Condensed Consolidated Statements of Operations link:presentationLink link:calculationLink link:definitionLink 00400 - Statement - Condensed Consolidated Statements of Cash Flows link:presentationLink link:calculationLink link:definitionLink 40401 - Disclosure - Investments - Equity Method and Cost Method Investments (Details) link:presentationLink link:calculationLink link:definitionLink 40602 - Disclosure - Goodwill and Intangible Assets - Intangible Asset by Major Class (Details) link:presentationLink link:calculationLink link:definitionLink 40701 - Disclosure - Leases - Assets Under Lease (Details) link:presentationLink link:calculationLink link:definitionLink 40702 - Disclosure - Leases - Future Minimum Lease Payments (Details) link:presentationLink link:calculationLink link:definitionLink 40801 - Disclosure - Long Term Debt - Schedule of Long-term Debt (Details) link:presentationLink link:calculationLink link:definitionLink 00300 - Statement - Condensed Consolidated Statements of Stockholders' Equity link:presentationLink link:calculationLink link:definitionLink 00305 - Statement - Condensed Consolidated Statements of Stockholders' Equity (Parenthetical) link:presentationLink link:calculationLink link:definitionLink 31103 - Disclosure - Stock-based Compensation (Tables) link:presentationLink link:calculationLink link:definitionLink 40101 - Disclosure - Business (Details) link:presentationLink link:calculationLink link:definitionLink 40201 - Disclosure - Summary of Significant Accounting Policies - Effect of Restatement on Consolidated Balance Sheet (Details) link:presentationLink link:calculationLink link:definitionLink 40202 - Disclosure - Summary of Significant Accounting Policies - Effect of Restatement on Consolidated Statements of Stockholders' Equity (Details) link:presentationLink link:calculationLink link:definitionLink 40204 - Disclosure - Summary of Significant Accounting Policies - Property and Equipment (Details) link:presentationLink link:calculationLink link:definitionLink 40301 - Disclosure - Revenue Recognition (Details) link:presentationLink link:calculationLink link:definitionLink 40302 - Disclosure - Revenue Recognition - Source of Revenue (Details) link:presentationLink link:calculationLink link:definitionLink 40303 - Disclosure - Revenue Recognition - Concentration of Net Receivable (Details) link:presentationLink link:calculationLink link:definitionLink 40402 - Disclosure - Investments (Details) link:presentationLink link:calculationLink link:definitionLink 40501 - Disclosure - Fair Value Measurements (Details) link:presentationLink link:calculationLink link:definitionLink 40802 - Disclosure - Long Term Debt (Details) link:presentationLink link:calculationLink link:definitionLink 41001 - Disclosure - Equity (Details) link:presentationLink link:calculationLink link:definitionLink 41101 - Disclosure - Stock-based Compensation - Compensation Expense (Details) link:presentationLink link:calculationLink link:definitionLink 41102 - Disclosure - Stock-based Compensation - Equity Incentive Plan (Details) link:presentationLink link:calculationLink link:definitionLink 41103 - Disclosure - Stock-based Compensation - Profits Interests (Details) link:presentationLink link:calculationLink link:definitionLink 41104 - Disclosure - Stock-based Compensation - Profits Interests Transactions and Number of Units Outstanding (Details) link:presentationLink link:calculationLink link:definitionLink 41105 - Disclosure - Stock-based Compensation - Monte Carlo Option Pricing Model (Details) link:presentationLink link:calculationLink link:definitionLink 41106 - Disclosure - Stock-based Compensation - 2021 Omnibus Incentive Plan (Details) link:presentationLink link:calculationLink link:definitionLink 41107 - Disclosure - Stock-based Compensation - 2021 Omnibus Incentive Plan (RSU Activity) (Details) link:presentationLink link:calculationLink link:definitionLink 41108 - Disclosure - Stock-based Compensation - Time-based Awards (Details) link:presentationLink link:calculationLink link:definitionLink 41109 - Disclosure - Stock-based Compensation - Performance-based Awards (Details) link:presentationLink link:calculationLink link:definitionLink 41301 - Disclosure - Earnings per Share (Details) link:presentationLink link:calculationLink link:definitionLink 41401 - Disclosure - Segment Reporting (Details) link:presentationLink link:calculationLink link:definitionLink 41402 - Disclosure - Segment Reporting - Operating Results (Details) link:presentationLink link:calculationLink link:definitionLink 41501 - Disclosure - Related-party (Details) link:presentationLink link:calculationLink link:definitionLink 00090 - Document - Document and Entity Information link:presentationLink link:calculationLink link:definitionLink 00105 - Statement - Condensed Consolidated Balance Sheets (Parenthetical) link:presentationLink link:calculationLink link:definitionLink 10101 - Disclosure - Business link:presentationLink link:calculationLink link:definitionLink 10201 - Disclosure - Summary of Significant Accounting Policies link:presentationLink link:calculationLink link:definitionLink 10301 - Disclosure - Revenue Recognition link:presentationLink link:calculationLink link:definitionLink 10401 - Disclosure - Investments link:presentationLink link:calculationLink link:definitionLink 10501 - Disclosure - Fair Value Measurements link:presentationLink link:calculationLink link:definitionLink 10601 - Disclosure - Goodwill and Intangible Assets link:presentationLink link:calculationLink link:definitionLink 10701 - Disclosure - Leases link:presentationLink link:calculationLink link:definitionLink 10801 - Disclosure - Long Term Debt link:presentationLink link:calculationLink link:definitionLink 10901 - Disclosure - Commitments and Contingencies link:presentationLink link:calculationLink link:definitionLink 11001 - Disclosure - Equity link:presentationLink link:calculationLink link:definitionLink 11101 - Disclosure - Stock-based Compensation link:presentationLink link:calculationLink link:definitionLink 11201 - Disclosure - Income Taxes link:presentationLink link:calculationLink link:definitionLink 11301 - Disclosure - Earnings per Share link:presentationLink link:calculationLink link:definitionLink 11401 - Disclosure - Segment Reporting link:presentationLink link:calculationLink link:definitionLink 11501 - Disclosure - Related-party link:presentationLink link:calculationLink link:definitionLink 11601 - Disclosure - Subsequent Events link:presentationLink link:calculationLink link:definitionLink 20202 - Disclosure - Summary of Significant Accounting Policies (Policies) link:presentationLink link:calculationLink link:definitionLink 30203 - Disclosure - Summary of Significant Accounting Policies (Tables) link:presentationLink link:calculationLink link:definitionLink 30303 - Disclosure - Revenue Recognition (Tables) link:presentationLink link:calculationLink link:definitionLink 30403 - Disclosure - Investments (Tables) link:presentationLink link:calculationLink link:definitionLink 30603 - Disclosure - Goodwill and Intangible Assets (Tables) link:presentationLink link:calculationLink link:definitionLink 30703 - Disclosure - Leases (Tables) link:presentationLink link:calculationLink link:definitionLink 30803 - Disclosure - Long Term Debt (Tables) link:presentationLink link:calculationLink link:definitionLink 31303 - Disclosure - Earnings per Share (Tables) link:presentationLink link:calculationLink link:definitionLink 31403 - Disclosure - Segment Reporting (Tables) link:presentationLink link:calculationLink link:definitionLink 40205 - Disclosure - Summary of Significant Accounting Policies - COVID-19 (Details) link:presentationLink link:calculationLink link:definitionLink 40601 - Disclosure - Goodwill and Intangible Assets (Details) link:presentationLink link:calculationLink link:definitionLink 41201 - Disclosure - Income Taxes (Details) link:presentationLink link:calculationLink link:definitionLink EX-101.CAL 8 tmb-20220331_cal.xml EX-101.CAL EX-101.DEF 9 tmb-20220331_def.xml EX-101.DEF EX-101.LAB 10 tmb-20220331_lab.xml EX-101.LAB EX-101.PRE 11 tmb-20220331_pre.xml EX-101.PRE XML 12 R1.htm IDEA: XBRL DOCUMENT v3.22.1
Document and Entity Information - shares
9 Months Ended
Mar. 31, 2022
May 09, 2022
Document and Entity Information [Abstract]    
Document Type 10-Q  
Document Quarterly Report true  
Document Transition Report false  
Document Period End Date Mar. 31, 2022  
Entity File Number 001-40159  
Entity Registrant Name InnovAge Holding Corp.  
Entity Incorporation, State or Country Code DE  
Entity Tax Identification Number 81-0710819  
Entity Address, Address Line One 8950 E. Lowry Boulevard  
Entity Address, City or Town Denver  
Entity Address State Or Province CO  
Entity Address, Postal Zip Code 80230  
City Area Code 844  
Local Phone Number 803-8745  
Title of 12(b) Security Common Stock, $0.001 par value  
Trading Symbol INNV  
Security Exchange Name NASDAQ  
Entity Current Reporting Status Yes  
Entity Interactive Data Current Yes  
Entity Filer Category Non-accelerated Filer  
Entity Small Business false  
Entity Emerging Growth Company true  
Entity Ex Transition Period false  
Entity Shell Company false  
Entity Common Stock, Shares Outstanding   135,525,006
Entity Central Index Key 0001834376  
Current Fiscal Year End Date --06-30  
Document Fiscal Year Focus 2022  
Document Fiscal Period Focus Q3  
Amendment Flag false  
XML 13 R2.htm IDEA: XBRL DOCUMENT v3.22.1
Condensed Consolidated Balance Sheets - USD ($)
$ in Thousands
Mar. 31, 2022
Jun. 30, 2021
Current Assets    
Cash and cash equivalents $ 199,493 $ 201,466
Restricted cash 18 2,234
Accounts receivable, net of allowance ($3,921 - March 31, 2022 and $4,350 - June 30, 2021) 31,905 32,582
Prepaid expenses and other 13,572 9,249
Income tax receivable 5,461 5,401
Total current assets 250,449 250,932
Noncurrent Assets    
Property and equipment, net 163,882 142,715
Investments 5,493 3,493
Deposits and other 5,378 3,877
Goodwill 124,217 124,217
Intangible assets, net 8,772 6,518
Total noncurrent assets 307,742 280,820
Total assets 558,191 531,752
Current Liabilities    
Accounts payable and accrued expenses 41,834 32,361
Reported and estimated claims 36,012 33,234
Due to Medicaid and Medicare 9,530 7,101
Current portion of long-term debt 3,793 3,790
Current portion of capital lease obligations 3,216 2,079
Total current liabilities 94,385 78,565
Noncurrent Liabilities    
Deferred tax liability, net 15,781 15,700
Capital lease obligations 10,282 5,190
Other noncurrent liabilities 2,570 2,758
Long-term debt, net of debt issuance costs 69,051 71,574
Total liabilities 192,069 173,787
Commitments and Contingencies (See Note 9)
Redeemable Noncontrolling Interests (See Note 4) 15,996 16,986
Stockholders' Equity    
Common stock, $0.001 par value; 500,000,000 authorized as of March 31, 2022 and June 30, 2021; 135,525,006 and 135,516,513 shares issued and outstanding as of March 31, 2022 and June 30, 2021, respectively 136 136
Additional paid-in capital 326,346 323,760
Retained earnings 17,437 10,663
Total InnovAge Holding Corp. 343,919 334,559
Noncontrolling interests 6,207 6,420
Total stockholders' equity 350,126 340,979
Total liabilities and stockholders' equity $ 558,191 $ 531,752
XML 14 R3.htm IDEA: XBRL DOCUMENT v3.22.1
Condensed Consolidated Balance Sheets (Parenthetical) - USD ($)
$ in Thousands
Mar. 31, 2022
Jun. 30, 2021
Condensed Consolidated Balance Sheets    
Allowance for loss $ 3,921 $ 4,350
Common stock, par value (in dollars per share) $ 0.001 $ 0.001
Common stock authorized (in shares) 500,000,000 500,000,000
Common stock issued (in shares) 135,525,006 135,516,513
Common stock outstanding (in shares) 135,525,006 135,516,513
XML 15 R4.htm IDEA: XBRL DOCUMENT v3.22.1
Condensed Consolidated Statements of Operations - USD ($)
$ in Thousands
3 Months Ended 9 Months Ended
Mar. 31, 2022
Mar. 31, 2021
Mar. 31, 2022
Mar. 31, 2021
Revenues        
Total revenues $ 177,359 $ 156,308 $ 525,780 $ 466,184
Expenses        
External provider costs 103,254 75,389 284,299 224,215
Cost of care, excluding depreciation and amortization 46,102 39,565 129,740 115,922
Sales and marketing 6,144 5,592 19,117 14,335
Corporate, general and administrative 24,682 18,595 74,248 105,901
Depreciation and amortization 3,850 3,311 10,435 9,262
Equity loss       1,343
Other operating income   19,222   18,211
Total expenses 184,032 161,674 517,839 489,189
Operating Income (Loss) (6,673) (5,366) 7,941 (23,005)
Other Income (Expense)        
Interest expense, net (709) (4,876) (1,930) (17,061)
Loss on extinguishment of debt   (13,488)   (14,479)
Gain on equity method investment   10,871   10,871
Other income (expense) 108 (2,267) (358) (2,222)
Total other expense (601) (9,760) (2,288) (22,891)
Income (Loss) Before Income Taxes (7,274) (15,126) 5,653 (45,896)
Provision (Benefit) for Income Taxes (4,116) (4,264) 81 5,159
Net Income (Loss) (3,158) (10,862) 5,572 (51,055)
Less: net loss attributable to noncontrolling interests (337) (352) (616) (595)
Net Income (Loss) Attributable to InnovAge Holding Corp. $ (2,821) $ (10,510) $ 6,188 $ (50,460)
Weighted-average number of common shares outstanding - basic 135,516,608 121,324,980 135,516,544 119,619,806
Weighted-average number of common shares outstanding - diluted 135,516,608 121,324,980 135,530,793 119,619,806
Net income (loss) per share - basic $ (0.02) $ (0.09) $ 0.05 $ (0.42)
Net income (loss) per share - diluted $ (0.02) $ (0.09) $ 0.05 $ (0.42)
Capitation revenue        
Revenues        
Total revenues $ 176,988 $ 155,835 $ 524,507 $ 464,294
Other service revenue        
Revenues        
Total revenues $ 371 $ 473 $ 1,273 $ 1,890
XML 16 R5.htm IDEA: XBRL DOCUMENT v3.22.1
Condensed Consolidated Statements of Stockholders' Equity - USD ($)
$ in Thousands
Common Stock
Additional Paid-in Capital
Retained Earnings (Deficit)
Treasury Stock
Noncontrolling Interests
Total
Balances, Beginning at Jun. 30, 2020 $ 133 $ 36,338 $ 64,737 $ (193) $ 6,735 $ 107,750
Balances, Beginning (in shares) at Jun. 30, 2020 132,718,461     102,030    
Balances, Ending at Dec. 31, 2020 $ 133 24,552 15,330 $ (77,796) 6,492 (31,289)
Balances, Ending (in shares) at Dec. 31, 2020 132,718,461     16,197,849    
Balances, Beginning at Jun. 30, 2020 $ 133 36,338 64,737 $ (193) 6,735 107,750
Balances, Beginning (in shares) at Jun. 30, 2020 132,718,461     102,030    
Treasury stock transaction       $ (77,603)   (77,603)
Treasury stock transaction (in shares)       16,095,819    
Treasury stock retirement $ (16) (77,780)   $ 77,796    
Treasury stock retirement (in shares) (16,197,849)     (16,197,849)    
Stock Option Cancellation, Value     (9,457)     (9,457)
Time based awards- option cancelation   (32,358)       (32,358)
Stock-based compensation   1,102       1,102
Reclassification of warrant liability   2,264       2,264
Owner contribution   20,000       20,000
Initial public offering of common stock, net of offering costs $ 19 373,561       373,580
Initial public offering of common stock, net of offering costs (in shares) 18,995,901          
Net income (loss)     (50,460)   (332) (50,792)
Net income (loss)           (51,055)
Adjustment to redemption value     (344)     (344)
Balances, Ending at Mar. 31, 2021 $ 136 323,127 4,476   6,403 334,142
Balances, Ending (in shares) at Mar. 31, 2021 135,516,513          
Redeemable non-controlling interests (Temporary Equity)            
Temporary Equity, Accretion to Redemption Value, Adjustment           16,838
Adjustment to redemption value           344
Net income (loss)           (263)
Ending balance at Mar. 31, 2021           16,919
Redeemable non-controlling interests (Temporary Equity)            
Net Income (Loss) Attributable to Redeemable Noncontrolling Interest           (51,055)
Balances, Beginning at Dec. 31, 2020 $ 133 24,552 15,330 $ (77,796) 6,492 (31,289)
Balances, Beginning (in shares) at Dec. 31, 2020 132,718,461     16,197,849    
Treasury stock retirement $ (16) (77,780)   $ 77,796    
Treasury stock retirement (in shares) (16,197,849)     (16,197,849)    
Stock-based compensation   530       530
Reclassification of warrant liability   2,264       2,264
Initial public offering of common stock, net of offering costs $ 19 373,561       373,580
Initial public offering of common stock, net of offering costs (in shares) 18,995,901          
Net income (loss)     (10,510)   (89) (10,599)
Net income (loss)           (10,862)
Adjustment to redemption value     (344)     (344)
Balances, Ending at Mar. 31, 2021 $ 136 323,127 4,476   6,403 334,142
Balances, Ending (in shares) at Mar. 31, 2021 135,516,513          
Redeemable non-controlling interests (Temporary Equity)            
Temporary Equity, Accretion to Redemption Value, Adjustment           16,838
Adjustment to redemption value           344
Net income (loss)           (263)
Ending balance at Mar. 31, 2021           16,919
Redeemable non-controlling interests (Temporary Equity)            
Net Income (Loss) Attributable to Redeemable Noncontrolling Interest           (10,862)
Balances, Beginning at Jun. 30, 2021 $ 136 323,760 10,663   6,420 340,979
Balances, Beginning (in shares) at Jun. 30, 2021 135,516,513          
Stock-based compensation   2,586       2,586
Stock-based compensation (in shares) 8,493          
Net income (loss)     6,188   (213) 5,975
Net income (loss)           5,572
Adjustment to redemption value     586     586
Balances, Ending at Mar. 31, 2022 $ 136 326,346 17,437   6,207 350,126
Balances, Ending (in shares) at Mar. 31, 2022 135,525,006          
Beginning balance at Jun. 30, 2021           16,986
Redeemable non-controlling interests (Temporary Equity)            
Adjustment to redemption value           (586)
Net income (loss)           (403)
Ending balance at Mar. 31, 2022           15,996
Redeemable non-controlling interests (Temporary Equity)            
Net Income (Loss) Attributable to Redeemable Noncontrolling Interest           5,572
Balances, Beginning at Dec. 31, 2021 $ 136 325,501 17,695   6,254 349,586
Balances, Beginning (in shares) at Dec. 31, 2021 135,516,513          
Stock-based compensation   845       845
Stock-based compensation (in shares) 8,493          
Net income (loss)     (2,821)   (47) (2,868)
Net income (loss)           (3,158)
Adjustment to redemption value     2,563     2,563
Balances, Ending at Mar. 31, 2022 $ 136 $ 326,346 $ 17,437   $ 6,207 350,126
Balances, Ending (in shares) at Mar. 31, 2022 135,525,006          
Beginning balance at Dec. 31, 2021           18,850
Redeemable non-controlling interests (Temporary Equity)            
Adjustment to redemption value           (2,563)
Net income (loss)           (290)
Ending balance at Mar. 31, 2022           15,996
Redeemable non-controlling interests (Temporary Equity)            
Net Income (Loss) Attributable to Redeemable Noncontrolling Interest           $ (3,158)
XML 17 R6.htm IDEA: XBRL DOCUMENT v3.22.1
Condensed Consolidated Statements of Stockholders' Equity (Parenthetical) - USD ($)
$ in Thousands
3 Months Ended 9 Months Ended
Mar. 31, 2021
Mar. 31, 2021
Condensed Consolidated Statements of Stockholders' Equity    
Offering costs $ 25,334 $ 25,334
XML 18 R7.htm IDEA: XBRL DOCUMENT v3.22.1
Condensed Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
9 Months Ended
Mar. 31, 2022
Mar. 31, 2021
Operating Activities    
Net income (loss) $ 5,572 $ (51,055)
Adjustments to reconcile net income (loss) to net cash provided by (used in) operating activities    
Loss on disposal of assets 358 2
Provision for uncollectible accounts 4,834 4,144
Depreciation and amortization 10,435 9,262
Gain on equity method investment   (10,871)
Loss on extinguishment of long-term debt   8,494
Amortization of deferred financing costs 322 948
Stock-based compensation 2,586 1,102
Deferred income taxes 81 (3,464)
Change in fair value of warrants   2,264
Change in fair value of contingent consideration   1,343
Changes in operating assets and liabilities, net of acquisitions    
Accounts receivable, net (4,157) (1,402)
Prepaid expenses and other (4,323) 635
Income tax receivable (60) 1,613
Deposits and other (1,501) (606)
Accounts payable and accrued expenses 4,705 7,717
Reported and estimated claims 2,778 114
Due to Medicaid and Medicare 2,429 12,732
Net cash provided by (used in) operating activities 24,059 (17,028)
Investing Activities    
Purchases of property and equipment (20,141) (14,083)
Purchase of intangible assets (1,437) (2,000)
Purchase of cost method investment (2,000)  
Net cash used in investing activities (23,578) (16,083)
Financing Activities    
Distributions to owners   (9,458)
Owner contributions   20,000
Payments on capital lease obligations (1,829) (1,685)
Proceeds from long-term debt   375,000
Principal payments on long-term debt (2,841) (512,649)
Payment of financing costs and debt premiums   (8,896)
Proceeds from initial public offering of common stock   373,580
Treasury stock purchases   (77,603)
Payments under acquisition agreements   (3,622)
Payments related to option cancellation   (32,358)
Net cash provided by (used in) financing activities (4,670) 122,309
INCREASE (DECREASE) IN CASH, CASH EQUIVALENTS & RESTRICTED CASH (4,189) 89,198
CASH, CASH EQUIVALENTS & RESTRICTED CASH, BEGINNING OF PERIOD 203,700 114,565
CASH, CASH EQUIVALENTS & RESTRICTED CASH, END OF PERIOD 199,511 203,763
Supplemental Cash Flows Information    
Interest paid 1,452 16,251
Income taxes paid 84 7,047
Prepayment penalty on extinguishment of debt   6,000
Intangibles and property and equipment included in accounts payable 4,577 224
Property and equipment purchased under capital leases $ 8,057 $ 3,517
XML 19 R8.htm IDEA: XBRL DOCUMENT v3.22.1
Business
9 Months Ended
Mar. 31, 2022
Business  
Business

Note 1:Business

InnovAge Holding Corp. (formerly, TCO Group Holdings, Inc.) was formed May 13, 2016, to acquire the business of Total Community Options, Inc. d/b/a InnovAge, which was formed in May 2007. In connection with the Company’s initial public offering (“IPO”), which occurred in March 2021, we changed the name of our Company from TCO Group Holdings, Inc. to InnovAge Holding Corp.

InnovAge Holding Corp. and its subsidiaries, are headquartered in Denver, Colorado. The Company manages, and in many cases directly provides, a broad range of medical and ancillary services for seniors in need of care and support to safely live independently in their homes and communities, including in-home care services (skilled, unskilled and personal care); in-center services such as primary care, physical therapy, occupational therapy, speech therapy, dental services, mental health and psychiatric services, meals, and activities; transportation to the Program of All-Inclusive Care for the Elderly (“PACE”) center and third-party medical appointments; and care management. The Company manages its business as one reportable segment, PACE.

As of March 31, 2022, the Company served approximately 6,800 PACE participants, making it the largest PACE provider in the United States of America (the “U.S.”) based upon participants served, and operates 18 PACE centers across Colorado, California, New Mexico, Pennsylvania and Virginia.

PACE is a fully-capitated managed care program, which serves the frail elderly, and predominantly dual-eligible, population in a community-based service model. InnovAge is obligated to provide and participants receive all needed healthcare services through an all-inclusive, coordinated model of care, and the Company is at risk for 100% of healthcare costs incurred with respect to the care of its participants. PACE programs receive capitation payments directly from Medicare Parts C and D, Medicaid, Veterans Administration (“VA”), and private pay sources. Additionally, under the Medicare Prescription Drug Plan, the Centers for Medicare and Medicaid Services (“CMS”) share part of the risk for providing prescription medication to the Company’s participants.

On March 8, 2021, we completed our IPO. The Company’s common stock began trading on the Nasdaq Stock Market LLC (“NASDAQ”) under the ticker symbol “INNV”.

XML 20 R9.htm IDEA: XBRL DOCUMENT v3.22.1
Summary of Significant Accounting Policies
9 Months Ended
Mar. 31, 2022
Summary of Significant Accounting Policies  
Summary of Significant Accounting Policies

Note 2:Summary of Significant Accounting Policies

The Company described its significant accounting policies in Note 2, “Summary of Significant Accounting Policies” of the Notes to Consolidated Financial Statements in its Annual Report on Form 10-K for the year ended June 30, 2021 (“2021 10-K”). During the nine months ended March 31, 2022, there were no significant changes to those accounting policies.

Basis of Preparation and Principles of Consolidation

The unaudited interim condensed consolidated financial statements and accompanying notes have been prepared in accordance with accounting principles generally accepted in the U.S. (“U.S. GAAP”) for interim financial information and with the instructions to Form 10-Q and Article 10 of Regulation S-X. Accordingly, certain information and footnote disclosures normally included in financial statements prepared in accordance with U.S. GAAP have been omitted pursuant to such regulations. These financial statements have been prepared on a basis consistent with the accounting principles applied for the fiscal year ended June 30, 2021. In the opinion of management, all adjustments (consisting of all normal and recurring adjustments) considered necessary for a fair presentation have been included. The condensed consolidated financial statements include the accounts of InnovAge, its wholly owned subsidiaries, variable interest entities (“VIEs”)

for which it is the primary beneficiary and entities for which it has a controlling interest. All intercompany accounts and transactions have been eliminated in consolidation.

The Company does not have any components of comprehensive income and comprehensive income is equal to net income reported in the statements of operations for all periods presented.

Restatement of Prior Period Financial Statements

Subsequent to the issuance of the Company’s consolidated financial statements as of and for the year ended June 30, 2021, we identified an error in our consolidated balance sheet and statement of stockholders’ equity as of June 30, 2021 related to the presentation of redeemable noncontrolling interests. Additionally, the error also impacted our condensed consolidated statements of shareholders’ equity for the three months and nine-months ended March 31, 2021. The Company incorrectly recorded redeemable noncontrolling interests of $17.0 million and $16.9 million as permanent equity rather than temporary equity as of June 30, 2021 and March 31, 2021, respectively.  As a result, the Company restated the June 30, 2021 and March 31, 2021 condensed consolidated financial statements to reflect this reclassification from permanent to temporary equity and to record the related adjustments to redemption value as of June 30, 2021 and March 31, 2021. Management has evaluated the materiality of this misstatement and concluded that it is not material to the prior period.

The effect of the restatement on the consolidated balance sheet as of June 30, 2021 is as follows (in thousands):

As Previously

    

Reported

    

Adjustments

    

As Restated

Redeemable Noncontrolling Interests (See Note 4)

 

 

16,986

 

16,986

Retained earnings

 

11,250

 

(587)

 

10,663

Total InnovAge Holding Corp.

 

335,146

 

(587)

 

334,559

Noncontrolling interests

 

22,819

 

(16,399)

 

6,420

Total stockholders’ equity

 

357,965

 

(16,986)

 

340,979

The effect of the restatement on the balances as of June 30, 2021 included in the consolidated statement of stockholders’ equity as of March 31, 2022 is as follows (in thousands):

Redeemable

Total Permanent

Noncontrolling

Retained

Noncontrolling

Stockholders’

Interests

    

Earnings

    

Interests

    

Equity

    

(Temporary Equity)

As Previously Reported

 

  

 

  

 

  

 

  

Balances, June 30, 2021

 

11,250

 

22,819

 

357,965

 

Adjustments

 

  

 

  

 

  

 

  

Balances, June 30, 2021

 

(587)

 

(16,399)

 

(16,986)

 

16,986

As Restated

 

  

 

  

 

  

 

  

Balances, June 30, 2021

 

10,663

 

6,420

 

340,979

 

16,986

The effect of the restatement on the consolidated statement of stockholders’ equity for the three months ended March 31, 2021 is as follows (in thousands):

Redeemable

Total Permanent

Noncontrolling

Retained

Noncontrolling

Stockholders’

Interests

Retained

    

Earnings

    

Interests

    

Equity

    

(Temporary Equity)

Earnings

As Previously Reported

 

  

 

  

 

  

 

  

Consolidation of equity method investment

16,838

16,838

Net income (loss)

(10,510)

(352)

(10,862)

Adjustment to redemption value

Balances, March 31, 2021

 

4,820

 

22,978

 

351,061

 

Adjustments

 

  

 

  

 

  

 

  

Consolidation of equity method investment

(16,838)

(16,838)

16,838

Net income (loss)

263

263

(263)

(10,862)

Adjustment to redemption value

(344)

(344)

344

Balances, March 31, 2021

 

(344)

 

(16,575)

 

(16,919)

 

16,919

As Restated

 

  

 

  

 

  

 

  

Consolidation of equity method investment

16,838

Net income (loss)

(10,510)

(89)

(10,599)

(263)

(10,862)

Adjustment to redemption value

 

(344)

 

 

(344)

 

344

Balances, March 31, 2021

4,476

6,403

334,142

16,919

The effect of the restatement on the consolidated statement of stockholders’ equity for the nine months ended March 31, 2021 is as follows (in thousands):

Redeemable

Total Permanent

Noncontrolling

Retained

Noncontrolling

Stockholders’

Interests

Retained

    

Earnings

    

Interests

    

Equity

    

(Temporary Equity)

Earnings

As Previously Reported

 

  

 

  

 

  

 

  

Consolidation of equity method investment

16,838

16,838

Net income (loss)

(50,460)

(595)

(51,055)

Adjustment to redemption value

Balances, March 31, 2021

 

4,820

 

22,978

 

351,061

 

Adjustments

 

  

 

  

 

  

 

  

Consolidation of equity method investment

(16,838)

(16,838)

16,838

Net income (loss)

263

263

(263)

(51,055)

Adjustment to redemption value

(344)

(344)

344

Balances, March 31, 2021

 

(344)

 

(16,575)

 

(16,919)

 

16,919

As Restated

 

  

 

  

 

  

 

  

Consolidation of equity method investment

16,838

Net income (loss)

(50,460)

(332)

(50,792)

(263)

(51,055)

Adjustment to redemption value

 

(344)

 

 

(344)

 

344

Balances, March 31, 2021

4,476

6,403

334,142

16,919

Property and Equipment

Property and equipment were comprised of the following as of March 31, 2022 and June 30, 2021:

    

Estimated

    

    

dollars in thousands

Useful Lives

March 31, 2022

June 30, 2021

Land

 

N/A

$

11,980

$

11,980

Buildings and leasehold improvements

 

10 - 40 years

 

121,661

 

104,724

Software

 

3 - 5 years

 

15,107

 

13,316

Equipment and vehicles

 

3 - 7 years

 

46,655

 

35,341

Construction in progress

 

N/A

 

22,336

 

22,130

 

 

217,739

187,491

Less accumulated depreciation and amortization

 

 

(53,857)

 

(44,776)

Total property and equipment, net

$

163,882

$

142,715

Depreciation of $3.8 million and $3.2 million was recorded during the three months ended March 31, 2022 and 2021, respectively. Depreciation of $9.9 million and $8.8 million was recorded during the nine months ended March 31, 2022 and 2021, respectively.

Coronavirus Pandemic (“COVID-19”)

As a PACE organization, we have been and will continue to be impacted by the effects of COVID-19. We closed all our centers in March 2020 and transitioned to a 100% in-home and virtual care model. We believe that the general lack of in-person interaction and the reduction in healthcare personnel, and specifically, trained personnel, impacted our ability to adhere to the complex government laws and regulations that apply to our business. We remain committed to carrying out our mission of caring for our participants. We continue to closely monitor the impact of COVID-19 on all aspects of our business, including the impacts to our employees, participants and suppliers. Due to the numerous evolving factors, we are unable to reliably estimate the ultimate impact the pandemic will have on our consolidated financial condition, results of operations or cash flows.

On March 27, 2020, the Coronavirus Aid, Relief, and Economic Security Act (“CARES Act”) was signed into legislation. Under the CARES Act, the state of Pennsylvania signed into law the Act 24 of 2020. We received $1.0 million in funding under the Act 24 of 2020, which was allocated to InnovAge centers in Pennsylvania. Of the $1.0 million, $0.7 million was recognized prior June 30, 2020 and the remaining balance of $0.3 million was recognized during the year ended June 30, 2021. The CARES Act also provides for the temporary suspension of the automatic 2% reduction of Medicare claim reimbursements (sequestration) for the period of May 1, 2020 through December 31, 2020. The Consolidated Appropriations Act, 2021, enacted December 27, 2020, extended this suspension for three more months, through March 31, 2021.  H.R. 1868, enacted on April 14, 2021 further extends the suspension through December 31, 2021. On December 10, 2021 the “Protecting Medicare and American Farmers from Sequester Cuts Act” extends the 2% Medicare sequester moratorium through March 31, 2022, and adjusts the sequester to 1% between April 1, 2022 and June 30, 2022.

Recently Adopted Accounting Pronouncements

Income Taxes

In December 2019, the Financial Accounting Standards Board (“FASB”) issued ASU 2019-12, Income Taxes Topic 740-Simplifying the Accounting for Income Taxes (“ASU 2019-12”), which intended to simplify various aspects related to accounting for income taxes. ASU 2019-12 removes certain exceptions to the general principles in Topic 740 and also clarifies and amends existing guidance to improve consistent application of Topic 740. This guidance is effective for companies with fiscal years beginning after December 15, 2020, including interim periods therein, and early adoption is permitted. The Company adopted ASU 2019-12 during the quarter ended September 30, 2021 and it did not have a material effect on the Company’s condensed consolidated financial statements.

Recent Accounting Pronouncements Not Yet Adopted

Leases

In February 2016, the FASB issued ASU 2016-02 Leases (“ASU 2016-02”), which was intended to increase transparency and comparability among organizations by recognizing lease assets and liabilities on the balance sheet and disclosing key information about leasing arrangements. Under the new guidance, lessees will be required to recognize a right-of-use asset and a lease liability, measured on a discounted basis, at the commencement date for all leases with terms greater than 12 months. Additionally, this guidance will require disclosures to help investors and other financial statement users to better understand the amount, timing, and uncertainty of cash flows arising from leases, including qualitative and quantitative requirements. The guidance should be applied under a modified retrospective transition approach for leases existing at the beginning of the earliest comparative period presented in the adoption-period financial statements. Any leases that expire before the initial application date will not require any accounting adjustment. In June 2020, FASB issued ASU 2020-05 Revenue from contracts with customers (Topic 606) and leases (Topic 842)—Effective dates for certain entities which deferred the new lease standard effective date for the Company to December 15, 2022, with early adoption permitted. The Company will adopt this ASU in the fiscal year beginning July 1, 2022 and has not yet determined the effect of the standard on its ongoing financial reporting.

Financial Instruments

In April 2019, the FASB issued ASU 2019-04, Codification Improvements to Topic 326, Financial Instruments—Credit Losses, Topic 815, Derivatives and Hedging, and Topic 825, Financial Instruments (“ASU 2019-04”), which requires entities to use a current expected credit loss (“CECL”) model to measure impairment for most financial assets that are not recorded at fair value through net income. Under the CECL model, an entity will estimate lifetime expected credit losses considering available relevant information about historical events, current conditions and supportable forecasts. The CECL model does not apply to available-for-sale debt securities. This guidance also expands the required credit loss disclosures and will be applied using a modified retrospective approach by recording a cumulative effect adjustment to retained earnings as of the beginning of the fiscal year of adoption. ASU 2019-04 is effective for the Company for fiscal years beginning after December 15, 2022, including interim periods within those fiscal years. The Company will adopt this guidance for the annual and interim reporting periods beginning July 1, 2023. The Company has not determined the effect of the standard on its condensed consolidated financial statements.

We do not expect that any other recently issued accounting guidance will have a significant effect on our condensed consolidated financial statements.

XML 21 R10.htm IDEA: XBRL DOCUMENT v3.22.1
Revenue Recognition
9 Months Ended
Mar. 31, 2022
Revenue Recognition  
Revenue Recognition

Note 3:Revenue Recognition

Under ASC 606, revenue is recognized when a customer obtains control of promised goods or services, in an amount that reflects the consideration which the entity expects to receive in exchange for those goods or services. To determine revenue recognition for arrangements that an entity determines are within the scope of ASC 606, the Company performed the following five steps: (i) Identify the contract(s) with a customer; (ii) Identify the performance obligations in the contract; (iii) Determine the transaction price; (iv) Allocate the transaction price to the performance obligations in the contract; and (v) Recognize revenue as the entity satisfies a performance obligation.

Capitation Revenue and Accounts Receivable

Our capitation revenue relates to contracts with participants in which our performance obligation is to provide healthcare services to the participants. Revenues are recorded during the period our obligations to provide healthcare services are satisfied as noted below within each service type. The Company contracts directly with Medicare and Medicaid on a per member, per month (“PMPM”) basis. We receive 100% of the pooled capitated payment to directly provide or manage the healthcare needs of our participants.

Fees are recorded gross in revenues because the Company is acting as a principal in providing for or overseeing comprehensive care provided to the participants. Neither the Company nor any of its affiliates is a registered insurance company because state law in the states in which it operates does not require such registration for risk-bearing providers.

In general, a participant enrolls in the PACE program and is considered a customer of InnovAge. The Company considers all contracts with participants as a single performance obligation to provide comprehensive medical, health, and social services that integrate acute and long-term care. The Company identified that contracts with customers in the PACE program have similar performance obligations and therefore groups them into one portfolio. This performance obligation is satisfied as the Company provides comprehensive care to its participants.

Our revenues are based on the estimated PMPM  amounts we expect to be entitled to receive from the capitated fees per participant that are paid monthly by Medicaid, Medicare, the VA, and private pay sources. Medicaid and Medicare capitation revenues are based on PMPM capitation rates under the PACE program.  VA is included in “Private Pay and other” and is also capitated.  Private pay includes direct payments from participants who do not qualify for the full capitated rate and have to pay all or a portion of the capitated rate.

The Company disaggregates capitation revenue from the following sources for the nine months ended:

    

March 31, 

    

    

2022

    

2021

    

Medicaid

 

53

%

53

%

Medicare

 

46

%

46

%

Private pay and other

 

1

%

1

%

Total

 

100

%

100

%

The Company determined the transaction price for these contracts is the amount we expect to be entitled to, which is the most likely amount. For certain capitation payments, the Company is subject to retroactive premium risk adjustments based on various factors. The Company estimates the amount of the adjustment and records it monthly on a straight-line basis. These adjustments are not expected to be material.

The capitation revenues are recognized based on the estimated PMPM transaction price to transfer the service for a distinct increment of the series (i.e. month). We recognize revenue in the month in which participants are entitled to receive comprehensive care benefits during the contract term. As the period between the time of service and time of payment is typically one year or less, the Company elected the practical expedient under ASC 606-10-32-18 and did not adjust for the effects of a significant financing component.

The Company also provides prescription drug benefits in accordance with Medicare Part D. Monthly payments received from CMS and the participants represent the bid amount for providing prescription drug coverage. The portion received from CMS is subject to risk sharing through Medicare Part D risk-sharing corridor provisions. These risk-sharing corridor provisions compare costs targeted in the Company’s bid to actual prescription drug costs. The Company estimates and records a monthly adjustment to Medicare Part D revenues associated with these risk-sharing corridor provisions. Medicare Part D comprised (i) 12% of capitation revenues for both the nine months ended March 31, 2022 and 2021 and (ii) 23% and 25% of external provider costs for the nine months ended March 31, 2022 and 2021, respectively.

Our accounts receivable as of March 31, 2022 and June 30, 2021 is primarily from capitation revenue arrangements. The concentration of net receivables from participants and third-party payers was as follows:

    

March 31, 

June 30, 

2022

    

2021

Medicaid

 

50

%

60

%

Medicare

 

37

%

20

%

Private pay and other

 

13

%

20

%

Total

 

100

%

100

%

The Company records accounts receivable at net realizable value, which includes an allowance for estimated uncollectible accounts. The allowance for uncollectible accounts reflects the Company’s best estimate of probable losses considering eligibility, historical experience, and existing economic conditions. The balance of the allowance for uncollectible accounts was $3.9 million as of March 31, 2022, compared to $4.4 million as of June 30, 2021. Accounts are written off as bad debts when they are deemed uncollectible based upon individual credit evaluations and specific circumstances underlying the accounts.

Other Service Revenue and Accounts Receivable

Other service revenue is comprised of rents earned related to Senior Housing and other fee for service revenue. Other service revenue was 0.2% and 0.4% of total revenue for the nine months ended March 31, 2022 and 2021, respectively, and 0.2% and 0.3% for the three months ended March 31, 2022 and 2021, respectively. Accounts receivable related to other service revenue were not significant as of both March 31, 2022 and June 30, 2021.

Laws and regulations governing the Medicare and Medicaid programs are complex and subject to change, as well as government review. Failure to comply with these laws can expose the entity to significant regulatory action, including fines, penalties, and exclusion from the Medicare and Medicaid programs. See Note 9, “Commitments and Contingencies”.

XML 22 R11.htm IDEA: XBRL DOCUMENT v3.22.1
Investments
9 Months Ended
Mar. 31, 2022
Investments  
Investments

Note 4:Investments

The Company holds equity method and cost method investments as of:

March 31, 

June 30, 

in thousands

2022

    

2021

Cost method investments

$

4,645

$

2,645

Equity method investments

 

848

 

848

Total investments

$

5,493

$

3,493

Nonconsolidated Entities

Cost Method Investments

The Company maintains two investments that are accounted for using the cost method. The investments do not have a readily determinable fair value and the Company has elected to record the investments at cost, less impairment, if any, plus or minus any changes resulting from observable price changes in orderly transactions for the identical or similar investment of the same issuer. During the nine months ended March 31, 2022 and 2021, there were no observable price changes or impairments recorded.

Jetdoc

In August 2021, the Company acquired a minority interest equal to 806,481 shares of the outstanding common

stock of Jetdoc, Inc. (“Jetdoc”), a telehealth and virtual urgent care app dedicated to effectively connecting users with medical professionals, for cash consideration of $2.0 million. The balance of the Company’s investment in Jetdoc is $2.0 million which represents the maximum exposure to loss.

Dispatch Health

Since 2019, the Company has maintained an investment of $2.6 million in DispatchHealth Holdings, Inc. (“Dispatch Health”). Dispatch Health offers  complete in-home on-demand healthcare. The balance of the Company’s investment is $2.6 million which represents the maximum exposure to loss.

Equity Method Investments

Pinewood Lodge

The Company’s operations include a Senior Housing unit that primarily includes the accounts of Continental Community Housing (“CCH”), the general partner of Pinewood Lodge, LLP (“ PWD”) which was organized to develop, construct, own, maintain, and operate certain apartment complexes intended for rental to low-income elderly individuals aged 62 or older.

PWD is a VIE, but the Company is not the primary beneficiary. The Company does not have the power to direct the activities that most significantly impact the economic performance of PWD. Accordingly, the Company does not consolidate PWD. PWD is accounted for using the equity method of accounting. The equity earnings of PWD are insignificant. As of March 31, 2022, the balance of the Company’s investment in PWD is $0.8 million which represents the maximum exposure to loss.

Noncontrolling Interest

Senior Housing

The Company’s operations include a 0.01% partnership interest in InnovAge Senior Housing Thornton, LLC (“SH1”), which was organized to develop, construct, own, maintain, and operate certain apartment complexes intended for rental to low-income elderly individuals aged 62 or older.

SH1 is a  VIE. The Company is the primary beneficiary of SH1 and consolidates SH1. The Company is the primary beneficiary of SH1 as it has the power to direct the activities that are most significant to SH1 and has an obligation to absorb losses or the right to receive benefits from SH1. The most significant activity of SH1 is the operation of the senior housing facility. The Company has provided a subordinated loan to SH1 and has provided a guarantee for a convertible term loan held by SH1.

Redeemable Noncontrolling Interest

InnovAge Sacramento

On March 18, 2019, in connection with the formation of InnovAge Sacramento, the joint venture with Adventist Health System/West (“Adventist”) and Eskaton Properties, Incorporated (“Eskaton”), the Company contributed $9.0 million in cash and land valued at $4.2 million for a 59.9% membership interest in the joint venture, InnovAge Sacramento. Further, Adventist contributed $5.8 million in cash and Eskaton contributed $3.0 million in cash for membership interests of 26.4% and 13.7%, respectively.

Prior to January 1, 2021, the Company did not consolidate InnovAge Sacramento. In the third quarter of fiscal year 2021, the Company made an additional contribution of $52,000 to obtain an additional 0.1% membership interest in the joint venture. With the acquisition of the additional 0.1% membership interest, the Company obtained control of InnovAge Sacramento effective January 1, 2021. Accordingly, beginning January 1, 2021, the results of InnovAge Sacramento are included in our consolidated results of operations.

Before consolidation on January 1, 2021, the Company recorded its proportionate share of net loss, which was a loss of $1.3 million for the six months ended December 31, 2020, as equity loss in the statement of operations.

When the joint venture was formed, the Company issued warrants to Adventist (the “Sacramento Warrants”) to purchase 5% of its issued and outstanding common stock par value $0.001 per share, at an exercise price equal to the fair market value per share at the time of exercise of the warrant. Pursuant to the original warrants, the Sacramento Warrants were to fully vest on the date on which Adventist would have made aggregate capital contributions in an amount greater than $25.0 million to one or more joint venture entities in which Adventist and the Company held equity (the “Investment Threshold”).

On February 9, 2021, we entered into an amendment agreement with Adventist to amend the Sacramento Warrants. The amendment removes the Investment Threshold requirement and grants Adventist the right to purchase up to $15.0 million of our common stock at an exercise price equal to the initial public offering price. The warrant was exercisable for one year beginning March 8, 2021, the date of the consummation of our IPO. The Sacramento Warrants expired in March 2022, without being exercised.

At inception, the Sacramento Warrants were initially determined to be equity-based payments to nonemployees and as such the measurement date for these warrants was considered to be the date when the Investment Threshold is reached. At the time of the amendment, due to the removal of the Investment Threshold, the Sacramento Warrants were evaluated under ASC 815-40, “Contracts in an Entity’s Own Equity,” which resulted in a liability classification from the date of the amendment through completion of our IPO, due to the variable amount of shares which could be issued. Upon completion of the IPO, the number of shares to be issued were no longer variable, which resulted in the warrants being recorded in equity. A charge of $2.3 million, representing the fair value of the Sacramento Warrants from inception through the date of completion of the IPO, was recorded in other income (expense) in the condensed consolidated statement of operations.

As described above, we obtained control of InnovAge Sacramento through acquisition of an additional 0.1% membership interest, which we consider to be a step acquisition, whereby the Company remeasured the previously held equity method investment to fair value. The amount by which the purchase price exceeds the fair value of the net assets acquired is recorded as goodwill. The fair value of the previously held equity investments was determined using a discounted cash flow model.  This resulted in recording a gain on consolidation of $10.9 million during the third quarter of fiscal year 2021.

The InnovAge California PACE-Sacramento LLC Limited Liability Company Agreement (the “JV Agreement”) includes numerous provisions whereby, if certain conditions are met, the Joint Venture may be required to purchase, at fair market value, certain members’ interests or certain members may be required to purchase, at fair market value, the interests of certain other members. As of March 31, 2022, none of the conditions specified in the JV Agreement had been met.  At the time the Company became a publicly traded company these put rights held by the noncontrolling interests of the Joint Venture were required to be presented as temporary equity. The redeemable noncontrolling interest of $15.9 million was recorded at carrying value as of March 31, 2022.

XML 23 R12.htm IDEA: XBRL DOCUMENT v3.22.1
Fair Value Measurements
9 Months Ended
Mar. 31, 2022
Fair Value Measurements  
Fair Value Measurements

Note 5:Fair Value Measurements

Fair value is defined as the price that would be received from selling an asset or paid to transfer a liability (an exit price) in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants, at the measurement date. A fair value hierarchy was established that requires an entity to maximize the use of observable inputs and minimize the use of unobservable inputs when measuring fair value. Observable inputs are inputs that reflect the assumptions market participants would use in pricing the asset or liability developed based on market data obtained from sources outside the reporting entity. Unobservable inputs are inputs that reflect the Company’s own assumptions based on market data and assumptions that market participants would use in pricing the asset or liability developed based on the best information available in the circumstances. The sensitivity to changes in inputs and their impact on fair value measurements can be significant.

The three levels of inputs that may be used to measure fair value are:

Level 1

Unadjusted quoted prices in active markets for identical assets or liabilities that the entity has the ability to access at the measurement date

Level 2

Quoted prices in markets that are not active or inputs that are observable, either directly or indirectly, for substantially the full term of the assets or liabilities

Level 3

Unobservable inputs to the valuation techniques that are significant to the fair value measurements of the assets or liabilities

Recurring Measurements

The Company’s investment in InnovAge Sacramento includes a put right for the noncontrolling interest holders to require the Company to repurchase the interest of the noncontrolling interest holders at fair value, after the initial term of the management services agreement in 2028. As a result, at each fiscal period end the Company reports this put right at the greater of i) carrying value of the redeemable noncontrolling interest or (ii) fair value of the redeemable noncontrolling interest. Because this asset does not have observable inputs, level 3 inputs are used to measure fair value. For the three months ended March 31, 2022, the Company recorded an adjustment to redemption value of the redeemable noncontrolling interest of $2.6 million, which was a reduction to carrying value. This adjustment represents the excess amount of fair value over the carrying value as of March 31, 2022.  The fair value of the redeemable noncontrolling interest is determined utilizing a discounted cash flow model.

Effective August 7, 2018, the Company finalized the acquisition of NewCourtland LIFE Program (“NewCourtland”) in Pennsylvania. The Company paid a base purchase price of $30.0 million, subject to certain net working capital and closing adjustments plus contingent consideration of up to $20.0 million. On March 8, 2021, we completed our IPO, which satisfied the condition that the Company sell equity securities pursuant to an effective registration statement. Accordingly, $20.0 million of contingent consideration was paid under the terms of the acquisition agreement. Since all of the contingent consideration of $20.0 million was paid, the lease payments in certain real estate leases between the Company and NewCourtland were reduced from their current amounts and allow the Company to exercise its option to purchase the leased buildings at fair market value, after the initial term of the lease.

As of  June 30, 2021 and March 31, 2022, there are no amounts of contingent consideration outstanding.  

There were no transfers in and out of Level 3 during the nine months ended March 31, 2022 or 2021.

XML 24 R13.htm IDEA: XBRL DOCUMENT v3.22.1
Goodwill and Intangible Assets
9 Months Ended
Mar. 31, 2022
Goodwill and Intangible Assets  
Goodwill and Intangible Assets

Note 6:Goodwill and Intangible Assets

Goodwill, which represents the excess of consideration paid over the fair value of net assets acquired through business acquisitions. Goodwill amounted to $124.2 million at each of March 31, 2022 and June 30, 2021. Goodwill is not amortized.

Pursuant to ASC 350, “Intangibles – Goodwill and Other,” we review the recoverability of goodwill annually as of April 1 or whenever significant events or changes occur which might impair the recovery of recorded amounts. For purposes of the annual goodwill impairment assessment, the Company has identified three reporting units. There were no indicators of impairment identified and no goodwill impairments recorded during the nine months ended March 31, 2022 and 2021.

Intangibles assets consisted of the following as of:

    

March 31, 

June 30, 

in thousands

2022

    

2021

Definite-lived intangible assets

$

9,350

$

6,600

Indefinite-lived intangible assets

2,000

2,000

Total intangible assets

11,350

8,600

Accumulated amortization

(2,578)

(2,082)

Balance as of end of period

$

8,772

$

6,518

Intangible assets consist primarily of customer relationships acquired through business acquisitions and technology-based assets. The Company recorded amortization expense of $0.5 million and $0.2 million for the nine months ended March 31, 2022 and 2021, respectively.

We review the recoverability of other intangible assets in conjunction with long-lived assets whenever events or changes in circumstances indicate the carrying amount of such assets may not be recoverable. There were no intangible asset impairments recorded during the nine months ended March 31, 2022 and 2021.

During the nine months ended March 31, 2022, the market value of our common stock declined below the carrying value of equity. As a result, we were required to qualitatively assess whether a triggering event had occurred and whether it was more likely than not that our goodwill was impaired as of March 31, 2022. We believe the impact of the regulatory actions described below to our planned opening of new centers and expansion into new service areas met the criteria of a triggering event, which required us to perform quantitative procedures as part of a Step 1 goodwill impairment analysis to asses whether it was more-likely-than-not that the fair value of the Company was greater than the net book value.

In September 2021, we were notified that CMS and the State of California had determined to suspend new enrollments at our Sacramento center based on deficiencies detected in an audit related to participant provision of services.  In December 2021, we were notified that CMS and Colorado Department of Health Care Policy and Financing (“HCPF”) had determined to suspend new enrollments at our Colorado centers based on deficiencies detected in an audit related to participant provision of services. In each case, the suspensions will remain in effect until CMS and the respective States determine that we have remediated the deficiencies to their satisfaction. During the third quarter ended March 31, 2022, we were notified by the State of Kentucky that they no longer intend to enter into an agreement with us relating to PACE services, and during the same period, CMS denied our initial application to develop a PACE center in the State of Indiana.

As a result of the above assessment, we concluded that there was no goodwill impairment based on a review of macroeconomic and industry considerations, the Company's financial results in each of our reporting units for the nine months ended March 31, 2022 and financial projections, inclusive of a sustained impact of the enrollment suspension and inability to open new centers. If assumptions or estimates in the fair value calculations change or if future cash flows vary from what was expected, including those assumptions relating to the duration and severity of the financial impact of the enrollment suspension at Sacramento and Colorado or new regulatory sanctions or other actions are imposed on the Company, this may impact the impairment analysis and could reduce the underlying cash flows used to estimate fair values and result in a decline in fair value that may trigger future impairment charges.

XML 25 R14.htm IDEA: XBRL DOCUMENT v3.22.1
Leases
9 Months Ended
Mar. 31, 2022
Leases  
Leases

Note 7:Leases

Property and equipment includes property under various capital leases. These leases have expiration dates ranging from August 2022 to July 2032, varying interest rates, and generally include an option to purchase the equipment at the end of the underlying lease period. The Company’s capital leases included the following at March 31, 2022 and June 30, 2021:

    

March 31, 2022

June 30, 2021

in thousands

Equipment

$

18,885

$

13,302

Less accumulated depreciation

 

(7,150)

 

(7,081)

Total capital leases

$

11,735

$

6,221

Certain of the Company’s property and equipment is leased under operating leases. Such leases generally have lease terms ranging from years 2022 through 2032 with renewal options. Total rental expense under operating leases was $1.3 million and $3.5 million for the three and nine months ended March 31, 2022, respectively, and $1.4 million and $3.5 million for the three and nine months ended March 31, 2021 respectively.

Future minimum lease payments for fiscal years beginning with remainder of fiscal year 2022 for capital leases having initial terms of more than one year and noncancelable operating leases were as follows:

    

    

Operating Leases

Capital Leases

Minimum Lease

in thousands

Obligations

Payments

Amount remaining in 2022

$

958

$

1,203

2023

 

4,405

 

4,872

2024

 

3,909

 

4,582

2025

 

3,126

 

4,122

2026

 

2,092

 

4,061

Thereafter

 

1,927

 

14,029

Total

 

16,417

$

32,869

Less amount representing interest

 

(2,912)

 

  

Total minimum lease payments

 

13,498

 

  

Less current maturities

 

(3,216)

 

  

Noncurrent maturities

$

10,282

 

  

XML 26 R15.htm IDEA: XBRL DOCUMENT v3.22.1
Long Term Debt
9 Months Ended
Mar. 31, 2022
Long Term Debt  
Long Term Debt

Note 8. Long Term Debt

Long-term debt consisted of the following at March 31, 2022 and June 30, 2021:

Interest rate

Maturity date

March 31, 2022

June 30, 2021

in thousands

Senior secured borrowings:

Term Loan Facility

(a)

March 8, 2026

$

72,188

$

75,000

Revolving Credit Facility (b)

(a)

March 8, 2026

Convertible term loan

6.68%

August 20, 2030

 

2,338

 

2,367

Total debt

 

74,526

 

77,367

Less unamortized debt issuance costs

 

1,681

 

2,003

Less current maturities

 

3,793

 

3,790

Noncurrent maturities

$

69,051

$

71,574

(a)The interest rates on the Term Loan Facility and Revolving Credit Facility are described below.
(b)The remaining capacity under the Revolving Credit Facility as of March 31, 2022 was $100.0 million, subject to (i) any issued amounts under our letters of credit, which as of March 31, 2022 was $2.6 million, and (ii) applicable covenant compliance restrictions and any other conditions precedent to borrowing.

2016 Credit Agreement

The Company originally entered into a senior secured borrowing agreement (the “2016 Credit Agreement”) on May 13, 2016, that consisted of a senior secured term loan for $75.0 million and a revolving credit facility for $20.0 million. The 2016 Credit Agreement was subsequently amended (i) on May 2, 2019 to increase the senior secured term loan to $190.0 million and a revolving credit facility for $30.0 million and a delayed draw term loan facility (“DDTL”) for $45.0 million and (ii) on July 27, 2020, to increase the senior secured term loan to $300.0 million, the revolving credit facility to $40.0 million and to terminate the DDTL.  The structure of the July 27, 2020 amendment to the 2016 Credit Agreement led to an extinguishment of debt for certain lenders and a modification of debt for other lenders. The total debt structure extinguishment for certain lenders was $57.1 million, and the write off of $1.0 million in debt issuance costs was recorded in loss on extinguishment of debt for the nine months ended March 31, 2021. The total debt structure that was modified was $250.0 million, while the new debt issued was $50.0 million, which resulted in $9.1 million of  capitalized debt issuance costs. Total amortization of deferred financing costs was $0.9 million for the nine months ended March 31, 2021.

Concurrent with the Company’s entry into the 2021 Credit Agreement (as defined below), the Company terminated and repaid in full all outstanding indebtedness under the 2016 Credit Agreement.

2021 Credit Agreement

On March 8, 2021, concurrently with the closing of the IPO, the Company entered into a new credit agreement (the “2021 Credit Agreement”) that replaced the 2016 Credit Agreement. The 2021 Credit Agreement consists of a senior secured term loan (the “Term Loan Facility”) of $75.0 million principal amount and a revolving credit facility (the “Revolving Credit Facility”) of $100.0 million maximum borrowing capacity. Loans under the 2021 Credit Agreement are secured by substantially all of the Company’s assets. Principal on the Term Loan Facility is paid each calendar quarter beginning September 2021 in an amount equal to 1.25% of the initial term loan on closing date. Proceeds of the Term Loan Facility, together with proceeds from the IPO, were used to repay amounts outstanding under the 2016 Credit Agreement.

Outstanding principal amounts under the 2021 Credit Agreement accrue interest at a variable interest rate. As of March 31, 2022, the interest rate on the Term Loan Facility was 2.21%. Under the terms of the 2021 Credit Agreement, the Revolving Credit Facility fee accrues at 0.25% of the average daily unused amount and is paid quarterly. As of March 31, 2022, we had no borrowings outstanding under the Revolving Credit Facility.

The 2021 Credit Agreement requires the Company to meet certain operational and reporting requirements, including, but not limited to, a secured net leverage ratio. Additionally, annual capital expenditures and permitted investments, including acquisitions, are limited to amounts specified in the 2021 Credit Agreement. The 2021 Credit Agreement also provides certain restrictions on dividend payments and other equity transactions and requires the Company to make prepayments under specified circumstances. As of March 31, 2022, the Company was in compliance with the covenants of the 2021 Credit Agreement.

The deferred financing costs of $2.0 million are amortized over the term of the underlying debt and unamortized amounts have been offset against long-term debt in the consolidated balance sheets. Total amortization of deferred financing costs was $0.3 million for the nine months ended March 31, 2022.

Convertible Term Loan

On June 29, 2015, SH1 entered into a convertible term loan. Monthly principal and interest payments of $0.02 million commenced on September 1, 2015. The loan is secured by a deed of trust to Public Trustee, assignment of leases and rents, security agreements, and SH1’s fixture filing.

XML 27 R16.htm IDEA: XBRL DOCUMENT v3.22.1
Commitments and Contingencies
9 Months Ended
Mar. 31, 2022
Commitments and Contingencies  
Commitments and Contingencies

Note 9: Commitments and Contingencies

Professional Liability

The Company pays fixed premiums for annual professional liability insurance coverage under a claims-made policy. Under such policy, only claims made and reported to the insurer are covered during the policy term, regardless of when the incident giving rise to the claim occurred. The Company records claim liabilities and expected recoveries, if any, at gross amounts. The Company is not currently aware of any unasserted claims or unreported incidents that are expected to exceed medical malpractice insurance coverage limits.

Litigation

From time to time, in the normal course of business, the Company is involved in or subject to legal proceedings related to its business, including those described below. The Company regularly evaluates the status of claims and legal proceedings in which it is involved in order to assess whether a loss is probable or there is a reasonable possibility that a loss may have been incurred, and to determine if accruals are appropriate. The Company expenses legal costs as such costs are incurred.

On October 14, 2021, the Company was named as a defendant in a putative class action complaint filed in the District Court for the District of Colorado on behalf of individuals who purchased or acquired shares of the Company’s common stock during a specified period. Through the complaint, plaintiffs are asserting claims against the Company, certain of the Company’s officers and the underwriters in the Company’s IPO, alleging violations of Sections 11 and 15 of the Securities Act of 1933 for making allegedly inaccurate and misleading statements and omissions in connection with the Company’s IPO and seeking compensatory damages, among other things. The plaintiffs have indicated that they intend to file an amended complaint on or before June 14, 2022. We are currently unable to predict the outcome of this matter.

In July 2021, the Company received a civil investigative demand from the Attorney General for the State of Colorado under the Colorado Medicaid False Claims Act. The demand requests information and documents regarding Medicaid billing, patient services and referrals in connection with the Company’s PACE program in Colorado. We continue to fully cooperate with the Attorney General and produce the requested information and documentation. We are currently unable to predict the outcome of this investigation.

 

In February 2022, the Company received a civil investigative demand from the Department of Justice (“DOJ”) under the Federal False Claims Act on similar subject matter.  The demand requests information and documents regarding audits, billing, orders tracking, and quality and timeliness of patient services in connection with the Company’s PACE programs in the states where the Company operates (California, Colorado, New Mexico, Pennsylvania, and Virginia).  The Company is fully cooperating with the DOJ to produce the requested information and documentation.  We are currently unable to predict the outcome of this investigation.

On April 20, 2022, the Board of Directors of the Company received a books and records demand pursuant to Section 220 of the Delaware General Corporation Law, from a purported stockholder of the Company, in connection with the stockholder’s investigation of, among other matters, potential breaches of fiduciary duty, mismanagement, self-dealing, corporate waste or other violations of law by the Company’s Board with respect to these matters. We are currently unable to predict the outcome of this matter.

Although the results of legal proceedings and claims are inherently unpredictable and uncertain, we do not believe that the outcomes of the legal proceedings with which we are currently involved, based on the currently available information, either individually or in the aggregate, will have a material adverse effect on our business, financial condition, or cash flows, though the outcomes could be material to the Company’s operating results for any particular period; depending in part, upon the operating results of such period. Regardless of the outcome, litigation has the potential to have an adverse impact on us due to any related defense and settlement costs, diversion of management resources, and other factors. 

XML 28 R17.htm IDEA: XBRL DOCUMENT v3.22.1
Equity
9 Months Ended
Mar. 31, 2022
Equity  
Equity

Note 10: Equity

Equity Owner Transaction

On July 27, 2020, InnovAge Holding Corp. (formerly TCO Group Holdings, Inc.), Ignite Aggregator LP (“Purchaser”), and the former equity holders of InnovAge Holding Corp. (“Sellers”) entered into a Securities Purchase Agreement (the “Agreement”), effective July 27, 2020. Under the terms of the Agreement, the Sellers sold a portion of their equity interest to the Purchaser. The Purchaser and the Sellers then contributed their equity interests in the Company to a newly formed limited partnership, TCO Group Holdings, L.P. (the “LP”) resulting in the Company being wholly owned by the LP.

Concurrently with the entry into the Agreement, the Company amended and restated its 2016 Credit Agreement, see Note 8, “Long Term Debt” for further discussion. A portion of the proceeds from the 2016 Credit Agreement were used by the Company to repurchase 16,095,819 shares of its common stock for $77.6 million from certain members of management, including certain members of the Board of Directors, and certain members of our equity partner. The common stock was then recognized as Treasury stock. The Treasury stock was retired in March 2021.

Additionally, as part of the Agreement, the Company executed an Option Cancellation Agreement (the “Cancellation Agreement”), which canceled the Company’s common stock option awards of 16,994,975 granted under the 2016 Equity Incentive Plan for $74.6 million. Such cancellation resulted in a settlement of the awards. Vesting of the contingent performance-based awards was not deemed probable at the time of the settlement resulting in the settlement of the contingent performance-based awards being recorded as Corporate, general and administrative. Vesting of the time vesting awards was deemed probable at the time of the settlement resulting in a portion of the settlement of the time vesting awards being recorded as Corporate, general and administrative expense and the remainder being recorded as a reduction to Additional paid-in capital. Of the total settlement, $45.4 million was recorded as Corporate, general and administrative expense and $32.4 million was recorded as a reduction to Additional paid-in capital. The Cancellation Agreement resulted in the option holders receiving the same amount of cash that they would have received had they exercised their options, participated in the repurchase described above and sold their remaining shares.

As part of the transaction, for the nine months ended March 31, 2021, the Company incurred $22.6 million in transaction costs, of which $13.1 million was recognized as Corporate, general and administrative expense and $9.5 million was recognized as a distribution to owners as the costs were paid on behalf of the owners. These costs were recorded during the nine months ended March 31, 2021.

XML 29 R18.htm IDEA: XBRL DOCUMENT v3.22.1
Stock-based Compensation
9 Months Ended
Mar. 31, 2022
Stock-based Compensation  
Stock-based Compensation

Note 11: Stock-based Compensation

A summary of our aggregate stock-based compensation expense is set forth below. Stock-based compensation expense is included in corporate, general and administrative expenses on our consolidated statements of operations.

Nine Months Ended

March 31, 

in thousands

2022

    

2021

Stock options (a)

$

359

$

45,387

Profits interests units

 

1,095

 

1,102

Restricted stock units

1,132

Total stock-based compensation expense

$

2,586

$

46,489

(a)The amount for 2021 relates to stock-based compensation expense recognized as a result of the Cancellation Agreement.

2016 Equity Incentive Plan

The Company maintained the 2016 Equity Incentive Plan pursuant to which various stock-based awards were granted to employees, directors, consultants, and advisers. The total number of shares of the Company’s common stock that was authorized under the 2016 Equity Incentive Plan was 17,836,636, of which a total of 16,994,976 awards were granted. On July 27, 2020, the Company, Ignite Aggregator LP, and the equity holders of the Company entered into a Securities Purchase Agreement, and in conjunction therewith, the Company amended and restated the 2016 Credit Agreement. A portion of the proceeds from the 2016 Credit Agreement were used by the Company to repurchase 16,095,819 shares of its common stock from the certain members of management, the Board of Directors, and members of our equity partner. Additionally, as part of the 2016 Credit Agreement, the Company executed the Cancellation Agreement with each of the 2016 Equity Incentive Plan option holders, pursuant to which the Company’s 16,994,976 common stock options which were granted under the 2016 Equity Incentive Plan, were cancelled. The Cancellation Agreement resulted in the option holders receiving the same amount of cash that they would have received had they exercised their options,

participated in the repurchase described above and sold their remaining shares. The 2016 Equity Incentive Plan was cancelled and replaced with the 2020 Equity Incentive Plan, as described below.

2020 Equity Incentive Plan

Profits Interests

The LP maintains the 2020 Equity Incentive Plan pursuant to which interests in the LP in the form of Class B Units (profits interests) may be granted to employees, directors, consultants, and advisers. A maximum number of 16,162,177 Class B Units are authorized for grant under the 2020 Equity Incentive Plan. As of March 31, 2022, a total of 13,009,137 profits interests units have been granted under the 2020 Equity Incentive Plan.

The Company used the Monte Carlo option model to determine the fair value of the profits interests units at the time of the grant. There were no grants during the nine months ended March 31, 2022.

A summary of profits interests activity for the nine months ended March 31, 2022 was as follows:

    

    

  

Number of

Weighted average

Time-based unit awards

units

grant date fair value

Outstanding balance, June 30, 2021

 

6,587,261

$

1.28

Forfeited

 

(2,409,972)

$

1.28

Outstanding balance, March 31, 2022

 

4,177,289

$

1.28

Number of

Weighted average

Performance-based unit awards

units

grant date fair value

Outstanding balance, June 30, 2021

 

6,223,262

$

0.57

Forfeited

 

(3,210,939)

$

0.57

Outstanding balance, March 31, 2022

 

3,012,323

$

0.57

The total unrecognized compensation cost related to profits interests units outstanding as of March 31, 2022 was $6.4 million, comprised (i) $4.3 million related to time-based unit awards expected to be recognized over a weighted-average period of 0.9 years and (ii) $2.1 million related to performance-based unit awards, which will be recorded when it is probable that the performance-based criteria will be met.

2021 Omnibus Incentive Plan

In March 2021, the compensation committee of our Board of Directors approved the InnovAge Holding Corp. 2021 Omnibus Incentive Plan (the “2021 Omnibus Incentive Plan”), pursuant to which various stock-based awards may be granted to employees, directors, consultants, and advisers. The total number of shares of the Company’s common stock authorized under the 2021 Omnibus Incentive Plan is 14,700,000. The Company has issued time-based restricted stock units under this plan to its employees which generally vest (i) on March 4, 2023, the second anniversary of the grant date, or (ii) over a three-year period with one-third vesting on each anniversary of the date of grant. Certain other vesting periods have also been used. The grant date fair value of restricted stock units with time based vesting is based on the closing market price of our common stock on the date of grant. Certain awards under this plan vest upon achieving specific share price performance critiera and are determined to have performance-based vesting conditions.

Restricted Stock Units

A summary of time-based vesting restricted stock units activity for the nine months ended March 31, 2022 was as follows:

Weighted

    

average

Number of

grant-date fair

Restricted stock units - time based

awards

value per share

Outstanding balance, June 30, 2021

 

48,470

$

22.87

Granted

 

315,177

$

8.99

Forfeited

(9,670)

$

23.35

Exercised

(8,493)

$

17.66

Outstanding balance, March 31, 2022

 

345,484

$

10.50

The total unrecognized compensation cost related to time based restricted stock units outstanding as of March 31, 2022 was $4.0 million and is expected to be recognized over a weighted-average period of 2.0 years.

A summary of performance based vesting restricted stock units activity for the nine months ended March 31, 2022 was as follows:

Weighted

    

average

Number of

grant-date fair

Restricted stock units - performance based

awards

value per share

Outstanding balance, June 30, 2021

 

$

Granted

 

258,767

$

5.18

Forfeited

$

Outstanding balance, March 31, 2022

 

258,767

$

5.18

The fair value of the performance based restricted stock units and performance based stock options granted during the nine months ended March 31, 2022, was based upon a Monte Carlo option pricing model using the assumptions in the following table:

2022

Expected volatility

34.5

%

Expected term (in years)

5.0

Interest rate

 

1.56

%

Dividend yield

 

0

%

Weighted-average fair values

$

5.18

Fair value of underlying stock

 

$

7.89

The total unrecognized compensation cost related to performance based vesting restricted stock units outstanding as of March 31, 2022 was $1.2 million and is expected to be recognized over a weighted-average period of 3.6 years.

Nonqualified Stock Options

A summary of time-based vesting stock option activity for the nine months ended March 31, 2022 was as follows:

Weighted

    

average

Number of

grant-date fair

Stock options - time based

awards

value per share

Outstanding balance, June 30, 2021

 

$

Granted

 

554,499

$

1.61

Forfeited

$

Outstanding balance, March 31, 2022

 

554,499

$

1.61

The total unrecognized compensation cost related to time-based vesting stock options outstanding as of March 31, 2022 was $0.7 million and is expected to be recognized over a weighted-average period of 2.5 years.

The fair value of the time-based stock options granted during the nine months ended March 31, 2022, was based upon the Black-Scholes option pricing model using the assumptions in the following table:

2022

Expected volatility

34.5

%

Weighted-average expected life (years) - time vesting units

2.9

Interest rate

 

0.83

%

Dividend yield

 

0

%

Weighted-average fair values

$

1.61

Fair value of underlying stock

 

$

7.89

A summary of performance-based vesting stock option activity for the nine months ended March 31, 2022 was as follows:

Weighted

    

average

Number of

grant-date fair

Stock options - performance based

awards

value per share

Outstanding balance, June 30, 2021

 

$

Granted

 

776,299

$

3.08

Forfeited

$

Outstanding balance, March 31, 2022

 

776,299

$

3.08

The fair value of the performance-based stock options granted during the nine months ended March 31, 2022, was based upon a Monte Carlo option pricing model using the assumptions in the table above under the ‘Restricted Stock Units’ heading.

The total unrecognized compensation cost related to performance-based vesting stock options outstanding as of March 31, 2022 was $2.2 million and is expected to be recognized over a weighted-average period of 3.6 years.

XML 30 R19.htm IDEA: XBRL DOCUMENT v3.22.1
Income Taxes
9 Months Ended
Mar. 31, 2022
Income Taxes  
Income Taxes

Note 12: Income Taxes

The Company recorded an income tax benefit of $4.1 million and $4.3 million for the three months ended March 31, 2022 and 2021, respectively. The Company recorded a tax provision of $0.1 million and $5.2 million for the nine months ended March 31, 2022 and 2021, respectively. This represents an effective tax rate of 56.6% and 28.2% for the three months ended March 31, 2022 and 2021, respectively. This represents an effective tax rate of 1.4% and (11.2)% for the nine months ended March 31, 2022 and 2021, respectively.

The effective rate for the nine months ended March 31, 2022 was different from the federal statutory rate primarily due to the Company’s book loss offset partially by disallowed officers’ compensation under Internal Revenue Code (“IRC”) Section 162(m) and lobbying expenses which occurred during the nine month period.

The Company assesses the valuation allowance recorded against deferred tax assets at each reporting date. The determination of whether a valuation allowance for deferred tax assets is appropriate requires the evaluation of positive and negative evidence that can be objectively verified. Consideration must be given to all sources of taxable income available to realize deferred tax assets, including, as applicable, the future reversal of existing temporary differences, future taxable income forecasts exclusive of the reversal of temporary differences and carryforwards, taxable income in carryback years and tax planning strategies. In estimating income taxes, the Company assesses the relative merits and risks of the appropriate income tax treatment of transactions taking into account statutory, judicial, and regulatory guidance. As of the nine-month period ended March 31, 2022, the Company has determined that it is not “more likely than not” that the deferred tax assets associated with certain state net operating losses will be realized and as such continues to maintain a valuation allowance against these state deferred tax assets.

The CARES Act, among other things, includes provisions relating to refundable payroll tax credits, deferment of the employer portion of social security payments, net operating loss carryback periods, alternative minimum tax credit refunds, modifications to the net interest deduction limitation and technical corrections to tax depreciation methods for qualified improvement property. The Company continues to examine the impacts that the CARES Act may have on its business. While several of these provisions may impact the Company, there have not been any significant impacts noted through March 31, 2022.

XML 31 R20.htm IDEA: XBRL DOCUMENT v3.22.1
Earnings per Share
9 Months Ended
Mar. 31, 2022
Earnings per Share  
Earnings per Share

Note 13: Earnings per Share

Basic earnings (loss) per share is computed using the weighted-average number of common shares outstanding during the period. Diluted earnings per share is computed using the weighted-average number of common shares outstanding during the period, plus the dilutive effect of outstanding options, using the treasury stock method and the average market price of the Company’s common stock during the applicable period. When a loss from continuing operations exists, all dilutive securities and potentially dilutive securities are anti-dilutive and are therefore excluded from the computation of diluted earnings per share. When net income from continuing operations exists, performance-based units, are omitted from the calculation of diluted EPS until it is determined that the performance criteria has been met at the end of the reporting period.

The following table sets forth the computation of basic and diluted net loss per common share:

Three months ended March 31, 

Nine months ended March 31, 

in thousands, except share values

    

2022

    

2021

    

2022

    

2021

Net income (loss) attributable to InnovAge Holding Corp.

$

(2,821)

$

(10,510)

$

6,188

$

(50,460)

Weighted average common shares outstanding (basic)

 

135,516,608

 

121,324,980

 

135,516,544

 

119,619,806

Earnings (loss) per share - basic

$

(0.02)

$

(0.09)

$

0.05

$

(0.42)

Dilutive shares

 

 

 

14,249

 

Weighted average common shares outstanding (diluted)

 

135,516,608

 

121,324,980

 

135,530,793

 

119,619,806

Earnings (loss) per share -diluted

$

(0.02)

$

(0.09)

$

0.05

$

(0.42)

XML 32 R21.htm IDEA: XBRL DOCUMENT v3.22.1
Segment Reporting
9 Months Ended
Mar. 31, 2022
Segment Reporting  
Segment Reporting

Note 14: Segment Reporting

The Company applies ASC Topic 280, "Segment Reporting," which establishes requirements to report selected segment information quarterly and to report annually entity-wide disclosures about operations, major customers and the geographies in which the entity holds material assets and reports revenue. An operating segment is defined as a component that engages in business activities whose operating results are reviewed by the Company’s chief executive officer, who is the chief operating decision maker (“CODM”), and for which discrete financial information is available. The Company has determined that it has five operating segments, three of which are related to the Company’s PACE offering. The PACE-related operating segments are based on three geographic divisions, which are West, Central, and East. Due to the similar economic characteristics, nature of services, and customers, we have aggregated our West, Central, and East operating segments into one reportable segment for PACE. The Company’s remaining two operating segments relate to Homecare and Senior Housing, which are immaterial operating segments, and are shown below as "Other" along with certain corporate unallocated expenses.

As of March 31, 2022, the Company served approximately 6,800 PACE participants, making it the largest PACE provider in the U.S. based upon participants served, and operates 18 PACE centers across Colorado, California, New Mexico, Pennsylvania and Virginia. PACE, an alternative to nursing homes, is a managed care, capitated program, which serves the frail elderly in a community-based service model. Participants receive all medical services through a comprehensive, consolidated model of care. Capitation payments are received from Medicare parts C and D; Medicaid; the VA, and private pay sources. The Company is at risk for all health and allied care costs incurred with respect to the care of its participants, although it does negotiate discounted rates with its provider network consisting of hospitals, nursing homes, assisted living facilities, and medical specialists. Additionally, under the Medicare Prescription Drug Plan, CMS shares part of the risk for providing prescription medication to the Company’s participants.

The Company evaluates performance and allocates capital resources to each segment based on an operating model that is designed to maximize the provision of services provided and profitability. The Company does not review assets by segment and therefore assets by segment are not disclosed below. For the periods presented, all of the Company’s long-lived assets were located in the U.S. and all revenue was earned in the U.S.

The Company’s management uses Center-level Contribution Margin as the measure for assessing performance of its segments. Center-level Contribution Margin is defined as total revenues less external provider costs and cost of care (excluding depreciation and amortization), which includes all medical and pharmacy costs. The Company allocates corporate level expenses to its segments with a majority of the allocation going to the PACE segment.

The following table summarizes the operating results regularly provided to the CODM by reportable segment for the three months ended March 31, 2022 and 2021:

March 31, 2022

March 31, 2021

in thousands

    

PACE

    

All other(1)

    

Totals

    

PACE

    

All other(1)

    

Totals

Capitation revenue

$

176,988

$

$

176,988

$

155,835

$

$

155,835

Other service revenue

 

166

 

205

 

371

 

(47)

 

520

 

473

Total revenues

 

177,154

 

205

 

177,359

 

155,788

 

520

 

156,308

External provider costs

 

103,254

 

 

103,254

 

75,389

 

 

75,389

Cost of care, excluding depreciation and amortization

 

45,995

 

107

 

46,102

 

38,867

 

698

 

39,565

Center-level Contribution Margin

 

27,905

 

98

 

28,003

 

41,532

 

(178)

 

41,354

Overhead costs(2)

 

30,911

 

(85)

 

30,826

 

24,217

 

(30)

 

24,187

Depreciation and amortization

 

3,760

 

90

 

3,850

 

3,181

 

130

 

3,311

Equity loss

 

 

 

 

 

 

Other operating income

 

 

 

 

19,222

 

 

19,222

Interest expense, net

 

(663)

 

(46)

 

(709)

 

(4,824)

 

(52)

 

(4,876)

Loss on extinguishment of debt

 

 

 

 

(13,488)

 

 

(13,488)

Gain on equity method investment

 

 

 

 

10,871

 

 

10,871

Other expense (income)

 

108

 

 

108

 

(2,267)

 

 

(2,267)

Income (Loss) Before Income Taxes

$

(7,321)

$

47

$

(7,274)

$

(14,796)

$

(330)

$

(15,126)

The following table summarizes the operating results regularly provided to the CODM by reportable segment for the nine months ended March 31, 2022 and 2021:

March 31, 2022

March 31, 2021

in thousands

    

PACE

    

All other(1)

    

Totals

    

PACE

    

All other(1)

    

Totals

Capitation revenue

$

524,507

$

$

524,507

$

464,294

$

$

464,294

Other service revenue

 

234

 

1,039

 

1,273

 

213

 

1,677

 

1,890

Total revenues

 

524,741

 

1,039

 

525,780

 

464,507

 

1,677

 

466,184

External provider costs

 

284,299

 

 

284,299

 

224,215

 

 

224,215

Cost of care, excluding depreciation and amortization

 

128,573

 

1,167

 

129,740

 

113,611

 

2,311

 

115,922

Center-Level Contribution Margin

 

111,869

 

(128)

 

111,741

 

126,681

 

(634)

 

126,047

Overhead costs(2)

 

93,463

 

(98)

 

93,365

 

120,249

 

(13)

 

120,236

Depreciation and amortization

 

10,130

 

305

 

10,435

 

8,901

 

361

 

9,262

Equity loss

 

 

 

 

1,343

 

 

1,343

Other operating (income) expense

 

 

 

 

18,211

 

 

18,211

Interest expense, net

 

(1,783)

 

(147)

 

(1,930)

 

(16,919)

 

(142)

 

(17,061)

Loss on extinguishment of debt

 

 

 

 

(14,479)

 

 

(14,479)

Gain on equity method investment

 

 

 

 

10,871

 

 

10,871

Other income

 

(357)

 

(1)

 

(358)

 

(2,222)

 

 

(2,222)

Income (Loss) Before Income Taxes

$

6,136

$

(483)

$

5,653

$

(44,772)

$

(1,124)

$

(45,896)

(1)Center-level Contribution Margin from segments below the quantitative thresholds are attributable to two operating segments of the Company. Those segments consist of Homecare and Senior Housing. Neither of those segments has ever met any of the quantitative thresholds for determining reportable segments.
(2)Overhead consists of the Sales and marketing and Corporate, general and administrative financial statement line items.
XML 33 R22.htm IDEA: XBRL DOCUMENT v3.22.1
Related-party
9 Months Ended
Mar. 31, 2022
Related-party  
Related-party

Note 15: Related-party

Pursuant to the PWD Amended and Restated Agreement of Limited Partnership, the general partner, who is a subsidiary of the Company (the “General Partner”), helped fund operating deficits and shortfalls of PWD in the form of a loan. At each of March 31, 2022 and June 30, 2021, $0.7 million was recorded in Deposits and other. Additionally, the General Partner is paid an administration fee of $35,000 per year.

XML 34 R23.htm IDEA: XBRL DOCUMENT v3.22.1
Subsequent Events
9 Months Ended
Mar. 31, 2022
Subsequent Events  
Subsequent Events

Note 16: Subsequent Events

The Company has evaluated subsequent events through May 10, 2022, the date on which the condensed consolidated financial statements were issued.

XML 35 R24.htm IDEA: XBRL DOCUMENT v3.22.1
Summary of Significant Accounting Policies (Policies)
9 Months Ended
Mar. 31, 2022
Summary of Significant Accounting Policies  
Basis of Preparation and Principles of Consolidation

Basis of Preparation and Principles of Consolidation

The unaudited interim condensed consolidated financial statements and accompanying notes have been prepared in accordance with accounting principles generally accepted in the U.S. (“U.S. GAAP”) for interim financial information and with the instructions to Form 10-Q and Article 10 of Regulation S-X. Accordingly, certain information and footnote disclosures normally included in financial statements prepared in accordance with U.S. GAAP have been omitted pursuant to such regulations. These financial statements have been prepared on a basis consistent with the accounting principles applied for the fiscal year ended June 30, 2021. In the opinion of management, all adjustments (consisting of all normal and recurring adjustments) considered necessary for a fair presentation have been included. The condensed consolidated financial statements include the accounts of InnovAge, its wholly owned subsidiaries, variable interest entities (“VIEs”)

for which it is the primary beneficiary and entities for which it has a controlling interest. All intercompany accounts and transactions have been eliminated in consolidation.

The Company does not have any components of comprehensive income and comprehensive income is equal to net income reported in the statements of operations for all periods presented.

Restatement of Prior Period Financial Statements

Restatement of Prior Period Financial Statements

Subsequent to the issuance of the Company’s consolidated financial statements as of and for the year ended June 30, 2021, we identified an error in our consolidated balance sheet and statement of stockholders’ equity as of June 30, 2021 related to the presentation of redeemable noncontrolling interests. Additionally, the error also impacted our condensed consolidated statements of shareholders’ equity for the three months and nine-months ended March 31, 2021. The Company incorrectly recorded redeemable noncontrolling interests of $17.0 million and $16.9 million as permanent equity rather than temporary equity as of June 30, 2021 and March 31, 2021, respectively.  As a result, the Company restated the June 30, 2021 and March 31, 2021 condensed consolidated financial statements to reflect this reclassification from permanent to temporary equity and to record the related adjustments to redemption value as of June 30, 2021 and March 31, 2021. Management has evaluated the materiality of this misstatement and concluded that it is not material to the prior period.

The effect of the restatement on the consolidated balance sheet as of June 30, 2021 is as follows (in thousands):

As Previously

    

Reported

    

Adjustments

    

As Restated

Redeemable Noncontrolling Interests (See Note 4)

 

 

16,986

 

16,986

Retained earnings

 

11,250

 

(587)

 

10,663

Total InnovAge Holding Corp.

 

335,146

 

(587)

 

334,559

Noncontrolling interests

 

22,819

 

(16,399)

 

6,420

Total stockholders’ equity

 

357,965

 

(16,986)

 

340,979

The effect of the restatement on the balances as of June 30, 2021 included in the consolidated statement of stockholders’ equity as of March 31, 2022 is as follows (in thousands):

Redeemable

Total Permanent

Noncontrolling

Retained

Noncontrolling

Stockholders’

Interests

    

Earnings

    

Interests

    

Equity

    

(Temporary Equity)

As Previously Reported

 

  

 

  

 

  

 

  

Balances, June 30, 2021

 

11,250

 

22,819

 

357,965

 

Adjustments

 

  

 

  

 

  

 

  

Balances, June 30, 2021

 

(587)

 

(16,399)

 

(16,986)

 

16,986

As Restated

 

  

 

  

 

  

 

  

Balances, June 30, 2021

 

10,663

 

6,420

 

340,979

 

16,986

The effect of the restatement on the consolidated statement of stockholders’ equity for the three months ended March 31, 2021 is as follows (in thousands):

Redeemable

Total Permanent

Noncontrolling

Retained

Noncontrolling

Stockholders’

Interests

Retained

    

Earnings

    

Interests

    

Equity

    

(Temporary Equity)

Earnings

As Previously Reported

 

  

 

  

 

  

 

  

Consolidation of equity method investment

16,838

16,838

Net income (loss)

(10,510)

(352)

(10,862)

Adjustment to redemption value

Balances, March 31, 2021

 

4,820

 

22,978

 

351,061

 

Adjustments

 

  

 

  

 

  

 

  

Consolidation of equity method investment

(16,838)

(16,838)

16,838

Net income (loss)

263

263

(263)

(10,862)

Adjustment to redemption value

(344)

(344)

344

Balances, March 31, 2021

 

(344)

 

(16,575)

 

(16,919)

 

16,919

As Restated

 

  

 

  

 

  

 

  

Consolidation of equity method investment

16,838

Net income (loss)

(10,510)

(89)

(10,599)

(263)

(10,862)

Adjustment to redemption value

 

(344)

 

 

(344)

 

344

Balances, March 31, 2021

4,476

6,403

334,142

16,919

The effect of the restatement on the consolidated statement of stockholders’ equity for the nine months ended March 31, 2021 is as follows (in thousands):

Redeemable

Total Permanent

Noncontrolling

Retained

Noncontrolling

Stockholders’

Interests

Retained

    

Earnings

    

Interests

    

Equity

    

(Temporary Equity)

Earnings

As Previously Reported

 

  

 

  

 

  

 

  

Consolidation of equity method investment

16,838

16,838

Net income (loss)

(50,460)

(595)

(51,055)

Adjustment to redemption value

Balances, March 31, 2021

 

4,820

 

22,978

 

351,061

 

Adjustments

 

  

 

  

 

  

 

  

Consolidation of equity method investment

(16,838)

(16,838)

16,838

Net income (loss)

263

263

(263)

(51,055)

Adjustment to redemption value

(344)

(344)

344

Balances, March 31, 2021

 

(344)

 

(16,575)

 

(16,919)

 

16,919

As Restated

 

  

 

  

 

  

 

  

Consolidation of equity method investment

16,838

Net income (loss)

(50,460)

(332)

(50,792)

(263)

(51,055)

Adjustment to redemption value

 

(344)

 

 

(344)

 

344

Balances, March 31, 2021

4,476

6,403

334,142

16,919

Property and Equipment

Property and Equipment

Property and equipment were comprised of the following as of March 31, 2022 and June 30, 2021:

    

Estimated

    

    

dollars in thousands

Useful Lives

March 31, 2022

June 30, 2021

Land

 

N/A

$

11,980

$

11,980

Buildings and leasehold improvements

 

10 - 40 years

 

121,661

 

104,724

Software

 

3 - 5 years

 

15,107

 

13,316

Equipment and vehicles

 

3 - 7 years

 

46,655

 

35,341

Construction in progress

 

N/A

 

22,336

 

22,130

 

 

217,739

187,491

Less accumulated depreciation and amortization

 

 

(53,857)

 

(44,776)

Total property and equipment, net

$

163,882

$

142,715

Depreciation of $3.8 million and $3.2 million was recorded during the three months ended March 31, 2022 and 2021, respectively. Depreciation of $9.9 million and $8.8 million was recorded during the nine months ended March 31, 2022 and 2021, respectively.

Coronavirus Pandemic ("COVID 19")

Coronavirus Pandemic (“COVID-19”)

As a PACE organization, we have been and will continue to be impacted by the effects of COVID-19. We closed all our centers in March 2020 and transitioned to a 100% in-home and virtual care model. We believe that the general lack of in-person interaction and the reduction in healthcare personnel, and specifically, trained personnel, impacted our ability to adhere to the complex government laws and regulations that apply to our business. We remain committed to carrying out our mission of caring for our participants. We continue to closely monitor the impact of COVID-19 on all aspects of our business, including the impacts to our employees, participants and suppliers. Due to the numerous evolving factors, we are unable to reliably estimate the ultimate impact the pandemic will have on our consolidated financial condition, results of operations or cash flows.

On March 27, 2020, the Coronavirus Aid, Relief, and Economic Security Act (“CARES Act”) was signed into legislation. Under the CARES Act, the state of Pennsylvania signed into law the Act 24 of 2020. We received $1.0 million in funding under the Act 24 of 2020, which was allocated to InnovAge centers in Pennsylvania. Of the $1.0 million, $0.7 million was recognized prior June 30, 2020 and the remaining balance of $0.3 million was recognized during the year ended June 30, 2021. The CARES Act also provides for the temporary suspension of the automatic 2% reduction of Medicare claim reimbursements (sequestration) for the period of May 1, 2020 through December 31, 2020. The Consolidated Appropriations Act, 2021, enacted December 27, 2020, extended this suspension for three more months, through March 31, 2021.  H.R. 1868, enacted on April 14, 2021 further extends the suspension through December 31, 2021. On December 10, 2021 the “Protecting Medicare and American Farmers from Sequester Cuts Act” extends the 2% Medicare sequester moratorium through March 31, 2022, and adjusts the sequester to 1% between April 1, 2022 and June 30, 2022.

Recently Adopted Accounting Pronouncements

Recently Adopted Accounting Pronouncements

Income Taxes

In December 2019, the Financial Accounting Standards Board (“FASB”) issued ASU 2019-12, Income Taxes Topic 740-Simplifying the Accounting for Income Taxes (“ASU 2019-12”), which intended to simplify various aspects related to accounting for income taxes. ASU 2019-12 removes certain exceptions to the general principles in Topic 740 and also clarifies and amends existing guidance to improve consistent application of Topic 740. This guidance is effective for companies with fiscal years beginning after December 15, 2020, including interim periods therein, and early adoption is permitted. The Company adopted ASU 2019-12 during the quarter ended September 30, 2021 and it did not have a material effect on the Company’s condensed consolidated financial statements.

Recent Accounting Pronouncements Not Yet Adopted

Recent Accounting Pronouncements Not Yet Adopted

Leases

In February 2016, the FASB issued ASU 2016-02 Leases (“ASU 2016-02”), which was intended to increase transparency and comparability among organizations by recognizing lease assets and liabilities on the balance sheet and disclosing key information about leasing arrangements. Under the new guidance, lessees will be required to recognize a right-of-use asset and a lease liability, measured on a discounted basis, at the commencement date for all leases with terms greater than 12 months. Additionally, this guidance will require disclosures to help investors and other financial statement users to better understand the amount, timing, and uncertainty of cash flows arising from leases, including qualitative and quantitative requirements. The guidance should be applied under a modified retrospective transition approach for leases existing at the beginning of the earliest comparative period presented in the adoption-period financial statements. Any leases that expire before the initial application date will not require any accounting adjustment. In June 2020, FASB issued ASU 2020-05 Revenue from contracts with customers (Topic 606) and leases (Topic 842)—Effective dates for certain entities which deferred the new lease standard effective date for the Company to December 15, 2022, with early adoption permitted. The Company will adopt this ASU in the fiscal year beginning July 1, 2022 and has not yet determined the effect of the standard on its ongoing financial reporting.

Financial Instruments

In April 2019, the FASB issued ASU 2019-04, Codification Improvements to Topic 326, Financial Instruments—Credit Losses, Topic 815, Derivatives and Hedging, and Topic 825, Financial Instruments (“ASU 2019-04”), which requires entities to use a current expected credit loss (“CECL”) model to measure impairment for most financial assets that are not recorded at fair value through net income. Under the CECL model, an entity will estimate lifetime expected credit losses considering available relevant information about historical events, current conditions and supportable forecasts. The CECL model does not apply to available-for-sale debt securities. This guidance also expands the required credit loss disclosures and will be applied using a modified retrospective approach by recording a cumulative effect adjustment to retained earnings as of the beginning of the fiscal year of adoption. ASU 2019-04 is effective for the Company for fiscal years beginning after December 15, 2022, including interim periods within those fiscal years. The Company will adopt this guidance for the annual and interim reporting periods beginning July 1, 2023. The Company has not determined the effect of the standard on its condensed consolidated financial statements.

We do not expect that any other recently issued accounting guidance will have a significant effect on our condensed consolidated financial statements.

XML 36 R25.htm IDEA: XBRL DOCUMENT v3.22.1
Summary of Significant Accounting Policies (Tables)
9 Months Ended
Mar. 31, 2022
Summary of Significant Accounting Policies  
Schedule of effect of restatement on financial statements

As Previously

    

Reported

    

Adjustments

    

As Restated

Redeemable Noncontrolling Interests (See Note 4)

 

 

16,986

 

16,986

Retained earnings

 

11,250

 

(587)

 

10,663

Total InnovAge Holding Corp.

 

335,146

 

(587)

 

334,559

Noncontrolling interests

 

22,819

 

(16,399)

 

6,420

Total stockholders’ equity

 

357,965

 

(16,986)

 

340,979

The effect of the restatement on the balances as of June 30, 2021 included in the consolidated statement of stockholders’ equity as of March 31, 2022 is as follows (in thousands):

Redeemable

Total Permanent

Noncontrolling

Retained

Noncontrolling

Stockholders’

Interests

    

Earnings

    

Interests

    

Equity

    

(Temporary Equity)

As Previously Reported

 

  

 

  

 

  

 

  

Balances, June 30, 2021

 

11,250

 

22,819

 

357,965

 

Adjustments

 

  

 

  

 

  

 

  

Balances, June 30, 2021

 

(587)

 

(16,399)

 

(16,986)

 

16,986

As Restated

 

  

 

  

 

  

 

  

Balances, June 30, 2021

 

10,663

 

6,420

 

340,979

 

16,986

The effect of the restatement on the consolidated statement of stockholders’ equity for the three months ended March 31, 2021 is as follows (in thousands):

Redeemable

Total Permanent

Noncontrolling

Retained

Noncontrolling

Stockholders’

Interests

Retained

    

Earnings

    

Interests

    

Equity

    

(Temporary Equity)

Earnings

As Previously Reported

 

  

 

  

 

  

 

  

Consolidation of equity method investment

16,838

16,838

Net income (loss)

(10,510)

(352)

(10,862)

Adjustment to redemption value

Balances, March 31, 2021

 

4,820

 

22,978

 

351,061

 

Adjustments

 

  

 

  

 

  

 

  

Consolidation of equity method investment

(16,838)

(16,838)

16,838

Net income (loss)

263

263

(263)

(10,862)

Adjustment to redemption value

(344)

(344)

344

Balances, March 31, 2021

 

(344)

 

(16,575)

 

(16,919)

 

16,919

As Restated

 

  

 

  

 

  

 

  

Consolidation of equity method investment

16,838

Net income (loss)

(10,510)

(89)

(10,599)

(263)

(10,862)

Adjustment to redemption value

 

(344)

 

 

(344)

 

344

Balances, March 31, 2021

4,476

6,403

334,142

16,919

The effect of the restatement on the consolidated statement of stockholders’ equity for the nine months ended March 31, 2021 is as follows (in thousands):

Redeemable

Total Permanent

Noncontrolling

Retained

Noncontrolling

Stockholders’

Interests

Retained

    

Earnings

    

Interests

    

Equity

    

(Temporary Equity)

Earnings

As Previously Reported

 

  

 

  

 

  

 

  

Consolidation of equity method investment

16,838

16,838

Net income (loss)

(50,460)

(595)

(51,055)

Adjustment to redemption value

Balances, March 31, 2021

 

4,820

 

22,978

 

351,061

 

Adjustments

 

  

 

  

 

  

 

  

Consolidation of equity method investment

(16,838)

(16,838)

16,838

Net income (loss)

263

263

(263)

(51,055)

Adjustment to redemption value

(344)

(344)

344

Balances, March 31, 2021

 

(344)

 

(16,575)

 

(16,919)

 

16,919

As Restated

 

  

 

  

 

  

 

  

Consolidation of equity method investment

16,838

Net income (loss)

(50,460)

(332)

(50,792)

(263)

(51,055)

Adjustment to redemption value

 

(344)

 

 

(344)

 

344

Balances, March 31, 2021

4,476

6,403

334,142

16,919

Schedule of property and equipment

    

Estimated

    

    

dollars in thousands

Useful Lives

March 31, 2022

June 30, 2021

Land

 

N/A

$

11,980

$

11,980

Buildings and leasehold improvements

 

10 - 40 years

 

121,661

 

104,724

Software

 

3 - 5 years

 

15,107

 

13,316

Equipment and vehicles

 

3 - 7 years

 

46,655

 

35,341

Construction in progress

 

N/A

 

22,336

 

22,130

 

 

217,739

187,491

Less accumulated depreciation and amortization

 

 

(53,857)

 

(44,776)

Total property and equipment, net

$

163,882

$

142,715

XML 37 R26.htm IDEA: XBRL DOCUMENT v3.22.1
Revenue Recognition (Tables)
9 Months Ended
Mar. 31, 2022
Revenue Recognition  
Schedule of source of revenue

    

March 31, 

    

    

2022

    

2021

    

Medicaid

 

53

%

53

%

Medicare

 

46

%

46

%

Private pay and other

 

1

%

1

%

Total

 

100

%

100

%

Schedule of concentration of net receivable

    

March 31, 

June 30, 

2022

    

2021

Medicaid

 

50

%

60

%

Medicare

 

37

%

20

%

Private pay and other

 

13

%

20

%

Total

 

100

%

100

%

XML 38 R27.htm IDEA: XBRL DOCUMENT v3.22.1
Investments (Tables)
9 Months Ended
Mar. 31, 2022
Investments  
Schedule of equity method and cost method investments

March 31, 

June 30, 

in thousands

2022

    

2021

Cost method investments

$

4,645

$

2,645

Equity method investments

 

848

 

848

Total investments

$

5,493

$

3,493

XML 39 R28.htm IDEA: XBRL DOCUMENT v3.22.1
Goodwill and Intangible Assets (Tables)
9 Months Ended
Mar. 31, 2022
Goodwill and Intangible Assets  
Summary of intangible assets by major class

    

March 31, 

June 30, 

in thousands

2022

    

2021

Definite-lived intangible assets

$

9,350

$

6,600

Indefinite-lived intangible assets

2,000

2,000

Total intangible assets

11,350

8,600

Accumulated amortization

(2,578)

(2,082)

Balance as of end of period

$

8,772

$

6,518

XML 40 R29.htm IDEA: XBRL DOCUMENT v3.22.1
Leases (Tables)
9 Months Ended
Mar. 31, 2022
Leases  
Schedule of Company's capital leases

    

March 31, 2022

June 30, 2021

in thousands

Equipment

$

18,885

$

13,302

Less accumulated depreciation

 

(7,150)

 

(7,081)

Total capital leases

$

11,735

$

6,221

Schedule of capital lease obligations

Future minimum lease payments for fiscal years beginning with remainder of fiscal year 2022 for capital leases having initial terms of more than one year and noncancelable operating leases were as follows:

    

    

Operating Leases

Capital Leases

Minimum Lease

in thousands

Obligations

Payments

Amount remaining in 2022

$

958

$

1,203

2023

 

4,405

 

4,872

2024

 

3,909

 

4,582

2025

 

3,126

 

4,122

2026

 

2,092

 

4,061

Thereafter

 

1,927

 

14,029

Total

 

16,417

$

32,869

Less amount representing interest

 

(2,912)

 

  

Total minimum lease payments

 

13,498

 

  

Less current maturities

 

(3,216)

 

  

Noncurrent maturities

$

10,282

 

  

Schedule of operating lease minimum lease payments

    

    

Operating Leases

Capital Leases

Minimum Lease

in thousands

Obligations

Payments

Amount remaining in 2022

$

958

$

1,203

2023

 

4,405

 

4,872

2024

 

3,909

 

4,582

2025

 

3,126

 

4,122

2026

 

2,092

 

4,061

Thereafter

 

1,927

 

14,029

Total

 

16,417

$

32,869

Less amount representing interest

 

(2,912)

 

  

Total minimum lease payments

 

13,498

 

  

Less current maturities

 

(3,216)

 

  

Noncurrent maturities

$

10,282

 

  

XML 41 R30.htm IDEA: XBRL DOCUMENT v3.22.1
Long Term Debt (Tables)
9 Months Ended
Mar. 31, 2022
Long Term Debt  
Schedule of long-term debt

Interest rate

Maturity date

March 31, 2022

June 30, 2021

in thousands

Senior secured borrowings:

Term Loan Facility

(a)

March 8, 2026

$

72,188

$

75,000

Revolving Credit Facility (b)

(a)

March 8, 2026

Convertible term loan

6.68%

August 20, 2030

 

2,338

 

2,367

Total debt

 

74,526

 

77,367

Less unamortized debt issuance costs

 

1,681

 

2,003

Less current maturities

 

3,793

 

3,790

Noncurrent maturities

$

69,051

$

71,574

(a)The interest rates on the Term Loan Facility and Revolving Credit Facility are described below.
(b)The remaining capacity under the Revolving Credit Facility as of March 31, 2022 was $100.0 million, subject to (i) any issued amounts under our letters of credit, which as of March 31, 2022 was $2.6 million, and (ii) applicable covenant compliance restrictions and any other conditions precedent to borrowing.
XML 42 R31.htm IDEA: XBRL DOCUMENT v3.22.1
Stock-based Compensation (Tables)
9 Months Ended
Mar. 31, 2022
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]  
Schedule of stock-based compensation expense

Nine Months Ended

March 31, 

in thousands

2022

    

2021

Stock options (a)

$

359

$

45,387

Profits interests units

 

1,095

 

1,102

Restricted stock units

1,132

Total stock-based compensation expense

$

2,586

$

46,489

(a)The amount for 2021 relates to stock-based compensation expense recognized as a result of the Cancellation Agreement.
Summary of profits interests transactions and number of units outstanding

    

    

  

Number of

Weighted average

Time-based unit awards

units

grant date fair value

Outstanding balance, June 30, 2021

 

6,587,261

$

1.28

Forfeited

 

(2,409,972)

$

1.28

Outstanding balance, March 31, 2022

 

4,177,289

$

1.28

Number of

Weighted average

Performance-based unit awards

units

grant date fair value

Outstanding balance, June 30, 2021

 

6,223,262

$

0.57

Forfeited

 

(3,210,939)

$

0.57

Outstanding balance, March 31, 2022

 

3,012,323

$

0.57

Time-based option awards  
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]  
Summary of weighted-average assumptions

2022

Expected volatility

34.5

%

Weighted-average expected life (years) - time vesting units

2.9

Interest rate

 

0.83

%

Dividend yield

 

0

%

Weighted-average fair values

$

1.61

Fair value of underlying stock

 

$

7.89

Summary of stock option activity

Weighted

    

average

Number of

grant-date fair

Stock options - time based

awards

value per share

Outstanding balance, June 30, 2021

 

$

Granted

 

554,499

$

1.61

Forfeited

$

Outstanding balance, March 31, 2022

 

554,499

$

1.61

Summary of restricted stock units activity

Weighted

    

average

Number of

grant-date fair

Restricted stock units - time based

awards

value per share

Outstanding balance, June 30, 2021

 

48,470

$

22.87

Granted

 

315,177

$

8.99

Forfeited

(9,670)

$

23.35

Exercised

(8,493)

$

17.66

Outstanding balance, March 31, 2022

 

345,484

$

10.50

Performance-based option awards  
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]  
Summary of weighted-average assumptions

2022

Expected volatility

34.5

%

Expected term (in years)

5.0

Interest rate

 

1.56

%

Dividend yield

 

0

%

Weighted-average fair values

$

5.18

Fair value of underlying stock

 

$

7.89

Summary of stock option activity

Weighted

    

average

Number of

grant-date fair

Stock options - performance based

awards

value per share

Outstanding balance, June 30, 2021

 

$

Granted

 

776,299

$

3.08

Forfeited

$

Outstanding balance, March 31, 2022

 

776,299

$

3.08

Summary of restricted stock units activity

Weighted

    

average

Number of

grant-date fair

Restricted stock units - performance based

awards

value per share

Outstanding balance, June 30, 2021

 

$

Granted

 

258,767

$

5.18

Forfeited

$

Outstanding balance, March 31, 2022

 

258,767

$

5.18

XML 43 R32.htm IDEA: XBRL DOCUMENT v3.22.1
Earnings per Share (Tables)
9 Months Ended
Mar. 31, 2022
Earnings per Share  
Schedule of earnings per share

The following table sets forth the computation of basic and diluted net loss per common share:

Three months ended March 31, 

Nine months ended March 31, 

in thousands, except share values

    

2022

    

2021

    

2022

    

2021

Net income (loss) attributable to InnovAge Holding Corp.

$

(2,821)

$

(10,510)

$

6,188

$

(50,460)

Weighted average common shares outstanding (basic)

 

135,516,608

 

121,324,980

 

135,516,544

 

119,619,806

Earnings (loss) per share - basic

$

(0.02)

$

(0.09)

$

0.05

$

(0.42)

Dilutive shares

 

 

 

14,249

 

Weighted average common shares outstanding (diluted)

 

135,516,608

 

121,324,980

 

135,530,793

 

119,619,806

Earnings (loss) per share -diluted

$

(0.02)

$

(0.09)

$

0.05

$

(0.42)

XML 44 R33.htm IDEA: XBRL DOCUMENT v3.22.1
Segment Reporting (Tables)
9 Months Ended
Mar. 31, 2022
Segment Reporting  
Schedule of operating results by reportable segments

March 31, 2022

March 31, 2021

in thousands

    

PACE

    

All other(1)

    

Totals

    

PACE

    

All other(1)

    

Totals

Capitation revenue

$

176,988

$

$

176,988

$

155,835

$

$

155,835

Other service revenue

 

166

 

205

 

371

 

(47)

 

520

 

473

Total revenues

 

177,154

 

205

 

177,359

 

155,788

 

520

 

156,308

External provider costs

 

103,254

 

 

103,254

 

75,389

 

 

75,389

Cost of care, excluding depreciation and amortization

 

45,995

 

107

 

46,102

 

38,867

 

698

 

39,565

Center-level Contribution Margin

 

27,905

 

98

 

28,003

 

41,532

 

(178)

 

41,354

Overhead costs(2)

 

30,911

 

(85)

 

30,826

 

24,217

 

(30)

 

24,187

Depreciation and amortization

 

3,760

 

90

 

3,850

 

3,181

 

130

 

3,311

Equity loss

 

 

 

 

 

 

Other operating income

 

 

 

 

19,222

 

 

19,222

Interest expense, net

 

(663)

 

(46)

 

(709)

 

(4,824)

 

(52)

 

(4,876)

Loss on extinguishment of debt

 

 

 

 

(13,488)

 

 

(13,488)

Gain on equity method investment

 

 

 

 

10,871

 

 

10,871

Other expense (income)

 

108

 

 

108

 

(2,267)

 

 

(2,267)

Income (Loss) Before Income Taxes

$

(7,321)

$

47

$

(7,274)

$

(14,796)

$

(330)

$

(15,126)

The following table summarizes the operating results regularly provided to the CODM by reportable segment for the nine months ended March 31, 2022 and 2021:

March 31, 2022

March 31, 2021

in thousands

    

PACE

    

All other(1)

    

Totals

    

PACE

    

All other(1)

    

Totals

Capitation revenue

$

524,507

$

$

524,507

$

464,294

$

$

464,294

Other service revenue

 

234

 

1,039

 

1,273

 

213

 

1,677

 

1,890

Total revenues

 

524,741

 

1,039

 

525,780

 

464,507

 

1,677

 

466,184

External provider costs

 

284,299

 

 

284,299

 

224,215

 

 

224,215

Cost of care, excluding depreciation and amortization

 

128,573

 

1,167

 

129,740

 

113,611

 

2,311

 

115,922

Center-Level Contribution Margin

 

111,869

 

(128)

 

111,741

 

126,681

 

(634)

 

126,047

Overhead costs(2)

 

93,463

 

(98)

 

93,365

 

120,249

 

(13)

 

120,236

Depreciation and amortization

 

10,130

 

305

 

10,435

 

8,901

 

361

 

9,262

Equity loss

 

 

 

 

1,343

 

 

1,343

Other operating (income) expense

 

 

 

 

18,211

 

 

18,211

Interest expense, net

 

(1,783)

 

(147)

 

(1,930)

 

(16,919)

 

(142)

 

(17,061)

Loss on extinguishment of debt

 

 

 

 

(14,479)

 

 

(14,479)

Gain on equity method investment

 

 

 

 

10,871

 

 

10,871

Other income

 

(357)

 

(1)

 

(358)

 

(2,222)

 

 

(2,222)

Income (Loss) Before Income Taxes

$

6,136

$

(483)

$

5,653

$

(44,772)

$

(1,124)

$

(45,896)

(1)Center-level Contribution Margin from segments below the quantitative thresholds are attributable to two operating segments of the Company. Those segments consist of Homecare and Senior Housing. Neither of those segments has ever met any of the quantitative thresholds for determining reportable segments.
(2)Overhead consists of the Sales and marketing and Corporate, general and administrative financial statement line items.
XML 45 R34.htm IDEA: XBRL DOCUMENT v3.22.1
Business (Details)
9 Months Ended
Mar. 31, 2022
item
segment
Center
$ / shares
Jun. 30, 2021
$ / shares
Segment Reporting Information [Line Items]    
Par value per share | $ / shares $ 0.001 $ 0.001
PACE    
Segment Reporting Information [Line Items]    
Number of reportable segments | segment 1  
Number of PACE participants | item 6,800  
Number of PACE centers excluding non-consolidating joint ventures | Center 18  
Percentage of obligation for health care costs 100.00%  
Operating segments | PACE    
Segment Reporting Information [Line Items]    
Number of reportable segments | segment 1  
Number of PACE participants | item 6,800  
XML 46 R35.htm IDEA: XBRL DOCUMENT v3.22.1
Summary of Significant Accounting Policies - Effect of Restatement on Consolidated Balance Sheet (Details) - USD ($)
$ in Thousands
Mar. 31, 2022
Dec. 31, 2021
Jun. 30, 2021
Mar. 31, 2021
Dec. 31, 2020
Jun. 30, 2020
Error Corrections and Prior Period Adjustments Restatement [Line Items]            
Redeemable Noncontrolling Interests (See Note 4) $ 15,996 $ 18,850 $ 16,986 $ 16,919    
Stockholders' Equity            
Retained earnings 17,437   10,663      
Total InnovAge Holding Corp. 343,919   334,559      
Noncontrolling interests 6,207   6,420      
Total stockholders' equity $ 350,126 $ 349,586 340,979 334,142 $ (31,289) $ 107,750
As Previously Reported            
Stockholders' Equity            
Retained earnings     11,250      
Total InnovAge Holding Corp.     335,146      
Noncontrolling interests     22,819      
Total stockholders' equity     357,965 351,061    
Adjustments            
Error Corrections and Prior Period Adjustments Restatement [Line Items]            
Redeemable Noncontrolling Interests (See Note 4)     16,986 16,919    
Stockholders' Equity            
Retained earnings     (587)      
Total InnovAge Holding Corp.     (587)      
Noncontrolling interests     (16,399)      
Total stockholders' equity     $ (16,986) $ (16,919)    
XML 47 R36.htm IDEA: XBRL DOCUMENT v3.22.1
Summary of Significant Accounting Policies - Effect of Restatement on Consolidated Statements of Stockholders' Equity (Details) - USD ($)
$ in Thousands
3 Months Ended 9 Months Ended
Mar. 31, 2022
Mar. 31, 2021
Mar. 31, 2022
Mar. 31, 2021
Dec. 31, 2021
Jun. 30, 2021
Dec. 31, 2020
Jun. 30, 2020
Error Corrections and Prior Period Adjustments Restatement [Line Items]                
Net income (loss) $ (2,868) $ (10,599) $ 5,975 $ (50,792)        
Adjustment to redemption value 2,563 (344) 586 (344)        
Total Stockholders' Equity, Balances 350,126 334,142 350,126 334,142 $ 349,586 $ 340,979 $ (31,289) $ 107,750
Temporary Equity, Accretion to Redemption Value, Adjustment   16,838   16,838        
Adjustment to redemption value (2,563) 344 (586) 344        
Net income (loss) (290) (263) (403) (263)        
Redeemable Noncontrolling Interests 15,996 16,919 15,996 16,919 18,850 16,986    
Net Income (Loss) Attributable to Redeemable Noncontrolling Interest (3,158) (10,862) 5,572 (51,055)        
Retained Earnings (Deficit)                
Error Corrections and Prior Period Adjustments Restatement [Line Items]                
Net income (loss) (2,821) (10,510) 6,188 (50,460)        
Adjustment to redemption value 2,563 (344) 586 (344)        
Total Stockholders' Equity, Balances 17,437 4,476 17,437 4,476 17,695 10,663 15,330 64,737
Noncontrolling Interests                
Error Corrections and Prior Period Adjustments Restatement [Line Items]                
Net income (loss) (47) (89) (213) (332)        
Total Stockholders' Equity, Balances $ 6,207 6,403 $ 6,207 6,403 $ 6,254 6,420 $ 6,492 $ 6,735
As Previously Reported                
Error Corrections and Prior Period Adjustments Restatement [Line Items]                
Consolidation Of Equity Method Investment   16,838   16,838        
Net income (loss)   (10,862)   (51,055)        
Total Stockholders' Equity, Balances   351,061   351,061   357,965    
As Previously Reported | Retained Earnings (Deficit)                
Error Corrections and Prior Period Adjustments Restatement [Line Items]                
Net income (loss)   (10,510)   (50,460)        
Total Stockholders' Equity, Balances   4,820   4,820   11,250    
As Previously Reported | Noncontrolling Interests                
Error Corrections and Prior Period Adjustments Restatement [Line Items]                
Consolidation Of Equity Method Investment   16,838   16,838        
Net income (loss)   (352)   (595)        
Total Stockholders' Equity, Balances   22,978   22,978   22,819    
Adjustments                
Error Corrections and Prior Period Adjustments Restatement [Line Items]                
Consolidation Of Equity Method Investment   (16,838)   (16,838)        
Net income (loss)   263   263        
Adjustment to redemption value   (344)   (344)        
Total Stockholders' Equity, Balances   (16,919)   (16,919)   (16,986)    
Temporary Equity, Accretion to Redemption Value, Adjustment   16,838   16,838        
Adjustment to redemption value   344   344        
Net income (loss)   (263)   (263)        
Redeemable Noncontrolling Interests   16,919   16,919   16,986    
Net Income (Loss) Attributable to Redeemable Noncontrolling Interest   (10,862)   (51,055)        
Adjustments | Retained Earnings (Deficit)                
Error Corrections and Prior Period Adjustments Restatement [Line Items]                
Adjustment to redemption value   (344)   (344)        
Total Stockholders' Equity, Balances   (344)   (344)   (587)    
Adjustments | Noncontrolling Interests                
Error Corrections and Prior Period Adjustments Restatement [Line Items]                
Consolidation Of Equity Method Investment   (16,838)   (16,838)        
Net income (loss)   263   263        
Total Stockholders' Equity, Balances   $ (16,575)   $ (16,575)   $ (16,399)    
XML 48 R37.htm IDEA: XBRL DOCUMENT v3.22.1
Summary of Significant Accounting Policies - Property and Equipment (Details) - USD ($)
$ in Thousands
3 Months Ended 9 Months Ended
Mar. 31, 2022
Mar. 31, 2021
Mar. 31, 2022
Mar. 31, 2021
Jun. 30, 2021
Summary of Significant Accounting Policies          
Property and equipment gross $ 217,739   $ 217,739   $ 187,491
Less accumulated depreciation and amortization (53,857)   (53,857)   (44,776)
Balance as of end of period 163,882   163,882   142,715
Depreciation 3,800 $ 3,200 9,900 $ 8,800  
Land          
Summary of Significant Accounting Policies          
Property and equipment gross 11,980   11,980   11,980
Buildings and leasehold improvements          
Summary of Significant Accounting Policies          
Property and equipment gross 121,661   $ 121,661   104,724
Buildings and leasehold improvements | Minimum          
Summary of Significant Accounting Policies          
Estimated Useful Lives     10 years    
Buildings and leasehold improvements | Maximum          
Summary of Significant Accounting Policies          
Estimated Useful Lives     40 years    
Software          
Summary of Significant Accounting Policies          
Property and equipment gross 15,107   $ 15,107   13,316
Software | Minimum          
Summary of Significant Accounting Policies          
Estimated Useful Lives     3 years    
Software | Maximum          
Summary of Significant Accounting Policies          
Estimated Useful Lives     5 years    
Equipment and vehicles          
Summary of Significant Accounting Policies          
Property and equipment gross 46,655   $ 46,655   35,341
Equipment and vehicles | Minimum          
Summary of Significant Accounting Policies          
Estimated Useful Lives     3 years    
Equipment and vehicles | Maximum          
Summary of Significant Accounting Policies          
Estimated Useful Lives     7 years    
Construction in progress          
Summary of Significant Accounting Policies          
Property and equipment gross $ 22,336   $ 22,336   $ 22,130
XML 49 R38.htm IDEA: XBRL DOCUMENT v3.22.1
Summary of Significant Accounting Policies - COVID-19 (Details) - USD ($)
$ in Millions
9 Months Ended 12 Months Ended
Mar. 31, 2022
Jun. 30, 2021
Jun. 30, 2020
Summary of Significant Accounting Policies      
Funding received, COVID-19 $ 1.0    
Reimbursement amount allocated $ 1.0    
Reimbursement amount recognized   $ 0.3 $ 0.7
XML 50 R39.htm IDEA: XBRL DOCUMENT v3.22.1
Revenue Recognition (Details) - USD ($)
$ in Thousands
3 Months Ended 9 Months Ended
Mar. 31, 2022
Mar. 31, 2021
Mar. 31, 2022
Mar. 31, 2021
Jun. 30, 2021
Revenue Recognition          
Pooled capitated payment     100.00%    
Allowances for uncollectable accounts $ 3,921   $ 3,921   $ 4,350
Capitated revenues | Customer concentration risk          
Revenue Recognition          
Risk percentage     100.00% 100.00%  
Medicare Part D | Capitated revenues | Customer concentration risk          
Revenue Recognition          
Risk percentage     12.00% 12.00%  
Medicare Part D | External provider costs. | Customer concentration risk          
Revenue Recognition          
Risk percentage     23.00% 25.00%  
Senior Housing | Other service revenue | Customer concentration risk          
Revenue Recognition          
Risk percentage 0.20% 0.30% 0.20% 0.40%  
XML 51 R40.htm IDEA: XBRL DOCUMENT v3.22.1
Revenue Recognition - Source of Revenue (Details) - Capitated revenues - Customer concentration risk
9 Months Ended
Mar. 31, 2022
Mar. 31, 2021
Disaggregation of Revenue [Line Items]    
Risk percentage 100.00% 100.00%
Medicaid    
Disaggregation of Revenue [Line Items]    
Risk percentage 53.00% 53.00%
Medicare    
Disaggregation of Revenue [Line Items]    
Risk percentage 46.00% 46.00%
Private pay and other    
Disaggregation of Revenue [Line Items]    
Risk percentage 1.00% 1.00%
XML 52 R41.htm IDEA: XBRL DOCUMENT v3.22.1
Revenue Recognition - Concentration of Net Receivable (Details) - Accounts Receivable - Customer concentration risk
9 Months Ended 12 Months Ended
Mar. 31, 2022
Jun. 30, 2021
Disaggregation of Revenue [Line Items]    
Risk percentage 100.00% 100.00%
Medicaid    
Disaggregation of Revenue [Line Items]    
Risk percentage 50.00% 60.00%
Medicare    
Disaggregation of Revenue [Line Items]    
Risk percentage 37.00% 20.00%
Private pay and other    
Disaggregation of Revenue [Line Items]    
Risk percentage 13.00% 20.00%
XML 53 R42.htm IDEA: XBRL DOCUMENT v3.22.1
Investments - Equity Method and Cost Method Investments (Details) - USD ($)
$ in Thousands
Mar. 31, 2022
Jun. 30, 2021
Investments    
Cost method investments $ 4,645 $ 2,645
Equity method investments 848 848
Total investments $ 5,493 $ 3,493
XML 54 R43.htm IDEA: XBRL DOCUMENT v3.22.1
Investments (Details)
1 Months Ended 3 Months Ended 6 Months Ended 9 Months Ended
Feb. 09, 2021
USD ($)
Mar. 18, 2019
USD ($)
$ / shares
Aug. 31, 2021
USD ($)
shares
Mar. 31, 2022
USD ($)
item
$ / shares
Mar. 31, 2021
USD ($)
Dec. 31, 2020
USD ($)
Mar. 31, 2022
USD ($)
item
$ / shares
Mar. 31, 2021
USD ($)
Jun. 30, 2021
USD ($)
$ / shares
Dec. 31, 2019
USD ($)
Investments                    
Number of investments | item       2     2      
Observable price changes             $ 0 $ 0    
Cash consideration             2,000,000      
Cost method investments       $ 4,645,000     4,645,000   $ 2,645,000  
Cash contributions               20,000,000    
Cash   $ 9,000,000.0   $ 199,493,000     $ 199,493,000   $ 201,466,000  
Land   $ 4,200,000                
Par value per share | $ / shares       $ 0.001     $ 0.001   $ 0.001  
Net loss, attributable to redeemable noncontrolling interest       $ (3,158,000) $ (10,862,000)   $ 5,572,000 $ (51,055,000)    
Change in fair value of warrants $ 2,300,000                  
Redeemable noncontrolling interests       15,900,000     15,900,000      
Gain on consolidation         $ 10,900,000          
Adventist Health System/West Joint Venture                    
Investments                    
Percentage of issued and outstanding equity interests   5.00%                
Par value per share | $ / shares   $ 0.001                
Capital contributions   $ 25,000,000.0                
Warrants right to purchase common stock $ 15,000,000.0                  
Warrant exercise term 1 year                  
InnovAge Sacramento                    
Investments                    
Membership interest (as a percent)   59.90%                
InnovAge Sacramento                    
Investments                    
Percentage of additional membership interest 0.10%       0.10%     0.10%    
PWD                    
Investments                    
Maximum exposure amount in VIE       $ 800,000     $ 800,000      
SH1                    
Investments                    
Partnership interest (as a percent)             0.01%      
InnovAge California Pace-Sacramento, LLC                    
Investments                    
Cash contributions         $ 52,000          
InnovAge California Pace-Sacramento, LLC | Adventist Health System/West Joint Venture                    
Investments                    
Cash contributions   $ 5,800,000                
InnovAge California Pace-Sacramento, LLC | Eskaton                    
Investments                    
Cash contributions   $ 3,000,000.0                
InnovAge California Pace-Sacramento, LLC | InnovAge Sacramento | Adventist Health System/West Joint Venture                    
Investments                    
Membership interest (as a percent)   26.40%                
InnovAge California Pace-Sacramento, LLC | InnovAge Sacramento | Eskaton                    
Investments                    
Membership interest (as a percent)   13.70%                
Jetdoc, Inc.                    
Investments                    
Shares acquired | shares     806,481              
Cash consideration     $ 2,000,000.0              
Maximum exposure to loss of the cost method investments     $ 2,000,000.0              
Dispatch Health Holdings, Inc.                    
Investments                    
Cost method investments                   $ 2,600,000
Maximum exposure to loss of the cost method investments                   $ 2,600,000
InnovAge Sacramento                    
Investments                    
Net loss, attributable to redeemable noncontrolling interest           $ (1,300,000)        
XML 55 R44.htm IDEA: XBRL DOCUMENT v3.22.1
Fair Value Measurements (Details) - USD ($)
3 Months Ended 9 Months Ended
Mar. 08, 2021
Aug. 07, 2018
Mar. 31, 2022
Mar. 31, 2022
Mar. 31, 2021
Jun. 30, 2021
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]            
Contingent consideration   $ 20,000,000.0 $ 0 $ 0   $ 0
Contingent consideration paid $ 20,000,000.0          
Transfers into Level 3       $ 0 $ 0  
InnovAge Sacramento            
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]            
Changes in fair value     $ 2,600,000      
NewCourtland LIFE Program            
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]            
Purchase price   30,000,000.0        
NewCourtland LIFE Program | Maximum            
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]            
Contingent consideration   $ 20,000,000.0        
XML 56 R45.htm IDEA: XBRL DOCUMENT v3.22.1
Goodwill and Intangible Assets (Details)
$ in Thousands
9 Months Ended
Mar. 31, 2022
USD ($)
item
Mar. 31, 2021
USD ($)
Jun. 30, 2021
USD ($)
Goodwill and Intangible Assets      
Goodwill $ 124,217   $ 124,217
Number of reporting units | item 3    
Impairment of goodwill $ 0 $ 0  
Amortization expense 500 200  
Intangible asset impairments $ 0 $ 0  
XML 57 R46.htm IDEA: XBRL DOCUMENT v3.22.1
Goodwill and Intangible Assets - Intangible Asset by Major Class (Details) - USD ($)
$ in Thousands
Mar. 31, 2022
Jun. 30, 2021
Intangible Assets, Net (Including Goodwill) [Abstract]    
Definite-lived intangible assets $ 9,350 $ 6,600
Indefinite-lived intangible assets 2,000 2,000
Total intangible assets 11,350 8,600
Accumulated amortization (2,578) (2,082)
Balance as of end of period $ 8,772 $ 6,518
XML 58 R47.htm IDEA: XBRL DOCUMENT v3.22.1
Leases - Assets Under Lease (Details) - USD ($)
$ in Thousands
3 Months Ended 9 Months Ended
Mar. 31, 2022
Mar. 31, 2021
Mar. 31, 2022
Mar. 31, 2021
Jun. 30, 2021
Operating Leased Assets [Line Items]          
Equipment $ 217,739   $ 217,739   $ 187,491
Less accumulated depreciation (53,857)   (53,857)   (44,776)
Balance as of end of period 163,882   163,882   142,715
Rental expense 1,300 $ 1,400 3,500 $ 3,500  
Equipment under capital leases          
Operating Leased Assets [Line Items]          
Equipment 18,885   18,885   13,302
Less accumulated depreciation (7,150)   (7,150)   (7,081)
Balance as of end of period $ 11,735   $ 11,735   $ 6,221
XML 59 R48.htm IDEA: XBRL DOCUMENT v3.22.1
Leases - Future Minimum Lease Payments (Details)
$ in Thousands
Mar. 31, 2022
USD ($)
Capital Leases Obligations  
Amount Remaining in 2022 $ 958
2023 4,405
2024 3,909
2025 3,126
2026 2,092
Thereafter 1,927
Total 16,417
Less amount representing interest (2,912)
Total minimum lease payments 13,498
Less current maturities (3,216)
Noncurrent maturities 10,282
Operating Leases Minimum Lease Payments  
Amount Remaining in 2022 1,203
2023 4,872
2024 4,582
2025 4,122
2026 4,061
Thereafter 14,029
Total $ 32,869
XML 60 R49.htm IDEA: XBRL DOCUMENT v3.22.1
Long Term Debt - Schedule of Long-term Debt (Details) - USD ($)
$ in Thousands
Mar. 31, 2022
Jun. 30, 2021
Debt Instrument [Line Items]    
Total debt $ 74,526 $ 77,367
Less unamortized debt issuance costs 1,681 2,003
Less current maturities 3,793 3,790
Noncurrent maturities 69,051 71,574
Senior secured term loan    
Debt Instrument [Line Items]    
Total debt 72,188 75,000
Convertible term loan    
Debt Instrument [Line Items]    
Total debt $ 2,338 $ 2,367
Interest rate (as a percent) 6.68% 6.68%
XML 61 R50.htm IDEA: XBRL DOCUMENT v3.22.1
Long Term Debt (Details) - USD ($)
9 Months Ended
Mar. 08, 2021
Jul. 27, 2020
Sep. 01, 2015
Mar. 31, 2022
Mar. 31, 2021
Jun. 30, 2021
May 02, 2019
May 13, 2016
Debt Instrument [Line Items]                
Loss on extinguishment of long-term debt         $ 8,494,000      
Outstanding borrowings       $ 74,526,000   $ 77,367,000    
Revolving credit facility                
Debt Instrument [Line Items]                
Remaining borrowing capacity       100,000,000.0        
Letters of credit, issued amounts       2,600,000        
Senior secured term loan                
Debt Instrument [Line Items]                
Outstanding borrowings       72,188,000   75,000,000    
Convertible term loan                
Debt Instrument [Line Items]                
Outstanding borrowings       $ 2,338,000   $ 2,367,000    
Interest rate (as a percent)       6.68%   6.68%    
Monthly principal and interest payments     $ 20,000.00          
2016 Credit Agreement                
Debt Instrument [Line Items]                
Debt extinguishment         57,100,000      
Loss on extinguishment of long-term debt         1,000,000.0      
Modified debt       $ 250,000,000.0        
Outstanding borrowings       50,000,000.0        
Amortization of deferred financing costs         $ 900,000      
Total deferred financing costs       9,100,000        
2016 Credit Agreement | Revolving credit facility                
Debt Instrument [Line Items]                
Loan amount   $ 40,000,000.0         $ 30,000,000.0 $ 20,000,000.0
2016 Credit Agreement | Senior secured term loan                
Debt Instrument [Line Items]                
Loan amount   300,000,000.0         190,000,000.0 $ 75,000,000.0
2016 Credit Agreement | Delayed draw term loan facility (DDTL)                
Debt Instrument [Line Items]                
Loan amount             $ 45,000,000.0  
Termination of loan   $ 45,000,000            
2021 Credit Agreement | Revolving credit facility                
Debt Instrument [Line Items]                
Loan amount $ 100,000,000.0              
Outstanding borrowings       0        
Amortization of deferred financing costs       300,000        
Total deferred financing costs       $ 2,000,000.0        
Revolving credit facility fee 0.25%              
2021 Credit Agreement | Senior secured term loan                
Debt Instrument [Line Items]                
Loan amount $ 75,000,000.0              
Percentage of aggregate outstanding principal amount 1.25%              
Interest rate (as a percent)       2.21%        
XML 62 R51.htm IDEA: XBRL DOCUMENT v3.22.1
Equity (Details) - USD ($)
$ in Thousands
9 Months Ended
Jul. 27, 2020
Mar. 31, 2021
Mar. 31, 2022
Jun. 30, 2021
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]        
Reduction in additional paid-in capital     $ 326,346 $ 323,760
Transaction costs   $ 22,600    
Dividends   9,500    
General and administrative expense        
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]        
Transaction costs   $ 13,100    
Credit Agreement        
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]        
Repurchase (in shares) 16,095,819      
Repurchase $ 77,600      
Cancellation Agreement        
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]        
Corporate, general and administrative expense 45,400      
Reduction in additional paid-in capital $ 32,400      
2016 Incentive Plan | Cancellation Agreement        
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]        
Shares cancelled (in shares) 16,994,975      
Shares cancelled $ 74,600      
XML 63 R52.htm IDEA: XBRL DOCUMENT v3.22.1
Stock-based Compensation - Compensation Expense (Details) - USD ($)
$ in Thousands
9 Months Ended
Mar. 31, 2022
Mar. 31, 2021
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]    
Total share-based compensation expense $ 2,586 $ 46,489
Stock Options    
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]    
Total share-based compensation expense 359 45,387
Profits Interests Units    
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]    
Total share-based compensation expense 1,095 $ 1,102
Restricted Stock Units    
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]    
Total share-based compensation expense $ 1,132  
XML 64 R53.htm IDEA: XBRL DOCUMENT v3.22.1
Stock-based Compensation - Equity Incentive Plan (Details) - 2016 Equity Incentive Plan - shares
9 Months Ended
Jul. 27, 2020
Mar. 31, 2022
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]    
Number of shares authorized   17,836,636
Granted (in shares)   16,994,976
Repurchase (in shares) 16,095,819  
Number of shares cancelled 16,994,976  
XML 65 R54.htm IDEA: XBRL DOCUMENT v3.22.1
Stock-based Compensation - Profits Interests (Details) - 2020 Equity Incentive Plan
9 Months Ended
Mar. 31, 2022
shares
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]  
Number of shares authorized 16,162,177
Profits interests granted 13,009,137
Granted (in shares) 0
XML 66 R55.htm IDEA: XBRL DOCUMENT v3.22.1
Stock-based Compensation - Profits Interests Transactions and Number of Units Outstanding (Details)
9 Months Ended
Mar. 31, 2022
$ / shares
shares
Time Vesting Units  
Number of Units  
Outstanding balance, June 30, 2021 | shares 6,587,261
Forfeited | shares (2,409,972)
Outstanding balance, March 31, 2022 | shares 4,177,289
Weighted-Average Grant Date FV  
Outstanding balance, June 30, 2021 | $ / shares $ 1.28
Forfeited | $ / shares 1.28
Outstanding balance, March 31, 2022 | $ / shares $ 1.28
Performance Vesting Units  
Number of Units  
Outstanding balance, June 30, 2021 | shares 6,223,262
Forfeited | shares (3,210,939)
Outstanding balance, March 31, 2022 | shares 3,012,323
Weighted-Average Grant Date FV  
Outstanding balance, June 30, 2021 | $ / shares $ 0.57
Forfeited | $ / shares 0.57
Outstanding balance, March 31, 2022 | $ / shares $ 0.57
XML 67 R56.htm IDEA: XBRL DOCUMENT v3.22.1
Stock-based Compensation - Monte Carlo Option Pricing Model (Details)
$ / shares in Units, $ in Millions
9 Months Ended
Mar. 31, 2022
USD ($)
$ / shares
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]  
Expected term (in years) 2 years 10 months 24 days
Profits Interests Units  
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]  
Unrecognized compensation cost | $ $ 6.4
Time Vesting Units  
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]  
Unrecognized compensation cost | $ $ 4.3
Weighted-average period (in years) 10 months 24 days
Performance Vesting Units  
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]  
Unrecognized compensation cost | $ $ 2.1
Time-based option awards  
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]  
Expected volatility 34.50%
Interest rate 0.83%
Dividend yield 0.00%
Weighted-average fair values | $ / shares $ 1.61
Fair value of underlying stock | $ / shares $ 7.89
Weighted-average period (in years) 2 years 6 months
Performance-based option awards  
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]  
Weighted-average period (in years) 3 years 7 months 6 days
Performance Based Restricted Stock Units [Member]  
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]  
Expected volatility 34.50%
Expected term (in years) 5 years
Interest rate 1.56%
Dividend yield 0.00%
Weighted-average fair values | $ / shares $ 5.18
Fair value of underlying stock | $ / shares $ 7.89
Unrecognized compensation cost | $ $ 1.2
Weighted-average period (in years) 3 years 7 months 6 days
Minimum | Time-based option awards  
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]  
Expected term (in years) 2 years 10 months 24 days
XML 68 R57.htm IDEA: XBRL DOCUMENT v3.22.1
Stock-based Compensation - 2021 Omnibus Incentive Plan (Details)
$ in Millions
9 Months Ended
Mar. 31, 2022
USD ($)
shares
2021 Omnibus Incentive Plan  
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]  
Number of shares authorized | shares 14,700,000
Vesting period 3 years
Percentage of vesting 33.33%
Performance Based Restricted Stock Units [Member]  
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]  
Unrecognized compensation cost $ 1.2
Weighted-average period (in years) 3 years 7 months 6 days
Time Based Restricted Stock Units [Member] | 2021 Omnibus Incentive Plan  
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]  
Unrecognized compensation cost $ 4.0
Weighted-average period (in years) 2 years
Performance-based option awards  
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]  
Weighted-average period (in years) 3 years 7 months 6 days
XML 69 R58.htm IDEA: XBRL DOCUMENT v3.22.1
Stock-based Compensation - 2021 Omnibus Incentive Plan (RSU Activity) (Details) - 2021 Omnibus Incentive Plan
9 Months Ended
Mar. 31, 2022
$ / shares
shares
Time Based Restricted Stock Units [Member]  
Number of Units  
Outstanding balance, June 30, 2021 | shares 48,470
Granted | shares 315,177
Forfeited | shares (9,670)
Exercised | shares (8,493)
Outstanding balance, March 31, 2022 | shares 345,484
Weighted-Average Grant Date FV  
Outstanding balance, June 30, 2021 | $ / shares $ 22.87
Granted | $ / shares 8.99
Forfeited | $ / shares 23.35
Exercised | $ / shares 17.66
Outstanding balance, March 31, 2022 | $ / shares $ 10.50
Performance Based Restricted Stock Units [Member]  
Number of Units  
Granted | shares 258,767
Outstanding balance, March 31, 2022 | shares 258,767
Weighted-Average Grant Date FV  
Granted | $ / shares $ 5.18
Outstanding balance, March 31, 2022 | $ / shares $ 5.18
XML 70 R59.htm IDEA: XBRL DOCUMENT v3.22.1
Stock-based Compensation - Time-based Awards (Details) - Time-based option awards
$ / shares in Units, $ in Millions
9 Months Ended
Mar. 31, 2022
USD ($)
$ / shares
shares
Number of Options  
Granted (in shares) | shares 554,499
Outstanding balance, March 31, 2022 | shares 554,499
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price [Abstract]  
Granted | $ / shares $ 1.61
Outstanding balance, March 31, 2022 | $ / shares $ 1.61
Unrecognized compensation cost | $ $ 0.7
Weighted-average period (in years) 2 years 6 months
XML 71 R60.htm IDEA: XBRL DOCUMENT v3.22.1
Stock-based Compensation - Performance-based Awards (Details) - Performance-based option awards
$ / shares in Units, $ in Millions
9 Months Ended
Mar. 31, 2022
USD ($)
$ / shares
shares
Number of Options  
Granted (in shares) | shares 776,299
Outstanding balance, March 31, 2022 | shares 776,299
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price [Abstract]  
Outstanding balance, June 30, 2021 $ 3.08
Granted 3.08
Outstanding balance, March 31, 2022 $ 3.08
Unrecognized compensation cost | $ $ 2.2
Weighted-average period (in years) 3 years 7 months 6 days
XML 72 R61.htm IDEA: XBRL DOCUMENT v3.22.1
Income Taxes (Details) - USD ($)
$ in Thousands
3 Months Ended 9 Months Ended
Mar. 31, 2022
Mar. 31, 2021
Mar. 31, 2022
Mar. 31, 2021
Income Taxes        
Effective tax rate (as a percent)     1.40% (11.20%)
Income tax provision $ (4,116) $ (4,264) $ 81 $ 5,159
Federal statutory tax rate (as a percent) 56.60%      
Federal statutory tax rate (as a percent)   28.20%    
XML 73 R62.htm IDEA: XBRL DOCUMENT v3.22.1
Earnings per Share (Details) - USD ($)
$ / shares in Units, $ in Thousands
3 Months Ended 9 Months Ended
Mar. 31, 2022
Mar. 31, 2021
Mar. 31, 2022
Mar. 31, 2021
Earnings per Share        
Net income (loss) attributable to InnovAge Holding Corp. $ (2,821) $ (10,510) $ 6,188 $ (50,460)
Weighted average common shares outstanding (basic) 135,516,608 121,324,980 135,516,544 119,619,806
Earnings (loss) per share - basic $ (0.02) $ (0.09) $ 0.05 $ (0.42)
Dilutive shares     14,249  
Weighted average common shares outstanding (diluted) 135,516,608 121,324,980 135,530,793 119,619,806
Earnings (loss) per share -diluted $ (0.02) $ (0.09) $ 0.05 $ (0.42)
XML 74 R63.htm IDEA: XBRL DOCUMENT v3.22.1
Segment Reporting (Details)
9 Months Ended
Mar. 31, 2022
division
item
segment
Center
PACE  
Segment Reporting Information [Line Items]  
Number of operating segments 3
Number of reportable segments 1
Number of PACE participants | item 6,800
Operating segments  
Segment Reporting Information [Line Items]  
Number of operating segments 5
Operating segments | PACE  
Segment Reporting Information [Line Items]  
Number of geographic divisions | division 3
Number of reportable segments 1
Number of PACE participants | item 6,800
Number of PACE centers | Center 18
Operating segments | Others  
Segment Reporting Information [Line Items]  
Number of operating segments 2
XML 75 R64.htm IDEA: XBRL DOCUMENT v3.22.1
Segment Reporting - Operating Results (Details) - USD ($)
$ in Thousands
3 Months Ended 9 Months Ended
Mar. 31, 2022
Mar. 31, 2021
Mar. 31, 2022
Mar. 31, 2021
Segment Reporting Information [Line Items]        
Total revenues $ 177,359 $ 156,308 $ 525,780 $ 466,184
External provider costs 103,254 75,389 284,299 224,215
Cost of care, excluding depreciation and amortization 46,102 39,565 129,740 115,922
Equity loss       (1,343)
Other operating (income) expense   (19,222)   (18,211)
Interest expense, net (709) (4,876) (1,930) (17,061)
Loss on extinguishment of debt       (8,494)
Gain on equity method investment   (10,871)   (10,871)
Other income 108 (2,267) (358) (2,222)
Income (Loss) Before Income Taxes (7,274) (15,126) 5,653 (45,896)
Capitation revenue        
Segment Reporting Information [Line Items]        
Total revenues 176,988 155,835 524,507 464,294
Other service revenue        
Segment Reporting Information [Line Items]        
Total revenues 371 473 1,273 1,890
Operating segments        
Segment Reporting Information [Line Items]        
Total revenues 177,359 156,308 525,780 466,184
External provider costs 103,254 75,389 284,299 224,215
Cost of care, excluding depreciation and amortization 46,102 39,565 129,740 115,922
Center-Level Contribution Margin 28,003 41,354 111,741 126,047
Overhead costs 30,826 24,187 93,365 120,236
Depreciation and amortization 3,850 3,311 10,435 9,262
Equity loss       1,343
Other operating (income) expense   19,222   18,211
Interest expense, net (709) (4,876) (1,930) (17,061)
Loss on extinguishment of debt   (13,488)   (14,479)
Gain on equity method investment   10,871   10,871
Other income 108 (2,267) (358) (2,222)
Income (Loss) Before Income Taxes (7,274) (15,126) 5,653 (45,896)
Operating segments | Capitation revenue        
Segment Reporting Information [Line Items]        
Total revenues 176,988 155,835 524,507 464,294
Operating segments | Other service revenue        
Segment Reporting Information [Line Items]        
Total revenues 371 473 1,273 1,890
Operating segments | PACE        
Segment Reporting Information [Line Items]        
Total revenues 177,154 155,788 524,741 464,507
External provider costs 103,254 75,389 284,299 224,215
Cost of care, excluding depreciation and amortization 45,995 38,867 128,573 113,611
Center-Level Contribution Margin 27,905 41,532 111,869 126,681
Overhead costs 30,911 24,217 93,463 120,249
Depreciation and amortization 3,760 3,181 10,130 8,901
Equity loss       1,343
Other operating (income) expense   19,222   18,211
Interest expense, net (663) (4,824) (1,783) (16,919)
Loss on extinguishment of debt   (13,488)   (14,479)
Gain on equity method investment   10,871   10,871
Other income 108 (2,267) (357) (2,222)
Income (Loss) Before Income Taxes (7,321) (14,796) 6,136 (44,772)
Operating segments | PACE | Capitation revenue        
Segment Reporting Information [Line Items]        
Total revenues 176,988 155,835 524,507 464,294
Operating segments | PACE | Other service revenue        
Segment Reporting Information [Line Items]        
Total revenues 166 (47) 234 213
Operating segments | Others        
Segment Reporting Information [Line Items]        
Total revenues 205 520 1,039 1,677
Cost of care, excluding depreciation and amortization 107 698 1,167 2,311
Center-Level Contribution Margin 98 (178) (128) (634)
Overhead costs (85) (30) (98) (13)
Depreciation and amortization 90 130 305 361
Interest expense, net (46) (52) (147) (142)
Other income     (1)  
Income (Loss) Before Income Taxes 47 (330) (483) (1,124)
Operating segments | Others | Other service revenue        
Segment Reporting Information [Line Items]        
Total revenues $ 205 $ 520 $ 1,039 $ 1,677
XML 76 R65.htm IDEA: XBRL DOCUMENT v3.22.1
Related-party (Details) - USD ($)
9 Months Ended
Mar. 31, 2022
Jun. 30, 2021
Related Party Transaction [Line Items]    
Revenue from related parties $ 35,000  
Deposits and other    
Related Party Transaction [Line Items]    
Loans and leases receivable, related parties $ 700,000 $ 700,000
XML 77 tmb-20220331x10q_htm.xml IDEA: XBRL DOCUMENT 0001834376 innv:AdventistHealthSystemWestJointVentureMember 2021-02-09 0001834376 innv:Sh1Member 2021-07-01 2022-03-31 0001834376 innv:PwdMember 2022-03-31 0001834376 us-gaap:TreasuryStockMember 2021-01-01 2021-03-31 0001834376 us-gaap:TreasuryStockMember 2020-07-01 2021-03-31 0001834376 innv:EquityIncentivePlan2016Member 2020-07-27 0001834376 innv:ThirdAmendedAndRestatedCreditAgreementMember 2020-07-27 2020-07-27 0001834376 innv:TwoThousandSixteenIncentivePlanMember innv:OptionCancelationAgreementMember 2020-07-27 2020-07-27 0001834376 us-gaap:AdditionalPaidInCapitalMember 2022-01-01 2022-03-31 0001834376 us-gaap:AdditionalPaidInCapitalMember 2021-07-01 2022-03-31 0001834376 us-gaap:CommonStockMember 2022-01-01 2022-03-31 0001834376 us-gaap:CommonStockMember 2021-07-01 2022-03-31 0001834376 us-gaap:CommonStockMember 2021-01-01 2021-03-31 0001834376 us-gaap:CommonStockMember 2020-07-01 2021-03-31 0001834376 us-gaap:RetainedEarningsMember 2022-03-31 0001834376 us-gaap:NoncontrollingInterestMember 2022-03-31 0001834376 us-gaap:AdditionalPaidInCapitalMember 2022-03-31 0001834376 us-gaap:RetainedEarningsMember 2021-12-31 0001834376 us-gaap:NoncontrollingInterestMember 2021-12-31 0001834376 us-gaap:AdditionalPaidInCapitalMember 2021-12-31 0001834376 srt:ScenarioPreviouslyReportedMember us-gaap:RetainedEarningsMember 2021-06-30 0001834376 srt:ScenarioPreviouslyReportedMember us-gaap:NoncontrollingInterestMember 2021-06-30 0001834376 srt:RestatementAdjustmentMember us-gaap:RetainedEarningsMember 2021-06-30 0001834376 srt:RestatementAdjustmentMember us-gaap:NoncontrollingInterestMember 2021-06-30 0001834376 us-gaap:RetainedEarningsMember 2021-06-30 0001834376 us-gaap:NoncontrollingInterestMember 2021-06-30 0001834376 us-gaap:AdditionalPaidInCapitalMember 2021-06-30 0001834376 srt:ScenarioPreviouslyReportedMember us-gaap:RetainedEarningsMember 2021-03-31 0001834376 srt:ScenarioPreviouslyReportedMember us-gaap:NoncontrollingInterestMember 2021-03-31 0001834376 srt:RestatementAdjustmentMember us-gaap:RetainedEarningsMember 2021-03-31 0001834376 srt:RestatementAdjustmentMember us-gaap:NoncontrollingInterestMember 2021-03-31 0001834376 us-gaap:RetainedEarningsMember 2021-03-31 0001834376 us-gaap:NoncontrollingInterestMember 2021-03-31 0001834376 us-gaap:AdditionalPaidInCapitalMember 2021-03-31 0001834376 srt:ScenarioPreviouslyReportedMember 2021-03-31 0001834376 us-gaap:RetainedEarningsMember 2020-12-31 0001834376 us-gaap:NoncontrollingInterestMember 2020-12-31 0001834376 us-gaap:AdditionalPaidInCapitalMember 2020-12-31 0001834376 2020-12-31 0001834376 us-gaap:RetainedEarningsMember 2020-06-30 0001834376 us-gaap:NoncontrollingInterestMember 2020-06-30 0001834376 us-gaap:AdditionalPaidInCapitalMember 2020-06-30 0001834376 us-gaap:CommonStockMember 2022-03-31 0001834376 us-gaap:CommonStockMember 2021-12-31 0001834376 us-gaap:CommonStockMember 2021-06-30 0001834376 us-gaap:CommonStockMember 2021-03-31 0001834376 us-gaap:TreasuryStockMember 2020-12-31 0001834376 us-gaap:CommonStockMember 2020-12-31 0001834376 us-gaap:TreasuryStockMember 2020-06-30 0001834376 us-gaap:CommonStockMember 2020-06-30 0001834376 innv:EquityIncentivePlan2016Member 2021-07-01 2022-03-31 0001834376 innv:EquityIncentivePlan2016Member 2020-07-27 2020-07-27 0001834376 innv:OmnibusIncentivePlan2021Member 2022-03-31 0001834376 innv:EquityIncentivePlan2020Member 2022-03-31 0001834376 innv:EquityIncentivePlan2016Member 2022-03-31 0001834376 srt:MinimumMember innv:TimeVestingAwardsMember 2021-07-01 2022-03-31 0001834376 innv:PerformanceBasedRestrictedStockUnitsMember innv:OmnibusIncentivePlan2021Member 2022-03-31 0001834376 innv:TimeBasedRestrictedStockUnitsMember innv:OmnibusIncentivePlan2021Member 2021-06-30 0001834376 innv:TimeVestingUnitsProfitInterestsMember 2021-06-30 0001834376 innv:PerformanceVestingUnitsProfitInterestsMember 2021-06-30 0001834376 innv:PerformanceBasedRestrictedStockUnitsMember innv:OmnibusIncentivePlan2021Member 2021-07-01 2022-03-31 0001834376 innv:EquityIncentivePlan2020Member 2021-07-01 2022-03-31 0001834376 innv:PerformanceVestingUnitsProfitInterestsMember 2021-07-01 2022-03-31 0001834376 innv:OmnibusIncentivePlan2021Member 2021-07-01 2022-03-31 0001834376 innv:OptionCancelationAgreementMember 2020-07-27 2020-07-27 0001834376 innv:TimeBasedOptionAwardMember 2021-07-01 2022-03-31 0001834376 us-gaap:OperatingSegmentsMember innv:OtherServiceRevenueMember us-gaap:AllOtherSegmentsMember 2022-01-01 2022-03-31 0001834376 us-gaap:OperatingSegmentsMember innv:OtherServiceRevenueMember innv:ProgramOfAllInclusiveCareForElderlyOperatingSegmentsMember 2022-01-01 2022-03-31 0001834376 us-gaap:OperatingSegmentsMember innv:CapitationRevenueMember innv:ProgramOfAllInclusiveCareForElderlyOperatingSegmentsMember 2022-01-01 2022-03-31 0001834376 us-gaap:OperatingSegmentsMember innv:OtherServiceRevenueMember 2022-01-01 2022-03-31 0001834376 us-gaap:OperatingSegmentsMember innv:CapitationRevenueMember 2022-01-01 2022-03-31 0001834376 innv:OtherServiceRevenueMember 2022-01-01 2022-03-31 0001834376 innv:CapitationRevenueMember 2022-01-01 2022-03-31 0001834376 us-gaap:OperatingSegmentsMember innv:OtherServiceRevenueMember us-gaap:AllOtherSegmentsMember 2021-07-01 2022-03-31 0001834376 us-gaap:OperatingSegmentsMember innv:OtherServiceRevenueMember innv:ProgramOfAllInclusiveCareForElderlyOperatingSegmentsMember 2021-07-01 2022-03-31 0001834376 us-gaap:OperatingSegmentsMember innv:CapitationRevenueMember innv:ProgramOfAllInclusiveCareForElderlyOperatingSegmentsMember 2021-07-01 2022-03-31 0001834376 us-gaap:OperatingSegmentsMember innv:OtherServiceRevenueMember 2021-07-01 2022-03-31 0001834376 us-gaap:OperatingSegmentsMember innv:CapitationRevenueMember 2021-07-01 2022-03-31 0001834376 innv:OtherServiceRevenueMember 2021-07-01 2022-03-31 0001834376 innv:CapitationRevenueMember 2021-07-01 2022-03-31 0001834376 us-gaap:OperatingSegmentsMember innv:OtherServiceRevenueMember us-gaap:AllOtherSegmentsMember 2021-01-01 2021-03-31 0001834376 us-gaap:OperatingSegmentsMember innv:OtherServiceRevenueMember innv:ProgramOfAllInclusiveCareForElderlyOperatingSegmentsMember 2021-01-01 2021-03-31 0001834376 us-gaap:OperatingSegmentsMember innv:CapitationRevenueMember innv:ProgramOfAllInclusiveCareForElderlyOperatingSegmentsMember 2021-01-01 2021-03-31 0001834376 us-gaap:OperatingSegmentsMember innv:OtherServiceRevenueMember 2021-01-01 2021-03-31 0001834376 us-gaap:OperatingSegmentsMember innv:CapitationRevenueMember 2021-01-01 2021-03-31 0001834376 innv:OtherServiceRevenueMember 2021-01-01 2021-03-31 0001834376 innv:CapitationRevenueMember 2021-01-01 2021-03-31 0001834376 us-gaap:OperatingSegmentsMember innv:OtherServiceRevenueMember us-gaap:AllOtherSegmentsMember 2020-07-01 2021-03-31 0001834376 us-gaap:OperatingSegmentsMember innv:OtherServiceRevenueMember innv:ProgramOfAllInclusiveCareForElderlyOperatingSegmentsMember 2020-07-01 2021-03-31 0001834376 us-gaap:OperatingSegmentsMember innv:CapitationRevenueMember innv:ProgramOfAllInclusiveCareForElderlyOperatingSegmentsMember 2020-07-01 2021-03-31 0001834376 us-gaap:OperatingSegmentsMember innv:OtherServiceRevenueMember 2020-07-01 2021-03-31 0001834376 us-gaap:OperatingSegmentsMember innv:CapitationRevenueMember 2020-07-01 2021-03-31 0001834376 innv:OtherServiceRevenueMember 2020-07-01 2021-03-31 0001834376 innv:CapitationRevenueMember 2020-07-01 2021-03-31 0001834376 2021-12-31 0001834376 srt:RestatementAdjustmentMember 2021-03-31 0001834376 srt:MinimumMember us-gaap:SoftwareAndSoftwareDevelopmentCostsMember 2021-07-01 2022-03-31 0001834376 srt:MinimumMember innv:EquipmentAndVehiclesMember 2021-07-01 2022-03-31 0001834376 srt:MinimumMember innv:BuildingAndLeaseholdImprovementsMember 2021-07-01 2022-03-31 0001834376 srt:MaximumMember us-gaap:SoftwareAndSoftwareDevelopmentCostsMember 2021-07-01 2022-03-31 0001834376 srt:MaximumMember innv:EquipmentAndVehiclesMember 2021-07-01 2022-03-31 0001834376 srt:MaximumMember innv:BuildingAndLeaseholdImprovementsMember 2021-07-01 2022-03-31 0001834376 us-gaap:SoftwareAndSoftwareDevelopmentCostsMember 2022-03-31 0001834376 us-gaap:LandMember 2022-03-31 0001834376 us-gaap:ConstructionInProgressMember 2022-03-31 0001834376 innv:EquipmentAndVehiclesMember 2022-03-31 0001834376 innv:BuildingAndLeaseholdImprovementsMember 2022-03-31 0001834376 us-gaap:SoftwareAndSoftwareDevelopmentCostsMember 2021-06-30 0001834376 us-gaap:LandMember 2021-06-30 0001834376 us-gaap:ConstructionInProgressMember 2021-06-30 0001834376 innv:EquipmentAndVehiclesMember 2021-06-30 0001834376 innv:BuildingAndLeaseholdImprovementsMember 2021-06-30 0001834376 us-gaap:VariableInterestEntityNotPrimaryBeneficiaryMember 2021-01-01 2021-03-31 0001834376 us-gaap:VariableInterestEntityNotPrimaryBeneficiaryMember innv:EskatonMember 2019-03-18 2019-03-18 0001834376 us-gaap:VariableInterestEntityNotPrimaryBeneficiaryMember innv:AdventistHealthSystemWestJointVentureMember 2019-03-18 2019-03-18 0001834376 innv:JetdocInc.Member 2021-08-01 2021-08-31 0001834376 us-gaap:GeneralAndAdministrativeExpenseMember 2020-07-01 2021-03-31 0001834376 us-gaap:NoncontrollingInterestMember 2022-01-01 2022-03-31 0001834376 us-gaap:NoncontrollingInterestMember 2021-07-01 2022-03-31 0001834376 srt:ScenarioPreviouslyReportedMember us-gaap:RetainedEarningsMember 2021-01-01 2021-03-31 0001834376 us-gaap:NoncontrollingInterestMember 2021-01-01 2021-03-31 0001834376 srt:ScenarioPreviouslyReportedMember us-gaap:RetainedEarningsMember 2020-07-01 2021-03-31 0001834376 us-gaap:NoncontrollingInterestMember 2020-07-01 2021-03-31 0001834376 innv:InnovageSacramentoMember 2020-07-01 2020-12-31 0001834376 srt:ScenarioPreviouslyReportedMember 2021-06-30 0001834376 srt:RestatementAdjustmentMember 2021-06-30 0001834376 us-gaap:ServiceOtherMember 2022-03-31 0001834376 us-gaap:ServiceOtherMember 2021-06-30 0001834376 us-gaap:RevolvingCreditFacilityMember innv:CreditAgreement2021CreditFacilityMember 2021-03-08 2021-03-08 0001834376 us-gaap:VariableInterestEntityNotPrimaryBeneficiaryMember innv:InnovageSacramentoMember innv:EskatonMember 2019-03-18 2019-03-18 0001834376 us-gaap:VariableInterestEntityNotPrimaryBeneficiaryMember innv:InnovageSacramentoMember innv:AdventistHealthSystemWestJointVentureMember 2019-03-18 2019-03-18 0001834376 innv:InnovageSacramentoMember 2019-03-18 2019-03-18 0001834376 innv:InnovageSacramentoMember 2022-01-01 2022-03-31 0001834376 2021-02-09 2021-02-09 0001834376 us-gaap:PerformanceSharesMember 2022-03-31 0001834376 innv:TimeVestingAwardsMember 2022-03-31 0001834376 innv:TimeBasedRestrictedStockUnitsMember innv:OmnibusIncentivePlan2021Member 2022-03-31 0001834376 innv:TimeVestingUnitsProfitInterestsMember 2022-03-31 0001834376 innv:ProfitsInterestsUnitsMember 2022-03-31 0001834376 innv:PerformanceVestingUnitsProfitInterestsMember 2022-03-31 0001834376 innv:PerformanceBasedRestrictedStockUnitsMember 2022-03-31 0001834376 us-gaap:PerformanceSharesMember 2021-07-01 2022-03-31 0001834376 innv:TimeVestingUnitsProfitInterestsMember 2021-07-01 2022-03-31 0001834376 us-gaap:ConvertibleDebtMember 2015-09-01 2015-09-01 0001834376 innv:CreditAgreement2021CreditFacilityMember us-gaap:SeniorLoansMember 2022-03-31 0001834376 us-gaap:RevolvingCreditFacilityMember innv:CreditAgreement2021CreditFacilityMember 2021-03-08 0001834376 innv:CreditAgreement2021CreditFacilityMember us-gaap:SeniorLoansMember 2021-03-08 0001834376 us-gaap:RevolvingCreditFacilityMember innv:CreditAgreement2016CreditFacilityMember 2020-07-27 0001834376 innv:CreditAgreement2016CreditFacilityMember us-gaap:SeniorLoansMember 2020-07-27 0001834376 us-gaap:RevolvingCreditFacilityMember innv:CreditAgreement2016CreditFacilityMember 2019-05-02 0001834376 innv:CreditAgreement2016CreditFacilityMember us-gaap:SeniorLoansMember 2019-05-02 0001834376 innv:CreditAgreement2016CreditFacilityMember innv:DelayedDrawTermLoanFacilityMember 2019-05-02 0001834376 us-gaap:RevolvingCreditFacilityMember innv:CreditAgreement2016CreditFacilityMember 2016-05-13 0001834376 innv:CreditAgreement2016CreditFacilityMember us-gaap:SeniorLoansMember 2016-05-13 0001834376 us-gaap:RevolvingCreditFacilityMember innv:CreditAgreement2021CreditFacilityMember 2022-03-31 0001834376 us-gaap:SeniorLoansMember 2022-03-31 0001834376 us-gaap:ConvertibleDebtMember 2022-03-31 0001834376 us-gaap:SeniorLoansMember 2021-06-30 0001834376 us-gaap:ConvertibleDebtMember 2021-06-30 0001834376 us-gaap:OperatingSegmentsMember us-gaap:AllOtherSegmentsMember 2022-01-01 2022-03-31 0001834376 us-gaap:OperatingSegmentsMember us-gaap:AllOtherSegmentsMember 2021-07-01 2022-03-31 0001834376 us-gaap:OperatingSegmentsMember us-gaap:AllOtherSegmentsMember 2021-01-01 2021-03-31 0001834376 us-gaap:OperatingSegmentsMember us-gaap:AllOtherSegmentsMember 2020-07-01 2021-03-31 0001834376 innv:SeniorHousingMember innv:OtherServiceRevenueMember us-gaap:CustomerConcentrationRiskMember 2022-01-01 2022-03-31 0001834376 innv:SeniorHousingMember innv:OtherServiceRevenueMember us-gaap:CustomerConcentrationRiskMember 2021-07-01 2022-03-31 0001834376 innv:PrivatePayAndOtherCustomerMember us-gaap:RevenueFromContractWithCustomerMember us-gaap:CustomerConcentrationRiskMember 2021-07-01 2022-03-31 0001834376 innv:PrivatePayAndOtherCustomerMember us-gaap:AccountsReceivableMember us-gaap:CustomerConcentrationRiskMember 2021-07-01 2022-03-31 0001834376 innv:MedicarePartDMember us-gaap:RevenueFromContractWithCustomerMember us-gaap:CustomerConcentrationRiskMember 2021-07-01 2022-03-31 0001834376 innv:MedicarePartDMember us-gaap:CostOfGoodsProductLineMember us-gaap:CustomerConcentrationRiskMember 2021-07-01 2022-03-31 0001834376 innv:MedicareCustomerMember us-gaap:RevenueFromContractWithCustomerMember us-gaap:CustomerConcentrationRiskMember 2021-07-01 2022-03-31 0001834376 innv:MedicareCustomerMember us-gaap:AccountsReceivableMember us-gaap:CustomerConcentrationRiskMember 2021-07-01 2022-03-31 0001834376 innv:MedicaidCustomerMember us-gaap:RevenueFromContractWithCustomerMember us-gaap:CustomerConcentrationRiskMember 2021-07-01 2022-03-31 0001834376 innv:MedicaidCustomerMember us-gaap:AccountsReceivableMember us-gaap:CustomerConcentrationRiskMember 2021-07-01 2022-03-31 0001834376 us-gaap:RevenueFromContractWithCustomerMember us-gaap:CustomerConcentrationRiskMember 2021-07-01 2022-03-31 0001834376 us-gaap:AccountsReceivableMember us-gaap:CustomerConcentrationRiskMember 2021-07-01 2022-03-31 0001834376 innv:SeniorHousingMember innv:OtherServiceRevenueMember us-gaap:CustomerConcentrationRiskMember 2021-01-01 2021-03-31 0001834376 innv:PrivatePayAndOtherCustomerMember us-gaap:AccountsReceivableMember us-gaap:CustomerConcentrationRiskMember 2020-07-01 2021-06-30 0001834376 innv:MedicareCustomerMember us-gaap:AccountsReceivableMember us-gaap:CustomerConcentrationRiskMember 2020-07-01 2021-06-30 0001834376 innv:MedicaidCustomerMember us-gaap:AccountsReceivableMember us-gaap:CustomerConcentrationRiskMember 2020-07-01 2021-06-30 0001834376 us-gaap:AccountsReceivableMember us-gaap:CustomerConcentrationRiskMember 2020-07-01 2021-06-30 0001834376 innv:SeniorHousingMember innv:OtherServiceRevenueMember us-gaap:CustomerConcentrationRiskMember 2020-07-01 2021-03-31 0001834376 innv:PrivatePayAndOtherCustomerMember us-gaap:RevenueFromContractWithCustomerMember us-gaap:CustomerConcentrationRiskMember 2020-07-01 2021-03-31 0001834376 innv:MedicarePartDMember us-gaap:RevenueFromContractWithCustomerMember us-gaap:CustomerConcentrationRiskMember 2020-07-01 2021-03-31 0001834376 innv:MedicarePartDMember us-gaap:CostOfGoodsProductLineMember us-gaap:CustomerConcentrationRiskMember 2020-07-01 2021-03-31 0001834376 innv:MedicareCustomerMember us-gaap:RevenueFromContractWithCustomerMember us-gaap:CustomerConcentrationRiskMember 2020-07-01 2021-03-31 0001834376 innv:MedicaidCustomerMember us-gaap:RevenueFromContractWithCustomerMember us-gaap:CustomerConcentrationRiskMember 2020-07-01 2021-03-31 0001834376 us-gaap:RevenueFromContractWithCustomerMember us-gaap:CustomerConcentrationRiskMember 2020-07-01 2021-03-31 0001834376 innv:AdventistHealthSystemWestJointVentureMember 2019-03-18 0001834376 2021-03-31 0001834376 2020-06-30 0001834376 2019-03-18 0001834376 srt:MaximumMember innv:NewcourtlandLifeProgramMember 2018-08-07 0001834376 2018-08-07 0001834376 innv:NewcourtlandLifeProgramMember 2018-08-07 2018-08-07 0001834376 innv:InnovageSacramentoMember 2021-03-31 0001834376 innv:InnovageSacramentoMember 2021-02-09 0001834376 us-gaap:RevolvingCreditFacilityMember innv:CreditAgreement2021CreditFacilityMember 2021-07-01 2022-03-31 0001834376 innv:CreditAgreement2016CreditFacilityMember 2020-07-01 2021-03-31 0001834376 us-gaap:RestrictedStockUnitsRSUMember 2021-07-01 2022-03-31 0001834376 us-gaap:EmployeeStockOptionMember 2021-07-01 2022-03-31 0001834376 innv:ProfitsInterestsUnitsMember 2021-07-01 2022-03-31 0001834376 us-gaap:EmployeeStockOptionMember 2020-07-01 2021-03-31 0001834376 innv:ProfitsInterestsUnitsMember 2020-07-01 2021-03-31 0001834376 innv:OptionCancelationAgreementMember 2020-07-27 0001834376 innv:EquipmentUnderCapitalLeaseMember 2022-03-31 0001834376 innv:EquipmentUnderCapitalLeaseMember 2021-06-30 0001834376 innv:TimeVestingAwardsMember 2021-07-01 2022-03-31 0001834376 innv:PerformanceBasedRestrictedStockUnitsMember 2021-07-01 2022-03-31 0001834376 innv:TimeBasedRestrictedStockUnitsMember innv:OmnibusIncentivePlan2021Member 2021-07-01 2022-03-31 0001834376 2020-07-01 2021-06-30 0001834376 2019-07-01 2020-06-30 0001834376 innv:AdventistHealthSystemWestJointVentureMember 2019-03-18 2019-03-18 0001834376 innv:ProgramOfAllInclusiveCareForElderlyOperatingSegmentsMember 2021-07-01 2022-03-31 0001834376 us-gaap:RevolvingCreditFacilityMember 2022-03-31 0001834376 us-gaap:OperatingSegmentsMember innv:ProgramOfAllInclusiveCareForElderlyOperatingSegmentsMember 2022-01-01 2022-03-31 0001834376 us-gaap:OperatingSegmentsMember 2022-01-01 2022-03-31 0001834376 us-gaap:OperatingSegmentsMember innv:ProgramOfAllInclusiveCareForElderlyOperatingSegmentsMember 2021-07-01 2022-03-31 0001834376 us-gaap:OperatingSegmentsMember 2021-07-01 2022-03-31 0001834376 us-gaap:OperatingSegmentsMember innv:ProgramOfAllInclusiveCareForElderlyOperatingSegmentsMember 2021-01-01 2021-03-31 0001834376 us-gaap:OperatingSegmentsMember 2021-01-01 2021-03-31 0001834376 us-gaap:OperatingSegmentsMember innv:ProgramOfAllInclusiveCareForElderlyOperatingSegmentsMember 2020-07-01 2021-03-31 0001834376 us-gaap:OperatingSegmentsMember 2020-07-01 2021-03-31 0001834376 innv:CreditAgreement2021CreditFacilityMember us-gaap:SeniorLoansMember 2021-03-08 2021-03-08 0001834376 innv:CreditAgreement2016CreditFacilityMember 2022-03-31 0001834376 innv:CreditAgreement2016CreditFacilityMember innv:DelayedDrawTermLoanFacilityMember 2020-07-27 2020-07-27 0001834376 innv:JetdocInc.Member 2021-08-31 0001834376 2021-06-30 0001834376 innv:DispatchhealthHoldingsIncMember 2019-12-31 0001834376 srt:ScenarioPreviouslyReportedMember us-gaap:NoncontrollingInterestMember 2021-01-01 2021-03-31 0001834376 srt:RestatementAdjustmentMember us-gaap:NoncontrollingInterestMember 2021-01-01 2021-03-31 0001834376 srt:ScenarioPreviouslyReportedMember 2021-01-01 2021-03-31 0001834376 srt:ScenarioPreviouslyReportedMember us-gaap:NoncontrollingInterestMember 2020-07-01 2021-03-31 0001834376 srt:RestatementAdjustmentMember us-gaap:NoncontrollingInterestMember 2020-07-01 2021-03-31 0001834376 srt:ScenarioPreviouslyReportedMember 2020-07-01 2021-03-31 0001834376 innv:AdventistHealthSystemWestJointVentureMember 2021-02-09 2021-02-09 0001834376 2022-03-31 0001834376 2021-03-08 2021-03-08 0001834376 us-gaap:RetainedEarningsMember 2022-01-01 2022-03-31 0001834376 2022-01-01 2022-03-31 0001834376 us-gaap:RetainedEarningsMember 2021-07-01 2022-03-31 0001834376 srt:RestatementAdjustmentMember us-gaap:RetainedEarningsMember 2021-01-01 2021-03-31 0001834376 us-gaap:RetainedEarningsMember 2021-01-01 2021-03-31 0001834376 srt:RestatementAdjustmentMember 2021-01-01 2021-03-31 0001834376 srt:RestatementAdjustmentMember us-gaap:RetainedEarningsMember 2020-07-01 2021-03-31 0001834376 us-gaap:RetainedEarningsMember 2020-07-01 2021-03-31 0001834376 srt:RestatementAdjustmentMember 2020-07-01 2021-03-31 0001834376 us-gaap:AdditionalPaidInCapitalMember 2021-01-01 2021-03-31 0001834376 2021-01-01 2021-03-31 0001834376 us-gaap:AdditionalPaidInCapitalMember 2020-07-01 2021-03-31 0001834376 2020-07-01 2021-03-31 0001834376 2022-05-09 0001834376 2021-07-01 2022-03-31 shares iso4217:USD pure innv:Center innv:division innv:item iso4217:USD shares innv:segment 0001834376 --06-30 2022 Q3 false 135516513 135525006 17000000 16900000 P1Y 45000000 0.333300 10-Q true 2022-03-31 false 001-40159 InnovAge Holding Corp. DE 81-0710819 8950 E. Lowry Boulevard Denver CO 80230 844 803-8745 Common Stock, $0.001 par value INNV NASDAQ Yes Yes Non-accelerated Filer false true false false 135525006 199493000 201466000 18000 2234000 3921000 4350000 31905000 32582000 13572000 9249000 5461000 5401000 250449000 250932000 163882000 142715000 5493000 3493000 5378000 3877000 124217000 124217000 8772000 6518000 307742000 280820000 558191000 531752000 41834000 32361000 36012000 33234000 9530000 7101000 3793000 3790000 3216000 2079000 94385000 78565000 15781000 15700000 10282000 5190000 2570000 2758000 69051000 71574000 192069000 173787000 15996000 16986000 0.001 0.001 500000000 500000000 135525006 135516513 136000 136000 326346000 323760000 17437000 10663000 343919000 334559000 6207000 6420000 350126000 340979000 558191000 531752000 176988000 155835000 524507000 464294000 371000 473000 1273000 1890000 177359000 156308000 525780000 466184000 103254000 75389000 284299000 224215000 46102000 39565000 129740000 115922000 6144000 5592000 19117000 14335000 24682000 18595000 74248000 105901000 3850000 3311000 10435000 9262000 -1343000 -19222000 -18211000 184032000 161674000 517839000 489189000 -6673000 -5366000 7941000 -23005000 709000 4876000 1930000 17061000 -13488000 -14479000 10871000 10871000 108000 -2267000 -358000 -2222000 -601000 -9760000 -2288000 -22891000 -7274000 -15126000 5653000 -45896000 -4116000 -4264000 81000 5159000 -3158000 -10862000 5572000 -51055000 -337000 -352000 -616000 -595000 -2821000 -10510000 6188000 -50460000 135516608 121324980 135516544 119619806 135516608 121324980 135530793 119619806 -0.02 -0.09 0.05 -0.42 -0.02 -0.09 0.05 -0.42 135516513 136000 325501000 17695000 6254000 349586000 18850000 8493 845000 845000 -2821000 -47000 -2868000 -290000 -3158000 -2563000 -2563000 -2563000 135525006 136000 326346000 17437000 6207000 350126000 15996000 135516513 136000 323760000 10663000 6420000 340979000 16986000 8493 2586000 2586000 6188000 -213000 5975000 -403000 5572000 -586000 -586000 -586000 135525006 136000 326346000 17437000 6207000 350126000 15996000 132718461 133000 24552000 15330000 16197849 -77796000 6492000 -31289000 -16197849 16000 77780000 -16197849 -77796000 530000 530000 2264000 2264000 25334000 18995901 19000 373561000 373580000 16838000 344000 344000 344000 -10510000 -89000 -10599000 -263000 -10862000 135516513 136000 323127000 4476000 6403000 334142000 16919000 132718461 133000 36338000 64737000 102030 -193000 6735000 107750000 16095819 77603000 77603000 -16197849 16000 77780000 -16197849 -77796000 9457000 9457000 32358000 32358000 1102000 1102000 2264000 2264000 20000000 20000000 25334000 18995901 19000 373561000 373580000 16838000 344000 344000 344000 -50460000 -332000 -50792000 -263000 -51055000 135516513 136000 323127000 4476000 6403000 334142000 16919000 5572000 -51055000 -358000 -2000 4834000 4144000 10435000 9262000 10871000 -8494000 322000 948000 2586000 1102000 81000 -3464000 -2264000 1343000 4157000 1402000 4323000 -635000 60000 -1613000 1501000 606000 4705000 7717000 2778000 114000 2429000 12732000 24059000 -17028000 20141000 14083000 1437000 2000000 2000000 -23578000 -16083000 9458000 20000000 1829000 1685000 375000000 2841000 512649000 8896000 373580000 77603000 3622000 32358000 -4670000 122309000 -4189000 89198000 203700000 114565000 199511000 203763000 1452000 16251000 84000 7047000 6000000 4577000 224000 8057000 3517000 <p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 12pt 0pt;"><span style="display:inline-block;text-align:left;width:36pt;"><b style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:bold;">Note 1:</b></span><b style="font-weight:bold;">Business</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">InnovAge Holding Corp. (formerly, TCO Group Holdings, Inc.) was formed May 13, 2016, to acquire the business of Total Community Options, Inc. d/b/a InnovAge, which was formed in May 2007. In connection with the Company’s initial public offering (“IPO”), which occurred in March 2021, we changed the name of our Company from TCO Group Holdings, Inc. to InnovAge Holding Corp.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">InnovAge Holding Corp. and its subsidiaries, are headquartered in Denver, Colorado. The Company manages, and in many cases directly provides, a broad range of medical and ancillary services for seniors in need of care and support to safely live independently in their homes and communities, including in-home care services (skilled, unskilled and personal care); in-center services such as primary care, physical therapy, occupational therapy, speech therapy, dental services, mental health and psychiatric services, meals, and activities; transportation to the Program of All-Inclusive Care for the Elderly (“PACE”) center and third-party medical appointments; and care management. The Company manages its business as one reportable segment, PACE. </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">As of March 31, 2022, the Company served approximately 6,800 PACE participants, making it the largest PACE provider in the United States of America (the “U.S.”) based upon participants served, and operates 18 PACE centers across Colorado, California, New Mexico, Pennsylvania and Virginia.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">PACE is a fully-capitated managed care program, which serves the frail elderly, and predominantly dual-eligible, population in a community-based service model. InnovAge is obligated to provide and participants receive all needed healthcare services through an all-inclusive, coordinated model of care, and the Company is at risk for 100% of healthcare costs incurred with respect to the care of its participants. PACE programs receive capitation payments directly from Medicare Parts C and D, Medicaid, Veterans Administration (“VA”), and private pay sources. Additionally, under the Medicare Prescription Drug Plan, the Centers for Medicare and Medicaid Services (“CMS”) share part of the risk for providing prescription medication to the Company’s participants.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">On March 8, 2021, we completed our IPO. The Company’s common stock began trading on the Nasdaq Stock Market LLC (“NASDAQ”) under the ticker symbol “INNV”. </p> 1 6800 18 1 <p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;"><span style="display:inline-block;text-indent:0pt;width:36pt;"><b style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:bold;">Note 2:</b></span>Summary of Significant Accounting Policies</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">The Company described its significant accounting policies in Note 2, “Summary of Significant Accounting Policies” of the Notes to Consolidated Financial Statements in its Annual Report on Form 10-K for the year ended June 30, 2021 (“2021 10-K”). During the nine months ended March 31, 2022, there were no significant changes to those accounting policies. </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;padding-left:54pt;text-indent:-54pt;margin:0pt 0pt 12pt 0pt;">Basis of Preparation and Principles of Consolidation</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:18pt;margin:0pt;">The unaudited interim condensed consolidated financial statements and accompanying notes have been prepared in accordance with accounting principles generally accepted in the U.S. (“U.S. GAAP”) for interim financial information and with the instructions to Form 10-Q and Article 10 of Regulation S-X. Accordingly, certain information and footnote disclosures normally included in financial statements prepared in accordance with U.S. GAAP have been omitted pursuant to such regulations. These financial statements have been prepared on a basis consistent with the accounting principles applied for the fiscal year ended June 30, 2021. In the opinion of management, all adjustments (consisting of all normal and recurring adjustments) considered necessary for a fair presentation have been included. The condensed consolidated financial statements include the accounts of InnovAge, its wholly owned subsidiaries, variable interest entities (“VIEs”) </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">for which it is the primary beneficiary and entities for which it has a controlling interest. All intercompany accounts and transactions have been eliminated in consolidation.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">The Company does not have any components of comprehensive income and comprehensive income is equal to net income reported in the statements of operations for all periods presented.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;"><span style="font-style:italic;font-weight:bold;">Restatement of Prior Period Financial Statements</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:18pt;margin:0pt 9pt 0pt 0pt;">Subsequent to the issuance of the Company’s consolidated financial statements as of and for the year ended June 30, 2021, we identified an error in our consolidated balance sheet and statement of stockholders’ equity as of June 30, 2021 related to the presentation of redeemable noncontrolling interests. Additionally, the error also impacted our condensed consolidated statements of shareholders’ equity for the three months and nine-months ended March 31, 2021. The Company incorrectly recorded redeemable noncontrolling interests of $17.0 million and $16.9 million as permanent equity rather than <span style="-sec-ix-hidden:Hidden_0tELu_FnUEigG2js346PFQ;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">temporary</span></span> <span style="-sec-ix-hidden:Hidden_2bM5XwY1D0WaUp80sEX8og;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">equity</span></span> as of June 30, 2021 and March 31, 2021, respectively.  As a result, the Company restated the June 30, 2021 and March 31, 2021 condensed consolidated financial statements to reflect this reclassification from permanent to temporary equity and to record the related adjustments to redemption value as of June 30, 2021 and March 31, 2021. Management has evaluated the materiality of this misstatement and concluded that it is not material to the prior period. </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:18pt;margin:0pt 9pt 0pt 0pt;"><span style="margin-right:0pt;visibility:hidden;">​</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 9.35pt 0pt 0pt;">The effect of the restatement on the consolidated balance sheet as of June 30, 2021 is as follows (<i style="font-style:italic;">in thousands</i>):</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:77.14%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:58.54%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.13%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:12.52%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.13%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:11.64%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.13%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:10.87%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:58.54%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.13%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.52%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">As Previously</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.13%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.13%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:bottom;width:58.54%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.13%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">    </b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.52%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Reported</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.13%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">    </b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.64%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Adjustments</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.13%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">    </b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.87%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">As Restated</b></p></td></tr><tr><td style="vertical-align:bottom;width:58.54%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">Redeemable Noncontrolling Interests (See Note 4)</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.13%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.52%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0pt 0pt;"> —</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.13%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0pt 0pt;"> 16,986</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.13%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.87%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0pt 0pt;"> 16,986</p></td></tr><tr><td style="vertical-align:bottom;width:58.54%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Retained earnings</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.13%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.52%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0pt 0pt;"> 11,250</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.13%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (587)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.13%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0pt 0pt;"> 10,663</p></td></tr><tr><td style="vertical-align:bottom;width:58.54%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Total InnovAge Holding Corp.</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.13%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.52%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0pt 0pt;"> 335,146</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.13%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (587)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.13%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.87%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0pt 0pt;"> 334,559</p></td></tr><tr><td style="vertical-align:bottom;width:58.54%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Noncontrolling interests</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.13%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.52%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0pt 0pt;"> 22,819</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.13%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (16,399)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.13%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0pt 0pt;"> 6,420</p></td></tr><tr><td style="vertical-align:bottom;width:58.54%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Total stockholders’ equity</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.13%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.52%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0pt 0pt;"> 357,965</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.13%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (16,986)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.13%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.87%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0pt 0pt;"> 340,979</p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"><span style="visibility:hidden;">​</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:18pt;margin:0pt;">The effect of the restatement on the balances as of June 30, 2021 included in the consolidated statement of stockholders’ equity as of March 31, 2022 is as follows (<i style="font-style:italic;">in thousands</i>):</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:18pt;margin:0pt;"><span style="visibility:hidden;">​</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:47.68%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:7.19%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:11.02%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:12.39%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:14.87%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:47.68%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.19%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.02%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.39%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Redeemable</b></p></td></tr><tr><td style="vertical-align:bottom;width:47.68%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.19%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.02%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.39%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Total Permanent</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Noncontrolling</b></p></td></tr><tr><td style="vertical-align:bottom;width:47.68%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.19%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Retained</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.02%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Noncontrolling</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.39%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Stockholders’</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Interests</b></p></td></tr><tr><td style="vertical-align:bottom;width:47.68%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">    </b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.19%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Earnings</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">    </b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.02%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Interests</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">    </b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.39%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Equity</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">    </b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.87%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">(Temporary Equity)</b></p></td></tr><tr><td style="vertical-align:bottom;width:47.68%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">As Previously Reported</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;"> </b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.19%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><b style="font-weight:bold;">  </b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.02%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;">  </p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.39%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;">  </p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.87%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;">  </p></td></tr><tr><td style="vertical-align:bottom;width:47.68%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Balances, June 30, 2021</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.19%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0pt 0pt;"> 11,250</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.02%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0pt 0pt;"> 22,819</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.39%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0pt 0pt;"> 357,965</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0pt 0pt;"> —</p></td></tr><tr><td style="vertical-align:bottom;width:47.68%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Adjustments</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;"> </b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.19%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><b style="font-weight:bold;">  </b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.02%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;">  </p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.39%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;">  </p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.87%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;">  </p></td></tr><tr><td style="vertical-align:bottom;width:47.68%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Balances, June 30, 2021</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.19%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (587)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.02%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (16,399)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.39%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (16,986)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0pt 0pt;"> 16,986</p></td></tr><tr><td style="vertical-align:bottom;width:47.68%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">As Restated</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;"> </b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.19%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><b style="font-weight:bold;">  </b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.02%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;">  </p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.39%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;">  </p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.87%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;">  </p></td></tr><tr><td style="vertical-align:bottom;width:47.68%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Balances, June 30, 2021</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.19%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0pt 0pt;"> 10,663</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.02%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0pt 0pt;"> 6,420</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.39%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0pt 0pt;"> 340,979</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0pt 0pt;"> 16,986</p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:18pt;margin:0pt;"><span style="visibility:hidden;">​</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">The effect of the restatement on the consolidated statement of stockholders’ equity for the three months ended March 31, 2021 is as follows (<i style="font-style:italic;">in thousands</i>):</p><table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;width:96.56%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:39.2%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:7.83%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:11.01%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:12.37%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:14.85%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:0.06%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:7.83%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:39.2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.83%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.01%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.85%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Redeemable</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.83%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:bottom;width:39.2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.83%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.01%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Total Permanent</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.85%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Noncontrolling</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.83%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:bottom;width:39.2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.83%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Retained</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.01%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Noncontrolling</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Stockholders’</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.85%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Interests</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.83%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Retained</b></p></td></tr><tr><td style="vertical-align:bottom;width:39.2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">    </b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.83%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Earnings</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">    </b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.01%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Interests</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">    </b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.37%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Equity</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">    </b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.85%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">(Temporary Equity)</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.83%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Earnings</b></p></td></tr><tr><td style="vertical-align:bottom;width:39.2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">As Previously Reported</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;"> </b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.83%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><b style="font-weight:bold;">  </b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.01%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;">  </p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;">  </p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.85%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;">  </p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.83%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:bottom;width:39.2%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Consolidation of equity method investment</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.83%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0pt 0pt;"> —</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.01%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0pt 0pt;"> 16,838</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.37%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0pt 0pt;"> 16,838</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.85%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0pt 0pt;"> —</p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.06%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.83%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0pt 0pt;"> —</p></td></tr><tr><td style="vertical-align:bottom;width:39.2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Net income (loss)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.83%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (10,510)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.01%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (352)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (10,862)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.85%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0pt 0pt;"> —</p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.83%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0pt 0pt;"> —</p></td></tr><tr><td style="vertical-align:bottom;width:39.2%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Adjustment to redemption value</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.83%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0pt 0pt;"> —</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.01%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0pt 0pt;"> —</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.37%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0pt 0pt;"> —</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.85%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0pt 0pt;"> —</p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.06%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.83%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0pt 0pt;"> —</p></td></tr><tr><td style="vertical-align:bottom;width:39.2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Balances, March 31, 2021</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.83%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0pt 0pt;"> 4,820</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.01%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0pt 0pt;"> 22,978</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0pt 0pt;"> 351,061</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.85%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0pt 0pt;"> —</p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.83%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0pt 0pt;"> —</p></td></tr><tr><td style="vertical-align:bottom;width:39.2%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Adjustments</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;"> </b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.83%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;">  </p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.01%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;">  </p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.37%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;">  </p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.85%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;">  </p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.06%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.83%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:bottom;width:39.2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Consolidation of equity method investment</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.83%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0pt 0pt;"> —</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.01%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (16,838)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (16,838)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.85%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0pt 0pt;"> 16,838</p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.83%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0pt 0pt;"> —</p></td></tr><tr><td style="vertical-align:bottom;width:39.2%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Net income (loss)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.83%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0pt 0pt;"> —</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.01%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0pt 0pt;"> 263</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.37%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0pt 0pt;"> 263</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.85%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (263)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.06%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.83%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (10,862)</p></td></tr><tr><td style="vertical-align:bottom;width:39.2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Adjustment to redemption value</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.83%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (344)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.01%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0pt 0pt;"> —</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (344)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.85%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0pt 0pt;"> 344</p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.83%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0pt 0pt;"> —</p></td></tr><tr><td style="vertical-align:bottom;width:39.2%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Balances, March 31, 2021</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.83%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (344)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.01%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (16,575)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.37%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (16,919)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.85%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0pt 0pt;"> 16,919</p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.06%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.83%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0pt 0pt;"> —</p></td></tr><tr><td style="vertical-align:bottom;width:39.2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">As Restated</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;"> </b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.83%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;">  </p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.01%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;">  </p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;">  </p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.85%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;">  </p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.83%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:bottom;width:39.2%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Consolidation of equity method investment</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.83%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0pt 0pt;"> —</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.01%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0pt 0pt;"> —</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.37%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0pt 0pt;"> —</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.85%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0pt 0pt;"> 16,838</p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.06%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.83%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0pt 0pt;"> —</p></td></tr><tr><td style="vertical-align:bottom;width:39.2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Net income (loss)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.83%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (10,510)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.01%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (89)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (10,599)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.85%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (263)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.83%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (10,862)</p></td></tr><tr><td style="vertical-align:bottom;width:39.2%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Adjustment to redemption value</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.83%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (344)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.01%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0pt 0pt;"> —</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.37%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (344)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.85%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0pt 0pt;"> 344</p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.06%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.83%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0pt 0pt;"> —</p></td></tr><tr><td style="vertical-align:bottom;width:39.2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Balances, March 31, 2021</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:11pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.83%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0pt 0pt;"> 4,476</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.01%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0pt 0pt;"> 6,403</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0pt 0pt;"> 334,142</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.85%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0pt 0pt;"> 16,919</p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.83%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0pt 0pt;"> —</p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"><span style="visibility:hidden;">​</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">The effect of the restatement on the consolidated statement of stockholders’ equity for the nine months ended March 31, 2021 is as follows (<i style="font-style:italic;">in thousands</i>):</p><table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;width:96.56%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:39.2%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:7.83%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:11.01%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:12.37%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:14.85%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:0.06%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:7.83%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:39.2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.83%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.01%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.85%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Redeemable</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.83%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:bottom;width:39.2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.83%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.01%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Total Permanent</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.85%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Noncontrolling</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.83%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:bottom;width:39.2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.83%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Retained</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.01%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Noncontrolling</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Stockholders’</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.85%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Interests</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.83%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Retained</b></p></td></tr><tr><td style="vertical-align:bottom;width:39.2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">    </b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.83%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Earnings</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">    </b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.01%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Interests</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">    </b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.37%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Equity</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">    </b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.85%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">(Temporary Equity)</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.83%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Earnings</b></p></td></tr><tr><td style="vertical-align:bottom;width:39.2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">As Previously Reported</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;"> </b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.83%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">  </b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.01%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;">  </p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;">  </p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.85%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;">  </p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.83%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:bottom;width:39.2%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Consolidation of equity method investment</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.83%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0.05pt 0pt;"> —</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.01%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0.05pt 0pt;"> 16,838</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.37%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0.05pt 0pt;"> 16,838</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.85%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0.05pt 0pt;"> —</p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.06%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.83%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0.05pt 0pt;"> —</p></td></tr><tr><td style="vertical-align:bottom;width:39.2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Net income (loss)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.83%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (50,460)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.01%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (595)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (51,055)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.85%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0.05pt 0pt;"> —</p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.83%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0.05pt 0pt;"> —</p></td></tr><tr><td style="vertical-align:bottom;width:39.2%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Adjustment to redemption value</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.83%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0.05pt 0pt;"> —</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.01%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0.05pt 0pt;"> —</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.37%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0.05pt 0pt;"> —</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.85%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0.05pt 0pt;"> —</p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.06%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.83%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0.05pt 0pt;"> —</p></td></tr><tr><td style="vertical-align:bottom;width:39.2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Balances, March 31, 2021</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.83%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0.05pt 0pt;"> 4,820</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.01%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0.05pt 0pt;"> 22,978</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0.05pt 0pt;"> 351,061</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.85%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0.05pt 0pt;"> —</p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.83%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0.05pt 0pt;"> —</p></td></tr><tr><td style="vertical-align:bottom;width:39.2%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Adjustments</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;"> </b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.83%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;">  </p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.01%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;">  </p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.37%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;">  </p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.85%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;">  </p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.06%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.83%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:bottom;width:39.2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Consolidation of equity method investment</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.83%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0.05pt 0pt;"> —</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.01%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (16,838)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (16,838)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.85%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0.05pt 0pt;"> 16,838</p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.83%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0.05pt 0pt;"> —</p></td></tr><tr><td style="vertical-align:bottom;width:39.2%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Net income (loss)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.83%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0.05pt 0pt;"> —</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.01%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0.05pt 0pt;"> 263</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.37%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0.05pt 0pt;"> 263</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.85%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (263)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.06%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.83%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (51,055)</p></td></tr><tr><td style="vertical-align:bottom;width:39.2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Adjustment to redemption value</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.83%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (344)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.01%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0.05pt 0pt;"> —</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (344)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.85%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0.05pt 0pt;"> 344</p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.83%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0.05pt 0pt;"> —</p></td></tr><tr><td style="vertical-align:bottom;width:39.2%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Balances, March 31, 2021</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.83%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (344)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.01%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (16,575)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.37%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (16,919)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.85%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0.05pt 0pt;"> 16,919</p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.06%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.83%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0.05pt 0pt;"> —</p></td></tr><tr><td style="vertical-align:bottom;width:39.2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">As Restated</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;"> </b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.83%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;">  </p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.01%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;">  </p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;">  </p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.85%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;">  </p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.83%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:bottom;width:39.2%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Consolidation of equity method investment</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.83%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0.05pt 0pt;"> —</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.01%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0.05pt 0pt;"> —</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.37%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0.05pt 0pt;"> —</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.85%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0.05pt 0pt;"> 16,838</p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.06%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.83%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0.05pt 0pt;"> —</p></td></tr><tr><td style="vertical-align:bottom;width:39.2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Net income (loss)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.83%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (50,460)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.01%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (332)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (50,792)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.85%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (263)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.83%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (51,055)</p></td></tr><tr><td style="vertical-align:bottom;width:39.2%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Adjustment to redemption value</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.83%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (344)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.01%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0.05pt 0pt;"> —</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.37%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (344)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.85%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0.05pt 0pt;"> 344</p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.06%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.83%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0.05pt 0pt;"> —</p></td></tr><tr><td style="vertical-align:bottom;width:39.2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Balances, March 31, 2021</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:11pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.83%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0.05pt 0pt;"> 4,476</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.01%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0.05pt 0pt;"> 6,403</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0.05pt 0pt;"> 334,142</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.85%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0.05pt 0pt;"> 16,919</p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.83%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0.05pt 0pt;"> —</p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;padding-left:54pt;text-indent:-54pt;margin:0pt 0pt 12pt 0pt;">Property and Equipment</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:18pt;margin:0pt;">Property and equipment were comprised of the following as of March 31, 2022 and June 30, 2021:</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 0pt 33.85pt;"><span style="margin-bottom:12pt;margin-left:0pt;visibility:hidden;">​</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:77.14%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:53.03%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.13%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:13.87%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.13%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.45%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:12.74%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.13%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.34%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:11.05%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:0.08%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:53.03%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.13%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">    </b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Estimated</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.13%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">    </b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.45%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.74%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.13%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">    </b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.08%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:53.03%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><i style="font-style:italic;">dollars in thousands</i></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.13%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.87%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Useful Lives</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.13%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:14.19%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">March 31, 2022</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.13%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:12.4%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">June 30, 2021</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.08%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:top;width:53.03%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Land</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.13%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.87%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;">N/A</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.13%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.45%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.74%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0pt 0pt;"> 11,980</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.13%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.34%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.05%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0pt 0pt;"> 11,980</p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.08%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:top;width:53.03%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Buildings and leasehold improvements</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.13%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;">10 - 40 years</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.13%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.45%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.74%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0pt 0pt;"> 121,661</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.13%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0pt 0pt;"> 104,724</p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.08%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:top;width:53.03%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Software</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.13%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.87%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;">3 - 5 years</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.13%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.45%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.74%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0pt 0pt;"> 15,107</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.13%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.34%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.05%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0pt 0pt;"> 13,316</p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.08%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:top;width:53.03%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Equipment and vehicles</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.13%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;">3 - 7 years</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.13%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.45%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.74%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0pt 0pt;"> 46,655</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.13%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0pt 0pt;"> 35,341</p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.08%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:top;width:53.03%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Construction in progress</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.13%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.87%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;">N/A</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.13%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.45%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.74%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0pt 0pt;"> 22,336</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.13%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.34%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.05%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0pt 0pt;"> 22,130</p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.08%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:top;width:53.03%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.13%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.13%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.45%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.74%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0pt 0pt;"> 217,739</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.13%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0pt 0pt;"> 187,491</p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.08%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:top;width:53.03%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Less accumulated depreciation and amortization</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.13%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.87%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.13%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.45%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.74%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (53,857)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.13%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.34%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.05%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (44,776)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.08%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:top;width:53.03%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 12pt;">Total property and equipment, net</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.13%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.13%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.45%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.74%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0pt 0pt;"> 163,882</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.13%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.34%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.05%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0pt 0pt;"> 142,715</p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.08%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:18pt;margin:12pt 0pt 12pt 0pt;">Depreciation of $3.8 million and $3.2 million was recorded during the three months ended March 31, 2022 and 2021, respectively. Depreciation of $9.9 million and $8.8 million was recorded during the nine months ended March 31, 2022 and 2021, respectively. </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;padding-left:54pt;text-indent:-54pt;margin:0pt 0pt 12pt 0pt;">Coronavirus Pandemic (“COVID-19”)</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">As a PACE organization, we have been and will continue to be impacted by the effects of COVID-19. We closed all our centers in March 2020 and transitioned to a 100% in-home and virtual care model. We believe that the general lack of in-person interaction and the reduction in healthcare personnel, and specifically, trained personnel, impacted our ability to adhere to the complex government laws and regulations that apply to our business. We remain committed to carrying out our mission of caring for our participants. We continue to closely monitor the impact of COVID-19 on all aspects of our business, including the impacts to our employees, participants and suppliers. Due to the numerous evolving factors, we are unable to reliably estimate the ultimate impact the pandemic will have on our consolidated financial condition, results of operations or cash flows.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">On March 27, 2020, the Coronavirus Aid, Relief, and Economic Security Act (“CARES Act”) was signed into legislation. Under the CARES Act, the state of Pennsylvania signed into law the Act 24 of 2020. We received $1.0 million in funding under the Act 24 of 2020, which was allocated to InnovAge centers in Pennsylvania. Of the $1.0 million, $0.7 million was recognized prior June 30, 2020 and the remaining balance of $0.3 million was recognized during the year ended June 30, 2021. The CARES Act also provides for the temporary suspension of the automatic 2% reduction of Medicare claim reimbursements (sequestration) for the period of May 1, 2020 through December 31, 2020. The Consolidated Appropriations Act, 2021, enacted December 27, 2020, extended this suspension for three more months, through March 31, 2021.  H.R. 1868, enacted on April 14, 2021 further extends the suspension through December 31, 2021. On December 10, 2021 the “Protecting Medicare and American Farmers from Sequester Cuts Act” extends the 2% Medicare sequester moratorium through March 31, 2022, and adjusts the sequester to 1% between April 1, 2022 and June 30, 2022.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;padding-left:54pt;text-indent:-54pt;margin:0pt 0pt 12pt 0pt;">Recently Adopted Accounting Pronouncements</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:36pt;text-align:justify;text-indent:-36pt;margin:0pt 0pt 12pt 0pt;"><span style="font-style:italic;font-weight:bold;">Income Taxes</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">In December 2019, the Financial Accounting Standards Board (“FASB”) issued ASU 2019-12, <i style="font-style:italic;">Income Taxes Topic 740-Simplifying the Accounting for Income Taxes </i>(“ASU 2019-12”), which intended to simplify various aspects related to accounting for income taxes. ASU 2019-12 removes certain exceptions to the general principles in Topic 740 and also clarifies and amends existing guidance to improve consistent application of Topic 740. This guidance is effective for companies with fiscal years beginning after December 15, 2020, including interim periods therein, and early adoption is permitted. The Company adopted ASU 2019-12 during the quarter ended September 30, 2021 and it did not have a material effect on the Company’s condensed consolidated financial statements.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;padding-left:54pt;text-indent:-54pt;margin:0pt 0pt 12pt 0pt;">Recent Accounting Pronouncements Not Yet Adopted</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;padding-left:54pt;text-indent:-54pt;margin:0pt 0pt 12pt 0pt;">Leases</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">In February 2016, the FASB issued ASU 2016-02 <i style="font-style:italic;">Leases</i> (“ASU 2016-02”), which was intended to increase transparency and comparability among organizations by recognizing lease assets and liabilities on the balance sheet and disclosing key information about leasing arrangements. Under the new guidance, lessees will be required to recognize a right-of-use asset and a lease liability, measured on a discounted basis, at the commencement date for all leases with terms greater than 12 months. Additionally, this guidance will require disclosures to help investors and other financial statement users to better understand the amount, timing, and uncertainty of cash flows arising from leases, including qualitative and quantitative requirements. The guidance should be applied under a modified retrospective transition approach for leases existing at the beginning of the earliest comparative period presented in the adoption-period financial statements. Any leases that expire before the initial application date will not require any accounting adjustment. In June 2020, FASB issued ASU 2020-05 <i style="font-style:italic;">Revenue from contracts with customers (Topic 606) and leases (Topic 842)—Effective dates for certain entities</i> which deferred the new lease standard effective date for the Company to December 15, 2022, with early adoption permitted. The Company will adopt this ASU in the fiscal year beginning July 1, 2022 and has not yet determined the effect of the standard on its ongoing financial reporting.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:36pt;text-align:justify;text-indent:-36pt;margin:0pt 0pt 12pt 0pt;"><span style="font-style:italic;font-weight:bold;">Financial Instruments</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">In April 2019, the FASB issued ASU 2019-04, <i style="font-style:italic;">Codification Improvements to Topic 326, Financial Instruments—Credit Losses, Topic 815, Derivatives and Hedging, and Topic 825, Financial Instruments (</i>“ASU 2019-04”<i style="font-style:italic;">)</i>, which requires entities to use a current expected credit loss (“CECL”) model to measure impairment for most financial assets that are not recorded at fair value through net income. Under the CECL model, an entity will estimate lifetime expected credit losses considering available relevant information about historical events, current conditions and supportable forecasts. The CECL model does not apply to available-for-sale debt securities. This guidance also expands the required credit loss disclosures and will be applied using a modified retrospective approach by recording a cumulative effect adjustment to retained earnings as of the beginning of the fiscal year of adoption. ASU 2019-04 is effective for the Company for fiscal years beginning after December 15, 2022, including interim periods within those fiscal years. The Company will adopt this guidance for the annual and interim reporting periods beginning July 1, 2023. The Company has not determined the effect of the standard on its condensed consolidated financial statements.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:18pt;margin:0pt;">We do not expect that any other recently issued accounting guidance will have a significant effect on our condensed consolidated financial statements.</p> <p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;padding-left:54pt;text-indent:-54pt;margin:0pt 0pt 12pt 0pt;">Basis of Preparation and Principles of Consolidation</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:18pt;margin:0pt;">The unaudited interim condensed consolidated financial statements and accompanying notes have been prepared in accordance with accounting principles generally accepted in the U.S. (“U.S. GAAP”) for interim financial information and with the instructions to Form 10-Q and Article 10 of Regulation S-X. Accordingly, certain information and footnote disclosures normally included in financial statements prepared in accordance with U.S. GAAP have been omitted pursuant to such regulations. These financial statements have been prepared on a basis consistent with the accounting principles applied for the fiscal year ended June 30, 2021. In the opinion of management, all adjustments (consisting of all normal and recurring adjustments) considered necessary for a fair presentation have been included. The condensed consolidated financial statements include the accounts of InnovAge, its wholly owned subsidiaries, variable interest entities (“VIEs”) </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">for which it is the primary beneficiary and entities for which it has a controlling interest. All intercompany accounts and transactions have been eliminated in consolidation.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">The Company does not have any components of comprehensive income and comprehensive income is equal to net income reported in the statements of operations for all periods presented.</p> <p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;"><span style="font-style:italic;font-weight:bold;">Restatement of Prior Period Financial Statements</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:18pt;margin:0pt 9pt 0pt 0pt;">Subsequent to the issuance of the Company’s consolidated financial statements as of and for the year ended June 30, 2021, we identified an error in our consolidated balance sheet and statement of stockholders’ equity as of June 30, 2021 related to the presentation of redeemable noncontrolling interests. Additionally, the error also impacted our condensed consolidated statements of shareholders’ equity for the three months and nine-months ended March 31, 2021. The Company incorrectly recorded redeemable noncontrolling interests of $17.0 million and $16.9 million as permanent equity rather than <span style="-sec-ix-hidden:Hidden_0tELu_FnUEigG2js346PFQ;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">temporary</span></span> <span style="-sec-ix-hidden:Hidden_2bM5XwY1D0WaUp80sEX8og;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">equity</span></span> as of June 30, 2021 and March 31, 2021, respectively.  As a result, the Company restated the June 30, 2021 and March 31, 2021 condensed consolidated financial statements to reflect this reclassification from permanent to temporary equity and to record the related adjustments to redemption value as of June 30, 2021 and March 31, 2021. Management has evaluated the materiality of this misstatement and concluded that it is not material to the prior period. </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:18pt;margin:0pt 9pt 0pt 0pt;"><span style="margin-right:0pt;visibility:hidden;">​</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 9.35pt 0pt 0pt;">The effect of the restatement on the consolidated balance sheet as of June 30, 2021 is as follows (<i style="font-style:italic;">in thousands</i>):</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:77.14%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:58.54%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.13%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:12.52%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.13%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:11.64%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.13%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:10.87%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:58.54%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.13%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.52%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">As Previously</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.13%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.13%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:bottom;width:58.54%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.13%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">    </b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.52%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Reported</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.13%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">    </b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.64%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Adjustments</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.13%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">    </b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.87%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">As Restated</b></p></td></tr><tr><td style="vertical-align:bottom;width:58.54%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">Redeemable Noncontrolling Interests (See Note 4)</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.13%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.52%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0pt 0pt;"> —</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.13%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0pt 0pt;"> 16,986</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.13%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.87%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0pt 0pt;"> 16,986</p></td></tr><tr><td style="vertical-align:bottom;width:58.54%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Retained earnings</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.13%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.52%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0pt 0pt;"> 11,250</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.13%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (587)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.13%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0pt 0pt;"> 10,663</p></td></tr><tr><td style="vertical-align:bottom;width:58.54%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Total InnovAge Holding Corp.</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.13%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.52%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0pt 0pt;"> 335,146</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.13%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (587)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.13%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.87%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0pt 0pt;"> 334,559</p></td></tr><tr><td style="vertical-align:bottom;width:58.54%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Noncontrolling interests</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.13%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.52%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0pt 0pt;"> 22,819</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.13%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (16,399)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.13%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0pt 0pt;"> 6,420</p></td></tr><tr><td style="vertical-align:bottom;width:58.54%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Total stockholders’ equity</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.13%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.52%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0pt 0pt;"> 357,965</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.13%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (16,986)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.13%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.87%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0pt 0pt;"> 340,979</p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"><span style="visibility:hidden;">​</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:18pt;margin:0pt;">The effect of the restatement on the balances as of June 30, 2021 included in the consolidated statement of stockholders’ equity as of March 31, 2022 is as follows (<i style="font-style:italic;">in thousands</i>):</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:18pt;margin:0pt;"><span style="visibility:hidden;">​</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:47.68%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:7.19%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:11.02%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:12.39%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:14.87%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:47.68%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.19%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.02%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.39%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Redeemable</b></p></td></tr><tr><td style="vertical-align:bottom;width:47.68%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.19%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.02%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.39%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Total Permanent</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Noncontrolling</b></p></td></tr><tr><td style="vertical-align:bottom;width:47.68%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.19%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Retained</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.02%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Noncontrolling</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.39%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Stockholders’</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Interests</b></p></td></tr><tr><td style="vertical-align:bottom;width:47.68%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">    </b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.19%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Earnings</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">    </b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.02%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Interests</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">    </b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.39%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Equity</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">    </b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.87%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">(Temporary Equity)</b></p></td></tr><tr><td style="vertical-align:bottom;width:47.68%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">As Previously Reported</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;"> </b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.19%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><b style="font-weight:bold;">  </b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.02%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;">  </p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.39%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;">  </p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.87%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;">  </p></td></tr><tr><td style="vertical-align:bottom;width:47.68%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Balances, June 30, 2021</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.19%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0pt 0pt;"> 11,250</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.02%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0pt 0pt;"> 22,819</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.39%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0pt 0pt;"> 357,965</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0pt 0pt;"> —</p></td></tr><tr><td style="vertical-align:bottom;width:47.68%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Adjustments</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;"> </b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.19%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><b style="font-weight:bold;">  </b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.02%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;">  </p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.39%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;">  </p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.87%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;">  </p></td></tr><tr><td style="vertical-align:bottom;width:47.68%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Balances, June 30, 2021</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.19%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (587)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.02%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (16,399)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.39%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (16,986)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0pt 0pt;"> 16,986</p></td></tr><tr><td style="vertical-align:bottom;width:47.68%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">As Restated</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;"> </b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.19%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><b style="font-weight:bold;">  </b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.02%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;">  </p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.39%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;">  </p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.87%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;">  </p></td></tr><tr><td style="vertical-align:bottom;width:47.68%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Balances, June 30, 2021</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.19%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0pt 0pt;"> 10,663</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.02%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0pt 0pt;"> 6,420</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.39%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0pt 0pt;"> 340,979</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0pt 0pt;"> 16,986</p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:18pt;margin:0pt;"><span style="visibility:hidden;">​</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">The effect of the restatement on the consolidated statement of stockholders’ equity for the three months ended March 31, 2021 is as follows (<i style="font-style:italic;">in thousands</i>):</p><table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;width:96.56%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:39.2%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:7.83%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:11.01%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:12.37%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:14.85%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:0.06%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:7.83%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:39.2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.83%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.01%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.85%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Redeemable</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.83%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:bottom;width:39.2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.83%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.01%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Total Permanent</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.85%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Noncontrolling</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.83%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:bottom;width:39.2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.83%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Retained</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.01%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Noncontrolling</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Stockholders’</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.85%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Interests</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.83%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Retained</b></p></td></tr><tr><td style="vertical-align:bottom;width:39.2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">    </b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.83%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Earnings</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">    </b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.01%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Interests</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">    </b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.37%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Equity</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">    </b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.85%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">(Temporary Equity)</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.83%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Earnings</b></p></td></tr><tr><td style="vertical-align:bottom;width:39.2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">As Previously Reported</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;"> </b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.83%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><b style="font-weight:bold;">  </b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.01%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;">  </p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;">  </p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.85%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;">  </p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.83%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:bottom;width:39.2%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Consolidation of equity method investment</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.83%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0pt 0pt;"> —</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.01%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0pt 0pt;"> 16,838</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.37%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0pt 0pt;"> 16,838</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.85%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0pt 0pt;"> —</p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.06%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.83%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0pt 0pt;"> —</p></td></tr><tr><td style="vertical-align:bottom;width:39.2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Net income (loss)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.83%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (10,510)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.01%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (352)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (10,862)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.85%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0pt 0pt;"> —</p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.83%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0pt 0pt;"> —</p></td></tr><tr><td style="vertical-align:bottom;width:39.2%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Adjustment to redemption value</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.83%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0pt 0pt;"> —</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.01%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0pt 0pt;"> —</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.37%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0pt 0pt;"> —</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.85%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0pt 0pt;"> —</p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.06%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.83%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0pt 0pt;"> —</p></td></tr><tr><td style="vertical-align:bottom;width:39.2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Balances, March 31, 2021</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.83%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0pt 0pt;"> 4,820</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.01%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0pt 0pt;"> 22,978</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0pt 0pt;"> 351,061</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.85%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0pt 0pt;"> —</p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.83%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0pt 0pt;"> —</p></td></tr><tr><td style="vertical-align:bottom;width:39.2%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Adjustments</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;"> </b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.83%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;">  </p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.01%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;">  </p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.37%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;">  </p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.85%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;">  </p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.06%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.83%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:bottom;width:39.2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Consolidation of equity method investment</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.83%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0pt 0pt;"> —</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.01%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (16,838)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (16,838)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.85%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0pt 0pt;"> 16,838</p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.83%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0pt 0pt;"> —</p></td></tr><tr><td style="vertical-align:bottom;width:39.2%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Net income (loss)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.83%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0pt 0pt;"> —</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.01%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0pt 0pt;"> 263</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.37%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0pt 0pt;"> 263</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.85%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (263)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.06%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.83%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (10,862)</p></td></tr><tr><td style="vertical-align:bottom;width:39.2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Adjustment to redemption value</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.83%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (344)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.01%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0pt 0pt;"> —</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (344)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.85%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0pt 0pt;"> 344</p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.83%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0pt 0pt;"> —</p></td></tr><tr><td style="vertical-align:bottom;width:39.2%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Balances, March 31, 2021</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.83%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (344)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.01%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (16,575)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.37%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (16,919)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.85%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0pt 0pt;"> 16,919</p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.06%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.83%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0pt 0pt;"> —</p></td></tr><tr><td style="vertical-align:bottom;width:39.2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">As Restated</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;"> </b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.83%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;">  </p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.01%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;">  </p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;">  </p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.85%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;">  </p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.83%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:bottom;width:39.2%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Consolidation of equity method investment</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.83%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0pt 0pt;"> —</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.01%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0pt 0pt;"> —</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.37%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0pt 0pt;"> —</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.85%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0pt 0pt;"> 16,838</p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.06%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.83%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0pt 0pt;"> —</p></td></tr><tr><td style="vertical-align:bottom;width:39.2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Net income (loss)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.83%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (10,510)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.01%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (89)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (10,599)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.85%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (263)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.83%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (10,862)</p></td></tr><tr><td style="vertical-align:bottom;width:39.2%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Adjustment to redemption value</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.83%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (344)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.01%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0pt 0pt;"> —</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.37%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (344)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.85%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0pt 0pt;"> 344</p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.06%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.83%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0pt 0pt;"> —</p></td></tr><tr><td style="vertical-align:bottom;width:39.2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Balances, March 31, 2021</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:11pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.83%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0pt 0pt;"> 4,476</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.01%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0pt 0pt;"> 6,403</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0pt 0pt;"> 334,142</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.85%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0pt 0pt;"> 16,919</p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.83%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0pt 0pt;"> —</p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"><span style="visibility:hidden;">​</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">The effect of the restatement on the consolidated statement of stockholders’ equity for the nine months ended March 31, 2021 is as follows (<i style="font-style:italic;">in thousands</i>):</p><table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;width:96.56%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:39.2%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:7.83%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:11.01%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:12.37%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:14.85%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:0.06%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:7.83%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:39.2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.83%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.01%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.85%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Redeemable</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.83%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:bottom;width:39.2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.83%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.01%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Total Permanent</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.85%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Noncontrolling</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.83%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:bottom;width:39.2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.83%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Retained</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.01%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Noncontrolling</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Stockholders’</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.85%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Interests</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.83%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Retained</b></p></td></tr><tr><td style="vertical-align:bottom;width:39.2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">    </b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.83%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Earnings</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">    </b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.01%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Interests</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">    </b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.37%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Equity</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">    </b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.85%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">(Temporary Equity)</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.83%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Earnings</b></p></td></tr><tr><td style="vertical-align:bottom;width:39.2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">As Previously Reported</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;"> </b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.83%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">  </b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.01%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;">  </p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;">  </p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.85%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;">  </p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.83%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:bottom;width:39.2%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Consolidation of equity method investment</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.83%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0.05pt 0pt;"> —</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.01%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0.05pt 0pt;"> 16,838</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.37%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0.05pt 0pt;"> 16,838</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.85%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0.05pt 0pt;"> —</p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.06%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.83%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0.05pt 0pt;"> —</p></td></tr><tr><td style="vertical-align:bottom;width:39.2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Net income (loss)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.83%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (50,460)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.01%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (595)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (51,055)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.85%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0.05pt 0pt;"> —</p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.83%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0.05pt 0pt;"> —</p></td></tr><tr><td style="vertical-align:bottom;width:39.2%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Adjustment to redemption value</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.83%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0.05pt 0pt;"> —</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.01%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0.05pt 0pt;"> —</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.37%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0.05pt 0pt;"> —</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.85%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0.05pt 0pt;"> —</p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.06%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.83%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0.05pt 0pt;"> —</p></td></tr><tr><td style="vertical-align:bottom;width:39.2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Balances, March 31, 2021</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.83%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0.05pt 0pt;"> 4,820</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.01%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0.05pt 0pt;"> 22,978</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0.05pt 0pt;"> 351,061</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.85%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0.05pt 0pt;"> —</p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.83%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0.05pt 0pt;"> —</p></td></tr><tr><td style="vertical-align:bottom;width:39.2%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Adjustments</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;"> </b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.83%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;">  </p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.01%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;">  </p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.37%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;">  </p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.85%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;">  </p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.06%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.83%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:bottom;width:39.2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Consolidation of equity method investment</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.83%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0.05pt 0pt;"> —</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.01%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (16,838)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (16,838)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.85%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0.05pt 0pt;"> 16,838</p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.83%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0.05pt 0pt;"> —</p></td></tr><tr><td style="vertical-align:bottom;width:39.2%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Net income (loss)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.83%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0.05pt 0pt;"> —</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.01%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0.05pt 0pt;"> 263</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.37%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0.05pt 0pt;"> 263</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.85%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (263)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.06%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.83%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (51,055)</p></td></tr><tr><td style="vertical-align:bottom;width:39.2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Adjustment to redemption value</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.83%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (344)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.01%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0.05pt 0pt;"> —</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (344)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.85%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0.05pt 0pt;"> 344</p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.83%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0.05pt 0pt;"> —</p></td></tr><tr><td style="vertical-align:bottom;width:39.2%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Balances, March 31, 2021</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.83%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (344)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.01%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (16,575)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.37%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (16,919)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.85%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0.05pt 0pt;"> 16,919</p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.06%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.83%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0.05pt 0pt;"> —</p></td></tr><tr><td style="vertical-align:bottom;width:39.2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">As Restated</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;"> </b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.83%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;">  </p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.01%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;">  </p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;">  </p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.85%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;">  </p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.83%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:bottom;width:39.2%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Consolidation of equity method investment</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.83%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0.05pt 0pt;"> —</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.01%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0.05pt 0pt;"> —</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.37%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0.05pt 0pt;"> —</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.85%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0.05pt 0pt;"> 16,838</p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.06%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.83%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0.05pt 0pt;"> —</p></td></tr><tr><td style="vertical-align:bottom;width:39.2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Net income (loss)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.83%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (50,460)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.01%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (332)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (50,792)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.85%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (263)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.83%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (51,055)</p></td></tr><tr><td style="vertical-align:bottom;width:39.2%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Adjustment to redemption value</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.83%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (344)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.01%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0.05pt 0pt;"> —</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.37%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (344)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.85%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0.05pt 0pt;"> 344</p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.06%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.83%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0.05pt 0pt;"> —</p></td></tr><tr><td style="vertical-align:bottom;width:39.2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Balances, March 31, 2021</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:11pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.83%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0.05pt 0pt;"> 4,476</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.01%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0.05pt 0pt;"> 6,403</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0.05pt 0pt;"> 334,142</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.85%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0.05pt 0pt;"> 16,919</p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.83%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0.05pt 0pt;"> —</p></td></tr></table> -17000000.0 -16900000 <table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:77.14%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:58.54%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.13%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:12.52%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.13%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:11.64%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.13%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:10.87%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:58.54%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.13%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.52%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">As Previously</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.13%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.13%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:bottom;width:58.54%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.13%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">    </b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.52%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Reported</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.13%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">    </b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.64%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Adjustments</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.13%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">    </b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.87%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">As Restated</b></p></td></tr><tr><td style="vertical-align:bottom;width:58.54%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">Redeemable Noncontrolling Interests (See Note 4)</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.13%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.52%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0pt 0pt;"> —</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.13%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0pt 0pt;"> 16,986</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.13%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.87%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0pt 0pt;"> 16,986</p></td></tr><tr><td style="vertical-align:bottom;width:58.54%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Retained earnings</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.13%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.52%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0pt 0pt;"> 11,250</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.13%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (587)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.13%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0pt 0pt;"> 10,663</p></td></tr><tr><td style="vertical-align:bottom;width:58.54%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Total InnovAge Holding Corp.</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.13%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.52%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0pt 0pt;"> 335,146</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.13%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (587)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.13%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.87%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0pt 0pt;"> 334,559</p></td></tr><tr><td style="vertical-align:bottom;width:58.54%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Noncontrolling interests</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.13%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.52%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0pt 0pt;"> 22,819</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.13%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (16,399)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.13%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0pt 0pt;"> 6,420</p></td></tr><tr><td style="vertical-align:bottom;width:58.54%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Total stockholders’ equity</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.13%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.52%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0pt 0pt;"> 357,965</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.13%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (16,986)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.13%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.87%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0pt 0pt;"> 340,979</p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"><span style="visibility:hidden;">​</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:18pt;margin:0pt;">The effect of the restatement on the balances as of June 30, 2021 included in the consolidated statement of stockholders’ equity as of March 31, 2022 is as follows (<i style="font-style:italic;">in thousands</i>):</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:18pt;margin:0pt;"><span style="visibility:hidden;">​</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:47.68%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:7.19%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:11.02%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:12.39%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:14.87%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:47.68%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.19%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.02%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.39%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Redeemable</b></p></td></tr><tr><td style="vertical-align:bottom;width:47.68%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.19%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.02%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.39%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Total Permanent</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Noncontrolling</b></p></td></tr><tr><td style="vertical-align:bottom;width:47.68%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.19%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Retained</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.02%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Noncontrolling</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.39%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Stockholders’</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Interests</b></p></td></tr><tr><td style="vertical-align:bottom;width:47.68%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">    </b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.19%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Earnings</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">    </b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.02%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Interests</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">    </b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.39%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Equity</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">    </b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.87%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">(Temporary Equity)</b></p></td></tr><tr><td style="vertical-align:bottom;width:47.68%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">As Previously Reported</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;"> </b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.19%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><b style="font-weight:bold;">  </b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.02%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;">  </p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.39%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;">  </p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.87%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;">  </p></td></tr><tr><td style="vertical-align:bottom;width:47.68%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Balances, June 30, 2021</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.19%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0pt 0pt;"> 11,250</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.02%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0pt 0pt;"> 22,819</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.39%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0pt 0pt;"> 357,965</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0pt 0pt;"> —</p></td></tr><tr><td style="vertical-align:bottom;width:47.68%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Adjustments</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;"> </b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.19%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><b style="font-weight:bold;">  </b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.02%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;">  </p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.39%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;">  </p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.87%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;">  </p></td></tr><tr><td style="vertical-align:bottom;width:47.68%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Balances, June 30, 2021</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.19%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (587)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.02%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (16,399)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.39%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (16,986)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0pt 0pt;"> 16,986</p></td></tr><tr><td style="vertical-align:bottom;width:47.68%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">As Restated</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;"> </b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.19%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><b style="font-weight:bold;">  </b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.02%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;">  </p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.39%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;">  </p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.87%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;">  </p></td></tr><tr><td style="vertical-align:bottom;width:47.68%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Balances, June 30, 2021</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.19%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0pt 0pt;"> 10,663</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.02%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0pt 0pt;"> 6,420</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.39%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0pt 0pt;"> 340,979</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0pt 0pt;"> 16,986</p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:18pt;margin:0pt;"><span style="visibility:hidden;">​</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">The effect of the restatement on the consolidated statement of stockholders’ equity for the three months ended March 31, 2021 is as follows (<i style="font-style:italic;">in thousands</i>):</p><table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;width:96.56%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:39.2%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:7.83%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:11.01%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:12.37%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:14.85%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:0.06%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:7.83%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:39.2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.83%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.01%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.85%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Redeemable</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.83%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:bottom;width:39.2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.83%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.01%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Total Permanent</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.85%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Noncontrolling</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.83%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:bottom;width:39.2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.83%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Retained</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.01%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Noncontrolling</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Stockholders’</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.85%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Interests</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.83%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Retained</b></p></td></tr><tr><td style="vertical-align:bottom;width:39.2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">    </b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.83%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Earnings</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">    </b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.01%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Interests</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">    </b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.37%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Equity</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">    </b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.85%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">(Temporary Equity)</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.83%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Earnings</b></p></td></tr><tr><td style="vertical-align:bottom;width:39.2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">As Previously Reported</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;"> </b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.83%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><b style="font-weight:bold;">  </b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.01%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;">  </p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;">  </p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.85%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;">  </p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.83%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:bottom;width:39.2%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Consolidation of equity method investment</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.83%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0pt 0pt;"> —</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.01%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0pt 0pt;"> 16,838</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.37%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0pt 0pt;"> 16,838</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.85%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0pt 0pt;"> —</p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.06%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.83%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0pt 0pt;"> —</p></td></tr><tr><td style="vertical-align:bottom;width:39.2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Net income (loss)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.83%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (10,510)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.01%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (352)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (10,862)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.85%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0pt 0pt;"> —</p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.83%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0pt 0pt;"> —</p></td></tr><tr><td style="vertical-align:bottom;width:39.2%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Adjustment to redemption value</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.83%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0pt 0pt;"> —</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.01%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0pt 0pt;"> —</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.37%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0pt 0pt;"> —</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.85%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0pt 0pt;"> —</p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.06%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.83%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0pt 0pt;"> —</p></td></tr><tr><td style="vertical-align:bottom;width:39.2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Balances, March 31, 2021</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.83%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0pt 0pt;"> 4,820</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.01%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0pt 0pt;"> 22,978</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0pt 0pt;"> 351,061</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.85%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0pt 0pt;"> —</p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.83%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0pt 0pt;"> —</p></td></tr><tr><td style="vertical-align:bottom;width:39.2%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Adjustments</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;"> </b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.83%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;">  </p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.01%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;">  </p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.37%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;">  </p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.85%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;">  </p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.06%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.83%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:bottom;width:39.2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Consolidation of equity method investment</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.83%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0pt 0pt;"> —</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.01%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (16,838)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (16,838)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.85%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0pt 0pt;"> 16,838</p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.83%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0pt 0pt;"> —</p></td></tr><tr><td style="vertical-align:bottom;width:39.2%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Net income (loss)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.83%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0pt 0pt;"> —</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.01%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0pt 0pt;"> 263</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.37%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0pt 0pt;"> 263</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.85%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (263)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.06%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.83%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (10,862)</p></td></tr><tr><td style="vertical-align:bottom;width:39.2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Adjustment to redemption value</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.83%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (344)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.01%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0pt 0pt;"> —</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (344)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.85%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0pt 0pt;"> 344</p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.83%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0pt 0pt;"> —</p></td></tr><tr><td style="vertical-align:bottom;width:39.2%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Balances, March 31, 2021</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.83%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (344)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.01%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (16,575)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.37%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (16,919)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.85%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0pt 0pt;"> 16,919</p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.06%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.83%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0pt 0pt;"> —</p></td></tr><tr><td style="vertical-align:bottom;width:39.2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">As Restated</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;"> </b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.83%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;">  </p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.01%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;">  </p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;">  </p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.85%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;">  </p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.83%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:bottom;width:39.2%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Consolidation of equity method investment</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.83%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0pt 0pt;"> —</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.01%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0pt 0pt;"> —</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.37%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0pt 0pt;"> —</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.85%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0pt 0pt;"> 16,838</p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.06%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.83%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0pt 0pt;"> —</p></td></tr><tr><td style="vertical-align:bottom;width:39.2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Net income (loss)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.83%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (10,510)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.01%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (89)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (10,599)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.85%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (263)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.83%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (10,862)</p></td></tr><tr><td style="vertical-align:bottom;width:39.2%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Adjustment to redemption value</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.83%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (344)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.01%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0pt 0pt;"> —</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.37%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (344)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.85%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0pt 0pt;"> 344</p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.06%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.83%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0pt 0pt;"> —</p></td></tr><tr><td style="vertical-align:bottom;width:39.2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Balances, March 31, 2021</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:11pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.83%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0pt 0pt;"> 4,476</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.01%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0pt 0pt;"> 6,403</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0pt 0pt;"> 334,142</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.85%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0pt 0pt;"> 16,919</p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.83%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0pt 0pt;"> —</p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"><span style="visibility:hidden;">​</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">The effect of the restatement on the consolidated statement of stockholders’ equity for the nine months ended March 31, 2021 is as follows (<i style="font-style:italic;">in thousands</i>):</p><table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;width:96.56%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:39.2%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:7.83%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:11.01%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:12.37%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:14.85%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:0.06%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:7.83%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:39.2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.83%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.01%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.85%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Redeemable</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.83%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:bottom;width:39.2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.83%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.01%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Total Permanent</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.85%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Noncontrolling</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.83%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:bottom;width:39.2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.83%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Retained</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.01%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Noncontrolling</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Stockholders’</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.85%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Interests</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.83%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Retained</b></p></td></tr><tr><td style="vertical-align:bottom;width:39.2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">    </b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.83%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Earnings</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">    </b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.01%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Interests</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">    </b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.37%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Equity</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">    </b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.85%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">(Temporary Equity)</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.83%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Earnings</b></p></td></tr><tr><td style="vertical-align:bottom;width:39.2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">As Previously Reported</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;"> </b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.83%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">  </b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.01%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;">  </p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;">  </p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.85%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;">  </p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.83%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:bottom;width:39.2%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Consolidation of equity method investment</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.83%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0.05pt 0pt;"> —</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.01%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0.05pt 0pt;"> 16,838</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.37%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0.05pt 0pt;"> 16,838</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.85%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0.05pt 0pt;"> —</p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.06%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.83%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0.05pt 0pt;"> —</p></td></tr><tr><td style="vertical-align:bottom;width:39.2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Net income (loss)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.83%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (50,460)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.01%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (595)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (51,055)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.85%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0.05pt 0pt;"> —</p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.83%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0.05pt 0pt;"> —</p></td></tr><tr><td style="vertical-align:bottom;width:39.2%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Adjustment to redemption value</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.83%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0.05pt 0pt;"> —</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.01%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0.05pt 0pt;"> —</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.37%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0.05pt 0pt;"> —</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.85%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0.05pt 0pt;"> —</p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.06%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.83%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0.05pt 0pt;"> —</p></td></tr><tr><td style="vertical-align:bottom;width:39.2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Balances, March 31, 2021</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.83%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0.05pt 0pt;"> 4,820</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.01%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0.05pt 0pt;"> 22,978</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0.05pt 0pt;"> 351,061</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.85%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0.05pt 0pt;"> —</p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.83%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0.05pt 0pt;"> —</p></td></tr><tr><td style="vertical-align:bottom;width:39.2%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Adjustments</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;"> </b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.83%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;">  </p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.01%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;">  </p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.37%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;">  </p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.85%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;">  </p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.06%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.83%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:bottom;width:39.2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Consolidation of equity method investment</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.83%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0.05pt 0pt;"> —</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.01%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (16,838)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (16,838)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.85%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0.05pt 0pt;"> 16,838</p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.83%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0.05pt 0pt;"> —</p></td></tr><tr><td style="vertical-align:bottom;width:39.2%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Net income (loss)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.83%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0.05pt 0pt;"> —</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.01%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0.05pt 0pt;"> 263</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.37%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0.05pt 0pt;"> 263</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.85%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (263)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.06%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.83%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (51,055)</p></td></tr><tr><td style="vertical-align:bottom;width:39.2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Adjustment to redemption value</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.83%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (344)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.01%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0.05pt 0pt;"> —</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (344)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.85%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0.05pt 0pt;"> 344</p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.83%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0.05pt 0pt;"> —</p></td></tr><tr><td style="vertical-align:bottom;width:39.2%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Balances, March 31, 2021</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.83%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (344)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.01%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (16,575)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.37%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (16,919)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.85%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0.05pt 0pt;"> 16,919</p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.06%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.83%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0.05pt 0pt;"> —</p></td></tr><tr><td style="vertical-align:bottom;width:39.2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">As Restated</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;"> </b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.83%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;">  </p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.01%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;">  </p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;">  </p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.85%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;">  </p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.83%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:bottom;width:39.2%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Consolidation of equity method investment</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.83%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0.05pt 0pt;"> —</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.01%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0.05pt 0pt;"> —</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.37%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0.05pt 0pt;"> —</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.85%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0.05pt 0pt;"> 16,838</p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.06%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.83%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0.05pt 0pt;"> —</p></td></tr><tr><td style="vertical-align:bottom;width:39.2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Net income (loss)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.83%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (50,460)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.01%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (332)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (50,792)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.85%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (263)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.83%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (51,055)</p></td></tr><tr><td style="vertical-align:bottom;width:39.2%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Adjustment to redemption value</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.83%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (344)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.01%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0.05pt 0pt;"> —</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.37%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (344)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.85%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0.05pt 0pt;"> 344</p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.06%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.83%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0.05pt 0pt;"> —</p></td></tr><tr><td style="vertical-align:bottom;width:39.2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Balances, March 31, 2021</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:11pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.83%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0.05pt 0pt;"> 4,476</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.01%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0.05pt 0pt;"> 6,403</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0.05pt 0pt;"> 334,142</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.85%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0.05pt 0pt;"> 16,919</p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.83%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0.05pt 0pt;"> —</p></td></tr></table> 16986000 16986000 11250000 -587000 10663000 335146000 -587000 334559000 22819000 -16399000 6420000 357965000 -16986000 340979000 11250000 22819000 357965000 -587000 -16399000 -16986000 16986000 10663000 6420000 340979000 16986000 16838000 16838000 -10510000 -352000 -10862000 4820000 22978000 351061000 -16838000 -16838000 16838000 263000 263000 -263000 -10862000 344000 344000 344000 -344000 -16575000 -16919000 16919000 16838000 -10510000 -89000 -10599000 -263000 -10862000 344000 344000 344000 4476000 6403000 334142000 16919000 16838000 16838000 -50460000 -595000 -51055000 4820000 22978000 351061000 -16838000 -16838000 16838000 263000 263000 -263000 -51055000 344000 344000 344000 -344000 -16575000 -16919000 16919000 16838000 -50460000 -332000 -50792000 -263000 -51055000 344000 344000 344000 4476000 6403000 334142000 16919000 <p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;padding-left:54pt;text-indent:-54pt;margin:0pt 0pt 12pt 0pt;">Property and Equipment</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:18pt;margin:0pt;">Property and equipment were comprised of the following as of March 31, 2022 and June 30, 2021:</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 0pt 33.85pt;"><span style="margin-bottom:12pt;margin-left:0pt;visibility:hidden;">​</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:77.14%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:53.03%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.13%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:13.87%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.13%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.45%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:12.74%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.13%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.34%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:11.05%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:0.08%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:53.03%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.13%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">    </b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Estimated</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.13%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">    </b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.45%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.74%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.13%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">    </b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.08%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:53.03%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><i style="font-style:italic;">dollars in thousands</i></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.13%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.87%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Useful Lives</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.13%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:14.19%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">March 31, 2022</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.13%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:12.4%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">June 30, 2021</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.08%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:top;width:53.03%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Land</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.13%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.87%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;">N/A</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.13%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.45%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.74%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0pt 0pt;"> 11,980</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.13%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.34%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.05%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0pt 0pt;"> 11,980</p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.08%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:top;width:53.03%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Buildings and leasehold improvements</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.13%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;">10 - 40 years</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.13%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.45%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.74%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0pt 0pt;"> 121,661</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.13%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0pt 0pt;"> 104,724</p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.08%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:top;width:53.03%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Software</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.13%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.87%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;">3 - 5 years</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.13%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.45%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.74%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0pt 0pt;"> 15,107</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.13%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.34%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.05%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0pt 0pt;"> 13,316</p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.08%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:top;width:53.03%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Equipment and vehicles</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.13%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;">3 - 7 years</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.13%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.45%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.74%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0pt 0pt;"> 46,655</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.13%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0pt 0pt;"> 35,341</p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.08%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:top;width:53.03%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Construction in progress</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.13%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.87%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;">N/A</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.13%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.45%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.74%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0pt 0pt;"> 22,336</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.13%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.34%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.05%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0pt 0pt;"> 22,130</p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.08%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:top;width:53.03%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.13%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.13%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.45%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.74%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0pt 0pt;"> 217,739</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.13%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0pt 0pt;"> 187,491</p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.08%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:top;width:53.03%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Less accumulated depreciation and amortization</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.13%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.87%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.13%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.45%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.74%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (53,857)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.13%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.34%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.05%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (44,776)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.08%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:top;width:53.03%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 12pt;">Total property and equipment, net</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.13%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.13%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.45%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.74%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0pt 0pt;"> 163,882</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.13%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.34%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.05%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0pt 0pt;"> 142,715</p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.08%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:18pt;margin:12pt 0pt 12pt 0pt;">Depreciation of $3.8 million and $3.2 million was recorded during the three months ended March 31, 2022 and 2021, respectively. Depreciation of $9.9 million and $8.8 million was recorded during the nine months ended March 31, 2022 and 2021, respectively. </p> <table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:77.14%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:53.03%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.13%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:13.87%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.13%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.45%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:12.74%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.13%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.34%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:11.05%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:0.08%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:53.03%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.13%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">    </b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Estimated</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.13%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">    </b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.45%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.74%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.13%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">    </b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.08%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:53.03%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><i style="font-style:italic;">dollars in thousands</i></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.13%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.87%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Useful Lives</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.13%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:14.19%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">March 31, 2022</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.13%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:12.4%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">June 30, 2021</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.08%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:top;width:53.03%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Land</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.13%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.87%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;">N/A</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.13%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.45%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.74%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0pt 0pt;"> 11,980</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.13%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.34%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.05%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0pt 0pt;"> 11,980</p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.08%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:top;width:53.03%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Buildings and leasehold improvements</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.13%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;">10 - 40 years</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.13%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.45%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.74%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0pt 0pt;"> 121,661</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.13%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0pt 0pt;"> 104,724</p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.08%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:top;width:53.03%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Software</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.13%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.87%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;">3 - 5 years</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.13%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.45%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.74%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0pt 0pt;"> 15,107</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.13%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.34%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.05%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0pt 0pt;"> 13,316</p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.08%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:top;width:53.03%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Equipment and vehicles</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.13%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;">3 - 7 years</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.13%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.45%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.74%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0pt 0pt;"> 46,655</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.13%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0pt 0pt;"> 35,341</p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.08%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:top;width:53.03%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Construction in progress</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.13%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.87%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;">N/A</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.13%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.45%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.74%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0pt 0pt;"> 22,336</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.13%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.34%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.05%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0pt 0pt;"> 22,130</p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.08%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:top;width:53.03%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.13%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.13%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.45%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.74%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0pt 0pt;"> 217,739</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.13%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0pt 0pt;"> 187,491</p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.08%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:top;width:53.03%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Less accumulated depreciation and amortization</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.13%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.87%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.13%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.45%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.74%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (53,857)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.13%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.34%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.05%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (44,776)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.08%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:top;width:53.03%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 12pt;">Total property and equipment, net</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.13%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.13%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.45%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.74%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0pt 0pt;"> 163,882</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.13%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.34%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.05%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0pt 0pt;"> 142,715</p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.08%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td></tr></table> 11980000 11980000 P10Y P40Y 121661000 104724000 P3Y P5Y 15107000 13316000 P3Y P7Y 46655000 35341000 22336000 22130000 217739000 187491000 53857000 44776000 163882000 142715000 3800000 3200000 9900000 8800000 <p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;padding-left:54pt;text-indent:-54pt;margin:0pt 0pt 12pt 0pt;">Coronavirus Pandemic (“COVID-19”)</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">As a PACE organization, we have been and will continue to be impacted by the effects of COVID-19. We closed all our centers in March 2020 and transitioned to a 100% in-home and virtual care model. We believe that the general lack of in-person interaction and the reduction in healthcare personnel, and specifically, trained personnel, impacted our ability to adhere to the complex government laws and regulations that apply to our business. We remain committed to carrying out our mission of caring for our participants. We continue to closely monitor the impact of COVID-19 on all aspects of our business, including the impacts to our employees, participants and suppliers. Due to the numerous evolving factors, we are unable to reliably estimate the ultimate impact the pandemic will have on our consolidated financial condition, results of operations or cash flows.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">On March 27, 2020, the Coronavirus Aid, Relief, and Economic Security Act (“CARES Act”) was signed into legislation. Under the CARES Act, the state of Pennsylvania signed into law the Act 24 of 2020. We received $1.0 million in funding under the Act 24 of 2020, which was allocated to InnovAge centers in Pennsylvania. Of the $1.0 million, $0.7 million was recognized prior June 30, 2020 and the remaining balance of $0.3 million was recognized during the year ended June 30, 2021. The CARES Act also provides for the temporary suspension of the automatic 2% reduction of Medicare claim reimbursements (sequestration) for the period of May 1, 2020 through December 31, 2020. The Consolidated Appropriations Act, 2021, enacted December 27, 2020, extended this suspension for three more months, through March 31, 2021.  H.R. 1868, enacted on April 14, 2021 further extends the suspension through December 31, 2021. On December 10, 2021 the “Protecting Medicare and American Farmers from Sequester Cuts Act” extends the 2% Medicare sequester moratorium through March 31, 2022, and adjusts the sequester to 1% between April 1, 2022 and June 30, 2022.</p> 1000000.0 1000000.0 700000 300000 <p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;padding-left:54pt;text-indent:-54pt;margin:0pt 0pt 12pt 0pt;">Recently Adopted Accounting Pronouncements</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:36pt;text-align:justify;text-indent:-36pt;margin:0pt 0pt 12pt 0pt;"><span style="font-style:italic;font-weight:bold;">Income Taxes</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">In December 2019, the Financial Accounting Standards Board (“FASB”) issued ASU 2019-12, <i style="font-style:italic;">Income Taxes Topic 740-Simplifying the Accounting for Income Taxes </i>(“ASU 2019-12”), which intended to simplify various aspects related to accounting for income taxes. ASU 2019-12 removes certain exceptions to the general principles in Topic 740 and also clarifies and amends existing guidance to improve consistent application of Topic 740. This guidance is effective for companies with fiscal years beginning after December 15, 2020, including interim periods therein, and early adoption is permitted. The Company adopted ASU 2019-12 during the quarter ended September 30, 2021 and it did not have a material effect on the Company’s condensed consolidated financial statements.</p> <p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;padding-left:54pt;text-indent:-54pt;margin:0pt 0pt 12pt 0pt;">Recent Accounting Pronouncements Not Yet Adopted</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;padding-left:54pt;text-indent:-54pt;margin:0pt 0pt 12pt 0pt;">Leases</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">In February 2016, the FASB issued ASU 2016-02 <i style="font-style:italic;">Leases</i> (“ASU 2016-02”), which was intended to increase transparency and comparability among organizations by recognizing lease assets and liabilities on the balance sheet and disclosing key information about leasing arrangements. Under the new guidance, lessees will be required to recognize a right-of-use asset and a lease liability, measured on a discounted basis, at the commencement date for all leases with terms greater than 12 months. Additionally, this guidance will require disclosures to help investors and other financial statement users to better understand the amount, timing, and uncertainty of cash flows arising from leases, including qualitative and quantitative requirements. The guidance should be applied under a modified retrospective transition approach for leases existing at the beginning of the earliest comparative period presented in the adoption-period financial statements. Any leases that expire before the initial application date will not require any accounting adjustment. In June 2020, FASB issued ASU 2020-05 <i style="font-style:italic;">Revenue from contracts with customers (Topic 606) and leases (Topic 842)—Effective dates for certain entities</i> which deferred the new lease standard effective date for the Company to December 15, 2022, with early adoption permitted. The Company will adopt this ASU in the fiscal year beginning July 1, 2022 and has not yet determined the effect of the standard on its ongoing financial reporting.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:36pt;text-align:justify;text-indent:-36pt;margin:0pt 0pt 12pt 0pt;"><span style="font-style:italic;font-weight:bold;">Financial Instruments</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">In April 2019, the FASB issued ASU 2019-04, <i style="font-style:italic;">Codification Improvements to Topic 326, Financial Instruments—Credit Losses, Topic 815, Derivatives and Hedging, and Topic 825, Financial Instruments (</i>“ASU 2019-04”<i style="font-style:italic;">)</i>, which requires entities to use a current expected credit loss (“CECL”) model to measure impairment for most financial assets that are not recorded at fair value through net income. Under the CECL model, an entity will estimate lifetime expected credit losses considering available relevant information about historical events, current conditions and supportable forecasts. The CECL model does not apply to available-for-sale debt securities. This guidance also expands the required credit loss disclosures and will be applied using a modified retrospective approach by recording a cumulative effect adjustment to retained earnings as of the beginning of the fiscal year of adoption. ASU 2019-04 is effective for the Company for fiscal years beginning after December 15, 2022, including interim periods within those fiscal years. The Company will adopt this guidance for the annual and interim reporting periods beginning July 1, 2023. The Company has not determined the effect of the standard on its condensed consolidated financial statements.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:18pt;margin:0pt;">We do not expect that any other recently issued accounting guidance will have a significant effect on our condensed consolidated financial statements.</p> <p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;"><span style="display:inline-block;text-indent:0pt;width:36pt;"><b style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:bold;">Note 3:</b></span>Revenue Recognition</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Under ASC 606, revenue is recognized when a customer obtains control of promised goods or services, in an amount that reflects the consideration which the entity expects to receive in exchange for those goods or services. To determine revenue recognition for arrangements that an entity determines are within the scope of ASC 606, the Company performed the following five steps: (i) Identify the contract(s) with a customer; (ii) Identify the performance obligations in the contract; (iii) Determine the transaction price; (iv) Allocate the transaction price to the performance obligations in the contract; and (v) Recognize revenue as the entity satisfies a performance obligation.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 12pt 0pt;"><i style="font-style:italic;">Capitation Revenue and Accounts Receivable</i></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Our capitation revenue relates to contracts with participants in which our performance obligation is to provide healthcare services to the participants. Revenues are recorded during the period our obligations to provide healthcare services are satisfied as noted below within each service type. The Company contracts directly with Medicare and Medicaid on a per member, per month (“PMPM”) basis. We receive 100% of the pooled capitated payment to directly provide or manage the healthcare needs of our participants.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Fees are recorded gross in revenues because the Company is acting as a principal in providing for or overseeing comprehensive care provided to the participants. Neither the Company nor any of its affiliates is a registered insurance company because state law in the states in which it operates does not require such registration for risk-bearing providers.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">In general, a participant enrolls in the PACE program and is considered a customer of InnovAge. The Company considers all contracts with participants as a single performance obligation to provide comprehensive medical, health, and social services that integrate acute and long-term care. The Company identified that contracts with customers in the PACE program have similar performance obligations and therefore groups them into one portfolio. This performance obligation is satisfied as the Company provides comprehensive care to its participants.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Our revenues are based on the estimated PMPM  amounts we expect to be entitled to receive from the capitated fees per participant that are paid monthly by Medicaid, Medicare, the VA, and private pay sources. Medicaid and Medicare capitation revenues are based on PMPM capitation rates under the PACE program.  VA is included in “Private Pay and other” and is also capitated.  Private pay includes direct payments from participants who do not qualify for the full capitated rate and have to pay all or a portion of the capitated rate.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">The Company disaggregates capitation revenue from the following sources for the nine months ended:</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;min-height:0.0pt;margin:0pt;"><span style="font-size:0pt;visibility:hidden;">​</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:80%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:72%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.57%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:10.56%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.15%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:10.56%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.15%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:72%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.57%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">    </b></p></td><td colspan="3" style="vertical-align:bottom;white-space:nowrap;width:23.27%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">March 31, </b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">    </b></p></td></tr><tr><td style="vertical-align:bottom;width:72%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.57%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">    </b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.56%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">2022</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">    </b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.56%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">2021</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">    </b></p></td></tr><tr><td style="vertical-align:bottom;width:72%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Medicaid</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.57%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.56%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0pt 0pt;"> 53</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.15%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">%</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.56%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0pt 0pt;"> 53</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.15%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">%</p></td></tr><tr><td style="vertical-align:bottom;width:72%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Medicare</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.57%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.56%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0pt 0pt;"> 46</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">%</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.56%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0pt 0pt;"> 46</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">%</p></td></tr><tr><td style="vertical-align:bottom;width:72%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Private pay and other</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.57%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.56%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0pt 0pt;"> 1</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.15%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">%</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.56%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0pt 0pt;"> 1</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.15%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">%</p></td></tr><tr><td style="vertical-align:bottom;width:72%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;">Total</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.57%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.56%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0pt 0pt;"> 100</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">%</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.56%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0pt 0pt;"> 100</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">%</p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:18pt;margin:0pt;"><span style="visibility:hidden;">​</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">The Company determined the transaction price for these contracts is the amount we expect to be entitled to, which is the most likely amount. For certain capitation payments, the Company is subject to retroactive premium risk adjustments based on various factors. The Company estimates the amount of the adjustment and records it monthly on a straight-line basis. These adjustments are not expected to be material. </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">The capitation revenues are recognized based on the estimated PMPM transaction price to transfer the service for a distinct increment of the series (i.e. month). We recognize revenue in the month in which participants are entitled to receive comprehensive care benefits during the contract term. As the period between the time of service and time of payment is typically one year or less, the Company elected the practical expedient under ASC 606-10-32-18 and did not adjust for the effects of a significant financing component.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">The Company also provides prescription drug benefits in accordance with Medicare Part D. Monthly payments received from CMS and the participants represent the bid amount for providing prescription drug coverage. The portion received from CMS is subject to risk sharing through Medicare Part D risk-sharing corridor provisions. These risk-sharing corridor provisions compare costs targeted in the Company’s bid to actual prescription drug costs. The Company estimates and records a monthly adjustment to Medicare Part D revenues associated with these risk-sharing corridor provisions. Medicare Part D comprised (i) 12% of capitation revenues for both the nine months ended March 31, 2022 and 2021 and (ii) 23% and 25% of external provider costs for the nine months ended March 31, 2022 and 2021, respectively.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Our accounts receivable as of March 31, 2022 and June 30, 2021 is primarily from capitation revenue arrangements. The concentration of net receivables from participants and third-party payers was as follows:</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;min-height:0.0pt;margin:0pt;"><span style="font-size:0pt;visibility:hidden;">​</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:80%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:72.18%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.24%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:10.58%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.24%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:10.58%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.16%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:72.18%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.24%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">    </b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.58%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">March 31, </b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.24%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.58%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">June 30, </b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.16%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:bottom;width:72.18%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.24%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.58%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2022</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.24%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">    </b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.58%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2021</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.16%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:bottom;width:72.18%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Medicaid</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.24%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.58%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0.05pt 0pt;"> 50</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.24%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">%</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.58%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0.05pt 0pt;"> 60</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.16%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">%</p></td></tr><tr><td style="vertical-align:bottom;width:72.18%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Medicare</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.24%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.58%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0.05pt 0pt;"> 37</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.24%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">%</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.58%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0.05pt 0pt;"> 20</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.16%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">%</p></td></tr><tr><td style="vertical-align:bottom;width:72.18%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Private pay and other</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.24%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.58%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0.05pt 0pt;"> 13</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.24%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">%</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.58%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0.05pt 0pt;"> 20</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.16%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">%</p></td></tr><tr><td style="vertical-align:bottom;width:72.18%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 6pt;">Total</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.24%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.58%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0.05pt 0pt;"> 100</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.24%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">%</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.58%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0.05pt 0pt;"> 100</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.16%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">%</p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 0pt 36pt;"><span style="margin-bottom:12pt;margin-left:0pt;visibility:hidden;background:#ffffff;">​</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">The Company records accounts receivable at net realizable value, which includes an allowance for estimated uncollectible accounts. The allowance for uncollectible accounts reflects the Company’s best estimate of probable losses considering eligibility, historical experience, and existing economic conditions. The balance of the allowance for uncollectible accounts was $3.9 million as of March 31, 2022, compared to $4.4 million as of June 30, 2021. Accounts are written off as bad debts when they are deemed uncollectible based upon individual credit evaluations and specific circumstances underlying the accounts. </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:36pt;text-align:justify;text-indent:-36pt;margin:0pt 0pt 12pt 0pt;"><i style="font-style:italic;">Other Service Revenue and Accounts Receivable</i></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Other service revenue is comprised of rents earned related to Senior Housing and other fee for service revenue. Other service revenue was 0.2% and 0.4% of total revenue for the nine months ended March 31, 2022 and 2021, respectively, and 0.2% and 0.3% for the three months ended March 31, 2022 and 2021, respectively. Accounts receivable related to other service revenue were not significant as of both March 31, 2022 and June 30, 2021.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Laws and regulations governing the Medicare and Medicaid programs are complex and subject to change, as well as government review. Failure to comply with these laws can expose the entity to significant regulatory action, including fines, penalties, and exclusion from the Medicare and Medicaid programs. See Note 9, “Commitments and Contingencies”.</p> 1 <p style="font-family:'Times New Roman','Times','serif';font-size:10pt;min-height:0.0pt;margin:0pt;"><span style="font-size:0pt;visibility:hidden;">​</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:80%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:72%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.57%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:10.56%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.15%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:10.56%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.15%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:72%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.57%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">    </b></p></td><td colspan="3" style="vertical-align:bottom;white-space:nowrap;width:23.27%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">March 31, </b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">    </b></p></td></tr><tr><td style="vertical-align:bottom;width:72%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.57%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">    </b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.56%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">2022</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">    </b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.56%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">2021</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">    </b></p></td></tr><tr><td style="vertical-align:bottom;width:72%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Medicaid</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.57%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.56%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0pt 0pt;"> 53</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.15%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">%</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.56%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0pt 0pt;"> 53</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.15%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">%</p></td></tr><tr><td style="vertical-align:bottom;width:72%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Medicare</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.57%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.56%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0pt 0pt;"> 46</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">%</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.56%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0pt 0pt;"> 46</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">%</p></td></tr><tr><td style="vertical-align:bottom;width:72%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Private pay and other</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.57%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.56%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0pt 0pt;"> 1</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.15%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">%</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.56%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0pt 0pt;"> 1</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.15%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">%</p></td></tr><tr><td style="vertical-align:bottom;width:72%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;">Total</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.57%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.56%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0pt 0pt;"> 100</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">%</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.56%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0pt 0pt;"> 100</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">%</p></td></tr></table> 0.53 0.53 0.46 0.46 0.01 0.01 1 1 0.12 0.12 0.23 0.25 <p style="font-family:'Times New Roman','Times','serif';font-size:10pt;min-height:0.0pt;margin:0pt;"><span style="font-size:0pt;visibility:hidden;">​</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:80%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:72.18%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.24%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:10.58%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.24%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:10.58%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.16%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:72.18%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.24%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">    </b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.58%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">March 31, </b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.24%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.58%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">June 30, </b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.16%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:bottom;width:72.18%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.24%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.58%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2022</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.24%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">    </b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.58%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2021</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.16%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:bottom;width:72.18%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Medicaid</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.24%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.58%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0.05pt 0pt;"> 50</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.24%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">%</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.58%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0.05pt 0pt;"> 60</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.16%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">%</p></td></tr><tr><td style="vertical-align:bottom;width:72.18%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Medicare</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.24%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.58%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0.05pt 0pt;"> 37</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.24%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">%</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.58%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0.05pt 0pt;"> 20</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.16%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">%</p></td></tr><tr><td style="vertical-align:bottom;width:72.18%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Private pay and other</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.24%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.58%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0.05pt 0pt;"> 13</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.24%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">%</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.58%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0.05pt 0pt;"> 20</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.16%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">%</p></td></tr><tr><td style="vertical-align:bottom;width:72.18%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 6pt;">Total</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.24%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.58%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0.05pt 0pt;"> 100</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.24%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">%</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.58%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0.05pt 0pt;"> 100</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.16%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">%</p></td></tr></table> 0.50 0.60 0.37 0.20 0.13 0.20 1 1 3900000 4400000 0.002 0.004 0.002 0.003 <p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;"><span style="display:inline-block;text-indent:0pt;width:36pt;"><b style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:bold;">Note 4:</b></span>Investments</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:18pt;margin:0pt;">The Company holds equity method and cost method investments as of: </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:18pt;margin:0pt;"><span style="visibility:hidden;">​</span></p><div style="padding-left:49.5pt;"><table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;width:80.68%;"><tr style="height:1pt;"><td style="vertical-align:bottom;white-space:nowrap;width:61.58%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:3.14%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.95%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:14.51%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:3.14%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.95%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:13.7%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:61.58%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.14%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.95%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.51%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">March 31, </b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.14%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.95%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">June 30, </b></p></td></tr><tr><td style="vertical-align:bottom;width:61.58%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><i style="font-style:italic;">in thousands</i></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.14%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:16.47%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2022</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.14%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">    </b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:15.65%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2021</b></p></td></tr><tr><td style="vertical-align:bottom;width:61.58%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Cost method investments</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.14%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.95%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.51%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0.05pt 0pt;"> 4,645</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.14%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.95%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.7%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0.05pt 0pt;"> 2,645</p></td></tr><tr><td style="vertical-align:bottom;width:61.58%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Equity method investments</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.14%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.95%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.51%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0.05pt 0pt;"> 848</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.14%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.95%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;"> </b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.7%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0.05pt 0pt;"> 848</p></td></tr><tr><td style="vertical-align:bottom;width:61.58%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 6pt;">Total investments</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.14%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.95%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.51%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0.05pt 0pt;"> 5,493</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.14%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.95%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.7%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0.05pt 0pt;"> 3,493</p></td></tr></table></div><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:18pt;text-align:justify;text-indent:-18pt;margin:0pt;"><span style="font-weight:bold;margin-bottom:12pt;visibility:hidden;">​</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:18pt;text-align:justify;text-indent:-18pt;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">Nonconsolidated Entities </b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;"><span style="font-style:italic;letter-spacing:0.2pt;">Cost Method Investments</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">The Company maintains two investments that are accounted for using the cost method. The investments do not have a readily determinable fair value and the Company has elected to record the investments at cost, less impairment, if any, plus or minus any changes resulting from observable price changes in orderly transactions for the identical or similar investment of the same issuer. During the nine months ended March 31, 2022 and 2021, there were no observable price changes or impairments recorded.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:36pt;text-align:justify;text-indent:-36pt;margin:0pt;"><i style="font-style:italic;">Jetdoc</i></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:36pt;text-align:justify;text-indent:-36pt;margin:0pt;"><span style="font-style:italic;margin-bottom:12pt;visibility:hidden;">​</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 0pt 18pt;">In August 2021, the Company acquired a minority interest equal to 806,481 shares of the outstanding common</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt;">stock of Jetdoc, Inc. (“Jetdoc”), a telehealth and virtual urgent care app dedicated to effectively connecting users with medical professionals, for cash consideration of $2.0 million. The balance of the Company’s investment in Jetdoc is $2.0 million which represents the maximum exposure to loss.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">​</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt;"><i style="font-style:italic;">Dispatch Health</i></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt;"><span style="font-style:italic;margin-bottom:12pt;visibility:hidden;">​</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:18pt;margin:0pt;">Since 2019, the Company has maintained an investment of $2.6 million in DispatchHealth Holdings, Inc. (“Dispatch Health”). Dispatch Health offers  complete in-home on-demand healthcare. The balance of the Company’s investment is $2.6 million which represents the maximum exposure to loss.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:18pt;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">​</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:18pt;text-align:justify;text-indent:-18pt;margin:0pt;"><span style="font-style:italic;font-weight:bold;">Equity Method Investments</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:18pt;text-align:justify;text-indent:-18pt;margin:0pt;"><span style="font-style:italic;font-weight:bold;margin-bottom:12pt;visibility:hidden;">​</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:18pt;text-align:justify;text-indent:-18pt;margin:0pt;"><i style="font-style:italic;">Pinewood Lodge</i></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:18pt;text-align:justify;text-indent:-18pt;margin:0pt;"><span style="font-style:italic;margin-bottom:12pt;visibility:hidden;">​</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">The Company’s operations include a Senior Housing unit that primarily includes the accounts of Continental Community Housing (“CCH”), the general partner of Pinewood Lodge, LLP (“ PWD”) which was organized to develop, construct, own, maintain, and operate certain apartment complexes intended for rental to low-income elderly individuals aged 62 or older.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">PWD is a VIE, but the Company is not the primary beneficiary. The Company does not have the power to direct the activities that most significantly impact the economic performance of PWD. Accordingly, the Company does not consolidate PWD. PWD is accounted for using the equity method of accounting. The equity earnings of PWD are insignificant. As of March 31, 2022, the balance of the Company’s investment in PWD is $0.8 million which represents the maximum exposure to loss.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;padding-left:18pt;text-indent:-18pt;margin:0pt 0pt 12pt 0pt;">Noncontrolling Interest</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;padding-left:18pt;text-indent:-18pt;margin:0pt;"><i style="font-style:italic;font-weight:normal;">Senior Housing</i></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:36pt;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">​</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">The Company’s operations include a 0.01% partnership interest in InnovAge Senior Housing Thornton, LLC (“SH1”), which was organized to develop, construct, own, maintain, and operate certain apartment complexes intended for rental to low-income elderly individuals aged 62 or older.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">SH1 is a  VIE. The Company is the primary beneficiary of SH1 and consolidates SH1. The Company is the primary beneficiary of SH1 as it has the power to direct the activities that are most significant to SH1 and has an obligation to absorb losses or the right to receive benefits from SH1. The most significant activity of SH1 is the operation of the senior housing facility. The Company has provided a subordinated loan to SH1 and has provided a guarantee for a convertible term loan held by SH1.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;padding-left:18pt;text-indent:-18pt;margin:0pt 0pt 12pt 0pt;">Redeemable Noncontrolling Interest</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:18pt;text-align:justify;text-indent:-18pt;margin:0pt;"><i style="font-style:italic;">InnovAge Sacramento</i></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:18pt;text-align:justify;text-indent:-18pt;margin:0pt;"><span style="font-style:italic;margin-bottom:12pt;visibility:hidden;">​</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">On March 18, 2019, in connection with the formation of InnovAge Sacramento, the joint venture with Adventist Health System/West (“Adventist”) and Eskaton Properties, Incorporated (“Eskaton”), the Company contributed $9.0 million in cash and land valued at $4.2 million for a 59.9% membership interest in the joint venture, InnovAge Sacramento. Further, Adventist contributed $5.8 million in cash and Eskaton contributed $3.0 million in cash for membership interests of 26.4% and 13.7%, respectively. </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Prior to January 1, 2021, the Company did not consolidate InnovAge Sacramento. In the third quarter of fiscal year 2021, the Company made an additional contribution of $52,000 to obtain an additional 0.1% membership interest in the joint venture. With the acquisition of the additional 0.1% membership interest, the Company obtained control of InnovAge Sacramento effective January 1, 2021. Accordingly, beginning January 1, 2021, the results of InnovAge Sacramento are included in our consolidated results of operations.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Before consolidation on January 1, 2021, the Company recorded its proportionate share of net loss, which was a loss of $1.3 million for the six months ended December 31, 2020, as equity loss in the statement of operations. </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">When the joint venture was formed, the Company issued warrants to Adventist (the “Sacramento Warrants”) to purchase 5% of its issued and outstanding common stock par value $0.001 per share, at an exercise price equal to the fair market value per share at the time of exercise of the warrant. Pursuant to the original warrants, the Sacramento Warrants were to fully vest on the date on which Adventist would have made aggregate capital contributions in an amount greater than $25.0 million to one or more joint venture entities in which Adventist and the Company held equity (the “Investment Threshold”). </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">On February 9, 2021, we entered into an amendment agreement with Adventist to amend the Sacramento Warrants. The amendment removes the Investment Threshold requirement and grants Adventist the right to purchase up to $15.0 million of our common stock at an exercise price equal to the initial public offering price. The warrant was exercisable for <span style="-sec-ix-hidden:Hidden_jSQG6mIPrk6s5AlQZKqQ-g;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">one</span></span> year beginning March 8, 2021, the date of the consummation of our IPO. The Sacramento Warrants expired in March 2022, without being exercised.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">At inception, the Sacramento Warrants were initially determined to be equity-based payments to nonemployees and as such the measurement date for these warrants was considered to be the date when the Investment Threshold is reached. At the time of the amendment, due to the removal of the Investment Threshold, the Sacramento Warrants were evaluated under ASC 815-40, “<i style="font-style:italic;">Contracts in an Entity’s Own Equity</i>,” which resulted in a liability classification from the date of the amendment through completion of our IPO, due to the variable amount of shares which could be issued. Upon completion of the IPO, the number of shares to be issued were no longer variable, which resulted in the warrants being recorded in equity. A charge of $2.3 million, representing the fair value of the Sacramento Warrants from inception through the date of completion of the IPO, was recorded in other income (expense) in the condensed consolidated statement of operations. </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">As described above, we obtained control of InnovAge Sacramento through acquisition of an additional 0.1% membership interest, which we consider to be a step acquisition, whereby the Company remeasured the previously held equity method investment to fair value. The amount by which the purchase price exceeds the fair value of the net assets acquired is recorded as goodwill. The fair value of the previously held equity investments was determined using a discounted cash flow model.  This resulted in recording a gain on consolidation of $10.9 million during the third quarter of fiscal year 2021. </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">The InnovAge California PACE-Sacramento LLC Limited Liability Company Agreement (the “JV Agreement”) includes numerous provisions whereby, if certain conditions are met, the Joint Venture may be required to purchase, at fair market value, certain members’ interests or certain members may be required to purchase, at fair market value, the interests of certain other members. As of March 31, 2022, none of the conditions specified in the JV Agreement had been met.  At the time the Company became a publicly traded company these put rights held by the noncontrolling interests of the Joint Venture were required to be presented as temporary equity. The redeemable noncontrolling interest of $15.9 million was recorded at carrying value as of March 31, 2022.</p> <p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:18pt;margin:0pt;"><span style="visibility:hidden;">​</span></p><div style="padding-left:49.5pt;"><table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;width:80.68%;"><tr style="height:1pt;"><td style="vertical-align:bottom;white-space:nowrap;width:61.58%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:3.14%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.95%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:14.51%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:3.14%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.95%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:13.7%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:61.58%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.14%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.95%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.51%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">March 31, </b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.14%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.95%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">June 30, </b></p></td></tr><tr><td style="vertical-align:bottom;width:61.58%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><i style="font-style:italic;">in thousands</i></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.14%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:16.47%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2022</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.14%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">    </b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:15.65%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2021</b></p></td></tr><tr><td style="vertical-align:bottom;width:61.58%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Cost method investments</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.14%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.95%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.51%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0.05pt 0pt;"> 4,645</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.14%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.95%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.7%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0.05pt 0pt;"> 2,645</p></td></tr><tr><td style="vertical-align:bottom;width:61.58%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Equity method investments</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.14%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.95%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.51%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0.05pt 0pt;"> 848</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.14%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.95%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;"> </b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.7%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0.05pt 0pt;"> 848</p></td></tr><tr><td style="vertical-align:bottom;width:61.58%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 6pt;">Total investments</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.14%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.95%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.51%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0.05pt 0pt;"> 5,493</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.14%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.95%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.7%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0.05pt 0pt;"> 3,493</p></td></tr></table></div> 4645000 2645000 848000 848000 5493000 3493000 2 0 0 806481 2000000.0 2000000.0 2600000 2600000 800000 800000 0.0001 0.0001 9000000.0 4200000 0.599 5800000 3000000.0 0.264 0.137 52000 0.001 0.001 -1300000 0.05 0.001 25000000.0 15000000.0 2300000 0.001 10900000 15900000 <p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;"><span style="display:inline-block;text-indent:0pt;width:36pt;"><b style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:bold;">Note 5:</b></span>Fair Value Measurements</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Fair value is defined as the price that would be received from selling an asset or paid to transfer a liability (an exit price) in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants, at the measurement date. A fair value hierarchy was established that requires an entity to maximize the use of observable inputs and minimize the use of unobservable inputs when measuring fair value. Observable inputs are inputs that reflect the assumptions market participants would use in pricing the asset or liability developed based on market data obtained from sources outside the reporting entity. Unobservable inputs are inputs that reflect the Company’s own assumptions based on market data and assumptions that market participants would use in pricing the asset or liability developed based on the best information available in the circumstances. The sensitivity to changes in inputs and their impact on fair value measurements can be significant.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">The three levels of inputs that may be used to measure fair value are:</p><table style="border-collapse:collapse;border:0;"><tr><td style="width:48.15pt;padding:0pt;"/><td style="vertical-align:text-top;white-space:nowrap;width:49.7pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;text-align:justify;"><b style="font-weight:bold;">Level 1</b></p></td><td style="padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;text-align:justify;">Unadjusted quoted prices in active markets for identical assets or liabilities that the entity has the ability to access at the measurement date</p></td></tr></table><table style="border-collapse:collapse;border:0;"><tr><td style="width:48.15pt;padding:0pt;"/><td style="vertical-align:text-top;white-space:nowrap;width:49.7pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;text-align:justify;"><b style="font-weight:bold;">Level 2</b></p></td><td style="padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;text-align:justify;">Quoted prices in markets that are not active or inputs that are observable, either directly or indirectly, for substantially the full term of the assets or liabilities</p></td></tr></table><table style="border-collapse:collapse;border:0;"><tr><td style="width:48.15pt;padding:0pt;"/><td style="vertical-align:text-top;white-space:nowrap;width:49.7pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;text-align:justify;"><b style="font-weight:bold;">Level 3</b></p></td><td style="padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;text-align:justify;">Unobservable inputs to the valuation techniques that are significant to the fair value measurements of the assets or liabilities</p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;padding-left:54pt;text-indent:-54pt;margin:0pt 0pt 12pt 0pt;">Recurring Measurements</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">The Company’s investment in InnovAge Sacramento includes a put right for the noncontrolling interest holders to require the Company to repurchase the interest of the noncontrolling interest holders at fair value, after the initial term of the management services agreement in 2028. As a result, at each fiscal period end the Company reports this put right at the greater of i) carrying value of the redeemable noncontrolling interest or (ii) fair value of the redeemable noncontrolling interest. Because this asset does not have observable inputs, level 3 inputs are used to measure fair value. For the three months ended March 31, 2022, the Company recorded an adjustment to redemption value of the redeemable noncontrolling interest of $2.6 million, which was a reduction to carrying value. This adjustment represents the excess amount of fair value over the carrying value as of March 31, 2022.  The fair value of the redeemable noncontrolling interest is determined utilizing a discounted cash flow model.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Effective August 7, 2018, the Company finalized the acquisition of NewCourtland LIFE Program (“NewCourtland”) in Pennsylvania. The Company paid a base purchase price of $30.0 million, subject to certain net working capital and closing adjustments plus contingent consideration of up to $20.0 million. On March 8, 2021, we completed our IPO, which satisfied the condition that the Company sell equity securities pursuant to an effective registration statement. Accordingly, $20.0 million of contingent consideration was paid under the terms of the acquisition agreement. Since all of the contingent consideration of $20.0 million was paid, the lease payments in certain real estate leases between the Company and NewCourtland were reduced from their current amounts and allow the Company to exercise its option to purchase the leased buildings at fair market value, after the initial term of the lease.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">As of  June 30, 2021 and March 31, 2022, there are no amounts of contingent consideration outstanding.  </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">There were no transfers in and out of Level 3 during the nine months ended March 31, 2022 or 2021.</p> 2600000 30000000.0 20000000.0 20000000.0 20000000.0 0 0 0 0 <p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;"><span style="display:inline-block;text-indent:0pt;width:36pt;"><b style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:bold;">Note 6:</b></span>Goodwill and Intangible Assets</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Goodwill, which represents the excess of consideration paid over the fair value of net assets acquired through business acquisitions. Goodwill amounted to $124.2 million at each of March 31, 2022 and June 30, 2021. Goodwill is not amortized.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Pursuant to ASC 350, “<i style="font-style:italic;">Intangibles – Goodwill and Other</i>,” we review the recoverability of goodwill annually as of April 1 or whenever significant events or changes occur which might impair the recovery of recorded amounts. For purposes of the annual goodwill impairment assessment, the Company has identified three reporting units. There were no indicators of impairment identified and no goodwill impairments recorded during the nine months ended March 31, 2022 and 2021.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Intangibles assets consisted of the following as of:</p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:80%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:61.57%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:3.14%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.95%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:14.51%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:3.14%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.95%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:13.71%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:61.57%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-style:italic;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.14%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">    </b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.95%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.51%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">March 31, </b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.14%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.95%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.71%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">June 30, </b></p></td></tr><tr><td style="vertical-align:bottom;width:61.57%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><i style="font-style:italic;">in thousands</i></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.14%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:16.46%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2022</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.14%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">    </b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:15.67%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2021</b></p></td></tr><tr><td style="vertical-align:bottom;width:61.57%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Definite-lived intangible assets</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.14%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.95%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.51%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0.05pt 0pt;"> 9,350</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.14%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.95%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.71%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0.05pt 0pt;"> 6,600</p></td></tr><tr><td style="vertical-align:bottom;width:61.57%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Indefinite-lived intangible assets</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.14%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.95%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.51%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0.05pt 0pt;"> 2,000</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.14%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.95%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.71%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0.05pt 0pt;"> 2,000</p></td></tr><tr><td style="vertical-align:bottom;width:61.57%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 6pt;">Total intangible assets</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.14%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.95%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.51%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0.05pt 0pt;"> 11,350</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.14%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.95%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.71%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0.05pt 0pt;"> 8,600</p></td></tr><tr><td style="vertical-align:bottom;width:61.57%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 12pt;">Accumulated amortization</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.14%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.95%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.51%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (2,578)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.14%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.95%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.71%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (2,082)</p></td></tr><tr><td style="vertical-align:bottom;width:61.57%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 6pt;">Balance as of end of period</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.14%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.95%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.51%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0.05pt 0pt;"> 8,772</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.14%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.95%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.71%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0.05pt 0pt;"> 6,518</p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:18pt;text-align:justify;text-indent:-18pt;margin:0pt 0pt 12pt 18pt;"><span style="margin-left:0pt;visibility:hidden;">​</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Intangible assets consist primarily of customer relationships acquired through business acquisitions and technology-based assets. The Company recorded amortization expense of $0.5 million and $0.2 million for the nine months ended March 31, 2022 and 2021, respectively. </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">We review the recoverability of other intangible assets in conjunction with long-lived assets whenever events or changes in circumstances indicate the carrying amount of such assets may not be recoverable. There were no intangible asset impairments recorded during the nine months ended March 31, 2022 and 2021. </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"><span style="background:#ffffff;">During the nine months ended March 31, 2022, the market value of our common stock declined below the carrying value of equity. As a result, we were required to qualitatively assess whether a triggering event had occurred and whether it was more likely than not that our goodwill was impaired as of March 31, 2022. We believe the impact of the regulatory actions described below to our planned opening of new centers and expansion into new service areas met the criteria of a triggering event, which required us to perform quantitative procedures as part of a Step 1 goodwill impairment analysis to asses whether it was more-likely-than-not that the fair value of the Company was greater than the net book value. </span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-bottom:12pt;text-align:justify;text-indent:18pt;margin:0pt;"><span style="letter-spacing:0.2pt;">In September 2021, we were notified that CMS and the State of California had determined to suspend new enrollments at our Sacramento center based on deficiencies detected in an audit related to participant provision of services.  In December 2021, we were notified that CMS and Colorado Department of Health Care Policy and Financing (“HCPF”) had determined to suspend new enrollments at our Colorado centers based on deficiencies detected in an audit related to participant provision of services. In each case, the suspensions will remain in effect until CMS and the respective States determine that we have remediated the deficiencies to their satisfaction. During the third quarter ended March 31, 2022, we were notified by the State of Kentucky that they no longer intend to enter into an agreement with us relating to PACE services, and during the same period, CMS denied our initial application to develop a PACE center in the State of Indiana. </span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:18pt;background:#ffffff;margin:0pt;">As a result of the above assessment, we concluded that there was no goodwill impairment based on a review of macroeconomic and industry considerations, the Company's financial results in each of our reporting units for the nine months ended March 31, 2022 and financial projections, inclusive of a sustained impact of the enrollment suspension and inability to open new centers. If assumptions or estimates in the fair value calculations change or if future cash flows vary from what was expected, including those assumptions relating to the duration and severity of the financial impact of the enrollment suspension at Sacramento and Colorado or new regulatory sanctions or other actions are imposed on the Company, this may impact the impairment analysis and could reduce the underlying cash flows used to estimate fair values and result in a decline in fair value that may trigger future impairment charges. </p> 124200000 124200000 3 0 0 <table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:80%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:61.57%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:3.14%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.95%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:14.51%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:3.14%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.95%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:13.71%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:61.57%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-style:italic;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.14%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">    </b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.95%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.51%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">March 31, </b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.14%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.95%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.71%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">June 30, </b></p></td></tr><tr><td style="vertical-align:bottom;width:61.57%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><i style="font-style:italic;">in thousands</i></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.14%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:16.46%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2022</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.14%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">    </b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:15.67%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2021</b></p></td></tr><tr><td style="vertical-align:bottom;width:61.57%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Definite-lived intangible assets</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.14%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.95%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.51%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0.05pt 0pt;"> 9,350</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.14%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.95%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.71%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0.05pt 0pt;"> 6,600</p></td></tr><tr><td style="vertical-align:bottom;width:61.57%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Indefinite-lived intangible assets</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.14%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.95%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.51%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0.05pt 0pt;"> 2,000</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.14%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.95%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.71%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0.05pt 0pt;"> 2,000</p></td></tr><tr><td style="vertical-align:bottom;width:61.57%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 6pt;">Total intangible assets</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.14%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.95%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.51%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0.05pt 0pt;"> 11,350</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.14%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.95%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.71%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0.05pt 0pt;"> 8,600</p></td></tr><tr><td style="vertical-align:bottom;width:61.57%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 12pt;">Accumulated amortization</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.14%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.95%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.51%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (2,578)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.14%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.95%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.71%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (2,082)</p></td></tr><tr><td style="vertical-align:bottom;width:61.57%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 6pt;">Balance as of end of period</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.14%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.95%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.51%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0.05pt 0pt;"> 8,772</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.14%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.95%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.71%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0.05pt 0pt;"> 6,518</p></td></tr></table> 9350000 6600000 2000000 2000000 11350000 8600000 2578000 2082000 8772000 6518000 500000 200000 0 0 0 <p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;"><span style="display:inline-block;text-indent:0pt;width:36pt;"><b style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:bold;">Note 7:</b></span>Leases</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Property and equipment includes property under various capital leases. These leases have expiration dates ranging from August 2022 to July 2032, varying interest rates, and generally include an option to purchase the equipment at the end of the underlying lease period. The Company’s capital leases included the following at March 31, 2022 and June 30, 2021:</p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:77.14%;"><tr style="height:1pt;"><td style="vertical-align:bottom;white-space:nowrap;width:47.42%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:3.45%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.16%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:18.96%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:3.44%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.16%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:18.96%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:3.41%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:47.42%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.45%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">    </b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:21.12%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">March 31, 2022</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:21.12%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">June 30, 2021</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.41%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:47.42%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><i style="font-style:italic;">in thousands</i></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.45%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.16%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:9pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:18.96%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:9pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:9pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.16%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:9pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:18.96%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:9pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.41%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:bottom;width:47.42%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Equipment</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.45%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.16%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:18.96%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0pt 0pt;"> 18,885</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.44%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.16%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:18.96%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0pt 0pt;"> 13,302</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.41%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:bottom;width:47.42%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Less accumulated depreciation</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.45%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.16%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:18.96%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (7,150)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.16%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:18.96%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (7,081)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.41%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:bottom;width:47.42%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 12pt;">Total capital leases</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.45%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.16%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:18.96%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0pt 0pt;"> 11,735</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.44%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.16%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:18.96%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0pt 0pt;"> 6,221</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.41%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Certain of the Company’s property and equipment is leased under operating leases. Such leases generally have lease terms ranging from years 2022 through 2032 with renewal options. Total rental expense under operating leases was $1.3 million and $3.5 million for the three and nine months ended March 31, 2022, respectively, and $1.4 million and $3.5 million for the three and nine months ended March 31, 2021 respectively.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Future minimum lease payments for fiscal years beginning with remainder of fiscal year 2022 for capital leases having initial terms of more than one year and noncancelable operating leases were as follows:</p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:77.28%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:68.43%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.13%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.14%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:11.26%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:0.07%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.99%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:13.94%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:68.43%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.13%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;">    </p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.14%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;">    </p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.26%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.07%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:15.94%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Operating Leases</b></p></td></tr><tr><td style="vertical-align:bottom;width:68.43%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.13%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:13.41%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Capital Leases</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.07%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:15.94%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Minimum Lease</b></p></td></tr><tr><td style="vertical-align:bottom;width:68.43%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><i style="font-style:italic;">in thousands</i></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.13%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:13.41%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Obligations</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.07%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:15.94%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Payments</b></p></td></tr><tr><td style="vertical-align:bottom;width:68.43%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Amount remaining in 2022</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.13%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.14%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.26%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0pt 0pt;"> 958</p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.07%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.99%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.94%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0pt 0pt;"> 1,203</p></td></tr><tr><td style="vertical-align:bottom;width:68.43%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">2023</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.13%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.14%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.26%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0pt 0pt;"> 4,405</p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.07%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.99%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.94%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0pt 0pt;"> 4,872</p></td></tr><tr><td style="vertical-align:bottom;width:68.43%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">2024</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.13%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.14%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.26%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0pt 0pt;"> 3,909</p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.07%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.99%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.94%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0pt 0pt;"> 4,582</p></td></tr><tr><td style="vertical-align:bottom;width:68.43%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">2025</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.13%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.14%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.26%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0pt 0pt;"> 3,126</p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.07%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.99%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.94%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0pt 0pt;"> 4,122</p></td></tr><tr><td style="vertical-align:bottom;width:68.43%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">2026</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.13%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.14%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.26%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0pt 0pt;"> 2,092</p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.07%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.99%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.94%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0pt 0pt;"> 4,061</p></td></tr><tr><td style="vertical-align:bottom;width:68.43%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Thereafter</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.13%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.14%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.26%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0pt 0pt;"> 1,927</p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.07%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.99%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.94%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0pt 0pt;"> 14,029</p></td></tr><tr><td style="vertical-align:bottom;width:68.43%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 12pt;">Total</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.13%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.14%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.26%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0pt 0pt;"> 16,417</p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.07%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.99%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.94%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0pt 0pt;"> 32,869</p></td></tr><tr><td style="vertical-align:bottom;width:68.43%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Less amount representing interest</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.13%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.14%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.26%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (2,912)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.07%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.99%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.94%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;">  </p></td></tr><tr><td style="vertical-align:bottom;width:68.43%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 12pt;">Total minimum lease payments</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.13%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.14%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.26%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0pt 0pt;"> 13,498</p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.07%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.99%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.94%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;">  </p></td></tr><tr><td style="vertical-align:bottom;width:68.43%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Less current maturities</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.13%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.14%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.26%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (3,216)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.07%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.99%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.94%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;">  </p></td></tr><tr><td style="vertical-align:bottom;width:68.43%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Noncurrent maturities</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.13%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.14%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.26%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0pt 0pt;"> 10,282</p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.07%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.99%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.94%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;">  </p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p> <table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:77.14%;"><tr style="height:1pt;"><td style="vertical-align:bottom;white-space:nowrap;width:47.42%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:3.45%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.16%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:18.96%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:3.44%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.16%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:18.96%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:3.41%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:47.42%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.45%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">    </b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:21.12%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">March 31, 2022</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:21.12%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">June 30, 2021</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.41%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:47.42%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><i style="font-style:italic;">in thousands</i></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.45%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.16%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:9pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:18.96%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:9pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:9pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.16%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:9pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:18.96%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:9pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.41%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:bottom;width:47.42%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Equipment</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.45%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.16%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:18.96%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0pt 0pt;"> 18,885</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.44%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.16%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:18.96%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0pt 0pt;"> 13,302</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.41%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:bottom;width:47.42%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Less accumulated depreciation</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.45%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.16%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:18.96%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (7,150)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.16%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:18.96%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (7,081)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.41%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:bottom;width:47.42%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 12pt;">Total capital leases</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.45%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.16%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:18.96%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0pt 0pt;"> 11,735</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.44%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.16%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:18.96%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0pt 0pt;"> 6,221</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.41%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td></tr></table> 18885000 13302000 7150000 7081000 11735000 6221000 1300000 3500000 1400000 3500000 <p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Future minimum lease payments for fiscal years beginning with remainder of fiscal year 2022 for capital leases having initial terms of more than one year and noncancelable operating leases were as follows:</p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:77.28%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:68.43%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.13%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.14%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:11.26%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:0.07%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.99%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:13.94%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:68.43%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.13%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;">    </p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.14%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;">    </p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.26%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.07%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:15.94%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Operating Leases</b></p></td></tr><tr><td style="vertical-align:bottom;width:68.43%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.13%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:13.41%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Capital Leases</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.07%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:15.94%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Minimum Lease</b></p></td></tr><tr><td style="vertical-align:bottom;width:68.43%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><i style="font-style:italic;">in thousands</i></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.13%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:13.41%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Obligations</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.07%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:15.94%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Payments</b></p></td></tr><tr><td style="vertical-align:bottom;width:68.43%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Amount remaining in 2022</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.13%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.14%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.26%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0pt 0pt;"> 958</p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.07%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.99%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.94%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0pt 0pt;"> 1,203</p></td></tr><tr><td style="vertical-align:bottom;width:68.43%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">2023</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.13%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.14%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.26%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0pt 0pt;"> 4,405</p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.07%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.99%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.94%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0pt 0pt;"> 4,872</p></td></tr><tr><td style="vertical-align:bottom;width:68.43%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">2024</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.13%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.14%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.26%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0pt 0pt;"> 3,909</p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.07%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.99%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.94%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0pt 0pt;"> 4,582</p></td></tr><tr><td style="vertical-align:bottom;width:68.43%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">2025</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.13%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.14%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.26%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0pt 0pt;"> 3,126</p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.07%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.99%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.94%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0pt 0pt;"> 4,122</p></td></tr><tr><td style="vertical-align:bottom;width:68.43%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">2026</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.13%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.14%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.26%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0pt 0pt;"> 2,092</p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.07%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.99%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.94%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0pt 0pt;"> 4,061</p></td></tr><tr><td style="vertical-align:bottom;width:68.43%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Thereafter</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.13%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.14%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.26%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0pt 0pt;"> 1,927</p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.07%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.99%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.94%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0pt 0pt;"> 14,029</p></td></tr><tr><td style="vertical-align:bottom;width:68.43%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 12pt;">Total</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.13%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.14%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.26%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0pt 0pt;"> 16,417</p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.07%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.99%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.94%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0pt 0pt;"> 32,869</p></td></tr><tr><td style="vertical-align:bottom;width:68.43%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Less amount representing interest</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.13%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.14%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.26%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (2,912)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.07%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.99%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.94%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;">  </p></td></tr><tr><td style="vertical-align:bottom;width:68.43%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 12pt;">Total minimum lease payments</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.13%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.14%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.26%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0pt 0pt;"> 13,498</p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.07%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.99%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.94%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;">  </p></td></tr><tr><td style="vertical-align:bottom;width:68.43%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Less current maturities</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.13%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.14%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.26%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (3,216)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.07%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.99%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.94%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;">  </p></td></tr><tr><td style="vertical-align:bottom;width:68.43%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Noncurrent maturities</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.13%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.14%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.26%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0pt 0pt;"> 10,282</p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.07%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.99%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.94%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;">  </p></td></tr></table> <table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:77.28%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:68.43%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.13%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.14%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:11.26%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:0.07%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.99%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:13.94%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:68.43%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.13%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;">    </p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.14%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;">    </p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.26%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.07%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:15.94%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Operating Leases</b></p></td></tr><tr><td style="vertical-align:bottom;width:68.43%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.13%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:13.41%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Capital Leases</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.07%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:15.94%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Minimum Lease</b></p></td></tr><tr><td style="vertical-align:bottom;width:68.43%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><i style="font-style:italic;">in thousands</i></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.13%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:13.41%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Obligations</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.07%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:15.94%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Payments</b></p></td></tr><tr><td style="vertical-align:bottom;width:68.43%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Amount remaining in 2022</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.13%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.14%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.26%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0pt 0pt;"> 958</p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.07%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.99%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.94%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0pt 0pt;"> 1,203</p></td></tr><tr><td style="vertical-align:bottom;width:68.43%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">2023</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.13%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.14%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.26%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0pt 0pt;"> 4,405</p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.07%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.99%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.94%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0pt 0pt;"> 4,872</p></td></tr><tr><td style="vertical-align:bottom;width:68.43%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">2024</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.13%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.14%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.26%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0pt 0pt;"> 3,909</p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.07%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.99%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.94%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0pt 0pt;"> 4,582</p></td></tr><tr><td style="vertical-align:bottom;width:68.43%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">2025</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.13%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.14%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.26%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0pt 0pt;"> 3,126</p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.07%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.99%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.94%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0pt 0pt;"> 4,122</p></td></tr><tr><td style="vertical-align:bottom;width:68.43%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">2026</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.13%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.14%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.26%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0pt 0pt;"> 2,092</p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.07%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.99%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.94%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0pt 0pt;"> 4,061</p></td></tr><tr><td style="vertical-align:bottom;width:68.43%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Thereafter</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.13%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.14%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.26%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0pt 0pt;"> 1,927</p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.07%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.99%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.94%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0pt 0pt;"> 14,029</p></td></tr><tr><td style="vertical-align:bottom;width:68.43%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 12pt;">Total</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.13%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.14%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.26%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0pt 0pt;"> 16,417</p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.07%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.99%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.94%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0pt 0pt;"> 32,869</p></td></tr><tr><td style="vertical-align:bottom;width:68.43%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Less amount representing interest</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.13%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.14%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.26%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (2,912)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.07%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.99%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.94%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;">  </p></td></tr><tr><td style="vertical-align:bottom;width:68.43%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 12pt;">Total minimum lease payments</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.13%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.14%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.26%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0pt 0pt;"> 13,498</p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.07%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.99%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.94%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;">  </p></td></tr><tr><td style="vertical-align:bottom;width:68.43%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Less current maturities</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.13%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.14%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.26%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (3,216)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.07%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.99%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.94%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;">  </p></td></tr><tr><td style="vertical-align:bottom;width:68.43%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Noncurrent maturities</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.13%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.14%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.26%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0pt 0pt;"> 10,282</p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.07%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.99%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.94%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;">  </p></td></tr></table> 958000 1203000 4405000 4872000 3909000 4582000 3126000 4122000 2092000 4061000 1927000 14029000 16417000 32869000 2912000 13498000 3216000 10282000 <p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">Note</b> <b style="font-weight:bold;">8. Long Term Debt</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Long-term debt consisted of the following at March 31, 2022 and June 30, 2021:</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;min-height:0.0pt;margin:0pt;"><span style="font-size:0pt;visibility:hidden;">​</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:80%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:40.69%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:11.38%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:0.69%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:17.1%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.53%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.39%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:12.29%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.53%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.3%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:10.71%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.35%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:40.69%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.38%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Interest rate</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.69%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:17.1%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Maturity date</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.53%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:13.68%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">March 31, 2022</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.53%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:12.01%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">June 30, 2021</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.35%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td></tr><tr style="height:0pt;visibility:hidden;"><td colspan="11" style="padding:0pt;"/></tr><tr><td style="vertical-align:bottom;width:40.69%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;width:11.38%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;width:0.69%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;width:17.1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.53%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="5" style="vertical-align:bottom;white-space:nowrap;width:27.23%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><i style="font-style:italic;">in thousands</i></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.35%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:bottom;width:40.69%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Senior secured borrowings:</p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.38%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.69%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:17.1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.53%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.39%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.29%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.53%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.3%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.71%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.35%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:bottom;width:40.69%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;">Term Loan Facility</p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.38%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;">(a)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.69%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:17.1%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;">March 8, 2026</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.53%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.39%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.29%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0pt 0pt;"> 72,188</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.53%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.3%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.71%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0pt 0pt;"> 75,000</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.35%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:bottom;width:40.69%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;">Revolving Credit Facility (b)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.38%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;">(a)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.69%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:17.1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;">March 8, 2026</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.53%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.39%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.29%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0pt 0pt;"> —</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.53%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.3%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.71%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0pt 0pt;"> —</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.35%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:bottom;width:40.69%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Convertible term loan</p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.38%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;">6.68%</p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.69%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:17.1%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;">August 20, 2030</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.53%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.39%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.29%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0pt 0pt;"> 2,338</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.53%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.3%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.71%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0pt 0pt;"> 2,367</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.35%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:bottom;width:40.69%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 12pt;">Total debt</p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.38%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.69%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:17.1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.53%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.39%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.29%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0pt 0pt;"> 74,526</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.53%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.3%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.71%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0pt 0pt;"> 77,367</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.35%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:bottom;width:40.69%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Less unamortized debt issuance costs</p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.38%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.69%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:17.1%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.53%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.39%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.29%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0pt 0pt;"> 1,681</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.53%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.3%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.71%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0pt 0pt;"> 2,003</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.35%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:bottom;width:40.69%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Less current maturities</p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.38%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.69%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:17.1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.53%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.39%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.29%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0pt 0pt;"> 3,793</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.53%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.3%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.71%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0pt 0pt;"> 3,790</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.35%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:bottom;width:40.69%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Noncurrent maturities</p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.38%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.69%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:17.1%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.53%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.39%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.29%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0pt 0pt;"> 69,051</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.53%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.3%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.71%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0pt 0pt;"> 71,574</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.35%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td></tr></table><div style="font-family:'Times New Roman','Times','serif';font-size:10.0pt;margin-bottom:0pt;margin-top:0pt;min-height:1.19em;position:relative;width:100%;"><div style="background-color:#000000;height:1px;position:relative;top:0.6em;width:25.0%;border:none;margin:0 auto 0 0;"/></div><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:22.5pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:8pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">(a)</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:8pt;font-style:normal;font-weight:normal;">The interest rates on the Term Loan Facility and Revolving Credit Facility are described below.</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:22.5pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:8pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">(b)</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:8pt;font-style:normal;font-weight:normal;">The remaining capacity under the Revolving Credit Facility as of March 31, 2022 was </span><span style="font-family:'Times New Roman','Times','serif';font-size:8pt;font-style:normal;font-weight:normal;">$100.0</span><span style="font-family:'Times New Roman','Times','serif';font-size:8pt;font-style:normal;font-weight:normal;"> million, subject to (i) any issued amounts under our letters of credit, which as of March 31, 2022 was </span><span style="font-family:'Times New Roman','Times','serif';font-size:8pt;font-style:normal;font-weight:normal;">$2.6</span><span style="font-family:'Times New Roman','Times','serif';font-size:8pt;font-style:normal;font-weight:normal;"> million, and (ii) applicable covenant compliance restrictions and any other conditions precedent to borrowing.</span></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:9.35pt;margin:0pt;"><span style="font-style:italic;margin-bottom:12pt;visibility:hidden;">​</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 12pt 0pt;"><i style="font-style:italic;">2016 Credit Agreement </i></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">The Company originally entered into a senior secured borrowing agreement (the “2016 Credit Agreement”) on May 13, 2016, that consisted of a senior secured term loan for $75.0 million and a revolving credit facility for $20.0 million. The 2016 Credit Agreement was subsequently amended (i) on May 2, 2019 to increase the senior secured term loan to $190.0 million and a revolving credit facility for $30.0 million and a delayed draw term loan facility (“DDTL”) for $45.0 million and (ii) on July 27, 2020, to increase the senior secured term loan to $300.0 million, the revolving credit facility to $40.0 million and to <span style="-sec-ix-hidden:Hidden_ooJbu5IsY0G2hsKQIRIa8A;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">terminate</span></span> the DDTL.  The structure of the July 27, 2020 amendment to the 2016 Credit Agreement led to an extinguishment of debt for certain lenders and a modification of debt for other lenders. The total debt structure extinguishment for certain lenders was $57.1 million, and the write off of $1.0 million in debt issuance costs was recorded in loss on extinguishment of debt for the nine months ended March 31, 2021. The total debt structure that was modified was $250.0 million, while the new debt issued was $50.0 million, which resulted in $9.1 million of  capitalized debt issuance costs. Total amortization of deferred financing costs was $0.9 million for the nine months ended March 31, 2021.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Concurrent with the Company’s entry into the 2021 Credit Agreement (as defined below), the Company terminated and repaid in full all outstanding indebtedness under the 2016 Credit Agreement.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 12pt 0pt;"><i style="font-style:italic;">2021 Credit Agreement </i></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">On March 8, 2021, concurrently with the closing of the IPO, the Company entered into a new credit agreement (the “2021 Credit Agreement”) that replaced the 2016 Credit Agreement. The 2021 Credit Agreement consists of a senior secured term loan (the “Term Loan Facility”) of $75.0 million principal amount and a revolving credit facility (the “Revolving Credit Facility”) of $100.0 million maximum borrowing capacity. Loans under the 2021 Credit Agreement are secured by substantially all of the Company’s assets. Principal on the Term Loan Facility is paid each calendar quarter beginning September 2021 in an amount equal to 1.25% of the initial term loan on closing date. Proceeds of the Term Loan Facility, together with proceeds from the IPO, were used to repay amounts outstanding under the 2016 Credit Agreement.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Outstanding principal amounts under the 2021 Credit Agreement accrue interest at a variable interest rate. As of March 31, 2022, the interest rate on the Term Loan Facility was 2.21%. Under the terms of the 2021 Credit Agreement, the Revolving Credit Facility fee accrues at 0.25% of the average daily unused amount and is paid quarterly. As of March 31, 2022, we had no borrowings outstanding under the Revolving Credit Facility.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">The 2021 Credit Agreement requires the Company to meet certain operational and reporting requirements, including, but not limited to, a secured net leverage ratio. Additionally, annual capital expenditures and permitted investments, including acquisitions, are limited to amounts specified in the 2021 Credit Agreement. The 2021 Credit Agreement also provides certain restrictions on dividend payments and other equity transactions and requires the Company to make prepayments under specified circumstances. As of March 31, 2022, the Company was in compliance with the covenants of the 2021 Credit Agreement.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">The deferred financing costs of $2.0 million are amortized over the term of the underlying debt and unamortized amounts have been offset against long-term debt in the consolidated balance sheets. Total amortization of deferred financing costs was $0.3 million for the nine months ended March 31, 2022. </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 12pt 0pt;"><i style="font-style:italic;white-space:pre-wrap;"> </i><i style="font-style:italic;">Convertible Term Loan</i></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:21.6pt;margin:0pt;">On June 29, 2015, SH1 entered into a convertible term loan. Monthly principal and interest payments of $0.02 million commenced on September 1, 2015. The loan is secured by a deed of trust to Public Trustee, assignment of leases and rents, security agreements, and SH1’s fixture filing. </p> <p style="font-family:'Times New Roman','Times','serif';font-size:10pt;min-height:0.0pt;margin:0pt;"><span style="font-size:0pt;visibility:hidden;">​</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:80%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:40.69%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:11.38%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:0.69%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:17.1%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.53%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.39%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:12.29%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.53%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.3%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:10.71%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.35%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:40.69%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.38%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Interest rate</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.69%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:17.1%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Maturity date</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.53%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:13.68%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">March 31, 2022</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.53%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:12.01%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">June 30, 2021</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.35%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td></tr><tr style="height:0pt;visibility:hidden;"><td colspan="11" style="padding:0pt;"/></tr><tr><td style="vertical-align:bottom;width:40.69%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;width:11.38%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;width:0.69%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;width:17.1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.53%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="5" style="vertical-align:bottom;white-space:nowrap;width:27.23%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><i style="font-style:italic;">in thousands</i></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.35%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:bottom;width:40.69%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Senior secured borrowings:</p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.38%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.69%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:17.1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.53%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.39%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.29%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.53%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.3%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.71%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.35%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:bottom;width:40.69%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;">Term Loan Facility</p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.38%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;">(a)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.69%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:17.1%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;">March 8, 2026</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.53%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.39%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.29%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0pt 0pt;"> 72,188</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.53%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.3%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.71%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0pt 0pt;"> 75,000</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.35%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:bottom;width:40.69%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;">Revolving Credit Facility (b)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.38%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;">(a)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.69%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:17.1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;">March 8, 2026</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.53%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.39%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.29%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0pt 0pt;"> —</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.53%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.3%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.71%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0pt 0pt;"> —</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.35%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:bottom;width:40.69%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Convertible term loan</p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.38%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;">6.68%</p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.69%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:17.1%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;">August 20, 2030</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.53%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.39%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.29%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0pt 0pt;"> 2,338</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.53%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.3%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.71%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0pt 0pt;"> 2,367</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.35%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:bottom;width:40.69%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 12pt;">Total debt</p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.38%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.69%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:17.1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.53%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.39%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.29%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0pt 0pt;"> 74,526</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.53%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.3%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.71%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0pt 0pt;"> 77,367</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.35%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:bottom;width:40.69%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Less unamortized debt issuance costs</p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.38%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.69%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:17.1%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.53%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.39%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.29%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0pt 0pt;"> 1,681</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.53%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.3%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.71%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0pt 0pt;"> 2,003</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.35%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:bottom;width:40.69%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Less current maturities</p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.38%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.69%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:17.1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.53%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.39%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.29%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0pt 0pt;"> 3,793</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.53%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.3%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.71%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0pt 0pt;"> 3,790</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.35%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:bottom;width:40.69%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Noncurrent maturities</p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.38%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.69%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:17.1%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.53%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.39%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.29%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0pt 0pt;"> 69,051</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.53%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.3%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.71%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0pt 0pt;"> 71,574</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.35%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td></tr></table><div style="font-family:'Times New Roman','Times','serif';font-size:10.0pt;margin-bottom:0pt;margin-top:0pt;min-height:1.19em;position:relative;width:100%;"><div style="background-color:#000000;height:1px;position:relative;top:0.6em;width:25.0%;border:none;margin:0 auto 0 0;"/></div><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:22.5pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:8pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">(a)</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:8pt;font-style:normal;font-weight:normal;">The interest rates on the Term Loan Facility and Revolving Credit Facility are described below.</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:22.5pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:8pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">(b)</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:8pt;font-style:normal;font-weight:normal;">The remaining capacity under the Revolving Credit Facility as of March 31, 2022 was </span><span style="font-family:'Times New Roman','Times','serif';font-size:8pt;font-style:normal;font-weight:normal;">$100.0</span><span style="font-family:'Times New Roman','Times','serif';font-size:8pt;font-style:normal;font-weight:normal;"> million, subject to (i) any issued amounts under our letters of credit, which as of March 31, 2022 was </span><span style="font-family:'Times New Roman','Times','serif';font-size:8pt;font-style:normal;font-weight:normal;">$2.6</span><span style="font-family:'Times New Roman','Times','serif';font-size:8pt;font-style:normal;font-weight:normal;"> million, and (ii) applicable covenant compliance restrictions and any other conditions precedent to borrowing.</span></td></tr></table> 72188000 75000000 0.0668 0.0668 2338000 2367000 74526000 77367000 -1681000 -2003000 3793000 3790000 69051000 71574000 100000000.0 2600000 75000000.0 20000000.0 190000000.0 30000000.0 45000000.0 300000000.0 40000000.0 57100000 -1000000.0 250000000.0 50000000.0 9100000 900000 75000000.0 100000000.0 0.0125 0.0221 0.0025 0 2000000.0 300000 20000.00 <p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;">Note 9: Commitments and Contingencies</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;padding-left:54pt;text-indent:-54pt;margin:0pt 0pt 12pt 0pt;">Professional Liability</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">The Company pays fixed premiums for annual professional liability insurance coverage under a claims-made policy. Under such policy, only claims made and reported to the insurer are covered during the policy term, regardless of when the incident giving rise to the claim occurred. The Company records claim liabilities and expected recoveries, if any, at gross amounts. The Company is not currently aware of any unasserted claims or unreported incidents that are expected to exceed medical malpractice insurance coverage limits.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;padding-left:54pt;text-indent:-54pt;margin:0pt 0pt 12pt 0pt;">Litigation</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:21.6pt;margin:0pt;">From time to time, in the normal course of business, the Company is involved in or subject to legal proceedings related to its business, including those described below. The Company regularly evaluates the status of claims and legal proceedings in which it is involved in order to assess whether a loss is probable or there is a reasonable possibility that a loss may have been incurred, and to determine if accruals are appropriate. The Company expenses legal costs as such costs are incurred.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:21.6pt;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">​</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:21.6pt;margin:0pt;">On October 14, 2021, the Company was named as a defendant in a putative class action complaint filed in the District Court for the District of Colorado on behalf of individuals who purchased or acquired shares of the Company’s common stock during a specified period. Through the complaint, plaintiffs are asserting claims against the Company, certain of the Company’s officers and the underwriters in the Company’s IPO, alleging violations of Sections 11 and 15 of the Securities Act of 1933 for making allegedly inaccurate and misleading statements and omissions in connection with the Company’s IPO and seeking compensatory damages, among other things. The plaintiffs have indicated that they intend to file an amended complaint on or before June 14, 2022. We are currently unable to predict the outcome of this matter.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:21.6pt;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">​</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt;"><span style="display:inline-block;text-align:left;width:18pt;"/><span style="letter-spacing:0.2pt;">In July 2021, the Company received a civil investigative demand from the Attorney General for the State of Colorado under the Colorado Medicaid False Claims Act. The demand requests information and documents regarding Medicaid billing, patient services and referrals in connection with the Company’s PACE program in Colorado. We continue to fully cooperate with the Attorney General and produce the requested information and documentation. We are currently unable to predict the outcome of this investigation.</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt;"><span style="letter-spacing:0.2pt;"> </span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt;"><span style="display:inline-block;text-align:left;width:18pt;"/><span style="letter-spacing:0.2pt;">In February 2022, the Company received a civil investigative demand from the Department of Justice (“DOJ”) under the Federal False Claims Act on similar subject matter.  The demand requests information and documents regarding audits, billing, orders tracking, and quality and timeliness of patient services in connection with the Company’s PACE programs in the states where the Company operates (California, Colorado, New Mexico, Pennsylvania, and Virginia).  </span><span style="letter-spacing:0.2pt;">The Company is fully cooperating with the DOJ to produce the requested information and documentation.  We are currently unable to predict the outcome of this investigation.</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt;"><span style="letter-spacing:0.2pt;margin-bottom:12pt;visibility:hidden;">​</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt;"><span style="display:inline-block;text-align:left;width:18pt;"/><span style="letter-spacing:0.2pt;">On April 20, 2022, the Board of Directors of the Company received a books and records demand pursuant to Section 220 of the Delaware General Corporation Law, from a purported stockholder of the Company, in connection with the stockholder’s investigation of, among other matters, potential breaches of fiduciary duty, mismanagement, self-dealing, corporate waste or other violations of law by the Company’s Board with respect to these matters. We are currently unable to predict the outcome of this matter.</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:21.6pt;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">​</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt;"><span style="display:inline-block;text-align:left;width:18pt;"/><span style="letter-spacing:0.2pt;">Although the results of legal proceedings and claims are inherently unpredictable and uncertain, we do not believe that the outcomes of the legal proceedings with which we are currently involved, based on the currently available information, either individually or in the aggregate, will have a material adverse effect on our business,</span> <span style="letter-spacing:0.2pt;">financial condition, or cash flows, though the outcomes could be material to the Company’s operating results for any particular period; depending in part, upon the operating results of such period. Regardless of the outcome, litigation has the potential to have an adverse impact on us due to any related defense and settlement costs, diversion of management resources, and other factors. </span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:21.6pt;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">​</span></p> <p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;"><span style="display:inline-block;text-indent:0pt;width:36pt;"><b style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:bold;">Note 10:</b></span> Equity</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;padding-left:18pt;text-indent:-18pt;margin:0pt 0pt 12pt 0pt;">Equity Owner Transaction</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">On July 27, 2020, InnovAge Holding Corp. (formerly TCO Group Holdings, Inc.), Ignite Aggregator LP (“Purchaser”), and the former equity holders of InnovAge Holding Corp. (“Sellers”) entered into a Securities Purchase Agreement (the “Agreement”), effective July 27, 2020. Under the terms of the Agreement, the Sellers sold a portion of their equity interest to the Purchaser. The Purchaser and the Sellers then contributed their equity interests in the Company to a newly formed limited partnership, TCO Group Holdings, L.P. (the “LP”) resulting in the Company being wholly owned by the LP.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Concurrently with the entry into the Agreement, the Company amended and restated its 2016 Credit Agreement, see Note 8, “Long Term Debt” for further discussion. A portion of the proceeds from the 2016 Credit Agreement were used by the Company to repurchase 16,095,819 shares of its common stock for $77.6 million from certain members of management, including certain members of the Board of Directors, and certain members of our equity partner. The common stock was then recognized as Treasury stock. The Treasury stock was retired in March 2021.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Additionally, as part of the Agreement, the Company executed an Option Cancellation Agreement (the “Cancellation Agreement”), which canceled the Company’s common stock option awards of 16,994,975 granted under the 2016 Equity Incentive Plan for $74.6 million. Such cancellation resulted in a settlement of the awards. Vesting of the contingent performance-based awards was not deemed probable at the time of the settlement resulting in the settlement of the contingent performance-based awards being recorded as Corporate, general and administrative. Vesting of the time vesting awards was deemed probable at the time of the settlement resulting in a portion of the settlement of the time vesting awards being recorded as Corporate, general and administrative expense and the remainder being recorded as a reduction to Additional paid-in capital. Of the total settlement, $45.4 million was recorded as Corporate, general and administrative expense and $32.4 million was recorded as a reduction to Additional paid-in capital. The Cancellation Agreement resulted in the option holders receiving the same amount of cash that they would have received had they exercised their options, participated in the repurchase described above and sold their remaining shares.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">As part of the transaction, for the nine months ended March 31, 2021, the Company incurred $22.6 million in transaction costs, of which $13.1 million was recognized as Corporate, general and administrative expense and $9.5 million was recognized as a distribution to owners as the costs were paid on behalf of the owners. These costs were recorded during the nine months ended March 31, 2021.</p> 16095819 77600000 16994975 74600000 45400000 32400000 22600000 13100000 9500000 <p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;"><span style="display:inline-block;text-indent:0pt;width:36pt;"><b style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:bold;">Note 11:</b></span> Stock-based Compensation</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">A summary of our aggregate stock-based compensation expense is set forth below. Stock-based compensation expense is included in corporate, general and administrative expenses on our consolidated statements of operations.</p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:80%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:70.23%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.17%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.36%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:10.3%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.17%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.36%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:10.19%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.17%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:70.23%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:11pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.17%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:11pt;visibility:hidden;">​</span></p></td><td colspan="5" style="vertical-align:bottom;white-space:nowrap;width:25.4%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Nine Months Ended </b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.17%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:bottom;width:70.23%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:11pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.17%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:11pt;visibility:hidden;">​</span></p></td><td colspan="5" style="vertical-align:bottom;white-space:nowrap;width:25.4%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">March 31, </b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.17%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:70.23%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;margin:0pt;"><i style="font-style:italic;">in thousands</i></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.17%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:11.66%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">2022</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.17%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">    </b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:11.56%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">2021</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.17%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:bottom;width:70.23%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.17%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.36%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:9pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.3%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:9pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.17%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:9pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.36%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:9pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.19%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:9pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.17%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:bottom;width:70.23%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Stock options (a)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.17%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.36%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.3%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0pt 0pt;"> 359</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.17%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.36%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.19%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0pt 0pt;"> 45,387</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.17%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:bottom;width:70.23%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Profits interests units</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.17%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.36%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.3%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0pt 0pt;"> 1,095</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.17%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.36%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.19%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0pt 0pt;"> 1,102</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.17%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:bottom;width:70.23%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Restricted stock units</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.17%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.36%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.3%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0pt 0pt;"> 1,132</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.17%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.36%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.19%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0pt 0pt;"> —</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.17%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:bottom;width:70.23%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;">Total stock-based compensation expense</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.17%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.36%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.3%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0pt 0pt;"> 2,586</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.17%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.36%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.19%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0pt 0pt;"> 46,489</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.17%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td></tr></table><div style="font-family:'Times New Roman','Times','serif';font-size:10.0pt;margin-bottom:0pt;margin-top:0pt;min-height:1.19em;position:relative;width:100%;"><div style="background-color:#000000;height:1px;position:relative;top:0.6em;width:25.0%;border:none;margin:0 auto 0 0;"/></div><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:36pt;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">​</span></p><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:22.5pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:8pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">(a)</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:8pt;font-style:normal;font-weight:normal;">The amount for 2021 relates to stock-based compensation expense recognized as a result of the Cancellation Agreement.</span></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 12pt 0pt;"><i style="font-style:italic;">2016 Equity Incentive Plan</i></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:18pt;margin:0pt;">The Company maintained the 2016 Equity Incentive Plan pursuant to which various stock-based awards were granted to employees, directors, consultants, and advisers. The total number of shares of the Company’s common stock that was authorized under the 2016 Equity Incentive Plan was 17,836,636, of which a total of 16,994,976 awards were granted. On July 27, 2020, the Company, Ignite Aggregator LP, and the equity holders of the Company entered into a Securities Purchase Agreement, and in conjunction therewith, the Company amended and restated the 2016 Credit Agreement. A portion of the proceeds from the 2016 Credit Agreement were used by the Company to repurchase 16,095,819 shares of its common stock from the certain members of management, the Board of Directors, and members of our equity partner. Additionally, as part of the 2016 Credit Agreement, <span style="letter-spacing:0.2pt;">the Company executed the Cancellation Agreement</span> <span style="letter-spacing:0.2pt;">with each of the 2016 Equity Incentive Plan option holders,</span> pursuant to which the Company’s 16,994,976 common stock options which were granted under the 2016 Equity Incentive Plan, were cancelled. The Cancellation Agreement resulted in the option holders receiving the same amount of cash that they would have received had they exercised their options, </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">participated in the repurchase described above and sold their remaining shares. The 2016 Equity Incentive Plan was cancelled and replaced with the 2020 Equity Incentive Plan, as described below.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 12pt 0pt;"><i style="font-style:italic;">2020 Equity Incentive Plan</i></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;text-align:justify;margin:0pt 0pt 12pt 0pt;"><i style="font-style:italic;font-weight:normal;">Profits Interests </i></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">The LP maintains the 2020 Equity Incentive Plan pursuant to which interests in the LP in the form of Class B Units (profits interests) may be granted to employees, directors, consultants, and advisers. A maximum number of 16,162,177 Class B Units are authorized for grant under the 2020 Equity Incentive Plan. As of March 31, 2022, a total of 13,009,137 profits interests units have been granted under the 2020 Equity Incentive Plan.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">The Company used the Monte Carlo option model to determine the fair value of the profits interests units at the time of the grant. There were no grants during the nine months ended March 31, 2022. </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">A summary of profits interests activity for the nine months ended March 31, 2022 was as follows:</p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:80%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:62.92%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:12.67%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.75%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:18.53%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:62.92%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">    </b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.67%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;">    </p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.75%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;">  </p></td><td style="vertical-align:bottom;white-space:nowrap;width:18.53%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:bottom;width:62.92%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:9pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:9pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.67%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Number of</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:9pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:20.28%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Weighted average</b></p></td></tr><tr><td style="vertical-align:bottom;width:62.92%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;margin:0pt;"><b style="font-weight:bold;">Time-based unit awards</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:9pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.67%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">units</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:9pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:20.28%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">grant date fair value</b></p></td></tr><tr><td style="vertical-align:bottom;width:62.92%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.67%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.75%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:18.53%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:bottom;width:62.92%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Outstanding balance, June 30, 2021</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.67%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0pt 0pt;"> 6,587,261</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.75%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:18.53%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0pt 0pt;"> 1.28</p></td></tr><tr><td style="vertical-align:bottom;width:62.92%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;">Forfeited</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.67%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (2,409,972)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.75%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:18.53%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0pt 0pt;"> 1.28</p></td></tr><tr><td style="vertical-align:bottom;width:62.92%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Outstanding balance, March 31, 2022</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.67%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0pt 0pt;"> 4,177,289</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.75%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:18.53%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0pt 0pt;"> 1.28</p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:18pt;margin:0pt;"><span style="visibility:hidden;">​</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:80.13%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:66.38%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:0.64%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:12.65%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:0.07%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.74%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:18.5%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:66.38%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:9pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:9pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.65%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Number of</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.07%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:9pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:20.24%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Weighted average</b></p></td></tr><tr><td style="vertical-align:bottom;width:66.38%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Performance-based unit awards</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:9pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.65%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">units</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.07%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:9pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:20.24%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">grant date fair value</b></p></td></tr><tr><td style="vertical-align:bottom;width:66.38%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.65%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.07%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.74%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:18.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:bottom;width:66.38%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Outstanding balance, June 30, 2021</p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.65%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0.05pt 0pt;"> 6,223,262</p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.07%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.74%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:18.5%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0.05pt 0pt;"> 0.57</p></td></tr><tr><td style="vertical-align:bottom;width:66.38%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 6pt;">Forfeited</p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.65%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (3,210,939)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.07%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.74%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:18.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0.05pt 0pt;"> 0.57</p></td></tr><tr><td style="vertical-align:bottom;width:66.38%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Outstanding balance, March 31, 2022</p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.65%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0.05pt 0pt;"> 3,012,323</p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.07%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.74%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:18.5%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0.05pt 0pt;"> 0.57</p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:18pt;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">​</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">The total unrecognized compensation cost related to profits interests units outstanding as of March 31, 2022 was $6.4 million, comprised (i) $4.3 million related to time-based unit awards expected to be recognized over a weighted-average period of 0.9 years and (ii) $2.1 million related to performance-based unit awards, which will be recorded when it is probable that the performance-based criteria will be met.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 12pt 0pt;"><i style="font-style:italic;">2021 Omnibus Incentive Plan</i></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">In March 2021, the compensation committee of our Board of Directors approved the InnovAge Holding Corp. 2021 Omnibus Incentive Plan (the “2021 Omnibus Incentive Plan”), pursuant to which various stock-based awards may be granted to employees, directors, consultants, and advisers. The total number of shares of the Company’s common stock authorized under the 2021 Omnibus Incentive Plan is 14,700,000. The Company has issued time-based restricted stock units under this plan to its employees which generally vest (i) on March 4, 2023, the second anniversary of the grant date, or (ii) over a three-year period with <span style="-sec-ix-hidden:Hidden_fYKUUlBL5kiKH6jWju6Idg;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">one</span></span>-third vesting on each anniversary of the date of grant. Certain other vesting periods have also been used. The grant date fair value of restricted stock units with time based vesting is based on the closing market price of our common stock on the date of grant. Certain awards under this plan vest upon achieving specific share price performance critiera and are determined to have performance-based vesting conditions.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;"><i style="font-style:italic;">Restricted Stock Units</i></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">A summary of time-based vesting restricted stock units activity for the nine months ended March 31, 2022 was as follows: </p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:80%;"><tr style="height:1pt;"><td style="vertical-align:bottom;white-space:nowrap;width:67.97%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.39%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:11.32%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.31%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.8%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:15.19%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:67.97%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.39%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.32%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.31%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.8%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:9pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:15.19%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Weighted</b></p></td></tr><tr><td style="vertical-align:bottom;width:67.97%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:9pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.39%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.32%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.31%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;margin:0pt 0pt 0.05pt 0pt;">    </p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.8%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:9pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:15.19%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">average</b></p></td></tr><tr><td style="vertical-align:bottom;width:67.97%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:9pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.39%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:9pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.32%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Number of</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.31%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:9pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.8%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:9pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:15.19%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">grant-date fair</b></p></td></tr><tr><td style="vertical-align:bottom;width:67.97%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Restricted stock units - time based</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.39%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:9pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.32%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">awards</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.31%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:9pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.8%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:9pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:15.19%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">value per share</b></p></td></tr><tr><td style="vertical-align:bottom;width:67.97%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:9pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.39%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:9pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.32%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:9pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.31%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:9pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.8%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:9pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:15.19%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:9pt;font-weight:bold;visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:bottom;width:67.97%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Outstanding balance, June 30, 2021</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.39%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.32%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0.05pt 0pt;"> 48,470</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.31%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.8%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:15.19%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0.05pt 0pt;"> 22.87</p></td></tr><tr><td style="vertical-align:bottom;width:67.97%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 6pt;">Granted</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.39%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.32%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0.05pt 0pt;"> 315,177</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.31%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.8%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:15.19%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0.05pt 0pt;"> 8.99</p></td></tr><tr><td style="vertical-align:bottom;width:67.97%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 6pt;">Forfeited</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.39%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.32%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (9,670)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.31%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.8%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:15.19%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0.05pt 0pt;"> 23.35</p></td></tr><tr><td style="vertical-align:bottom;width:67.97%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 6pt;">Exercised</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.39%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.32%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (8,493)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.31%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.8%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:15.19%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0.05pt 0pt;"> 17.66</p></td></tr><tr><td style="vertical-align:bottom;width:67.97%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Outstanding balance, March 31, 2022</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.39%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.32%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0.05pt 0pt;"> 345,484</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.31%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.8%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:15.19%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0.05pt 0pt;"> 10.50</p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;text-indent:21.6pt;margin:0pt;"><span style="font-weight:normal;margin-bottom:12pt;visibility:hidden;">​</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">The total unrecognized compensation cost related to time based restricted stock units outstanding as of March 31, 2022 was $4.0 million and is expected to be recognized over a weighted-average period of 2.0 years.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">A summary of performance based vesting restricted stock units activity for the nine months ended March 31, 2022 was as follows: </p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:80%;"><tr style="height:1pt;"><td style="vertical-align:bottom;white-space:nowrap;width:67.97%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.39%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:11.32%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.31%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.8%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:15.19%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:67.97%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.39%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.32%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.31%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.8%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:9pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:15.19%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Weighted</b></p></td></tr><tr><td style="vertical-align:bottom;width:67.97%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:9pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.39%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.32%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.31%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;margin:0pt;">    </p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.8%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:9pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:15.19%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">average</b></p></td></tr><tr><td style="vertical-align:bottom;width:67.97%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:9pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.39%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:9pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.32%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Number of</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.31%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:9pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.8%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:9pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:15.19%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">grant-date fair</b></p></td></tr><tr><td style="vertical-align:bottom;width:67.97%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;margin:0pt;"><b style="font-weight:bold;">Restricted stock units - performance based</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.39%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:9pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.32%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">awards</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.31%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:9pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.8%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:9pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:15.19%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">value per share</b></p></td></tr><tr><td style="vertical-align:bottom;width:67.97%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:9pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.39%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:9pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.32%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:9pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.31%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:9pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.8%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:9pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:15.19%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:9pt;font-weight:bold;visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:bottom;width:67.97%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Outstanding balance, June 30, 2021</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.39%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.32%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0pt 0pt;"> —</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.31%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.8%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:15.19%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0pt 0pt;"> —</p></td></tr><tr><td style="vertical-align:bottom;width:67.97%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;">Granted</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.39%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.32%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0pt 0pt;"> 258,767</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.31%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.8%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:15.19%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0pt 0pt;"> 5.18</p></td></tr><tr><td style="vertical-align:bottom;width:67.97%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;">Forfeited</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.39%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.32%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0pt 0pt;"> —</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.31%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.8%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:15.19%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0pt 0pt;"> —</p></td></tr><tr><td style="vertical-align:bottom;width:67.97%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Outstanding balance, March 31, 2022</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.39%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.32%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0pt 0pt;"> 258,767</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.31%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.8%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:15.19%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0pt 0pt;"> 5.18</p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:18pt;margin:0pt;"><span style="visibility:hidden;">​</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">The fair value of the performance based restricted stock units and performance based stock options granted during the nine months ended March 31, 2022, was based upon a Monte Carlo option pricing model using the assumptions in the following table:</p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:80%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:78.98%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:3.34%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.08%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:13.43%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.15%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:78.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:15.51%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2022</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:bottom;width:78.98%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Expected volatility</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.34%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.08%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.43%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0.05pt 0pt;"> 34.5</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.15%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">%</p></td></tr><tr><td style="vertical-align:bottom;width:78.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Expected term (in years)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.08%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.43%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0.05pt 0pt;"> 5.0</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:bottom;width:78.98%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Interest rate</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.34%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;"> </span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.08%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.43%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0.05pt 0pt;"> 1.56</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.15%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">%</p></td></tr><tr><td style="vertical-align:bottom;width:78.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Dividend yield</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;"> </span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.08%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.43%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0.05pt 0pt;">0</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">%</p></td></tr><tr><td style="vertical-align:bottom;width:78.98%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Weighted-average fair values</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.34%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.08%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.43%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0.05pt 0pt;"> 5.18</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.15%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:bottom;width:78.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Fair value of underlying stock</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;"> </span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.08%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.43%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0.05pt 0pt;"> 7.89</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;visibility:hidden;">​</span></p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;text-indent:21.6pt;margin:0pt;"><span style="font-weight:normal;margin-bottom:12pt;visibility:hidden;">​</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;text-indent:21.6pt;margin:0pt 0pt 12pt 0pt;"><span style="font-weight:normal;">The total unrecognized compensation cost related to performance based vesting restricted stock units outstanding as of March 31, 2022 was </span><span style="font-weight:normal;">$1.2</span><span style="font-weight:normal;"> million and is expected to be recognized over a weighted-average period of </span><span style="font-weight:normal;">3.6</span><span style="font-weight:normal;"> years. </span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;"><i style="font-style:italic;">Nonqualified Stock Options</i></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">A summary of time-based vesting stock option activity for the nine months ended March 31, 2022 was as follows:</p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:80%;"><tr style="height:1pt;"><td style="vertical-align:bottom;white-space:nowrap;width:67.97%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.39%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:11.32%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.31%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.8%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:15.19%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:67.97%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.39%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.32%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.31%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.8%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:9pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:15.19%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Weighted</b></p></td></tr><tr><td style="vertical-align:bottom;width:67.97%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:9pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.39%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.32%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.31%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;margin:0pt 0pt 0.05pt 0pt;">    </p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.8%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:9pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:15.19%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">average</b></p></td></tr><tr><td style="vertical-align:bottom;width:67.97%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:9pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.39%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:9pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.32%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Number of</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.31%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:9pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.8%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:9pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:15.19%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">grant-date fair</b></p></td></tr><tr><td style="vertical-align:bottom;width:67.97%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Stock options - time based</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.39%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:9pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.32%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">awards</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.31%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:9pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.8%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:9pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:15.19%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">value per share</b></p></td></tr><tr><td style="vertical-align:bottom;width:67.97%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:9pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.39%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:9pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.32%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:9pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.31%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:9pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.8%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:9pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:15.19%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:9pt;font-weight:bold;visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:bottom;width:67.97%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Outstanding balance, June 30, 2021</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.39%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.32%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0.05pt 0pt;"> —</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.31%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.8%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:15.19%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0.05pt 0pt;"> —</p></td></tr><tr><td style="vertical-align:bottom;width:67.97%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 6pt;">Granted</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.39%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.32%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0.05pt 0pt;"> 554,499</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.31%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.8%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:15.19%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0.05pt 0pt;"> 1.61</p></td></tr><tr><td style="vertical-align:bottom;width:67.97%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 6pt;">Forfeited</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.39%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.32%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0.05pt 0pt;"> —</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.31%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.8%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:15.19%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0.05pt 0pt;"> —</p></td></tr><tr><td style="vertical-align:bottom;width:67.97%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Outstanding balance, March 31, 2022</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.39%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.32%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0.05pt 0pt;"> 554,499</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.31%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.8%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:15.19%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0.05pt 0pt;"> 1.61</p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt;"><span style="font-weight:normal;margin-bottom:12pt;visibility:hidden;">​</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">The total unrecognized compensation cost related to time-based vesting stock options outstanding as of March 31, 2022 was $0.7 million and is expected to be recognized over a weighted-average period of 2.5 years. </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">The fair value of the time-based stock options granted during the nine months ended March 31, 2022, was based upon the Black-Scholes option pricing model using the assumptions in the following table:</p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:84.38%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:78.99%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:3.35%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.1%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:13.44%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.1%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:78.99%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.35%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:15.54%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">2022</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:bottom;width:78.99%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Expected volatility</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.35%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.1%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.44%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0pt 0pt;"> 34.5</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.1%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">%</p></td></tr><tr><td style="vertical-align:bottom;width:78.99%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Weighted-average expected life (years) - time vesting units</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.35%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0pt 0pt;"> 2.9</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:bottom;width:78.99%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Interest rate</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.35%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;"> </span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.1%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.44%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0pt 0pt;"> 0.83</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.1%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">%</p></td></tr><tr><td style="vertical-align:bottom;width:78.99%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Dividend yield</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.35%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;"> </span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0pt 0pt;">0</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">%</p></td></tr><tr><td style="vertical-align:bottom;width:78.99%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Weighted-average fair values</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.35%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.1%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.44%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0pt 0pt;"> 1.61</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.1%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:bottom;width:78.99%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Fair value of underlying stock</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.35%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;"> </span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0pt 0pt;"> 7.89</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;visibility:hidden;">​</span></p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:18pt;margin:0pt;"><span style="visibility:hidden;">​</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">A summary of performance-based vesting stock option activity for the nine months ended March 31, 2022 was as follows: </p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:80%;"><tr style="height:1pt;"><td style="vertical-align:bottom;white-space:nowrap;width:67.97%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.39%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:11.32%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.31%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.8%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:15.19%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:67.97%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.39%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.32%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.31%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.8%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:9pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:15.19%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Weighted</b></p></td></tr><tr><td style="vertical-align:bottom;width:67.97%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:9pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.39%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.32%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.31%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;margin:0pt;">    </p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.8%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:9pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:15.19%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">average</b></p></td></tr><tr><td style="vertical-align:bottom;width:67.97%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:9pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.39%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:9pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.32%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Number of</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.31%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:9pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.8%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:9pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:15.19%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">grant-date fair</b></p></td></tr><tr><td style="vertical-align:bottom;width:67.97%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;margin:0pt;"><b style="font-weight:bold;">Stock options - performance based</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.39%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:9pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.32%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">awards</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.31%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:9pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.8%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:9pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:15.19%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">value per share</b></p></td></tr><tr><td style="vertical-align:bottom;width:67.97%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:9pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.39%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:9pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.32%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:9pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.31%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:9pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.8%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:9pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:15.19%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:9pt;font-weight:bold;visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:bottom;width:67.97%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Outstanding balance, June 30, 2021</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.39%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.32%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0pt 0pt;"> —</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.31%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.8%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:15.19%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0pt 0pt;"> —</p></td></tr><tr><td style="vertical-align:bottom;width:67.97%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;">Granted</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.39%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.32%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0pt 0pt;"> 776,299</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.31%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.8%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:15.19%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0pt 0pt;"> 3.08</p></td></tr><tr><td style="vertical-align:bottom;width:67.97%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;">Forfeited</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.39%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.32%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0pt 0pt;"> —</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.31%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.8%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:15.19%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0pt 0pt;"> —</p></td></tr><tr><td style="vertical-align:bottom;width:67.97%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Outstanding balance, March 31, 2022</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.39%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.32%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0pt 0pt;"> 776,299</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.31%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.8%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:15.19%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0pt 0pt;"> 3.08</p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:18pt;margin:0pt;"><span style="visibility:hidden;">​</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:18pt;margin:0pt;">The fair value of the performance-based stock options granted during the nine months ended March 31, 2022, was based upon a Monte Carlo option pricing model using the assumptions in the table above under the ‘Restricted Stock Units’ heading.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:18pt;margin:0pt;"><span style="visibility:hidden;">​</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:18pt;margin:0pt;">The total unrecognized compensation cost related to performance-based vesting stock options outstanding as of March 31, 2022 was $2.2 million and is expected to be recognized over a weighted-average period of 3.6 years. </p> <table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:80%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:70.23%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.17%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.36%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:10.3%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.17%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.36%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:10.19%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.17%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:70.23%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:11pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.17%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:11pt;visibility:hidden;">​</span></p></td><td colspan="5" style="vertical-align:bottom;white-space:nowrap;width:25.4%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Nine Months Ended </b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.17%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:bottom;width:70.23%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:11pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.17%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:11pt;visibility:hidden;">​</span></p></td><td colspan="5" style="vertical-align:bottom;white-space:nowrap;width:25.4%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">March 31, </b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.17%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:70.23%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;margin:0pt;"><i style="font-style:italic;">in thousands</i></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.17%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:11.66%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">2022</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.17%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">    </b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:11.56%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">2021</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.17%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:bottom;width:70.23%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.17%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.36%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:9pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.3%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:9pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.17%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:9pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.36%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:9pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.19%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:9pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.17%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:bottom;width:70.23%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Stock options (a)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.17%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.36%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.3%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0pt 0pt;"> 359</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.17%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.36%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.19%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0pt 0pt;"> 45,387</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.17%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:bottom;width:70.23%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Profits interests units</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.17%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.36%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.3%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0pt 0pt;"> 1,095</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.17%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.36%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.19%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0pt 0pt;"> 1,102</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.17%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:bottom;width:70.23%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Restricted stock units</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.17%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.36%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.3%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0pt 0pt;"> 1,132</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.17%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.36%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.19%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0pt 0pt;"> —</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.17%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:bottom;width:70.23%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;">Total stock-based compensation expense</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.17%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.36%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.3%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0pt 0pt;"> 2,586</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.17%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.36%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.19%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0pt 0pt;"> 46,489</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.17%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td></tr></table><div style="font-family:'Times New Roman','Times','serif';font-size:10.0pt;margin-bottom:0pt;margin-top:0pt;min-height:1.19em;position:relative;width:100%;"><div style="background-color:#000000;height:1px;position:relative;top:0.6em;width:25.0%;border:none;margin:0 auto 0 0;"/></div><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:36pt;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">​</span></p><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:22.5pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:8pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">(a)</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:8pt;font-style:normal;font-weight:normal;">The amount for 2021 relates to stock-based compensation expense recognized as a result of the Cancellation Agreement.</span></td></tr></table> 359000 45387000 1095000 1102000 1132000 2586000 46489000 17836636 16994976 16095819 16994976 16162177 13009137 0 <table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:80%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:62.92%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:12.67%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.75%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:18.53%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:62.92%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">    </b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.67%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;">    </p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.75%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;">  </p></td><td style="vertical-align:bottom;white-space:nowrap;width:18.53%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:bottom;width:62.92%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:9pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:9pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.67%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Number of</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:9pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:20.28%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Weighted average</b></p></td></tr><tr><td style="vertical-align:bottom;width:62.92%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;margin:0pt;"><b style="font-weight:bold;">Time-based unit awards</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:9pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.67%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">units</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:9pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:20.28%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">grant date fair value</b></p></td></tr><tr><td style="vertical-align:bottom;width:62.92%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.67%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.75%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:18.53%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:bottom;width:62.92%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Outstanding balance, June 30, 2021</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.67%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0pt 0pt;"> 6,587,261</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.75%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:18.53%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0pt 0pt;"> 1.28</p></td></tr><tr><td style="vertical-align:bottom;width:62.92%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;">Forfeited</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.67%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (2,409,972)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.75%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:18.53%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0pt 0pt;"> 1.28</p></td></tr><tr><td style="vertical-align:bottom;width:62.92%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Outstanding balance, March 31, 2022</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.67%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0pt 0pt;"> 4,177,289</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.75%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:18.53%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0pt 0pt;"> 1.28</p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:18pt;margin:0pt;"><span style="visibility:hidden;">​</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:80.13%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:66.38%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:0.64%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:12.65%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:0.07%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.74%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:18.5%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:66.38%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:9pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:9pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.65%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Number of</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.07%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:9pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:20.24%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Weighted average</b></p></td></tr><tr><td style="vertical-align:bottom;width:66.38%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Performance-based unit awards</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:9pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.65%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">units</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.07%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:9pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:20.24%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">grant date fair value</b></p></td></tr><tr><td style="vertical-align:bottom;width:66.38%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.65%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.07%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.74%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:18.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:bottom;width:66.38%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Outstanding balance, June 30, 2021</p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.65%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0.05pt 0pt;"> 6,223,262</p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.07%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.74%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:18.5%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0.05pt 0pt;"> 0.57</p></td></tr><tr><td style="vertical-align:bottom;width:66.38%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 6pt;">Forfeited</p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.65%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (3,210,939)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.07%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.74%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:18.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0.05pt 0pt;"> 0.57</p></td></tr><tr><td style="vertical-align:bottom;width:66.38%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Outstanding balance, March 31, 2022</p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.65%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0.05pt 0pt;"> 3,012,323</p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.07%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.74%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:18.5%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0.05pt 0pt;"> 0.57</p></td></tr></table> 6587261 1.28 2409972 1.28 4177289 1.28 6223262 0.57 3210939 0.57 3012323 0.57 6400000 4300000 P0Y10M24D 2100000 14700000 P3Y <table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:80%;"><tr style="height:1pt;"><td style="vertical-align:bottom;white-space:nowrap;width:67.97%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.39%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:11.32%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.31%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.8%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:15.19%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:67.97%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.39%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.32%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.31%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.8%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:9pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:15.19%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Weighted</b></p></td></tr><tr><td style="vertical-align:bottom;width:67.97%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:9pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.39%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.32%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.31%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;margin:0pt 0pt 0.05pt 0pt;">    </p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.8%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:9pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:15.19%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">average</b></p></td></tr><tr><td style="vertical-align:bottom;width:67.97%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:9pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.39%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:9pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.32%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Number of</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.31%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:9pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.8%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:9pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:15.19%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">grant-date fair</b></p></td></tr><tr><td style="vertical-align:bottom;width:67.97%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Restricted stock units - time based</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.39%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:9pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.32%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">awards</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.31%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:9pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.8%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:9pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:15.19%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">value per share</b></p></td></tr><tr><td style="vertical-align:bottom;width:67.97%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:9pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.39%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:9pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.32%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:9pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.31%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:9pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.8%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:9pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:15.19%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:9pt;font-weight:bold;visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:bottom;width:67.97%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Outstanding balance, June 30, 2021</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.39%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.32%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0.05pt 0pt;"> 48,470</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.31%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.8%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:15.19%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0.05pt 0pt;"> 22.87</p></td></tr><tr><td style="vertical-align:bottom;width:67.97%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 6pt;">Granted</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.39%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.32%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0.05pt 0pt;"> 315,177</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.31%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.8%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:15.19%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0.05pt 0pt;"> 8.99</p></td></tr><tr><td style="vertical-align:bottom;width:67.97%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 6pt;">Forfeited</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.39%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.32%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (9,670)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.31%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.8%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:15.19%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0.05pt 0pt;"> 23.35</p></td></tr><tr><td style="vertical-align:bottom;width:67.97%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 6pt;">Exercised</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.39%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.32%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (8,493)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.31%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.8%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:15.19%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0.05pt 0pt;"> 17.66</p></td></tr><tr><td style="vertical-align:bottom;width:67.97%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Outstanding balance, March 31, 2022</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.39%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.32%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0.05pt 0pt;"> 345,484</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.31%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.8%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:15.19%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0.05pt 0pt;"> 10.50</p></td></tr></table> 48470 22.87 315177 8.99 9670 23.35 8493 17.66 345484 10.50 4000000.0 P2Y <table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:80%;"><tr style="height:1pt;"><td style="vertical-align:bottom;white-space:nowrap;width:67.97%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.39%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:11.32%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.31%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.8%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:15.19%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:67.97%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.39%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.32%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.31%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.8%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:9pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:15.19%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Weighted</b></p></td></tr><tr><td style="vertical-align:bottom;width:67.97%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:9pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.39%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.32%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.31%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;margin:0pt;">    </p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.8%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:9pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:15.19%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">average</b></p></td></tr><tr><td style="vertical-align:bottom;width:67.97%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:9pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.39%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:9pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.32%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Number of</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.31%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:9pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.8%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:9pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:15.19%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">grant-date fair</b></p></td></tr><tr><td style="vertical-align:bottom;width:67.97%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;margin:0pt;"><b style="font-weight:bold;">Restricted stock units - performance based</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.39%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:9pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.32%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">awards</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.31%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:9pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.8%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:9pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:15.19%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">value per share</b></p></td></tr><tr><td style="vertical-align:bottom;width:67.97%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:9pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.39%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:9pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.32%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:9pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.31%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:9pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.8%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:9pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:15.19%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:9pt;font-weight:bold;visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:bottom;width:67.97%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Outstanding balance, June 30, 2021</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.39%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.32%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0pt 0pt;"> —</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.31%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.8%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:15.19%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0pt 0pt;"> —</p></td></tr><tr><td style="vertical-align:bottom;width:67.97%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;">Granted</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.39%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.32%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0pt 0pt;"> 258,767</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.31%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.8%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:15.19%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0pt 0pt;"> 5.18</p></td></tr><tr><td style="vertical-align:bottom;width:67.97%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;">Forfeited</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.39%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.32%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0pt 0pt;"> —</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.31%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.8%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:15.19%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0pt 0pt;"> —</p></td></tr><tr><td style="vertical-align:bottom;width:67.97%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Outstanding balance, March 31, 2022</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.39%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.32%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0pt 0pt;"> 258,767</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.31%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.8%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:15.19%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0pt 0pt;"> 5.18</p></td></tr></table> 258767 5.18 258767 5.18 <table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:80%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:78.98%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:3.34%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.08%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:13.43%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.15%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:78.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:15.51%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2022</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:bottom;width:78.98%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Expected volatility</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.34%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.08%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.43%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0.05pt 0pt;"> 34.5</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.15%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">%</p></td></tr><tr><td style="vertical-align:bottom;width:78.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Expected term (in years)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.08%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.43%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0.05pt 0pt;"> 5.0</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:bottom;width:78.98%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Interest rate</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.34%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;"> </span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.08%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.43%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0.05pt 0pt;"> 1.56</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.15%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">%</p></td></tr><tr><td style="vertical-align:bottom;width:78.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Dividend yield</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;"> </span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.08%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.43%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0.05pt 0pt;">0</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">%</p></td></tr><tr><td style="vertical-align:bottom;width:78.98%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Weighted-average fair values</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.34%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.08%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.43%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0.05pt 0pt;"> 5.18</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.15%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:bottom;width:78.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Fair value of underlying stock</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;"> </span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.08%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.43%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0.05pt 0pt;"> 7.89</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;visibility:hidden;">​</span></p></td></tr></table> 0.345 P5Y 0.0156 0 5.18 7.89 1200000 P3Y7M6D <table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:80%;"><tr style="height:1pt;"><td style="vertical-align:bottom;white-space:nowrap;width:67.97%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.39%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:11.32%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.31%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.8%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:15.19%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:67.97%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.39%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.32%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.31%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.8%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:9pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:15.19%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Weighted</b></p></td></tr><tr><td style="vertical-align:bottom;width:67.97%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:9pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.39%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.32%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.31%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;margin:0pt 0pt 0.05pt 0pt;">    </p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.8%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:9pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:15.19%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">average</b></p></td></tr><tr><td style="vertical-align:bottom;width:67.97%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:9pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.39%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:9pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.32%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Number of</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.31%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:9pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.8%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:9pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:15.19%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">grant-date fair</b></p></td></tr><tr><td style="vertical-align:bottom;width:67.97%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Stock options - time based</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.39%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:9pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.32%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">awards</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.31%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:9pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.8%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:9pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:15.19%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">value per share</b></p></td></tr><tr><td style="vertical-align:bottom;width:67.97%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:9pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.39%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:9pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.32%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:9pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.31%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:9pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.8%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:9pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:15.19%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:9pt;font-weight:bold;visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:bottom;width:67.97%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Outstanding balance, June 30, 2021</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.39%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.32%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0.05pt 0pt;"> —</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.31%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.8%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:15.19%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0.05pt 0pt;"> —</p></td></tr><tr><td style="vertical-align:bottom;width:67.97%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 6pt;">Granted</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.39%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.32%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0.05pt 0pt;"> 554,499</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.31%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.8%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:15.19%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0.05pt 0pt;"> 1.61</p></td></tr><tr><td style="vertical-align:bottom;width:67.97%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 6pt;">Forfeited</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.39%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.32%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0.05pt 0pt;"> —</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.31%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.8%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:15.19%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0.05pt 0pt;"> —</p></td></tr><tr><td style="vertical-align:bottom;width:67.97%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Outstanding balance, March 31, 2022</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.39%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.32%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0.05pt 0pt;"> 554,499</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.31%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.8%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:15.19%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0.05pt 0pt;"> 1.61</p></td></tr></table> 554499 1.61 554499 1.61 700000 P2Y6M <table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:84.38%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:78.99%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:3.35%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.1%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:13.44%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.1%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:78.99%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.35%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:15.54%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">2022</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:bottom;width:78.99%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Expected volatility</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.35%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.1%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.44%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0pt 0pt;"> 34.5</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.1%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">%</p></td></tr><tr><td style="vertical-align:bottom;width:78.99%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Weighted-average expected life (years) - time vesting units</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.35%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0pt 0pt;"> 2.9</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:bottom;width:78.99%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Interest rate</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.35%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;"> </span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.1%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.44%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0pt 0pt;"> 0.83</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.1%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">%</p></td></tr><tr><td style="vertical-align:bottom;width:78.99%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Dividend yield</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.35%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;"> </span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0pt 0pt;">0</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">%</p></td></tr><tr><td style="vertical-align:bottom;width:78.99%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Weighted-average fair values</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.35%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.1%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.44%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0pt 0pt;"> 1.61</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.1%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:bottom;width:78.99%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Fair value of underlying stock</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.35%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;"> </span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0pt 0pt;"> 7.89</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;visibility:hidden;">​</span></p></td></tr></table> 0.345 P2Y10M24D P2Y10M24D 0.0083 0 1.61 7.89 <table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:80%;"><tr style="height:1pt;"><td style="vertical-align:bottom;white-space:nowrap;width:67.97%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.39%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:11.32%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.31%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.8%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:15.19%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:67.97%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.39%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.32%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.31%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.8%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:9pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:15.19%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Weighted</b></p></td></tr><tr><td style="vertical-align:bottom;width:67.97%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:9pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.39%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.32%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.31%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;margin:0pt;">    </p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.8%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:9pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:15.19%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">average</b></p></td></tr><tr><td style="vertical-align:bottom;width:67.97%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:9pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.39%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:9pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.32%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Number of</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.31%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:9pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.8%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:9pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:15.19%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">grant-date fair</b></p></td></tr><tr><td style="vertical-align:bottom;width:67.97%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;margin:0pt;"><b style="font-weight:bold;">Stock options - performance based</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.39%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:9pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.32%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">awards</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.31%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:9pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.8%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:9pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:15.19%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">value per share</b></p></td></tr><tr><td style="vertical-align:bottom;width:67.97%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:9pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.39%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:9pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.32%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:9pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.31%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:9pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.8%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:9pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:15.19%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:9pt;font-weight:bold;visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:bottom;width:67.97%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Outstanding balance, June 30, 2021</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.39%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.32%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0pt 0pt;"> —</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.31%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.8%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:15.19%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0pt 0pt;"> —</p></td></tr><tr><td style="vertical-align:bottom;width:67.97%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;">Granted</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.39%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.32%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0pt 0pt;"> 776,299</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.31%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.8%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:15.19%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0pt 0pt;"> 3.08</p></td></tr><tr><td style="vertical-align:bottom;width:67.97%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;">Forfeited</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.39%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.32%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0pt 0pt;"> —</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.31%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.8%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:15.19%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0pt 0pt;"> —</p></td></tr><tr><td style="vertical-align:bottom;width:67.97%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Outstanding balance, March 31, 2022</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.39%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.32%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0pt 0pt;"> 776,299</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.31%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.8%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:15.19%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0pt 0pt;"> 3.08</p></td></tr></table> 776299 3.08 776299 3.08 2200000 P3Y7M6D <p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;">Note 12: Income Taxes </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">The Company recorded an income tax benefit of $4.1 million and $4.3 million for the three months ended March 31, 2022 and 2021, respectively. The Company recorded a tax provision of $0.1 million and $5.2 million for the nine months ended March 31, 2022 and 2021, respectively. This represents an effective tax rate of 56.6% and 28.2% for the three months ended March 31, 2022 and 2021, respectively. This represents an effective tax rate of 1.4% and (11.2)% for the nine months ended March 31, 2022 and 2021, respectively. </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">The effective rate for the nine months ended March 31, 2022 was different from the federal statutory rate primarily due to the Company’s book loss offset partially by disallowed officers’ compensation under Internal Revenue Code (“IRC”) Section 162(m) and lobbying expenses which occurred during the nine month period.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">The Company assesses the valuation allowance recorded against deferred tax assets at each reporting date. The determination of whether a valuation allowance for deferred tax assets is appropriate requires the evaluation of positive and negative evidence that can be objectively verified. Consideration must be given to all sources of taxable income available to realize deferred tax assets, including, as applicable, the future reversal of existing temporary differences, future taxable income forecasts exclusive of the reversal of temporary differences and carryforwards, taxable income in carryback years and tax planning strategies. In estimating income taxes, the Company assesses the relative merits and risks of the appropriate income tax treatment of transactions taking into account statutory, judicial, and regulatory guidance. As of the nine-month period ended March 31, 2022, the Company has determined that it is not “more likely than not” that the deferred tax assets associated with certain state net operating losses will be realized and as such continues to maintain a valuation allowance against these state deferred tax assets.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">The CARES Act, among other things, includes provisions relating to refundable payroll tax credits, deferment of the employer portion of social security payments, net operating loss carryback periods, alternative minimum tax credit refunds, modifications to the net interest deduction limitation and technical corrections to tax depreciation methods for qualified improvement property. The Company continues to examine the impacts that the CARES Act may have on its business. While several of these provisions may impact the Company, there have not been any significant impacts noted through March 31, 2022.</p> -4100000 -4300000 100000 5200000 0.566 0.282 0.014 -0.112 <p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;"><span style="display:inline-block;text-indent:0pt;width:36pt;"><b style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:bold;">Note 13:</b></span> Earnings per Share </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Basic earnings (loss) per share is computed using the weighted-average number of common shares outstanding during the period. Diluted earnings per share is computed using the weighted-average number of common shares outstanding during the period, plus the dilutive effect of outstanding options, using the treasury stock method and the average market price of the Company’s common stock during the applicable period. When a loss from continuing operations exists, all dilutive securities and potentially dilutive securities are anti-dilutive and are therefore excluded from the computation of diluted earnings per share. When net income from continuing operations exists, performance-based units, are omitted from the calculation of diluted EPS until it is determined that the performance criteria has been met at the end of the reporting period. </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">The following table sets forth the computation of basic and diluted net loss per common share:</p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:80%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:28.75%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:14.46%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:14.46%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:14.46%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:14.46%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:28.75%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-style:italic;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="5" style="vertical-align:bottom;white-space:nowrap;width:33.56%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Three months ended March 31, </b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="5" style="vertical-align:bottom;white-space:nowrap;width:33.56%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Nine months ended March 31, </b></p></td></tr><tr><td style="vertical-align:bottom;width:28.75%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><i style="font-style:italic;">in thousands, except share values</i></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">    </b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:15.75%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2022</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">    </b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:15.75%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2021</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">    </b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:15.75%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2022</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">    </b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:15.75%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2021</b></p></td></tr><tr><td style="vertical-align:bottom;width:28.75%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Net income (loss) attributable to InnovAge Holding Corp.</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.46%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (2,821)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.46%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (10,510)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.46%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0.05pt 0pt;"> 6,188</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.46%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (50,460)</p></td></tr><tr><td style="vertical-align:bottom;width:28.75%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Weighted average common shares outstanding (basic)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.46%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0.05pt 0pt;"> 135,516,608</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.46%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0.05pt 0pt;"> 121,324,980</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.46%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0.05pt 0pt;"> 135,516,544</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.46%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0.05pt 0pt;"> 119,619,806</p></td></tr><tr><td style="vertical-align:bottom;width:28.75%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Earnings (loss) per share - basic</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">$</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.46%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;"> (0.02)</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">$</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.46%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;"> (0.09)</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">$</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.46%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0.05pt 0pt;"><b style="font-weight:bold;"> 0.05</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">$</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.46%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;"> (0.42)</b></p></td></tr><tr><td style="vertical-align:bottom;width:28.75%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.46%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.46%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.46%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.46%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:bottom;width:28.75%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Dilutive shares</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.46%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0.05pt 0pt;"> —</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.46%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0.05pt 0pt;"> —</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.46%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0.05pt 0pt;"> 14,249</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.46%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0.05pt 0pt;"> —</p></td></tr><tr><td style="vertical-align:bottom;width:28.75%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Weighted average common shares outstanding (diluted)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.46%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0.05pt 0pt;"> 135,516,608</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.46%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0.05pt 0pt;"> 121,324,980</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.46%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0.05pt 0pt;"> 135,530,793</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.46%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0.05pt 0pt;"> 119,619,806</p></td></tr><tr><td style="vertical-align:bottom;width:28.75%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Earnings (loss) per share -diluted</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">$</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.46%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;"> (0.02)</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">$</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.46%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;"> (0.09)</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">$</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.46%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0.05pt 0pt;"><b style="font-weight:bold;"> 0.05</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">$</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.46%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;"> (0.42)</b></p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:36pt;margin:0pt 0pt 0pt 36pt;"><span style="font-size:1pt;margin-bottom:12pt;margin-left:0pt;visibility:hidden;">​</span></p> <p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">The following table sets forth the computation of basic and diluted net loss per common share:</p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:80%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:28.75%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:14.46%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:14.46%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:14.46%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:14.46%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:28.75%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-style:italic;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="5" style="vertical-align:bottom;white-space:nowrap;width:33.56%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Three months ended March 31, </b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="5" style="vertical-align:bottom;white-space:nowrap;width:33.56%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Nine months ended March 31, </b></p></td></tr><tr><td style="vertical-align:bottom;width:28.75%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><i style="font-style:italic;">in thousands, except share values</i></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">    </b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:15.75%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2022</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">    </b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:15.75%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2021</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">    </b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:15.75%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2022</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">    </b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:15.75%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2021</b></p></td></tr><tr><td style="vertical-align:bottom;width:28.75%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Net income (loss) attributable to InnovAge Holding Corp.</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.46%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (2,821)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.46%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (10,510)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.46%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0.05pt 0pt;"> 6,188</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.46%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (50,460)</p></td></tr><tr><td style="vertical-align:bottom;width:28.75%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Weighted average common shares outstanding (basic)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.46%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0.05pt 0pt;"> 135,516,608</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.46%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0.05pt 0pt;"> 121,324,980</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.46%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0.05pt 0pt;"> 135,516,544</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.46%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0.05pt 0pt;"> 119,619,806</p></td></tr><tr><td style="vertical-align:bottom;width:28.75%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Earnings (loss) per share - basic</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">$</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.46%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;"> (0.02)</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">$</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.46%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;"> (0.09)</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">$</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.46%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0.05pt 0pt;"><b style="font-weight:bold;"> 0.05</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">$</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.46%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;"> (0.42)</b></p></td></tr><tr><td style="vertical-align:bottom;width:28.75%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.46%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.46%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.46%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.46%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:bottom;width:28.75%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Dilutive shares</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.46%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0.05pt 0pt;"> —</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.46%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0.05pt 0pt;"> —</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.46%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0.05pt 0pt;"> 14,249</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.46%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0.05pt 0pt;"> —</p></td></tr><tr><td style="vertical-align:bottom;width:28.75%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Weighted average common shares outstanding (diluted)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.46%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0.05pt 0pt;"> 135,516,608</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.46%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0.05pt 0pt;"> 121,324,980</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.46%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0.05pt 0pt;"> 135,530,793</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.46%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0.05pt 0pt;"> 119,619,806</p></td></tr><tr><td style="vertical-align:bottom;width:28.75%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Earnings (loss) per share -diluted</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">$</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.46%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;"> (0.02)</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">$</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.46%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;"> (0.09)</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">$</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.46%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0.05pt 0pt;"><b style="font-weight:bold;"> 0.05</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.28%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">$</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.46%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;"> (0.42)</b></p></td></tr></table> -2821000 -10510000 6188000 -50460000 135516608 121324980 135516544 119619806 -0.02 -0.09 0.05 -0.42 14249 135516608 121324980 135530793 119619806 -0.02 -0.09 0.05 -0.42 <p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;"><span style="display:inline-block;text-indent:0pt;width:36pt;"><b style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:bold;">Note 14:</b></span> Segment Reporting</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">The Company applies ASC Topic 280, "<i style="font-style:italic;">Segment Reporting</i>," which establishes requirements to report selected segment information quarterly and to report annually entity-wide disclosures about operations, major customers and the geographies in which the entity holds material assets and reports revenue. An operating segment is defined as a component that engages in business activities whose operating results are reviewed by the Company’s chief executive officer, who is the chief operating decision maker (“CODM”), and for which discrete financial information is available. The Company has determined that it has five operating segments, three of which are related to the Company’s PACE offering. The PACE-related operating segments are based on three geographic divisions, which are West, Central, and East. Due to the similar economic characteristics, nature of services, and customers, we have aggregated our West, Central, and East operating segments into one reportable segment for PACE. The Company’s remaining two operating segments relate to Homecare and Senior Housing, which are immaterial operating segments, and are shown below as "Other" along with certain corporate unallocated expenses.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">As of March 31, 2022, the Company served approximately 6,800 PACE participants, making it the largest PACE provider in the U.S. based upon participants served, and operates 18 PACE centers across Colorado, California, New Mexico, Pennsylvania and Virginia. PACE, an alternative to nursing homes, is a managed care, capitated program, which serves the frail elderly in a community-based service model. Participants receive all medical services through a comprehensive, consolidated model of care. Capitation payments are received from Medicare parts C and D; Medicaid; the VA, and private pay sources. The Company is at risk for all health and allied care costs incurred with respect to the care of its participants, although it does negotiate discounted rates with its provider network consisting of hospitals, nursing homes, assisted living facilities, and medical specialists. Additionally, under the Medicare Prescription Drug Plan, CMS shares part of the risk for providing prescription medication to the Company’s participants.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">The Company evaluates performance and allocates capital resources to each segment based on an operating model that is designed to maximize the provision of services provided and profitability. The Company does not review assets by segment and therefore assets by segment are not disclosed below. For the periods presented, all of the Company’s long-lived assets were located in the U.S. and all revenue was earned in the U.S.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">The Company’s management uses Center-level Contribution Margin as the measure for assessing performance of its segments. Center-level Contribution Margin is defined as total revenues less external provider costs and cost of care (excluding depreciation and amortization), which includes all medical and pharmacy costs. The Company allocates corporate level expenses to its segments with a majority of the allocation going to the PACE segment.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:18pt;margin:0pt;">The following table summarizes the operating results regularly provided to the CODM by reportable segment for the three months ended March 31, 2022 and 2021:</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">​</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:27.54%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.26%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.95%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:7.99%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.95%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:7.56%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.97%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:7.96%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.27%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.97%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:7.96%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.27%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.97%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:7.56%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.27%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.97%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:7.96%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td></tr><tr style="height:1pt;"><td style="vertical-align:bottom;width:27.54%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.26%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.95%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:7.99%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.95%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:7.56%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.97%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:7.96%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.27%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.97%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:7.96%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.27%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.97%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:7.56%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.27%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.97%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:7.96%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:27.54%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-style:italic;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.26%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="8" style="vertical-align:bottom;white-space:nowrap;width:33.92%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">March 31, 2022</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.27%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="8" style="vertical-align:bottom;white-space:nowrap;width:33.97%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">March 31, 2021</b></p></td></tr><tr><td style="vertical-align:bottom;width:27.54%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><i style="font-style:italic;">in thousands</i></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.26%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">    </b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:9.95%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">PACE</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">    </b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:9.51%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">All other</b><sup style="font-size:6pt;font-weight:bold;line-height:100%;top:0pt;vertical-align:top;">(1)</sup></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">    </b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:9.94%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Totals</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.27%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">    </b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:9.94%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">PACE</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.27%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">    </b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:9.54%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">All other</b><sup style="font-size:6pt;font-weight:bold;line-height:100%;top:0pt;vertical-align:top;">(1)</sup></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.27%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">    </b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:9.94%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Totals</b></p></td></tr><tr><td style="vertical-align:bottom;width:27.54%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 6pt;">Capitation revenue</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.26%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.95%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.99%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0.05pt 0pt;"> 176,988</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.95%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.56%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0.05pt 0pt;"> —</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.97%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.96%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0.05pt 0pt;"> 176,988</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.27%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.97%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.96%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0.05pt 0pt;"> 155,835</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.27%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.97%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.56%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0.05pt 0pt;"> —</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.27%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.97%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.96%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0.05pt 0pt;"> 155,835</p></td></tr><tr><td style="vertical-align:bottom;width:27.54%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 6pt;">Other service revenue</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.26%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.95%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.99%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0.05pt 0pt;"> 166</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.95%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.56%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0.05pt 0pt;"> 205</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.97%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.96%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0.05pt 0pt;"> 371</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.27%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.97%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.96%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (47)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.27%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.97%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.56%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0.05pt 0pt;"> 520</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.27%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.97%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.96%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0.05pt 0pt;"> 473</p></td></tr><tr><td style="vertical-align:bottom;width:27.54%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Total revenues</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.26%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.95%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.99%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0.05pt 0pt;"> 177,154</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.95%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.56%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0.05pt 0pt;"> 205</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.97%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.96%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0.05pt 0pt;"> 177,359</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.27%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.97%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.96%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0.05pt 0pt;"> 155,788</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.27%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.97%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.56%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0.05pt 0pt;"> 520</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.27%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.97%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.96%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0.05pt 0pt;"> 156,308</p></td></tr><tr><td style="vertical-align:bottom;width:27.54%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 6pt;">External provider costs</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.26%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.95%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.99%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0.05pt 0pt;"> 103,254</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.95%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.56%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0.05pt 0pt;"> —</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.97%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.96%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0.05pt 0pt;"> 103,254</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.27%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.97%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.96%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0.05pt 0pt;"> 75,389</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.27%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.97%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.56%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0.05pt 0pt;"> —</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.27%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.97%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.96%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0.05pt 0pt;"> 75,389</p></td></tr><tr><td style="vertical-align:bottom;width:27.54%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 6pt;">Cost of care, excluding depreciation and amortization</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.26%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.95%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.99%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0.05pt 0pt;"> 45,995</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.95%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.56%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0.05pt 0pt;"> 107</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.97%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.96%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0.05pt 0pt;"> 46,102</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.27%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.97%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.96%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0.05pt 0pt;"> 38,867</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.27%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.97%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.56%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0.05pt 0pt;"> 698</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.27%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.97%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.96%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0.05pt 0pt;"> 39,565</p></td></tr><tr><td style="vertical-align:bottom;width:27.54%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Center-level Contribution Margin</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.26%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.95%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.99%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0.05pt 0pt;"> 27,905</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.95%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.56%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0.05pt 0pt;"> 98</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.97%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.96%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0.05pt 0pt;"> 28,003</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.27%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.97%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.96%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0.05pt 0pt;"> 41,532</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.27%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.97%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.56%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (178)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.27%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.97%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.96%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0.05pt 0pt;"> 41,354</p></td></tr><tr><td style="vertical-align:bottom;width:27.54%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 6pt;">Overhead costs<sup style="font-size:7.5pt;line-height:100%;top:0pt;vertical-align:top;">(2)</sup></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.26%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.95%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.99%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0.05pt 0pt;"> 30,911</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.95%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.56%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (85)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.97%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.96%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0.05pt 0pt;"> 30,826</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.27%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.97%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.96%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0.05pt 0pt;"> 24,217</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.27%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.97%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.56%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (30)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.27%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.97%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.96%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0.05pt 0pt;"> 24,187</p></td></tr><tr><td style="vertical-align:bottom;width:27.54%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 6pt;">Depreciation and amortization</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.26%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.95%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.99%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0.05pt 0pt;"> 3,760</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.95%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.56%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0.05pt 0pt;"> 90</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.97%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.96%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0.05pt 0pt;"> 3,850</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.27%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.97%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.96%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0.05pt 0pt;"> 3,181</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.27%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.97%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.56%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0.05pt 0pt;"> 130</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.27%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.97%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.96%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0.05pt 0pt;"> 3,311</p></td></tr><tr><td style="vertical-align:bottom;width:27.54%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 6pt;">Equity loss</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.26%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.95%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.99%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0.05pt 0pt;"> —</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.95%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.56%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0.05pt 0pt;"> —</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.97%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.96%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0.05pt 0pt;"> —</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.27%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.97%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.96%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0.05pt 0pt;"> —</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.27%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.97%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.56%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0.05pt 0pt;"> —</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.27%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.97%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.96%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0.05pt 0pt;"> —</p></td></tr><tr><td style="vertical-align:bottom;width:27.54%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 6pt;">Other operating income</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.26%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.95%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.99%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0.05pt 0pt;"> —</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.95%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.56%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0.05pt 0pt;"> —</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.97%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.96%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0.05pt 0pt;"> —</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.27%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.97%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.96%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0.05pt 0pt;"> 19,222</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.27%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.97%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.56%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0.05pt 0pt;"> —</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.27%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.97%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.96%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0.05pt 0pt;"> 19,222</p></td></tr><tr><td style="vertical-align:bottom;width:27.54%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 6pt;">Interest expense, net</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.26%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.95%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.99%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (663)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.95%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.56%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (46)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.97%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.96%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (709)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.27%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.97%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.96%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (4,824)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.27%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.97%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.56%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (52)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.27%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.97%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.96%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (4,876)</p></td></tr><tr><td style="vertical-align:bottom;width:27.54%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 6pt;">Loss on extinguishment of debt</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.26%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.95%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.99%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0.05pt 0pt;"> —</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.95%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.56%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0.05pt 0pt;"> —</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.97%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.96%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0.05pt 0pt;"> —</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.27%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.97%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.96%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (13,488)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.27%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.97%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.56%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0.05pt 0pt;"> —</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.27%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.97%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.96%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (13,488)</p></td></tr><tr><td style="vertical-align:bottom;width:27.54%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 6pt;">Gain on equity method investment</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.26%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.95%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.99%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0.05pt 0pt;"> —</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.95%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.56%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0.05pt 0pt;"> —</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.97%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.96%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0.05pt 0pt;"> —</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.27%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.97%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.96%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0.05pt 0pt;"> 10,871</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.27%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.97%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.56%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0.05pt 0pt;"> —</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.27%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.97%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.96%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0.05pt 0pt;"> 10,871</p></td></tr><tr><td style="vertical-align:bottom;width:27.54%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 6pt;">Other expense (income)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.26%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.95%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.99%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0.05pt 0pt;"> 108</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.95%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.56%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0.05pt 0pt;"> —</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.97%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.96%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0.05pt 0pt;"> 108</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.27%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.97%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.96%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (2,267)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.27%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.97%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.56%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0.05pt 0pt;"> —</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.27%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.97%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.96%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (2,267)</p></td></tr><tr><td style="vertical-align:bottom;width:27.54%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Income (Loss) Before Income Taxes</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.26%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.95%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.99%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (7,321)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.95%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.56%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0.05pt 0pt;"> 47</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.97%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.96%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (7,274)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.27%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.97%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.96%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (14,796)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.27%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.97%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.56%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (330)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.27%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.97%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.96%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (15,126)</p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">​</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:18pt;margin:0pt;">The following table summarizes the operating results regularly provided to the CODM by reportable segment for the nine months ended March 31, 2022 and 2021:</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">​</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:27.54%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.26%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.96%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:7.96%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.26%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.96%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:7.55%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.26%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.97%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:7.96%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.27%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.97%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:7.96%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.27%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.97%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:7.56%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.27%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.97%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:7.96%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:27.54%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-style:italic;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.26%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="8" style="vertical-align:bottom;white-space:nowrap;width:33.92%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">March 31, 2022</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.27%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="8" style="vertical-align:bottom;white-space:nowrap;width:33.97%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">March 31, 2021</b></p></td></tr><tr><td style="vertical-align:bottom;width:27.54%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><i style="font-style:italic;">in thousands</i></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.26%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">    </b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:9.93%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">PACE</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.26%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">    </b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:9.51%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">All other</b><sup style="font-size:6pt;font-weight:bold;line-height:100%;top:0pt;vertical-align:top;">(1)</sup></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.26%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">    </b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:9.94%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Totals</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.27%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">    </b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:9.94%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">PACE</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.27%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">    </b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:9.54%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">All other</b><sup style="font-size:6pt;font-weight:bold;line-height:100%;top:0pt;vertical-align:top;">(1)</sup></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.27%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">    </b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:9.94%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Totals</b></p></td></tr><tr><td style="vertical-align:bottom;width:27.54%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 6pt;">Capitation revenue</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.26%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.96%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.96%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0.05pt 0pt;"> 524,507</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.26%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.96%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.55%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0.05pt 0pt;"> —</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.26%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.97%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.96%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0.05pt 0pt;"> 524,507</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.27%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.97%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.96%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0.05pt 0pt;"> 464,294</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.27%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.97%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.56%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0.05pt 0pt;"> —</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.27%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.97%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.96%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0.05pt 0pt;"> 464,294</p></td></tr><tr><td style="vertical-align:bottom;width:27.54%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 6pt;">Other service revenue</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.26%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.96%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.96%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0.05pt 0pt;"> 234</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.26%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.96%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.55%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0.05pt 0pt;"> 1,039</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.26%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.97%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.96%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0.05pt 0pt;"> 1,273</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.27%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.97%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.96%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0.05pt 0pt;"> 213</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.27%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.97%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.56%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0.05pt 0pt;"> 1,677</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.27%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.97%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.96%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0.05pt 0pt;"> 1,890</p></td></tr><tr><td style="vertical-align:bottom;width:27.54%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Total revenues</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.26%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.96%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.96%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0.05pt 0pt;"> 524,741</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.26%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.96%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.55%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0.05pt 0pt;"> 1,039</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.26%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.97%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.96%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0.05pt 0pt;"> 525,780</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.27%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.97%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.96%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0.05pt 0pt;"> 464,507</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.27%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.97%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.56%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0.05pt 0pt;"> 1,677</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.27%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.97%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.96%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0.05pt 0pt;"> 466,184</p></td></tr><tr><td style="vertical-align:bottom;width:27.54%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 6pt;">External provider costs</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.26%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.96%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.96%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0.05pt 0pt;"> 284,299</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.26%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.96%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.55%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0.05pt 0pt;"> —</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.26%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.97%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.96%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0.05pt 0pt;"> 284,299</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.27%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.97%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.96%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0.05pt 0pt;"> 224,215</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.27%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.97%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.56%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0.05pt 0pt;"> —</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.27%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.97%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.96%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0.05pt 0pt;"> 224,215</p></td></tr><tr><td style="vertical-align:bottom;width:27.54%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 6pt;">Cost of care, excluding depreciation and amortization</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.26%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.96%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.96%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0.05pt 0pt;"> 128,573</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.26%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.96%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.55%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0.05pt 0pt;"> 1,167</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.26%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.97%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.96%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0.05pt 0pt;"> 129,740</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.27%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.97%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.96%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0.05pt 0pt;"> 113,611</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.27%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.97%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.56%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0.05pt 0pt;"> 2,311</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.27%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.97%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.96%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0.05pt 0pt;"> 115,922</p></td></tr><tr><td style="vertical-align:bottom;width:27.54%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Center-Level Contribution Margin</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.26%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.96%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.96%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0.05pt 0pt;"> 111,869</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.26%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.96%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.55%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (128)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.26%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.97%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.96%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0.05pt 0pt;"> 111,741</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.27%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.97%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.96%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0.05pt 0pt;"> 126,681</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.27%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.97%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.56%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (634)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.27%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.97%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.96%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0.05pt 0pt;"> 126,047</p></td></tr><tr><td style="vertical-align:bottom;width:27.54%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 6pt;">Overhead costs<sup style="font-size:7.5pt;line-height:100%;top:0pt;vertical-align:top;">(2)</sup></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.26%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.96%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.96%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0.05pt 0pt;"> 93,463</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.26%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.96%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.55%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (98)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.26%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.97%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.96%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0.05pt 0pt;"> 93,365</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.27%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.97%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.96%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0.05pt 0pt;"> 120,249</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.27%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.97%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.56%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (13)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.27%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.97%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.96%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0.05pt 0pt;"> 120,236</p></td></tr><tr><td style="vertical-align:bottom;width:27.54%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 6pt;">Depreciation and amortization</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.26%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.96%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.96%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0.05pt 0pt;"> 10,130</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.26%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.96%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.55%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0.05pt 0pt;"> 305</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.26%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.97%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.96%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0.05pt 0pt;"> 10,435</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.27%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.97%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.96%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0.05pt 0pt;"> 8,901</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.27%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.97%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.56%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0.05pt 0pt;"> 361</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.27%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.97%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.96%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0.05pt 0pt;"> 9,262</p></td></tr><tr><td style="vertical-align:bottom;width:27.54%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 6pt;">Equity loss</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.26%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.96%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.96%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0.05pt 0pt;"> —</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.26%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.96%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.55%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0.05pt 0pt;"> —</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.26%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.97%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.96%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0.05pt 0pt;"> —</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.27%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.97%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.96%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0.05pt 0pt;"> 1,343</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.27%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.97%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.56%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0.05pt 0pt;"> —</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.27%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.97%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.96%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0.05pt 0pt;"> 1,343</p></td></tr><tr><td style="vertical-align:bottom;width:27.54%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 6pt;">Other operating (income) expense</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.26%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.96%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.96%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0.05pt 0pt;"> —</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.26%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.96%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.55%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0.05pt 0pt;"> —</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.26%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.97%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.96%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0.05pt 0pt;"> —</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.27%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.97%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.96%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0.05pt 0pt;"> 18,211</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.27%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.97%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.56%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0.05pt 0pt;"> —</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.27%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.97%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.96%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0.05pt 0pt;"> 18,211</p></td></tr><tr><td style="vertical-align:bottom;width:27.54%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 6pt;">Interest expense, net</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.26%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.96%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.96%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (1,783)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.26%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.96%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.55%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (147)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.26%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.97%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.96%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (1,930)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.27%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.97%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.96%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (16,919)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.27%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.97%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.56%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (142)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.27%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.97%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.96%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (17,061)</p></td></tr><tr><td style="vertical-align:bottom;width:27.54%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 6pt;">Loss on extinguishment of debt</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.26%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.96%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.96%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0.05pt 0pt;"> —</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.26%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.96%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.55%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0.05pt 0pt;"> —</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.26%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.97%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.96%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0.05pt 0pt;"> —</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.27%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.97%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.96%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (14,479)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.27%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.97%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.56%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0.05pt 0pt;"> —</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.27%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.97%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.96%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (14,479)</p></td></tr><tr><td style="vertical-align:bottom;width:27.54%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 6pt;">Gain on equity method investment</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.26%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.96%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.96%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0.05pt 0pt;"> —</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.26%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.96%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.55%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0.05pt 0pt;"> —</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.26%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.97%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.96%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0.05pt 0pt;"> —</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.27%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.97%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.96%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0.05pt 0pt;"> 10,871</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.27%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.97%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.56%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0.05pt 0pt;"> —</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.27%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.97%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.96%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0.05pt 0pt;"> 10,871</p></td></tr><tr><td style="vertical-align:bottom;width:27.54%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 6pt;">Other income</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.26%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.96%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.96%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (357)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.26%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.96%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.55%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (1)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.26%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.97%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.96%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (358)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.27%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.97%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.96%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (2,222)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.27%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.97%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.56%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0.05pt 0pt;"> —</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.27%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.97%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.96%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (2,222)</p></td></tr><tr><td style="vertical-align:bottom;width:27.54%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Income (Loss) Before Income Taxes</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.26%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.96%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.96%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0.05pt 0pt;"> 6,136</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.26%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.96%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.55%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (483)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.26%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.97%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.96%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0.05pt 0pt;"> 5,653</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.27%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.97%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.96%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (44,772)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.27%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.97%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.56%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (1,124)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.27%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.97%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.96%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (45,896)</p></td></tr></table><div style="font-family:'Times New Roman','Times','serif';font-size:10.0pt;margin-bottom:0pt;min-height:1.19em;position:relative;width:100%;"><div style="background-color:#000000;height:1pt;position:relative;top:0.6em;width:25.0%;border:none;margin:0 auto 0 0;"/></div><div style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-left:0pt;margin-top:0pt;text-indent:0pt;"><span style="display:inline-block;font-size:9pt;min-width:36pt;white-space:nowrap;">(1)</span><span style="font-size:9pt;">Center-level Contribution Margin from segments below the quantitative thresholds are attributable to </span><span style="font-size:9pt;">two</span><span style="font-size:9pt;"> operating segments of the Company. Those segments consist of Homecare and Senior Housing. Neither of those segments has ever met any of the quantitative thresholds for determining reportable segments.</span></div><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="font-family:'Times New Roman','Times','serif';font-size:9pt;vertical-align:text-top;white-space:nowrap;width:36pt;padding:0pt;">(2)</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:9pt;font-style:normal;font-weight:normal;">Overhead consists of the Sales and marketing and Corporate, general and administrative financial statement line items.</span></td></tr></table> 5 3 3 1 2 6800 18 <p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">​</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:27.54%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.26%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.95%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:7.99%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.95%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:7.56%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.97%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:7.96%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.27%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.97%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:7.96%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.27%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.97%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:7.56%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.27%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.97%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:7.96%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td></tr><tr style="height:1pt;"><td style="vertical-align:bottom;width:27.54%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.26%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.95%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:7.99%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.95%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:7.56%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.97%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:7.96%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.27%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.97%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:7.96%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.27%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.97%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:7.56%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.27%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.97%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:7.96%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:27.54%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-style:italic;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.26%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="8" style="vertical-align:bottom;white-space:nowrap;width:33.92%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">March 31, 2022</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.27%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="8" style="vertical-align:bottom;white-space:nowrap;width:33.97%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">March 31, 2021</b></p></td></tr><tr><td style="vertical-align:bottom;width:27.54%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><i style="font-style:italic;">in thousands</i></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.26%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">    </b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:9.95%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">PACE</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">    </b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:9.51%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">All other</b><sup style="font-size:6pt;font-weight:bold;line-height:100%;top:0pt;vertical-align:top;">(1)</sup></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">    </b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:9.94%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Totals</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.27%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">    </b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:9.94%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">PACE</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.27%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">    </b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:9.54%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">All other</b><sup style="font-size:6pt;font-weight:bold;line-height:100%;top:0pt;vertical-align:top;">(1)</sup></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.27%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">    </b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:9.94%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Totals</b></p></td></tr><tr><td style="vertical-align:bottom;width:27.54%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 6pt;">Capitation revenue</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.26%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.95%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.99%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0.05pt 0pt;"> 176,988</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.95%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.56%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0.05pt 0pt;"> —</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.97%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.96%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0.05pt 0pt;"> 176,988</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.27%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.97%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.96%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0.05pt 0pt;"> 155,835</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.27%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.97%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.56%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0.05pt 0pt;"> —</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.27%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.97%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.96%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0.05pt 0pt;"> 155,835</p></td></tr><tr><td style="vertical-align:bottom;width:27.54%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 6pt;">Other service revenue</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.26%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.95%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.99%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0.05pt 0pt;"> 166</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.95%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.56%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0.05pt 0pt;"> 205</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.97%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.96%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0.05pt 0pt;"> 371</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.27%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.97%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.96%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (47)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.27%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.97%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.56%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0.05pt 0pt;"> 520</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.27%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.97%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.96%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0.05pt 0pt;"> 473</p></td></tr><tr><td style="vertical-align:bottom;width:27.54%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Total revenues</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.26%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.95%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.99%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0.05pt 0pt;"> 177,154</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.95%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.56%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0.05pt 0pt;"> 205</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.97%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.96%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0.05pt 0pt;"> 177,359</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.27%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.97%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.96%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0.05pt 0pt;"> 155,788</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.27%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.97%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.56%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0.05pt 0pt;"> 520</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.27%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.97%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.96%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0.05pt 0pt;"> 156,308</p></td></tr><tr><td style="vertical-align:bottom;width:27.54%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 6pt;">External provider costs</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.26%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.95%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.99%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0.05pt 0pt;"> 103,254</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.95%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.56%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0.05pt 0pt;"> —</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.97%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.96%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0.05pt 0pt;"> 103,254</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.27%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.97%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.96%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0.05pt 0pt;"> 75,389</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.27%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.97%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.56%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0.05pt 0pt;"> —</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.27%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.97%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.96%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0.05pt 0pt;"> 75,389</p></td></tr><tr><td style="vertical-align:bottom;width:27.54%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 6pt;">Cost of care, excluding depreciation and amortization</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.26%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.95%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.99%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0.05pt 0pt;"> 45,995</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.95%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.56%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0.05pt 0pt;"> 107</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.97%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.96%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0.05pt 0pt;"> 46,102</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.27%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.97%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.96%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0.05pt 0pt;"> 38,867</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.27%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.97%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.56%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0.05pt 0pt;"> 698</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.27%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.97%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.96%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0.05pt 0pt;"> 39,565</p></td></tr><tr><td style="vertical-align:bottom;width:27.54%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Center-level Contribution Margin</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.26%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.95%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.99%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0.05pt 0pt;"> 27,905</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.95%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.56%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0.05pt 0pt;"> 98</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.97%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.96%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0.05pt 0pt;"> 28,003</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.27%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.97%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.96%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0.05pt 0pt;"> 41,532</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.27%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.97%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.56%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (178)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.27%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.97%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.96%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0.05pt 0pt;"> 41,354</p></td></tr><tr><td style="vertical-align:bottom;width:27.54%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 6pt;">Overhead costs<sup style="font-size:7.5pt;line-height:100%;top:0pt;vertical-align:top;">(2)</sup></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.26%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.95%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.99%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0.05pt 0pt;"> 30,911</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.95%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.56%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (85)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.97%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.96%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0.05pt 0pt;"> 30,826</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.27%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.97%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.96%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0.05pt 0pt;"> 24,217</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.27%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.97%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.56%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (30)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.27%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.97%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.96%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0.05pt 0pt;"> 24,187</p></td></tr><tr><td style="vertical-align:bottom;width:27.54%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 6pt;">Depreciation and amortization</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.26%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.95%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.99%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0.05pt 0pt;"> 3,760</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.95%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.56%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0.05pt 0pt;"> 90</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.97%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.96%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0.05pt 0pt;"> 3,850</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.27%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.97%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.96%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0.05pt 0pt;"> 3,181</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.27%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.97%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.56%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0.05pt 0pt;"> 130</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.27%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.97%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.96%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0.05pt 0pt;"> 3,311</p></td></tr><tr><td style="vertical-align:bottom;width:27.54%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 6pt;">Equity loss</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.26%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.95%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.99%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0.05pt 0pt;"> —</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.95%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.56%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0.05pt 0pt;"> —</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.97%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.96%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0.05pt 0pt;"> —</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.27%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.97%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.96%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0.05pt 0pt;"> —</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.27%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.97%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.56%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0.05pt 0pt;"> —</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.27%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.97%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.96%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0.05pt 0pt;"> —</p></td></tr><tr><td style="vertical-align:bottom;width:27.54%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 6pt;">Other operating income</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.26%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.95%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.99%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0.05pt 0pt;"> —</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.95%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.56%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0.05pt 0pt;"> —</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.97%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.96%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0.05pt 0pt;"> —</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.27%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.97%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.96%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0.05pt 0pt;"> 19,222</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.27%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.97%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.56%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0.05pt 0pt;"> —</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.27%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.97%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.96%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0.05pt 0pt;"> 19,222</p></td></tr><tr><td style="vertical-align:bottom;width:27.54%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 6pt;">Interest expense, net</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.26%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.95%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.99%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (663)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.95%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.56%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (46)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.97%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.96%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (709)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.27%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.97%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.96%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (4,824)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.27%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.97%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.56%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (52)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.27%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.97%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.96%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (4,876)</p></td></tr><tr><td style="vertical-align:bottom;width:27.54%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 6pt;">Loss on extinguishment of debt</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.26%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.95%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.99%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0.05pt 0pt;"> —</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.95%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.56%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0.05pt 0pt;"> —</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.97%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.96%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0.05pt 0pt;"> —</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.27%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.97%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.96%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (13,488)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.27%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.97%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.56%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0.05pt 0pt;"> —</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.27%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.97%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.96%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (13,488)</p></td></tr><tr><td style="vertical-align:bottom;width:27.54%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 6pt;">Gain on equity method investment</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.26%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.95%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.99%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0.05pt 0pt;"> —</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.95%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.56%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0.05pt 0pt;"> —</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.97%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.96%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0.05pt 0pt;"> —</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.27%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.97%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.96%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0.05pt 0pt;"> 10,871</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.27%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.97%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.56%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0.05pt 0pt;"> —</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.27%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.97%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.96%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0.05pt 0pt;"> 10,871</p></td></tr><tr><td style="vertical-align:bottom;width:27.54%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 6pt;">Other expense (income)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.26%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.95%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.99%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0.05pt 0pt;"> 108</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.95%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.56%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0.05pt 0pt;"> —</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.97%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.96%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0.05pt 0pt;"> 108</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.27%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.97%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.96%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (2,267)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.27%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.97%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.56%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0.05pt 0pt;"> —</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.27%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.97%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.96%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (2,267)</p></td></tr><tr><td style="vertical-align:bottom;width:27.54%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Income (Loss) Before Income Taxes</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.26%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.95%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.99%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (7,321)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.95%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.56%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0.05pt 0pt;"> 47</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.97%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.96%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (7,274)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.27%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.97%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.96%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (14,796)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.27%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.97%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.56%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (330)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.27%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.97%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.96%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (15,126)</p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">​</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:18pt;margin:0pt;">The following table summarizes the operating results regularly provided to the CODM by reportable segment for the nine months ended March 31, 2022 and 2021:</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">​</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:27.54%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.26%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.96%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:7.96%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.26%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.96%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:7.55%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.26%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.97%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:7.96%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.27%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.97%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:7.96%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.27%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.97%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:7.56%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.27%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.97%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:7.96%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:27.54%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-style:italic;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.26%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="8" style="vertical-align:bottom;white-space:nowrap;width:33.92%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">March 31, 2022</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.27%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="8" style="vertical-align:bottom;white-space:nowrap;width:33.97%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">March 31, 2021</b></p></td></tr><tr><td style="vertical-align:bottom;width:27.54%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><i style="font-style:italic;">in thousands</i></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.26%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">    </b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:9.93%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">PACE</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.26%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">    </b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:9.51%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">All other</b><sup style="font-size:6pt;font-weight:bold;line-height:100%;top:0pt;vertical-align:top;">(1)</sup></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.26%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">    </b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:9.94%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Totals</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.27%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">    </b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:9.94%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">PACE</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.27%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">    </b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:9.54%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">All other</b><sup style="font-size:6pt;font-weight:bold;line-height:100%;top:0pt;vertical-align:top;">(1)</sup></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.27%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">    </b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:9.94%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Totals</b></p></td></tr><tr><td style="vertical-align:bottom;width:27.54%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 6pt;">Capitation revenue</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.26%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.96%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.96%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0.05pt 0pt;"> 524,507</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.26%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.96%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.55%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0.05pt 0pt;"> —</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.26%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.97%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.96%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0.05pt 0pt;"> 524,507</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.27%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.97%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.96%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0.05pt 0pt;"> 464,294</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.27%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.97%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.56%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0.05pt 0pt;"> —</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.27%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.97%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.96%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0.05pt 0pt;"> 464,294</p></td></tr><tr><td style="vertical-align:bottom;width:27.54%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 6pt;">Other service revenue</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.26%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.96%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.96%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0.05pt 0pt;"> 234</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.26%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.96%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.55%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0.05pt 0pt;"> 1,039</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.26%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.97%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.96%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0.05pt 0pt;"> 1,273</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.27%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.97%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.96%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0.05pt 0pt;"> 213</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.27%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.97%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.56%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0.05pt 0pt;"> 1,677</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.27%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.97%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.96%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0.05pt 0pt;"> 1,890</p></td></tr><tr><td style="vertical-align:bottom;width:27.54%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Total revenues</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.26%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.96%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.96%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0.05pt 0pt;"> 524,741</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.26%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.96%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.55%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0.05pt 0pt;"> 1,039</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.26%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.97%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.96%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0.05pt 0pt;"> 525,780</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.27%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.97%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.96%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0.05pt 0pt;"> 464,507</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.27%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.97%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.56%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0.05pt 0pt;"> 1,677</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.27%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.97%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.96%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0.05pt 0pt;"> 466,184</p></td></tr><tr><td style="vertical-align:bottom;width:27.54%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 6pt;">External provider costs</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.26%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.96%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.96%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0.05pt 0pt;"> 284,299</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.26%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.96%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.55%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0.05pt 0pt;"> —</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.26%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.97%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.96%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0.05pt 0pt;"> 284,299</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.27%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.97%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.96%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0.05pt 0pt;"> 224,215</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.27%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.97%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.56%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0.05pt 0pt;"> —</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.27%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.97%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.96%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0.05pt 0pt;"> 224,215</p></td></tr><tr><td style="vertical-align:bottom;width:27.54%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 6pt;">Cost of care, excluding depreciation and amortization</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.26%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.96%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.96%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0.05pt 0pt;"> 128,573</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.26%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.96%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.55%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0.05pt 0pt;"> 1,167</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.26%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.97%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.96%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0.05pt 0pt;"> 129,740</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.27%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.97%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.96%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0.05pt 0pt;"> 113,611</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.27%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.97%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.56%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0.05pt 0pt;"> 2,311</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.27%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.97%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.96%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0.05pt 0pt;"> 115,922</p></td></tr><tr><td style="vertical-align:bottom;width:27.54%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Center-Level Contribution Margin</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.26%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.96%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.96%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0.05pt 0pt;"> 111,869</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.26%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.96%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.55%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (128)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.26%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.97%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.96%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0.05pt 0pt;"> 111,741</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.27%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.97%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.96%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0.05pt 0pt;"> 126,681</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.27%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.97%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.56%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (634)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.27%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.97%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.96%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0.05pt 0pt;"> 126,047</p></td></tr><tr><td style="vertical-align:bottom;width:27.54%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 6pt;">Overhead costs<sup style="font-size:7.5pt;line-height:100%;top:0pt;vertical-align:top;">(2)</sup></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.26%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.96%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.96%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0.05pt 0pt;"> 93,463</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.26%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.96%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.55%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (98)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.26%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.97%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.96%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0.05pt 0pt;"> 93,365</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.27%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.97%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.96%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0.05pt 0pt;"> 120,249</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.27%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.97%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.56%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (13)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.27%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.97%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.96%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0.05pt 0pt;"> 120,236</p></td></tr><tr><td style="vertical-align:bottom;width:27.54%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 6pt;">Depreciation and amortization</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.26%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.96%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.96%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0.05pt 0pt;"> 10,130</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.26%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.96%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.55%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0.05pt 0pt;"> 305</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.26%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.97%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.96%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0.05pt 0pt;"> 10,435</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.27%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.97%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.96%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0.05pt 0pt;"> 8,901</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.27%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.97%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.56%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0.05pt 0pt;"> 361</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.27%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.97%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.96%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0.05pt 0pt;"> 9,262</p></td></tr><tr><td style="vertical-align:bottom;width:27.54%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 6pt;">Equity loss</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.26%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.96%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.96%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0.05pt 0pt;"> —</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.26%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.96%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.55%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0.05pt 0pt;"> —</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.26%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.97%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.96%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0.05pt 0pt;"> —</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.27%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.97%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.96%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0.05pt 0pt;"> 1,343</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.27%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.97%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.56%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0.05pt 0pt;"> —</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.27%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.97%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.96%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0.05pt 0pt;"> 1,343</p></td></tr><tr><td style="vertical-align:bottom;width:27.54%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 6pt;">Other operating (income) expense</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.26%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.96%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.96%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0.05pt 0pt;"> —</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.26%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.96%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.55%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0.05pt 0pt;"> —</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.26%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.97%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.96%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0.05pt 0pt;"> —</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.27%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.97%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.96%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0.05pt 0pt;"> 18,211</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.27%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.97%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.56%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0.05pt 0pt;"> —</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.27%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.97%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.96%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0.05pt 0pt;"> 18,211</p></td></tr><tr><td style="vertical-align:bottom;width:27.54%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 6pt;">Interest expense, net</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.26%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.96%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.96%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (1,783)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.26%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.96%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.55%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (147)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.26%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.97%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.96%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (1,930)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.27%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.97%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.96%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (16,919)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.27%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.97%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.56%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (142)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.27%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.97%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.96%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (17,061)</p></td></tr><tr><td style="vertical-align:bottom;width:27.54%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 6pt;">Loss on extinguishment of debt</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.26%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.96%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.96%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0.05pt 0pt;"> —</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.26%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.96%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.55%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0.05pt 0pt;"> —</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.26%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.97%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.96%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0.05pt 0pt;"> —</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.27%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.97%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.96%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (14,479)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.27%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.97%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.56%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0.05pt 0pt;"> —</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.27%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.97%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.96%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (14,479)</p></td></tr><tr><td style="vertical-align:bottom;width:27.54%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 6pt;">Gain on equity method investment</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.26%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.96%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.96%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0.05pt 0pt;"> —</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.26%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.96%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.55%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0.05pt 0pt;"> —</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.26%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.97%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.96%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0.05pt 0pt;"> —</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.27%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.97%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.96%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0.05pt 0pt;"> 10,871</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.27%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.97%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.56%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0.05pt 0pt;"> —</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.27%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.97%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.96%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0.05pt 0pt;"> 10,871</p></td></tr><tr><td style="vertical-align:bottom;width:27.54%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 6pt;">Other income</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.26%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.96%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.96%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (357)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.26%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.96%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.55%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (1)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.26%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.97%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.96%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (358)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.27%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.97%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.96%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (2,222)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.27%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.97%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.56%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0.05pt 0pt;"> —</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.27%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.97%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.96%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (2,222)</p></td></tr><tr><td style="vertical-align:bottom;width:27.54%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Income (Loss) Before Income Taxes</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.26%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.96%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.96%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0.05pt 0pt;"> 6,136</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.26%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.96%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.55%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (483)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.26%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.97%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.96%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0.05pt 0pt;"> 5,653</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.27%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.97%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.96%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (44,772)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.27%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.97%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.56%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (1,124)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.27%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.97%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.96%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (45,896)</p></td></tr></table><div style="font-family:'Times New Roman','Times','serif';font-size:10.0pt;margin-bottom:0pt;min-height:1.19em;position:relative;width:100%;"><div style="background-color:#000000;height:1pt;position:relative;top:0.6em;width:25.0%;border:none;margin:0 auto 0 0;"/></div><div style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-left:0pt;margin-top:0pt;text-indent:0pt;"><span style="display:inline-block;font-size:9pt;min-width:36pt;white-space:nowrap;">(1)</span><span style="font-size:9pt;">Center-level Contribution Margin from segments below the quantitative thresholds are attributable to </span><span style="font-size:9pt;">two</span><span style="font-size:9pt;"> operating segments of the Company. Those segments consist of Homecare and Senior Housing. Neither of those segments has ever met any of the quantitative thresholds for determining reportable segments.</span></div><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="font-family:'Times New Roman','Times','serif';font-size:9pt;vertical-align:text-top;white-space:nowrap;width:36pt;padding:0pt;">(2)</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:9pt;font-style:normal;font-weight:normal;">Overhead consists of the Sales and marketing and Corporate, general and administrative financial statement line items.</span></td></tr></table> 176988000 176988000 155835000 155835000 166000 205000 371000 -47000 520000 473000 177154000 205000 177359000 155788000 520000 156308000 103254000 103254000 75389000 75389000 45995000 107000 46102000 38867000 698000 39565000 27905000 98000 28003000 41532000 -178000 41354000 30911000 -85000 30826000 24217000 -30000 24187000 3760000 90000 3850000 3181000 130000 3311000 19222000 19222000 663000 46000 709000 4824000 52000 4876000 -13488000 -13488000 -10871000 -10871000 108000 108000 -2267000 -2267000 -7321000 47000 -7274000 -14796000 -330000 -15126000 524507000 524507000 464294000 464294000 234000 1039000 1273000 213000 1677000 1890000 524741000 1039000 525780000 464507000 1677000 466184000 284299000 284299000 224215000 224215000 128573000 1167000 129740000 113611000 2311000 115922000 111869000 -128000 111741000 126681000 -634000 126047000 93463000 -98000 93365000 120249000 -13000 120236000 10130000 305000 10435000 8901000 361000 9262000 1343000 1343000 18211000 18211000 1783000 147000 1930000 16919000 142000 17061000 -14479000 -14479000 -10871000 -10871000 -357000 -1000 -358000 -2222000 -2222000 6136000 -483000 5653000 -44772000 -1124000 -45896000 2 <p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;"><span style="display:inline-block;text-indent:0pt;width:36pt;"><b style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:bold;">Note 15:</b></span> Related-party</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Pursuant to the PWD Amended and Restated Agreement of Limited Partnership, the general partner, who is a subsidiary of the Company (the “General Partner”), helped fund operating deficits and shortfalls of PWD in the form of a loan. At each of March 31, 2022 and June 30, 2021, $0.7 million was recorded in Deposits and other. Additionally, the General Partner is paid an administration fee of $35,000 per year.</p> 700000 700000 35000 <p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;">Note 16: Subsequent Events</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">The Company has evaluated subsequent events through May 10, 2022, the date on which the condensed consolidated financial statements were issued.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:36pt;margin:0pt 0pt 0pt 36pt;"><span style="margin-bottom:12pt;margin-left:0pt;visibility:hidden;">​</span></p> EXCEL 78 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx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end XML 79 Show.js IDEA: XBRL DOCUMENT // Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission. Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105. var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0); e.removeAttribute('id');a.parentNode.appendChild(e)}} if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'} e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}} XML 80 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 81 FilingSummary.xml IDEA: XBRL DOCUMENT 3.22.1 html 252 313 1 false 65 0 false 8 false false R1.htm 00090 - Document - Document and Entity Information Sheet http://www.innovage.com/role/DocumentDocumentAndEntityInformation Document and Entity Information Cover 1 false false R2.htm 00100 - Statement - Condensed Consolidated Balance Sheets Sheet http://www.innovage.com/role/StatementCondensedConsolidatedBalanceSheets Condensed Consolidated Balance Sheets Statements 2 false false R3.htm 00105 - Statement - Condensed Consolidated Balance Sheets (Parenthetical) Sheet http://www.innovage.com/role/StatementCondensedConsolidatedBalanceSheetsParenthetical Condensed Consolidated Balance Sheets (Parenthetical) Statements 3 false false R4.htm 00200 - Statement - Condensed Consolidated Statements of Operations Sheet http://www.innovage.com/role/StatementCondensedConsolidatedStatementsOfOperations Condensed Consolidated Statements of Operations Statements 4 false false R5.htm 00300 - Statement - Condensed Consolidated Statements of Stockholders' Equity Sheet http://www.innovage.com/role/StatementCondensedConsolidatedStatementsOfStockholdersEquity Condensed Consolidated Statements of Stockholders' Equity Statements 5 false false R6.htm 00305 - Statement - Condensed Consolidated Statements of Stockholders' Equity (Parenthetical) Sheet http://www.innovage.com/role/StatementCondensedConsolidatedStatementsOfStockholdersEquityParenthetical Condensed Consolidated Statements of Stockholders' Equity (Parenthetical) Statements 6 false false R7.htm 00400 - Statement - Condensed Consolidated Statements of Cash Flows Sheet http://www.innovage.com/role/StatementCondensedConsolidatedStatementsOfCashFlows Condensed Consolidated Statements of Cash Flows Statements 7 false false R8.htm 10101 - Disclosure - Business Sheet http://www.innovage.com/role/DisclosureBusiness Business Notes 8 false false R9.htm 10201 - Disclosure - Summary of Significant Accounting Policies Sheet http://www.innovage.com/role/DisclosureSummaryOfSignificantAccountingPolicies Summary of Significant Accounting Policies Notes 9 false false R10.htm 10301 - Disclosure - Revenue Recognition Sheet http://www.innovage.com/role/DisclosureRevenueRecognition Revenue Recognition Notes 10 false false R11.htm 10401 - Disclosure - Investments Sheet http://www.innovage.com/role/DisclosureInvestments Investments Notes 11 false false R12.htm 10501 - Disclosure - Fair Value Measurements Sheet http://www.innovage.com/role/DisclosureFairValueMeasurements Fair Value Measurements Notes 12 false false R13.htm 10601 - Disclosure - Goodwill and Intangible Assets Sheet http://www.innovage.com/role/DisclosureGoodwillAndIntangibleAssets Goodwill and Intangible Assets Notes 13 false false R14.htm 10701 - Disclosure - Leases Sheet http://www.innovage.com/role/DisclosureLeases Leases Notes 14 false false R15.htm 10801 - Disclosure - Long Term Debt Sheet http://www.innovage.com/role/DisclosureLongTermDebt Long Term Debt Notes 15 false false R16.htm 10901 - Disclosure - Commitments and Contingencies Sheet http://www.innovage.com/role/DisclosureCommitmentsAndContingencies Commitments and Contingencies Notes 16 false false R17.htm 11001 - Disclosure - Equity Sheet http://www.innovage.com/role/DisclosureEquity Equity Notes 17 false false R18.htm 11101 - Disclosure - Stock-based Compensation Sheet http://www.innovage.com/role/DisclosureStockBasedCompensation Stock-based Compensation Notes 18 false false R19.htm 11201 - Disclosure - Income Taxes Sheet http://www.innovage.com/role/DisclosureIncomeTaxes Income Taxes Notes 19 false false R20.htm 11301 - Disclosure - Earnings per Share Sheet http://www.innovage.com/role/DisclosureEarningsPerShare Earnings per Share Notes 20 false false R21.htm 11401 - Disclosure - Segment Reporting Sheet http://www.innovage.com/role/DisclosureSegmentReporting Segment Reporting Notes 21 false false R22.htm 11501 - Disclosure - Related-party Sheet http://www.innovage.com/role/DisclosureRelatedParty Related-party Notes 22 false false R23.htm 11601 - Disclosure - Subsequent Events Sheet http://www.innovage.com/role/DisclosureSubsequentEvents Subsequent Events Notes 23 false false R24.htm 20202 - Disclosure - Summary of Significant Accounting Policies (Policies) Sheet http://www.innovage.com/role/DisclosureSummaryOfSignificantAccountingPoliciesPolicies Summary of Significant Accounting Policies (Policies) Policies http://www.innovage.com/role/DisclosureSummaryOfSignificantAccountingPolicies 24 false false R25.htm 30203 - Disclosure - Summary of Significant Accounting Policies (Tables) Sheet http://www.innovage.com/role/DisclosureSummaryOfSignificantAccountingPoliciesTables Summary of Significant Accounting Policies (Tables) Tables http://www.innovage.com/role/DisclosureSummaryOfSignificantAccountingPolicies 25 false false R26.htm 30303 - Disclosure - Revenue Recognition (Tables) Sheet http://www.innovage.com/role/DisclosureRevenueRecognitionTables Revenue Recognition (Tables) Tables http://www.innovage.com/role/DisclosureRevenueRecognition 26 false false R27.htm 30403 - Disclosure - Investments (Tables) Sheet http://www.innovage.com/role/DisclosureInvestmentsTables Investments (Tables) Tables http://www.innovage.com/role/DisclosureInvestments 27 false false R28.htm 30603 - Disclosure - Goodwill and Intangible Assets (Tables) Sheet http://www.innovage.com/role/DisclosureGoodwillAndIntangibleAssetsTables Goodwill and Intangible Assets (Tables) Tables http://www.innovage.com/role/DisclosureGoodwillAndIntangibleAssets 28 false false R29.htm 30703 - Disclosure - Leases (Tables) Sheet http://www.innovage.com/role/DisclosureLeasesTables Leases (Tables) Tables http://www.innovage.com/role/DisclosureLeases 29 false false R30.htm 30803 - Disclosure - Long Term Debt (Tables) Sheet http://www.innovage.com/role/DisclosureLongTermDebtTables Long Term Debt (Tables) Tables http://www.innovage.com/role/DisclosureLongTermDebt 30 false false R31.htm 31103 - Disclosure - Stock-based Compensation (Tables) Sheet http://www.innovage.com/role/DisclosureStockBasedCompensationTables Stock-based Compensation (Tables) Tables http://www.innovage.com/role/DisclosureStockBasedCompensation 31 false false R32.htm 31303 - Disclosure - Earnings per Share (Tables) Sheet http://www.innovage.com/role/DisclosureEarningsPerShareTables Earnings per Share (Tables) Tables http://www.innovage.com/role/DisclosureEarningsPerShare 32 false false R33.htm 31403 - Disclosure - Segment Reporting (Tables) Sheet http://www.innovage.com/role/DisclosureSegmentReportingTables Segment Reporting (Tables) Tables http://www.innovage.com/role/DisclosureSegmentReporting 33 false false R34.htm 40101 - Disclosure - Business (Details) Sheet http://www.innovage.com/role/DisclosureBusinessDetails Business (Details) Details http://www.innovage.com/role/DisclosureBusiness 34 false false R35.htm 40201 - Disclosure - Summary of Significant Accounting Policies - Effect of Restatement on Consolidated Balance Sheet (Details) Sheet http://www.innovage.com/role/DisclosureSummaryOfSignificantAccountingPoliciesEffectOfRestatementOnConsolidatedBalanceSheetDetails Summary of Significant Accounting Policies - Effect of Restatement on Consolidated Balance Sheet (Details) Details 35 false false R36.htm 40202 - Disclosure - Summary of Significant Accounting Policies - Effect of Restatement on Consolidated Statements of Stockholders' Equity (Details) Sheet http://www.innovage.com/role/DisclosureSummaryOfSignificantAccountingPoliciesEffectOfRestatementOnConsolidatedStatementsOfStockholdersEquityDetails Summary of Significant Accounting Policies - Effect of Restatement on Consolidated Statements of Stockholders' Equity (Details) Details 36 false false R37.htm 40204 - Disclosure - Summary of Significant Accounting Policies - Property and Equipment (Details) Sheet http://www.innovage.com/role/DisclosureSummaryOfSignificantAccountingPoliciesPropertyAndEquipmentDetails Summary of Significant Accounting Policies - Property and Equipment (Details) Details 37 false false R38.htm 40205 - Disclosure - Summary of Significant Accounting Policies - COVID-19 (Details) Sheet http://www.innovage.com/role/DisclosureSummaryOfSignificantAccountingPoliciesCovid19Details Summary of Significant Accounting Policies - COVID-19 (Details) Details 38 false false R39.htm 40301 - Disclosure - Revenue Recognition (Details) Sheet http://www.innovage.com/role/DisclosureRevenueRecognitionDetails Revenue Recognition (Details) Details http://www.innovage.com/role/DisclosureRevenueRecognitionTables 39 false false R40.htm 40302 - Disclosure - Revenue Recognition - Source of Revenue (Details) Sheet http://www.innovage.com/role/DisclosureRevenueRecognitionSourceOfRevenueDetails Revenue Recognition - Source of Revenue (Details) Details 40 false false R41.htm 40303 - Disclosure - Revenue Recognition - Concentration of Net Receivable (Details) Sheet http://www.innovage.com/role/DisclosureRevenueRecognitionConcentrationOfNetReceivableDetails Revenue Recognition - Concentration of Net Receivable (Details) Details 41 false false R42.htm 40401 - Disclosure - Investments - Equity Method and Cost Method Investments (Details) Sheet http://www.innovage.com/role/DisclosureInvestmentsEquityMethodAndCostMethodInvestmentsDetails Investments - Equity Method and Cost Method Investments (Details) Details 42 false false R43.htm 40402 - Disclosure - Investments (Details) Sheet http://www.innovage.com/role/DisclosureInvestmentsDetails Investments (Details) Details http://www.innovage.com/role/DisclosureInvestmentsTables 43 false false R44.htm 40501 - Disclosure - Fair Value Measurements (Details) Sheet http://www.innovage.com/role/DisclosureFairValueMeasurementsDetails Fair Value Measurements (Details) Details http://www.innovage.com/role/DisclosureFairValueMeasurements 44 false false R45.htm 40601 - Disclosure - Goodwill and Intangible Assets (Details) Sheet http://www.innovage.com/role/DisclosureGoodwillAndIntangibleAssetsDetails Goodwill and Intangible Assets (Details) Details http://www.innovage.com/role/DisclosureGoodwillAndIntangibleAssetsTables 45 false false R46.htm 40602 - Disclosure - Goodwill and Intangible Assets - Intangible Asset by Major Class (Details) Sheet http://www.innovage.com/role/DisclosureGoodwillAndIntangibleAssetsIntangibleAssetByMajorClassDetails Goodwill and Intangible Assets - Intangible Asset by Major Class (Details) Details 46 false false R47.htm 40701 - Disclosure - Leases - Assets Under Lease (Details) Sheet http://www.innovage.com/role/DisclosureLeasesAssetsUnderLeaseDetails Leases - Assets Under Lease (Details) Details 47 false false R48.htm 40702 - Disclosure - Leases - Future Minimum Lease Payments (Details) Sheet http://www.innovage.com/role/DisclosureLeasesFutureMinimumLeasePaymentsDetails Leases - Future Minimum Lease Payments (Details) Details 48 false false R49.htm 40801 - Disclosure - Long Term Debt - Schedule of Long-term Debt (Details) Sheet http://www.innovage.com/role/DisclosureLongTermDebtScheduleOfLongTermDebtDetails Long Term Debt - Schedule of Long-term Debt (Details) Details 49 false false R50.htm 40802 - Disclosure - Long Term Debt (Details) Sheet http://www.innovage.com/role/DisclosureLongTermDebtDetails Long Term Debt (Details) Details http://www.innovage.com/role/DisclosureLongTermDebtTables 50 false false R51.htm 41001 - Disclosure - Equity (Details) Sheet http://www.innovage.com/role/DisclosureEquityDetails Equity (Details) Details http://www.innovage.com/role/DisclosureEquity 51 false false R52.htm 41101 - Disclosure - Stock-based Compensation - Compensation Expense (Details) Sheet http://www.innovage.com/role/DisclosureStockBasedCompensationCompensationExpenseDetails Stock-based Compensation - Compensation Expense (Details) Details 52 false false R53.htm 41102 - Disclosure - Stock-based Compensation - Equity Incentive Plan (Details) Sheet http://www.innovage.com/role/DisclosureStockBasedCompensationEquityIncentivePlanDetails Stock-based Compensation - Equity Incentive Plan (Details) Details 53 false false R54.htm 41103 - Disclosure - Stock-based Compensation - Profits Interests (Details) Sheet http://www.innovage.com/role/DisclosureStockBasedCompensationProfitsInterestsDetails Stock-based Compensation - Profits Interests (Details) Details 54 false false R55.htm 41104 - Disclosure - Stock-based Compensation - Profits Interests Transactions and Number of Units Outstanding (Details) Sheet http://www.innovage.com/role/DisclosureStockBasedCompensationProfitsInterestsTransactionsAndNumberOfUnitsOutstandingDetails Stock-based Compensation - Profits Interests Transactions and Number of Units Outstanding (Details) Details 55 false false R56.htm 41105 - Disclosure - Stock-based Compensation - Monte Carlo Option Pricing Model (Details) Sheet http://www.innovage.com/role/DisclosureStockBasedCompensationMonteCarloOptionPricingModelDetails Stock-based Compensation - Monte Carlo Option Pricing Model (Details) Details 56 false false R57.htm 41106 - Disclosure - Stock-based Compensation - 2021 Omnibus Incentive Plan (Details) Sheet http://www.innovage.com/role/DisclosureStockBasedCompensation2021OmnibusIncentivePlanDetails Stock-based Compensation - 2021 Omnibus Incentive Plan (Details) Details 57 false false R58.htm 41107 - Disclosure - Stock-based Compensation - 2021 Omnibus Incentive Plan (RSU Activity) (Details) Sheet http://www.innovage.com/role/DisclosureStockBasedCompensation2021OmnibusIncentivePlanRsuActivityDetails Stock-based Compensation - 2021 Omnibus Incentive Plan (RSU Activity) (Details) Details 58 false false R59.htm 41108 - Disclosure - Stock-based Compensation - Time-based Awards (Details) Sheet http://www.innovage.com/role/DisclosureStockBasedCompensationTimeBasedAwardsDetails Stock-based Compensation - Time-based Awards (Details) Details 59 false false R60.htm 41109 - Disclosure - Stock-based Compensation - Performance-based Awards (Details) Sheet http://www.innovage.com/role/DisclosureStockBasedCompensationPerformanceBasedAwardsDetails Stock-based Compensation - Performance-based Awards (Details) Details 60 false false R61.htm 41201 - Disclosure - Income Taxes (Details) Sheet http://www.innovage.com/role/DisclosureIncomeTaxesDetails Income Taxes (Details) Details http://www.innovage.com/role/DisclosureIncomeTaxes 61 false false R62.htm 41301 - Disclosure - Earnings per Share (Details) Sheet http://www.innovage.com/role/DisclosureEarningsPerShareDetails Earnings per Share (Details) Details http://www.innovage.com/role/DisclosureEarningsPerShareTables 62 false false R63.htm 41401 - Disclosure - Segment Reporting (Details) Sheet http://www.innovage.com/role/DisclosureSegmentReportingDetails Segment Reporting (Details) Details http://www.innovage.com/role/DisclosureSegmentReportingTables 63 false false R64.htm 41402 - Disclosure - Segment Reporting - Operating Results (Details) Sheet http://www.innovage.com/role/DisclosureSegmentReportingOperatingResultsDetails Segment Reporting - Operating Results (Details) Details 64 false false R65.htm 41501 - Disclosure - Related-party (Details) Sheet http://www.innovage.com/role/DisclosureRelatedPartyDetails Related-party (Details) Details http://www.innovage.com/role/DisclosureRelatedParty 65 false false All Reports Book All Reports tmb-20220331x10q.htm tmb-20220331.xsd tmb-20220331_cal.xml tmb-20220331_def.xml tmb-20220331_lab.xml tmb-20220331_pre.xml tmb-20220331xex31d1.htm tmb-20220331xex31d2.htm tmb-20220331xex32d1.htm tmb-20220331xex32d2.htm tmb-20220331x10q004.jpg http://fasb.org/us-gaap/2020-01-31 http://xbrl.sec.gov/dei/2020-01-31 true true JSON 84 MetaLinks.json IDEA: XBRL DOCUMENT { "instance": { "tmb-20220331x10q.htm": { "axisCustom": 0, "axisStandard": 22, "contextCount": 252, "dts": { "calculationLink": { "local": [ "tmb-20220331_cal.xml" ] }, "definitionLink": { "local": [ "tmb-20220331_def.xml" ], "remote": [ "http://xbrl.fasb.org/srt/2020/elts/srt-eedm1-def-2020-01-31.xml", "http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-eedm-def-2020-01-31.xml" ] }, "inline": { "local": [ "tmb-20220331x10q.htm" ] }, "labelLink": { "local": [ "tmb-20220331_lab.xml" ] }, "presentationLink": { "local": [ "tmb-20220331_pre.xml" ] }, "schema": { "local": [ "tmb-20220331.xsd" ], "remote": [ "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd", "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd", "http://www.xbrl.org/2003/xl-2003-12-31.xsd", "http://www.xbrl.org/2003/xlink-2003-12-31.xsd", "http://www.xbrl.org/2005/xbrldt-2005.xsd", "http://www.xbrl.org/2006/ref-2006-02-27.xsd", "http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd", "http://www.xbrl.org/dtr/type/numeric-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/deprecated-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/reference-2009-12-16.xsd", "http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd", "http://xbrl.fasb.org/srt/2020/elts/srt-roles-2020-01-31.xsd", "http://xbrl.fasb.org/srt/2020/elts/srt-types-2020-01-31.xsd", "http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd", "http://xbrl.fasb.org/us-gaap/2020/elts/us-roles-2020-01-31.xsd", "http://xbrl.fasb.org/us-gaap/2020/elts/us-types-2020-01-31.xsd", "https://xbrl.sec.gov/country/2020/country-2020-01-31.xsd", "https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd" ] } }, "elementCount": 486, "entityCount": 1, "hidden": { "http://fasb.org/us-gaap/2020-01-31": 8, "http://www.innovage.com/20220331": 1, "http://xbrl.sec.gov/dei/2020-01-31": 5, "total": 14 }, "keyCustom": 51, "keyStandard": 262, "memberCustom": 35, "memberStandard": 27, "nsprefix": "innv", "nsuri": "http://www.innovage.com/20220331", "report": { "R1": { "firstAnchor": { "ancestors": [ "p", "div", "div", "body", "html" ], "baseRef": "tmb-20220331x10q.htm", "contextRef": "Duration_7_1_2021_To_3_31_2022_h8PJxyv3mE2CWKanK8K2DA", "decimals": null, "first": true, "lang": "en-US", "name": "dei:DocumentType", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "document", "isDefault": "true", "longName": "00090 - Document - Document and Entity Information", "role": "http://www.innovage.com/role/DocumentDocumentAndEntityInformation", "shortName": "Document and Entity Information", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "p", "div", "div", "body", "html" ], "baseRef": "tmb-20220331x10q.htm", "contextRef": "Duration_7_1_2021_To_3_31_2022_h8PJxyv3mE2CWKanK8K2DA", "decimals": null, "first": true, "lang": "en-US", "name": "dei:DocumentType", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R10": { "firstAnchor": { "ancestors": [ "div", "div", "body", "html" ], "baseRef": "tmb-20220331x10q.htm", "contextRef": "Duration_7_1_2021_To_3_31_2022_h8PJxyv3mE2CWKanK8K2DA", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:RevenueFromContractWithCustomerTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "10301 - Disclosure - Revenue Recognition", "role": "http://www.innovage.com/role/DisclosureRevenueRecognition", "shortName": "Revenue Recognition", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "div", "body", "html" ], "baseRef": "tmb-20220331x10q.htm", "contextRef": "Duration_7_1_2021_To_3_31_2022_h8PJxyv3mE2CWKanK8K2DA", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:RevenueFromContractWithCustomerTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R11": { "firstAnchor": { "ancestors": [ "div", "div", "body", "html" ], "baseRef": "tmb-20220331x10q.htm", "contextRef": "Duration_7_1_2021_To_3_31_2022_h8PJxyv3mE2CWKanK8K2DA", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "10401 - Disclosure - Investments", "role": "http://www.innovage.com/role/DisclosureInvestments", "shortName": "Investments", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "div", "body", "html" ], "baseRef": "tmb-20220331x10q.htm", "contextRef": "Duration_7_1_2021_To_3_31_2022_h8PJxyv3mE2CWKanK8K2DA", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R12": { "firstAnchor": { "ancestors": [ "div", "div", "body", "html" ], "baseRef": "tmb-20220331x10q.htm", "contextRef": "Duration_7_1_2021_To_3_31_2022_h8PJxyv3mE2CWKanK8K2DA", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:FairValueDisclosuresTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "10501 - Disclosure - Fair Value Measurements", "role": "http://www.innovage.com/role/DisclosureFairValueMeasurements", "shortName": "Fair Value Measurements", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "div", "body", "html" ], "baseRef": "tmb-20220331x10q.htm", "contextRef": "Duration_7_1_2021_To_3_31_2022_h8PJxyv3mE2CWKanK8K2DA", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:FairValueDisclosuresTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R13": { "firstAnchor": { "ancestors": [ "div", "div", "body", "html" ], "baseRef": "tmb-20220331x10q.htm", "contextRef": "Duration_7_1_2021_To_3_31_2022_h8PJxyv3mE2CWKanK8K2DA", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "10601 - Disclosure - Goodwill and Intangible Assets", "role": "http://www.innovage.com/role/DisclosureGoodwillAndIntangibleAssets", "shortName": "Goodwill and Intangible Assets", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "div", "body", "html" ], "baseRef": "tmb-20220331x10q.htm", "contextRef": "Duration_7_1_2021_To_3_31_2022_h8PJxyv3mE2CWKanK8K2DA", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R14": { "firstAnchor": { "ancestors": [ "div", "div", "body", "html" ], "baseRef": "tmb-20220331x10q.htm", "contextRef": "Duration_7_1_2021_To_3_31_2022_h8PJxyv3mE2CWKanK8K2DA", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:LeasesOfLesseeDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "10701 - Disclosure - Leases", "role": "http://www.innovage.com/role/DisclosureLeases", "shortName": "Leases", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "div", "body", "html" ], "baseRef": "tmb-20220331x10q.htm", "contextRef": "Duration_7_1_2021_To_3_31_2022_h8PJxyv3mE2CWKanK8K2DA", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:LeasesOfLesseeDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R15": { "firstAnchor": { "ancestors": [ "div", "div", "body", "html" ], "baseRef": "tmb-20220331x10q.htm", "contextRef": "Duration_7_1_2021_To_3_31_2022_h8PJxyv3mE2CWKanK8K2DA", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:DebtDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "10801 - Disclosure - Long Term Debt", "role": "http://www.innovage.com/role/DisclosureLongTermDebt", "shortName": "Long Term Debt", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "div", "body", "html" ], "baseRef": "tmb-20220331x10q.htm", "contextRef": "Duration_7_1_2021_To_3_31_2022_h8PJxyv3mE2CWKanK8K2DA", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:DebtDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R16": { "firstAnchor": { "ancestors": [ "div", "div", "body", "html" ], "baseRef": "tmb-20220331x10q.htm", "contextRef": "Duration_7_1_2021_To_3_31_2022_h8PJxyv3mE2CWKanK8K2DA", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "10901 - Disclosure - Commitments and Contingencies", "role": "http://www.innovage.com/role/DisclosureCommitmentsAndContingencies", "shortName": "Commitments and Contingencies", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "div", "body", "html" ], "baseRef": "tmb-20220331x10q.htm", "contextRef": "Duration_7_1_2021_To_3_31_2022_h8PJxyv3mE2CWKanK8K2DA", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R17": { "firstAnchor": { "ancestors": [ "div", "div", "body", "html" ], "baseRef": "tmb-20220331x10q.htm", "contextRef": "Duration_7_1_2021_To_3_31_2022_h8PJxyv3mE2CWKanK8K2DA", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:StockholdersEquityNoteDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "11001 - Disclosure - Equity", "role": "http://www.innovage.com/role/DisclosureEquity", "shortName": "Equity", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "div", "body", "html" ], "baseRef": "tmb-20220331x10q.htm", "contextRef": "Duration_7_1_2021_To_3_31_2022_h8PJxyv3mE2CWKanK8K2DA", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:StockholdersEquityNoteDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R18": { "firstAnchor": { "ancestors": [ "div", "div", "body", "html" ], "baseRef": "tmb-20220331x10q.htm", "contextRef": "Duration_7_1_2021_To_3_31_2022_h8PJxyv3mE2CWKanK8K2DA", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "11101 - Disclosure - Stock-based Compensation", "role": "http://www.innovage.com/role/DisclosureStockBasedCompensation", "shortName": "Stock-based Compensation", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "div", "body", "html" ], "baseRef": "tmb-20220331x10q.htm", "contextRef": "Duration_7_1_2021_To_3_31_2022_h8PJxyv3mE2CWKanK8K2DA", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R19": { "firstAnchor": { "ancestors": [ "div", "div", "body", "html" ], "baseRef": "tmb-20220331x10q.htm", "contextRef": "Duration_7_1_2021_To_3_31_2022_h8PJxyv3mE2CWKanK8K2DA", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:IncomeTaxDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "11201 - Disclosure - Income Taxes", "role": "http://www.innovage.com/role/DisclosureIncomeTaxes", "shortName": "Income Taxes", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "div", "body", "html" ], "baseRef": "tmb-20220331x10q.htm", "contextRef": "Duration_7_1_2021_To_3_31_2022_h8PJxyv3mE2CWKanK8K2DA", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:IncomeTaxDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R2": { "firstAnchor": { "ancestors": [ "p", "td", "tr", "table", "div", "div", "body", "html" ], "baseRef": "tmb-20220331x10q.htm", "contextRef": "As_Of_3_31_2022_CNhezx4iDEqpDR_QYmAHmg", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue", "reportCount": 1, "unitRef": "Unit_Standard_USD_-XJKlZ2wQUeX9Czwk1DwSw", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "00100 - Statement - Condensed Consolidated Balance Sheets", "role": "http://www.innovage.com/role/StatementCondensedConsolidatedBalanceSheets", "shortName": "Condensed Consolidated Balance Sheets", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "p", "td", "tr", "table", "div", "div", "body", "html" ], "baseRef": "tmb-20220331x10q.htm", "contextRef": "As_Of_3_31_2022_CNhezx4iDEqpDR_QYmAHmg", "decimals": "-3", "lang": null, "name": "us-gaap:RestrictedCashCurrent", "reportCount": 1, "unique": true, "unitRef": "Unit_Standard_USD_-XJKlZ2wQUeX9Czwk1DwSw", "xsiNil": "false" } }, "R20": { "firstAnchor": { "ancestors": [ "div", "div", "body", "html" ], "baseRef": "tmb-20220331x10q.htm", "contextRef": "Duration_7_1_2021_To_3_31_2022_h8PJxyv3mE2CWKanK8K2DA", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:EarningsPerShareTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "11301 - Disclosure - Earnings per Share", "role": "http://www.innovage.com/role/DisclosureEarningsPerShare", "shortName": "Earnings per Share", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "div", "body", "html" ], "baseRef": "tmb-20220331x10q.htm", "contextRef": "Duration_7_1_2021_To_3_31_2022_h8PJxyv3mE2CWKanK8K2DA", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:EarningsPerShareTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R21": { "firstAnchor": { "ancestors": [ "div", "div", "body", "html" ], "baseRef": "tmb-20220331x10q.htm", "contextRef": "Duration_7_1_2021_To_3_31_2022_h8PJxyv3mE2CWKanK8K2DA", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:SegmentReportingDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "11401 - Disclosure - Segment Reporting", "role": "http://www.innovage.com/role/DisclosureSegmentReporting", "shortName": "Segment Reporting", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "div", "body", "html" ], "baseRef": "tmb-20220331x10q.htm", "contextRef": "Duration_7_1_2021_To_3_31_2022_h8PJxyv3mE2CWKanK8K2DA", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:SegmentReportingDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R22": { "firstAnchor": { "ancestors": [ "div", "div", "body", "html" ], "baseRef": "tmb-20220331x10q.htm", "contextRef": "Duration_7_1_2021_To_3_31_2022_h8PJxyv3mE2CWKanK8K2DA", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:RelatedPartyTransactionsDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "11501 - Disclosure - Related-party", "role": "http://www.innovage.com/role/DisclosureRelatedParty", "shortName": "Related-party", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "div", "body", "html" ], "baseRef": "tmb-20220331x10q.htm", "contextRef": "Duration_7_1_2021_To_3_31_2022_h8PJxyv3mE2CWKanK8K2DA", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:RelatedPartyTransactionsDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R23": { "firstAnchor": { "ancestors": [ "div", "div", "body", "html" ], "baseRef": "tmb-20220331x10q.htm", "contextRef": "Duration_7_1_2021_To_3_31_2022_h8PJxyv3mE2CWKanK8K2DA", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:SubsequentEventsTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "11601 - Disclosure - Subsequent Events", "role": "http://www.innovage.com/role/DisclosureSubsequentEvents", "shortName": "Subsequent Events", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "div", "body", "html" ], "baseRef": "tmb-20220331x10q.htm", "contextRef": "Duration_7_1_2021_To_3_31_2022_h8PJxyv3mE2CWKanK8K2DA", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:SubsequentEventsTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R24": { "firstAnchor": { "ancestors": [ "us-gaap:BasisOfPresentationAndSignificantAccountingPoliciesTextBlock", "div", "div", "body", "html" ], "baseRef": "tmb-20220331x10q.htm", "contextRef": "Duration_7_1_2021_To_3_31_2022_h8PJxyv3mE2CWKanK8K2DA", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ConsolidationPolicyTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "20202 - Disclosure - Summary of Significant Accounting Policies (Policies)", "role": "http://www.innovage.com/role/DisclosureSummaryOfSignificantAccountingPoliciesPolicies", "shortName": "Summary of Significant Accounting Policies (Policies)", "subGroupType": "policies", "uniqueAnchor": { "ancestors": [ "us-gaap:BasisOfPresentationAndSignificantAccountingPoliciesTextBlock", "div", "div", "body", "html" ], "baseRef": "tmb-20220331x10q.htm", "contextRef": "Duration_7_1_2021_To_3_31_2022_h8PJxyv3mE2CWKanK8K2DA", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ConsolidationPolicyTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R25": { "firstAnchor": { "ancestors": [ "us-gaap:PriorPeriodReclassificationAdjustmentDescription", "ix:continuation", "div", "div", "body", "html" ], "baseRef": "tmb-20220331x10q.htm", "contextRef": "Duration_7_1_2021_To_3_31_2022_h8PJxyv3mE2CWKanK8K2DA", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfErrorCorrectionsAndPriorPeriodAdjustmentsTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "30203 - Disclosure - Summary of Significant Accounting Policies (Tables)", "role": "http://www.innovage.com/role/DisclosureSummaryOfSignificantAccountingPoliciesTables", "shortName": "Summary of Significant Accounting Policies (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "us-gaap:PriorPeriodReclassificationAdjustmentDescription", "ix:continuation", "div", "div", "body", "html" ], "baseRef": "tmb-20220331x10q.htm", "contextRef": "Duration_7_1_2021_To_3_31_2022_h8PJxyv3mE2CWKanK8K2DA", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfErrorCorrectionsAndPriorPeriodAdjustmentsTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R26": { "firstAnchor": { "ancestors": [ "ix:continuation", "div", "div", "body", "html" ], "baseRef": "tmb-20220331x10q.htm", "contextRef": "Duration_7_1_2021_To_3_31_2022_h8PJxyv3mE2CWKanK8K2DA", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:DisaggregationOfRevenueTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "30303 - Disclosure - Revenue Recognition (Tables)", "role": "http://www.innovage.com/role/DisclosureRevenueRecognitionTables", "shortName": "Revenue Recognition (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "ix:continuation", "div", "div", "body", "html" ], "baseRef": "tmb-20220331x10q.htm", "contextRef": "Duration_7_1_2021_To_3_31_2022_h8PJxyv3mE2CWKanK8K2DA", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:DisaggregationOfRevenueTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R27": { "firstAnchor": { "ancestors": [ "us-gaap:InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock", "div", "div", "body", "html" ], "baseRef": "tmb-20220331x10q.htm", "contextRef": "Duration_7_1_2021_To_3_31_2022_h8PJxyv3mE2CWKanK8K2DA", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:InvestmentHoldingsScheduleOfInvestmentsTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "30403 - Disclosure - Investments (Tables)", "role": "http://www.innovage.com/role/DisclosureInvestmentsTables", "shortName": "Investments (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "us-gaap:InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock", "div", "div", "body", "html" ], "baseRef": "tmb-20220331x10q.htm", "contextRef": "Duration_7_1_2021_To_3_31_2022_h8PJxyv3mE2CWKanK8K2DA", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:InvestmentHoldingsScheduleOfInvestmentsTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R28": { "firstAnchor": { "ancestors": [ "us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock", "div", "div", "body", "html" ], "baseRef": "tmb-20220331x10q.htm", "contextRef": "Duration_7_1_2021_To_3_31_2022_h8PJxyv3mE2CWKanK8K2DA", "decimals": null, "first": true, "lang": "en-US", "name": "innv:ScheduleOfFiniteLivedAndIndefiniteLivedIntangibleAssetsByMajorClassTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "30603 - Disclosure - Goodwill and Intangible Assets (Tables)", "role": "http://www.innovage.com/role/DisclosureGoodwillAndIntangibleAssetsTables", "shortName": "Goodwill and Intangible Assets (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock", "div", "div", "body", "html" ], "baseRef": "tmb-20220331x10q.htm", "contextRef": "Duration_7_1_2021_To_3_31_2022_h8PJxyv3mE2CWKanK8K2DA", "decimals": null, "first": true, "lang": "en-US", "name": "innv:ScheduleOfFiniteLivedAndIndefiniteLivedIntangibleAssetsByMajorClassTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R29": { "firstAnchor": { "ancestors": [ "us-gaap:LeasesOfLesseeDisclosureTextBlock", "div", "div", "body", "html" ], "baseRef": "tmb-20220331x10q.htm", "contextRef": "Duration_7_1_2021_To_3_31_2022_h8PJxyv3mE2CWKanK8K2DA", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfCapitalLeasedAsssetsTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "30703 - Disclosure - Leases (Tables)", "role": "http://www.innovage.com/role/DisclosureLeasesTables", "shortName": "Leases (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "us-gaap:LeasesOfLesseeDisclosureTextBlock", "div", "div", "body", "html" ], "baseRef": "tmb-20220331x10q.htm", "contextRef": "Duration_7_1_2021_To_3_31_2022_h8PJxyv3mE2CWKanK8K2DA", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfCapitalLeasedAsssetsTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R3": { "firstAnchor": { "ancestors": [ "p", "td", "tr", "table", "div", "div", "body", "html" ], "baseRef": "tmb-20220331x10q.htm", "contextRef": "As_Of_3_31_2022_CNhezx4iDEqpDR_QYmAHmg", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:AllowanceForDoubtfulAccountsReceivable", "reportCount": 1, "unitRef": "Unit_Standard_USD_-XJKlZ2wQUeX9Czwk1DwSw", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "00105 - Statement - Condensed Consolidated Balance Sheets (Parenthetical)", "role": "http://www.innovage.com/role/StatementCondensedConsolidatedBalanceSheetsParenthetical", "shortName": "Condensed Consolidated Balance Sheets (Parenthetical)", "subGroupType": "parenthetical", "uniqueAnchor": { "ancestors": [ "span", "p", "td", "tr", "table", "div", "div", "body", "html" ], "baseRef": "tmb-20220331x10q.htm", "contextRef": "As_Of_3_31_2022_CNhezx4iDEqpDR_QYmAHmg", "decimals": "0", "lang": null, "name": "us-gaap:CommonStockSharesAuthorized", "reportCount": 1, "unique": true, "unitRef": "Unit_Standard_shares_nwFNuYtE90uvcwdWsI1nJA", "xsiNil": "false" } }, "R30": { "firstAnchor": { "ancestors": [ "us-gaap:DebtDisclosureTextBlock", "div", "div", "body", "html" ], "baseRef": "tmb-20220331x10q.htm", "contextRef": "Duration_7_1_2021_To_3_31_2022_h8PJxyv3mE2CWKanK8K2DA", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfDebtInstrumentsTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "30803 - Disclosure - Long Term Debt (Tables)", "role": "http://www.innovage.com/role/DisclosureLongTermDebtTables", "shortName": "Long Term Debt (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "us-gaap:DebtDisclosureTextBlock", "div", "div", "body", "html" ], "baseRef": "tmb-20220331x10q.htm", "contextRef": "Duration_7_1_2021_To_3_31_2022_h8PJxyv3mE2CWKanK8K2DA", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfDebtInstrumentsTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R31": { "firstAnchor": { "ancestors": [ "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock", "div", "div", "body", "html" ], "baseRef": "tmb-20220331x10q.htm", "contextRef": "Duration_7_1_2021_To_3_31_2022_h8PJxyv3mE2CWKanK8K2DA", "decimals": null, "first": true, "lang": "en-US", "name": "innv:ScheduleOfAllocatedShareBasedCompensationExpensesTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "31103 - Disclosure - Stock-based Compensation (Tables)", "role": "http://www.innovage.com/role/DisclosureStockBasedCompensationTables", "shortName": "Stock-based Compensation (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock", "div", "div", "body", "html" ], "baseRef": "tmb-20220331x10q.htm", "contextRef": "Duration_7_1_2021_To_3_31_2022_h8PJxyv3mE2CWKanK8K2DA", "decimals": null, "first": true, "lang": "en-US", "name": "innv:ScheduleOfAllocatedShareBasedCompensationExpensesTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R32": { "firstAnchor": { "ancestors": [ "ix:continuation", "div", "div", "body", "html" ], "baseRef": "tmb-20220331x10q.htm", "contextRef": "Duration_7_1_2021_To_3_31_2022_h8PJxyv3mE2CWKanK8K2DA", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "31303 - Disclosure - Earnings per Share (Tables)", "role": "http://www.innovage.com/role/DisclosureEarningsPerShareTables", "shortName": "Earnings per Share (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "ix:continuation", "div", "div", "body", "html" ], "baseRef": "tmb-20220331x10q.htm", "contextRef": "Duration_7_1_2021_To_3_31_2022_h8PJxyv3mE2CWKanK8K2DA", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R33": { "firstAnchor": { "ancestors": [ "ix:continuation", "div", "div", "body", "html" ], "baseRef": "tmb-20220331x10q.htm", "contextRef": "Duration_7_1_2021_To_3_31_2022_h8PJxyv3mE2CWKanK8K2DA", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "31403 - Disclosure - Segment Reporting (Tables)", "role": "http://www.innovage.com/role/DisclosureSegmentReportingTables", "shortName": "Segment Reporting (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "ix:continuation", "div", "div", "body", "html" ], "baseRef": "tmb-20220331x10q.htm", "contextRef": "Duration_7_1_2021_To_3_31_2022_h8PJxyv3mE2CWKanK8K2DA", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R34": { "firstAnchor": { "ancestors": [ "span", "p", "td", "tr", "table", "div", "div", "body", "html" ], "baseRef": "tmb-20220331x10q.htm", "contextRef": "As_Of_3_31_2022_CNhezx4iDEqpDR_QYmAHmg", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:CommonStockParOrStatedValuePerShare", "reportCount": 1, "unitRef": "Unit_Divide_USD_shares_W-bMpWnKQ0KNvyLOL4jW4Q", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "40101 - Disclosure - Business (Details)", "role": "http://www.innovage.com/role/DisclosureBusinessDetails", "shortName": "Business (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "p", "us-gaap:BusinessDescriptionAndBasisOfPresentationTextBlock", "div", "div", "body", "html" ], "baseRef": "tmb-20220331x10q.htm", "contextRef": "Duration_7_1_2021_To_3_31_2022_us-gaap_StatementBusinessSegmentsAxis_innv_ProgramOfAllInclusiveCareForElderlyOperatingSegmentsMember_wV3jwD1x1k2XLB47ihKHhg", "decimals": "0", "lang": null, "name": "innv:NumberOfCentersExcludingNonConsolidatingJointVentures", "reportCount": 1, "unique": true, "unitRef": "Unit_Standard_Center_pFoIC50DBECzTueYfeI-fQ", "xsiNil": "false" } }, "R35": { "firstAnchor": { "ancestors": [ "p", "td", "tr", "table", "div", "div", "body", "html" ], "baseRef": "tmb-20220331x10q.htm", "contextRef": "As_Of_3_31_2022_CNhezx4iDEqpDR_QYmAHmg", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:RedeemableNoncontrollingInterestEquityCarryingAmount", "reportCount": 1, "unitRef": "Unit_Standard_USD_-XJKlZ2wQUeX9Czwk1DwSw", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "40201 - Disclosure - Summary of Significant Accounting Policies - Effect of Restatement on Consolidated Balance Sheet (Details)", "role": "http://www.innovage.com/role/DisclosureSummaryOfSignificantAccountingPoliciesEffectOfRestatementOnConsolidatedBalanceSheetDetails", "shortName": "Summary of Significant Accounting Policies - Effect of Restatement on Consolidated Balance Sheet (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "p", "td", "tr", "table", "us-gaap:ScheduleOfErrorCorrectionsAndPriorPeriodAdjustmentsTextBlock", "us-gaap:PriorPeriodReclassificationAdjustmentDescription", "ix:continuation", "div", "div", "body", "html" ], "baseRef": "tmb-20220331x10q.htm", "contextRef": "As_Of_6_30_2021_srt_RestatementAxis_srt_ScenarioPreviouslyReportedMember_2icrPX7Ax0O51cP5IKz1OA", "decimals": "-3", "lang": null, "name": "us-gaap:RetainedEarningsAccumulatedDeficit", "reportCount": 1, "unique": true, "unitRef": "Unit_Standard_USD_-XJKlZ2wQUeX9Czwk1DwSw", "xsiNil": "false" } }, "R36": { "firstAnchor": { "ancestors": [ "p", "td", "tr", "table", "div", "div", "body", "html" ], "baseRef": "tmb-20220331x10q.htm", "contextRef": "Duration_1_1_2022_To_3_31_2022_u5JYg9AjsUaOb1mFgPD3gQ", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest", "reportCount": 1, "unitRef": "Unit_Standard_USD_-XJKlZ2wQUeX9Czwk1DwSw", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "40202 - Disclosure - Summary of Significant Accounting Policies - Effect of Restatement on Consolidated Statements of Stockholders' Equity (Details)", "role": "http://www.innovage.com/role/DisclosureSummaryOfSignificantAccountingPoliciesEffectOfRestatementOnConsolidatedStatementsOfStockholdersEquityDetails", "shortName": "Summary of Significant Accounting Policies - Effect of Restatement on Consolidated Statements of Stockholders' Equity (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "p", "td", "tr", "table", "ix:continuation", "ix:continuation", "ix:continuation", "div", "div", "body", "html" ], "baseRef": "tmb-20220331x10q.htm", "contextRef": "Duration_1_1_2021_To_3_31_2021_srt_RestatementAxis_srt_ScenarioPreviouslyReportedMember_a-R-YVfC3kGlQehZGmRNnA", "decimals": "-3", "lang": null, "name": "innv:ConsolidationOfEquityMethodInvestment", "reportCount": 1, "unique": true, "unitRef": "Unit_Standard_USD_-XJKlZ2wQUeX9Czwk1DwSw", "xsiNil": "false" } }, "R37": { "firstAnchor": { "ancestors": [ "p", "td", "tr", "table", "us-gaap:PropertyPlantAndEquipmentTextBlock", "us-gaap:PropertyPlantAndEquipmentPolicyTextBlock", "ix:continuation", "div", "div", "body", "html" ], "baseRef": "tmb-20220331x10q.htm", "contextRef": "As_Of_3_31_2022_CNhezx4iDEqpDR_QYmAHmg", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:PropertyPlantAndEquipmentGross", "reportCount": 1, "unitRef": "Unit_Standard_USD_-XJKlZ2wQUeX9Czwk1DwSw", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "40204 - Disclosure - Summary of Significant Accounting Policies - Property and Equipment (Details)", "role": "http://www.innovage.com/role/DisclosureSummaryOfSignificantAccountingPoliciesPropertyAndEquipmentDetails", "shortName": "Summary of Significant Accounting Policies - Property and Equipment (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "p", "us-gaap:PropertyPlantAndEquipmentPolicyTextBlock", "ix:continuation", "div", "div", "body", "html" ], "baseRef": "tmb-20220331x10q.htm", "contextRef": "Duration_1_1_2022_To_3_31_2022_u5JYg9AjsUaOb1mFgPD3gQ", "decimals": "-5", "lang": null, "name": "us-gaap:Depreciation", "reportCount": 1, "unique": true, "unitRef": "Unit_Standard_USD_-XJKlZ2wQUeX9Czwk1DwSw", "xsiNil": "false" } }, "R38": { "firstAnchor": { "ancestors": [ "p", "innv:UnusualOrInfrequentItemsOrBothCovid19PolicyPolicyTextBlock", "ix:continuation", "div", "div", "body", "html" ], "baseRef": "tmb-20220331x10q.htm", "contextRef": "Duration_7_1_2021_To_3_31_2022_h8PJxyv3mE2CWKanK8K2DA", "decimals": "-5", "first": true, "lang": null, "name": "innv:FundAmountReceivedCovid19", "reportCount": 1, "unique": true, "unitRef": "Unit_Standard_USD_-XJKlZ2wQUeX9Czwk1DwSw", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "40205 - Disclosure - Summary of Significant Accounting Policies - COVID-19 (Details)", "role": "http://www.innovage.com/role/DisclosureSummaryOfSignificantAccountingPoliciesCovid19Details", "shortName": "Summary of Significant Accounting Policies - COVID-19 (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "p", "innv:UnusualOrInfrequentItemsOrBothCovid19PolicyPolicyTextBlock", "ix:continuation", "div", "div", "body", "html" ], "baseRef": "tmb-20220331x10q.htm", "contextRef": "Duration_7_1_2021_To_3_31_2022_h8PJxyv3mE2CWKanK8K2DA", "decimals": "-5", "first": true, "lang": null, "name": "innv:FundAmountReceivedCovid19", "reportCount": 1, "unique": true, "unitRef": "Unit_Standard_USD_-XJKlZ2wQUeX9Czwk1DwSw", "xsiNil": "false" } }, "R39": { "firstAnchor": { "ancestors": [ "p", "us-gaap:RevenueFromContractWithCustomerTextBlock", "div", "div", "body", "html" ], "baseRef": "tmb-20220331x10q.htm", "contextRef": "Duration_7_1_2021_To_3_31_2022_h8PJxyv3mE2CWKanK8K2DA", "decimals": "2", "first": true, "lang": null, "name": "innv:PercentageOfPooledCapitatedPaymentReceived", "reportCount": 1, "unique": true, "unitRef": "Unit_Standard_pure_0z-esHzw4UebrWMIiDms8g", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "40301 - Disclosure - Revenue Recognition (Details)", "role": "http://www.innovage.com/role/DisclosureRevenueRecognitionDetails", "shortName": "Revenue Recognition (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "p", "us-gaap:RevenueFromContractWithCustomerTextBlock", "div", "div", "body", "html" ], "baseRef": "tmb-20220331x10q.htm", "contextRef": "Duration_7_1_2021_To_3_31_2022_h8PJxyv3mE2CWKanK8K2DA", "decimals": "2", "first": true, "lang": null, "name": "innv:PercentageOfPooledCapitatedPaymentReceived", "reportCount": 1, "unique": true, "unitRef": "Unit_Standard_pure_0z-esHzw4UebrWMIiDms8g", "xsiNil": "false" } }, "R4": { "firstAnchor": { "ancestors": [ "p", "td", "tr", "table", "div", "div", "body", "html" ], "baseRef": "tmb-20220331x10q.htm", "contextRef": "Duration_1_1_2022_To_3_31_2022_u5JYg9AjsUaOb1mFgPD3gQ", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax", "reportCount": 1, "unitRef": "Unit_Standard_USD_-XJKlZ2wQUeX9Czwk1DwSw", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "00200 - Statement - Condensed Consolidated Statements of Operations", "role": "http://www.innovage.com/role/StatementCondensedConsolidatedStatementsOfOperations", "shortName": "Condensed Consolidated Statements of Operations", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "p", "td", "tr", "table", "div", "div", "body", "html" ], "baseRef": "tmb-20220331x10q.htm", "contextRef": "Duration_1_1_2022_To_3_31_2022_u5JYg9AjsUaOb1mFgPD3gQ", "decimals": "-3", "lang": null, "name": "us-gaap:SellingAndMarketingExpense", "reportCount": 1, "unique": true, "unitRef": "Unit_Standard_USD_-XJKlZ2wQUeX9Czwk1DwSw", "xsiNil": "false" } }, "R40": { "firstAnchor": { "ancestors": [ "p", "td", "tr", "table", "us-gaap:DisaggregationOfRevenueTableTextBlock", "ix:continuation", "div", "div", "body", "html" ], "baseRef": "tmb-20220331x10q.htm", "contextRef": "Duration_7_1_2021_To_3_31_2022_us-gaap_ConcentrationRiskByBenchmarkAxis_us-gaap_RevenueFromContractWithCustomerMember_us-gaap_ConcentrationRiskByTypeAxis_us-gaap_CustomerConcentrationRiskMember_7ub9p-TSOECYM9RVMxDYXQ", "decimals": "2", "first": true, "lang": null, "name": "us-gaap:ConcentrationRiskPercentage1", "reportCount": 1, "unitRef": "Unit_Standard_pure_0z-esHzw4UebrWMIiDms8g", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "40302 - Disclosure - Revenue Recognition - Source of Revenue (Details)", "role": "http://www.innovage.com/role/DisclosureRevenueRecognitionSourceOfRevenueDetails", "shortName": "Revenue Recognition - Source of Revenue (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "p", "td", "tr", "table", "us-gaap:DisaggregationOfRevenueTableTextBlock", "ix:continuation", "div", "div", "body", "html" ], "baseRef": "tmb-20220331x10q.htm", "contextRef": "Duration_7_1_2021_To_3_31_2022_srt_MajorCustomersAxis_innv_MedicaidCustomerMember_us-gaap_ConcentrationRiskByBenchmarkAxis_us-gaap_RevenueFromContractWithCustomerMember_us-gaap_ConcentrationRiskByTypeAxis_us-gaap_CustomerConcentrationRiskMember_qiccuLFc9EyIwarD-6HnSg", "decimals": "2", "lang": null, "name": "us-gaap:ConcentrationRiskPercentage1", "reportCount": 1, "unique": true, "unitRef": "Unit_Standard_pure_0z-esHzw4UebrWMIiDms8g", "xsiNil": "false" } }, "R41": { "firstAnchor": { "ancestors": [ "p", "td", "tr", "table", "us-gaap:ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock", "ix:continuation", "div", "div", "body", "html" ], "baseRef": "tmb-20220331x10q.htm", "contextRef": "Duration_7_1_2021_To_3_31_2022_us-gaap_ConcentrationRiskByBenchmarkAxis_us-gaap_AccountsReceivableMember_us-gaap_ConcentrationRiskByTypeAxis_us-gaap_CustomerConcentrationRiskMember_Ly8nHODzAkOOv05IVBeAdA", "decimals": "2", "first": true, "lang": null, "name": "us-gaap:ConcentrationRiskPercentage1", "reportCount": 1, "unique": true, "unitRef": "Unit_Standard_pure_0z-esHzw4UebrWMIiDms8g", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "40303 - Disclosure - Revenue Recognition - Concentration of Net Receivable (Details)", "role": "http://www.innovage.com/role/DisclosureRevenueRecognitionConcentrationOfNetReceivableDetails", "shortName": "Revenue Recognition - Concentration of Net Receivable (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "p", "td", "tr", "table", "us-gaap:ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock", "ix:continuation", "div", "div", "body", "html" ], "baseRef": "tmb-20220331x10q.htm", "contextRef": "Duration_7_1_2021_To_3_31_2022_us-gaap_ConcentrationRiskByBenchmarkAxis_us-gaap_AccountsReceivableMember_us-gaap_ConcentrationRiskByTypeAxis_us-gaap_CustomerConcentrationRiskMember_Ly8nHODzAkOOv05IVBeAdA", "decimals": "2", "first": true, "lang": null, "name": "us-gaap:ConcentrationRiskPercentage1", "reportCount": 1, "unique": true, "unitRef": "Unit_Standard_pure_0z-esHzw4UebrWMIiDms8g", "xsiNil": "false" } }, "R42": { "firstAnchor": { "ancestors": [ "p", "td", "tr", "table", "div", "us-gaap:InvestmentHoldingsScheduleOfInvestmentsTableTextBlock", "us-gaap:InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock", "div", "div", "body", "html" ], "baseRef": "tmb-20220331x10q.htm", "contextRef": "As_Of_3_31_2022_CNhezx4iDEqpDR_QYmAHmg", "decimals": "-3", "first": true, "lang": null, "name": "innv:CostMethodInvestment", "reportCount": 1, "unitRef": "Unit_Standard_USD_-XJKlZ2wQUeX9Czwk1DwSw", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "40401 - Disclosure - Investments - Equity Method and Cost Method Investments (Details)", "role": "http://www.innovage.com/role/DisclosureInvestmentsEquityMethodAndCostMethodInvestmentsDetails", "shortName": "Investments - Equity Method and Cost Method Investments (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "p", "td", "tr", "table", "div", "us-gaap:InvestmentHoldingsScheduleOfInvestmentsTableTextBlock", "us-gaap:InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock", "div", "div", "body", "html" ], "baseRef": "tmb-20220331x10q.htm", "contextRef": "As_Of_3_31_2022_CNhezx4iDEqpDR_QYmAHmg", "decimals": "-3", "lang": null, "name": "us-gaap:EquityMethodInvestments", "reportCount": 1, "unique": true, "unitRef": "Unit_Standard_USD_-XJKlZ2wQUeX9Czwk1DwSw", "xsiNil": "false" } }, "R43": { "firstAnchor": { "ancestors": [ "p", "us-gaap:InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock", "div", "div", "body", "html" ], "baseRef": "tmb-20220331x10q.htm", "contextRef": "As_Of_3_31_2022_CNhezx4iDEqpDR_QYmAHmg", "decimals": "0", "first": true, "lang": null, "name": "innv:NumberOfInvestmentsAccountedUnderCostMethod", "reportCount": 1, "unitRef": "Unit_Standard_item_GU38gLfw70GA5EL90oe0Ag", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "40402 - Disclosure - Investments (Details)", "role": "http://www.innovage.com/role/DisclosureInvestmentsDetails", "shortName": "Investments (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "innv:EquitySecuritiesIncreaseDecreaseFromObservablePriceChanges", "p", "us-gaap:InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock", "div", "div", "body", "html" ], "baseRef": "tmb-20220331x10q.htm", "contextRef": "Duration_7_1_2021_To_3_31_2022_h8PJxyv3mE2CWKanK8K2DA", "decimals": "0", "lang": null, "name": "innv:EquitySecuritiesIncreaseDecreaseFromObservablePriceChanges", "reportCount": 1, "unique": true, "unitRef": "Unit_Standard_USD_-XJKlZ2wQUeX9Czwk1DwSw", "xsiNil": "false" } }, "R44": { "firstAnchor": { "ancestors": [ "p", "ix:continuation", "div", "div", "body", "html" ], "baseRef": "tmb-20220331x10q.htm", "contextRef": "As_Of_8_7_2018_LN46nplFwUyagacGAgvLcg", "decimals": "-5", "first": true, "lang": null, "name": "us-gaap:BusinessCombinationContingentConsiderationLiability", "reportCount": 1, "unique": true, "unitRef": "Unit_Standard_USD_-XJKlZ2wQUeX9Czwk1DwSw", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "40501 - Disclosure - Fair Value Measurements (Details)", "role": "http://www.innovage.com/role/DisclosureFairValueMeasurementsDetails", "shortName": "Fair Value Measurements (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "p", "ix:continuation", "div", "div", "body", "html" ], "baseRef": "tmb-20220331x10q.htm", "contextRef": "As_Of_8_7_2018_LN46nplFwUyagacGAgvLcg", "decimals": "-5", "first": true, "lang": null, "name": "us-gaap:BusinessCombinationContingentConsiderationLiability", "reportCount": 1, "unique": true, "unitRef": "Unit_Standard_USD_-XJKlZ2wQUeX9Czwk1DwSw", "xsiNil": "false" } }, "R45": { "firstAnchor": { "ancestors": [ "p", "td", "tr", "table", "div", "div", "body", "html" ], "baseRef": "tmb-20220331x10q.htm", "contextRef": "As_Of_3_31_2022_CNhezx4iDEqpDR_QYmAHmg", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:Goodwill", "reportCount": 1, "unitRef": "Unit_Standard_USD_-XJKlZ2wQUeX9Czwk1DwSw", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "40601 - Disclosure - Goodwill and Intangible Assets (Details)", "role": "http://www.innovage.com/role/DisclosureGoodwillAndIntangibleAssetsDetails", "shortName": "Goodwill and Intangible Assets (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "p", "us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock", "div", "div", "body", "html" ], "baseRef": "tmb-20220331x10q.htm", "contextRef": "Duration_7_1_2021_To_3_31_2022_h8PJxyv3mE2CWKanK8K2DA", "decimals": "0", "lang": null, "name": "us-gaap:NumberOfReportingUnits", "reportCount": 1, "unique": true, "unitRef": "Unit_Standard_item_GU38gLfw70GA5EL90oe0Ag", "xsiNil": "false" } }, "R46": { "firstAnchor": { "ancestors": [ "p", "td", "tr", "table", "innv:ScheduleOfFiniteLivedAndIndefiniteLivedIntangibleAssetsByMajorClassTableTextBlock", "us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock", "div", "div", "body", "html" ], "baseRef": "tmb-20220331x10q.htm", "contextRef": "As_Of_3_31_2022_CNhezx4iDEqpDR_QYmAHmg", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:FiniteLivedIntangibleAssetsGross", "reportCount": 1, "unique": true, "unitRef": "Unit_Standard_USD_-XJKlZ2wQUeX9Czwk1DwSw", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "40602 - Disclosure - Goodwill and Intangible Assets - Intangible Asset by Major Class (Details)", "role": "http://www.innovage.com/role/DisclosureGoodwillAndIntangibleAssetsIntangibleAssetByMajorClassDetails", "shortName": "Goodwill and Intangible Assets - Intangible Asset by Major Class (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "p", "td", "tr", "table", "innv:ScheduleOfFiniteLivedAndIndefiniteLivedIntangibleAssetsByMajorClassTableTextBlock", "us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock", "div", "div", "body", "html" ], "baseRef": "tmb-20220331x10q.htm", "contextRef": "As_Of_3_31_2022_CNhezx4iDEqpDR_QYmAHmg", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:FiniteLivedIntangibleAssetsGross", "reportCount": 1, "unique": true, "unitRef": "Unit_Standard_USD_-XJKlZ2wQUeX9Czwk1DwSw", "xsiNil": "false" } }, "R47": { "firstAnchor": { "ancestors": [ "p", "td", "tr", "table", "us-gaap:PropertyPlantAndEquipmentTextBlock", "us-gaap:PropertyPlantAndEquipmentPolicyTextBlock", "ix:continuation", "div", "div", "body", "html" ], "baseRef": "tmb-20220331x10q.htm", "contextRef": "As_Of_3_31_2022_CNhezx4iDEqpDR_QYmAHmg", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:PropertyPlantAndEquipmentGross", "reportCount": 1, "unitRef": "Unit_Standard_USD_-XJKlZ2wQUeX9Czwk1DwSw", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "40701 - Disclosure - Leases - Assets Under Lease (Details)", "role": "http://www.innovage.com/role/DisclosureLeasesAssetsUnderLeaseDetails", "shortName": "Leases - Assets Under Lease (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "p", "us-gaap:LeasesOfLesseeDisclosureTextBlock", "div", "div", "body", "html" ], "baseRef": "tmb-20220331x10q.htm", "contextRef": "Duration_1_1_2022_To_3_31_2022_u5JYg9AjsUaOb1mFgPD3gQ", "decimals": "-5", "lang": null, "name": "us-gaap:OperatingLeasesRentExpenseNet", "reportCount": 1, "unique": true, "unitRef": "Unit_Standard_USD_-XJKlZ2wQUeX9Czwk1DwSw", "xsiNil": "false" } }, "R48": { "firstAnchor": { "ancestors": [ "p", "td", "tr", "table", "us-gaap:ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock", "us-gaap:ScheduleOfFutureMinimumLeasePaymentsForCapitalLeasesTableTextBlock", "ix:continuation", "div", "div", "body", "html" ], "baseRef": "tmb-20220331x10q.htm", "contextRef": "As_Of_3_31_2022_CNhezx4iDEqpDR_QYmAHmg", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:CapitalLeasesFutureMinimumPaymentsRemainderOfFiscalYear", "reportCount": 1, "unique": true, "unitRef": "Unit_Standard_USD_-XJKlZ2wQUeX9Czwk1DwSw", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "40702 - Disclosure - Leases - Future Minimum Lease Payments (Details)", "role": "http://www.innovage.com/role/DisclosureLeasesFutureMinimumLeasePaymentsDetails", "shortName": "Leases - Future Minimum Lease Payments (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "p", "td", "tr", "table", "us-gaap:ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock", "us-gaap:ScheduleOfFutureMinimumLeasePaymentsForCapitalLeasesTableTextBlock", "ix:continuation", "div", "div", "body", "html" ], "baseRef": "tmb-20220331x10q.htm", "contextRef": "As_Of_3_31_2022_CNhezx4iDEqpDR_QYmAHmg", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:CapitalLeasesFutureMinimumPaymentsRemainderOfFiscalYear", "reportCount": 1, "unique": true, "unitRef": "Unit_Standard_USD_-XJKlZ2wQUeX9Czwk1DwSw", "xsiNil": "false" } }, "R49": { "firstAnchor": { "ancestors": [ "p", "td", "tr", "table", "us-gaap:ScheduleOfDebtInstrumentsTextBlock", "us-gaap:DebtDisclosureTextBlock", "div", "div", "body", "html" ], "baseRef": "tmb-20220331x10q.htm", "contextRef": "As_Of_3_31_2022_CNhezx4iDEqpDR_QYmAHmg", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:DebtInstrumentCarryingAmount", "reportCount": 1, "unitRef": "Unit_Standard_USD_-XJKlZ2wQUeX9Czwk1DwSw", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "40801 - Disclosure - Long Term Debt - Schedule of Long-term Debt (Details)", "role": "http://www.innovage.com/role/DisclosureLongTermDebtScheduleOfLongTermDebtDetails", "shortName": "Long Term Debt - Schedule of Long-term Debt (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "p", "td", "tr", "table", "us-gaap:ScheduleOfDebtInstrumentsTextBlock", "us-gaap:DebtDisclosureTextBlock", "div", "div", "body", "html" ], "baseRef": "tmb-20220331x10q.htm", "contextRef": "As_Of_3_31_2022_CNhezx4iDEqpDR_QYmAHmg", "decimals": "-3", "lang": null, "name": "us-gaap:DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet", "reportCount": 1, "unique": true, "unitRef": "Unit_Standard_USD_-XJKlZ2wQUeX9Czwk1DwSw", "xsiNil": "false" } }, "R5": { "firstAnchor": { "ancestors": [ "p", "td", "tr", "table", "div", "div", "body", "html" ], "baseRef": "tmb-20220331x10q.htm", "contextRef": "As_Of_6_30_2020_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember_WKo96_s-IkOQcJFPsdf_6w", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest", "reportCount": 1, "unitRef": "Unit_Standard_USD_-XJKlZ2wQUeX9Czwk1DwSw", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "00300 - Statement - Condensed Consolidated Statements of Stockholders' Equity", "role": "http://www.innovage.com/role/StatementCondensedConsolidatedStatementsOfStockholdersEquity", "shortName": "Condensed Consolidated Statements of Stockholders' Equity", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "p", "td", "tr", "table", "div", "div", "body", "html" ], "baseRef": "tmb-20220331x10q.htm", "contextRef": "Duration_7_1_2020_To_3_31_2021_us-gaap_StatementEquityComponentsAxis_us-gaap_TreasuryStockMember_H_HNeyEZrUu4z0RmJJdSfw", "decimals": "-3", "lang": null, "name": "us-gaap:TreasuryStockValueAcquiredCostMethod", "reportCount": 1, "unique": true, "unitRef": "Unit_Standard_USD_-XJKlZ2wQUeX9Czwk1DwSw", "xsiNil": "false" } }, "R50": { "firstAnchor": { "ancestors": [ "p", "td", "tr", "table", "div", "div", "body", "html" ], "baseRef": "tmb-20220331x10q.htm", "contextRef": "Duration_7_1_2020_To_3_31_2021_RpfHS6cISUK5uZCab3vmzg", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:GainsLossesOnExtinguishmentOfDebt", "reportCount": 1, "unitRef": "Unit_Standard_USD_-XJKlZ2wQUeX9Czwk1DwSw", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "40802 - Disclosure - Long Term Debt (Details)", "role": "http://www.innovage.com/role/DisclosureLongTermDebtDetails", "shortName": "Long Term Debt (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "us-gaap:ScheduleOfDebtInstrumentsTextBlock", "us-gaap:DebtDisclosureTextBlock", "div", "div", "body", "html" ], "baseRef": "tmb-20220331x10q.htm", "contextRef": "As_Of_3_31_2022_us-gaap_CreditFacilityAxis_us-gaap_RevolvingCreditFacilityMember_nHDr9708aE-Fzq_koboXzA", "decimals": "-5", "lang": null, "name": "us-gaap:LineOfCreditFacilityRemainingBorrowingCapacity", "reportCount": 1, "unique": true, "unitRef": "Unit_Standard_USD_-XJKlZ2wQUeX9Czwk1DwSw", "xsiNil": "false" } }, "R51": { "firstAnchor": { "ancestors": [ "p", "td", "tr", "table", "div", "div", "body", "html" ], "baseRef": "tmb-20220331x10q.htm", "contextRef": "As_Of_3_31_2022_CNhezx4iDEqpDR_QYmAHmg", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:AdditionalPaidInCapital", "reportCount": 1, "unitRef": "Unit_Standard_USD_-XJKlZ2wQUeX9Czwk1DwSw", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "41001 - Disclosure - Equity (Details)", "role": "http://www.innovage.com/role/DisclosureEquityDetails", "shortName": "Equity (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "p", "ix:continuation", "div", "div", "body", "html" ], "baseRef": "tmb-20220331x10q.htm", "contextRef": "Duration_7_1_2020_To_3_31_2021_RpfHS6cISUK5uZCab3vmzg", "decimals": "-5", "lang": null, "name": "us-gaap:PaymentsOfStockIssuanceCosts", "reportCount": 1, "unique": true, "unitRef": "Unit_Standard_USD_-XJKlZ2wQUeX9Czwk1DwSw", "xsiNil": "false" } }, "R52": { "firstAnchor": { "ancestors": [ "p", "td", "tr", "table", "innv:ScheduleOfAllocatedShareBasedCompensationExpensesTableTextBlock", "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock", "div", "div", "body", "html" ], "baseRef": "tmb-20220331x10q.htm", "contextRef": "Duration_7_1_2021_To_3_31_2022_h8PJxyv3mE2CWKanK8K2DA", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:AllocatedShareBasedCompensationExpense", "reportCount": 1, "unique": true, "unitRef": "Unit_Standard_USD_-XJKlZ2wQUeX9Czwk1DwSw", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "41101 - Disclosure - Stock-based Compensation - Compensation Expense (Details)", "role": "http://www.innovage.com/role/DisclosureStockBasedCompensationCompensationExpenseDetails", "shortName": "Stock-based Compensation - Compensation Expense (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "p", "td", "tr", "table", "innv:ScheduleOfAllocatedShareBasedCompensationExpensesTableTextBlock", "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock", "div", "div", "body", "html" ], "baseRef": "tmb-20220331x10q.htm", "contextRef": "Duration_7_1_2021_To_3_31_2022_h8PJxyv3mE2CWKanK8K2DA", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:AllocatedShareBasedCompensationExpense", "reportCount": 1, "unique": true, "unitRef": "Unit_Standard_USD_-XJKlZ2wQUeX9Czwk1DwSw", "xsiNil": "false" } }, "R53": { "firstAnchor": { "ancestors": [ "p", "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock", "div", "div", "body", "html" ], "baseRef": "tmb-20220331x10q.htm", "contextRef": "As_Of_3_31_2022_us-gaap_PlanNameAxis_innv_EquityIncentivePlan2016Member_8KrwXjerDUeyApR1GqQlaQ", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized", "reportCount": 1, "unique": true, "unitRef": "Unit_Standard_shares_nwFNuYtE90uvcwdWsI1nJA", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "41102 - Disclosure - Stock-based Compensation - Equity Incentive Plan (Details)", "role": "http://www.innovage.com/role/DisclosureStockBasedCompensationEquityIncentivePlanDetails", "shortName": "Stock-based Compensation - Equity Incentive Plan (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "p", "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock", "div", "div", "body", "html" ], "baseRef": "tmb-20220331x10q.htm", "contextRef": "As_Of_3_31_2022_us-gaap_PlanNameAxis_innv_EquityIncentivePlan2016Member_8KrwXjerDUeyApR1GqQlaQ", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized", "reportCount": 1, "unique": true, "unitRef": "Unit_Standard_shares_nwFNuYtE90uvcwdWsI1nJA", "xsiNil": "false" } }, "R54": { "firstAnchor": { "ancestors": [ "p", "ix:continuation", "div", "div", "body", "html" ], "baseRef": "tmb-20220331x10q.htm", "contextRef": "As_Of_3_31_2022_us-gaap_PlanNameAxis_innv_EquityIncentivePlan2020Member_rag44nfHrke165df4B0dcQ", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized", "reportCount": 1, "unique": true, "unitRef": "Unit_Standard_shares_nwFNuYtE90uvcwdWsI1nJA", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "41103 - Disclosure - Stock-based Compensation - Profits Interests (Details)", "role": "http://www.innovage.com/role/DisclosureStockBasedCompensationProfitsInterestsDetails", "shortName": "Stock-based Compensation - Profits Interests (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "p", "ix:continuation", "div", "div", "body", "html" ], "baseRef": "tmb-20220331x10q.htm", "contextRef": "As_Of_3_31_2022_us-gaap_PlanNameAxis_innv_EquityIncentivePlan2020Member_rag44nfHrke165df4B0dcQ", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized", "reportCount": 1, "unique": true, "unitRef": "Unit_Standard_shares_nwFNuYtE90uvcwdWsI1nJA", "xsiNil": "false" } }, "R55": { "firstAnchor": { "ancestors": [ "p", "td", "tr", "table", "us-gaap:ScheduleOfOtherShareBasedCompensationActivityTableTextBlock", "ix:continuation", "div", "div", "body", "html" ], "baseRef": "tmb-20220331x10q.htm", "contextRef": "As_Of_6_30_2021_us-gaap_AwardTypeAxis_innv_TimeVestingUnitsProfitInterestsMember_d1CBulPOlkmr7WlDmpy35Q", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber", "reportCount": 1, "unique": true, "unitRef": "Unit_Standard_shares_nwFNuYtE90uvcwdWsI1nJA", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "41104 - Disclosure - Stock-based Compensation - Profits Interests Transactions and Number of Units Outstanding (Details)", "role": "http://www.innovage.com/role/DisclosureStockBasedCompensationProfitsInterestsTransactionsAndNumberOfUnitsOutstandingDetails", "shortName": "Stock-based Compensation - Profits Interests Transactions and Number of Units Outstanding (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "p", "td", "tr", "table", "us-gaap:ScheduleOfOtherShareBasedCompensationActivityTableTextBlock", "ix:continuation", "div", "div", "body", "html" ], "baseRef": "tmb-20220331x10q.htm", "contextRef": "As_Of_6_30_2021_us-gaap_AwardTypeAxis_innv_TimeVestingUnitsProfitInterestsMember_d1CBulPOlkmr7WlDmpy35Q", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber", "reportCount": 1, "unique": true, "unitRef": "Unit_Standard_shares_nwFNuYtE90uvcwdWsI1nJA", "xsiNil": "false" } }, "R56": { "firstAnchor": { "ancestors": [ "p", "td", "tr", "table", "us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock", "ix:continuation", "div", "div", "body", "html" ], "baseRef": "tmb-20220331x10q.htm", "contextRef": "Duration_7_1_2021_To_3_31_2022_h8PJxyv3mE2CWKanK8K2DA", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "41105 - Disclosure - Stock-based Compensation - Monte Carlo Option Pricing Model (Details)", "role": "http://www.innovage.com/role/DisclosureStockBasedCompensationMonteCarloOptionPricingModelDetails", "shortName": "Stock-based Compensation - Monte Carlo Option Pricing Model (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "p", "td", "tr", "table", "us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock", "ix:continuation", "div", "div", "body", "html" ], "baseRef": "tmb-20220331x10q.htm", "contextRef": "Duration_7_1_2021_To_3_31_2022_h8PJxyv3mE2CWKanK8K2DA", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R57": { "firstAnchor": { "ancestors": [ "p", "ix:continuation", "div", "div", "body", "html" ], "baseRef": "tmb-20220331x10q.htm", "contextRef": "As_Of_3_31_2022_us-gaap_PlanNameAxis_innv_OmnibusIncentivePlan2021Member_HzC87FRQqUmSl12_PHr4sA", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized", "reportCount": 1, "unique": true, "unitRef": "Unit_Standard_shares_nwFNuYtE90uvcwdWsI1nJA", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "41106 - Disclosure - Stock-based Compensation - 2021 Omnibus Incentive Plan (Details)", "role": "http://www.innovage.com/role/DisclosureStockBasedCompensation2021OmnibusIncentivePlanDetails", "shortName": "Stock-based Compensation - 2021 Omnibus Incentive Plan (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "p", "ix:continuation", "div", "div", "body", "html" ], "baseRef": "tmb-20220331x10q.htm", "contextRef": "As_Of_3_31_2022_us-gaap_PlanNameAxis_innv_OmnibusIncentivePlan2021Member_HzC87FRQqUmSl12_PHr4sA", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized", "reportCount": 1, "unique": true, "unitRef": "Unit_Standard_shares_nwFNuYtE90uvcwdWsI1nJA", "xsiNil": "false" } }, "R58": { "firstAnchor": { "ancestors": [ "p", "td", "tr", "table", "us-gaap:ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock", "ix:continuation", "div", "div", "body", "html" ], "baseRef": "tmb-20220331x10q.htm", "contextRef": "As_Of_6_30_2021_us-gaap_AwardTypeAxis_innv_TimeBasedRestrictedStockUnitsMember_us-gaap_PlanNameAxis_innv_OmnibusIncentivePlan2021Member_qyUvkjApf0WCm3510IO8dg", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber", "reportCount": 1, "unique": true, "unitRef": "Unit_Standard_shares_nwFNuYtE90uvcwdWsI1nJA", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "41107 - Disclosure - Stock-based Compensation - 2021 Omnibus Incentive Plan (RSU Activity) (Details)", "role": "http://www.innovage.com/role/DisclosureStockBasedCompensation2021OmnibusIncentivePlanRsuActivityDetails", "shortName": "Stock-based Compensation - 2021 Omnibus Incentive Plan (RSU Activity) (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "p", "td", "tr", "table", "us-gaap:ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock", "ix:continuation", "div", "div", "body", "html" ], "baseRef": "tmb-20220331x10q.htm", "contextRef": "As_Of_6_30_2021_us-gaap_AwardTypeAxis_innv_TimeBasedRestrictedStockUnitsMember_us-gaap_PlanNameAxis_innv_OmnibusIncentivePlan2021Member_qyUvkjApf0WCm3510IO8dg", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber", "reportCount": 1, "unique": true, "unitRef": "Unit_Standard_shares_nwFNuYtE90uvcwdWsI1nJA", "xsiNil": "false" } }, "R59": { "firstAnchor": { "ancestors": [ "p", "td", "tr", "table", "us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock", "ix:continuation", "div", "div", "body", "html" ], "baseRef": "tmb-20220331x10q.htm", "contextRef": "Duration_7_1_2021_To_3_31_2022_us-gaap_AwardTypeAxis_innv_TimeVestingAwardsMember_JZnicHhTc0CLRF40wrFz6g", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross", "reportCount": 1, "unique": true, "unitRef": "Unit_Standard_shares_nwFNuYtE90uvcwdWsI1nJA", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "41108 - Disclosure - Stock-based Compensation - Time-based Awards (Details)", "role": "http://www.innovage.com/role/DisclosureStockBasedCompensationTimeBasedAwardsDetails", "shortName": "Stock-based Compensation - Time-based Awards (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "p", "td", "tr", "table", "us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock", "ix:continuation", "div", "div", "body", "html" ], "baseRef": "tmb-20220331x10q.htm", "contextRef": "Duration_7_1_2021_To_3_31_2022_us-gaap_AwardTypeAxis_innv_TimeVestingAwardsMember_JZnicHhTc0CLRF40wrFz6g", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross", "reportCount": 1, "unique": true, "unitRef": "Unit_Standard_shares_nwFNuYtE90uvcwdWsI1nJA", "xsiNil": "false" } }, "R6": { "firstAnchor": { "ancestors": [ "p", "td", "tr", "table", "div", "div", "body", "html" ], "baseRef": "tmb-20220331x10q.htm", "contextRef": "Duration_1_1_2021_To_3_31_2021_pa4mhbXWF0eTecfRpFdphA", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts", "reportCount": 1, "unique": true, "unitRef": "Unit_Standard_USD_-XJKlZ2wQUeX9Czwk1DwSw", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "00305 - Statement - Condensed Consolidated Statements of Stockholders' Equity (Parenthetical)", "role": "http://www.innovage.com/role/StatementCondensedConsolidatedStatementsOfStockholdersEquityParenthetical", "shortName": "Condensed Consolidated Statements of Stockholders' Equity (Parenthetical)", "subGroupType": "parenthetical", "uniqueAnchor": { "ancestors": [ "p", "td", "tr", "table", "div", "div", "body", "html" ], "baseRef": "tmb-20220331x10q.htm", "contextRef": "Duration_1_1_2021_To_3_31_2021_pa4mhbXWF0eTecfRpFdphA", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts", "reportCount": 1, "unique": true, "unitRef": "Unit_Standard_USD_-XJKlZ2wQUeX9Czwk1DwSw", "xsiNil": "false" } }, "R60": { "firstAnchor": { "ancestors": [ "p", "td", "tr", "table", "us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock", "ix:continuation", "div", "div", "body", "html" ], "baseRef": "tmb-20220331x10q.htm", "contextRef": "Duration_7_1_2021_To_3_31_2022_us-gaap_AwardTypeAxis_us-gaap_PerformanceSharesMember_2Zb_yKxZdUCrHsLFM8Nhvw", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross", "reportCount": 1, "unique": true, "unitRef": "Unit_Standard_shares_nwFNuYtE90uvcwdWsI1nJA", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "41109 - Disclosure - Stock-based Compensation - Performance-based Awards (Details)", "role": "http://www.innovage.com/role/DisclosureStockBasedCompensationPerformanceBasedAwardsDetails", "shortName": "Stock-based Compensation - Performance-based Awards (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "p", "td", "tr", "table", "us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock", "ix:continuation", "div", "div", "body", "html" ], "baseRef": "tmb-20220331x10q.htm", "contextRef": "Duration_7_1_2021_To_3_31_2022_us-gaap_AwardTypeAxis_us-gaap_PerformanceSharesMember_2Zb_yKxZdUCrHsLFM8Nhvw", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross", "reportCount": 1, "unique": true, "unitRef": "Unit_Standard_shares_nwFNuYtE90uvcwdWsI1nJA", "xsiNil": "false" } }, "R61": { "firstAnchor": { "ancestors": [ "p", "us-gaap:IncomeTaxDisclosureTextBlock", "div", "div", "body", "html" ], "baseRef": "tmb-20220331x10q.htm", "contextRef": "Duration_7_1_2021_To_3_31_2022_h8PJxyv3mE2CWKanK8K2DA", "decimals": "3", "first": true, "lang": null, "name": "us-gaap:EffectiveIncomeTaxRateContinuingOperations", "reportCount": 1, "unique": true, "unitRef": "Unit_Standard_pure_0z-esHzw4UebrWMIiDms8g", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "41201 - Disclosure - Income Taxes (Details)", "role": "http://www.innovage.com/role/DisclosureIncomeTaxesDetails", "shortName": "Income Taxes (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "p", "us-gaap:IncomeTaxDisclosureTextBlock", "div", "div", "body", "html" ], "baseRef": "tmb-20220331x10q.htm", "contextRef": "Duration_7_1_2021_To_3_31_2022_h8PJxyv3mE2CWKanK8K2DA", "decimals": "3", "first": true, "lang": null, "name": "us-gaap:EffectiveIncomeTaxRateContinuingOperations", "reportCount": 1, "unique": true, "unitRef": "Unit_Standard_pure_0z-esHzw4UebrWMIiDms8g", "xsiNil": "false" } }, "R62": { "firstAnchor": { "ancestors": [ "p", "td", "tr", "table", "div", "div", "body", "html" ], "baseRef": "tmb-20220331x10q.htm", "contextRef": "Duration_1_1_2022_To_3_31_2022_u5JYg9AjsUaOb1mFgPD3gQ", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:NetIncomeLoss", "reportCount": 1, "unitRef": "Unit_Standard_USD_-XJKlZ2wQUeX9Czwk1DwSw", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "41301 - Disclosure - Earnings per Share (Details)", "role": "http://www.innovage.com/role/DisclosureEarningsPerShareDetails", "shortName": "Earnings per Share (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "p", "td", "tr", "table", "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock", "ix:continuation", "div", "div", "body", "html" ], "baseRef": "tmb-20220331x10q.htm", "contextRef": "Duration_7_1_2021_To_3_31_2022_h8PJxyv3mE2CWKanK8K2DA", "decimals": "0", "lang": null, "name": "us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment", "reportCount": 1, "unique": true, "unitRef": "Unit_Standard_shares_nwFNuYtE90uvcwdWsI1nJA", "xsiNil": "false" } }, "R63": { "firstAnchor": { "ancestors": [ "p", "us-gaap:SegmentReportingDisclosureTextBlock", "div", "div", "body", "html" ], "baseRef": "tmb-20220331x10q.htm", "contextRef": "Duration_7_1_2021_To_3_31_2022_us-gaap_StatementBusinessSegmentsAxis_innv_ProgramOfAllInclusiveCareForElderlyOperatingSegmentsMember_wV3jwD1x1k2XLB47ihKHhg", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:NumberOfOperatingSegments", "reportCount": 1, "unique": true, "unitRef": "Unit_Standard_segment__FvkfQWTAEGv5eAmeLG-jA", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "41401 - Disclosure - Segment Reporting (Details)", "role": "http://www.innovage.com/role/DisclosureSegmentReportingDetails", "shortName": "Segment Reporting (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "p", "us-gaap:SegmentReportingDisclosureTextBlock", "div", "div", "body", "html" ], "baseRef": "tmb-20220331x10q.htm", "contextRef": "Duration_7_1_2021_To_3_31_2022_us-gaap_StatementBusinessSegmentsAxis_innv_ProgramOfAllInclusiveCareForElderlyOperatingSegmentsMember_wV3jwD1x1k2XLB47ihKHhg", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:NumberOfOperatingSegments", "reportCount": 1, "unique": true, "unitRef": "Unit_Standard_segment__FvkfQWTAEGv5eAmeLG-jA", "xsiNil": "false" } }, "R64": { "firstAnchor": { "ancestors": [ "p", "td", "tr", "table", "div", "div", "body", "html" ], "baseRef": "tmb-20220331x10q.htm", "contextRef": "Duration_1_1_2022_To_3_31_2022_u5JYg9AjsUaOb1mFgPD3gQ", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax", "reportCount": 1, "unitRef": "Unit_Standard_USD_-XJKlZ2wQUeX9Czwk1DwSw", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "41402 - Disclosure - Segment Reporting - Operating Results (Details)", "role": "http://www.innovage.com/role/DisclosureSegmentReportingOperatingResultsDetails", "shortName": "Segment Reporting - Operating Results (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "p", "td", "tr", "table", "us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock", "ix:continuation", "div", "div", "body", "html" ], "baseRef": "tmb-20220331x10q.htm", "contextRef": "Duration_1_1_2022_To_3_31_2022_srt_ConsolidationItemsAxis_us-gaap_OperatingSegmentsMember_AyykgQgxDUWFQuQiZKbgYw", "decimals": "-3", "lang": null, "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax", "reportCount": 1, "unique": true, "unitRef": "Unit_Standard_USD_-XJKlZ2wQUeX9Czwk1DwSw", "xsiNil": "false" } }, "R65": { "firstAnchor": { "ancestors": [ "p", "us-gaap:RelatedPartyTransactionsDisclosureTextBlock", "div", "div", "body", "html" ], "baseRef": "tmb-20220331x10q.htm", "contextRef": "Duration_7_1_2021_To_3_31_2022_h8PJxyv3mE2CWKanK8K2DA", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:RevenueFromRelatedParties", "reportCount": 1, "unique": true, "unitRef": "Unit_Standard_USD_-XJKlZ2wQUeX9Czwk1DwSw", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "41501 - Disclosure - Related-party (Details)", "role": "http://www.innovage.com/role/DisclosureRelatedPartyDetails", "shortName": "Related-party (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "p", "us-gaap:RelatedPartyTransactionsDisclosureTextBlock", "div", "div", "body", "html" ], "baseRef": "tmb-20220331x10q.htm", "contextRef": "Duration_7_1_2021_To_3_31_2022_h8PJxyv3mE2CWKanK8K2DA", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:RevenueFromRelatedParties", "reportCount": 1, "unique": true, "unitRef": "Unit_Standard_USD_-XJKlZ2wQUeX9Czwk1DwSw", "xsiNil": "false" } }, "R7": { "firstAnchor": { "ancestors": [ "p", "td", "tr", "table", "div", "div", "body", "html" ], "baseRef": "tmb-20220331x10q.htm", "contextRef": "Duration_7_1_2021_To_3_31_2022_h8PJxyv3mE2CWKanK8K2DA", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:ProfitLoss", "reportCount": 1, "unitRef": "Unit_Standard_USD_-XJKlZ2wQUeX9Czwk1DwSw", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "00400 - Statement - Condensed Consolidated Statements of Cash Flows", "role": "http://www.innovage.com/role/StatementCondensedConsolidatedStatementsOfCashFlows", "shortName": "Condensed Consolidated Statements of Cash Flows", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "p", "td", "tr", "table", "div", "div", "body", "html" ], "baseRef": "tmb-20220331x10q.htm", "contextRef": "Duration_7_1_2021_To_3_31_2022_h8PJxyv3mE2CWKanK8K2DA", "decimals": "-3", "lang": null, "name": "us-gaap:GainLossOnDispositionOfAssets1", "reportCount": 1, "unique": true, "unitRef": "Unit_Standard_USD_-XJKlZ2wQUeX9Czwk1DwSw", "xsiNil": "false" } }, "R8": { "firstAnchor": { "ancestors": [ "div", "div", "body", "html" ], "baseRef": "tmb-20220331x10q.htm", "contextRef": "Duration_7_1_2021_To_3_31_2022_h8PJxyv3mE2CWKanK8K2DA", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:BusinessDescriptionAndBasisOfPresentationTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "10101 - Disclosure - Business", "role": "http://www.innovage.com/role/DisclosureBusiness", "shortName": "Business", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "div", "body", "html" ], "baseRef": "tmb-20220331x10q.htm", "contextRef": "Duration_7_1_2021_To_3_31_2022_h8PJxyv3mE2CWKanK8K2DA", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:BusinessDescriptionAndBasisOfPresentationTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R9": { "firstAnchor": { "ancestors": [ "div", "div", "body", "html" ], "baseRef": "tmb-20220331x10q.htm", "contextRef": "Duration_7_1_2021_To_3_31_2022_h8PJxyv3mE2CWKanK8K2DA", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:BasisOfPresentationAndSignificantAccountingPoliciesTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "10201 - Disclosure - Summary of Significant Accounting Policies", "role": "http://www.innovage.com/role/DisclosureSummaryOfSignificantAccountingPolicies", "shortName": "Summary of Significant Accounting Policies", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "div", "body", "html" ], "baseRef": "tmb-20220331x10q.htm", "contextRef": "Duration_7_1_2021_To_3_31_2022_h8PJxyv3mE2CWKanK8K2DA", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:BasisOfPresentationAndSignificantAccountingPoliciesTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } } }, "segmentCount": 65, "tag": { "dei_AmendmentFlag": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.", "label": "Amendment Flag" } } }, "localname": "AmendmentFlag", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://www.innovage.com/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_CityAreaCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Area code of city", "label": "City Area Code" } } }, "localname": "CityAreaCode", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://www.innovage.com/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_CoverAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Cover page.", "label": "Document and Entity Information [Abstract]" } } }, "localname": "CoverAbstract", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "xbrltype": "stringItemType" }, "dei_CurrentFiscalYearEndDate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "End date of current fiscal year in the format --MM-DD.", "label": "Current Fiscal Year End Date" } } }, "localname": "CurrentFiscalYearEndDate", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://www.innovage.com/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "gMonthDayItemType" }, "dei_DocumentFiscalPeriodFocus": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Fiscal period values are FY, Q1, Q2, and Q3. 1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.", "label": "Document Fiscal Period Focus" } } }, "localname": "DocumentFiscalPeriodFocus", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://www.innovage.com/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "fiscalPeriodItemType" }, "dei_DocumentFiscalYearFocus": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.", "label": "Document Fiscal Year Focus" } } }, "localname": "DocumentFiscalYearFocus", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://www.innovage.com/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "gYearItemType" }, "dei_DocumentPeriodEndDate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The end date of the period reflected on the cover page if a periodic report. For all other reports and registration statements containing historical data, it is the date up through which that historical data is presented. If there is no historical data in the report, use the filing date. The format of the date is YYYY-MM-DD.", "label": "Document Period End Date" } } }, "localname": "DocumentPeriodEndDate", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://www.innovage.com/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "dateItemType" }, "dei_DocumentQuarterlyReport": { "auth_ref": [ "r453" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true only for a form used as an quarterly report.", "label": "Document Quarterly Report" } } }, "localname": "DocumentQuarterlyReport", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://www.innovage.com/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_DocumentTransitionReport": { "auth_ref": [ "r454" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true only for a form used as a transition report.", "label": "Document Transition Report" } } }, "localname": "DocumentTransitionReport", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://www.innovage.com/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_DocumentType": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.", "label": "Document Type" } } }, "localname": "DocumentType", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://www.innovage.com/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "submissionTypeItemType" }, "dei_EntityAddressAddressLine1": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Address Line 1 such as Attn, Building Name, Street Name", "label": "Entity Address, Address Line One" } } }, "localname": "EntityAddressAddressLine1", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://www.innovage.com/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressCityOrTown": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Name of the City or Town", "label": "Entity Address, City or Town" } } }, "localname": "EntityAddressCityOrTown", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://www.innovage.com/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressPostalZipCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Code for the postal or zip code", "label": "Entity Address, Postal Zip Code" } } }, "localname": "EntityAddressPostalZipCode", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://www.innovage.com/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressStateOrProvince": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Name of the state or province.", "label": "Entity Address State Or Province" } } }, "localname": "EntityAddressStateOrProvince", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://www.innovage.com/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "stateOrProvinceItemType" }, "dei_EntityCentralIndexKey": { "auth_ref": [ "r455" ], "lang": { "en-us": { "role": { "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.", "label": "Entity Central Index Key" } } }, "localname": "EntityCentralIndexKey", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://www.innovage.com/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "centralIndexKeyItemType" }, "dei_EntityCommonStockSharesOutstanding": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.", "label": "Entity Common Stock, Shares Outstanding" } } }, "localname": "EntityCommonStockSharesOutstanding", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://www.innovage.com/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "sharesItemType" }, "dei_EntityCurrentReportingStatus": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.", "label": "Entity Current Reporting Status" } } }, "localname": "EntityCurrentReportingStatus", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://www.innovage.com/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "yesNoItemType" }, "dei_EntityDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "All the names of the entities being reported upon in a document. Any legal structure used to conduct activities or to hold assets. Some examples of such structures are corporations, partnerships, limited liability companies, grantor trusts, and other trusts. This item does not include business and geographical segments which are included in the geographical or business segments domains.", "label": "Entity [Domain]", "terseLabel": "Entity [Domain]" } } }, "localname": "EntityDomain", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://www.innovage.com/role/DisclosureInvestmentsDetails" ], "xbrltype": "domainItemType" }, "dei_EntityEmergingGrowthCompany": { "auth_ref": [ "r455" ], "lang": { "en-us": { "role": { "documentation": "Indicate if registrant meets the emerging growth company criteria.", "label": "Entity Emerging Growth Company" } } }, "localname": "EntityEmergingGrowthCompany", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://www.innovage.com/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_EntityExTransitionPeriod": { "auth_ref": [ "r457" ], "lang": { "en-us": { "role": { "documentation": "Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards.", "label": "Entity Ex Transition Period" } } }, "localname": "EntityExTransitionPeriod", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://www.innovage.com/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_EntityFileNumber": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.", "label": "Entity File Number" } } }, "localname": "EntityFileNumber", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://www.innovage.com/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "fileNumberItemType" }, "dei_EntityFilerCategory": { "auth_ref": [ "r455" ], "lang": { "en-us": { "role": { "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.", "label": "Entity Filer Category" } } }, "localname": "EntityFilerCategory", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://www.innovage.com/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "filerCategoryItemType" }, "dei_EntityIncorporationStateCountryCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Two-character EDGAR code representing the state or country of incorporation.", "label": "Entity Incorporation, State or Country Code" } } }, "localname": "EntityIncorporationStateCountryCode", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://www.innovage.com/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "edgarStateCountryItemType" }, "dei_EntityInteractiveDataCurrent": { "auth_ref": [ "r456" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).", "label": "Entity Interactive Data Current" } } }, "localname": "EntityInteractiveDataCurrent", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://www.innovage.com/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "yesNoItemType" }, "dei_EntityRegistrantName": { "auth_ref": [ "r455" ], "lang": { "en-us": { "role": { "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.", "label": "Entity Registrant Name" } } }, "localname": "EntityRegistrantName", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://www.innovage.com/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityShellCompany": { "auth_ref": [ "r455" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.", "label": "Entity Shell Company" } } }, "localname": "EntityShellCompany", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://www.innovage.com/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_EntitySmallBusiness": { "auth_ref": [ "r455" ], "lang": { "en-us": { "role": { "documentation": "Indicates that the company is a Smaller Reporting Company (SRC).", "label": "Entity Small Business" } } }, "localname": "EntitySmallBusiness", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://www.innovage.com/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_EntityTaxIdentificationNumber": { "auth_ref": [ "r455" ], "lang": { "en-us": { "role": { "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.", "label": "Entity Tax Identification Number" } } }, "localname": "EntityTaxIdentificationNumber", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://www.innovage.com/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "employerIdItemType" }, "dei_LegalEntityAxis": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The set of legal entities associated with a report.", "label": "Legal Entity [Axis]" } } }, "localname": "LegalEntityAxis", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://www.innovage.com/role/DisclosureInvestmentsDetails" ], "xbrltype": "stringItemType" }, "dei_LocalPhoneNumber": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Local phone number for entity.", "label": "Local Phone Number" } } }, "localname": "LocalPhoneNumber", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://www.innovage.com/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_Security12bTitle": { "auth_ref": [ "r451" ], "lang": { "en-us": { "role": { "documentation": "Title of a 12(b) registered security.", "label": "Title of 12(b) Security" } } }, "localname": "Security12bTitle", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://www.innovage.com/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "securityTitleItemType" }, "dei_SecurityExchangeName": { "auth_ref": [ "r452" ], "lang": { "en-us": { "role": { "documentation": "Name of the Exchange on which a security is registered.", "label": "Security Exchange Name" } } }, "localname": "SecurityExchangeName", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://www.innovage.com/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "edgarExchangeCodeItemType" }, "dei_TradingSymbol": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Trading symbol of an instrument as listed on an exchange.", "label": "Trading Symbol" } } }, "localname": "TradingSymbol", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://www.innovage.com/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "tradingSymbolItemType" }, "innv_AdjustmentToRedemptionValue": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Adjustment to redemption value.", "label": "Adjustment To Redemption Value", "negatedLabel": "Adjustment to redemption value" } } }, "localname": "AdjustmentToRedemptionValue", "nsuri": "http://www.innovage.com/20220331", "presentation": [ "http://www.innovage.com/role/DisclosureSummaryOfSignificantAccountingPoliciesEffectOfRestatementOnConsolidatedStatementsOfStockholdersEquityDetails", "http://www.innovage.com/role/StatementCondensedConsolidatedStatementsOfStockholdersEquity" ], "xbrltype": "monetaryItemType" }, "innv_AdjustmentsToAdditionalPaidInCapitalOwnersContribution": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of increase in additional paid in capital (APIC) resulting from owners contribution.", "label": "Adjustments to Additional Paid in Capital, Owners Contribution", "terseLabel": "Owner contribution" } } }, "localname": "AdjustmentsToAdditionalPaidInCapitalOwnersContribution", "nsuri": "http://www.innovage.com/20220331", "presentation": [ "http://www.innovage.com/role/StatementCondensedConsolidatedStatementsOfStockholdersEquity" ], "xbrltype": "monetaryItemType" }, "innv_AdjustmentsToAdditionalPaidInCapitalReclassificationOfWarrantLiability": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of increase in additional paid in capital (APIC) resulting from the reclassification of warrant liability.", "label": "Adjustments to Additional Paid in Capital, Reclassification Of Warrant Liability", "terseLabel": "Reclassification of warrant liability" } } }, "localname": "AdjustmentsToAdditionalPaidInCapitalReclassificationOfWarrantLiability", "nsuri": "http://www.innovage.com/20220331", "presentation": [ "http://www.innovage.com/role/StatementCondensedConsolidatedStatementsOfStockholdersEquity" ], "xbrltype": "monetaryItemType" }, "innv_AdjustmentsToAdditionalPaidInCapitalTimeBasedAwardsOptionCancelation": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of decrease in additional paid in capital (APIC) resulting from cancelation of time based awards option.", "label": "Adjustments to Additional Paid in Capital, Time Based Awards Option Cancelation", "negatedLabel": "Time based awards- option cancelation" } } }, "localname": "AdjustmentsToAdditionalPaidInCapitalTimeBasedAwardsOptionCancelation", "nsuri": "http://www.innovage.com/20220331", "presentation": [ "http://www.innovage.com/role/StatementCondensedConsolidatedStatementsOfStockholdersEquity" ], "xbrltype": "monetaryItemType" }, "innv_AdventistHealthSystemWestJointVentureMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Represents the information pertaining to Adventist Health System/West Joint Venture.", "label": "Adventist Health System West Joint Venture [Member]", "terseLabel": "Adventist Health System/West Joint Venture" } } }, "localname": "AdventistHealthSystemWestJointVentureMember", "nsuri": "http://www.innovage.com/20220331", "presentation": [ "http://www.innovage.com/role/DisclosureInvestmentsDetails" ], "xbrltype": "domainItemType" }, "innv_BuildingAndLeaseholdImprovementsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Facility held for productive use including, but not limited to, office, production, storage and distribution facilities and additions or improvements to assets held under a lease arrangement.", "label": "Building And Leasehold Improvements [Member]", "terseLabel": "Buildings and leasehold improvements" } } }, "localname": "BuildingAndLeaseholdImprovementsMember", "nsuri": "http://www.innovage.com/20220331", "presentation": [ "http://www.innovage.com/role/DisclosureSummaryOfSignificantAccountingPoliciesPropertyAndEquipmentDetails" ], "xbrltype": "domainItemType" }, "innv_BusinessCombinationContingentConsiderationPaid": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Contingent consideration paid.", "label": "Business Combination Contingent Consideration Paid", "terseLabel": "Contingent consideration paid" } } }, "localname": "BusinessCombinationContingentConsiderationPaid", "nsuri": "http://www.innovage.com/20220331", "presentation": [ "http://www.innovage.com/role/DisclosureFairValueMeasurementsDetails" ], "xbrltype": "monetaryItemType" }, "innv_CapitalLeasesFutureMinimumPaymentsDueAfterYearFour": { "auth_ref": [], "calculation": { "http://www.innovage.com/role/DisclosureLeasesFutureMinimumLeasePaymentsDetails": { "order": 6.0, "parentTag": "us-gaap_CapitalLeasesFutureMinimumPaymentsDue", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of minimum lease payments for capital leases due after the fourth fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.", "label": "Capital Leases Future Minimum Payments Due After Year Four", "terseLabel": "Thereafter" } } }, "localname": "CapitalLeasesFutureMinimumPaymentsDueAfterYearFour", "nsuri": "http://www.innovage.com/20220331", "presentation": [ "http://www.innovage.com/role/DisclosureLeasesFutureMinimumLeasePaymentsDetails" ], "xbrltype": "monetaryItemType" }, "innv_CapitationRevenueMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Represents information pertaining to capitation revenue.", "label": "Capitation Revenue [Member]", "terseLabel": "Capitation revenue" } } }, "localname": "CapitationRevenueMember", "nsuri": "http://www.innovage.com/20220331", "presentation": [ "http://www.innovage.com/role/DisclosureSegmentReportingOperatingResultsDetails", "http://www.innovage.com/role/StatementCondensedConsolidatedStatementsOfOperations" ], "xbrltype": "domainItemType" }, "innv_ClassOfWarrantOrRightSecuritiesCalledByWarrantsOrRightsValue": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Value of securities into which the class of warrant or right may be converted. For example, but not limited to, 500,000 warrants may be converted into 1,000,000 shares.", "label": "Class of Warrant or Right, Securities Called by Warrants or Rights, Value", "terseLabel": "Warrants right to purchase common stock" } } }, "localname": "ClassOfWarrantOrRightSecuritiesCalledByWarrantsOrRightsValue", "nsuri": "http://www.innovage.com/20220331", "presentation": [ "http://www.innovage.com/role/DisclosureInvestmentsDetails" ], "xbrltype": "monetaryItemType" }, "innv_ConsolidationOfEquityMethodInvestment": { "auth_ref": [], "calculation": { "http://www.innovage.com/role/StatementCondensedConsolidatedStatementsOfCashFlows": { "order": 4.0, "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Consolidation of equity method investment.", "label": "Consolidation Of Equity Method Investment" } } }, "localname": "ConsolidationOfEquityMethodInvestment", "nsuri": "http://www.innovage.com/20220331", "presentation": [ "http://www.innovage.com/role/DisclosureSummaryOfSignificantAccountingPoliciesEffectOfRestatementOnConsolidatedStatementsOfStockholdersEquityDetails", "http://www.innovage.com/role/StatementCondensedConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "innv_CostMethodInvestment": { "auth_ref": [], "calculation": { "http://www.innovage.com/role/DisclosureInvestmentsEquityMethodAndCostMethodInvestmentsDetails": { "order": 1.0, "parentTag": "us-gaap_LongTermInvestments", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount, after adjustment, of cost-method investment. Adjustments include, but are not limited to, dividends received in excess of earnings after date of investment that are considered a return of investment and other than temporary impairments.", "label": "Cost Method Investment", "terseLabel": "Cost method investments" } } }, "localname": "CostMethodInvestment", "nsuri": "http://www.innovage.com/20220331", "presentation": [ "http://www.innovage.com/role/DisclosureInvestmentsDetails", "http://www.innovage.com/role/DisclosureInvestmentsEquityMethodAndCostMethodInvestmentsDetails" ], "xbrltype": "monetaryItemType" }, "innv_CostMethodInvestmentMaximumExposureToLoss": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The amount of maximum exposure to loss under the cost method investments.", "label": "Cost Method Investment, Maximum Exposure to Loss", "terseLabel": "Maximum exposure to loss of the cost method investments" } } }, "localname": "CostMethodInvestmentMaximumExposureToLoss", "nsuri": "http://www.innovage.com/20220331", "presentation": [ "http://www.innovage.com/role/DisclosureInvestmentsDetails" ], "xbrltype": "monetaryItemType" }, "innv_CreditAgreement2016CreditFacilityMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Represents information pertaining to 2016 credit agreement.", "label": "Credit Agreement2016 Credit Facility [Member]", "terseLabel": "2016 Credit Agreement" } } }, "localname": "CreditAgreement2016CreditFacilityMember", "nsuri": "http://www.innovage.com/20220331", "presentation": [ "http://www.innovage.com/role/DisclosureLongTermDebtDetails" ], "xbrltype": "domainItemType" }, "innv_CreditAgreement2021CreditFacilityMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Represents information pertaining to 2021 credit agreement .", "label": "Credit Agreement2021 Credit Facility [Member]", "terseLabel": "2021 Credit Agreement" } } }, "localname": "CreditAgreement2021CreditFacilityMember", "nsuri": "http://www.innovage.com/20220331", "presentation": [ "http://www.innovage.com/role/DisclosureLongTermDebtDetails" ], "xbrltype": "domainItemType" }, "innv_DebtInstrumentLoanTerminatedAmount": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The amount of termination of loan.", "label": "Debt Instrument Loan Terminated Amount", "terseLabel": "Termination of loan" } } }, "localname": "DebtInstrumentLoanTerminatedAmount", "nsuri": "http://www.innovage.com/20220331", "presentation": [ "http://www.innovage.com/role/DisclosureLongTermDebtDetails" ], "xbrltype": "monetaryItemType" }, "innv_DebtInstrumentModifiedAmount": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The amount of debt instrument that was modified.", "label": "Debt Instrument Modified Amount", "terseLabel": "Modified debt" } } }, "localname": "DebtInstrumentModifiedAmount", "nsuri": "http://www.innovage.com/20220331", "presentation": [ "http://www.innovage.com/role/DisclosureLongTermDebtDetails" ], "xbrltype": "monetaryItemType" }, "innv_DebtInstrumentPeriodicPaymentPrincipalPercent": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Percentage of the required periodic payments applied to principal.", "label": "Debt Instrument, Periodic Payment, Principal, Percent", "terseLabel": "Percentage of aggregate outstanding principal amount" } } }, "localname": "DebtInstrumentPeriodicPaymentPrincipalPercent", "nsuri": "http://www.innovage.com/20220331", "presentation": [ "http://www.innovage.com/role/DisclosureLongTermDebtDetails" ], "xbrltype": "percentItemType" }, "innv_DelayedDrawTermLoanFacilityMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Represents the information pertaining to delayed draw term loan facility.", "label": "Delayed Draw Term Loan Facility [Member]", "terseLabel": "Delayed draw term loan facility (DDTL)" } } }, "localname": "DelayedDrawTermLoanFacilityMember", "nsuri": "http://www.innovage.com/20220331", "presentation": [ "http://www.innovage.com/role/DisclosureLongTermDebtDetails" ], "xbrltype": "domainItemType" }, "innv_DepositsAndOtherAssetsNoncurrent": { "auth_ref": [], "calculation": { "http://www.innovage.com/role/StatementCondensedConsolidatedBalanceSheets": { "order": 4.0, "parentTag": "us-gaap_AssetsNoncurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The amount of non current portion of deposits and other assets as at the end of the reporting period.", "label": "Deposits and Other Assets , Noncurrent", "verboseLabel": "Deposits and other" } } }, "localname": "DepositsAndOtherAssetsNoncurrent", "nsuri": "http://www.innovage.com/20220331", "presentation": [ "http://www.innovage.com/role/StatementCondensedConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "innv_DispatchhealthHoldingsIncMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Represents information pertaining to Dispatch Health Holdings, Inc.", "label": "Dispatchhealth Holdings Inc [Member]", "terseLabel": "Dispatch Health Holdings, Inc." } } }, "localname": "DispatchhealthHoldingsIncMember", "nsuri": "http://www.innovage.com/20220331", "presentation": [ "http://www.innovage.com/role/DisclosureInvestmentsDetails" ], "xbrltype": "domainItemType" }, "innv_DueToStateAndFederalHealthPrograms": { "auth_ref": [], "calculation": { "http://www.innovage.com/role/StatementCondensedConsolidatedBalanceSheets": { "order": 3.0, "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amounts payable to state and federal health programs such as Medicare and Medicaid.", "label": "Due to State and Federal Health Programs", "terseLabel": "Due to Medicaid and Medicare" } } }, "localname": "DueToStateAndFederalHealthPrograms", "nsuri": "http://www.innovage.com/20220331", "presentation": [ "http://www.innovage.com/role/StatementCondensedConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "innv_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRateOther": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Percentage of domestic federal statutory tax rate applicable to pretax income (loss), subject to special adjustments.", "label": "Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate Other", "terseLabel": "Federal statutory tax rate (as a percent)" } } }, "localname": "EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRateOther", "nsuri": "http://www.innovage.com/20220331", "presentation": [ "http://www.innovage.com/role/DisclosureIncomeTaxesDetails" ], "xbrltype": "percentItemType" }, "innv_EquipmentAndVehiclesMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Tangible personal property used to produce goods and services and equipment used primarily for road transportation.", "label": "Equipment And Vehicles [Member]", "terseLabel": "Equipment and vehicles" } } }, "localname": "EquipmentAndVehiclesMember", "nsuri": "http://www.innovage.com/20220331", "presentation": [ "http://www.innovage.com/role/DisclosureSummaryOfSignificantAccountingPoliciesPropertyAndEquipmentDetails" ], "xbrltype": "domainItemType" }, "innv_EquipmentUnderCapitalLeaseMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Represents information pertaining to equipment under capital lease.", "label": "Equipment Under Capital Lease [Member]", "terseLabel": "Equipment under capital leases" } } }, "localname": "EquipmentUnderCapitalLeaseMember", "nsuri": "http://www.innovage.com/20220331", "presentation": [ "http://www.innovage.com/role/DisclosureLeasesAssetsUnderLeaseDetails" ], "xbrltype": "domainItemType" }, "innv_EquityIncentivePlan2016Member": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Represents the information pertaining to 2016 equity incentive plan.", "label": "Equity Incentive Plan2016 [Member]", "terseLabel": "2016 Equity Incentive Plan" } } }, "localname": "EquityIncentivePlan2016Member", "nsuri": "http://www.innovage.com/20220331", "presentation": [ "http://www.innovage.com/role/DisclosureStockBasedCompensationEquityIncentivePlanDetails" ], "xbrltype": "domainItemType" }, "innv_EquityIncentivePlan2020Member": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Represents the information pertaining to 2020 equity incentive plan.", "label": "Equity Incentive Plan2020 [Member]", "terseLabel": "2020 Equity Incentive Plan" } } }, "localname": "EquityIncentivePlan2020Member", "nsuri": "http://www.innovage.com/20220331", "presentation": [ "http://www.innovage.com/role/DisclosureStockBasedCompensationProfitsInterestsDetails" ], "xbrltype": "domainItemType" }, "innv_EquitySecuritiesIncreaseDecreaseFromObservablePriceChanges": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The amount of increase (decrease) from observable price changes in equity securities.", "label": "Equity Securities, Increase (Decrease) from Observable Price Changes", "terseLabel": "Observable price changes" } } }, "localname": "EquitySecuritiesIncreaseDecreaseFromObservablePriceChanges", "nsuri": "http://www.innovage.com/20220331", "presentation": [ "http://www.innovage.com/role/DisclosureInvestmentsDetails" ], "xbrltype": "monetaryItemType" }, "innv_EskatonMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Represents the information pertaining to Eskaton.", "label": "Eskaton [Member]", "terseLabel": "Eskaton" } } }, "localname": "EskatonMember", "nsuri": "http://www.innovage.com/20220331", "presentation": [ "http://www.innovage.com/role/DisclosureInvestmentsDetails" ], "xbrltype": "domainItemType" }, "innv_ExternalProviderCosts": { "auth_ref": [], "calculation": { "http://www.innovage.com/role/StatementCondensedConsolidatedStatementsOfOperations": { "order": 1.0, "parentTag": "us-gaap_CostsAndExpenses", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of external provider costs.", "label": "External Provider Costs", "terseLabel": "External provider costs" } } }, "localname": "ExternalProviderCosts", "nsuri": "http://www.innovage.com/20220331", "presentation": [ "http://www.innovage.com/role/DisclosureSegmentReportingOperatingResultsDetails", "http://www.innovage.com/role/StatementCondensedConsolidatedStatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "innv_FairValueOfContingentConsideration": { "auth_ref": [], "calculation": { "http://www.innovage.com/role/StatementCondensedConsolidatedStatementsOfCashFlows": { "order": 11.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The amount of fair value contingent consideration during the reporting period.", "label": "Fair Value of Contingent Consideration", "terseLabel": "Change in fair value of contingent consideration" } } }, "localname": "FairValueOfContingentConsideration", "nsuri": "http://www.innovage.com/20220331", "presentation": [ "http://www.innovage.com/role/StatementCondensedConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "innv_FundAmountReceivedCovid19": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of fund received for under Covid-19 funding from Act 24 of 2020.", "label": "Fund Amount Received, Covid 19", "terseLabel": "Funding received, COVID-19" } } }, "localname": "FundAmountReceivedCovid19", "nsuri": "http://www.innovage.com/20220331", "presentation": [ "http://www.innovage.com/role/DisclosureSummaryOfSignificantAccountingPoliciesCovid19Details" ], "xbrltype": "monetaryItemType" }, "innv_GainLossInEquityOfNonconsolidatedEntities": { "auth_ref": [], "calculation": { "http://www.innovage.com/role/StatementCondensedConsolidatedStatementsOfCashFlows": { "order": 3.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The amount of gain (loss) in equity of nonconsolidated entities.", "label": "Gain (Loss) in Equity of Nonconsolidated Entities", "negatedLabel": "Change in fair value of warrants" } } }, "localname": "GainLossInEquityOfNonconsolidatedEntities", "nsuri": "http://www.innovage.com/20220331", "presentation": [ "http://www.innovage.com/role/StatementCondensedConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "innv_GainLossOnConsolidation": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Gain (loss) on consolidation.", "label": "Gain Loss On Consolidation", "terseLabel": "Gain on consolidation" } } }, "localname": "GainLossOnConsolidation", "nsuri": "http://www.innovage.com/20220331", "presentation": [ "http://www.innovage.com/role/DisclosureInvestmentsDetails" ], "xbrltype": "monetaryItemType" }, "innv_GainLossOnExtinguishmentOfDebtBeforeWriteOffOfDebtIssuanceCost": { "auth_ref": [], "calculation": { "http://www.innovage.com/role/StatementCondensedConsolidatedStatementsOfOperations": { "order": 2.0, "parentTag": "us-gaap_NonoperatingIncomeExpense", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "This item excludes the write-off of amounts previously capitalized as debt issuance costs.", "label": "Gain Loss On Extinguishment Of Debt before Write off of Debt Issuance Cost", "terseLabel": "Loss on extinguishment of debt" } } }, "localname": "GainLossOnExtinguishmentOfDebtBeforeWriteOffOfDebtIssuanceCost", "nsuri": "http://www.innovage.com/20220331", "presentation": [ "http://www.innovage.com/role/StatementCondensedConsolidatedStatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "innv_IncreaseDecreaseInDueToStateAndFederalHealthPrograms": { "auth_ref": [], "calculation": { "http://www.innovage.com/role/StatementCondensedConsolidatedStatementsOfCashFlows": { "order": 18.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The increase (decrease) during the reporting period in the amounts of due to Medicaid and Medicare.", "label": "Increase (Decrease) in Due to State and Federal Health Programs", "terseLabel": "Due to Medicaid and Medicare" } } }, "localname": "IncreaseDecreaseInDueToStateAndFederalHealthPrograms", "nsuri": "http://www.innovage.com/20220331", "presentation": [ "http://www.innovage.com/role/StatementCondensedConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "innv_IncreaseDecreaseInReportedAndEstimatedClaims": { "auth_ref": [], "calculation": { "http://www.innovage.com/role/StatementCondensedConsolidatedStatementsOfCashFlows": { "order": 17.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The increase (decrease) during the reporting period in the amounts of reported and estimated claims.", "label": "Increase (Decrease) in Reported and Estimated Claims", "terseLabel": "Reported and estimated claims" } } }, "localname": "IncreaseDecreaseInReportedAndEstimatedClaims", "nsuri": "http://www.innovage.com/20220331", "presentation": [ "http://www.innovage.com/role/StatementCondensedConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "innv_InnovageSacramentoMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Represents information relating to InnovAge Sacramento.", "label": "Innovage Sacramento [Member]", "terseLabel": "InnovAge Sacramento" } } }, "localname": "InnovageSacramentoMember", "nsuri": "http://www.innovage.com/20220331", "presentation": [ "http://www.innovage.com/role/DisclosureFairValueMeasurementsDetails", "http://www.innovage.com/role/DisclosureInvestmentsDetails" ], "xbrltype": "domainItemType" }, "innv_JetdocInc.Member": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Represents information pertaining to Jetdoc, Inc.", "label": "Jetdoc Inc. [Member]", "terseLabel": "Jetdoc, Inc." } } }, "localname": "JetdocInc.Member", "nsuri": "http://www.innovage.com/20220331", "presentation": [ "http://www.innovage.com/role/DisclosureInvestmentsDetails" ], "xbrltype": "domainItemType" }, "innv_LineOfCreditFacilityIssuedAmount": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Issued amounts under letters of credit.", "label": "Line Of Credit Facility Issued Amount", "terseLabel": "Letters of credit, issued amounts" } } }, "localname": "LineOfCreditFacilityIssuedAmount", "nsuri": "http://www.innovage.com/20220331", "presentation": [ "http://www.innovage.com/role/DisclosureLongTermDebtDetails" ], "xbrltype": "monetaryItemType" }, "innv_MedicaidCustomerMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Represents information pertaining to medicaid customer.", "label": "Medicaid Customer [Member]", "terseLabel": "Medicaid" } } }, "localname": "MedicaidCustomerMember", "nsuri": "http://www.innovage.com/20220331", "presentation": [ "http://www.innovage.com/role/DisclosureRevenueRecognitionConcentrationOfNetReceivableDetails", "http://www.innovage.com/role/DisclosureRevenueRecognitionSourceOfRevenueDetails" ], "xbrltype": "domainItemType" }, "innv_MedicareCustomerMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Represents information pertaining to medicare customer.", "label": "Medicare Customer [Member]", "terseLabel": "Medicare" } } }, "localname": "MedicareCustomerMember", "nsuri": "http://www.innovage.com/20220331", "presentation": [ "http://www.innovage.com/role/DisclosureRevenueRecognitionConcentrationOfNetReceivableDetails", "http://www.innovage.com/role/DisclosureRevenueRecognitionSourceOfRevenueDetails" ], "xbrltype": "domainItemType" }, "innv_MedicarePartDMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Represents the information pertaining to Medicare Part D.", "label": "Medicare Part D [Member]", "terseLabel": "Medicare Part D" } } }, "localname": "MedicarePartDMember", "nsuri": "http://www.innovage.com/20220331", "presentation": [ "http://www.innovage.com/role/DisclosureRevenueRecognitionDetails" ], "xbrltype": "domainItemType" }, "innv_NewcourtlandLifeProgramMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Represents information pertaining to NewCourtland LIFE Program.", "label": "Newcourtland Life Program [Member]", "terseLabel": "NewCourtland LIFE Program" } } }, "localname": "NewcourtlandLifeProgramMember", "nsuri": "http://www.innovage.com/20220331", "presentation": [ "http://www.innovage.com/role/DisclosureFairValueMeasurementsDetails" ], "xbrltype": "domainItemType" }, "innv_NumberOfCenters": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Number of centers.", "label": "Number of Centers", "terseLabel": "Number of PACE centers" } } }, "localname": "NumberOfCenters", "nsuri": "http://www.innovage.com/20220331", "presentation": [ "http://www.innovage.com/role/DisclosureSegmentReportingDetails" ], "xbrltype": "integerItemType" }, "innv_NumberOfCentersExcludingNonConsolidatingJointVentures": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Represents information pertaining to number of centers excluding non-consolidating joint ventures.", "label": "Number of Centers Excluding Non-consolidating Joint Ventures", "terseLabel": "Number of PACE centers excluding non-consolidating joint ventures" } } }, "localname": "NumberOfCentersExcludingNonConsolidatingJointVentures", "nsuri": "http://www.innovage.com/20220331", "presentation": [ "http://www.innovage.com/role/DisclosureBusinessDetails" ], "xbrltype": "integerItemType" }, "innv_NumberOfGeographicDivisions": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Number of geographic divisions.", "label": "Number of Geographic Divisions", "terseLabel": "Number of geographic divisions" } } }, "localname": "NumberOfGeographicDivisions", "nsuri": "http://www.innovage.com/20220331", "presentation": [ "http://www.innovage.com/role/DisclosureSegmentReportingDetails" ], "xbrltype": "integerItemType" }, "innv_NumberOfInvestmentsAccountedUnderCostMethod": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The number of investments held by company which are accounted under cost method.", "label": "Number of Investments Accounted Under Cost Method", "terseLabel": "Number of investments" } } }, "localname": "NumberOfInvestmentsAccountedUnderCostMethod", "nsuri": "http://www.innovage.com/20220331", "presentation": [ "http://www.innovage.com/role/DisclosureInvestmentsDetails" ], "xbrltype": "integerItemType" }, "innv_NumberOfParticipants": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Number of participants.", "label": "Number of Participants", "terseLabel": "Number of PACE participants" } } }, "localname": "NumberOfParticipants", "nsuri": "http://www.innovage.com/20220331", "presentation": [ "http://www.innovage.com/role/DisclosureBusinessDetails", "http://www.innovage.com/role/DisclosureSegmentReportingDetails" ], "xbrltype": "integerItemType" }, "innv_OmnibusIncentivePlan2021Member": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Represents information pertaining to omnibus incentive plan 2021.", "label": "Omnibus Incentive Plan2021 [Member]", "terseLabel": "2021 Omnibus Incentive Plan" } } }, "localname": "OmnibusIncentivePlan2021Member", "nsuri": "http://www.innovage.com/20220331", "presentation": [ "http://www.innovage.com/role/DisclosureStockBasedCompensation2021OmnibusIncentivePlanDetails", "http://www.innovage.com/role/DisclosureStockBasedCompensation2021OmnibusIncentivePlanRsuActivityDetails" ], "xbrltype": "domainItemType" }, "innv_OperatingLeasesFutureMinimumPaymentsDueAfterYearFour": { "auth_ref": [], "calculation": { "http://www.innovage.com/role/DisclosureLeasesFutureMinimumLeasePaymentsDetails": { "order": 6.0, "parentTag": "us-gaap_OperatingLeasesFutureMinimumPaymentsDue", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of required minimum rental payments for operating leases having an initial or remaining non-cancelable lease term in excess of one year due after the fourth fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.", "label": "Operating Leases Future Minimum Payments Due After Year Four", "terseLabel": "Thereafter" } } }, "localname": "OperatingLeasesFutureMinimumPaymentsDueAfterYearFour", "nsuri": "http://www.innovage.com/20220331", "presentation": [ "http://www.innovage.com/role/DisclosureLeasesFutureMinimumLeasePaymentsDetails" ], "xbrltype": "monetaryItemType" }, "innv_OptionCancelationAgreementMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Represents the information pertaining to Option Cancelation Agreement.", "label": "Option Cancelation Agreement [Member]", "terseLabel": "Cancellation Agreement" } } }, "localname": "OptionCancelationAgreementMember", "nsuri": "http://www.innovage.com/20220331", "presentation": [ "http://www.innovage.com/role/DisclosureEquityDetails" ], "xbrltype": "domainItemType" }, "innv_OtherServiceRevenueMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Represents information pertaining to other service revenue.", "label": "Other Service Revenue [Member]", "terseLabel": "Other service revenue" } } }, "localname": "OtherServiceRevenueMember", "nsuri": "http://www.innovage.com/20220331", "presentation": [ "http://www.innovage.com/role/DisclosureRevenueRecognitionDetails", "http://www.innovage.com/role/DisclosureSegmentReportingOperatingResultsDetails", "http://www.innovage.com/role/StatementCondensedConsolidatedStatementsOfOperations" ], "xbrltype": "domainItemType" }, "innv_PaymentsRelatedToOptionCancelation": { "auth_ref": [], "calculation": { "http://www.innovage.com/role/StatementCondensedConsolidatedStatementsOfCashFlows": { "order": 8.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The cash outflow for payments related to option cancellation.", "label": "Payments Related to Option Cancelation", "negatedLabel": "Payments related to option cancellation" } } }, "localname": "PaymentsRelatedToOptionCancelation", "nsuri": "http://www.innovage.com/20220331", "presentation": [ "http://www.innovage.com/role/StatementCondensedConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "innv_PaymentsUnderAcquisitionAgreement": { "auth_ref": [], "calculation": { "http://www.innovage.com/role/StatementCondensedConsolidatedStatementsOfCashFlows": { "order": 10.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The cash outflow under acquisition agreements.", "label": "Payments Under Acquisition Agreement", "negatedLabel": "Payments under acquisition agreements" } } }, "localname": "PaymentsUnderAcquisitionAgreement", "nsuri": "http://www.innovage.com/20220331", "presentation": [ "http://www.innovage.com/role/StatementCondensedConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "innv_PercentageOfHealthCareCostsIncurred": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Percentage of health care cost incurred.", "label": "Percentage of Health Care Costs Incurred", "terseLabel": "Percentage of obligation for health care costs" } } }, "localname": "PercentageOfHealthCareCostsIncurred", "nsuri": "http://www.innovage.com/20220331", "presentation": [ "http://www.innovage.com/role/DisclosureBusinessDetails" ], "xbrltype": "percentItemType" }, "innv_PercentageOfIssuedAndOutstandingEquityInterests": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Percentage of issued and outstanding equity interests.", "label": "Percentage of Issued and Outstanding Equity Interests", "terseLabel": "Percentage of issued and outstanding equity interests" } } }, "localname": "PercentageOfIssuedAndOutstandingEquityInterests", "nsuri": "http://www.innovage.com/20220331", "presentation": [ "http://www.innovage.com/role/DisclosureInvestmentsDetails" ], "xbrltype": "percentItemType" }, "innv_PercentageOfPooledCapitatedPaymentReceived": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Percentage of pooled capitated payment received.", "label": "Percentage of pooled Capitated Payment Received", "terseLabel": "Pooled capitated payment" } } }, "localname": "PercentageOfPooledCapitatedPaymentReceived", "nsuri": "http://www.innovage.com/20220331", "presentation": [ "http://www.innovage.com/role/DisclosureRevenueRecognitionDetails" ], "xbrltype": "percentItemType" }, "innv_PerformanceBasedRestrictedStockUnitsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Represents the information pertaining to performance based restricted stock units.", "label": "Performance Based Restricted Stock Units [Member]", "terseLabel": "Performance Based Restricted Stock Units [Member]" } } }, "localname": "PerformanceBasedRestrictedStockUnitsMember", "nsuri": "http://www.innovage.com/20220331", "presentation": [ "http://www.innovage.com/role/DisclosureStockBasedCompensation2021OmnibusIncentivePlanDetails", "http://www.innovage.com/role/DisclosureStockBasedCompensation2021OmnibusIncentivePlanRsuActivityDetails", "http://www.innovage.com/role/DisclosureStockBasedCompensationMonteCarloOptionPricingModelDetails" ], "xbrltype": "domainItemType" }, "innv_PerformanceVestingUnitsProfitInterestsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Represents the information pertaining to performance vesting units of profit interests.", "label": "Performance Vesting Units Profit Interests [Member]", "terseLabel": "Performance Vesting Units" } } }, "localname": "PerformanceVestingUnitsProfitInterestsMember", "nsuri": "http://www.innovage.com/20220331", "presentation": [ "http://www.innovage.com/role/DisclosureStockBasedCompensationMonteCarloOptionPricingModelDetails", "http://www.innovage.com/role/DisclosureStockBasedCompensationProfitsInterestsTransactionsAndNumberOfUnitsOutstandingDetails" ], "xbrltype": "domainItemType" }, "innv_PrivatePayAndOtherCustomerMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Represents information pertaining to private pay and other customer.", "label": "Private Pay And Other Customer [Member]", "terseLabel": "Private pay and other" } } }, "localname": "PrivatePayAndOtherCustomerMember", "nsuri": "http://www.innovage.com/20220331", "presentation": [ "http://www.innovage.com/role/DisclosureRevenueRecognitionConcentrationOfNetReceivableDetails", "http://www.innovage.com/role/DisclosureRevenueRecognitionSourceOfRevenueDetails" ], "xbrltype": "domainItemType" }, "innv_ProfitsInterestsUnitsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Represents the information pertaining to profits interests units.", "label": "Profits Interests Units [Member]", "terseLabel": "Profits Interests Units" } } }, "localname": "ProfitsInterestsUnitsMember", "nsuri": "http://www.innovage.com/20220331", "presentation": [ "http://www.innovage.com/role/DisclosureStockBasedCompensationCompensationExpenseDetails", "http://www.innovage.com/role/DisclosureStockBasedCompensationMonteCarloOptionPricingModelDetails" ], "xbrltype": "domainItemType" }, "innv_ProgramOfAllInclusiveCareForElderlyOperatingSegmentsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Represents information pertaining to Program of All-inclusive Care for the Elderly Operating Segments.", "label": "Program Of All Inclusive Care For Elderly Operating Segments [Member]", "terseLabel": "PACE" } } }, "localname": "ProgramOfAllInclusiveCareForElderlyOperatingSegmentsMember", "nsuri": "http://www.innovage.com/20220331", "presentation": [ "http://www.innovage.com/role/DisclosureBusinessDetails", "http://www.innovage.com/role/DisclosureSegmentReportingDetails", "http://www.innovage.com/role/DisclosureSegmentReportingOperatingResultsDetails" ], "xbrltype": "domainItemType" }, "innv_PropertyAndEquipmentIncludedInAccountsPayable": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Intangibles and property and equipment included in accounts payable.", "label": "Property and Equipment Included in Accounts Payable", "terseLabel": "Intangibles and property and equipment included in accounts payable" } } }, "localname": "PropertyAndEquipmentIncludedInAccountsPayable", "nsuri": "http://www.innovage.com/20220331", "presentation": [ "http://www.innovage.com/role/StatementCondensedConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "innv_PropertyAndEquipmentPurchasedUnderCapitalLeases": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Property and equipment purchased under capital leases.", "label": "Property and Equipment Purchased Under Capital Leases", "terseLabel": "Property and equipment purchased under capital leases" } } }, "localname": "PropertyAndEquipmentPurchasedUnderCapitalLeases", "nsuri": "http://www.innovage.com/20220331", "presentation": [ "http://www.innovage.com/role/StatementCondensedConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "innv_PwdMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Represents the information pertaining to PWD Variable Interest Entity.", "label": "Pwd [Member]", "terseLabel": "PWD" } } }, "localname": "PwdMember", "nsuri": "http://www.innovage.com/20220331", "presentation": [ "http://www.innovage.com/role/DisclosureInvestmentsDetails" ], "xbrltype": "domainItemType" }, "innv_RecentAccountingPronouncementsNotYetAdoptedPolicyPolicyTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy relating to recent accounting pronouncements not yet adopted.", "label": "Recent Accounting Pronouncements Not Yet Adopted Policy [Policy Text Block]", "terseLabel": "Recent Accounting Pronouncements Not Yet Adopted" } } }, "localname": "RecentAccountingPronouncementsNotYetAdoptedPolicyPolicyTextBlock", "nsuri": "http://www.innovage.com/20220331", "presentation": [ "http://www.innovage.com/role/DisclosureSummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "innv_ReimbursementAmountAllocatedCovid19": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of reimbursement allocated for specified centers from amount allocated for Covid 19.", "label": "Reimbursement Amount Allocated, Covid 19", "terseLabel": "Reimbursement amount allocated" } } }, "localname": "ReimbursementAmountAllocatedCovid19", "nsuri": "http://www.innovage.com/20220331", "presentation": [ "http://www.innovage.com/role/DisclosureSummaryOfSignificantAccountingPoliciesCovid19Details" ], "xbrltype": "monetaryItemType" }, "innv_ReimbursementAmountRecognizedCovid19": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of reimbursement amount recognized as reduction of expense from amount allocated for Covid 19.", "label": "Reimbursement Amount Recognized, Covid 19", "terseLabel": "Reimbursement amount recognized" } } }, "localname": "ReimbursementAmountRecognizedCovid19", "nsuri": "http://www.innovage.com/20220331", "presentation": [ "http://www.innovage.com/role/DisclosureSummaryOfSignificantAccountingPoliciesCovid19Details" ], "xbrltype": "monetaryItemType" }, "innv_ReportedAndEstimatedClaimsCurrent": { "auth_ref": [], "calculation": { "http://www.innovage.com/role/StatementCondensedConsolidatedBalanceSheets": { "order": 2.0, "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Carrying value as of the balance sheet date of the portion of reported and estimated claims due within one year or the operating cycle, if longer.", "label": "Reported and Estimated Claims, Current", "terseLabel": "Reported and estimated claims" } } }, "localname": "ReportedAndEstimatedClaimsCurrent", "nsuri": "http://www.innovage.com/20220331", "presentation": [ "http://www.innovage.com/role/StatementCondensedConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "innv_ScheduleOfAllocatedShareBasedCompensationExpensesTableTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of allocated share based compensation expenses.", "label": "Schedule of Allocated Share Based Compensation Expenses [Table Text Block]", "terseLabel": "Schedule of stock-based compensation expense" } } }, "localname": "ScheduleOfAllocatedShareBasedCompensationExpensesTableTextBlock", "nsuri": "http://www.innovage.com/20220331", "presentation": [ "http://www.innovage.com/role/DisclosureStockBasedCompensationTables" ], "xbrltype": "textBlockItemType" }, "innv_ScheduleOfFiniteLivedAndIndefiniteLivedIntangibleAssetsByMajorClassTableTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of amortizable finite-lived intangible assets, including the gross carrying amount and accumulated amortization, and indefinite-lived intangible assets not subject to amortization. excluding goodwill.", "label": "Schedule of Finite Lived And Indefinite Lived Intangible Assets By Major Class [Table Text Block]", "terseLabel": "Summary of intangible assets by major class" } } }, "localname": "ScheduleOfFiniteLivedAndIndefiniteLivedIntangibleAssetsByMajorClassTableTextBlock", "nsuri": "http://www.innovage.com/20220331", "presentation": [ "http://www.innovage.com/role/DisclosureGoodwillAndIntangibleAssetsTables" ], "xbrltype": "textBlockItemType" }, "innv_SeniorHousingMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Represents the information pertaining to senior housing.", "label": "Senior Housing [Member]", "terseLabel": "Senior Housing" } } }, "localname": "SeniorHousingMember", "nsuri": "http://www.innovage.com/20220331", "presentation": [ "http://www.innovage.com/role/DisclosureRevenueRecognitionDetails" ], "xbrltype": "domainItemType" }, "innv_Sh1Member": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Represents the information pertaining to SH1 Variable Interest Entity.", "label": "Sh1 [Member]", "terseLabel": "SH1" } } }, "localname": "Sh1Member", "nsuri": "http://www.innovage.com/20220331", "presentation": [ "http://www.innovage.com/role/DisclosureInvestmentsDetails" ], "xbrltype": "domainItemType" }, "innv_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExercisedInPeriod": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The number of equity-based payment instruments, excluding stock (or unit) options, that were exercised during the reporting period.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Exercised in Period", "negatedLabel": "Exercised" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExercisedInPeriod", "nsuri": "http://www.innovage.com/20220331", "presentation": [ "http://www.innovage.com/role/DisclosureStockBasedCompensation2021OmnibusIncentivePlanRsuActivityDetails" ], "xbrltype": "sharesItemType" }, "innv_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExercisedInPeriodWeightedAverageGrantDateFairValue": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The weighted average fair value as of grant date pertaining to an equity-based award plan other than a stock (or unit) option plan exercised during the period.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Exercised in Period, Weighted Average Grant Date Fair Value", "terseLabel": "Exercised" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExercisedInPeriodWeightedAverageGrantDateFairValue", "nsuri": "http://www.innovage.com/20220331", "presentation": [ "http://www.innovage.com/role/DisclosureStockBasedCompensation2021OmnibusIncentivePlanRsuActivityDetails" ], "xbrltype": "perShareItemType" }, "innv_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageFairValue": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The estimated weighted average fair value.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Weighted Average Fair Value", "terseLabel": "Weighted-average fair values" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageFairValue", "nsuri": "http://www.innovage.com/20220331", "presentation": [ "http://www.innovage.com/role/DisclosureStockBasedCompensationMonteCarloOptionPricingModelDetails" ], "xbrltype": "perShareItemType" }, "innv_SharesAcquired": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The number of shares acquired.", "label": "Shares Acquired", "terseLabel": "Shares acquired" } } }, "localname": "SharesAcquired", "nsuri": "http://www.innovage.com/20220331", "presentation": [ "http://www.innovage.com/role/DisclosureInvestmentsDetails" ], "xbrltype": "sharesItemType" }, "innv_StockOptionCancellationValue": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of decrease in equity resulting from cancellation of stock option.", "label": "Stock Option Cancellation, Value", "negatedLabel": "Stock Option Cancellation, Value" } } }, "localname": "StockOptionCancellationValue", "nsuri": "http://www.innovage.com/20220331", "presentation": [ "http://www.innovage.com/role/StatementCondensedConsolidatedStatementsOfStockholdersEquity" ], "xbrltype": "monetaryItemType" }, "innv_ThirdAmendedAndRestatedCreditAgreementMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Represents the information pertaining to Third Amended and Restated Credit Agreement.", "label": "Third Amended And Restated Credit Agreement [Member]", "terseLabel": "Credit Agreement" } } }, "localname": "ThirdAmendedAndRestatedCreditAgreementMember", "nsuri": "http://www.innovage.com/20220331", "presentation": [ "http://www.innovage.com/role/DisclosureEquityDetails" ], "xbrltype": "domainItemType" }, "innv_TimeBasedOptionAwardMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Represents information pertaining to time based option award.", "label": "Time Based Option Award [Member]", "terseLabel": "Time-based option awards" } } }, "localname": "TimeBasedOptionAwardMember", "nsuri": "http://www.innovage.com/20220331", "presentation": [ "http://www.innovage.com/role/DisclosureStockBasedCompensationTables" ], "xbrltype": "domainItemType" }, "innv_TimeBasedRestrictedStockUnitsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Represents the information pertaining to time based restricted stock units.", "label": "Time Based Restricted Stock Units [Member]", "terseLabel": "Time Based Restricted Stock Units [Member]" } } }, "localname": "TimeBasedRestrictedStockUnitsMember", "nsuri": "http://www.innovage.com/20220331", "presentation": [ "http://www.innovage.com/role/DisclosureStockBasedCompensation2021OmnibusIncentivePlanDetails", "http://www.innovage.com/role/DisclosureStockBasedCompensation2021OmnibusIncentivePlanRsuActivityDetails", "http://www.innovage.com/role/DisclosureStockBasedCompensationMonteCarloOptionPricingModelDetails" ], "xbrltype": "domainItemType" }, "innv_TimeVestingAwardsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Represents the information pertaining to Time Vesting Awards.", "label": "Time Vesting Awards [Member]", "terseLabel": "Time-based option awards" } } }, "localname": "TimeVestingAwardsMember", "nsuri": "http://www.innovage.com/20220331", "presentation": [ "http://www.innovage.com/role/DisclosureStockBasedCompensationMonteCarloOptionPricingModelDetails", "http://www.innovage.com/role/DisclosureStockBasedCompensationTimeBasedAwardsDetails" ], "xbrltype": "domainItemType" }, "innv_TimeVestingUnitsProfitInterestsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Represents the information pertaining to time vesting units of profit interests.", "label": "Time Vesting Units Profit Interests [Member]", "terseLabel": "Time Vesting Units" } } }, "localname": "TimeVestingUnitsProfitInterestsMember", "nsuri": "http://www.innovage.com/20220331", "presentation": [ "http://www.innovage.com/role/DisclosureStockBasedCompensationMonteCarloOptionPricingModelDetails", "http://www.innovage.com/role/DisclosureStockBasedCompensationProfitsInterestsTransactionsAndNumberOfUnitsOutstandingDetails" ], "xbrltype": "domainItemType" }, "innv_TwoThousandSixteenIncentivePlanMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Represents the information pertaining to 2016 Incentive Plan.", "label": "Two Thousand Sixteen Incentive Plan [Member]", "terseLabel": "2016 Incentive Plan" } } }, "localname": "TwoThousandSixteenIncentivePlanMember", "nsuri": "http://www.innovage.com/20220331", "presentation": [ "http://www.innovage.com/role/DisclosureEquityDetails" ], "xbrltype": "domainItemType" }, "innv_UnusualOrInfrequentItemsOrBothCovid19PolicyPolicyTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for Coronavirus Pandemic (\"COVID19\").", "label": "Unusual or Infrequent Items, or Both, COVID 19 Policy [Policy Text Block]", "terseLabel": "Coronavirus Pandemic (\"COVID 19\")" } } }, "localname": "UnusualOrInfrequentItemsOrBothCovid19PolicyPolicyTextBlock", "nsuri": "http://www.innovage.com/20220331", "presentation": [ "http://www.innovage.com/role/DisclosureSummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "srt_ConsolidatedEntitiesAxis": { "auth_ref": [ "r323", "r324", "r329", "r330", "r450" ], "lang": { "en-us": { "role": { "label": "Consolidated Entities [Axis]" } } }, "localname": "ConsolidatedEntitiesAxis", "nsuri": "http://fasb.org/srt/2020-01-31", "presentation": [ "http://www.innovage.com/role/DisclosureInvestmentsDetails" ], "xbrltype": "stringItemType" }, "srt_ConsolidatedEntitiesDomain": { "auth_ref": [ "r323", "r324", "r329", "r330" ], "lang": { "en-us": { "role": { "label": "Consolidated Entities [Domain]", "terseLabel": "Consolidated Entities [Domain]" } } }, "localname": "ConsolidatedEntitiesDomain", "nsuri": "http://fasb.org/srt/2020-01-31", "presentation": [ "http://www.innovage.com/role/DisclosureInvestmentsDetails" ], "xbrltype": "domainItemType" }, "srt_ConsolidationItemsAxis": { "auth_ref": [ "r140", "r153", "r154", "r155", "r156", "r158", "r160", "r164" ], "lang": { "en-us": { "role": { "label": "Consolidation Items [Axis]" } } }, "localname": "ConsolidationItemsAxis", "nsuri": "http://fasb.org/srt/2020-01-31", "presentation": [ "http://www.innovage.com/role/DisclosureBusinessDetails", "http://www.innovage.com/role/DisclosureSegmentReportingDetails", "http://www.innovage.com/role/DisclosureSegmentReportingOperatingResultsDetails" ], "xbrltype": "stringItemType" }, "srt_ConsolidationItemsDomain": { "auth_ref": [ "r140", "r153", "r154", "r155", "r156", "r158", "r160", "r164" ], "lang": { "en-us": { "role": { "label": "Consolidation Items [Domain]", "terseLabel": "Consolidation Items [Domain]" } } }, "localname": "ConsolidationItemsDomain", "nsuri": "http://fasb.org/srt/2020-01-31", "presentation": [ "http://www.innovage.com/role/DisclosureBusinessDetails", "http://www.innovage.com/role/DisclosureSegmentReportingDetails", "http://www.innovage.com/role/DisclosureSegmentReportingOperatingResultsDetails" ], "xbrltype": "domainItemType" }, "srt_MajorCustomersAxis": { "auth_ref": [ "r169", "r244", "r248", "r433" ], "lang": { "en-us": { "role": { "label": "Customer [Axis]" } } }, "localname": "MajorCustomersAxis", "nsuri": "http://fasb.org/srt/2020-01-31", "presentation": [ "http://www.innovage.com/role/DisclosureRevenueRecognitionConcentrationOfNetReceivableDetails", "http://www.innovage.com/role/DisclosureRevenueRecognitionDetails", "http://www.innovage.com/role/DisclosureRevenueRecognitionSourceOfRevenueDetails" ], "xbrltype": "stringItemType" }, "srt_MaximumMember": { "auth_ref": [ "r257", "r259", "r378", "r379", "r380", "r381", "r382", "r383", "r384", "r431", "r434" ], "lang": { "en-us": { "role": { "label": "Maximum [Member]", "terseLabel": "Maximum" } } }, "localname": "MaximumMember", "nsuri": "http://fasb.org/srt/2020-01-31", "presentation": [ "http://www.innovage.com/role/DisclosureFairValueMeasurementsDetails", "http://www.innovage.com/role/DisclosureSummaryOfSignificantAccountingPoliciesPropertyAndEquipmentDetails" ], "xbrltype": "domainItemType" }, "srt_MinimumMember": { "auth_ref": [ "r257", "r259", "r378", "r379", "r380", "r381", "r382", "r383", "r384", "r431", "r434" ], "lang": { "en-us": { "role": { "label": "Minimum [Member]", "terseLabel": "Minimum" } } }, "localname": "MinimumMember", "nsuri": "http://fasb.org/srt/2020-01-31", "presentation": [ "http://www.innovage.com/role/DisclosureStockBasedCompensationMonteCarloOptionPricingModelDetails", "http://www.innovage.com/role/DisclosureSummaryOfSignificantAccountingPoliciesPropertyAndEquipmentDetails" ], "xbrltype": "domainItemType" }, "srt_NameOfMajorCustomerDomain": { "auth_ref": [ "r169", "r244", "r248", "r433" ], "lang": { "en-us": { "role": { "label": "Name Of Major Customer [Domain]", "terseLabel": "Customer [Domain]" } } }, "localname": "NameOfMajorCustomerDomain", "nsuri": "http://fasb.org/srt/2020-01-31", "presentation": [ "http://www.innovage.com/role/DisclosureRevenueRecognitionConcentrationOfNetReceivableDetails", "http://www.innovage.com/role/DisclosureRevenueRecognitionDetails", "http://www.innovage.com/role/DisclosureRevenueRecognitionSourceOfRevenueDetails" ], "xbrltype": "domainItemType" }, "srt_OwnershipAxis": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Ownership [Axis]" } } }, "localname": "OwnershipAxis", "nsuri": "http://fasb.org/srt/2020-01-31", "presentation": [ "http://www.innovage.com/role/DisclosureInvestmentsDetails" ], "xbrltype": "stringItemType" }, "srt_OwnershipDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Ownership [Domain]", "terseLabel": "Ownership [Domain]" } } }, "localname": "OwnershipDomain", "nsuri": "http://fasb.org/srt/2020-01-31", "presentation": [ "http://www.innovage.com/role/DisclosureInvestmentsDetails" ], "xbrltype": "domainItemType" }, "srt_ProductOrServiceAxis": { "auth_ref": [ "r166", "r244", "r246", "r385", "r430", "r432" ], "lang": { "en-us": { "role": { "label": "Product and Service [Axis]" } } }, "localname": "ProductOrServiceAxis", "nsuri": "http://fasb.org/srt/2020-01-31", "presentation": [ "http://www.innovage.com/role/DisclosureRelatedPartyDetails", "http://www.innovage.com/role/DisclosureSegmentReportingOperatingResultsDetails", "http://www.innovage.com/role/StatementCondensedConsolidatedStatementsOfOperations" ], "xbrltype": "stringItemType" }, "srt_ProductsAndServicesDomain": { "auth_ref": [ "r166", "r244", "r246", "r385", "r430", "r432" ], "lang": { "en-us": { "role": { "label": "Products And Services [Domain]", "terseLabel": "Product and Service [Domain]" } } }, "localname": "ProductsAndServicesDomain", "nsuri": "http://fasb.org/srt/2020-01-31", "presentation": [ "http://www.innovage.com/role/DisclosureRelatedPartyDetails", "http://www.innovage.com/role/DisclosureSegmentReportingOperatingResultsDetails", "http://www.innovage.com/role/StatementCondensedConsolidatedStatementsOfOperations" ], "xbrltype": "domainItemType" }, "srt_RangeAxis": { "auth_ref": [ "r254", "r257", "r259", "r378", "r379", "r380", "r381", "r382", "r383", "r384", "r431", "r434" ], "lang": { "en-us": { "role": { "label": "Statistical Measurement [Axis]" } } }, "localname": "RangeAxis", "nsuri": "http://fasb.org/srt/2020-01-31", "presentation": [ "http://www.innovage.com/role/DisclosureFairValueMeasurementsDetails", "http://www.innovage.com/role/DisclosureStockBasedCompensationMonteCarloOptionPricingModelDetails", "http://www.innovage.com/role/DisclosureSummaryOfSignificantAccountingPoliciesPropertyAndEquipmentDetails" ], "xbrltype": "stringItemType" }, "srt_RangeMember": { "auth_ref": [ "r254", "r257", "r259", "r378", "r379", "r380", "r381", "r382", "r383", "r384", "r431", "r434" ], "lang": { "en-us": { "role": { "label": "Range [Member]", "terseLabel": "Statistical Measurement [Domain]" } } }, "localname": "RangeMember", "nsuri": "http://fasb.org/srt/2020-01-31", "presentation": [ "http://www.innovage.com/role/DisclosureFairValueMeasurementsDetails", "http://www.innovage.com/role/DisclosureStockBasedCompensationMonteCarloOptionPricingModelDetails", "http://www.innovage.com/role/DisclosureSummaryOfSignificantAccountingPoliciesPropertyAndEquipmentDetails" ], "xbrltype": "domainItemType" }, "srt_RestatementAdjustmentMember": { "auth_ref": [ "r101", "r102", "r103", "r104", "r105", "r106", "r107", "r108", "r109", "r111", "r112", "r114", "r115", "r126" ], "lang": { "en-us": { "role": { "label": "Restatement Adjustment [Member]", "terseLabel": "Adjustments" } } }, "localname": "RestatementAdjustmentMember", "nsuri": "http://fasb.org/srt/2020-01-31", "presentation": [ "http://www.innovage.com/role/DisclosureSummaryOfSignificantAccountingPoliciesEffectOfRestatementOnConsolidatedBalanceSheetDetails", "http://www.innovage.com/role/DisclosureSummaryOfSignificantAccountingPoliciesEffectOfRestatementOnConsolidatedStatementsOfStockholdersEquityDetails" ], "xbrltype": "domainItemType" }, "srt_RestatementAxis": { "auth_ref": [ "r101", "r102", "r103", "r104", "r105", "r106", "r107", "r108", "r109", "r111", "r112", "r113", "r114", "r115", "r126", "r179", "r180", "r289", "r301", "r435", "r436", "r437", "r438", "r439", "r440", "r441", "r442", "r443", "r444" ], "lang": { "en-us": { "role": { "label": "Revision of Prior Period [Axis]" } } }, "localname": "RestatementAxis", "nsuri": "http://fasb.org/srt/2020-01-31", "presentation": [ "http://www.innovage.com/role/DisclosureSummaryOfSignificantAccountingPoliciesEffectOfRestatementOnConsolidatedBalanceSheetDetails", "http://www.innovage.com/role/DisclosureSummaryOfSignificantAccountingPoliciesEffectOfRestatementOnConsolidatedStatementsOfStockholdersEquityDetails" ], "xbrltype": "stringItemType" }, "srt_RestatementDomain": { "auth_ref": [ "r101", "r102", "r103", "r104", "r105", "r106", "r107", "r108", "r109", "r111", "r112", "r113", "r114", "r115", "r126", "r179", "r180", "r289", "r301", "r435", "r436", "r437", "r438", "r439", "r440", "r441", "r442", "r443", "r444" ], "lang": { "en-us": { "role": { "label": "Restatement [Domain]", "terseLabel": "Revision of Prior Period [Domain]" } } }, "localname": "RestatementDomain", "nsuri": "http://fasb.org/srt/2020-01-31", "presentation": [ "http://www.innovage.com/role/DisclosureSummaryOfSignificantAccountingPoliciesEffectOfRestatementOnConsolidatedBalanceSheetDetails", "http://www.innovage.com/role/DisclosureSummaryOfSignificantAccountingPoliciesEffectOfRestatementOnConsolidatedStatementsOfStockholdersEquityDetails" ], "xbrltype": "domainItemType" }, "srt_ScenarioPreviouslyReportedMember": { "auth_ref": [ "r101", "r103", "r104", "r105", "r106", "r107", "r108", "r109", "r111", "r112", "r114", "r115", "r126", "r179", "r180", "r289", "r301", "r435", "r436", "r437", "r438", "r439", "r440", "r441", "r442", "r443", "r444" ], "lang": { "en-us": { "role": { "label": "Scenario Previously Reported [Member]", "terseLabel": "As Previously Reported" } } }, "localname": "ScenarioPreviouslyReportedMember", "nsuri": "http://fasb.org/srt/2020-01-31", "presentation": [ "http://www.innovage.com/role/DisclosureSummaryOfSignificantAccountingPoliciesEffectOfRestatementOnConsolidatedBalanceSheetDetails", "http://www.innovage.com/role/DisclosureSummaryOfSignificantAccountingPoliciesEffectOfRestatementOnConsolidatedStatementsOfStockholdersEquityDetails" ], "xbrltype": "domainItemType" }, "us-gaap_AccountingPoliciesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Summary of Significant Accounting Policies" } } }, "localname": "AccountingPoliciesAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "xbrltype": "stringItemType" }, "us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent": { "auth_ref": [ "r38" ], "calculation": { "http://www.innovage.com/role/StatementCondensedConsolidatedBalanceSheets": { "order": 1.0, "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Sum of the carrying values as of the balance sheet date of obligations incurred through that date and due within one year (or the operating cycle, if longer), including liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received, taxes, interest, rent and utilities, accrued salaries and bonuses, payroll taxes and fringe benefits.", "label": "Accounts Payable and Accrued Liabilities, Current", "terseLabel": "Accounts payable and accrued expenses" } } }, "localname": "AccountsPayableAndAccruedLiabilitiesCurrent", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.innovage.com/role/StatementCondensedConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_AccountsReceivableMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Due from customers or clients for goods or services that have been delivered or sold.", "label": "Accounts Receivable [Member]", "terseLabel": "Accounts Receivable" } } }, "localname": "AccountsReceivableMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.innovage.com/role/DisclosureRevenueRecognitionConcentrationOfNetReceivableDetails" ], "xbrltype": "domainItemType" }, "us-gaap_AccountsReceivableNetCurrent": { "auth_ref": [ "r5", "r23", "r171", "r172" ], "calculation": { "http://www.innovage.com/role/StatementCondensedConsolidatedBalanceSheets": { "order": 3.0, "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current.", "label": "Accounts Receivable, after Allowance for Credit Loss, Current", "verboseLabel": "Accounts receivable, net of allowance ($3,921 - March 31, 2022 and $4,350 - June 30, 2021)" } } }, "localname": "AccountsReceivableNetCurrent", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.innovage.com/role/StatementCondensedConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment": { "auth_ref": [ "r35", "r201" ], "calculation": { "http://www.innovage.com/role/DisclosureLeasesAssetsUnderLeaseDetails": { "order": 1.0, "parentTag": "us-gaap_PropertyPlantAndEquipmentNet", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of accumulated depreciation, depletion and amortization for physical assets used in the normal conduct of business to produce goods and services.", "label": "Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment", "negatedLabel": "Less accumulated depreciation", "negatedTerseLabel": "Less accumulated depreciation and amortization" } } }, "localname": "AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.innovage.com/role/DisclosureLeasesAssetsUnderLeaseDetails", "http://www.innovage.com/role/DisclosureSummaryOfSignificantAccountingPoliciesPropertyAndEquipmentDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_AdditionalPaidInCapital": { "auth_ref": [ "r24", "r289" ], "calculation": { "http://www.innovage.com/role/StatementCondensedConsolidatedBalanceSheets": { "order": 1.0, "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Excess of issue price over par or stated value of the entity's capital stock and amounts received from other transactions involving the entity's stock or stockholders. Includes adjustments to additional paid in capital. Some examples of such adjustments include recording the issuance of debt with a beneficial conversion feature and certain tax consequences of equity instruments awarded to employees. Use this element for the aggregate amount of additional paid-in capital associated with common and preferred stock. For additional paid-in capital associated with only common stock, use the element additional paid in capital, common stock. For additional paid-in capital associated with only preferred stock, use the element additional paid in capital, preferred stock.", "label": "Additional Paid in Capital", "terseLabel": "Reduction in additional paid-in capital", "verboseLabel": "Additional paid-in capital" } } }, "localname": "AdditionalPaidInCapital", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.innovage.com/role/DisclosureEquityDetails", "http://www.innovage.com/role/StatementCondensedConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_AdditionalPaidInCapitalMember": { "auth_ref": [ "r101", "r102", "r104", "r286", "r287", "r288" ], "lang": { "en-us": { "role": { "documentation": "Excess of issue price over par or stated value of the entity's capital stock and amounts received from other transactions involving the entity's stock or stockholders.", "label": "Additional Paid In Capital [Member]", "terseLabel": "Additional Paid-in Capital" } } }, "localname": "AdditionalPaidInCapitalMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.innovage.com/role/StatementCondensedConsolidatedStatementsOfStockholdersEquity" ], "xbrltype": "domainItemType" }, "us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts": { "auth_ref": [ "r225", "r231" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of decrease in additional paid in capital (APIC) resulting from direct costs associated with issuing stock. Includes, but is not limited to, legal and accounting fees and direct costs associated with stock issues under a shelf registration.", "label": "Adjustments to Additional Paid in Capital, Stock Issued, Issuance Costs", "terseLabel": "Offering costs" } } }, "localname": "AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.innovage.com/role/StatementCondensedConsolidatedStatementsOfStockholdersEquityParenthetical" ], "xbrltype": "monetaryItemType" }, "us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract]", "terseLabel": "Adjustments to reconcile net income (loss) to net cash provided by (used in) operating activities" } } }, "localname": "AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.innovage.com/role/StatementCondensedConsolidatedStatementsOfCashFlows" ], "xbrltype": "stringItemType" }, "us-gaap_AllOtherSegmentsMember": { "auth_ref": [ "r135", "r153", "r154", "r155", "r156", "r158" ], "lang": { "en-us": { "role": { "documentation": "Operating segments classified as other. Excludes intersegment elimination and reconciling items.", "label": "All Other Segments [Member]", "terseLabel": "Others" } } }, "localname": "AllOtherSegmentsMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.innovage.com/role/DisclosureSegmentReportingDetails", "http://www.innovage.com/role/DisclosureSegmentReportingOperatingResultsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_AllocatedShareBasedCompensationExpense": { "auth_ref": [ "r261", "r283", "r291" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.", "label": "Share-based Payment Arrangement, Expense", "terseLabel": "Total share-based compensation expense" } } }, "localname": "AllocatedShareBasedCompensationExpense", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.innovage.com/role/DisclosureStockBasedCompensationCompensationExpenseDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_AllowanceForDoubtfulAccountsReceivable": { "auth_ref": [ "r173", "r181", "r182", "r184" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of allowance for credit loss on accounts receivable.", "label": "Accounts Receivable, Allowance for Credit Loss", "terseLabel": "Allowance for loss", "verboseLabel": "Allowances for uncollectable accounts" } } }, "localname": "AllowanceForDoubtfulAccountsReceivable", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.innovage.com/role/DisclosureRevenueRecognitionDetails", "http://www.innovage.com/role/StatementCondensedConsolidatedBalanceSheetsParenthetical" ], "xbrltype": "monetaryItemType" }, "us-gaap_AmortizationOfFinancingCosts": { "auth_ref": [ "r59", "r89", "r355" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of amortization expense attributable to debt issuance costs.", "label": "Amortization of Debt Issuance Costs", "terseLabel": "Amortization of deferred financing costs" } } }, "localname": "AmortizationOfFinancingCosts", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.innovage.com/role/DisclosureLongTermDebtDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_AmortizationOfFinancingCostsAndDiscounts": { "auth_ref": [ "r89", "r355" ], "calculation": { "http://www.innovage.com/role/StatementCondensedConsolidatedStatementsOfCashFlows": { "order": 8.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of amortization expense attributable to debt discount (premium) and debt issuance costs.", "label": "Amortization of Debt Issuance Costs and Discounts", "terseLabel": "Amortization of deferred financing costs" } } }, "localname": "AmortizationOfFinancingCostsAndDiscounts", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.innovage.com/role/StatementCondensedConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_AmortizationOfIntangibleAssets": { "auth_ref": [ "r89", "r192", "r195" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method.", "label": "Amortization of Intangible Assets", "terseLabel": "Amortization expense" } } }, "localname": "AmortizationOfIntangibleAssets", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.innovage.com/role/DisclosureGoodwillAndIntangibleAssetsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_ArrangementsAndNonarrangementTransactionsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Collaborative arrangement and arrangement other than collaborative applicable to revenue-generating activity or operations.", "label": "Arrangements And Nonarrangement Transactions [Member]", "terseLabel": "Collaborative Arrangement and Arrangement Other than Collaborative [Domain]" } } }, "localname": "ArrangementsAndNonarrangementTransactionsMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.innovage.com/role/DisclosureEquityDetails" ], "xbrltype": "domainItemType" }, "us-gaap_Assets": { "auth_ref": [ "r96", "r148", "r155", "r162", "r177", "r323", "r329", "r344", "r401", "r419" ], "calculation": { "http://www.innovage.com/role/StatementCondensedConsolidatedBalanceSheets": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.", "label": "Assets", "totalLabel": "Total assets" } } }, "localname": "Assets", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.innovage.com/role/StatementCondensedConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_AssetsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Assets [Abstract]", "verboseLabel": "Assets" } } }, "localname": "AssetsAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.innovage.com/role/StatementCondensedConsolidatedBalanceSheets" ], "xbrltype": "stringItemType" }, "us-gaap_AssetsCurrent": { "auth_ref": [ "r6", "r7", "r50", "r96", "r177", "r323", "r329", "r344" ], "calculation": { "http://www.innovage.com/role/StatementCondensedConsolidatedBalanceSheets": { "order": 1.0, "parentTag": "us-gaap_Assets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.", "label": "Assets, Current", "totalLabel": "Total current assets" } } }, "localname": "AssetsCurrent", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.innovage.com/role/StatementCondensedConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_AssetsCurrentAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Assets, Current [Abstract]", "terseLabel": "Current Assets" } } }, "localname": "AssetsCurrentAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.innovage.com/role/StatementCondensedConsolidatedBalanceSheets" ], "xbrltype": "stringItemType" }, "us-gaap_AssetsNoncurrent": { "auth_ref": [ "r10", "r11", "r12", "r13", "r14", "r15", "r16", "r17", "r96", "r177", "r323", "r329", "r344" ], "calculation": { "http://www.innovage.com/role/StatementCondensedConsolidatedBalanceSheets": { "order": 2.0, "parentTag": "us-gaap_Assets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold or consumed after one year or beyond the normal operating cycle, if longer.", "label": "Assets, Noncurrent", "totalLabel": "Total noncurrent assets" } } }, "localname": "AssetsNoncurrent", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.innovage.com/role/StatementCondensedConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_AssetsNoncurrentAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Assets, Noncurrent [Abstract]", "terseLabel": "Noncurrent Assets" } } }, "localname": "AssetsNoncurrentAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.innovage.com/role/StatementCondensedConsolidatedBalanceSheets" ], "xbrltype": "stringItemType" }, "us-gaap_AwardTypeAxis": { "auth_ref": [ "r263", "r285" ], "lang": { "en-us": { "role": { "documentation": "Information by type of award under share-based payment arrangement.", "label": "Award Type [Axis]" } } }, "localname": "AwardTypeAxis", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.innovage.com/role/DisclosureEquityDetails", "http://www.innovage.com/role/DisclosureStockBasedCompensation2021OmnibusIncentivePlanDetails", "http://www.innovage.com/role/DisclosureStockBasedCompensation2021OmnibusIncentivePlanRsuActivityDetails", "http://www.innovage.com/role/DisclosureStockBasedCompensationCompensationExpenseDetails", "http://www.innovage.com/role/DisclosureStockBasedCompensationMonteCarloOptionPricingModelDetails", "http://www.innovage.com/role/DisclosureStockBasedCompensationPerformanceBasedAwardsDetails", "http://www.innovage.com/role/DisclosureStockBasedCompensationProfitsInterestsTransactionsAndNumberOfUnitsOutstandingDetails", "http://www.innovage.com/role/DisclosureStockBasedCompensationTables", "http://www.innovage.com/role/DisclosureStockBasedCompensationTimeBasedAwardsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock": { "auth_ref": [ "r100" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for the basis of presentation and significant accounting policies concepts. Basis of presentation describes the underlying basis used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS). Accounting policies describe all significant accounting policies of the reporting entity.", "label": "Basis of Presentation and Significant Accounting Policies [Text Block]", "terseLabel": "Summary of Significant Accounting Policies" } } }, "localname": "BasisOfPresentationAndSignificantAccountingPoliciesTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.innovage.com/role/DisclosureSummaryOfSignificantAccountingPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_BusinessAcquisitionAcquireeDomain": { "auth_ref": [ "r256", "r258" ], "lang": { "en-us": { "role": { "documentation": "Identification of the acquiree in a material business combination (or series of individually immaterial business combinations), which may include the name or other type of identification of the acquiree.", "label": "Business Acquisition Acquiree [Domain]", "terseLabel": "Business Acquisition, Acquiree [Domain]" } } }, "localname": "BusinessAcquisitionAcquireeDomain", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.innovage.com/role/DisclosureFairValueMeasurementsDetails", "http://www.innovage.com/role/DisclosureInvestmentsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_BusinessAcquisitionAxis": { "auth_ref": [ "r256", "r258", "r311", "r312" ], "lang": { "en-us": { "role": { "documentation": "Information by business combination or series of individually immaterial business combinations.", "label": "Business Acquisition [Axis]" } } }, "localname": "BusinessAcquisitionAxis", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.innovage.com/role/DisclosureFairValueMeasurementsDetails", "http://www.innovage.com/role/DisclosureInvestmentsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired": { "auth_ref": [ "r310" ], "lang": { "en-us": { "role": { "documentation": "Percentage of voting equity interests acquired at the acquisition date in the business combination.", "label": "Business Acquisition, Percentage of Voting Interests Acquired", "terseLabel": "Percentage of additional membership interest" } } }, "localname": "BusinessAcquisitionPercentageOfVotingInterestsAcquired", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.innovage.com/role/DisclosureInvestmentsDetails" ], "xbrltype": "percentItemType" }, "us-gaap_BusinessCombinationConsiderationTransferred1": { "auth_ref": [ "r314", "r315", "r317" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of consideration transferred, consisting of acquisition-date fair value of assets transferred by the acquirer, liabilities incurred by the acquirer, and equity interest issued by the acquirer.", "label": "Business Combination, Consideration Transferred", "terseLabel": "Purchase price" } } }, "localname": "BusinessCombinationConsiderationTransferred1", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.innovage.com/role/DisclosureFairValueMeasurementsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_BusinessCombinationContingentConsiderationLiability": { "auth_ref": [ "r313", "r316", "r318" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of liability recognized arising from contingent consideration in a business combination.", "label": "Business Combination, Contingent Consideration, Liability", "terseLabel": "Contingent consideration" } } }, "localname": "BusinessCombinationContingentConsiderationLiability", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.innovage.com/role/DisclosureFairValueMeasurementsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_BusinessDescriptionAndBasisOfPresentationTextBlock": { "auth_ref": [ "r3", "r100", "r134" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for the business description and basis of presentation concepts. Business description describes the nature and type of organization including but not limited to organizational structure as may be applicable to holding companies, parent and subsidiary relationships, business divisions, business units, business segments, affiliates and information about significant ownership of the reporting entity. Basis of presentation describes the underlying basis used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS).", "label": "Business Description and Basis of Presentation [Text Block]", "terseLabel": "Business" } } }, "localname": "BusinessDescriptionAndBasisOfPresentationTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.innovage.com/role/DisclosureBusiness" ], "xbrltype": "textBlockItemType" }, "us-gaap_CapitalLeaseObligationsCurrent": { "auth_ref": [ "r18", "r361", "r363" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of capital lease obligation due within one year or the normal operating cycle, if longer.", "label": "Capital Lease Obligations, Current", "negatedLabel": "Less current maturities" } } }, "localname": "CapitalLeaseObligationsCurrent", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.innovage.com/role/DisclosureLeasesFutureMinimumLeasePaymentsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_CapitalLeaseObligationsNoncurrent": { "auth_ref": [ "r42", "r361", "r363" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount equal to the present value (the principal) at the beginning of the lease term of minimum lease payments during the lease term (excluding that portion of the payments representing executory costs such as insurance, maintenance, and taxes to be paid by the lessor, together with any profit thereon) net of payments or other amounts applied to the principal, through the balance sheet date and due to be paid more than one year (or one operating cycle, if longer) after the balance sheet date.", "label": "Capital Lease Obligations, Noncurrent", "terseLabel": "Noncurrent maturities" } } }, "localname": "CapitalLeaseObligationsNoncurrent", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.innovage.com/role/DisclosureLeasesFutureMinimumLeasePaymentsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_CapitalLeasesFutureMinimumPaymentsDue": { "auth_ref": [ "r363" ], "calculation": { "http://www.innovage.com/role/DisclosureLeasesFutureMinimumLeasePaymentsDetails": { "order": 1.0, "parentTag": "us-gaap_CapitalLeasesFutureMinimumPaymentsPresentValueOfNetMinimumPayments", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of minimum lease payments for capital leases.", "label": "Capital Leases, Future Minimum Payments Due", "totalLabel": "Total" } } }, "localname": "CapitalLeasesFutureMinimumPaymentsDue", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.innovage.com/role/DisclosureLeasesFutureMinimumLeasePaymentsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_CapitalLeasesFutureMinimumPaymentsDueAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Capital Leases, Future Minimum Payments Due, Fiscal Year Maturity [Abstract]", "terseLabel": "Capital Leases Obligations" } } }, "localname": "CapitalLeasesFutureMinimumPaymentsDueAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.innovage.com/role/DisclosureLeasesFutureMinimumLeasePaymentsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_CapitalLeasesFutureMinimumPaymentsDueCurrent": { "auth_ref": [ "r363" ], "calculation": { "http://www.innovage.com/role/DisclosureLeasesFutureMinimumLeasePaymentsDetails": { "order": 2.0, "parentTag": "us-gaap_CapitalLeasesFutureMinimumPaymentsDue", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of minimum lease payments for capital leases due in the next fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.", "label": "Capital Leases, Future Minimum Payments Due, Next Twelve Months", "verboseLabel": "2023" } } }, "localname": "CapitalLeasesFutureMinimumPaymentsDueCurrent", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.innovage.com/role/DisclosureLeasesFutureMinimumLeasePaymentsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_CapitalLeasesFutureMinimumPaymentsDueInFourYears": { "auth_ref": [ "r363" ], "calculation": { "http://www.innovage.com/role/DisclosureLeasesFutureMinimumLeasePaymentsDetails": { "order": 5.0, "parentTag": "us-gaap_CapitalLeasesFutureMinimumPaymentsDue", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of minimum lease payments for capital leases due in the fourth fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.", "label": "Capital Leases, Future Minimum Payments Due in Four Years", "terseLabel": "2026" } } }, "localname": "CapitalLeasesFutureMinimumPaymentsDueInFourYears", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.innovage.com/role/DisclosureLeasesFutureMinimumLeasePaymentsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_CapitalLeasesFutureMinimumPaymentsDueInThreeYears": { "auth_ref": [ "r363" ], "calculation": { "http://www.innovage.com/role/DisclosureLeasesFutureMinimumLeasePaymentsDetails": { "order": 4.0, "parentTag": "us-gaap_CapitalLeasesFutureMinimumPaymentsDue", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of minimum lease payments for capital leases due in the third fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.", "label": "Capital Leases, Future Minimum Payments Due in Three Years", "terseLabel": "2025" } } }, "localname": "CapitalLeasesFutureMinimumPaymentsDueInThreeYears", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.innovage.com/role/DisclosureLeasesFutureMinimumLeasePaymentsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_CapitalLeasesFutureMinimumPaymentsDueInTwoYears": { "auth_ref": [ "r363" ], "calculation": { "http://www.innovage.com/role/DisclosureLeasesFutureMinimumLeasePaymentsDetails": { "order": 3.0, "parentTag": "us-gaap_CapitalLeasesFutureMinimumPaymentsDue", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of minimum lease payments for capital leases due in the second fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.", "label": "Capital Leases, Future Minimum Payments Due in Two Years", "terseLabel": "2024" } } }, "localname": "CapitalLeasesFutureMinimumPaymentsDueInTwoYears", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.innovage.com/role/DisclosureLeasesFutureMinimumLeasePaymentsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_CapitalLeasesFutureMinimumPaymentsInterestIncludedInPayments": { "auth_ref": [ "r363" ], "calculation": { "http://www.innovage.com/role/DisclosureLeasesFutureMinimumLeasePaymentsDetails": { "order": 2.0, "parentTag": "us-gaap_CapitalLeasesFutureMinimumPaymentsPresentValueOfNetMinimumPayments", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount necessary to reduce net minimum lease payments to present value for capital leases.", "label": "Capital Leases, Future Minimum Payments, Interest Included in Payments", "negatedLabel": "Less amount representing interest" } } }, "localname": "CapitalLeasesFutureMinimumPaymentsInterestIncludedInPayments", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.innovage.com/role/DisclosureLeasesFutureMinimumLeasePaymentsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_CapitalLeasesFutureMinimumPaymentsPresentValueOfNetMinimumPayments": { "auth_ref": [ "r363" ], "calculation": { "http://www.innovage.com/role/DisclosureLeasesFutureMinimumLeasePaymentsDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Present value of minimum lease payments for capital leases net of executory costs, including amounts paid by the lessee to the lessor for insurance, maintenance and taxes.", "label": "Capital Leases, Future Minimum Payments, Present Value of Net Minimum Payments", "totalLabel": "Total minimum lease payments" } } }, "localname": "CapitalLeasesFutureMinimumPaymentsPresentValueOfNetMinimumPayments", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.innovage.com/role/DisclosureLeasesFutureMinimumLeasePaymentsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_CapitalLeasesFutureMinimumPaymentsRemainderOfFiscalYear": { "auth_ref": [], "calculation": { "http://www.innovage.com/role/DisclosureLeasesFutureMinimumLeasePaymentsDetails": { "order": 1.0, "parentTag": "us-gaap_CapitalLeasesFutureMinimumPaymentsDue", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of minimum lease payments for capital leases due in the remainder of the fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.", "label": "Capital Leases, Future Minimum Payments, Remainder of Fiscal Year", "terseLabel": "Amount Remaining in 2022" } } }, "localname": "CapitalLeasesFutureMinimumPaymentsRemainderOfFiscalYear", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.innovage.com/role/DisclosureLeasesFutureMinimumLeasePaymentsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_CashAndCashEquivalentsAtCarryingValue": { "auth_ref": [ "r4", "r31", "r91" ], "calculation": { "http://www.innovage.com/role/StatementCondensedConsolidatedBalanceSheets": { "order": 1.0, "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.", "label": "Cash and Cash Equivalents, at Carrying Value", "terseLabel": "Cash and cash equivalents", "verboseLabel": "Cash" } } }, "localname": "CashAndCashEquivalentsAtCarryingValue", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.innovage.com/role/DisclosureInvestmentsDetails", "http://www.innovage.com/role/StatementCondensedConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents": { "auth_ref": [ "r84", "r91", "r93" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.", "label": "Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents", "periodEndLabel": "CASH, CASH EQUIVALENTS & RESTRICTED CASH, END OF PERIOD", "periodStartLabel": "CASH, CASH EQUIVALENTS & RESTRICTED CASH, BEGINNING OF PERIOD" } } }, "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.innovage.com/role/StatementCondensedConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect": { "auth_ref": [ "r84", "r345" ], "calculation": { "http://www.innovage.com/role/StatementCondensedConsolidatedStatementsOfCashFlows": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.", "label": "Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect", "totalLabel": "INCREASE (DECREASE) IN CASH, CASH EQUIVALENTS & RESTRICTED CASH" } } }, "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.innovage.com/role/StatementCondensedConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_CommitmentsAndContingencies": { "auth_ref": [ "r44", "r210", "r407", "r424" ], "calculation": { "http://www.innovage.com/role/StatementCondensedConsolidatedBalanceSheets": { "order": 3.0, "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur.", "label": "Commitments and Contingencies.", "terseLabel": "Commitments and Contingencies (See Note 9)" } } }, "localname": "CommitmentsAndContingencies", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.innovage.com/role/StatementCondensedConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_CommitmentsAndContingenciesDisclosureAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Commitments and Contingencies" } } }, "localname": "CommitmentsAndContingenciesDisclosureAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "xbrltype": "stringItemType" }, "us-gaap_CommitmentsAndContingenciesDisclosureTextBlock": { "auth_ref": [ "r207", "r208", "r209", "r211" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for commitments and contingencies.", "label": "Commitments and Contingencies Disclosure [Text Block]", "terseLabel": "Commitments and Contingencies" } } }, "localname": "CommitmentsAndContingenciesDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.innovage.com/role/DisclosureCommitmentsAndContingencies" ], "xbrltype": "textBlockItemType" }, "us-gaap_CommonStockMember": { "auth_ref": [ "r101", "r102" ], "lang": { "en-us": { "role": { "documentation": "Stock that is subordinate to all other stock of the issuer.", "label": "Common Stock [Member]", "terseLabel": "Common Stock" } } }, "localname": "CommonStockMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.innovage.com/role/StatementCondensedConsolidatedStatementsOfStockholdersEquity" ], "xbrltype": "domainItemType" }, "us-gaap_CommonStockParOrStatedValuePerShare": { "auth_ref": [ "r22" ], "lang": { "en-us": { "role": { "documentation": "Face amount or stated value per share of common stock.", "label": "Common Stock, Par or Stated Value Per Share", "terseLabel": "Par value per share", "verboseLabel": "Common stock, par value (in dollars per share)" } } }, "localname": "CommonStockParOrStatedValuePerShare", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.innovage.com/role/DisclosureBusinessDetails", "http://www.innovage.com/role/DisclosureInvestmentsDetails", "http://www.innovage.com/role/StatementCondensedConsolidatedBalanceSheetsParenthetical" ], "xbrltype": "perShareItemType" }, "us-gaap_CommonStockSharesAuthorized": { "auth_ref": [ "r22" ], "lang": { "en-us": { "role": { "documentation": "The maximum number of common shares permitted to be issued by an entity's charter and bylaws.", "label": "Common Stock, Shares Authorized", "terseLabel": "Common stock authorized (in shares)" } } }, "localname": "CommonStockSharesAuthorized", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.innovage.com/role/StatementCondensedConsolidatedBalanceSheetsParenthetical" ], "xbrltype": "sharesItemType" }, "us-gaap_CommonStockSharesIssued": { "auth_ref": [ "r22" ], "lang": { "en-us": { "role": { "documentation": "Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.", "label": "Common Stock, Shares, Issued", "terseLabel": "Common stock issued (in shares)" } } }, "localname": "CommonStockSharesIssued", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.innovage.com/role/StatementCondensedConsolidatedBalanceSheetsParenthetical" ], "xbrltype": "sharesItemType" }, "us-gaap_CommonStockSharesOutstanding": { "auth_ref": [ "r22", "r225" ], "lang": { "en-us": { "role": { "documentation": "Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.", "label": "Common Stock, Shares, Outstanding", "terseLabel": "Common stock outstanding (in shares)" } } }, "localname": "CommonStockSharesOutstanding", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.innovage.com/role/StatementCondensedConsolidatedBalanceSheetsParenthetical" ], "xbrltype": "sharesItemType" }, "us-gaap_CommonStockValue": { "auth_ref": [ "r22" ], "calculation": { "http://www.innovage.com/role/StatementCondensedConsolidatedBalanceSheets": { "order": 2.0, "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.", "label": "Common Stock, Value, Issued", "terseLabel": "Common stock, $0.001 par value; 500,000,000 authorized as of March 31, 2022 and June 30, 2021; 135,525,006 and 135,516,513 shares issued and outstanding as of March 31, 2022 and June 30, 2021, respectively" } } }, "localname": "CommonStockValue", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.innovage.com/role/StatementCondensedConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_ConcentrationRiskBenchmarkDomain": { "auth_ref": [ "r132", "r133", "r169", "r342", "r343" ], "lang": { "en-us": { "role": { "documentation": "The denominator in a calculation of a disclosed concentration risk percentage.", "label": "Concentration Risk Benchmark [Domain]", "terseLabel": "Concentration Risk Benchmark [Domain]" } } }, "localname": "ConcentrationRiskBenchmarkDomain", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.innovage.com/role/DisclosureRevenueRecognitionConcentrationOfNetReceivableDetails", "http://www.innovage.com/role/DisclosureRevenueRecognitionDetails", "http://www.innovage.com/role/DisclosureRevenueRecognitionSourceOfRevenueDetails" ], "xbrltype": "domainItemType" }, "us-gaap_ConcentrationRiskByBenchmarkAxis": { "auth_ref": [ "r132", "r133", "r169", "r342", "r343", "r445" ], "lang": { "en-us": { "role": { "documentation": "Information by benchmark of concentration risk.", "label": "Concentration Risk Benchmark [Axis]" } } }, "localname": "ConcentrationRiskByBenchmarkAxis", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.innovage.com/role/DisclosureRevenueRecognitionConcentrationOfNetReceivableDetails", "http://www.innovage.com/role/DisclosureRevenueRecognitionDetails", "http://www.innovage.com/role/DisclosureRevenueRecognitionSourceOfRevenueDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ConcentrationRiskByTypeAxis": { "auth_ref": [ "r132", "r133", "r169", "r342", "r343", "r445" ], "lang": { "en-us": { "role": { "documentation": "Information by type of concentration risk, for example, but not limited to, asset, liability, net assets, geographic, customer, employees, supplier, lender.", "label": "Concentration Risk Type [Axis]" } } }, "localname": "ConcentrationRiskByTypeAxis", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.innovage.com/role/DisclosureRevenueRecognitionConcentrationOfNetReceivableDetails", "http://www.innovage.com/role/DisclosureRevenueRecognitionDetails", "http://www.innovage.com/role/DisclosureRevenueRecognitionSourceOfRevenueDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ConcentrationRiskPercentage1": { "auth_ref": [ "r132", "r133", "r169", "r342", "r343" ], "lang": { "en-us": { "role": { "documentation": "For an entity that discloses a concentration risk in relation to quantitative amount, which serves as the \"benchmark\" (or denominator) in the equation, this concept represents the concentration percentage derived from the division.", "label": "Concentration Risk, Percentage", "verboseLabel": "Risk percentage" } } }, "localname": "ConcentrationRiskPercentage1", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.innovage.com/role/DisclosureRevenueRecognitionConcentrationOfNetReceivableDetails", "http://www.innovage.com/role/DisclosureRevenueRecognitionDetails", "http://www.innovage.com/role/DisclosureRevenueRecognitionSourceOfRevenueDetails" ], "xbrltype": "percentItemType" }, "us-gaap_ConcentrationRiskTypeDomain": { "auth_ref": [ "r132", "r133", "r169", "r342", "r343" ], "lang": { "en-us": { "role": { "documentation": "For an entity that discloses a concentration risk as a percentage of some financial balance or benchmark, identifies the type (for example, asset, liability, net assets, geographic, customer, employees, supplier, lender) of the concentration.", "label": "Concentration Risk Type [Domain]", "terseLabel": "Concentration Risk Type [Domain]" } } }, "localname": "ConcentrationRiskTypeDomain", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.innovage.com/role/DisclosureRevenueRecognitionConcentrationOfNetReceivableDetails", "http://www.innovage.com/role/DisclosureRevenueRecognitionDetails", "http://www.innovage.com/role/DisclosureRevenueRecognitionSourceOfRevenueDetails" ], "xbrltype": "domainItemType" }, "us-gaap_ConsolidationPolicyTextBlock": { "auth_ref": [ "r94", "r325" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy regarding (1) the principles it follows in consolidating or combining the separate financial statements, including the principles followed in determining the inclusion or exclusion of subsidiaries or other entities in the consolidated or combined financial statements and (2) its treatment of interests (for example, common stock, a partnership interest or other means of exerting influence) in other entities, for example consolidation or use of the equity or cost methods of accounting. The accounting policy may also address the accounting treatment for intercompany accounts and transactions, noncontrolling interest, and the income statement treatment in consolidation for issuances of stock by a subsidiary.", "label": "Consolidation, Policy [Policy Text Block]", "terseLabel": "Basis of Preparation and Principles of Consolidation" } } }, "localname": "ConsolidationPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.innovage.com/role/DisclosureSummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_ConstructionInProgressMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Structure or a modification to a structure under construction. Includes recently completed structures or modifications to structures that have not been placed into service.", "label": "Construction In Progress [Member]", "terseLabel": "Construction in progress" } } }, "localname": "ConstructionInProgressMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.innovage.com/role/DisclosureSummaryOfSignificantAccountingPoliciesPropertyAndEquipmentDetails" ], "xbrltype": "domainItemType" }, "us-gaap_ConvertibleDebtMember": { "auth_ref": [ "r213" ], "lang": { "en-us": { "role": { "documentation": "Borrowing which can be exchanged for a specified number of another security at the option of the issuer or the holder, for example, but not limited to, the entity's common stock.", "label": "Convertible Debt [Member]", "terseLabel": "Convertible term loan" } } }, "localname": "ConvertibleDebtMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.innovage.com/role/DisclosureLongTermDebtDetails", "http://www.innovage.com/role/DisclosureLongTermDebtScheduleOfLongTermDebtDetails" ], "xbrltype": "domainItemType" }, "us-gaap_CostOfGoodsAndServicesSoldDepreciationAndAmortization": { "auth_ref": [ "r60" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of expense for allocation of cost of tangible and intangible assets over their useful lives directly used in production of good and rendering of service.", "label": "Cost, Depreciation and Amortization", "terseLabel": "Depreciation and amortization" } } }, "localname": "CostOfGoodsAndServicesSoldDepreciationAndAmortization", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.innovage.com/role/DisclosureSegmentReportingOperatingResultsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_CostOfGoodsAndServicesSoldOverhead": { "auth_ref": [ "r60" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Indirect cost incurred related to good produced and service rendered.", "label": "Cost, Overhead", "verboseLabel": "Overhead costs" } } }, "localname": "CostOfGoodsAndServicesSoldOverhead", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.innovage.com/role/DisclosureSegmentReportingOperatingResultsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_CostOfGoodsProductLineMember": { "auth_ref": [ "r132" ], "lang": { "en-us": { "role": { "documentation": "Cost of product sold and service rendered from specified product or service, when it serves as benchmark in concentration of risk calculation.", "label": "Cost Of Goods Product Line [Member]", "terseLabel": "External provider costs." } } }, "localname": "CostOfGoodsProductLineMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.innovage.com/role/DisclosureRevenueRecognitionDetails" ], "xbrltype": "domainItemType" }, "us-gaap_CostsAndExpenses": { "auth_ref": [ "r63" ], "calculation": { "http://www.innovage.com/role/StatementCondensedConsolidatedStatementsOfOperations": { "order": 1.0, "parentTag": "us-gaap_OperatingIncomeLoss", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Total costs of sales and operating expenses for the period.", "label": "Costs and Expenses", "totalLabel": "Total expenses" } } }, "localname": "CostsAndExpenses", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.innovage.com/role/StatementCondensedConsolidatedStatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_CreditFacilityAxis": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Information by type of credit facility. Credit facilities provide capital to borrowers without the need to structure a loan for each borrowing.", "label": "Credit Facility [Axis]" } } }, "localname": "CreditFacilityAxis", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.innovage.com/role/DisclosureLongTermDebtDetails", "http://www.innovage.com/role/DisclosureLongTermDebtScheduleOfLongTermDebtDetails" ], "xbrltype": "stringItemType" }, "us-gaap_CreditFacilityDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Type of credit facility. Credit facilities provide capital to borrowers without the need to structure a loan for each borrowing.", "label": "Credit Facility [Domain]", "terseLabel": "Credit Facility [Domain]" } } }, "localname": "CreditFacilityDomain", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.innovage.com/role/DisclosureLongTermDebtDetails", "http://www.innovage.com/role/DisclosureLongTermDebtScheduleOfLongTermDebtDetails" ], "xbrltype": "domainItemType" }, "us-gaap_CustomerConcentrationRiskMember": { "auth_ref": [ "r131", "r169" ], "lang": { "en-us": { "role": { "documentation": "Reflects the percentage that revenues in the period from one or more significant customers is to net revenues, as defined by the entity, such as total net revenues, product line revenues, segment revenues. The risk is the materially adverse effects of loss of a significant customer.", "label": "Customer Concentration Risk [Member]", "terseLabel": "Customer concentration risk" } } }, "localname": "CustomerConcentrationRiskMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.innovage.com/role/DisclosureRevenueRecognitionConcentrationOfNetReceivableDetails", "http://www.innovage.com/role/DisclosureRevenueRecognitionDetails", "http://www.innovage.com/role/DisclosureRevenueRecognitionSourceOfRevenueDetails" ], "xbrltype": "domainItemType" }, "us-gaap_DebtDisclosureAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Long Term Debt" } } }, "localname": "DebtDisclosureAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "xbrltype": "stringItemType" }, "us-gaap_DebtDisclosureTextBlock": { "auth_ref": [ "r218" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for information about short-term and long-term debt arrangements, which includes amounts of borrowings under each line of credit, note payable, commercial paper issue, bonds indenture, debenture issue, own-share lending arrangements and any other contractual agreement to repay funds, and about the underlying arrangements, rationale for a classification as long-term, including repayment terms, interest rates, collateral provided, restrictions on use of assets and activities, whether or not in compliance with debt covenants, and other matters important to users of the financial statements, such as the effects of refinancing and noncompliance with debt covenants.", "label": "Debt Disclosure [Text Block]", "terseLabel": "Long Term Debt" } } }, "localname": "DebtDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.innovage.com/role/DisclosureLongTermDebt" ], "xbrltype": "textBlockItemType" }, "us-gaap_DebtInstrumentAxis": { "auth_ref": [ "r18", "r19", "r20", "r402", "r403", "r418" ], "lang": { "en-us": { "role": { "documentation": "Information by type of debt instrument, including, but not limited to, draws against credit facilities.", "label": "Debt Instrument [Axis]" } } }, "localname": "DebtInstrumentAxis", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.innovage.com/role/DisclosureLongTermDebtDetails" ], "xbrltype": "stringItemType" }, "us-gaap_DebtInstrumentCarryingAmount": { "auth_ref": [ "r20", "r214", "r403", "r418" ], "calculation": { "http://www.innovage.com/role/DisclosureLongTermDebtScheduleOfLongTermDebtDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount, before unamortized (discount) premium and debt issuance costs, of long-term debt. Includes, but is not limited to, notes payable, bonds payable, commercial loans, mortgage loans, convertible debt, subordinated debt and other types of debt.", "label": "Long-term Debt, Gross", "terseLabel": "Outstanding borrowings", "totalLabel": "Total debt" } } }, "localname": "DebtInstrumentCarryingAmount", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.innovage.com/role/DisclosureLongTermDebtDetails", "http://www.innovage.com/role/DisclosureLongTermDebtScheduleOfLongTermDebtDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DebtInstrumentFaceAmount": { "auth_ref": [ "r354", "r356" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Face (par) amount of debt instrument at time of issuance.", "label": "Debt Instrument, Face Amount", "terseLabel": "Loan amount" } } }, "localname": "DebtInstrumentFaceAmount", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.innovage.com/role/DisclosureLongTermDebtDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DebtInstrumentInterestRateStatedPercentage": { "auth_ref": [ "r41" ], "lang": { "en-us": { "role": { "documentation": "Contractual interest rate for funds borrowed, under the debt agreement.", "label": "Debt Instrument, Interest Rate, Stated Percentage", "terseLabel": "Interest rate (as a percent)" } } }, "localname": "DebtInstrumentInterestRateStatedPercentage", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.innovage.com/role/DisclosureLongTermDebtDetails", "http://www.innovage.com/role/DisclosureLongTermDebtScheduleOfLongTermDebtDetails" ], "xbrltype": "percentItemType" }, "us-gaap_DebtInstrumentLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Debt Instrument [Line Items]" } } }, "localname": "DebtInstrumentLineItems", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.innovage.com/role/DisclosureLongTermDebtDetails", "http://www.innovage.com/role/DisclosureLongTermDebtScheduleOfLongTermDebtDetails" ], "xbrltype": "stringItemType" }, "us-gaap_DebtInstrumentNameDomain": { "auth_ref": [ "r42" ], "lang": { "en-us": { "role": { "documentation": "The name for the particular debt instrument or borrowing that distinguishes it from other debt instruments or borrowings, including draws against credit facilities.", "label": "Debt Instrument Name [Domain]", "terseLabel": "Debt Instrument, Name [Domain]" } } }, "localname": "DebtInstrumentNameDomain", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.innovage.com/role/DisclosureLongTermDebtDetails" ], "xbrltype": "domainItemType" }, "us-gaap_DebtInstrumentPeriodicPayment": { "auth_ref": [ "r42", "r416" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of the required periodic payments including both interest and principal payments.", "label": "Debt Instrument, Periodic Payment", "terseLabel": "Monthly principal and interest payments" } } }, "localname": "DebtInstrumentPeriodicPayment", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.innovage.com/role/DisclosureLongTermDebtDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DebtInstrumentTable": { "auth_ref": [ "r42", "r99", "r226", "r227", "r228", "r229", "r353", "r354", "r356", "r417" ], "lang": { "en-us": { "role": { "documentation": "A table or schedule providing information pertaining to long-term debt instruments or arrangements, including identification, terms, features, collateral requirements and other information necessary to a fair presentation. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the company, if longer.", "label": "Schedule of Long-term Debt Instruments [Table]" } } }, "localname": "DebtInstrumentTable", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.innovage.com/role/DisclosureLongTermDebtDetails", "http://www.innovage.com/role/DisclosureLongTermDebtScheduleOfLongTermDebtDetails" ], "xbrltype": "stringItemType" }, "us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet": { "auth_ref": [ "r215", "r355" ], "calculation": { "http://www.innovage.com/role/DisclosureLongTermDebtScheduleOfLongTermDebtDetails": { "order": 1.0, "parentTag": "us-gaap_DebtInstrumentCarryingAmount", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of unamortized debt discount (premium) and debt issuance costs.", "label": "Debt Instrument, Unamortized Discount (Premium) and Debt Issuance Costs, Net", "negatedLabel": "Less unamortized debt issuance costs" } } }, "localname": "DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.innovage.com/role/DisclosureLongTermDebtScheduleOfLongTermDebtDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredFinanceCostsNet": { "auth_ref": [ "r36", "r355" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount, after accumulated amortization, of debt issuance costs. Includes, but is not limited to, legal, accounting, underwriting, printing, and registration costs.", "label": "Debt Issuance Costs, Net", "terseLabel": "Total deferred financing costs" } } }, "localname": "DeferredFinanceCostsNet", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.innovage.com/role/DisclosureLongTermDebtDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredIncomeTaxLiabilitiesNet": { "auth_ref": [ "r293", "r294" ], "calculation": { "http://www.innovage.com/role/StatementCondensedConsolidatedBalanceSheets": { "order": 2.0, "parentTag": "us-gaap_Liabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount, after deferred tax asset, of deferred tax liability attributable to taxable differences with jurisdictional netting.", "label": "Deferred Income Tax Liabilities, Net", "terseLabel": "Deferred tax liability, net" } } }, "localname": "DeferredIncomeTaxLiabilitiesNet", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.innovage.com/role/StatementCondensedConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredIncomeTaxesAndTaxCredits": { "auth_ref": [ "r90" ], "calculation": { "http://www.innovage.com/role/StatementCondensedConsolidatedStatementsOfCashFlows": { "order": 10.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of deferred income tax expense (benefit) and income tax credits.", "label": "Deferred Income Taxes and Tax Credits", "terseLabel": "Deferred income taxes" } } }, "localname": "DeferredIncomeTaxesAndTaxCredits", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.innovage.com/role/StatementCondensedConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_Depreciation": { "auth_ref": [ "r89", "r199" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.", "label": "Depreciation" } } }, "localname": "Depreciation", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.innovage.com/role/DisclosureSummaryOfSignificantAccountingPoliciesPropertyAndEquipmentDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DepreciationDepletionAndAmortization": { "auth_ref": [ "r89", "r143" ], "calculation": { "http://www.innovage.com/role/StatementCondensedConsolidatedStatementsOfCashFlows": { "order": 5.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 }, "http://www.innovage.com/role/StatementCondensedConsolidatedStatementsOfOperations": { "order": 5.0, "parentTag": "us-gaap_CostsAndExpenses", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets.", "label": "Depreciation, Depletion and Amortization", "terseLabel": "Depreciation and amortization" } } }, "localname": "DepreciationDepletionAndAmortization", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.innovage.com/role/StatementCondensedConsolidatedStatementsOfCashFlows", "http://www.innovage.com/role/StatementCondensedConsolidatedStatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_DirectOperatingCosts": { "auth_ref": [ "r68" ], "calculation": { "http://www.innovage.com/role/StatementCondensedConsolidatedStatementsOfOperations": { "order": 2.0, "parentTag": "us-gaap_CostsAndExpenses", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The aggregate direct operating costs incurred during the reporting period.", "label": "Direct Operating Costs", "terseLabel": "Cost of care, excluding depreciation and amortization" } } }, "localname": "DirectOperatingCosts", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.innovage.com/role/DisclosureSegmentReportingOperatingResultsDetails", "http://www.innovage.com/role/StatementCondensedConsolidatedStatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_DisaggregationOfRevenueLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Disaggregation of Revenue [Line Items]", "terseLabel": "Revenue Recognition" } } }, "localname": "DisaggregationOfRevenueLineItems", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.innovage.com/role/DisclosureRevenueRecognitionConcentrationOfNetReceivableDetails", "http://www.innovage.com/role/DisclosureRevenueRecognitionDetails", "http://www.innovage.com/role/DisclosureRevenueRecognitionSourceOfRevenueDetails" ], "xbrltype": "stringItemType" }, "us-gaap_DisaggregationOfRevenueTable": { "auth_ref": [ "r244", "r246", "r247", "r248", "r249", "r250", "r251", "r252" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of information about disaggregation of revenue into categories depicting how nature, amount, timing, and uncertainty of revenue and cash flows are affected by economic factor.", "label": "Disaggregation of Revenue [Table]" } } }, "localname": "DisaggregationOfRevenueTable", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.innovage.com/role/DisclosureRevenueRecognitionConcentrationOfNetReceivableDetails", "http://www.innovage.com/role/DisclosureRevenueRecognitionDetails", "http://www.innovage.com/role/DisclosureRevenueRecognitionSourceOfRevenueDetails" ], "xbrltype": "stringItemType" }, "us-gaap_DisaggregationOfRevenueTableTextBlock": { "auth_ref": [ "r244" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of disaggregation of revenue into categories depicting how nature, amount, timing, and uncertainty of revenue and cash flows are affected by economic factor.", "label": "Disaggregation of Revenue [Table Text Block]", "terseLabel": "Schedule of source of revenue" } } }, "localname": "DisaggregationOfRevenueTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.innovage.com/role/DisclosureRevenueRecognitionTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock": { "auth_ref": [ "r292" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for share-based payment arrangement.", "label": "Share-based Payment Arrangement [Text Block]", "terseLabel": "Stock-based Compensation" } } }, "localname": "DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.innovage.com/role/DisclosureStockBasedCompensation" ], "xbrltype": "textBlockItemType" }, "us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Stock-based Compensation" } } }, "localname": "DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "xbrltype": "stringItemType" }, "us-gaap_Dividends": { "auth_ref": [ "r231", "r415" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of paid and unpaid cash, stock, and paid-in-kind (PIK) dividends declared, for example, but not limited to, common and preferred stock.", "label": "Dividends", "terseLabel": "Dividends" } } }, "localname": "Dividends", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.innovage.com/role/DisclosureEquityDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_EarningsPerShareAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Earnings per Share" } } }, "localname": "EarningsPerShareAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "xbrltype": "stringItemType" }, "us-gaap_EarningsPerShareBasic": { "auth_ref": [ "r56", "r107", "r108", "r109", "r110", "r111", "r116", "r118", "r120", "r121", "r122", "r126", "r127", "r411", "r428" ], "lang": { "en-us": { "role": { "documentation": "The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.", "label": "Earnings Per Share, Basic", "terseLabel": "Net income (loss) per share - basic", "verboseLabel": "Earnings (loss) per share - basic" } } }, "localname": "EarningsPerShareBasic", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.innovage.com/role/DisclosureEarningsPerShareDetails", "http://www.innovage.com/role/StatementCondensedConsolidatedStatementsOfOperations" ], "xbrltype": "perShareItemType" }, "us-gaap_EarningsPerShareDiluted": { "auth_ref": [ "r56", "r107", "r108", "r109", "r110", "r111", "r118", "r120", "r121", "r122", "r126", "r127", "r411", "r428" ], "lang": { "en-us": { "role": { "documentation": "The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.", "label": "Earnings Per Share, Diluted", "terseLabel": "Net income (loss) per share - diluted", "verboseLabel": "Earnings (loss) per share -diluted" } } }, "localname": "EarningsPerShareDiluted", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.innovage.com/role/DisclosureEarningsPerShareDetails", "http://www.innovage.com/role/StatementCondensedConsolidatedStatementsOfOperations" ], "xbrltype": "perShareItemType" }, "us-gaap_EarningsPerShareTextBlock": { "auth_ref": [ "r123", "r124", "r125", "r128" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for earnings per share.", "label": "Earnings Per Share [Text Block]", "terseLabel": "Earnings per Share" } } }, "localname": "EarningsPerShareTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.innovage.com/role/DisclosureEarningsPerShare" ], "xbrltype": "textBlockItemType" }, "us-gaap_EffectiveIncomeTaxRateContinuingOperations": { "auth_ref": [ "r296" ], "lang": { "en-us": { "role": { "documentation": "Percentage of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.", "label": "Effective Income Tax Rate Reconciliation, Percent", "terseLabel": "Effective tax rate (as a percent)" } } }, "localname": "EffectiveIncomeTaxRateContinuingOperations", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.innovage.com/role/DisclosureIncomeTaxesDetails" ], "xbrltype": "percentItemType" }, "us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate": { "auth_ref": [ "r296", "r304" ], "lang": { "en-us": { "role": { "documentation": "Percentage of domestic federal statutory tax rate applicable to pretax income (loss).", "label": "Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent", "terseLabel": "Federal statutory tax rate (as a percent)" } } }, "localname": "EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.innovage.com/role/DisclosureIncomeTaxesDetails" ], "xbrltype": "percentItemType" }, "us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1": { "auth_ref": [ "r284" ], "lang": { "en-us": { "role": { "documentation": "Weighted-average period over which cost not yet recognized is expected to be recognized for award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.", "label": "Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Period for Recognition", "terseLabel": "Weighted-average period (in years)" } } }, "localname": "EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.innovage.com/role/DisclosureStockBasedCompensation2021OmnibusIncentivePlanDetails", "http://www.innovage.com/role/DisclosureStockBasedCompensationMonteCarloOptionPricingModelDetails", "http://www.innovage.com/role/DisclosureStockBasedCompensationPerformanceBasedAwardsDetails", "http://www.innovage.com/role/DisclosureStockBasedCompensationTimeBasedAwardsDetails" ], "xbrltype": "durationItemType" }, "us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions": { "auth_ref": [ "r284" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cost to be recognized for nonvested award under share-based payment arrangement. Excludes share and unit options.", "label": "Share-based Payment Arrangement, Nonvested Award, Excluding Option, Cost Not yet Recognized, Amount", "terseLabel": "Unrecognized compensation cost" } } }, "localname": "EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.innovage.com/role/DisclosureStockBasedCompensation2021OmnibusIncentivePlanDetails", "http://www.innovage.com/role/DisclosureStockBasedCompensationMonteCarloOptionPricingModelDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions": { "auth_ref": [ "r284" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cost to be recognized for option under share-based payment arrangement.", "label": "Share-based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount", "terseLabel": "Unrecognized compensation cost" } } }, "localname": "EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.innovage.com/role/DisclosureStockBasedCompensationPerformanceBasedAwardsDetails", "http://www.innovage.com/role/DisclosureStockBasedCompensationTimeBasedAwardsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_EmployeeStockOptionMember": { "auth_ref": [ "r282" ], "lang": { "en-us": { "role": { "documentation": "Share-based payment arrangement granting right, subject to vesting and other restrictions, to purchase or sell certain number of shares at predetermined price for specified period of time.", "label": "Employee Stock Option [Member]", "terseLabel": "Stock Options" } } }, "localname": "EmployeeStockOptionMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.innovage.com/role/DisclosureStockBasedCompensationCompensationExpenseDetails" ], "xbrltype": "domainItemType" }, "us-gaap_EquityAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Equity" } } }, "localname": "EquityAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "xbrltype": "stringItemType" }, "us-gaap_EquityComponentDomain": { "auth_ref": [ "r101", "r102", "r104", "r106", "r112", "r115", "r129", "r178", "r225", "r231", "r286", "r287", "r288", "r300", "r301", "r346", "r347", "r348", "r349", "r350", "r351", "r435", "r436", "r437" ], "lang": { "en-us": { "role": { "documentation": "Components of equity are the parts of the total Equity balance including that which is allocated to common, preferred, treasury stock, retained earnings, etc.", "label": "Equity Component [Domain]", "terseLabel": "Equity Component [Domain]" } } }, "localname": "EquityComponentDomain", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.innovage.com/role/DisclosureSummaryOfSignificantAccountingPoliciesEffectOfRestatementOnConsolidatedStatementsOfStockholdersEquityDetails", "http://www.innovage.com/role/StatementCondensedConsolidatedStatementsOfStockholdersEquity" ], "xbrltype": "domainItemType" }, "us-gaap_EquityMethodInvestmentRealizedGainLossOnDisposal": { "auth_ref": [ "r61", "r62", "r89" ], "calculation": { "http://www.innovage.com/role/StatementCondensedConsolidatedStatementsOfCashFlows": { "order": 6.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 }, "http://www.innovage.com/role/StatementCondensedConsolidatedStatementsOfOperations": { "order": 4.0, "parentTag": "us-gaap_NonoperatingIncomeExpense", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of gain (loss) on sale or disposal of an equity method investment.", "label": "Equity Method Investment, Realized Gain (Loss) on Disposal", "negatedLabel": "Gain on equity method investment", "verboseLabel": "Gain on equity method investment" } } }, "localname": "EquityMethodInvestmentRealizedGainLossOnDisposal", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.innovage.com/role/DisclosureSegmentReportingOperatingResultsDetails", "http://www.innovage.com/role/StatementCondensedConsolidatedStatementsOfCashFlows", "http://www.innovage.com/role/StatementCondensedConsolidatedStatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_EquityMethodInvestments": { "auth_ref": [ "r32", "r149", "r176" ], "calculation": { "http://www.innovage.com/role/DisclosureInvestmentsEquityMethodAndCostMethodInvestmentsDetails": { "order": 2.0, "parentTag": "us-gaap_LongTermInvestments", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "This item represents the carrying amount on the entity's balance sheet of its investment in common stock of an equity method investee. This is not an indicator of the fair value of the investment, rather it is the initial cost adjusted for the entity's share of earnings and losses of the investee, adjusted for any distributions (dividends) and other than temporary impairment (OTTI) losses recognized.", "label": "Equity Method Investments", "terseLabel": "Equity method investments" } } }, "localname": "EquityMethodInvestments", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.innovage.com/role/DisclosureInvestmentsEquityMethodAndCostMethodInvestmentsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Error Corrections and Prior Period Adjustments Restatement [Line Items]" } } }, "localname": "ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementLineItems", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.innovage.com/role/DisclosureSummaryOfSignificantAccountingPoliciesEffectOfRestatementOnConsolidatedBalanceSheetDetails", "http://www.innovage.com/role/DisclosureSummaryOfSignificantAccountingPoliciesEffectOfRestatementOnConsolidatedStatementsOfStockholdersEquityDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ExtinguishmentOfDebtAmount": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Gross amount of debt extinguished.", "label": "Extinguishment of Debt, Amount", "terseLabel": "Debt extinguishment" } } }, "localname": "ExtinguishmentOfDebtAmount", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.innovage.com/role/DisclosureLongTermDebtDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_FairValueAdjustmentOfWarrants": { "auth_ref": [ "r89", "r219" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of expense (income) related to adjustment to fair value of warrant liability.", "label": "Fair Value Adjustment of Warrants", "terseLabel": "Change in fair value of warrants" } } }, "localname": "FairValueAdjustmentOfWarrants", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.innovage.com/role/DisclosureInvestmentsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_FairValueDisclosuresAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Fair Value Measurements" } } }, "localname": "FairValueDisclosuresAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "xbrltype": "stringItemType" }, "us-gaap_FairValueDisclosuresTextBlock": { "auth_ref": [ "r340" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for the fair value of financial instruments (as defined), including financial assets and financial liabilities (collectively, as defined), and the measurements of those instruments as well as disclosures related to the fair value of non-financial assets and liabilities. Such disclosures about the financial instruments, assets, and liabilities would include: (1) the fair value of the required items together with their carrying amounts (as appropriate); (2) for items for which it is not practicable to estimate fair value, disclosure would include: (a) information pertinent to estimating fair value (including, carrying amount, effective interest rate, and maturity, and (b) the reasons why it is not practicable to estimate fair value; (3) significant concentrations of credit risk including: (a) information about the activity, region, or economic characteristics identifying a concentration, (b) the maximum amount of loss the entity is exposed to based on the gross fair value of the related item, (c) policy for requiring collateral or other security and information as to accessing such collateral or security, and (d) the nature and brief description of such collateral or security; (4) quantitative information about market risks and how such risks are managed; (5) for items measured on both a recurring and nonrecurring basis information regarding the inputs used to develop the fair value measurement; and (6) for items presented in the financial statement for which fair value measurement is elected: (a) information necessary to understand the reasons for the election, (b) discussion of the effect of fair value changes on earnings, (c) a description of [similar groups] items for which the election is made and the relation thereof to the balance sheet, the aggregate carrying value of items included in the balance sheet that are not eligible for the election; (7) all other required (as defined) and desired information.", "label": "Fair Value Disclosures [Text Block]", "terseLabel": "Fair Value Measurements" } } }, "localname": "FairValueDisclosuresTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.innovage.com/role/DisclosureFairValueMeasurements" ], "xbrltype": "textBlockItemType" }, "us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]" } } }, "localname": "FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.innovage.com/role/DisclosureFairValueMeasurementsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable": { "auth_ref": [ "r338", "r341" ], "lang": { "en-us": { "role": { "documentation": "Schedule of information required and determined to be provided for purposes of reconciling beginning and ending balances of fair value measurements of liabilities using significant unobservable inputs (level 3). Separately presenting changes during the period, attributable to: (1) total gains or losses for the period (realized and unrealized) and location reported in the statement of income (or activities); (2) purchases, sales, issuances, and settlements (net); (3) transfers in and/or out of Level 3.", "label": "Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Table]" } } }, "localname": "FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.innovage.com/role/DisclosureFairValueMeasurementsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationLiabilityTransfersIntoLevel3": { "auth_ref": [ "r339" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of transfers of financial instrument classified as a liability into level 3 of the fair value hierarchy.", "label": "Fair Value, Measurement with Unobservable Inputs Reconciliation, Liability, Transfers Into Level 3", "terseLabel": "Transfers into Level 3" } } }, "localname": "FairValueMeasurementWithUnobservableInputsReconciliationLiabilityTransfersIntoLevel3", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.innovage.com/role/DisclosureFairValueMeasurementsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_FinanceLeaseLiabilityCurrent": { "auth_ref": [ "r365" ], "calculation": { "http://www.innovage.com/role/StatementCondensedConsolidatedBalanceSheets": { "order": 5.0, "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Present value of lessee's discounted obligation for lease payments from finance lease, classified as current.", "label": "Finance Lease, Liability, Current", "terseLabel": "Current portion of capital lease obligations" } } }, "localname": "FinanceLeaseLiabilityCurrent", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.innovage.com/role/StatementCondensedConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_FinanceLeaseLiabilityNoncurrent": { "auth_ref": [ "r365" ], "calculation": { "http://www.innovage.com/role/StatementCondensedConsolidatedBalanceSheets": { "order": 3.0, "parentTag": "us-gaap_Liabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Present value of lessee's discounted obligation for lease payments from finance lease, classified as noncurrent.", "label": "Finance Lease, Liability, Noncurrent", "terseLabel": "Capital lease obligations" } } }, "localname": "FinanceLeaseLiabilityNoncurrent", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.innovage.com/role/StatementCondensedConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_FinanceLeasePrincipalPayments": { "auth_ref": [ "r366", "r367" ], "calculation": { "http://www.innovage.com/role/StatementCondensedConsolidatedStatementsOfCashFlows": { "order": 3.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of cash outflow for principal payment on finance lease.", "label": "Finance Lease, Principal Payments", "negatedLabel": "Payments on capital lease obligations" } } }, "localname": "FinanceLeasePrincipalPayments", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.innovage.com/role/StatementCondensedConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization": { "auth_ref": [ "r194" ], "calculation": { "http://www.innovage.com/role/DisclosureGoodwillAndIntangibleAssetsIntangibleAssetByMajorClassDetails": { "order": 1.0, "parentTag": "us-gaap_IntangibleAssetsNetExcludingGoodwill", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Accumulated amount of amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.", "label": "Finite-Lived Intangible Assets, Accumulated Amortization", "negatedLabel": "Accumulated amortization" } } }, "localname": "FiniteLivedIntangibleAssetsAccumulatedAmortization", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.innovage.com/role/DisclosureGoodwillAndIntangibleAssetsIntangibleAssetByMajorClassDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_FiniteLivedIntangibleAssetsGross": { "auth_ref": [ "r194", "r386" ], "calculation": { "http://www.innovage.com/role/DisclosureGoodwillAndIntangibleAssetsIntangibleAssetByMajorClassDetails": { "order": 1.0, "parentTag": "us-gaap_IntangibleAssetsGrossExcludingGoodwill", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount before amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.", "label": "Finite-Lived Intangible Assets, Gross", "verboseLabel": "Definite-lived intangible assets" } } }, "localname": "FiniteLivedIntangibleAssetsGross", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.innovage.com/role/DisclosureGoodwillAndIntangibleAssetsIntangibleAssetByMajorClassDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_GainLossOnDispositionOfAssets1": { "auth_ref": [ "r89" ], "calculation": { "http://www.innovage.com/role/StatementCondensedConsolidatedStatementsOfCashFlows": { "order": 2.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of gain (loss) on sale or disposal of assets, including but not limited to property plant and equipment, intangible assets and equity in securities of subsidiaries or equity method investee.", "label": "Gain (Loss) on Disposition of Assets", "negatedLabel": "Loss on disposal of assets" } } }, "localname": "GainLossOnDispositionOfAssets1", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.innovage.com/role/StatementCondensedConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_GainsLossesOnExtinguishmentOfDebt": { "auth_ref": [ "r89", "r216", "r217" ], "calculation": { "http://www.innovage.com/role/StatementCondensedConsolidatedStatementsOfCashFlows": { "order": 7.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Difference between the fair value of payments made and the carrying amount of debt which is extinguished prior to maturity.", "label": "Gain (Loss) on Extinguishment of Debt", "negatedLabel": "Loss on extinguishment of long-term debt", "terseLabel": "Loss on extinguishment of debt" } } }, "localname": "GainsLossesOnExtinguishmentOfDebt", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.innovage.com/role/DisclosureLongTermDebtDetails", "http://www.innovage.com/role/DisclosureSegmentReportingOperatingResultsDetails", "http://www.innovage.com/role/StatementCondensedConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_GeneralAndAdministrativeExpense": { "auth_ref": [ "r69" ], "calculation": { "http://www.innovage.com/role/StatementCondensedConsolidatedStatementsOfOperations": { "order": 4.0, "parentTag": "us-gaap_CostsAndExpenses", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line.", "label": "General and Administrative Expense.", "terseLabel": "Corporate, general and administrative" } } }, "localname": "GeneralAndAdministrativeExpense", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.innovage.com/role/StatementCondensedConsolidatedStatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_GeneralAndAdministrativeExpenseMember": { "auth_ref": [ "r57" ], "lang": { "en-us": { "role": { "documentation": "Primary financial statement caption encompassing general and administrative expense.", "label": "General And Administrative Expense [Member]", "terseLabel": "General and administrative expense" } } }, "localname": "GeneralAndAdministrativeExpenseMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.innovage.com/role/DisclosureEquityDetails" ], "xbrltype": "domainItemType" }, "us-gaap_Goodwill": { "auth_ref": [ "r185", "r187", "r400" ], "calculation": { "http://www.innovage.com/role/StatementCondensedConsolidatedBalanceSheets": { "order": 5.0, "parentTag": "us-gaap_AssetsNoncurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.", "label": "Goodwill", "terseLabel": "Goodwill" } } }, "localname": "Goodwill", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.innovage.com/role/DisclosureGoodwillAndIntangibleAssetsDetails", "http://www.innovage.com/role/StatementCondensedConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Goodwill and Intangible Assets" } } }, "localname": "GoodwillAndIntangibleAssetsDisclosureAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "xbrltype": "stringItemType" }, "us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock": { "auth_ref": [ "r198" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for goodwill and intangible assets.", "label": "Goodwill and Intangible Assets Disclosure [Text Block]", "terseLabel": "Goodwill and Intangible Assets" } } }, "localname": "GoodwillAndIntangibleAssetsDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.innovage.com/role/DisclosureGoodwillAndIntangibleAssets" ], "xbrltype": "textBlockItemType" }, "us-gaap_GoodwillImpairmentLoss": { "auth_ref": [ "r89", "r186", "r188", "r190" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of loss from the write-down of an asset representing the future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.", "label": "Goodwill, Impairment Loss", "terseLabel": "Impairment of goodwill" } } }, "localname": "GoodwillImpairmentLoss", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.innovage.com/role/DisclosureGoodwillAndIntangibleAssetsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_GrossProfit": { "auth_ref": [ "r65", "r96", "r148", "r154", "r158", "r161", "r164", "r177", "r344" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Aggregate revenue less cost of goods and services sold or operating expenses directly attributable to the revenue generation activity.", "label": "Gross Profit", "terseLabel": "Center-Level Contribution Margin" } } }, "localname": "GrossProfit", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.innovage.com/role/DisclosureSegmentReportingOperatingResultsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_ImpairmentOfIntangibleAssetsFinitelived": { "auth_ref": [ "r89", "r197" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The amount of impairment loss recognized in the period resulting from the write-down of the carrying amount of a finite-lived intangible asset to fair value.", "label": "Impairment of Intangible Assets, Finite-lived", "terseLabel": "Intangible asset impairments" } } }, "localname": "ImpairmentOfIntangibleAssetsFinitelived", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.innovage.com/role/DisclosureGoodwillAndIntangibleAssetsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncomeLossFromEquityMethodInvestments": { "auth_ref": [ "r54", "r89", "r145", "r176", "r409", "r426" ], "calculation": { "http://www.innovage.com/role/StatementCondensedConsolidatedStatementsOfOperations": { "order": 6.0, "parentTag": "us-gaap_CostsAndExpenses", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of income (loss) for proportionate share of equity method investee's income (loss).", "label": "Income (Loss) from Equity Method Investments", "negatedLabel": "Equity loss", "terseLabel": "Equity loss" } } }, "localname": "IncomeLossFromEquityMethodInvestments", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.innovage.com/role/DisclosureSegmentReportingOperatingResultsDetails", "http://www.innovage.com/role/StatementCondensedConsolidatedStatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncomeLossIncludingPortionAttributableToNoncontrollingInterest": { "auth_ref": [ "r66" ], "calculation": { "http://www.innovage.com/role/StatementCondensedConsolidatedStatementsOfOperations": { "order": 2.0, "parentTag": "us-gaap_ProfitLoss", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount, before tax, of income (loss) including portion attributable to noncontrolling interest. Includes, but is not limited to, income (loss) from continuing operations, discontinued operations and equity method investments.", "label": "Income (Loss), Including Portion Attributable to Noncontrolling Interest, before Tax", "totalLabel": "Income (Loss) Before Income Taxes" } } }, "localname": "IncomeLossIncludingPortionAttributableToNoncontrollingInterest", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.innovage.com/role/DisclosureSegmentReportingOperatingResultsDetails", "http://www.innovage.com/role/StatementCondensedConsolidatedStatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncomeStatementAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Condensed Consolidated Statements of Operations" } } }, "localname": "IncomeStatementAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "xbrltype": "stringItemType" }, "us-gaap_IncomeStatementLocationAxis": { "auth_ref": [ "r203" ], "lang": { "en-us": { "role": { "documentation": "Information by location in the income statement.", "label": "Income Statement Location [Axis]" } } }, "localname": "IncomeStatementLocationAxis", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.innovage.com/role/DisclosureEquityDetails" ], "xbrltype": "stringItemType" }, "us-gaap_IncomeStatementLocationDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Location in the income statement.", "label": "Income Statement Location [Domain]", "terseLabel": "Income Statement Location [Domain]" } } }, "localname": "IncomeStatementLocationDomain", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.innovage.com/role/DisclosureEquityDetails" ], "xbrltype": "domainItemType" }, "us-gaap_IncomeTaxDisclosureAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Income Taxes" } } }, "localname": "IncomeTaxDisclosureAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "xbrltype": "stringItemType" }, "us-gaap_IncomeTaxDisclosureTextBlock": { "auth_ref": [ "r297", "r298", "r299", "r302", "r305", "r307", "r308", "r309" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for income taxes. Disclosures may include net deferred tax liability or asset recognized in an enterprise's statement of financial position, net change during the year in the total valuation allowance, approximate tax effect of each type of temporary difference and carryforward that gives rise to a significant portion of deferred tax liabilities and deferred tax assets, utilization of a tax carryback, and tax uncertainties information.", "label": "Income Tax Disclosure [Text Block]", "terseLabel": "Income Taxes" } } }, "localname": "IncomeTaxDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.innovage.com/role/DisclosureIncomeTaxes" ], "xbrltype": "textBlockItemType" }, "us-gaap_IncomeTaxExpenseBenefit": { "auth_ref": [ "r97", "r114", "r115", "r146", "r295", "r303", "r306", "r429" ], "calculation": { "http://www.innovage.com/role/StatementCondensedConsolidatedStatementsOfOperations": { "order": 1.0, "parentTag": "us-gaap_ProfitLoss", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.", "label": "Income Tax Expense (Benefit)", "terseLabel": "Income tax provision", "verboseLabel": "Provision (Benefit) for Income Taxes" } } }, "localname": "IncomeTaxExpenseBenefit", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.innovage.com/role/DisclosureIncomeTaxesDetails", "http://www.innovage.com/role/StatementCondensedConsolidatedStatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncomeTaxesPaid": { "auth_ref": [ "r86", "r92" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The amount of cash paid during the current period to foreign, federal, state, and local authorities as taxes on income.", "label": "Income Taxes Paid", "terseLabel": "Income taxes paid" } } }, "localname": "IncomeTaxesPaid", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.innovage.com/role/StatementCondensedConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncomeTaxesReceivable": { "auth_ref": [ "r47", "r406", "r425" ], "calculation": { "http://www.innovage.com/role/StatementCondensedConsolidatedBalanceSheets": { "order": 5.0, "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Carrying amount due within one year of the balance sheet date (or one operating cycle, if longer) from tax authorities as of the balance sheet date representing refunds of overpayments or recoveries based on agreed-upon resolutions of disputes.", "label": "Income Taxes Receivable, Current", "terseLabel": "Income tax receivable" } } }, "localname": "IncomeTaxesReceivable", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.innovage.com/role/StatementCondensedConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities": { "auth_ref": [ "r88" ], "calculation": { "http://www.innovage.com/role/StatementCondensedConsolidatedStatementsOfCashFlows": { "order": 16.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The increase (decrease) during the reporting period in the amounts payable to vendors for goods and services received and the amount of obligations and expenses incurred but not paid.", "label": "Increase (Decrease) in Accounts Payable and Accrued Liabilities", "terseLabel": "Accounts payable and accrued expenses" } } }, "localname": "IncreaseDecreaseInAccountsPayableAndAccruedLiabilities", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.innovage.com/role/StatementCondensedConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInAccountsReceivable": { "auth_ref": [ "r88" ], "calculation": { "http://www.innovage.com/role/StatementCondensedConsolidatedStatementsOfCashFlows": { "order": 12.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The increase (decrease) during the reporting period in amount due within one year (or one business cycle) from customers for the credit sale of goods and services.", "label": "Increase (Decrease) in Accounts Receivable", "negatedLabel": "Accounts receivable, net" } } }, "localname": "IncreaseDecreaseInAccountsReceivable", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.innovage.com/role/StatementCondensedConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInDepositOtherAssets": { "auth_ref": [ "r88" ], "calculation": { "http://www.innovage.com/role/StatementCondensedConsolidatedStatementsOfCashFlows": { "order": 15.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The increase (decrease) during the reporting period in moneys or securities given as security including, but not limited to, contract, escrow, or earnest money deposits, retainage (if applicable), deposits with clearing organizations and others, collateral, or margin deposits.", "label": "Increase (Decrease) in Deposit Assets", "negatedLabel": "Deposits and other" } } }, "localname": "IncreaseDecreaseInDepositOtherAssets", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.innovage.com/role/StatementCondensedConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInIncomeTaxesReceivable": { "auth_ref": [ "r88" ], "calculation": { "http://www.innovage.com/role/StatementCondensedConsolidatedStatementsOfCashFlows": { "order": 14.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The increase (decrease) during the reporting period in income taxes receivable, which represents the amount due from tax authorities for refunds of overpayments or recoveries of income taxes paid.", "label": "Increase (Decrease) in Income Taxes Receivable", "negatedLabel": "Income tax receivable" } } }, "localname": "IncreaseDecreaseInIncomeTaxesReceivable", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.innovage.com/role/StatementCondensedConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInOperatingAssetsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Increase (Decrease) in Operating Assets [Abstract]", "terseLabel": "Changes in operating assets and liabilities, net of acquisitions" } } }, "localname": "IncreaseDecreaseInOperatingAssetsAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.innovage.com/role/StatementCondensedConsolidatedStatementsOfCashFlows" ], "xbrltype": "stringItemType" }, "us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets": { "auth_ref": [ "r88" ], "calculation": { "http://www.innovage.com/role/StatementCondensedConsolidatedStatementsOfCashFlows": { "order": 13.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of increase (decrease) in prepaid expenses, and assets classified as other.", "label": "Increase (Decrease) in Prepaid Expense and Other Assets", "negatedLabel": "Prepaid expenses and other" } } }, "localname": "IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.innovage.com/role/StatementCondensedConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInTemporaryEquityRollForward": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.", "label": "Increase (Decrease) in Temporary Equity [Roll Forward]", "terseLabel": "Redeemable non-controlling interests (Temporary Equity)" } } }, "localname": "IncreaseDecreaseInTemporaryEquityRollForward", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.innovage.com/role/StatementCondensedConsolidatedStatementsOfStockholdersEquity" ], "xbrltype": "stringItemType" }, "us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill": { "auth_ref": [ "r196" ], "calculation": { "http://www.innovage.com/role/DisclosureGoodwillAndIntangibleAssetsIntangibleAssetByMajorClassDetails": { "order": 2.0, "parentTag": "us-gaap_IntangibleAssetsGrossExcludingGoodwill", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of assets, excluding financial assets and goodwill, lacking physical substance and having a projected indefinite period of benefit.", "label": "Indefinite-lived Intangible Assets (Excluding Goodwill)", "verboseLabel": "Indefinite-lived intangible assets" } } }, "localname": "IndefiniteLivedIntangibleAssetsExcludingGoodwill", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.innovage.com/role/DisclosureGoodwillAndIntangibleAssetsIntangibleAssetByMajorClassDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_IntangibleAssetsGrossExcludingGoodwill": { "auth_ref": [], "calculation": { "http://www.innovage.com/role/DisclosureGoodwillAndIntangibleAssetsIntangibleAssetByMajorClassDetails": { "order": 2.0, "parentTag": "us-gaap_IntangibleAssetsNetExcludingGoodwill", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount before accumulated amortization of intangible assets, excluding goodwill.", "label": "Intangible Assets, Gross (Excluding Goodwill)", "totalLabel": "Total intangible assets" } } }, "localname": "IntangibleAssetsGrossExcludingGoodwill", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.innovage.com/role/DisclosureGoodwillAndIntangibleAssetsIntangibleAssetByMajorClassDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_IntangibleAssetsNetExcludingGoodwill": { "auth_ref": [ "r191", "r193" ], "calculation": { "http://www.innovage.com/role/DisclosureGoodwillAndIntangibleAssetsIntangibleAssetByMajorClassDetails": { "order": null, "parentTag": null, "root": true, "weight": null }, "http://www.innovage.com/role/StatementCondensedConsolidatedBalanceSheets": { "order": 3.0, "parentTag": "us-gaap_AssetsNoncurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Sum of the carrying amounts of all intangible assets, excluding goodwill, as of the balance sheet date, net of accumulated amortization and impairment charges.", "label": "Intangible Assets, Net (Excluding Goodwill)", "terseLabel": "Intangible assets, net", "totalLabel": "Balance as of end of period" } } }, "localname": "IntangibleAssetsNetExcludingGoodwill", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.innovage.com/role/DisclosureGoodwillAndIntangibleAssetsIntangibleAssetByMajorClassDetails", "http://www.innovage.com/role/StatementCondensedConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_IntangibleAssetsNetIncludingGoodwillAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Intangible Assets, Net (Including Goodwill) [Abstract]" } } }, "localname": "IntangibleAssetsNetIncludingGoodwillAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.innovage.com/role/DisclosureGoodwillAndIntangibleAssetsIntangibleAssetByMajorClassDetails" ], "xbrltype": "stringItemType" }, "us-gaap_InterestExpense": { "auth_ref": [ "r53", "r142", "r352", "r355", "r412" ], "calculation": { "http://www.innovage.com/role/StatementCondensedConsolidatedStatementsOfOperations": { "order": 1.0, "parentTag": "us-gaap_NonoperatingIncomeExpense", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of the cost of borrowed funds accounted for as interest expense.", "label": "Interest Expense", "negatedLabel": "Interest expense, net" } } }, "localname": "InterestExpense", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.innovage.com/role/DisclosureSegmentReportingOperatingResultsDetails", "http://www.innovage.com/role/StatementCondensedConsolidatedStatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_InterestPaidNet": { "auth_ref": [ "r82", "r85", "r92" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of cash paid for interest, excluding capitalized interest, classified as operating activity. Includes, but is not limited to, payment to settle zero-coupon bond for accreted interest of debt discount and debt instrument with insignificant coupon interest rate in relation to effective interest rate of borrowing attributable to accreted interest of debt discount.", "label": "Interest Paid, Excluding Capitalized Interest, Operating Activities", "terseLabel": "Interest paid" } } }, "localname": "InterestPaidNet", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.innovage.com/role/StatementCondensedConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_InvestmentHoldingsScheduleOfInvestmentsTableTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of data and information required in the supplementary schedule applicable to management investment companies listing holdings of unaffiliated investments.", "label": "Investment Holdings, Schedule of Investments [Table Text Block]", "terseLabel": "Schedule of equity method and cost method investments" } } }, "localname": "InvestmentHoldingsScheduleOfInvestmentsTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.innovage.com/role/DisclosureInvestmentsTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Investments" } } }, "localname": "InvestmentsDebtAndEquitySecuritiesAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "xbrltype": "stringItemType" }, "us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock": { "auth_ref": [ "r175", "r399", "r414", "r447" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for investments in certain debt and equity securities.", "label": "Investments in Debt and Marketable Equity Securities (and Certain Trading Assets) Disclosure [Text Block]", "verboseLabel": "Investments" } } }, "localname": "InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.innovage.com/role/DisclosureInvestments" ], "xbrltype": "textBlockItemType" }, "us-gaap_Land": { "auth_ref": [ "r8", "r34" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount before accumulated depletion of real estate held for productive use, excluding land held for sale.", "label": "Land.", "terseLabel": "Land" } } }, "localname": "Land", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.innovage.com/role/DisclosureInvestmentsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LandMember": { "auth_ref": [ "r246" ], "lang": { "en-us": { "role": { "documentation": "Part of earth's surface not covered by water.", "label": "Land [Member]", "terseLabel": "Land" } } }, "localname": "LandMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.innovage.com/role/DisclosureSummaryOfSignificantAccountingPoliciesPropertyAndEquipmentDetails" ], "xbrltype": "domainItemType" }, "us-gaap_LeasesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Leases" } } }, "localname": "LeasesAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "xbrltype": "stringItemType" }, "us-gaap_LeasesOfLesseeDisclosureTextBlock": { "auth_ref": [ "r364" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for lessee entity's leasing arrangements including, but not limited to, all of the following: (a.) The basis on which contingent rental payments are determined, (b.) The existence and terms of renewal or purchase options and escalation clauses, (c.) Restrictions imposed by lease agreements, such as those concerning dividends, additional debt, and further leasing.", "label": "Leases of Lessee Disclosure [Text Block]", "terseLabel": "Leases" } } }, "localname": "LeasesOfLesseeDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.innovage.com/role/DisclosureLeases" ], "xbrltype": "textBlockItemType" }, "us-gaap_Liabilities": { "auth_ref": [ "r39", "r96", "r156", "r177", "r324", "r329", "r330", "r344" ], "calculation": { "http://www.innovage.com/role/StatementCondensedConsolidatedBalanceSheets": { "order": 1.0, "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future.", "label": "Liabilities", "totalLabel": "Total liabilities" } } }, "localname": "Liabilities", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.innovage.com/role/StatementCondensedConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_LiabilitiesAndStockholdersEquity": { "auth_ref": [ "r28", "r96", "r177", "r344", "r405", "r422" ], "calculation": { "http://www.innovage.com/role/StatementCondensedConsolidatedBalanceSheets": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.", "label": "Liabilities and Equity", "totalLabel": "Total liabilities and stockholders' equity" } } }, "localname": "LiabilitiesAndStockholdersEquity", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.innovage.com/role/StatementCondensedConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_LiabilitiesAndStockholdersEquityAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Liabilities and Equity [Abstract]", "terseLabel": "Liabilities and Stockholders' Equity" } } }, "localname": "LiabilitiesAndStockholdersEquityAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.innovage.com/role/StatementCondensedConsolidatedBalanceSheets" ], "xbrltype": "stringItemType" }, "us-gaap_LiabilitiesCurrent": { "auth_ref": [ "r40", "r96", "r177", "r324", "r329", "r330", "r344" ], "calculation": { "http://www.innovage.com/role/StatementCondensedConsolidatedBalanceSheets": { "order": 1.0, "parentTag": "us-gaap_Liabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.", "label": "Liabilities, Current", "totalLabel": "Total current liabilities" } } }, "localname": "LiabilitiesCurrent", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.innovage.com/role/StatementCondensedConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_LiabilitiesCurrentAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Liabilities, Current [Abstract]", "terseLabel": "Current Liabilities" } } }, "localname": "LiabilitiesCurrentAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.innovage.com/role/StatementCondensedConsolidatedBalanceSheets" ], "xbrltype": "stringItemType" }, "us-gaap_LiabilitiesFairValueAdjustment": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of addition (reduction) to the amount at which a liability could be incurred (settled) in a current transaction between willing parties.", "label": "Liabilities, Fair Value Adjustment", "terseLabel": "Changes in fair value" } } }, "localname": "LiabilitiesFairValueAdjustment", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.innovage.com/role/DisclosureFairValueMeasurementsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LiabilitiesNoncurrentAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Liabilities, Noncurrent [Abstract]", "terseLabel": "Noncurrent Liabilities" } } }, "localname": "LiabilitiesNoncurrentAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.innovage.com/role/StatementCondensedConsolidatedBalanceSheets" ], "xbrltype": "stringItemType" }, "us-gaap_LimitedLiabilityCompanyLLCOrLimitedPartnershipLPMembersOrLimitedPartnersOwnershipInterest": { "auth_ref": [ "r130" ], "lang": { "en-us": { "role": { "documentation": "Percentage investment held by members or limited partners of limited liability company (LLC) or limited partnership (LP).", "label": "Limited Liability Company or Limited Partnership, Members or Limited Partners, Ownership Interest", "terseLabel": "Membership interest (as a percent)" } } }, "localname": "LimitedLiabilityCompanyLLCOrLimitedPartnershipLPMembersOrLimitedPartnersOwnershipInterest", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.innovage.com/role/DisclosureInvestmentsDetails" ], "xbrltype": "percentItemType" }, "us-gaap_LineOfCreditFacilityCommitmentFeePercentage": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The fee, expressed as a percentage of the line of credit facility, for the line of credit facility regardless of whether the facility has been used.", "label": "Line of Credit Facility, Commitment Fee Percentage", "verboseLabel": "Revolving credit facility fee" } } }, "localname": "LineOfCreditFacilityCommitmentFeePercentage", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.innovage.com/role/DisclosureLongTermDebtDetails" ], "xbrltype": "percentItemType" }, "us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity": { "auth_ref": [ "r37" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of borrowing capacity currently available under the credit facility (current borrowing capacity less the amount of borrowings outstanding).", "label": "Line of Credit Facility, Remaining Borrowing Capacity", "terseLabel": "Remaining borrowing capacity" } } }, "localname": "LineOfCreditFacilityRemainingBorrowingCapacity", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.innovage.com/role/DisclosureLongTermDebtDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LoansAndLeasesReceivableRelatedParties": { "auth_ref": [ "r371", "r408" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "For an unclassified balance sheet, reflects the carrying amount of unpaid loan amounts due from related parties at the balance sheet date.", "label": "Loans and Leases Receivable, Related Parties", "terseLabel": "Loans and leases receivable, related parties" } } }, "localname": "LoansAndLeasesReceivableRelatedParties", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.innovage.com/role/DisclosureRelatedPartyDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LongTermDebtCurrent": { "auth_ref": [ "r38" ], "calculation": { "http://www.innovage.com/role/DisclosureLongTermDebtScheduleOfLongTermDebtDetails": { "order": 2.0, "parentTag": "us-gaap_DebtInstrumentCarryingAmount", "weight": 1.0 }, "http://www.innovage.com/role/StatementCondensedConsolidatedBalanceSheets": { "order": 4.0, "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount, after unamortized (discount) premium and debt issuance costs, of long-term debt, classified as current. Includes, but not limited to, notes payable, bonds payable, debentures, mortgage loans and commercial paper. Excludes capital lease obligations.", "label": "Long-term Debt, Current Maturities", "terseLabel": "Current portion of long-term debt", "verboseLabel": "Less current maturities" } } }, "localname": "LongTermDebtCurrent", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.innovage.com/role/DisclosureLongTermDebtScheduleOfLongTermDebtDetails", "http://www.innovage.com/role/StatementCondensedConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_LongTermDebtNoncurrent": { "auth_ref": [ "r42" ], "calculation": { "http://www.innovage.com/role/DisclosureLongTermDebtScheduleOfLongTermDebtDetails": { "order": 3.0, "parentTag": "us-gaap_DebtInstrumentCarryingAmount", "weight": 1.0 }, "http://www.innovage.com/role/StatementCondensedConsolidatedBalanceSheets": { "order": 5.0, "parentTag": "us-gaap_Liabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount after unamortized (discount) premium and debt issuance costs of long-term debt classified as noncurrent and excluding amounts to be repaid within one year or the normal operating cycle, if longer. Includes, but not limited to, notes payable, bonds payable, debentures, mortgage loans and commercial paper. Excludes capital lease obligations.", "label": "Long-term Debt, Excluding Current Maturities", "terseLabel": "Long-term debt, net of debt issuance costs", "verboseLabel": "Noncurrent maturities" } } }, "localname": "LongTermDebtNoncurrent", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.innovage.com/role/DisclosureLongTermDebtScheduleOfLongTermDebtDetails", "http://www.innovage.com/role/StatementCondensedConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_LongTermInvestments": { "auth_ref": [ "r32" ], "calculation": { "http://www.innovage.com/role/DisclosureInvestmentsEquityMethodAndCostMethodInvestmentsDetails": { "order": null, "parentTag": null, "root": true, "weight": null }, "http://www.innovage.com/role/StatementCondensedConsolidatedBalanceSheets": { "order": 2.0, "parentTag": "us-gaap_AssetsNoncurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The total amount of investments that are intended to be held for an extended period of time (longer than one operating cycle).", "label": "Long-term Investments", "terseLabel": "Investments", "totalLabel": "Total investments" } } }, "localname": "LongTermInvestments", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.innovage.com/role/DisclosureInvestmentsEquityMethodAndCostMethodInvestmentsDetails", "http://www.innovage.com/role/StatementCondensedConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_LongtermDebtTypeAxis": { "auth_ref": [ "r42" ], "lang": { "en-us": { "role": { "documentation": "Information by type of long-term debt.", "label": "Long-term Debt, Type [Axis]" } } }, "localname": "LongtermDebtTypeAxis", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.innovage.com/role/DisclosureLongTermDebtDetails", "http://www.innovage.com/role/DisclosureLongTermDebtScheduleOfLongTermDebtDetails" ], "xbrltype": "stringItemType" }, "us-gaap_LongtermDebtTypeDomain": { "auth_ref": [ "r42", "r212" ], "lang": { "en-us": { "role": { "documentation": "Type of long-term debt arrangement, such as notes, line of credit, commercial paper, asset-based financing, project financing, letter of credit financing. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the company, if longer.", "label": "Longterm Debt Type [Domain]", "terseLabel": "Long-term Debt, Type [Domain]" } } }, "localname": "LongtermDebtTypeDomain", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.innovage.com/role/DisclosureLongTermDebtDetails", "http://www.innovage.com/role/DisclosureLongTermDebtScheduleOfLongTermDebtDetails" ], "xbrltype": "domainItemType" }, "us-gaap_MinorityInterest": { "auth_ref": [ "r49", "r96", "r177", "r344", "r404", "r421" ], "calculation": { "http://www.innovage.com/role/StatementCondensedConsolidatedBalanceSheets": { "order": 1.0, "parentTag": "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which is directly or indirectly attributable to that ownership interest in subsidiary equity which is not attributable to the parent (that is, noncontrolling interest, previously referred to as minority interest).", "label": "Stockholders' Equity Attributable to Noncontrolling Interest", "terseLabel": "Noncontrolling interests" } } }, "localname": "MinorityInterest", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.innovage.com/role/DisclosureSummaryOfSignificantAccountingPoliciesEffectOfRestatementOnConsolidatedBalanceSheetDetails", "http://www.innovage.com/role/StatementCondensedConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_NetCashProvidedByUsedInFinancingActivities": { "auth_ref": [ "r84" ], "calculation": { "http://www.innovage.com/role/StatementCondensedConsolidatedStatementsOfCashFlows": { "order": 3.0, "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.", "label": "Net Cash Provided by (Used in) Financing Activities", "totalLabel": "Net cash provided by (used in) financing activities" } } }, "localname": "NetCashProvidedByUsedInFinancingActivities", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.innovage.com/role/StatementCondensedConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Net Cash Provided by (Used in) Financing Activities [Abstract]", "terseLabel": "Financing Activities" } } }, "localname": "NetCashProvidedByUsedInFinancingActivitiesAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.innovage.com/role/StatementCondensedConsolidatedStatementsOfCashFlows" ], "xbrltype": "stringItemType" }, "us-gaap_NetCashProvidedByUsedInInvestingActivities": { "auth_ref": [ "r84" ], "calculation": { "http://www.innovage.com/role/StatementCondensedConsolidatedStatementsOfCashFlows": { "order": 2.0, "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.", "label": "Net Cash Provided by (Used in) Investing Activities", "totalLabel": "Net cash used in investing activities" } } }, "localname": "NetCashProvidedByUsedInInvestingActivities", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.innovage.com/role/StatementCondensedConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Net Cash Provided by (Used in) Investing Activities [Abstract]", "terseLabel": "Investing Activities" } } }, "localname": "NetCashProvidedByUsedInInvestingActivitiesAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.innovage.com/role/StatementCondensedConsolidatedStatementsOfCashFlows" ], "xbrltype": "stringItemType" }, "us-gaap_NetCashProvidedByUsedInOperatingActivities": { "auth_ref": [ "r84", "r87", "r90" ], "calculation": { "http://www.innovage.com/role/StatementCondensedConsolidatedStatementsOfCashFlows": { "order": 1.0, "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "weight": 1.0 } }, "lang": { "en-us": { "role": { "documentation": "Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.", "label": "Net Cash Provided by (Used in) Operating Activities", "totalLabel": "Net cash provided by (used in) operating activities" } } }, "localname": "NetCashProvidedByUsedInOperatingActivities", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.innovage.com/role/StatementCondensedConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Net Cash Provided by (Used in) Operating Activities [Abstract]", "terseLabel": "Operating Activities" } } }, "localname": "NetCashProvidedByUsedInOperatingActivitiesAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.innovage.com/role/StatementCondensedConsolidatedStatementsOfCashFlows" ], "xbrltype": "stringItemType" }, "us-gaap_NetIncomeLoss": { "auth_ref": [ "r2", "r51", "r52", "r55", "r90", "r96", "r105", "r107", "r108", "r109", "r110", "r114", "r115", "r119", "r148", "r154", "r158", "r161", "r164", "r177", "r344", "r410", "r427" ], "calculation": { "http://www.innovage.com/role/StatementCondensedConsolidatedStatementsOfOperations": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.", "label": "Net Income (Loss) Attributable to Parent", "terseLabel": "Net income (loss) attributable to InnovAge Holding Corp.", "totalLabel": "Net Income (Loss) Attributable to InnovAge Holding Corp." } } }, "localname": "NetIncomeLoss", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.innovage.com/role/DisclosureEarningsPerShareDetails", "http://www.innovage.com/role/StatementCondensedConsolidatedStatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_NetIncomeLossAttributableToNoncontrollingInterest": { "auth_ref": [ "r51", "r52", "r114", "r115", "r327", "r335" ], "calculation": { "http://www.innovage.com/role/StatementCondensedConsolidatedStatementsOfOperations": { "order": 1.0, "parentTag": "us-gaap_NetIncomeLoss", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of Net Income (Loss) attributable to noncontrolling interest.", "label": "Net Income (Loss) Attributable to Noncontrolling Interest", "verboseLabel": "Less: net loss attributable to noncontrolling interests" } } }, "localname": "NetIncomeLossAttributableToNoncontrollingInterest", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.innovage.com/role/StatementCondensedConsolidatedStatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_NetIncomeLossAttributableToRedeemableNoncontrollingInterest": { "auth_ref": [ "r67" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of Net Income (Loss) attributable to redeemable noncontrolling interest.", "label": "Net Income (Loss) Attributable to Redeemable Noncontrolling Interest", "terseLabel": "Net Income (Loss) Attributable to Redeemable Noncontrolling Interest", "verboseLabel": "Net loss, attributable to redeemable noncontrolling interest" } } }, "localname": "NetIncomeLossAttributableToRedeemableNoncontrollingInterest", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.innovage.com/role/DisclosureInvestmentsDetails", "http://www.innovage.com/role/DisclosureSummaryOfSignificantAccountingPoliciesEffectOfRestatementOnConsolidatedStatementsOfStockholdersEquityDetails", "http://www.innovage.com/role/StatementCondensedConsolidatedStatementsOfStockholdersEquity" ], "xbrltype": "monetaryItemType" }, "us-gaap_NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest": { "auth_ref": [ "r222", "r327", "r328" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount after income tax of income (loss) including the portion attributable to nonredeemable noncontrolling interest. Excludes the portion attributable to redeemable noncontrolling interest recognized as temporary equity.", "label": "Net Income (Loss), Including Portion Attributable to Nonredeemable Noncontrolling Interest", "terseLabel": "Net income (loss)" } } }, "localname": "NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.innovage.com/role/DisclosureSummaryOfSignificantAccountingPoliciesEffectOfRestatementOnConsolidatedStatementsOfStockholdersEquityDetails", "http://www.innovage.com/role/StatementCondensedConsolidatedStatementsOfStockholdersEquity" ], "xbrltype": "monetaryItemType" }, "us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact.", "label": "New Accounting Pronouncements, Policy [Policy Text Block]", "terseLabel": "Recently Adopted Accounting Pronouncements" } } }, "localname": "NewAccountingPronouncementsPolicyPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.innovage.com/role/DisclosureSummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_NoncontrollingInterestMember": { "auth_ref": [ "r101", "r102", "r104", "r231", "r320" ], "lang": { "en-us": { "role": { "documentation": "This element represents that portion of equity (net assets) in a subsidiary not attributable, directly or indirectly, to the parent. A noncontrolling interest is sometimes called a minority interest.", "label": "Noncontrolling Interest [Member]", "terseLabel": "Noncontrolling Interests" } } }, "localname": "NoncontrollingInterestMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.innovage.com/role/DisclosureSummaryOfSignificantAccountingPoliciesEffectOfRestatementOnConsolidatedStatementsOfStockholdersEquityDetails", "http://www.innovage.com/role/StatementCondensedConsolidatedStatementsOfStockholdersEquity" ], "xbrltype": "domainItemType" }, "us-gaap_NonoperatingIncomeExpense": { "auth_ref": [ "r70" ], "calculation": { "http://www.innovage.com/role/StatementCondensedConsolidatedStatementsOfOperations": { "order": 1.0, "parentTag": "us-gaap_IncomeLossIncludingPortionAttributableToNoncontrollingInterest", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).", "label": "Nonoperating Income (Expense)", "totalLabel": "Total other expense" } } }, "localname": "NonoperatingIncomeExpense", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.innovage.com/role/StatementCondensedConsolidatedStatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_NumberOfOperatingSegments": { "auth_ref": [ "r136" ], "lang": { "en-us": { "role": { "documentation": "Number of operating segments. An operating segment is a component of an enterprise: (a) that engages in business activities from which it may earn revenues and incur expenses (including revenues and expenses relating to transactions with other components of the same enterprise), (b) whose operating results are regularly reviewed by the enterprise's chief operating decision maker to make decisions about resources to be allocated to the segment and assess its performance, and (c) for which discrete financial information is available. An operating segment may engage in business activities for which it has yet to earn revenues, for example, start-up operations may be operating segments before earning revenues.", "label": "Number of Operating Segments", "terseLabel": "Number of operating segments" } } }, "localname": "NumberOfOperatingSegments", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.innovage.com/role/DisclosureSegmentReportingDetails" ], "xbrltype": "integerItemType" }, "us-gaap_NumberOfReportableSegments": { "auth_ref": [ "r136" ], "lang": { "en-us": { "role": { "documentation": "Number of segments reported by the entity. A reportable segment is a component of an entity for which there is an accounting requirement to report separate financial information on that component in the entity's financial statements.", "label": "Number of Reportable Segments", "terseLabel": "Number of reportable segments" } } }, "localname": "NumberOfReportableSegments", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.innovage.com/role/DisclosureBusinessDetails", "http://www.innovage.com/role/DisclosureSegmentReportingDetails" ], "xbrltype": "integerItemType" }, "us-gaap_NumberOfReportingUnits": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Number of reporting units tested for impairment of goodwill. A reporting unit is an operating segment or one level below an operating segment.", "label": "Number of Reporting Units", "terseLabel": "Number of reporting units" } } }, "localname": "NumberOfReportingUnits", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.innovage.com/role/DisclosureGoodwillAndIntangibleAssetsDetails" ], "xbrltype": "integerItemType" }, "us-gaap_OperatingExpensesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Operating Expenses [Abstract]", "verboseLabel": "Expenses" } } }, "localname": "OperatingExpensesAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.innovage.com/role/StatementCondensedConsolidatedStatementsOfOperations" ], "xbrltype": "stringItemType" }, "us-gaap_OperatingIncomeLoss": { "auth_ref": [ "r148", "r154", "r158", "r161", "r164" ], "calculation": { "http://www.innovage.com/role/StatementCondensedConsolidatedStatementsOfOperations": { "order": 2.0, "parentTag": "us-gaap_IncomeLossIncludingPortionAttributableToNoncontrollingInterest", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The net result for the period of deducting operating expenses from operating revenues.", "label": "Operating Income (Loss)", "totalLabel": "Operating Income (Loss)" } } }, "localname": "OperatingIncomeLoss", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.innovage.com/role/StatementCondensedConsolidatedStatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingLeasedAssetsLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Operating Leased Assets [Line Items]" } } }, "localname": "OperatingLeasedAssetsLineItems", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.innovage.com/role/DisclosureLeasesAssetsUnderLeaseDetails" ], "xbrltype": "stringItemType" }, "us-gaap_OperatingLeasesFutureMinimumPaymentsDue": { "auth_ref": [ "r357", "r359" ], "calculation": { "http://www.innovage.com/role/DisclosureLeasesFutureMinimumLeasePaymentsDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of required minimum rental payments for leases having an initial or remaining non-cancelable letter-terms in excess of one year.", "label": "Operating Leases, Future Minimum Payments Due", "totalLabel": "Total" } } }, "localname": "OperatingLeasesFutureMinimumPaymentsDue", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.innovage.com/role/DisclosureLeasesFutureMinimumLeasePaymentsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingLeasesFutureMinimumPaymentsDueAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Operating Leases, Future Minimum Payments Due, Fiscal Year Maturity [Abstract]", "terseLabel": "Operating Leases Minimum Lease Payments" } } }, "localname": "OperatingLeasesFutureMinimumPaymentsDueAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.innovage.com/role/DisclosureLeasesFutureMinimumLeasePaymentsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_OperatingLeasesFutureMinimumPaymentsDueCurrent": { "auth_ref": [ "r357", "r359" ], "calculation": { "http://www.innovage.com/role/DisclosureLeasesFutureMinimumLeasePaymentsDetails": { "order": 2.0, "parentTag": "us-gaap_OperatingLeasesFutureMinimumPaymentsDue", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of required minimum rental payments for operating leases having an initial or remaining non-cancelable lease term in excess of one year due in the next fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.", "label": "Operating Leases, Future Minimum Payments Due, Next Twelve Months", "verboseLabel": "2023" } } }, "localname": "OperatingLeasesFutureMinimumPaymentsDueCurrent", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.innovage.com/role/DisclosureLeasesFutureMinimumLeasePaymentsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFourYears": { "auth_ref": [ "r357", "r359" ], "calculation": { "http://www.innovage.com/role/DisclosureLeasesFutureMinimumLeasePaymentsDetails": { "order": 5.0, "parentTag": "us-gaap_OperatingLeasesFutureMinimumPaymentsDue", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of required minimum rental payments for operating leases having an initial or remaining non-cancelable lease term in excess of one year due in the fourth fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.", "label": "Operating Leases, Future Minimum Payments, Due in Four Years", "terseLabel": "2026" } } }, "localname": "OperatingLeasesFutureMinimumPaymentsDueInFourYears", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.innovage.com/role/DisclosureLeasesFutureMinimumLeasePaymentsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingLeasesFutureMinimumPaymentsDueInThreeYears": { "auth_ref": [ "r357", "r359" ], "calculation": { "http://www.innovage.com/role/DisclosureLeasesFutureMinimumLeasePaymentsDetails": { "order": 4.0, "parentTag": "us-gaap_OperatingLeasesFutureMinimumPaymentsDue", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of required minimum rental payments for operating leases having an initial or remaining non-cancelable lease term in excess of one year due in the third fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.", "label": "Operating Leases, Future Minimum Payments, Due in Three Years", "terseLabel": "2025" } } }, "localname": "OperatingLeasesFutureMinimumPaymentsDueInThreeYears", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.innovage.com/role/DisclosureLeasesFutureMinimumLeasePaymentsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingLeasesFutureMinimumPaymentsDueInTwoYears": { "auth_ref": [ "r357", "r359" ], "calculation": { "http://www.innovage.com/role/DisclosureLeasesFutureMinimumLeasePaymentsDetails": { "order": 3.0, "parentTag": "us-gaap_OperatingLeasesFutureMinimumPaymentsDue", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of required minimum rental payments for operating leases having an initial or remaining non-cancelable lease term in excess of one year due in the second fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.", "label": "Operating Leases, Future Minimum Payments, Due in Two Years", "terseLabel": "2024" } } }, "localname": "OperatingLeasesFutureMinimumPaymentsDueInTwoYears", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.innovage.com/role/DisclosureLeasesFutureMinimumLeasePaymentsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingLeasesFutureMinimumPaymentsRemainderOfFiscalYear": { "auth_ref": [], "calculation": { "http://www.innovage.com/role/DisclosureLeasesFutureMinimumLeasePaymentsDetails": { "order": 1.0, "parentTag": "us-gaap_OperatingLeasesFutureMinimumPaymentsDue", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of required minimum rental payments for operating leases having an initial or remaining non-cancelable lease term in excess of one year due in the remainder of the fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.", "label": "Operating Leases, Future Minimum Payments, Remainder of Fiscal Year", "terseLabel": "Amount Remaining in 2022" } } }, "localname": "OperatingLeasesFutureMinimumPaymentsRemainderOfFiscalYear", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.innovage.com/role/DisclosureLeasesFutureMinimumLeasePaymentsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingLeasesRentExpenseNet": { "auth_ref": [ "r358" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Rental expense for the reporting period incurred under operating leases, including minimum and any contingent rent expense, net of related sublease income.", "label": "Operating Leases, Rent Expense, Net", "terseLabel": "Rental expense" } } }, "localname": "OperatingLeasesRentExpenseNet", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.innovage.com/role/DisclosureLeasesAssetsUnderLeaseDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingSegmentsMember": { "auth_ref": [ "r153", "r154", "r155", "r156", "r158", "r164" ], "lang": { "en-us": { "role": { "documentation": "Identifies components of an entity that engage in business activities from which they may earn revenue and incur expenses, including transactions with other components of the same entity.", "label": "Operating Segments [Member]", "terseLabel": "Operating segments" } } }, "localname": "OperatingSegmentsMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.innovage.com/role/DisclosureBusinessDetails", "http://www.innovage.com/role/DisclosureSegmentReportingDetails", "http://www.innovage.com/role/DisclosureSegmentReportingOperatingResultsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Business" } } }, "localname": "OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "xbrltype": "stringItemType" }, "us-gaap_OtherLiabilitiesNoncurrent": { "auth_ref": [ "r43" ], "calculation": { "http://www.innovage.com/role/StatementCondensedConsolidatedBalanceSheets": { "order": 4.0, "parentTag": "us-gaap_Liabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of liabilities classified as other, due after one year or the normal operating cycle, if longer.", "label": "Other Liabilities, Noncurrent", "terseLabel": "Other noncurrent liabilities" } } }, "localname": "OtherLiabilitiesNoncurrent", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.innovage.com/role/StatementCondensedConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherNonoperatingIncomeExpense": { "auth_ref": [ "r71" ], "calculation": { "http://www.innovage.com/role/StatementCondensedConsolidatedStatementsOfOperations": { "order": 3.0, "parentTag": "us-gaap_NonoperatingIncomeExpense", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of income (expense) related to nonoperating activities, classified as other.", "label": "Other Nonoperating Income (Expense)", "terseLabel": "Other income (expense)", "verboseLabel": "Other income" } } }, "localname": "OtherNonoperatingIncomeExpense", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.innovage.com/role/DisclosureSegmentReportingOperatingResultsDetails", "http://www.innovage.com/role/StatementCondensedConsolidatedStatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherNonoperatingIncomeExpenseAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Other Nonoperating Income (Expense) [Abstract]", "terseLabel": "Other Income (Expense)" } } }, "localname": "OtherNonoperatingIncomeExpenseAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.innovage.com/role/StatementCondensedConsolidatedStatementsOfOperations" ], "xbrltype": "stringItemType" }, "us-gaap_OtherOperatingIncomeExpenseNet": { "auth_ref": [], "calculation": { "http://www.innovage.com/role/StatementCondensedConsolidatedStatementsOfOperations": { "order": 7.0, "parentTag": "us-gaap_CostsAndExpenses", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The net amount of other operating income and expenses, the components of which are not separately disclosed on the income statement, from items that are associated with the entity's normal revenue producing operations.", "label": "Other Operating Income (Expense), Net", "negatedLabel": "Other operating income", "verboseLabel": "Other operating (income) expense" } } }, "localname": "OtherOperatingIncomeExpenseNet", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.innovage.com/role/DisclosureSegmentReportingOperatingResultsDetails", "http://www.innovage.com/role/StatementCondensedConsolidatedStatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_PartnersCapitalAccountContributions": { "auth_ref": [ "r230", "r231" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Total contributions made by each class of partners (i.e., general, limited and preferred partners).", "label": "Partners' Capital Account, Contributions", "terseLabel": "Capital contributions" } } }, "localname": "PartnersCapitalAccountContributions", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.innovage.com/role/DisclosureInvestmentsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_PaymentsForRepurchaseOfCommonStock": { "auth_ref": [ "r77" ], "calculation": { "http://www.innovage.com/role/StatementCondensedConsolidatedStatementsOfCashFlows": { "order": 7.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The cash outflow to reacquire common stock during the period.", "label": "Payments for Repurchase of Common Stock", "negatedLabel": "Treasury stock purchases" } } }, "localname": "PaymentsForRepurchaseOfCommonStock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.innovage.com/role/StatementCondensedConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_PaymentsOfDebtExtinguishmentCosts": { "auth_ref": [ "r80" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of cash outflow for cost from early extinguishment and prepayment of debt. Includes, but is not limited to, third-party cost, premium paid, and other fee paid to lender directly for debt extinguishment or debt prepayment. Excludes accrued interest.", "label": "Payment for Debt Extinguishment or Debt Prepayment Cost", "verboseLabel": "Prepayment penalty on extinguishment of debt" } } }, "localname": "PaymentsOfDebtExtinguishmentCosts", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.innovage.com/role/StatementCondensedConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_PaymentsOfDebtIssuanceCosts": { "auth_ref": [ "r79" ], "calculation": { "http://www.innovage.com/role/StatementCondensedConsolidatedStatementsOfCashFlows": { "order": 6.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The cash outflow paid to third parties in connection with debt origination, which will be amortized over the remaining maturity period of the associated long-term debt.", "label": "Payments of Debt Issuance Costs", "negatedLabel": "Payment of financing costs and debt premiums" } } }, "localname": "PaymentsOfDebtIssuanceCosts", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.innovage.com/role/StatementCondensedConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_PaymentsOfDividends": { "auth_ref": [ "r77" ], "calculation": { "http://www.innovage.com/role/StatementCondensedConsolidatedStatementsOfCashFlows": { "order": 1.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Cash outflow in the form of capital distributions and dividends to common shareholders, preferred shareholders and noncontrolling interests.", "label": "Payments of Dividends", "negatedLabel": "Distributions to owners" } } }, "localname": "PaymentsOfDividends", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.innovage.com/role/StatementCondensedConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_PaymentsOfStockIssuanceCosts": { "auth_ref": [ "r81" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The cash outflow for cost incurred directly with the issuance of an equity security.", "label": "Payments of Stock Issuance Costs", "terseLabel": "Transaction costs" } } }, "localname": "PaymentsOfStockIssuanceCosts", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.innovage.com/role/DisclosureEquityDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_PaymentsToAcquireIntangibleAssets": { "auth_ref": [ "r72" ], "calculation": { "http://www.innovage.com/role/StatementCondensedConsolidatedStatementsOfCashFlows": { "order": 2.0, "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The cash outflow to acquire asset without physical form usually arising from contractual or other legal rights, excluding goodwill.", "label": "Payments to Acquire Intangible Assets", "negatedLabel": "Purchase of intangible assets" } } }, "localname": "PaymentsToAcquireIntangibleAssets", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.innovage.com/role/StatementCondensedConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_PaymentsToAcquireInvestments": { "auth_ref": [ "r73" ], "calculation": { "http://www.innovage.com/role/StatementCondensedConsolidatedStatementsOfCashFlows": { "order": 3.0, "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The cash outflow associated with the purchase of all investments (debt, security, other) during the period.", "label": "Payments to Acquire Investments", "negatedLabel": "Purchase of cost method investment", "verboseLabel": "Cash consideration" } } }, "localname": "PaymentsToAcquireInvestments", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.innovage.com/role/DisclosureInvestmentsDetails", "http://www.innovage.com/role/StatementCondensedConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_PaymentsToAcquirePropertyPlantAndEquipment": { "auth_ref": [ "r72" ], "calculation": { "http://www.innovage.com/role/StatementCondensedConsolidatedStatementsOfCashFlows": { "order": 1.0, "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.", "label": "Payments to Acquire Property, Plant, and Equipment", "negatedLabel": "Purchases of property and equipment" } } }, "localname": "PaymentsToAcquirePropertyPlantAndEquipment", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.innovage.com/role/StatementCondensedConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_PerformanceSharesMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Share-based payment arrangement awarded for meeting performance target.", "label": "Performance Shares [Member]", "terseLabel": "Performance-based option awards" } } }, "localname": "PerformanceSharesMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.innovage.com/role/DisclosureStockBasedCompensation2021OmnibusIncentivePlanDetails", "http://www.innovage.com/role/DisclosureStockBasedCompensationMonteCarloOptionPricingModelDetails", "http://www.innovage.com/role/DisclosureStockBasedCompensationPerformanceBasedAwardsDetails", "http://www.innovage.com/role/DisclosureStockBasedCompensationTables" ], "xbrltype": "domainItemType" }, "us-gaap_PlanNameAxis": { "auth_ref": [ "r263", "r285" ], "lang": { "en-us": { "role": { "documentation": "Information by plan name for share-based payment arrangement.", "label": "Plan Name [Axis]" } } }, "localname": "PlanNameAxis", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.innovage.com/role/DisclosureStockBasedCompensation2021OmnibusIncentivePlanDetails", "http://www.innovage.com/role/DisclosureStockBasedCompensation2021OmnibusIncentivePlanRsuActivityDetails", "http://www.innovage.com/role/DisclosureStockBasedCompensationEquityIncentivePlanDetails", "http://www.innovage.com/role/DisclosureStockBasedCompensationProfitsInterestsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_PlanNameDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Plan name for share-based payment arrangement.", "label": "Plan Name [Domain]", "terseLabel": "Plan Name [Domain]" } } }, "localname": "PlanNameDomain", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.innovage.com/role/DisclosureStockBasedCompensation2021OmnibusIncentivePlanDetails", "http://www.innovage.com/role/DisclosureStockBasedCompensation2021OmnibusIncentivePlanRsuActivityDetails", "http://www.innovage.com/role/DisclosureStockBasedCompensationEquityIncentivePlanDetails", "http://www.innovage.com/role/DisclosureStockBasedCompensationProfitsInterestsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_PrepaidExpenseAndOtherAssetsCurrent": { "auth_ref": [ "r6", "r29", "r30" ], "calculation": { "http://www.innovage.com/role/StatementCondensedConsolidatedBalanceSheets": { "order": 4.0, "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer.", "label": "Prepaid Expense and Other Assets, Current", "terseLabel": "Prepaid expenses and other" } } }, "localname": "PrepaidExpenseAndOtherAssetsCurrent", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.innovage.com/role/StatementCondensedConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_PriorPeriodReclassificationAdjustmentDescription": { "auth_ref": [ "r0" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for reclassification affecting comparability of financial statement. Excludes amendment to accounting standards, other change in accounting principle, and correction of error.", "label": "Reclassification, Comparability Adjustment [Policy Text Block]", "terseLabel": "Restatement of Prior Period Financial Statements" } } }, "localname": "PriorPeriodReclassificationAdjustmentDescription", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.innovage.com/role/DisclosureSummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_ProceedsFromContributionsFromParent": { "auth_ref": [ "r76" ], "calculation": { "http://www.innovage.com/role/StatementCondensedConsolidatedStatementsOfCashFlows": { "order": 2.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The cash inflow from parent as a source of financing that is recorded as additional paid in capital.", "label": "Proceeds from Contributions from Parent", "terseLabel": "Cash contributions", "verboseLabel": "Owner contributions" } } }, "localname": "ProceedsFromContributionsFromParent", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.innovage.com/role/DisclosureInvestmentsDetails", "http://www.innovage.com/role/StatementCondensedConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProceedsFromIssuanceInitialPublicOffering": { "auth_ref": [ "r74" ], "calculation": { "http://www.innovage.com/role/StatementCondensedConsolidatedStatementsOfCashFlows": { "order": 9.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The cash inflow associated with the amount received from entity's first offering of stock to the public.", "label": "Proceeds from Issuance Initial Public Offering", "terseLabel": "Proceeds from initial public offering of common stock" } } }, "localname": "ProceedsFromIssuanceInitialPublicOffering", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.innovage.com/role/StatementCondensedConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProceedsFromIssuanceOfLongTermDebt": { "auth_ref": [ "r75" ], "calculation": { "http://www.innovage.com/role/StatementCondensedConsolidatedStatementsOfCashFlows": { "order": 4.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The cash inflow from a debt initially having maturity due after one year or beyond the operating cycle, if longer.", "label": "Proceeds from Issuance of Long-term Debt", "terseLabel": "Proceeds from long-term debt" } } }, "localname": "ProceedsFromIssuanceOfLongTermDebt", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.innovage.com/role/StatementCondensedConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProfitLoss": { "auth_ref": [ "r2", "r51", "r52", "r83", "r96", "r105", "r114", "r115", "r148", "r154", "r158", "r161", "r164", "r177", "r322", "r326", "r328", "r335", "r336", "r344", "r413" ], "calculation": { "http://www.innovage.com/role/StatementCondensedConsolidatedStatementsOfCashFlows": { "order": 1.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 }, "http://www.innovage.com/role/StatementCondensedConsolidatedStatementsOfOperations": { "order": 2.0, "parentTag": "us-gaap_NetIncomeLoss", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.", "label": "Net Income (Loss), Including Portion Attributable to Noncontrolling Interest", "terseLabel": "Net income (loss)", "totalLabel": "Net Income (Loss)" } } }, "localname": "ProfitLoss", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.innovage.com/role/StatementCondensedConsolidatedStatementsOfCashFlows", "http://www.innovage.com/role/StatementCondensedConsolidatedStatementsOfOperations", "http://www.innovage.com/role/StatementCondensedConsolidatedStatementsOfStockholdersEquity" ], "xbrltype": "monetaryItemType" }, "us-gaap_PropertyPlantAndEquipmentByTypeAxis": { "auth_ref": [ "r35", "r202" ], "lang": { "en-us": { "role": { "documentation": "Information by type of long-lived, physical assets used to produce goods and services and not intended for resale.", "label": "Long-Lived Tangible Asset [Axis]" } } }, "localname": "PropertyPlantAndEquipmentByTypeAxis", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.innovage.com/role/DisclosureLeasesAssetsUnderLeaseDetails", "http://www.innovage.com/role/DisclosureSummaryOfSignificantAccountingPoliciesPropertyAndEquipmentDetails" ], "xbrltype": "stringItemType" }, "us-gaap_PropertyPlantAndEquipmentGross": { "auth_ref": [ "r34", "r200" ], "calculation": { "http://www.innovage.com/role/DisclosureLeasesAssetsUnderLeaseDetails": { "order": 2.0, "parentTag": "us-gaap_PropertyPlantAndEquipmentNet", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount before accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.", "label": "Property, Plant and Equipment, Gross", "terseLabel": "Equipment", "verboseLabel": "Property and equipment gross" } } }, "localname": "PropertyPlantAndEquipmentGross", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.innovage.com/role/DisclosureLeasesAssetsUnderLeaseDetails", "http://www.innovage.com/role/DisclosureSummaryOfSignificantAccountingPoliciesPropertyAndEquipmentDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_PropertyPlantAndEquipmentLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Property, Plant and Equipment [Line Items]", "terseLabel": "Summary of Significant Accounting Policies" } } }, "localname": "PropertyPlantAndEquipmentLineItems", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.innovage.com/role/DisclosureSummaryOfSignificantAccountingPoliciesPropertyAndEquipmentDetails" ], "xbrltype": "stringItemType" }, "us-gaap_PropertyPlantAndEquipmentNet": { "auth_ref": [ "r13", "r14", "r202", "r423" ], "calculation": { "http://www.innovage.com/role/DisclosureLeasesAssetsUnderLeaseDetails": { "order": null, "parentTag": null, "root": true, "weight": null }, "http://www.innovage.com/role/StatementCondensedConsolidatedBalanceSheets": { "order": 1.0, "parentTag": "us-gaap_AssetsNoncurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.", "label": "Property, Plant and Equipment, Net", "totalLabel": "Balance as of end of period", "verboseLabel": "Property and equipment, net" } } }, "localname": "PropertyPlantAndEquipmentNet", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.innovage.com/role/DisclosureLeasesAssetsUnderLeaseDetails", "http://www.innovage.com/role/DisclosureSummaryOfSignificantAccountingPoliciesPropertyAndEquipmentDetails", "http://www.innovage.com/role/StatementCondensedConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_PropertyPlantAndEquipmentPolicyTextBlock": { "auth_ref": [ "r33", "r94", "r202", "r448", "r449" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for long-lived, physical asset used in normal conduct of business and not intended for resale. Includes, but is not limited to, work of art, historical treasure, and similar asset classified as collections.", "label": "Property, Plant and Equipment, Policy [Policy Text Block]", "terseLabel": "Property and Equipment" } } }, "localname": "PropertyPlantAndEquipmentPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.innovage.com/role/DisclosureSummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_PropertyPlantAndEquipmentTextBlock": { "auth_ref": [ "r13", "r202" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation.", "label": "Property, Plant and Equipment [Table Text Block]", "terseLabel": "Schedule of property and equipment" } } }, "localname": "PropertyPlantAndEquipmentTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.innovage.com/role/DisclosureSummaryOfSignificantAccountingPoliciesTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_PropertyPlantAndEquipmentTypeDomain": { "auth_ref": [ "r13", "r200" ], "lang": { "en-us": { "role": { "documentation": "Listing of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale. Examples include land, buildings, machinery and equipment, and other types of furniture and equipment including, but not limited to, office equipment, furniture and fixtures, and computer equipment and software.", "label": "Property Plant And Equipment Type [Domain]", "terseLabel": "Long-Lived Tangible Asset [Domain]" } } }, "localname": "PropertyPlantAndEquipmentTypeDomain", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.innovage.com/role/DisclosureLeasesAssetsUnderLeaseDetails", "http://www.innovage.com/role/DisclosureSummaryOfSignificantAccountingPoliciesPropertyAndEquipmentDetails" ], "xbrltype": "domainItemType" }, "us-gaap_PropertyPlantAndEquipmentUsefulLife": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Useful life of long lived, physical assets used in the normal conduct of business and not intended for resale, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Examples include, but not limited to, land, buildings, machinery and equipment, office equipment, furniture and fixtures, and computer equipment.", "label": "Property, Plant and Equipment, Useful Life", "terseLabel": "Estimated Useful Lives" } } }, "localname": "PropertyPlantAndEquipmentUsefulLife", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.innovage.com/role/DisclosureSummaryOfSignificantAccountingPoliciesPropertyAndEquipmentDetails" ], "xbrltype": "durationItemType" }, "us-gaap_ProvisionForDoubtfulAccounts": { "auth_ref": [ "r58", "r183" ], "calculation": { "http://www.innovage.com/role/StatementCondensedConsolidatedStatementsOfCashFlows": { "order": 4.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of expense (reversal of expense) for expected credit loss on accounts receivable.", "label": "Accounts Receivable, Credit Loss Expense (Reversal)", "terseLabel": "Provision for uncollectible accounts" } } }, "localname": "ProvisionForDoubtfulAccounts", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.innovage.com/role/StatementCondensedConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount": { "auth_ref": [ "r220", "r221", "r223", "r224" ], "calculation": { "http://www.innovage.com/role/StatementCondensedConsolidatedBalanceSheets": { "order": 4.0, "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "As of the reporting date, the aggregate carrying amount of all noncontrolling interests which are redeemable by the (parent) entity (1) at a fixed or determinable price on a fixed or determinable date, (2) at the option of the holder of the noncontrolling interest, or (3) upon occurrence of an event that is not solely within the control of the (parent) entity. This item includes noncontrolling interest holder's ownership (or holders' ownership) regardless of the type of equity interest (common, preferred, other) including all potential organizational (legal) forms of the investee entity.", "label": "Redeemable Noncontrolling Interest, Equity, Carrying Amount", "periodEndLabel": "Ending balance", "periodStartLabel": "Beginning balance", "terseLabel": "Redeemable Noncontrolling Interests (See Note 4)", "verboseLabel": "Redeemable Noncontrolling Interests" } } }, "localname": "RedeemableNoncontrollingInterestEquityCarryingAmount", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.innovage.com/role/DisclosureSummaryOfSignificantAccountingPoliciesEffectOfRestatementOnConsolidatedBalanceSheetDetails", "http://www.innovage.com/role/DisclosureSummaryOfSignificantAccountingPoliciesEffectOfRestatementOnConsolidatedStatementsOfStockholdersEquityDetails", "http://www.innovage.com/role/StatementCondensedConsolidatedBalanceSheets", "http://www.innovage.com/role/StatementCondensedConsolidatedStatementsOfStockholdersEquity" ], "xbrltype": "monetaryItemType" }, "us-gaap_RedeemableNoncontrollingInterestEquityFairValue": { "auth_ref": [ "r220", "r221", "r223", "r224" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The aggregate fair value as of the reporting date of all noncontrolling interests which are redeemable by the (parent) entity (1) at a fixed or determinable price on a fixed or determinable date, (2) at the option of the holder of the noncontrolling interest, or (3) upon occurrence of an event that is not solely within the control of the (parent) entity. This item includes noncontrolling interest holder's ownership (or holders' ownership) regardless of the type of equity interest (common, preferred, other) including all potential organizational (legal) forms of the investee entity.", "label": "Redeemable Noncontrolling Interest, Equity, Fair Value", "terseLabel": "Redeemable noncontrolling interests" } } }, "localname": "RedeemableNoncontrollingInterestEquityFairValue", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.innovage.com/role/DisclosureInvestmentsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_RelatedPartyDomain": { "auth_ref": [ "r255", "r370", "r371" ], "lang": { "en-us": { "role": { "documentation": "Related parties include affiliates; other entities for which investments are accounted for by the equity method by the entity; trusts for benefit of employees; and principal owners, management, and members of immediate families. It also may include other parties with which the entity may control or can significantly influence the management or operating policies of the other to an extent that one of the transacting parties might be prevented from fully pursuing its own separate interests.", "label": "Related Party [Domain]", "terseLabel": "Related Party [Domain]" } } }, "localname": "RelatedPartyDomain", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.innovage.com/role/DisclosureInvestmentsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_RelatedPartyTransactionLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Related Party Transaction [Line Items]" } } }, "localname": "RelatedPartyTransactionLineItems", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.innovage.com/role/DisclosureRelatedPartyDetails" ], "xbrltype": "stringItemType" }, "us-gaap_RelatedPartyTransactionsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Related-party" } } }, "localname": "RelatedPartyTransactionsAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "xbrltype": "stringItemType" }, "us-gaap_RelatedPartyTransactionsByRelatedPartyAxis": { "auth_ref": [ "r255", "r370", "r373", "r387", "r388", "r389", "r390", "r391", "r392", "r393", "r394", "r395", "r396", "r397", "r398" ], "lang": { "en-us": { "role": { "documentation": "Information by type of related party. Related parties include, but not limited to, affiliates; other entities for which investments are accounted for by the equity method by the entity; trusts for benefit of employees; and principal owners, management, and members of immediate families. It also may include other parties with which the entity may control or can significantly influence the management or operating policies of the other to an extent that one of the transacting parties might be prevented from fully pursuing its own separate interests.", "label": "Related Party [Axis]" } } }, "localname": "RelatedPartyTransactionsByRelatedPartyAxis", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.innovage.com/role/DisclosureInvestmentsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_RelatedPartyTransactionsDisclosureTextBlock": { "auth_ref": [ "r368", "r369", "r371", "r374", "r375" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for related party transactions. Examples of related party transactions include transactions between (a) a parent company and its subsidiary; (b) subsidiaries of a common parent; (c) and entity and its principal owners; and (d) affiliates.", "label": "Related Party Transactions Disclosure [Text Block]", "terseLabel": "Related-party" } } }, "localname": "RelatedPartyTransactionsDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.innovage.com/role/DisclosureRelatedParty" ], "xbrltype": "textBlockItemType" }, "us-gaap_RepaymentsOfLongTermDebt": { "auth_ref": [ "r78" ], "calculation": { "http://www.innovage.com/role/StatementCondensedConsolidatedStatementsOfCashFlows": { "order": 5.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The cash outflow for debt initially having maturity due after one year or beyond the normal operating cycle, if longer.", "label": "Repayments of Long-term Debt", "negatedLabel": "Principal payments on long-term debt" } } }, "localname": "RepaymentsOfLongTermDebt", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.innovage.com/role/StatementCondensedConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_RestrictedCashCurrent": { "auth_ref": [ "r4", "r9", "r93" ], "calculation": { "http://www.innovage.com/role/StatementCondensedConsolidatedBalanceSheets": { "order": 2.0, "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cash restricted as to withdrawal or usage, classified as current. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits.", "label": "Restricted Cash, Current", "terseLabel": "Restricted cash" } } }, "localname": "RestrictedCashCurrent", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.innovage.com/role/StatementCondensedConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_RestrictedStockUnitsRSUMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Share instrument which is convertible to stock or an equivalent amount of cash, after a specified period of time or when specified performance conditions are met.", "label": "Restricted Stock Units R S U [Member]", "terseLabel": "Restricted Stock Units" } } }, "localname": "RestrictedStockUnitsRSUMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.innovage.com/role/DisclosureStockBasedCompensation2021OmnibusIncentivePlanDetails", "http://www.innovage.com/role/DisclosureStockBasedCompensation2021OmnibusIncentivePlanRsuActivityDetails", "http://www.innovage.com/role/DisclosureStockBasedCompensationCompensationExpenseDetails", "http://www.innovage.com/role/DisclosureStockBasedCompensationMonteCarloOptionPricingModelDetails" ], "xbrltype": "domainItemType" }, "us-gaap_RetainedEarningsAccumulatedDeficit": { "auth_ref": [ "r25", "r231", "r289", "r420", "r439", "r444" ], "calculation": { "http://www.innovage.com/role/StatementCondensedConsolidatedBalanceSheets": { "order": 3.0, "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The cumulative amount of the reporting entity's undistributed earnings or deficit.", "label": "Retained Earnings (Accumulated Deficit)", "terseLabel": "Retained earnings" } } }, "localname": "RetainedEarningsAccumulatedDeficit", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.innovage.com/role/DisclosureSummaryOfSignificantAccountingPoliciesEffectOfRestatementOnConsolidatedBalanceSheetDetails", "http://www.innovage.com/role/StatementCondensedConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_RetainedEarningsMember": { "auth_ref": [ "r101", "r102", "r104", "r106", "r112", "r115", "r178", "r286", "r287", "r288", "r300", "r301", "r435", "r437" ], "lang": { "en-us": { "role": { "documentation": "The cumulative amount of the reporting entity's undistributed earnings or deficit.", "label": "Retained Earnings [Member]", "terseLabel": "Retained Earnings (Deficit)" } } }, "localname": "RetainedEarningsMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.innovage.com/role/DisclosureSummaryOfSignificantAccountingPoliciesEffectOfRestatementOnConsolidatedStatementsOfStockholdersEquityDetails", "http://www.innovage.com/role/StatementCondensedConsolidatedStatementsOfStockholdersEquity" ], "xbrltype": "domainItemType" }, "us-gaap_RevenueFromContractWithCustomerAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Revenue Recognition" } } }, "localname": "RevenueFromContractWithCustomerAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "xbrltype": "stringItemType" }, "us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax": { "auth_ref": [ "r139", "r140", "r153", "r159", "r160", "r166", "r167", "r169", "r243", "r244", "r385" ], "calculation": { "http://www.innovage.com/role/StatementCondensedConsolidatedStatementsOfOperations": { "order": 2.0, "parentTag": "us-gaap_OperatingIncomeLoss", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.", "label": "Revenue from Contract with Customer, Including Assessed Tax", "terseLabel": "Total revenues" } } }, "localname": "RevenueFromContractWithCustomerExcludingAssessedTax", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.innovage.com/role/DisclosureSegmentReportingOperatingResultsDetails", "http://www.innovage.com/role/StatementCondensedConsolidatedStatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_RevenueFromContractWithCustomerMember": { "auth_ref": [ "r132", "r169" ], "lang": { "en-us": { "role": { "documentation": "Revenue from satisfaction of performance obligation by transferring promised product and service to customer, when it serves as benchmark in concentration of risk calculation.", "label": "Revenue From Contract With Customer [Member]", "terseLabel": "Capitated revenues" } } }, "localname": "RevenueFromContractWithCustomerMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.innovage.com/role/DisclosureRevenueRecognitionDetails", "http://www.innovage.com/role/DisclosureRevenueRecognitionSourceOfRevenueDetails" ], "xbrltype": "domainItemType" }, "us-gaap_RevenueFromContractWithCustomerTextBlock": { "auth_ref": [ "r235", "r236", "r237", "r238", "r239", "r240", "r241", "r242", "r245", "r253" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure of revenue from contract with customer to transfer good or service and to transfer nonfinancial asset. Includes, but is not limited to, disaggregation of revenue, credit loss recognized from contract with customer, judgment and change in judgment related to contract with customer, and asset recognized from cost incurred to obtain or fulfill contract with customer. Excludes insurance and lease contracts.", "label": "Revenue from Contract with Customer [Text Block]", "terseLabel": "Revenue Recognition" } } }, "localname": "RevenueFromContractWithCustomerTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.innovage.com/role/DisclosureRevenueRecognition" ], "xbrltype": "textBlockItemType" }, "us-gaap_RevenueFromRelatedParties": { "auth_ref": [ "r64", "r446" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of revenue, fees and commissions earned from transactions between (a) a parent company and its subsidiaries; (b) subsidiaries of a common parent; (c) an entity and trusts for the benefit of employees, for example, but not limited to, pension and profit-sharing trusts that are managed by or under the trusteeship of the entity's management; (d) an entity and its principal, owners, management, or members of their immediate families; and (e) affiliates.", "label": "Revenue from Related Parties", "terseLabel": "Revenue from related parties" } } }, "localname": "RevenueFromRelatedParties", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.innovage.com/role/DisclosureRelatedPartyDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_RevenuesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Revenues [Abstract]", "verboseLabel": "Revenues" } } }, "localname": "RevenuesAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.innovage.com/role/StatementCondensedConsolidatedStatementsOfOperations" ], "xbrltype": "stringItemType" }, "us-gaap_RevolvingCreditFacilityMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Arrangement in which loan proceeds can continuously be obtained following repayments, but the total amount borrowed cannot exceed a specified maximum amount.", "label": "Revolving Credit Facility [Member]", "terseLabel": "Revolving credit facility" } } }, "localname": "RevolvingCreditFacilityMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.innovage.com/role/DisclosureLongTermDebtDetails", "http://www.innovage.com/role/DisclosureLongTermDebtScheduleOfLongTermDebtDetails" ], "xbrltype": "domainItemType" }, "us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock": { "auth_ref": [ "r48" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the various types of trade accounts and notes receivable and for each the gross carrying value, allowance, and net carrying value as of the balance sheet date. Presentation is categorized by current, noncurrent and unclassified receivables.", "label": "Schedule of Accounts, Notes, Loans and Financing Receivable [Table Text Block]", "terseLabel": "Schedule of concentration of net receivable" } } }, "localname": "ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.innovage.com/role/DisclosureRevenueRecognitionTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfCapitalLeasedAsssetsTableTextBlock": { "auth_ref": [ "r362" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of long-lived, depreciable assets that are subject to a lease meeting the criteria for capitalization and are used in the normal conduct of business to produce goods and services. Examples may include land, buildings, machinery and equipment, and other types of furniture and equipment including, but not limited to, office equipment, furniture and fixtures, and computer equipment and software.", "label": "Schedule of Capital Leased Assets [Table Text Block]", "terseLabel": "Schedule of Company's capital leases" } } }, "localname": "ScheduleOfCapitalLeasedAsssetsTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.innovage.com/role/DisclosureLeasesTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfDebtInstrumentsTextBlock": { "auth_ref": [ "r42", "r99", "r226", "r227", "r228", "r229", "r353", "r354", "r356", "r417" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of long-debt instruments or arrangements, including identification, terms, features, collateral requirements and other information necessary to a fair presentation. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the entity, if longer.", "label": "Schedule of Long-term Debt Instruments [Table Text Block]", "terseLabel": "Schedule of long-term debt" } } }, "localname": "ScheduleOfDebtInstrumentsTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.innovage.com/role/DisclosureLongTermDebtTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock": { "auth_ref": [ "r122" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of an entity's basic and diluted earnings per share calculations, including a reconciliation of numerators and denominators of the basic and diluted per-share computations for income from continuing operations.", "label": "Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]", "terseLabel": "Schedule of earnings per share" } } }, "localname": "ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.innovage.com/role/DisclosureEarningsPerShareTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfErrorCorrectionsAndPriorPeriodAdjustmentRestatementTable": { "auth_ref": [ "r103", "r107", "r108", "r111", "r112", "r114", "r115", "r126" ], "lang": { "en-us": { "role": { "documentation": "Schedule of prior period adjustments to correct an error in previously issued financial statements. The disclosure may include, but is not limited to: (1) the effect of the correction on each financial statement line item and any per-share amounts affected for each prior period presented (2) the cumulative effect of the change on retained earnings or other appropriate components of equity or net assets in the statement of financial position, as of the beginning of the earliest period presented, and (3) the effect of the prior period adjustment (both gross and net of applicable income tax) on the net income of each prior period presented in the entity's annual report for the year in which the adjustments are made. This table can be used to disclose the amounts as previously reported and the effect of the correction or other adjustment on per line item or per share amount basis. This table uses as its line items financial statement line items that are affected by prior period adjustments.", "label": "Schedule of Error Corrections and Prior Period Adjustment Restatement [Table]" } } }, "localname": "ScheduleOfErrorCorrectionsAndPriorPeriodAdjustmentRestatementTable", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.innovage.com/role/DisclosureSummaryOfSignificantAccountingPoliciesEffectOfRestatementOnConsolidatedBalanceSheetDetails", "http://www.innovage.com/role/DisclosureSummaryOfSignificantAccountingPoliciesEffectOfRestatementOnConsolidatedStatementsOfStockholdersEquityDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfErrorCorrectionsAndPriorPeriodAdjustmentsTextBlock": { "auth_ref": [ "r113", "r114", "r115" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of prior period adjustments to previously issued financial statements including (1) the effect of the correction on each financial statement line item and any per-share amounts affected for each prior period presented (2) the cumulative effect of the change on retained earnings or other appropriate components of equity or net assets in the statement of financial position, as of the beginning of the earliest period presented, and (3) the effect of the prior period adjustments (both gross and net of applicable income tax) on the net income of each prior period presented in the entity's annual report for the year in which the adjustments are made.", "label": "Schedule of Error Corrections and Prior Period Adjustments [Table Text Block]", "terseLabel": "Schedule of effect of restatement on financial statements" } } }, "localname": "ScheduleOfErrorCorrectionsAndPriorPeriodAdjustmentsTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.innovage.com/role/DisclosureSummaryOfSignificantAccountingPoliciesTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfFutureMinimumLeasePaymentsForCapitalLeasesTableTextBlock": { "auth_ref": [ "r363" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of future minimum lease payments as of the date of the latest balance sheet presented, in aggregate and for each of the five years succeeding fiscal years, with separate deductions from the total for the amount representing executor costs, including any profit thereon, included in the minimum lease payments and for the amount of the imputed interest necessary to reduce the net minimum lease payments to present value.", "label": "Schedule of Future Minimum Lease Payments for Capital Leases [Table Text Block]", "terseLabel": "Schedule of capital lease obligations" } } }, "localname": "ScheduleOfFutureMinimumLeasePaymentsForCapitalLeasesTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.innovage.com/role/DisclosureLeasesTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock": { "auth_ref": [ "r360" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of future minimum payments required in the aggregate and for each of the five succeeding fiscal years for operating leases having initial or remaining noncancelable lease terms in excess of one year and the total minimum rentals to be received in the future under noncancelable subleases as of the balance sheet date.", "label": "Schedule of Future Minimum Rental Payments for Operating Leases [Table Text Block]", "terseLabel": "Schedule of operating lease minimum lease payments" } } }, "localname": "ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.innovage.com/role/DisclosureLeasesTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfOperatingLeasedAssetsTable": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Schedule of long-lived, depreciable assets that are subject to a operating lease agreements and are used in the normal conduct of business to produce goods and services. Examples may include land, buildings, machinery and equipment, and other types of furniture and equipment including, but not limited to, office equipment, furniture and fixtures, and computer equipment and software.", "label": "Schedule of Operating Leased Assets [Table]" } } }, "localname": "ScheduleOfOperatingLeasedAssetsTable", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.innovage.com/role/DisclosureLeasesAssetsUnderLeaseDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfOtherShareBasedCompensationActivityTableTextBlock": { "auth_ref": [ "r271" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of activity for outstanding award under share-based payment arrangement excluding share and unit options and nonvested award.", "label": "Share-based Payment Arrangement, Outstanding Award, Activity, Excluding Option [Table Text Block]", "terseLabel": "Summary of profits interests transactions and number of units outstanding" } } }, "localname": "ScheduleOfOtherShareBasedCompensationActivityTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.innovage.com/role/DisclosureStockBasedCompensationTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfPropertyPlantAndEquipmentTable": { "auth_ref": [ "r35", "r202" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of information about physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation.", "label": "Property, Plant and Equipment [Table]" } } }, "localname": "ScheduleOfPropertyPlantAndEquipmentTable", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.innovage.com/role/DisclosureSummaryOfSignificantAccountingPoliciesPropertyAndEquipmentDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable": { "auth_ref": [ "r98", "r372", "r373" ], "lang": { "en-us": { "role": { "documentation": "Schedule of quantitative and qualitative information pertaining to related party transactions. Examples of related party transactions include transactions between (a) a parent company and its subsidiary; (b) subsidiaries of a common parent; (c) and entity and its principal owners; and (d) affiliates.", "label": "Schedule of Related Party Transactions, by Related Party [Table]" } } }, "localname": "ScheduleOfRelatedPartyTransactionsByRelatedPartyTable", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.innovage.com/role/DisclosureRelatedPartyDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable": { "auth_ref": [ "r148", "r151", "r157", "r189" ], "lang": { "en-us": { "role": { "documentation": "A table disclosing the profit or loss and total assets for each reportable segment of the entity. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss.", "label": "Schedule of Segment Reporting Information, by Segment [Table]" } } }, "localname": "ScheduleOfSegmentReportingInformationBySegmentTable", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.innovage.com/role/DisclosureBusinessDetails", "http://www.innovage.com/role/DisclosureSegmentReportingDetails", "http://www.innovage.com/role/DisclosureSegmentReportingOperatingResultsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock": { "auth_ref": [ "r148", "r151", "r157", "r189" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the profit or loss and total assets for each reportable segment. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss.", "label": "Schedule of Segment Reporting Information, by Segment [Table Text Block]", "terseLabel": "Schedule of operating results by reportable segments" } } }, "localname": "ScheduleOfSegmentReportingInformationBySegmentTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.innovage.com/role/DisclosureSegmentReportingTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable": { "auth_ref": [ "r263", "r285" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of information about share-based payment arrangement.", "label": "Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table]" } } }, "localname": "ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.innovage.com/role/DisclosureEquityDetails", "http://www.innovage.com/role/DisclosureStockBasedCompensation2021OmnibusIncentivePlanDetails", "http://www.innovage.com/role/DisclosureStockBasedCompensation2021OmnibusIncentivePlanRsuActivityDetails", "http://www.innovage.com/role/DisclosureStockBasedCompensationCompensationExpenseDetails", "http://www.innovage.com/role/DisclosureStockBasedCompensationEquityIncentivePlanDetails", "http://www.innovage.com/role/DisclosureStockBasedCompensationMonteCarloOptionPricingModelDetails", "http://www.innovage.com/role/DisclosureStockBasedCompensationPerformanceBasedAwardsDetails", "http://www.innovage.com/role/DisclosureStockBasedCompensationProfitsInterestsDetails", "http://www.innovage.com/role/DisclosureStockBasedCompensationProfitsInterestsTransactionsAndNumberOfUnitsOutstandingDetails", "http://www.innovage.com/role/DisclosureStockBasedCompensationTables", "http://www.innovage.com/role/DisclosureStockBasedCompensationTimeBasedAwardsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock": { "auth_ref": [ "r267" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the number and weighted-average grant date fair value for restricted stock units that were outstanding at the beginning and end of the year, and the number of restricted stock units that were granted, vested, or forfeited during the year.", "label": "Share-based Payment Arrangement, Restricted Stock Unit, Activity [Table Text Block]", "verboseLabel": "Summary of restricted stock units activity" } } }, "localname": "ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.innovage.com/role/DisclosureStockBasedCompensationTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock": { "auth_ref": [ "r267", "r275", "r277" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure for stock option plans. Includes, but is not limited to, outstanding awards at beginning and end of year, grants, exercises, forfeitures, and weighted-average grant date fair value.", "label": "Share-based Payment Arrangement, Option, Activity [Table Text Block]", "terseLabel": "Summary of stock option activity" } } }, "localname": "ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.innovage.com/role/DisclosureStockBasedCompensationTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock": { "auth_ref": [ "r278" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the significant assumptions used during the year to estimate the fair value of stock options, including, but not limited to: (a) expected term of share options and similar instruments, (b) expected volatility of the entity's shares, (c) expected dividends, (d) risk-free rate(s), and (e) discount for post-vesting restrictions.", "label": "Schedule of Share-based Payment Award, Stock Options, Valuation Assumptions [Table Text Block]", "verboseLabel": "Summary of weighted-average assumptions" } } }, "localname": "ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.innovage.com/role/DisclosureStockBasedCompensationTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfTradingSecuritiesAndOtherTradingAssetsLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Debt and Equity Securities, FV-NI [Line Items]", "verboseLabel": "Investments" } } }, "localname": "ScheduleOfTradingSecuritiesAndOtherTradingAssetsLineItems", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.innovage.com/role/DisclosureInvestmentsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfTradingSecuritiesAndOtherTradingAssetsTable": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Disclosure of information about investment in debt security measured at fair value with change in fair value recognized in net income (trading) and investment in equity security with change in fair value recognized in net income (FV-NI).", "label": "Debt Securities, Trading, and Equity Securities, FV-NI [Table]" } } }, "localname": "ScheduleOfTradingSecuritiesAndOtherTradingAssetsTable", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.innovage.com/role/DisclosureInvestmentsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_SegmentDomain": { "auth_ref": [ "r135", "r139", "r140", "r141", "r142", "r143", "r144", "r145", "r146", "r147", "r148", "r149", "r150", "r153", "r154", "r155", "r156", "r158", "r159", "r160", "r161", "r162", "r164", "r169", "r430" ], "lang": { "en-us": { "role": { "documentation": "Components of an entity that engage in business activities from which they may earn revenue and incur expenses, including transactions with other components of the same entity.", "label": "Segment [Domain]", "terseLabel": "Segments [Domain]" } } }, "localname": "SegmentDomain", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.innovage.com/role/DisclosureBusinessDetails", "http://www.innovage.com/role/DisclosureSegmentReportingDetails", "http://www.innovage.com/role/DisclosureSegmentReportingOperatingResultsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_SegmentReportingAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Segment Reporting" } } }, "localname": "SegmentReportingAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "xbrltype": "stringItemType" }, "us-gaap_SegmentReportingDisclosureTextBlock": { "auth_ref": [ "r135", "r137", "r138", "r148", "r152", "r158", "r162", "r163", "r164", "r165", "r166", "r168", "r169", "r170" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for reporting segments including data and tables. Reportable segments include those that meet any of the following quantitative thresholds a) it's reported revenue, including sales to external customers and intersegment sales or transfers is 10 percent or more of the combined revenue, internal and external, of all operating segments b) the absolute amount of its reported profit or loss is 10 percent or more of the greater, in absolute amount of 1) the combined reported profit of all operating segments that did not report a loss or 2) the combined reported loss of all operating segments that did report a loss c) its assets are 10 percent or more of the combined assets of all operating segments.", "label": "Segment Reporting Disclosure [Text Block]", "terseLabel": "Segment Reporting" } } }, "localname": "SegmentReportingDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.innovage.com/role/DisclosureSegmentReporting" ], "xbrltype": "textBlockItemType" }, "us-gaap_SegmentReportingInformationLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Segment Reporting Information [Line Items]" } } }, "localname": "SegmentReportingInformationLineItems", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.innovage.com/role/DisclosureBusinessDetails", "http://www.innovage.com/role/DisclosureSegmentReportingDetails", "http://www.innovage.com/role/DisclosureSegmentReportingOperatingResultsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_SellingAndMarketingExpense": { "auth_ref": [], "calculation": { "http://www.innovage.com/role/StatementCondensedConsolidatedStatementsOfOperations": { "order": 3.0, "parentTag": "us-gaap_CostsAndExpenses", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The aggregate total amount of expenses directly related to the marketing or selling of products or services.", "label": "Selling and Marketing Expense", "terseLabel": "Sales and marketing" } } }, "localname": "SellingAndMarketingExpense", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.innovage.com/role/StatementCondensedConsolidatedStatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_SellingGeneralAndAdministrativeExpense": { "auth_ref": [ "r69" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The aggregate total costs related to selling a firm's product and services, as well as all other general and administrative expenses. Direct selling expenses (for example, credit, warranty, and advertising) are expenses that can be directly linked to the sale of specific products. Indirect selling expenses are expenses that cannot be directly linked to the sale of specific products, for example telephone expenses, Internet, and postal charges. General and administrative expenses include salaries of non-sales personnel, rent, utilities, communication, etc.", "label": "Selling, General and Administrative Expense", "terseLabel": "Corporate, general and administrative expense" } } }, "localname": "SellingGeneralAndAdministrativeExpense", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.innovage.com/role/DisclosureEquityDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_SeniorLoansMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "A senior loan takes priority over other debt securities sold by the issuer. In the event the issuer goes bankrupt, senior debt holders receive priority for [must receive] repayment [prior] relative to junior and unsecured (general) creditors.", "label": "Senior Loans [Member]", "terseLabel": "Senior secured term loan" } } }, "localname": "SeniorLoansMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.innovage.com/role/DisclosureLongTermDebtDetails", "http://www.innovage.com/role/DisclosureLongTermDebtScheduleOfLongTermDebtDetails" ], "xbrltype": "domainItemType" }, "us-gaap_ServiceOtherMember": { "auth_ref": [ "r246" ], "lang": { "en-us": { "role": { "documentation": "Assistance, including, but not limited to, technology, license and maintenance, license and service, maintenance, oil and gas, financial service, and other financial service, classified as other.", "label": "Service Other [Member]", "terseLabel": "Deposits and other" } } }, "localname": "ServiceOtherMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.innovage.com/role/DisclosureRelatedPartyDetails" ], "xbrltype": "domainItemType" }, "us-gaap_ShareBasedCompensation": { "auth_ref": [ "r88" ], "calculation": { "http://www.innovage.com/role/StatementCondensedConsolidatedStatementsOfCashFlows": { "order": 9.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of noncash expense for share-based payment arrangement.", "label": "Share-based Payment Arrangement, Noncash Expense", "terseLabel": "Stock-based compensation" } } }, "localname": "ShareBasedCompensation", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.innovage.com/role/StatementCondensedConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1": { "auth_ref": [ "r264" ], "lang": { "en-us": { "role": { "documentation": "Period over which grantee's right to exercise award under share-based payment arrangement is no longer contingent on satisfaction of service or performance condition, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days. Includes, but is not limited to, combination of market, performance or service condition.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Period", "verboseLabel": "Vesting period" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.innovage.com/role/DisclosureStockBasedCompensation2021OmnibusIncentivePlanDetails" ], "xbrltype": "durationItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod": { "auth_ref": [ "r270" ], "lang": { "en-us": { "role": { "documentation": "The number of equity-based payment instruments, excluding stock (or unit) options, that were forfeited during the reporting period.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeited in Period", "negatedLabel": "Forfeited" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.innovage.com/role/DisclosureStockBasedCompensation2021OmnibusIncentivePlanRsuActivityDetails", "http://www.innovage.com/role/DisclosureStockBasedCompensationProfitsInterestsTransactionsAndNumberOfUnitsOutstandingDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue": { "auth_ref": [ "r274" ], "lang": { "en-us": { "role": { "documentation": "Weighted average fair value as of the grant date of equity-based award plans other than stock (unit) option plans that were not exercised or put into effect as a result of the occurrence of a terminating event.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeitures, Weighted Average Grant Date Fair Value", "verboseLabel": "Forfeited" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.innovage.com/role/DisclosureStockBasedCompensation2021OmnibusIncentivePlanRsuActivityDetails", "http://www.innovage.com/role/DisclosureStockBasedCompensationProfitsInterestsTransactionsAndNumberOfUnitsOutstandingDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod": { "auth_ref": [ "r273" ], "lang": { "en-us": { "role": { "documentation": "The number of grants made during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period", "terseLabel": "Profits interests granted", "verboseLabel": "Granted" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.innovage.com/role/DisclosureStockBasedCompensation2021OmnibusIncentivePlanRsuActivityDetails", "http://www.innovage.com/role/DisclosureStockBasedCompensationProfitsInterestsDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue": { "auth_ref": [ "r273" ], "lang": { "en-us": { "role": { "documentation": "The weighted average fair value at grant date for nonvested equity-based awards issued during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value", "terseLabel": "Granted" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.innovage.com/role/DisclosureStockBasedCompensation2021OmnibusIncentivePlanRsuActivityDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber": { "auth_ref": [ "r272" ], "lang": { "en-us": { "role": { "documentation": "The number of non-vested equity-based payment instruments, excluding stock (or unit) options, that validly exist and are outstanding as of the balance sheet date.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number", "periodEndLabel": "Outstanding balance, March 31, 2022", "periodStartLabel": "Outstanding balance, June 30, 2021" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.innovage.com/role/DisclosureStockBasedCompensation2021OmnibusIncentivePlanRsuActivityDetails", "http://www.innovage.com/role/DisclosureStockBasedCompensationProfitsInterestsTransactionsAndNumberOfUnitsOutstandingDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward]", "terseLabel": "Number of Units" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.innovage.com/role/DisclosureStockBasedCompensation2021OmnibusIncentivePlanRsuActivityDetails", "http://www.innovage.com/role/DisclosureStockBasedCompensationProfitsInterestsTransactionsAndNumberOfUnitsOutstandingDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue": { "auth_ref": [ "r272" ], "lang": { "en-us": { "role": { "documentation": "Per share or unit weighted-average fair value of nonvested award under share-based payment arrangement. Excludes share and unit options.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value", "periodEndLabel": "Outstanding balance, March 31, 2022", "periodStartLabel": "Outstanding balance, June 30, 2021" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.innovage.com/role/DisclosureStockBasedCompensation2021OmnibusIncentivePlanRsuActivityDetails", "http://www.innovage.com/role/DisclosureStockBasedCompensationProfitsInterestsTransactionsAndNumberOfUnitsOutstandingDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value [Abstract]", "terseLabel": "Weighted-Average Grant Date FV" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.innovage.com/role/DisclosureStockBasedCompensation2021OmnibusIncentivePlanRsuActivityDetails", "http://www.innovage.com/role/DisclosureStockBasedCompensationProfitsInterestsTransactionsAndNumberOfUnitsOutstandingDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate": { "auth_ref": [ "r281" ], "lang": { "en-us": { "role": { "documentation": "The estimated dividend rate (a percentage of the share price) to be paid (expected dividends) to holders of the underlying shares over the option's term.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Rate", "terseLabel": "Dividend yield" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.innovage.com/role/DisclosureStockBasedCompensationMonteCarloOptionPricingModelDetails", "http://www.innovage.com/role/DisclosureStockBasedCompensationProfitsInterestsDetails" ], "xbrltype": "percentItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate": { "auth_ref": [ "r280" ], "lang": { "en-us": { "role": { "documentation": "The estimated measure of the percentage by which a share price is expected to fluctuate during a period. Volatility also may be defined as a probability-weighted measure of the dispersion of returns about the mean. The volatility of a share price is the standard deviation of the continuously compounded rates of return on the share over a specified period. That is the same as the standard deviation of the differences in the natural logarithms of the stock prices plus dividends, if any, over the period.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate", "terseLabel": "Expected volatility" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.innovage.com/role/DisclosureStockBasedCompensationMonteCarloOptionPricingModelDetails" ], "xbrltype": "percentItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The maximum risk-free interest rate assumption that is used in valuing an option on its own shares.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate, Maximum", "terseLabel": "Interest rate" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.innovage.com/role/DisclosureStockBasedCompensationMonteCarloOptionPricingModelDetails" ], "xbrltype": "percentItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Share-based Compensation Arrangement by Share-based Payment Award [Line Items]" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.innovage.com/role/DisclosureEquityDetails", "http://www.innovage.com/role/DisclosureStockBasedCompensation2021OmnibusIncentivePlanDetails", "http://www.innovage.com/role/DisclosureStockBasedCompensation2021OmnibusIncentivePlanRsuActivityDetails", "http://www.innovage.com/role/DisclosureStockBasedCompensationCompensationExpenseDetails", "http://www.innovage.com/role/DisclosureStockBasedCompensationEquityIncentivePlanDetails", "http://www.innovage.com/role/DisclosureStockBasedCompensationMonteCarloOptionPricingModelDetails", "http://www.innovage.com/role/DisclosureStockBasedCompensationPerformanceBasedAwardsDetails", "http://www.innovage.com/role/DisclosureStockBasedCompensationProfitsInterestsDetails", "http://www.innovage.com/role/DisclosureStockBasedCompensationProfitsInterestsTransactionsAndNumberOfUnitsOutstandingDetails", "http://www.innovage.com/role/DisclosureStockBasedCompensationTables", "http://www.innovage.com/role/DisclosureStockBasedCompensationTimeBasedAwardsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized": { "auth_ref": [ "r265" ], "lang": { "en-us": { "role": { "documentation": "Number of shares authorized for issuance under share-based payment arrangement.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Authorized", "terseLabel": "Number of shares authorized" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.innovage.com/role/DisclosureStockBasedCompensation2021OmnibusIncentivePlanDetails", "http://www.innovage.com/role/DisclosureStockBasedCompensationEquityIncentivePlanDetails", "http://www.innovage.com/role/DisclosureStockBasedCompensationProfitsInterestsDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod": { "auth_ref": [ "r270" ], "lang": { "en-us": { "role": { "documentation": "The number of shares under options that were cancelled during the reporting period as a result of occurrence of a terminating event specified in contractual agreements pertaining to the stock option plan.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period", "terseLabel": "Number of shares cancelled", "verboseLabel": "Forfeited (in shares)" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.innovage.com/role/DisclosureStockBasedCompensationEquityIncentivePlanDetails", "http://www.innovage.com/role/DisclosureStockBasedCompensationPerformanceBasedAwardsDetails", "http://www.innovage.com/role/DisclosureStockBasedCompensationTimeBasedAwardsDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Gross number of share options (or share units) granted during the period.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross", "terseLabel": "Granted (in shares)" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.innovage.com/role/DisclosureStockBasedCompensationEquityIncentivePlanDetails", "http://www.innovage.com/role/DisclosureStockBasedCompensationPerformanceBasedAwardsDetails", "http://www.innovage.com/role/DisclosureStockBasedCompensationProfitsInterestsDetails", "http://www.innovage.com/role/DisclosureStockBasedCompensationTimeBasedAwardsDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber": { "auth_ref": [ "r269", "r285" ], "lang": { "en-us": { "role": { "documentation": "Number of options outstanding, including both vested and non-vested options.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number", "periodEndLabel": "Outstanding balance, March 31, 2022", "periodStartLabel": "Outstanding balance, June 30, 2021" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.innovage.com/role/DisclosureStockBasedCompensationPerformanceBasedAwardsDetails", "http://www.innovage.com/role/DisclosureStockBasedCompensationTimeBasedAwardsDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding [Roll Forward]", "terseLabel": "Number of Options" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.innovage.com/role/DisclosureStockBasedCompensationPerformanceBasedAwardsDetails", "http://www.innovage.com/role/DisclosureStockBasedCompensationTimeBasedAwardsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice": { "auth_ref": [ "r268" ], "lang": { "en-us": { "role": { "documentation": "Weighted average price at which grantees can acquire the shares reserved for issuance under the stock option plan.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price", "periodEndLabel": "Outstanding balance, March 31, 2022", "periodStartLabel": "Outstanding balance, June 30, 2021", "terseLabel": "Outstanding balance, June 30, 2021" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.innovage.com/role/DisclosureStockBasedCompensationPerformanceBasedAwardsDetails", "http://www.innovage.com/role/DisclosureStockBasedCompensationTimeBasedAwardsDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price [Abstract]" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.innovage.com/role/DisclosureStockBasedCompensationPerformanceBasedAwardsDetails", "http://www.innovage.com/role/DisclosureStockBasedCompensationTimeBasedAwardsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain": { "auth_ref": [ "r260", "r266" ], "lang": { "en-us": { "role": { "documentation": "Award under share-based payment arrangement.", "label": "Share Based Compensation Arrangements By Share Based Payment Award Award Type And Plan Name [Domain]", "terseLabel": "Award Type [Domain]" } } }, "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.innovage.com/role/DisclosureEquityDetails", "http://www.innovage.com/role/DisclosureStockBasedCompensation2021OmnibusIncentivePlanDetails", "http://www.innovage.com/role/DisclosureStockBasedCompensation2021OmnibusIncentivePlanRsuActivityDetails", "http://www.innovage.com/role/DisclosureStockBasedCompensationCompensationExpenseDetails", "http://www.innovage.com/role/DisclosureStockBasedCompensationMonteCarloOptionPricingModelDetails", "http://www.innovage.com/role/DisclosureStockBasedCompensationPerformanceBasedAwardsDetails", "http://www.innovage.com/role/DisclosureStockBasedCompensationProfitsInterestsTransactionsAndNumberOfUnitsOutstandingDetails", "http://www.innovage.com/role/DisclosureStockBasedCompensationTables", "http://www.innovage.com/role/DisclosureStockBasedCompensationTimeBasedAwardsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Weighted average per share amount at which grantees can acquire shares of common stock by exercise of options.", "label": "Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price", "terseLabel": "Granted" } } }, "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.innovage.com/role/DisclosureStockBasedCompensationPerformanceBasedAwardsDetails", "http://www.innovage.com/role/DisclosureStockBasedCompensationTimeBasedAwardsDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_SharePrice": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Price of a single share of a number of saleable stocks of a company.", "label": "Share Price", "terseLabel": "Fair value of underlying stock" } } }, "localname": "SharePrice", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.innovage.com/role/DisclosureStockBasedCompensationMonteCarloOptionPricingModelDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage": { "auth_ref": [ "r264" ], "lang": { "en-us": { "role": { "documentation": "Percentage of vesting of award under share-based payment arrangement.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Rights, Percentage", "terseLabel": "Percentage of vesting" } } }, "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.innovage.com/role/DisclosureStockBasedCompensation2021OmnibusIncentivePlanDetails", "http://www.innovage.com/role/DisclosureStockBasedCompensationEquityIncentivePlanDetails" ], "xbrltype": "percentItemType" }, "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1": { "auth_ref": [ "r279", "r290" ], "lang": { "en-us": { "role": { "documentation": "Expected term of award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Term", "verboseLabel": "Expected term (in years)" } } }, "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.innovage.com/role/DisclosureStockBasedCompensationMonteCarloOptionPricingModelDetails" ], "xbrltype": "durationItemType" }, "us-gaap_SharesOutstanding": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Number of shares issued which are neither cancelled nor held in the treasury.", "label": "Shares, Outstanding", "periodEndLabel": "Balances, Ending (in shares)", "periodStartLabel": "Balances, Beginning (in shares)" } } }, "localname": "SharesOutstanding", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.innovage.com/role/StatementCondensedConsolidatedStatementsOfStockholdersEquity" ], "xbrltype": "sharesItemType" }, "us-gaap_SoftwareAndSoftwareDevelopmentCostsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Purchased software applications and internally developed software for sale, licensing or long-term internal use.", "label": "Software And Software Development Costs [Member]", "terseLabel": "Software" } } }, "localname": "SoftwareAndSoftwareDevelopmentCostsMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.innovage.com/role/DisclosureSummaryOfSignificantAccountingPoliciesPropertyAndEquipmentDetails" ], "xbrltype": "domainItemType" }, "us-gaap_StatementBusinessSegmentsAxis": { "auth_ref": [ "r1", "r135", "r139", "r140", "r141", "r142", "r143", "r144", "r145", "r146", "r147", "r148", "r149", "r150", "r153", "r154", "r155", "r156", "r158", "r159", "r160", "r161", "r162", "r164", "r169", "r189", "r204", "r205", "r206", "r430" ], "lang": { "en-us": { "role": { "documentation": "Information by business segments.", "label": "Segments [Axis]" } } }, "localname": "StatementBusinessSegmentsAxis", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.innovage.com/role/DisclosureBusinessDetails", "http://www.innovage.com/role/DisclosureSegmentReportingDetails", "http://www.innovage.com/role/DisclosureSegmentReportingOperatingResultsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_StatementEquityComponentsAxis": { "auth_ref": [ "r46", "r101", "r102", "r104", "r106", "r112", "r115", "r129", "r178", "r225", "r231", "r286", "r287", "r288", "r300", "r301", "r346", "r347", "r348", "r349", "r350", "r351", "r435", "r436", "r437" ], "lang": { "en-us": { "role": { "documentation": "Information by component of equity.", "label": "Equity Components [Axis]" } } }, "localname": "StatementEquityComponentsAxis", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.innovage.com/role/DisclosureSummaryOfSignificantAccountingPoliciesEffectOfRestatementOnConsolidatedStatementsOfStockholdersEquityDetails", "http://www.innovage.com/role/StatementCondensedConsolidatedStatementsOfStockholdersEquity" ], "xbrltype": "stringItemType" }, "us-gaap_StatementLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Statement [Line Items]" } } }, "localname": "StatementLineItems", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.innovage.com/role/StatementCondensedConsolidatedStatementsOfOperations", "http://www.innovage.com/role/StatementCondensedConsolidatedStatementsOfStockholdersEquity" ], "xbrltype": "stringItemType" }, "us-gaap_StatementOfCashFlowsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Condensed Consolidated Statements of Cash Flows" } } }, "localname": "StatementOfCashFlowsAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "xbrltype": "stringItemType" }, "us-gaap_StatementOfFinancialPositionAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Condensed Consolidated Balance Sheets" } } }, "localname": "StatementOfFinancialPositionAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "xbrltype": "stringItemType" }, "us-gaap_StatementOfStockholdersEquityAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Condensed Consolidated Statements of Stockholders' Equity" } } }, "localname": "StatementOfStockholdersEquityAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "xbrltype": "stringItemType" }, "us-gaap_StatementTable": { "auth_ref": [ "r101", "r102", "r104", "r129", "r385" ], "lang": { "en-us": { "role": { "documentation": "Schedule reflecting a Statement of Income, Statement of Cash Flows, Statement of Financial Position, Statement of Shareholders' Equity and Other Comprehensive Income, or other statement as needed.", "label": "Statement [Table]" } } }, "localname": "StatementTable", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.innovage.com/role/StatementCondensedConsolidatedStatementsOfOperations", "http://www.innovage.com/role/StatementCondensedConsolidatedStatementsOfStockholdersEquity" ], "xbrltype": "stringItemType" }, "us-gaap_StockIssuedDuringPeriodSharesNewIssues": { "auth_ref": [ "r21", "r22", "r225", "r231" ], "lang": { "en-us": { "role": { "documentation": "Number of new stock issued during the period.", "label": "Stock Issued During Period, Shares, New Issues", "terseLabel": "Common stock issued", "verboseLabel": "Initial public offering of common stock, net of offering costs (in shares)" } } }, "localname": "StockIssuedDuringPeriodSharesNewIssues", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.innovage.com/role/DisclosureBusinessDetails", "http://www.innovage.com/role/StatementCondensedConsolidatedStatementsOfStockholdersEquity" ], "xbrltype": "sharesItemType" }, "us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation": { "auth_ref": [ "r21", "r22", "r225", "r231" ], "lang": { "en-us": { "role": { "documentation": "Number, after forfeiture, of shares or units issued under share-based payment arrangement. Excludes shares or units issued under employee stock ownership plan (ESOP).", "label": "Shares Issued, Shares, Share-based Payment Arrangement, after Forfeiture", "terseLabel": "Stock-based compensation (in shares)" } } }, "localname": "StockIssuedDuringPeriodSharesShareBasedCompensation", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.innovage.com/role/StatementCondensedConsolidatedStatementsOfStockholdersEquity" ], "xbrltype": "sharesItemType" }, "us-gaap_StockIssuedDuringPeriodValueNewIssues": { "auth_ref": [ "r21", "r22", "r225", "r231" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Equity impact of the value of new stock issued during the period. Includes shares issued in an initial public offering or a secondary public offering.", "label": "Stock Issued During Period, Value, New Issues", "verboseLabel": "Initial public offering of common stock, net of offering costs" } } }, "localname": "StockIssuedDuringPeriodValueNewIssues", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.innovage.com/role/StatementCondensedConsolidatedStatementsOfStockholdersEquity" ], "xbrltype": "monetaryItemType" }, "us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation": { "auth_ref": [ "r21", "r22", "r231", "r262", "r276" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Value, after forfeiture, of shares issued under share-based payment arrangement. Excludes employee stock ownership plan (ESOP).", "label": "Shares Issued, Value, Share-based Payment Arrangement, after Forfeiture", "terseLabel": "Stock-based compensation" } } }, "localname": "StockIssuedDuringPeriodValueShareBasedCompensation", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.innovage.com/role/StatementCondensedConsolidatedStatementsOfStockholdersEquity" ], "xbrltype": "monetaryItemType" }, "us-gaap_StockRepurchasedAndRetiredDuringPeriodShares": { "auth_ref": [ "r21", "r22", "r225", "r231" ], "lang": { "en-us": { "role": { "documentation": "Number of shares that have been repurchased and retired during the period.", "label": "Stock Repurchased and Retired During Period, Shares", "terseLabel": "Shares cancelled (in shares)" } } }, "localname": "StockRepurchasedAndRetiredDuringPeriodShares", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.innovage.com/role/DisclosureEquityDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_StockRepurchasedAndRetiredDuringPeriodValue": { "auth_ref": [ "r21", "r22", "r225", "r231" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Equity impact of the value of stock that has been repurchased and retired during the period. The excess of the purchase price over par value can be charged against retained earnings (once the excess is fully allocated to additional paid in capital).", "label": "Stock Repurchased and Retired During Period, Value", "terseLabel": "Shares cancelled" } } }, "localname": "StockRepurchasedAndRetiredDuringPeriodValue", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.innovage.com/role/DisclosureEquityDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_StockRepurchasedDuringPeriodShares": { "auth_ref": [ "r21", "r22", "r225", "r231" ], "lang": { "en-us": { "role": { "documentation": "Number of shares that have been repurchased during the period and have not been retired and are not held in treasury. Some state laws may govern the circumstances under which an entity may acquire its own stock and prescribe the accounting treatment therefore. This element is used when state law does not recognize treasury stock.", "label": "Stock Repurchased During Period, Shares", "terseLabel": "Repurchase (in shares)" } } }, "localname": "StockRepurchasedDuringPeriodShares", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.innovage.com/role/DisclosureEquityDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_StockRepurchasedDuringPeriodValue": { "auth_ref": [ "r21", "r22", "r225", "r231" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Equity impact of the value of stock that has been repurchased during the period and has not been retired and is not held in treasury. Some state laws may mandate the circumstances under which an entity may acquire its own stock and prescribe the accounting treatment therefore. This element is used when state law does not recognize treasury stock.", "label": "Stock Repurchased During Period, Value", "terseLabel": "Repurchase" } } }, "localname": "StockRepurchasedDuringPeriodValue", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.innovage.com/role/DisclosureEquityDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_StockholdersEquity": { "auth_ref": [ "r22", "r26", "r27", "r96", "r174", "r177", "r344" ], "calculation": { "http://www.innovage.com/role/StatementCondensedConsolidatedBalanceSheets": { "order": 2.0, "parentTag": "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.", "label": "Stockholders' Equity Attributable to Parent", "terseLabel": "Total InnovAge Holding Corp.", "totalLabel": "Total InnovAge Holding Corp." } } }, "localname": "StockholdersEquity", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.innovage.com/role/DisclosureSummaryOfSignificantAccountingPoliciesEffectOfRestatementOnConsolidatedBalanceSheetDetails", "http://www.innovage.com/role/StatementCondensedConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest": { "auth_ref": [ "r96", "r101", "r102", "r104", "r106", "r112", "r177", "r178", "r231", "r286", "r287", "r288", "r300", "r301", "r320", "r321", "r334", "r344", "r346", "r347", "r351", "r436", "r437" ], "calculation": { "http://www.innovage.com/role/StatementCondensedConsolidatedBalanceSheets": { "order": 2.0, "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of stockholders' equity (deficit), net of receivables from officers, directors, owners, and affiliates of the entity, attributable to both the parent and noncontrolling interests. Amount excludes temporary equity. Alternate caption for the concept is permanent equity.", "label": "Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest", "periodEndLabel": "Balances, Ending", "periodStartLabel": "Balances, Beginning", "terseLabel": "Total Stockholders' Equity, Balances", "totalLabel": "Total stockholders' equity", "verboseLabel": "Total stockholders' equity" } } }, "localname": "StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.innovage.com/role/DisclosureSummaryOfSignificantAccountingPoliciesEffectOfRestatementOnConsolidatedBalanceSheetDetails", "http://www.innovage.com/role/DisclosureSummaryOfSignificantAccountingPoliciesEffectOfRestatementOnConsolidatedStatementsOfStockholdersEquityDetails", "http://www.innovage.com/role/StatementCondensedConsolidatedBalanceSheets", "http://www.innovage.com/role/StatementCondensedConsolidatedStatementsOfStockholdersEquity" ], "xbrltype": "monetaryItemType" }, "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest [Abstract]", "terseLabel": "Stockholders' Equity" } } }, "localname": "StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.innovage.com/role/DisclosureSummaryOfSignificantAccountingPoliciesEffectOfRestatementOnConsolidatedBalanceSheetDetails", "http://www.innovage.com/role/StatementCondensedConsolidatedBalanceSheets" ], "xbrltype": "stringItemType" }, "us-gaap_StockholdersEquityNoteDisclosureTextBlock": { "auth_ref": [ "r95", "r231", "r234" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for shareholders' equity comprised of portions attributable to the parent entity and noncontrolling interest, including other comprehensive income. Includes, but is not limited to, balances of common stock, preferred stock, additional paid-in capital, other capital and retained earnings, accumulated balance for each classification of other comprehensive income and amount of comprehensive income.", "label": "Stockholders' Equity Note Disclosure [Text Block]", "terseLabel": "Equity" } } }, "localname": "StockholdersEquityNoteDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.innovage.com/role/DisclosureEquity" ], "xbrltype": "textBlockItemType" }, "us-gaap_SubsequentEventsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Subsequent Events" } } }, "localname": "SubsequentEventsAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "xbrltype": "stringItemType" }, "us-gaap_SubsequentEventsTextBlock": { "auth_ref": [ "r376", "r377" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for significant events or transactions that occurred after the balance sheet date through the date the financial statements were issued or the date the financial statements were available to be issued. Examples include: the sale of a capital stock issue, purchase of a business, settlement of litigation, catastrophic loss, significant foreign exchange rate changes, loans to insiders or affiliates, and transactions not in the ordinary course of business.", "label": "Subsequent Events [Text Block]", "terseLabel": "Subsequent Events" } } }, "localname": "SubsequentEventsTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.innovage.com/role/DisclosureSubsequentEvents" ], "xbrltype": "textBlockItemType" }, "us-gaap_SupplementalCashFlowInformationAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Supplemental Cash Flow Information [Abstract]", "terseLabel": "Supplemental Cash Flows Information" } } }, "localname": "SupplementalCashFlowInformationAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.innovage.com/role/StatementCondensedConsolidatedStatementsOfCashFlows" ], "xbrltype": "stringItemType" }, "us-gaap_TemporaryEquityAccretionToRedemptionValueAdjustment": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of decrease to net income for accretion of temporary equity to its redemption value to derive net income apportioned to common stockholders.", "label": "Temporary Equity, Accretion to Redemption Value, Adjustment", "terseLabel": "Temporary Equity, Accretion to Redemption Value, Adjustment" } } }, "localname": "TemporaryEquityAccretionToRedemptionValueAdjustment", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.innovage.com/role/DisclosureSummaryOfSignificantAccountingPoliciesEffectOfRestatementOnConsolidatedStatementsOfStockholdersEquityDetails", "http://www.innovage.com/role/StatementCondensedConsolidatedStatementsOfStockholdersEquity" ], "xbrltype": "monetaryItemType" }, "us-gaap_TemporaryEquityNetIncome": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The portion of net income or loss attributable to temporary equity interest.", "label": "Temporary Equity, Net Income", "terseLabel": "Net income (loss)" } } }, "localname": "TemporaryEquityNetIncome", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.innovage.com/role/DisclosureSummaryOfSignificantAccountingPoliciesEffectOfRestatementOnConsolidatedStatementsOfStockholdersEquityDetails", "http://www.innovage.com/role/StatementCondensedConsolidatedStatementsOfStockholdersEquity" ], "xbrltype": "monetaryItemType" }, "us-gaap_TemporaryEquityOtherChanges": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of increase (decrease) in temporary equity from changes classified as other.", "label": "Temporary Equity, Other Changes", "terseLabel": "Adjustment to redemption value" } } }, "localname": "TemporaryEquityOtherChanges", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.innovage.com/role/DisclosureSummaryOfSignificantAccountingPoliciesEffectOfRestatementOnConsolidatedStatementsOfStockholdersEquityDetails", "http://www.innovage.com/role/StatementCondensedConsolidatedStatementsOfStockholdersEquity" ], "xbrltype": "monetaryItemType" }, "us-gaap_TreasuryStockCommonShares": { "auth_ref": [ "r233" ], "lang": { "en-us": { "role": { "documentation": "Number of previously issued common shares repurchased by the issuing entity and held in treasury.", "label": "Treasury Stock, Common, Shares", "terseLabel": "Repurchase (in shares)" } } }, "localname": "TreasuryStockCommonShares", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.innovage.com/role/DisclosureStockBasedCompensationEquityIncentivePlanDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_TreasuryStockMember": { "auth_ref": [ "r45", "r233" ], "lang": { "en-us": { "role": { "documentation": "Shares of an entity that have been repurchased by the entity. This stock has no voting rights and receives no dividends. Note that treasury stock may be recorded at its total cost or separately as par (or stated) value and additional paid in capital. Classified within stockholders' equity if nonredeemable or redeemable solely at the option of the issuer. Classified within temporary equity if redemption is outside the control of the issuer.", "label": "Treasury Stock [Member]", "terseLabel": "Treasury Stock" } } }, "localname": "TreasuryStockMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.innovage.com/role/StatementCondensedConsolidatedStatementsOfStockholdersEquity" ], "xbrltype": "domainItemType" }, "us-gaap_TreasuryStockRetiredCostMethodAmount": { "auth_ref": [ "r22", "r225", "r232" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of decrease of par value, additional paid in capital (APIC) and retained earnings of common and preferred stock retired from treasury when treasury stock is accounted for under the cost method.", "label": "Treasury Stock, Retired, Cost Method, Amount", "negatedLabel": "Treasury stock retirement" } } }, "localname": "TreasuryStockRetiredCostMethodAmount", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.innovage.com/role/StatementCondensedConsolidatedStatementsOfStockholdersEquity" ], "xbrltype": "monetaryItemType" }, "us-gaap_TreasuryStockSharesAcquired": { "auth_ref": [ "r22", "r225", "r231" ], "lang": { "en-us": { "role": { "documentation": "Number of shares that have been repurchased during the period and are being held in treasury.", "label": "Treasury Stock, Shares, Acquired", "terseLabel": "Treasury stock transaction (in shares)" } } }, "localname": "TreasuryStockSharesAcquired", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.innovage.com/role/StatementCondensedConsolidatedStatementsOfStockholdersEquity" ], "xbrltype": "sharesItemType" }, "us-gaap_TreasuryStockSharesRetired": { "auth_ref": [ "r22", "r225", "r231" ], "lang": { "en-us": { "role": { "documentation": "Number of shares of common and preferred stock retired from treasury during the period.", "label": "Treasury Stock, Shares, Retired", "verboseLabel": "Treasury stock retirement (in shares)" } } }, "localname": "TreasuryStockSharesRetired", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.innovage.com/role/StatementCondensedConsolidatedStatementsOfStockholdersEquity" ], "xbrltype": "sharesItemType" }, "us-gaap_TreasuryStockValueAcquiredCostMethod": { "auth_ref": [ "r225", "r231", "r233" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Equity impact of the cost of common and preferred stock that were repurchased during the period. Recorded using the cost method.", "label": "Treasury Stock, Value, Acquired, Cost Method", "negatedLabel": "Treasury stock transaction" } } }, "localname": "TreasuryStockValueAcquiredCostMethod", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.innovage.com/role/StatementCondensedConsolidatedStatementsOfStockholdersEquity" ], "xbrltype": "monetaryItemType" }, "us-gaap_TypeOfArrangementAxis": { "auth_ref": [ "r319" ], "lang": { "en-us": { "role": { "documentation": "Information by collaborative arrangement and arrangement other than collaborative applicable to revenue-generating activity or operations.", "label": "Collaborative Arrangement and Arrangement Other than Collaborative [Axis]" } } }, "localname": "TypeOfArrangementAxis", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.innovage.com/role/DisclosureEquityDetails" ], "xbrltype": "stringItemType" }, "us-gaap_VariableInterestEntityEntityMaximumLossExposureAmount": { "auth_ref": [ "r331", "r333" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The reporting entity's maximum amount of exposure to loss as a result of its involvement with the Variable Interest Entity (VIE).", "label": "Variable Interest Entity, Reporting Entity Involvement, Maximum Loss Exposure, Amount", "terseLabel": "Maximum exposure amount in VIE" } } }, "localname": "VariableInterestEntityEntityMaximumLossExposureAmount", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.innovage.com/role/DisclosureInvestmentsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_VariableInterestEntityNotPrimaryBeneficiaryMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Variable Interest Entities (VIE) in which the entity does not have a controlling financial interest (as defined) and of which it is therefore not the primary beneficiary. VIEs of which the entity is not the primary beneficiary because it does not have the power to direct the activities of the VIE that most significantly impact the VIE's economic performance and for which it does not have the obligation to absorb losses of the VIE that could potentially be significant to the VIE or the right to receive benefits from the VIE that could potentially be significant to the VIE are not included in the consolidated financial statements of the entity.", "label": "Variable Interest Entity Not Primary Beneficiary [Member]", "terseLabel": "InnovAge California Pace-Sacramento, LLC" } } }, "localname": "VariableInterestEntityNotPrimaryBeneficiaryMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.innovage.com/role/DisclosureInvestmentsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_VariableInterestEntityOwnershipPercentage": { "auth_ref": [ "r332" ], "lang": { "en-us": { "role": { "documentation": "Percentage of the Variable Interest Entity's (VIE) voting interest owned by (or beneficial interest in) the reporting entity (directly or indirectly).", "label": "Variable Interest Entity, Qualitative or Quantitative Information, Ownership Percentage", "terseLabel": "Partnership interest (as a percent)" } } }, "localname": "VariableInterestEntityOwnershipPercentage", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.innovage.com/role/DisclosureInvestmentsDetails" ], "xbrltype": "percentItemType" }, "us-gaap_WarrantsAndRightsOutstandingTerm": { "auth_ref": [ "r337" ], "lang": { "en-us": { "role": { "documentation": "Period between issuance and expiration of outstanding warrant and right embodying unconditional obligation requiring redemption by transferring asset at specified or determinable date or upon event certain to occur, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.", "label": "Warrants and Rights Outstanding, Term", "terseLabel": "Warrant exercise term" } } }, "localname": "WarrantsAndRightsOutstandingTerm", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.innovage.com/role/DisclosureInvestmentsDetails" ], "xbrltype": "durationItemType" }, "us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment": { "auth_ref": [ "r122" ], "lang": { "en-us": { "role": { "documentation": "The sum of dilutive potential common shares or units used in the calculation of the diluted per-share or per-unit computation.", "label": "Weighted Average Number Diluted Shares Outstanding Adjustment", "terseLabel": "Dilutive shares" } } }, "localname": "WeightedAverageNumberDilutedSharesOutstandingAdjustment", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.innovage.com/role/DisclosureEarningsPerShareDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding": { "auth_ref": [ "r117", "r122" ], "lang": { "en-us": { "role": { "documentation": "The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.", "label": "Weighted Average Number of Shares Outstanding, Diluted", "terseLabel": "Weighted-average number of common shares outstanding - diluted", "verboseLabel": "Weighted average common shares outstanding (diluted)" } } }, "localname": "WeightedAverageNumberOfDilutedSharesOutstanding", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.innovage.com/role/DisclosureEarningsPerShareDetails", "http://www.innovage.com/role/StatementCondensedConsolidatedStatementsOfOperations" ], "xbrltype": "sharesItemType" }, "us-gaap_WeightedAverageNumberOfSharesOutstandingBasic": { "auth_ref": [ "r116", "r122" ], "lang": { "en-us": { "role": { "documentation": "Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.", "label": "Weighted Average Number of Shares Outstanding, Basic", "terseLabel": "Weighted-average number of common shares outstanding - basic", "verboseLabel": "Weighted average common shares outstanding (basic)" } } }, "localname": "WeightedAverageNumberOfSharesOutstandingBasic", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.innovage.com/role/DisclosureEarningsPerShareDetails", "http://www.innovage.com/role/StatementCondensedConsolidatedStatementsOfOperations" ], "xbrltype": "sharesItemType" } }, "unitCount": 8 } }, "std_ref": { "r0": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "205", "URI": "http://asc.fasb.org/extlink&oid=6359566&loc=d3e326-107755" }, "r1": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)", "Topic": "205", "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=d3e1361-107760" }, "r10": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(10))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r100": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "235", "URI": "http://asc.fasb.org/topic&trid=2122369" }, "r101": { "Name": "Accounting Standards Codification", "Paragraph": "23", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=115929471&loc=d3e21914-107793" }, "r102": { "Name": "Accounting Standards Codification", "Paragraph": "24", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=115929471&loc=d3e21930-107793" }, "r103": { "Name": "Accounting Standards Codification", "Paragraph": "27", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=115929471&loc=d3e22044-107793" }, "r104": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=115929471&loc=d3e21711-107793" }, "r105": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)(2)", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22499-107794" }, "r106": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)(3)", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22499-107794" }, "r107": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22694-107794" }, "r108": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22694-107794" }, "r109": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22583-107794" }, "r11": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(11))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r110": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22595-107794" }, "r111": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22644-107794" }, "r112": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22644-107794" }, "r113": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22644-107794" }, "r114": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22658-107794" }, "r115": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22663-107794" }, "r116": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=121326447&loc=d3e1448-109256" }, "r117": { "Name": "Accounting Standards Codification", "Paragraph": "16", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=121326447&loc=d3e1505-109256" }, "r118": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=121326447&loc=d3e1252-109256" }, "r119": { "Name": "Accounting Standards Codification", "Paragraph": "60B", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=121326447&loc=SL5780133-109256" }, "r12": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(12))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r120": { "Name": "Accounting Standards Codification", "Paragraph": "60B", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=121326447&loc=SL5780133-109256" }, "r121": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=121326447&loc=d3e1337-109256" }, "r122": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=6371337&loc=d3e3550-109257" }, "r123": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=6371337&loc=d3e3550-109257" }, "r124": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=6371337&loc=d3e3630-109257" }, "r125": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=109243012&loc=SL65017193-207537" }, "r126": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=120380238&loc=d3e3842-109258" }, "r127": { "Name": "Accounting Standards Codification", "Paragraph": "52", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=120380238&loc=d3e4984-109258" }, "r128": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "260", "URI": "http://asc.fasb.org/topic&trid=2144383" }, "r129": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "272", "URI": "http://asc.fasb.org/extlink&oid=6828210&loc=d3e70191-108054" }, "r13": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(13))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r130": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "272", "URI": "http://asc.fasb.org/extlink&oid=6373374&loc=d3e70478-108055" }, "r131": { "Name": "Accounting Standards Codification", "Paragraph": "18", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "275", "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6351-108592" }, "r132": { "Name": "Accounting Standards Codification", "Paragraph": "18", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6351-108592" }, "r133": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6404-108592" }, "r134": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "275", "URI": "http://asc.fasb.org/topic&trid=2134479" }, "r135": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8657-108599" }, "r136": { "Name": "Accounting Standards Codification", "Paragraph": "18", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8672-108599" }, "r137": { "Name": "Accounting Standards Codification", "Paragraph": "21", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8721-108599" }, "r138": { "Name": "Accounting Standards Codification", "Paragraph": "21", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8721-108599" }, "r139": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8736-108599" }, "r14": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(14))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r140": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8736-108599" }, "r141": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8736-108599" }, "r142": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8736-108599" }, "r143": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8736-108599" }, "r144": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8736-108599" }, "r145": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(g)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8736-108599" }, "r146": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(h)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8736-108599" }, "r147": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(j)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8736-108599" }, "r148": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8736-108599" }, "r149": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8813-108599" }, "r15": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(15))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r150": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8813-108599" }, "r151": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8813-108599" }, "r152": { "Name": "Accounting Standards Codification", "Paragraph": "26", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8844-108599" }, "r153": { "Name": "Accounting Standards Codification", "Paragraph": "30", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8906-108599" }, "r154": { "Name": "Accounting Standards Codification", "Paragraph": "30", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8906-108599" }, "r155": { "Name": "Accounting Standards Codification", "Paragraph": "30", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8906-108599" }, "r156": { "Name": "Accounting Standards Codification", "Paragraph": "30", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8906-108599" }, "r157": { "Name": "Accounting Standards Codification", "Paragraph": "30", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8906-108599" }, "r158": { "Name": "Accounting Standards Codification", "Paragraph": "31", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8924-108599" }, "r159": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8933-108599" }, "r16": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(16))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r160": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8933-108599" }, "r161": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8933-108599" }, "r162": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8933-108599" }, "r163": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8933-108599" }, "r164": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8933-108599" }, "r165": { "Name": "Accounting Standards Codification", "Paragraph": "34", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8981-108599" }, "r166": { "Name": "Accounting Standards Codification", "Paragraph": "40", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e9031-108599" }, "r167": { "Name": "Accounting Standards Codification", "Paragraph": "41", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e9038-108599" }, "r168": { "Name": "Accounting Standards Codification", "Paragraph": "41", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e9038-108599" }, "r169": { "Name": "Accounting Standards Codification", "Paragraph": "42", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e9054-108599" }, "r17": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(17))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r170": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "280", "URI": "http://asc.fasb.org/topic&trid=2134510" }, "r171": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "310", "URI": "http://asc.fasb.org/extlink&oid=121593590&loc=d3e4428-111522" }, "r172": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "310", "URI": "http://asc.fasb.org/extlink&oid=121593590&loc=d3e4531-111522" }, "r173": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "310", "URI": "http://asc.fasb.org/extlink&oid=121611835&loc=d3e5074-111524" }, "r174": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 4.E)", "Topic": "310", "URI": "http://asc.fasb.org/extlink&oid=27010918&loc=d3e74512-122707" }, "r175": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "320", "URI": "http://asc.fasb.org/topic&trid=2196928" }, "r176": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "323", "URI": "http://asc.fasb.org/extlink&oid=109237563&loc=d3e33749-111570" }, "r177": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "323", "URI": "http://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571" }, "r178": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "326", "URI": "http://asc.fasb.org/extlink&oid=121646688&loc=SL121648383-210437" }, "r179": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(e)(3)", "Topic": "326", "URI": "http://asc.fasb.org/extlink&oid=121646688&loc=SL121648383-210437" }, "r18": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(19))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r180": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(e)(4)", "Topic": "326", "URI": "http://asc.fasb.org/extlink&oid=121646688&loc=SL121648383-210437" }, "r181": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Topic": "326", "URI": "http://asc.fasb.org/extlink&oid=121599878&loc=SL82895884-210446" }, "r182": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "326", "URI": "http://asc.fasb.org/extlink&oid=121599337&loc=SL82919249-210447" }, "r183": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "326", "URI": "http://asc.fasb.org/extlink&oid=121599337&loc=SL82919249-210447" }, "r184": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(f)", "Topic": "326", "URI": "http://asc.fasb.org/extlink&oid=121599337&loc=SL82919249-210447" }, "r185": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Topic": "350", "URI": "http://asc.fasb.org/extlink&oid=99380562&loc=d3e13770-109266" }, "r186": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Topic": "350", "URI": "http://asc.fasb.org/extlink&oid=99380562&loc=d3e13777-109266" }, "r187": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Topic": "350", "URI": "http://asc.fasb.org/extlink&oid=120320667&loc=SL49117168-202975" }, "r188": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(e)", "Topic": "350", "URI": "http://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267" }, "r189": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "350", "URI": "http://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267" }, "r19": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(20))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r190": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "350", "URI": "http://asc.fasb.org/extlink&oid=121556970&loc=d3e13854-109267" }, "r191": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "350", "URI": "http://asc.fasb.org/extlink&oid=6388964&loc=d3e16212-109274" }, "r192": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "350", "URI": "http://asc.fasb.org/extlink&oid=6388964&loc=d3e16225-109274" }, "r193": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "((a)(1),(b))", "Topic": "350", "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275" }, "r194": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(a)(1)", "Topic": "350", "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275" }, "r195": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(a)(2)", "Topic": "350", "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275" }, "r196": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(b)", "Topic": "350", "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275" }, "r197": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(b)", "Topic": "350", "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16373-109275" }, "r198": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "350", "URI": "http://asc.fasb.org/topic&trid=2144416" }, "r199": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "360", "URI": "http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229" }, "r2": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "205", "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=SL51721683-107760" }, "r20": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(22))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r200": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "360", "URI": "http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229" }, "r201": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "360", "URI": "http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229" }, "r202": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "360", "URI": "http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229" }, "r203": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "360", "URI": "http://asc.fasb.org/extlink&oid=109226691&loc=d3e2941-110230" }, "r204": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)", "Topic": "360", "URI": "http://asc.fasb.org/extlink&oid=109226691&loc=d3e2941-110230" }, "r205": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "420", "URI": "http://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869" }, "r206": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 5.P.4(d))", "Topic": "420", "URI": "http://asc.fasb.org/extlink&oid=115931487&loc=d3e140904-122747" }, "r207": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "440", "URI": "http://asc.fasb.org/extlink&oid=121559207&loc=d3e25336-109308" }, "r208": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "440", "URI": "http://asc.fasb.org/extlink&oid=121559207&loc=d3e25336-109308" }, "r209": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "440", "URI": "http://asc.fasb.org/topic&trid=2144648" }, "r21": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(28))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r210": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "450", "URI": "http://asc.fasb.org/extlink&oid=121557415&loc=d3e14326-108349" }, "r211": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "450", "URI": "http://asc.fasb.org/topic&trid=2127136" }, "r212": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=6802200&loc=SL6230698-112601" }, "r213": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "25", "SubTopic": "20", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=109126253&loc=d3e4852-112606" }, "r214": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(1)", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=120520924&loc=SL6031897-161870" }, "r215": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(2)", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=120520924&loc=SL6031897-161870" }, "r216": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "40", "SubTopic": "50", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=117329964&loc=d3e12317-112629" }, "r217": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "40", "SubTopic": "50", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=117329964&loc=d3e12355-112629" }, "r218": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "470", "URI": "http://asc.fasb.org/topic&trid=2208564" }, "r219": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "25", "SubTopic": "10", "Topic": "480", "URI": "http://asc.fasb.org/extlink&oid=109262497&loc=d3e20148-110875" }, "r22": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(29))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r220": { "Name": "Accounting Standards Codification", "Paragraph": "3A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(12)(c)", "Topic": "480", "URI": "http://asc.fasb.org/extlink&oid=65877616&loc=SL6540498-122764" }, "r221": { "Name": "Accounting Standards Codification", "Paragraph": "3A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(16)(c)", "Topic": "480", "URI": "http://asc.fasb.org/extlink&oid=65877616&loc=SL6540498-122764" }, "r222": { "Name": "Accounting Standards Codification", "Paragraph": "3A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(3)", "Topic": "480", "URI": "http://asc.fasb.org/extlink&oid=65877616&loc=SL6540498-122764" }, "r223": { "Name": "Accounting Standards Codification", "Paragraph": "3A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "14", "Topic": "480", "URI": "http://asc.fasb.org/extlink&oid=65877616&loc=SL6540498-122764" }, "r224": { "Name": "Accounting Standards Codification", "Paragraph": "3A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "15", "Topic": "480", "URI": "http://asc.fasb.org/extlink&oid=65877616&loc=SL6540498-122764" }, "r225": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=109259400&loc=d3e21463-112644" }, "r226": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=109259400&loc=d3e21475-112644" }, "r227": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=109259400&loc=d3e21506-112644" }, "r228": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=109259400&loc=d3e21521-112644" }, "r229": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=109259400&loc=d3e21538-112644" }, "r23": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(3))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r230": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 4.F)", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=120397183&loc=d3e187085-122770" }, "r231": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.3-04)", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=120397183&loc=d3e187085-122770" }, "r232": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=120397183&loc=d3e187085-122770" }, "r233": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=6405813&loc=d3e23239-112655" }, "r234": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "505", "URI": "http://asc.fasb.org/topic&trid=2208762" }, "r235": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=121604090&loc=SL49130551-203045" }, "r236": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=121604090&loc=SL49130554-203045" }, "r237": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=121604090&loc=SL49130554-203045" }, "r238": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=121604090&loc=SL49130554-203045" }, "r239": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=121604090&loc=SL49130554-203045" }, "r24": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(30)(a)(1))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r240": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=121604090&loc=SL49130554-203045" }, "r241": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)(2)", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=121604090&loc=SL49130556-203045" }, "r242": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=121604090&loc=SL49130558-203045" }, "r243": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=121604090&loc=SL49130543-203045" }, "r244": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=121604090&loc=SL49130545-203045" }, "r245": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=121604090&loc=SL49130550-203045" }, "r246": { "Name": "Accounting Standards Codification", "Paragraph": "91", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=121551570&loc=SL49130690-203046-203046" }, "r247": { "Name": "Accounting Standards Codification", "Paragraph": "91", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=121551570&loc=SL49130690-203046-203046" }, "r248": { "Name": "Accounting Standards Codification", "Paragraph": "91", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=121551570&loc=SL49130690-203046-203046" }, "r249": { "Name": "Accounting Standards Codification", "Paragraph": "91", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=121551570&loc=SL49130690-203046-203046" }, "r25": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(30)(a)(3))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r250": { "Name": "Accounting Standards Codification", "Paragraph": "91", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=121551570&loc=SL49130690-203046-203046" }, "r251": { "Name": "Accounting Standards Codification", "Paragraph": "91", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Subparagraph": "(f)", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=121551570&loc=SL49130690-203046-203046" }, "r252": { "Name": "Accounting Standards Codification", "Paragraph": "91", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Subparagraph": "(g)", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=121551570&loc=SL49130690-203046-203046" }, "r253": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "606", "URI": "http://asc.fasb.org/topic&trid=49130388" }, "r254": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(i)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920" }, "r255": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(n)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920" }, "r256": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "50", "SubTopic": "80", "Subparagraph": "(a)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450702-114947" }, "r257": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "80", "Subparagraph": "(d)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450657-114947" }, "r258": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "80", "Subparagraph": "(a)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450673-114947" }, "r259": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "55", "SubTopic": "80", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=35742348&loc=SL14450788-114948" }, "r26": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(30))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r260": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5047-113901" }, "r261": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5047-113901" }, "r262": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5047-113901" }, "r263": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5047-113901" }, "r264": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(1)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r265": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(3)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r266": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a),(g)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r267": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r268": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(i)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r269": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(i)-(ii)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r27": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(31))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r270": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iv)(3)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r271": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r272": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)(i)-(ii)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r273": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)(iii)(1)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r274": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)(iii)(3)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r275": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r276": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)(1)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r277": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r278": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(2)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r279": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(2)(i)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r28": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(32))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r280": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(2)(ii)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r281": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(2)(iii)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r282": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(g)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r283": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(h)(1)(i)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r284": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(i)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r285": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r286": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333" }, "r287": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(f)(1)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333" }, "r288": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(f)(2)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333" }, "r289": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(g)(2)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333" }, "r29": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(7))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r290": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 14.D.2)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=115993241&loc=d3e301413-122809" }, "r291": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 14.F)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=115993241&loc=d3e301413-122809" }, "r292": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "718", "URI": "http://asc.fasb.org/topic&trid=2228938" }, "r293": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=120406818&loc=d3e31917-109318" }, "r294": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=120406818&loc=d3e31931-109318" }, "r295": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32672-109319" }, "r296": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32687-109319" }, "r297": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32705-109319" }, "r298": { "Name": "Accounting Standards Codification", "Paragraph": "17", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32809-109319" }, "r299": { "Name": "Accounting Standards Codification", "Paragraph": "21", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32857-109319" }, "r3": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "205", "URI": "http://asc.fasb.org/topic&trid=2122149" }, "r30": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(8))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r300": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(d)(2)", "Topic": "740" }, "r301": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(d)(3)", "Topic": "740" }, "r302": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB TOPIC 6.I.5.Q1)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=116825942&loc=d3e330036-122817" }, "r303": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB TOPIC 6.I.7)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=116825942&loc=d3e330036-122817" }, "r304": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 6.I.Fact.4)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=116825942&loc=d3e330036-122817" }, "r305": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 11.C)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=116825942&loc=d3e330215-122817" }, "r306": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=120385591&loc=d3e38679-109324" }, "r307": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "270", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=6424409&loc=d3e44925-109338" }, "r308": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(a)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=6424122&loc=d3e41874-109331" }, "r309": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "740", "URI": "http://asc.fasb.org/topic&trid=2144680" }, "r31": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.1)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r310": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "805", "URI": "http://asc.fasb.org/extlink&oid=79982066&loc=d3e1392-128463" }, "r311": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "805", "URI": "http://asc.fasb.org/extlink&oid=79982066&loc=d3e1392-128463" }, "r312": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "805", "URI": "http://asc.fasb.org/extlink&oid=79982066&loc=d3e1486-128463" }, "r313": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "25", "SubTopic": "30", "Topic": "805", "URI": "http://asc.fasb.org/extlink&oid=6911189&loc=d3e6408-128476" }, "r314": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "30", "SubTopic": "30", "Topic": "805", "URI": "http://asc.fasb.org/extlink&oid=116859721&loc=d3e6578-128477" }, "r315": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "30", "SubTopic": "30", "Topic": "805", "URI": "http://asc.fasb.org/extlink&oid=116859721&loc=d3e6613-128477" }, "r316": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "35", "SubTopic": "30", "Subparagraph": "(b)", "Topic": "805", "URI": "http://asc.fasb.org/extlink&oid=116859824&loc=d3e6819-128478" }, "r317": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(b)", "Topic": "805", "URI": "http://asc.fasb.org/extlink&oid=120321790&loc=d3e6927-128479" }, "r318": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(c)(1)", "Topic": "805", "URI": "http://asc.fasb.org/extlink&oid=120321790&loc=d3e6927-128479" }, "r319": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "808", "URI": "http://asc.fasb.org/extlink&oid=6931272&loc=SL5834143-161434" }, "r32": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.12)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r320": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=108774443&loc=SL4568447-111683" }, "r321": { "Name": "Accounting Standards Codification", "Paragraph": "16", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=108774443&loc=SL4568740-111683" }, "r322": { "Name": "Accounting Standards Codification", "Paragraph": "19", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=108774443&loc=SL4569616-111683" }, "r323": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=116870748&loc=SL6758485-165988" }, "r324": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=116870748&loc=SL6758485-165988" }, "r325": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=109239629&loc=d3e5614-111684" }, "r326": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(1)", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684" }, "r327": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(2)", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684" }, "r328": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684" }, "r329": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(bb)", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=121559654&loc=d3e5710-111685" }, "r33": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.13(a))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r330": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=121559654&loc=d3e5710-111685" }, "r331": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "b", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=121559654&loc=d3e5728-111685" }, "r332": { "Name": "Accounting Standards Codification", "Paragraph": "5A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=121559654&loc=SL6759159-111685" }, "r333": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=121559654&loc=d3e5747-111685" }, "r334": { "Name": "Accounting Standards Codification", "Paragraph": "4I", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=120409616&loc=SL4590271-111686" }, "r335": { "Name": "Accounting Standards Codification", "Paragraph": "4J", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=120409616&loc=SL4591551-111686" }, "r336": { "Name": "Accounting Standards Codification", "Paragraph": "4K", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=120409616&loc=SL4591552-111686" }, "r337": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(bbb)(2)", "Topic": "820", "URI": "http://asc.fasb.org/extlink&oid=117815213&loc=d3e19207-110258" }, "r338": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "820", "URI": "http://asc.fasb.org/extlink&oid=117815213&loc=d3e19207-110258" }, "r339": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(3)", "Topic": "820", "URI": "http://asc.fasb.org/extlink&oid=117815213&loc=d3e19207-110258" }, "r34": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.13)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r340": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "820", "URI": "http://asc.fasb.org/extlink&oid=117815213&loc=d3e19207-110258" }, "r341": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "820", "URI": "http://asc.fasb.org/extlink&oid=117815213&loc=d3e19279-110258" }, "r342": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "825", "URI": "http://asc.fasb.org/extlink&oid=121572278&loc=d3e13531-108611" }, "r343": { "Name": "Accounting Standards Codification", "Paragraph": "21", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "825", "URI": "http://asc.fasb.org/extlink&oid=121572278&loc=d3e13537-108611" }, "r344": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)", "Topic": "825", "URI": "http://asc.fasb.org/extlink&oid=75031198&loc=d3e14064-108612" }, "r345": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "230", "Topic": "830", "URI": "http://asc.fasb.org/extlink&oid=98513438&loc=d3e33268-110906" }, "r346": { "Name": "Accounting Standards Codification", "Paragraph": "17", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "830", "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32136-110900" }, "r347": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Subparagraph": "(a)", "Topic": "830", "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900" }, "r348": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Subparagraph": "(b)", "Topic": "830", "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900" }, "r349": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Subparagraph": "(c)", "Topic": "830", "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900" }, "r35": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.14)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r350": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Subparagraph": "(d)", "Topic": "830", "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900" }, "r351": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Topic": "830", "URI": "http://asc.fasb.org/extlink&oid=6450520&loc=d3e32583-110901" }, "r352": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "835", "URI": "http://asc.fasb.org/extlink&oid=6450988&loc=d3e26243-108391" }, "r353": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "835", "URI": "http://asc.fasb.org/extlink&oid=119993939&loc=d3e28541-108399" }, "r354": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "835", "URI": "http://asc.fasb.org/extlink&oid=119993939&loc=d3e28551-108399" }, "r355": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "835", "URI": "http://asc.fasb.org/extlink&oid=119993939&loc=d3e28555-108399" }, "r356": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "55", "SubTopic": "30", "Topic": "835", "URI": "http://asc.fasb.org/extlink&oid=114775985&loc=d3e28878-108400" }, "r357": { "Name": "Accounting Standards Codification", "Paragraph": "40", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Subparagraph": "(Note 3)", "Topic": "840", "URI": "http://asc.fasb.org/extlink&oid=121580752&loc=d3e38371-112697" }, "r358": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "840", "URI": "http://asc.fasb.org/extlink&oid=121573735&loc=d3e41499-112717" }, "r359": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "840", "URI": "http://asc.fasb.org/extlink&oid=121573735&loc=d3e41502-112717" }, "r36": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.17)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r360": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "840", "URI": "http://asc.fasb.org/extlink&oid=121573735&loc=d3e41502-112717" }, "r361": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "840", "URI": "http://asc.fasb.org/extlink&oid=121569800&loc=d3e45023-112735" }, "r362": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(a)", "Topic": "840", "URI": "http://asc.fasb.org/extlink&oid=121616839&loc=d3e45280-112737" }, "r363": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(b)", "Topic": "840", "URI": "http://asc.fasb.org/extlink&oid=121616839&loc=d3e45280-112737" }, "r364": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "840", "URI": "http://asc.fasb.org/topic&trid=2208923" }, "r365": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "842", "URI": "http://asc.fasb.org/extlink&oid=121603541&loc=SL77918627-209977" }, "r366": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "842", "URI": "http://asc.fasb.org/extlink&oid=121603541&loc=SL77918643-209977" }, "r367": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(g)(1)", "Topic": "842", "URI": "http://asc.fasb.org/extlink&oid=121609121&loc=SL77918686-209980" }, "r368": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "850", "URI": "http://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864" }, "r369": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "850", "URI": "http://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864" }, "r37": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.19(b),22(b))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r370": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "850", "URI": "http://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864" }, "r371": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "850", "URI": "http://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864" }, "r372": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "850", "URI": "http://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864" }, "r373": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "850", "URI": "http://asc.fasb.org/extlink&oid=6457730&loc=d3e39603-107864" }, "r374": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "850", "URI": "http://asc.fasb.org/extlink&oid=6457730&loc=d3e39691-107864" }, "r375": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "850", "URI": "http://asc.fasb.org/topic&trid=2122745" }, "r376": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "855", "URI": "http://asc.fasb.org/extlink&oid=6842918&loc=SL6314017-165662" }, "r377": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "855", "URI": "http://asc.fasb.org/topic&trid=2122774" }, "r378": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)(1)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719" }, "r379": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)(2)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719" }, "r38": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.19,20)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r380": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)(3)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719" }, "r381": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(1)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719" }, "r382": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(2)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719" }, "r383": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(3)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719" }, "r384": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "910", "URI": "http://asc.fasb.org/extlink&oid=119991564&loc=SL119991595-234733" }, "r385": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 11.L)", "Topic": "924", "URI": "http://asc.fasb.org/extlink&oid=6472922&loc=d3e499488-122856" }, "r386": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "340", "Topic": "928", "URI": "http://asc.fasb.org/extlink&oid=6473545&loc=d3e61844-108004" }, "r387": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(a)", "Topic": "932", "URI": "http://asc.fasb.org/extlink&oid=68064819&loc=d3e61929-109447" }, "r388": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(b)", "Topic": "932", "URI": "http://asc.fasb.org/extlink&oid=68064819&loc=d3e61929-109447" }, "r389": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(a)", "Topic": "932", "URI": "http://asc.fasb.org/extlink&oid=68064819&loc=d3e62059-109447" }, "r39": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.19-26)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r390": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(b)", "Topic": "932", "URI": "http://asc.fasb.org/extlink&oid=68064819&loc=d3e62059-109447" }, "r391": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(a)", "Topic": "932", "URI": "http://asc.fasb.org/extlink&oid=68064819&loc=d3e62395-109447" }, "r392": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(b)", "Topic": "932", "URI": "http://asc.fasb.org/extlink&oid=68064819&loc=d3e62395-109447" }, "r393": { "Name": "Accounting Standards Codification", "Paragraph": "33", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(a)", "Topic": "932", "URI": "http://asc.fasb.org/extlink&oid=68064819&loc=d3e62479-109447" }, "r394": { "Name": "Accounting Standards Codification", "Paragraph": "33", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(b)", "Topic": "932", "URI": "http://asc.fasb.org/extlink&oid=68064819&loc=d3e62479-109447" }, "r395": { "Name": "Accounting Standards Codification", "Paragraph": "35A", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(a)", "Topic": "932", "URI": "http://asc.fasb.org/extlink&oid=68064819&loc=SL6807758-109447" }, "r396": { "Name": "Accounting Standards Codification", "Paragraph": "35A", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(b)", "Topic": "932", "URI": "http://asc.fasb.org/extlink&oid=68064819&loc=SL6807758-109447" }, "r397": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(c)(1)", "Topic": "932", "URI": "http://asc.fasb.org/extlink&oid=68064819&loc=d3e61872-109447" }, "r398": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(c)(2)", "Topic": "932", "URI": "http://asc.fasb.org/extlink&oid=68064819&loc=d3e61872-109447" }, "r399": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "SubTopic": "320", "Topic": "940", "URI": "http://asc.fasb.org/subtopic&trid=2176304" }, "r4": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=121566466&loc=d3e6676-107765" }, "r40": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.21)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r400": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(10)(1))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878" }, "r401": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(11))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878" }, "r402": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(13))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878" }, "r403": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(16))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878" }, "r404": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(22))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878" }, "r405": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(23))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878" }, "r406": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03.10)", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878" }, "r407": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03.17)", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878" }, "r408": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03.7(e))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878" }, "r409": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.9-04(13)(f))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260" }, "r41": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.22(a)(1))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r410": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.9-04(22))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260" }, "r411": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.9-04(27))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260" }, "r412": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.9-04.9)", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260" }, "r413": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "235", "Subparagraph": "(SX 210.9-05(b)(2))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120399901&loc=d3e537907-122884" }, "r414": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "SubTopic": "320", "Topic": "942", "URI": "http://asc.fasb.org/subtopic&trid=2209399" }, "r415": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "405", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=6957935&loc=d3e64057-112817" }, "r416": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "470", "Subparagraph": "(c)", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=75038535&loc=d3e64711-112823" }, "r417": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "470", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=75038535&loc=d3e64711-112823" }, "r418": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(16))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910" }, "r419": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(12))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910" }, "r42": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.22)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r420": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(23)(a)(4))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910" }, "r421": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(24))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910" }, "r422": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(25))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910" }, "r423": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(8))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910" }, "r424": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03.(a),19)", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910" }, "r425": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03.5(c))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910" }, "r426": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(10))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263" }, "r427": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(18))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263" }, "r428": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(23))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263" }, "r429": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(9))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263" }, "r43": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.24)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r430": { "Name": "Accounting Standards Codification", "Paragraph": "4H", "Publisher": "FASB", "Section": "50", "SubTopic": "40", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=116884468&loc=SL65671331-158438" }, "r431": { "Name": "Accounting Standards Codification", "Paragraph": "7A", "Publisher": "FASB", "Section": "50", "SubTopic": "40", "Subparagraph": "(d)", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=121643868&loc=SL117782755-158439" }, "r432": { "Name": "Accounting Standards Codification", "Paragraph": "13H", "Publisher": "FASB", "Section": "55", "SubTopic": "40", "Subparagraph": "(a)", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=121639165&loc=SL117783719-158441" }, "r433": { "Name": "Accounting Standards Codification", "Paragraph": "13H", "Publisher": "FASB", "Section": "55", "SubTopic": "40", "Subparagraph": "(c)", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=121639165&loc=SL117783719-158441" }, "r434": { "Name": "Accounting Standards Codification", "Paragraph": "29F", "Publisher": "FASB", "Section": "55", "SubTopic": "40", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=121639165&loc=SL117819544-158441" }, "r435": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(e)", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=121370832&loc=SL117420844-207641" }, "r436": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(f)(1)", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=121370832&loc=SL117420844-207641" }, "r437": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(f)(2)", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=121370832&loc=SL117420844-207641" }, "r438": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(g)(1)", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=121370832&loc=SL117420844-207641" }, "r439": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(g)(2)(i)", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=121370832&loc=SL117420844-207641" }, "r44": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.25)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r440": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(g)(2)(ii)", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=121370832&loc=SL117420844-207641" }, "r441": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(g)(2)(iii)", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=121370832&loc=SL117420844-207641" }, "r442": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(g)(2)(iv)", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=121370832&loc=SL117420844-207641" }, "r443": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(h)(1)", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=121370832&loc=SL117420844-207641" }, "r444": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(h)(2)", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=121370832&loc=SL117420844-207641" }, "r445": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "825", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=99380617&loc=SL75241803-196195" }, "r446": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.6-07.1(c))", "Topic": "946", "URI": "http://asc.fasb.org/extlink&oid=120401555&loc=SL114874292-224272" }, "r447": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "SubTopic": "320", "Topic": "946", "URI": "http://asc.fasb.org/subtopic&trid=2324412" }, "r448": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "360", "Subparagraph": "(d)", "Topic": "958", "URI": "http://asc.fasb.org/extlink&oid=120429125&loc=d3e99779-112916" }, "r449": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "360", "Topic": "958", "URI": "http://asc.fasb.org/extlink&oid=120429125&loc=d3e99893-112916" }, "r45": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.29,30)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r450": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "360", "Subparagraph": "(SX 210.12-28(Footnote 4))", "Topic": "970", "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024" }, "r451": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b" }, "r452": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "d1-1" }, "r453": { "Name": "Form 10-Q", "Number": "240", "Publisher": "SEC", "Section": "308", "Subsection": "a" }, "r454": { "Name": "Forms 10-K, 10-Q, 20-F", "Number": "240", "Publisher": "SEC", "Section": "13", "Subsection": "a-1" }, "r455": { "Name": "Regulation 12B", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b-2" }, "r456": { "Name": "Regulation S-T", "Number": "232", "Publisher": "SEC", "Section": "405" }, "r457": { "Name": "Securities Act", "Number": "7A", "Publisher": "SEC", "Section": "B", "Subsection": "2" }, "r46": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.29-31)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r47": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.3(a)(4))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r48": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.3,4)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r49": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.31)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r5": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=121566466&loc=d3e6676-107765" }, "r50": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.9)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r51": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=SL7669619-108580" }, "r52": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=SL7669625-108580" }, "r53": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(210.5-03(11))", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227" }, "r54": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(12))", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227" }, "r55": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(20))", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227" }, "r56": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(25))", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227" }, "r57": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(4))", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227" }, "r58": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(5))", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227" }, "r59": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(8))", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227" }, "r6": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=121566466&loc=d3e6676-107765" }, "r60": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(b)(2))", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227" }, "r61": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(b)(7)(c))", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227" }, "r62": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(b)(9)(a))", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227" }, "r63": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03)", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227" }, "r64": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.1(e))", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227" }, "r65": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.1,2)", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227" }, "r66": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.18)", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227" }, "r67": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.19)", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227" }, "r68": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.2)", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227" }, "r69": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.4)", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227" }, "r7": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=121566466&loc=d3e6801-107765" }, "r70": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.7)", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227" }, "r71": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.9)", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227" }, "r72": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3213-108585" }, "r73": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3213-108585" }, "r74": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3255-108585" }, "r75": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3255-108585" }, "r76": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3255-108585" }, "r77": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3291-108585" }, "r78": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3291-108585" }, "r79": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3291-108585" }, "r8": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=121566466&loc=d3e6812-107765" }, "r80": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(g)", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3291-108585" }, "r81": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3291-108585" }, "r82": { "Name": "Accounting Standards Codification", "Paragraph": "17", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3367-108585" }, "r83": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3000-108585" }, "r84": { "Name": "Accounting Standards Codification", "Paragraph": "24", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3521-108585" }, "r85": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3536-108585" }, "r86": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(f)", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3536-108585" }, "r87": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3536-108585" }, "r88": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3602-108585" }, "r89": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3602-108585" }, "r9": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(1))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r90": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3602-108585" }, "r91": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3044-108585" }, "r92": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=121583591&loc=d3e4297-108586" }, "r93": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=121583591&loc=SL98516268-108586" }, "r94": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "235", "URI": "http://asc.fasb.org/extlink&oid=84158767&loc=d3e18780-107790" }, "r95": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(e)(1))", "Topic": "235", "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690" }, "r96": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(g)(1)(ii))", "Topic": "235", "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690" }, "r97": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(h))", "Topic": "235", "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690" }, "r98": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(k))", "Topic": "235", "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690" }, "r99": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08.(e),(f))", "Topic": "235", "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690" } }, "version": "2.1" } ZIP 85 0001558370-22-008163-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0001558370-22-008163-xbrl.zip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�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end